Table of Contents - Issue

Recent articles
-
Lactation Education as an Important Tool for Infant Nutrition and Maternal HealthAuthor: Shenel FreemanDOI: 10.21522/TIJPH.2013.13.01.Art001
Lactation Education as an Important Tool for Infant Nutrition and Maternal Health
Abstract:
Background: Numerous social and medical institutions encourage breastfeeding education and ensure that the WHO recommendations are followed. However, the postpartum period is associated with a great number of psychological challenges, which can contribute to the effectiveness of specific programs or invalidate their effects. Unfortunately, too many programs disregard the importance of the psychological aspects and mainly the underlying beliefs of the females on the education outcomes. It is crucial to consider lactation education from the perspective of the mothers as the target audience. Purpose: The current research focused on how the beliefs of young first-time mothers and their attitudes to different types of sessions influenced the well-being of these mothers and their kids. Methods: The current quantitative research analyzed and compared the perceived effects that different types of lactation education can have on mother’s and infant’s well-being. Results: According to the results, education with the psychological component was associated with higher scores and higher perceived benefits by first-time mothers. Factor 1 (Psychological Education Perception) reveals that factors were “Not Normally Distributed” (p < 0.05). Factors 2, 3, and 4 were Normally Distributed (p > 0.05). ANOVA Results for Normally Distributed Factors revealed no significant difference between groups for Factor 2,3,4. Kruskal-Wallis Test for Non-Normal Factors revealed a highly significant difference (p < 10⁻¹⁶⁰) for Factor 1. Conclusion: Generally, it becomes clear that psychological aspects have a strong impact on perceptions of education value. In contrast, education challenges, mental health benefits, and infant well-being perceptions do not depend on the presence or absence of any mental health training. This suggests that mothers who received psychological education perceived their learning experience as more valuable and were more motivated to accept the support and education and learn all relevant materials properly.
Lactation Education as an Important Tool for Infant Nutrition and Maternal Health
References:
[1]. WHO, 2023, Breastfeeding education for increased breastfeeding duration. Date of access: 30/01/2025. https://www.who.int/tools/elena/interventions/breastfeeding-education
[2]. Mitchell, K. B., & Johnson, H. M., 2022, Challenges in the management of breast conditions during lactation. Obstetrics and Gynecology Clinics, 49(1), 35-55.
[3]. Sarı, E., Akcaboy, M., Özturk, S., Çoban, G., & Şenel, S., 2022, Breastfeeding education in a newly organized lactation consultation clinic: an evaluation of its effects on the improvement of maternal attitudes to breastfeeding. Turkish Archives of Pediatrics, 57(3), 290.
[4]. Ashour, E. S., El-Sayed Amr, T. E. S., Alenezi, A., & Mohamed Awed, H. A. E. L., 2023, Effect of maternal insomnia on postpartum self-care efficacy among primiparous women. Assiut Scientific Nursing Journal, 11(36), 65-78.
[5]. Minamida, T., Iseki, A., Sakai, H., Imura, M., Okano, T., & Tanii, H., 2020, Do postpartum anxiety and breastfeeding self‐efficacy and bonding at early postpartum predict postpartum depression and the breastfeeding method? Infant Mental Health Journal, 41(5), 662-676.
[6]. Mikšić, Š., Uglešić, B., Jakab, J., Holik, D., Milostić Srb, A., & Degmečić, D., 2020, Positive effect of breastfeeding on child development, anxiety, and postpartum depression. International Journal of Environmental Research and Public Health, 17(8), 2725.
[7]. Donegan, T., 2022, Mindful responding in a crisis. In: Mindfulness in the Birth Sphere, edited by L. Davies and S. Crowther (Routledge), pp. 211-231.
[8]. Qin, X., Liu, C., Zhu, W., Chen, Y., & Wang, Y., 2022, Preventing postpartum depression in the early postpartum period using an app-based cognitive behavioral therapy program: a pilot randomized controlled study. International Journal of Environmental Research and Public Health, 19(24), 16824.
[9]. Rajapakshe, W., Wickramasurendra, A. K., Amarasinghe, R. R., Wijerathne, S. L. M. K. A., Wijesinghe, N. D., & Madhavika, N., 2024, Application of the Health Belief Model (HBM) to explore the quality of sexual and reproductive health (SRH) education in Sri Lanka. International Journal of Environmental Research and Public Health, 21(12), 1703.
[10]. Khani Jeihooni, A., Mohammadkhah, F., Razmjouie, F., Harsini, P. A., & Sedghi Jahromi, F., 2022, Effect of educational intervention based on health belief model on mothers monitoring growth of 6–12 months child with growth disorders. BMC pediatrics, 22(1), 561.
[11]. Xu, A., Baysari, M. T., Stocker, S. L., Leow, L. J., Day, R. O., & Carland, J. E., 2020, Researchers’ views on, and experiences with, the requirement to obtain informed consent in research involving human participants: a qualitative study. BMC Medical Ethics, 21, 1-11.
[12]. Fakhar, H., Lamrabet, M., Echantoufi, N., El Khattabi, K., & Ajana, L., 2024, Artificial intelligence from teachers’ perspectives and understanding: Moroccan study. International Journal of Information and Education Technology, 14(6), 856-862.
[13]. Tseng, J. F., Chen, S. R., Au, H. K., Chipojola, R., Lee, G. T., Lee, P. H., & Kuo, S. Y., 2020, Effectiveness of an integrated breastfeeding education program to improve self-efficacy and exclusive breastfeeding rate: a single-blind, randomised controlled study. International Journal of Nursing Studies, 111, 103770.
[14]. Bednarek, A., Bodys-Cupak, I., Serwin, A., & Cipora, E., 2023, Mothers’ attitudes towards breastfeeding in terms of health safety and professional lactation education: a national survey of women. Journal of Multidisciplinary Healthcare,3273-3286.
[15]. Bell, E., Hunter, C., Benitez, T., Uysal, J., Walovich, C., McConnell, L., & Wang, M., 2022, Intervention strategies and lessons learned from a student-led initiative to support lactating women in the university setting. Health Promotion Practice, 23(1), 154-165.
[16]. Campbell, S. H., de Oliveira Bernardes, N., Tharmaratnam, T., & Mendonca Vieira, F. V., 2022, Educational resources and curriculum on lactation for health undergraduate students: a scoping review. Journal of Human Lactation, 38(1), 89-99.
[17]. Gorbunova, T., Segadelli, J., Anderson, N., & Ciupitu-Plath, C., 2023, Could education be the best galactagogue? Development and content validation of provider and patient checklists to promote lactation among Black parents. Journal of Human Lactation, 39(3), 500-504.
[18]. Francis, J., Mildon, A., Stewart, S., Underhill, B., Tarasuk, V., Di Ruggiero, E., & O'Connor, D. L., 2020, Vulnerable mothers' experiences breastfeeding with an enhanced community lactation support program. Maternal & Child Nutrition, 16(3), e12957.
[19]. Bonsu, A. B., Dzomeku, V. M., Apiribu, F., Obiri-Yeboah, S., Asamoah, B., Mensah, K. B., & Donkor, P., 2018. Having a child with orofacial cleft: Initial reaction and psychosocial experiences of Ghanaian mothers. International Journal of Africa Nursing Sciences, 8, 132-140.
[20]. Chrzan-Dętkoś, M., Walczak-Kozłowska, T., & Lipowska, M., 2021, The need for additional mental health support for women in the postpartum period in the times of epidemic crisis. BMC Pregnancy and Childbirth, 21, 1-9.
Viewed PDF 32 2 -
Overcoming Barriers to Telehealth: A Study on Smartphone Consultation Services in Nairobi Using the UTAUT FrameworkAuthor: Adeiza Ben AdinoyiDOI: 10.21522/TIJPH.2013.13.01.Art002
Overcoming Barriers to Telehealth: A Study on Smartphone Consultation Services in Nairobi Using the UTAUT Framework
Abstract:
The rapid expansion of the mobile market has catalysed significant advancements in healthcare through the development of smartphone-based consultation services. This study investigates factors influencing healthcare professionals' adoption and usage of these services in Nairobi, Kenya, leveraging the Unified Theory of Acceptance and Use of Technology (UTAUT). We collected quantitative data via a structured online survey from 48 healthcare providers actively involved in telemedicine. Our analysis identified key determinants: performance expectancy, effort expectancy, social influence, and facilitating conditions. The results revealed that performance expectancy and social influence positively influenced the behavioural intention to adopt smartphone-based consultations, while effort expectancy had a negative impact. Gender, age, experience, and voluntary usage were significant moderators. The regression analysis indicated that the younger, the more experienced, and the female healthcare providers showed higher intentions to adopt these technologies. Despite infrastructure and regulatory challenges, the widespread use of smartphones in Kenya provides a promising platform for enhancing healthcare delivery. The findings highlight the need for targeted training and awareness programs, alongside clear regulatory frameworks, to overcome adoption barriers. This study offers localised insights into telemedicine adoption, highlighting the potential of smartphone-based consultation services to alleviate healthcare system burdens and improve access, particularly in urban and underserved regions. These insights are crucial for policymakers, healthcare providers, and technology developers aiming to enhance telemedicine adoption and integration in Nairobi and similar contexts.
Overcoming Barriers to Telehealth: A Study on Smartphone Consultation Services in Nairobi Using the UTAUT Framework
References:
[1]. Nopany, S., & Manonmani, S., 2021, Applications of big data analytics in healthcare management systems. International Journal of Scientific Research and Engineering Development, 4(4).
[2]. Andrushchak, V., & Sheremetieva, D., 2024, Data science in healthcare: Top 7 feasible applications. Data Science in Healthcare.
[3]. Onsongo, S., & Kagotho, E., 2024, Telemedicine in Africa: Applications, opportunities, and challenges. A Comprehensive Overview of Telemedicine [Working Title], doi: 10.5772/intechopen.1005094.
[4]. Mbunge, E., Muchemwa, B., & Batani, J., 2022, Are we there yet? Unbundling the potential adoption and integration of telemedicine to improve virtual healthcare services in African health systems. Sensors International, 3, 100152, doi: 10.1016/j.sintl.2021.100152.
[5]. Darcourt, J. G., et al., 2021, Analysis of the implementation of telehealth visits for care of patients with cancer in Houston during the COVID-19 pandemic. JCO Oncol Pract, 17(1), e36–e43, doi: 10.1200/OP.20.00572.
[6]. Okoroafor, I. J., Chukwuneke, F. N., & Ifebunandu, N., 2017, Telemedicine and biomedical care in Africa: Prospects and challenges. Niger J Clin Pract, 20, 1–5.
[7]. Dodoo, J. E., Al-Samarraie, H., & Alsswey, A., 2022, The development of telemedicine programs in Sub-Saharan Africa: progress and associated challenges. Health Technol, 12(1), 33–46, doi: 10.1007/s12553-021-00626-7.
[8]. Davis, F. D., 1989, Perceived usefulness, perceived ease of use, and user acceptance of Information Technology. MIS Quarterly, 13(3), 319–340, doi: 10.2307/249008.
[9]. Granić, A., & Marangunić, N., 2019, Technology acceptance model in educational context: A systematic literature review. British Journal of Educational Technology, 50(5), 2572–2593, doi: 10.1111/bjet.12864.
[10]. Marikyan, D., & Papagiannidis, S., 2023, Technology Acceptance Model: A review. In S. Papagiannidis (Ed), TheoryHub Book, https://open.ncl.ac.uk, ISBN: 9781739604400.
[11]. Gu, D., et al., 2021, Assessing the adoption of e-health technology in a developing country: An extension of the UTAUT model. Sage Open, 11(3), 1–16, doi: 10.1177/21582440211027565.
[12]. Rouidi, M., Elouadi, A. E., Hamdoune, A., Choujtani, K., & Chati, A., 2022, TAM-UTAUT and the acceptance of remote healthcare technologies by healthcare professionals: A systematic review. Inform Med Unlocked, 32, 101008, doi: 10.1016/j.imu.2022.101008.
[13]. Cobelli, N., Cassia, F., & Donvito, R., 2023, Pharmacists’ attitudes and intention to adopt telemedicine: Integrating the market-orientation paradigm and the UTAUT. Technol Forecast Soc Change, 196, 122871, doi: 10.1016/j.techfore.2023.122871.
[14]. Abdekhoda, M., Dehnad, A., & Zarei, J., 2022, Factors influencing adoption of e-learning in healthcare: Integration of UTAUT and TTF model. BMC Med Inform Decis Mak, 22(1), 327, doi: 10.1186/s12911-022-02060-9.
[15]. Njoroge, M., Zurovac, D., Ogara, E. A., Chuma, J., & Kirigia, D., 2017, Assessing the feasibility of eHealth and mHealth: a systematic review and analysis of initiatives implemented in Kenya. BMC Res Notes, 10(1), 90, doi: 10.1186/s13104-017-2416-0.
[16]. Onsongo, S., & Kagotho, E., 2024, Telemedicine in Africa: Applications, opportunities, and challenges. A Comprehensive Overview of Telemedicine [Working Title], doi: 10.5772/intechopen.1005094.
[17]. Jaguga, F., & Kwobah, E., 2020, Mental health response to the COVID-19 pandemic in Kenya: A review. Int J Ment Health Syst, 14(1), 1–6, doi: 10.1186/S13033-020-00400-8.
[18]. Chitungo, I., Mhango, M., Mbunge, E., Dzobo, M., Musuka, G., & Dzinamarira, T., 2021, Utility of telemedicine in sub-Saharan Africa during the COVID-19 pandemic. Hum Behav Emerg Technol, 5, 843–853, doi: 10.1002/hbe2.297.
[19]. Venkatesh, V., Thong, J. Y. L., Chan, F. K. Y., Hu, P. J. H., & Brown, S. A., 2011, Extending the two-stage information systems continuance model: Incorporating UTAUT predictors and the role of context. Information Systems Journal, 29(1), 150–175.
[20]. Williams, M. D., Rana, N. P., & Dwivedi, Y. K., 2015, The unified theory of acceptance and use of technology (UTAUT): A literature review. Journal of Enterprise Information Management, 28(3), 443–488.
[21]. Chao, C. M., 2019, Factors determining the behavioral intention to use mobile learning: An application and extension of the UTAUT model. Front Psychol, 10, 1652, doi: 10.3389/fpsyg.2019.01652.
[22]. Al-Maroof, R. S., Alshurideh, M. T., Salloum, S. A., & Al-Enezi, A., 2018, The acceptance of google classroom among students: An exploratory study using PLS-SEM approach. In International Conference on Advanced Machine Learning Technologies and Applications, Cham: Springer, 59–70, doi: 10.1007/978-3-030-42358-5_6.
[23]. Dwivedi, Y. K., Rana, N. P., Jeyaraj, A., Clement, M., & Williams, M. D., 2019, Re-examining the Unified Theory of Acceptance and Use of Technology (UTAUT): Towards a revised theoretical model. Information Systems Frontiers, 21(3), 719–734, doi: 10.1007/s10796-017-9774-y.
[24]. Ly, B., & Ly, R., 2022, Internet banking adoption under Technology Acceptance Model—Evidence from Cambodian users. Computers in Human Behavior Reports, 7, 100224, doi: 10.1016/j.chbr.2022.100224.
[25]. Oliveira, T., Thomas, M., Baptista, G., & Campos, F., 2017, Mobile payment: Understanding the determinants of customer adoption and intention to recommend the technology. Comput Human Behav, 61, 404–414.
[26]. Scherer, R., Siddiq, F., & Tondeur, J., 2019, The technology acceptance model (TAM): A meta-analytic structural equation modeling approach to explaining teachers’ adoption of digital technology in education. Comput Educ, 128, 13–35, doi: 10.1016/j.compedu.2018.09.009.
Viewed PDF 23 0 -
Influence of Acid and Alkali Surface Modifications on Titanium Implants: Enhancing Osseointegration and Osteoblast DifferentiationAuthor: Palati SindujaDOI: 10.21522/TIJPH.2013.13.01.Art003
Influence of Acid and Alkali Surface Modifications on Titanium Implants: Enhancing Osseointegration and Osteoblast Differentiation
Abstract:
Titanium implants are widely used in biomedical applications due to their excellent biocompatibility and mechanical properties. However, achieving optimal osseointegration remains a challenge. Surface modification techniques, such as acid etching and alkali etching, have been shown to improve implant surface properties, including roughness and chemistry, thereby enhancing cellular adhesion and modulating molecular pathways critical for bone formation. This study evaluated titanium implant surfaces modified using acid etching and alkali etching. Surface topographies were characterized using scanning electron microscopy (SEM), revealing distinct morphologies. Acid-etched surfaces exhibited uniformly roughened structures, while alkali-etched surfaces showed smoother textures with pits. Chemical composition analysis, performed using X-ray photoelectron spectroscopy (XPS), indicated significant alterations, including the formation of bioactive layers that enhance implant integration. In vitro experiments demonstrated that acid-etched surfaces significantly promoted osteoblast adhesion and differentiation compared to alkali-etched surfaces. This was supported by the upregulation of osteogenic molecular markers such as Runx2, SP7, and DLX5, which are vital for bone formation. These findings suggest that acid etching enhances the biological performance of titanium implants, facilitating cellular behaviours necessary for successful osseointegration. In conclusion, acid etching and alkali etching are effective methods for improving titanium implant surfaces, with acid-etched surfaces showing superior potential in promoting osteoblast differentiation and adhesion. Further research is needed to investigate the long-term clinical impact of these surface modifications to optimize implant success and durability.
Influence of Acid and Alkali Surface Modifications on Titanium Implants: Enhancing Osseointegration and Osteoblast Differentiation
References:
[1]. Sivakumar, N. K., Palaniyappan, S., Sekar, V., Alodhayb, A., & Braim, M. 2023. An optimization approach for studying the effect of lattice unit cell’s design-based factors on additively manufactured poly methyl methacrylate cranio-implant. Journal of the Mechanical Behavior of Biomedical Materials, 141(105791), 105791. https://doi.org/10.1016/j.jmbbm.2023.105791
[2]. Patil, S., Bhandi, S., Alzahrani, K. J., Alnfiai, M. M., Testarelli, L., Soffe, B. W., Licari, F. W., Awan, K. H., & Tanaka, E. 2023. Efficacy of laser in re-osseointegration of dental implants-a systematic review. Lasers in Medical Science, 38(1), 199. https://doi.org/10.1007/s10103-023-03860-9
[3]. Madhu, K., Kannan, S., Perumal, A., & Shanmugam, P. 2023. Biofunctionalized nanocomposite coating on Cp-titanium with reduce implant failures. Vacuum, 215(112328), 112328. https://doi.org/10.1016/j.vacuum.2023.112328
[4]. Raval, A., S Yadav, N., Narwani, S., Somkuwar, K., Verma, V., Almubarak, H., Alqahtani, S. M., Tasleem, R., Luke, A. M., Kuriadom, S. T., & Karobari, M. I. 2023. Antibacterial efficacy and surface characteristics of boron nitride coated dental implant: An in-vitro study. Journal of Functional Biomaterials,ss 14(4). https://doi.org/10.3390/jfb14040201
[5]. Duraisamy, R., Ganapathy, D. and Shanmugam, R., 2021. Applications of chitosan in dental implantology-A literature review. Int. J. Dent. Oral Sci, 8, pp.4140-4146.
https://doi.org/10.19070/2377-8075-21000846
[6]. Groner, Y., Ito, Y., Liu, P., Neil, J. C., Speck, N. A., & van Wijnen, A. 2017. RUNX Proteins in Development and Cancer. Springer. https://play.google.com/store/books/details?id=1pNcDgAAQBAJ
[7]. Biosynthesis of Vitex-negundo mineralized hydroxyapatite coating on Ti for implant applications. (n.d.).
[8]. Liu, L., Luo, P., Liao, H., Yang, K., Yang, S., & Tu, M., 2024. Effects of aligned PLGA/SrCSH composite scaffolds on in vitro growth and osteogenic differentiation of human mesenchymal stem cells. Journal of Biomedical Materials Research. Part B, Applied Biomaterials, 112(1), e35366. https://doi.org/10.1002/jbm.b.35366
[9]. Pederson, E. D., Lamberts, B. L., NAVAL DENTAL RESEARCH INST GREAT LAKES IL., & Naval Dental Research Institute (U.S.)., 1989. Effect of Root-Surface Modification of Human Teeth on Adherence of Fibronectin. https://books.google.com/books/about/Effect_of_Root_Surface_Modification_of_H.html?hl=&id=xujdNwAACAAJ
[10]. Adden, N., 2006. Modification of Titanium to Generate Biocompatible and Bioactive Implant Surfaces. https://books.google.com/books/about/Modification_of_Titanium_to_Generate_Bio.html?hl=&id=OAoBPwAACAAJ
[11]. Kim, K.-H., Narayanan, R., & Rautray, T. R., 2010. Surface Modification of Titanium for Biomaterial Applications. https://books.google.com/books/about/Surface_Modification_of_Titanium_for_Bio.html?hl=&id=Ii0cQgAACAAJ
[12]. Omoniala, K., 2016. Surface Modification Strategies for Antimicrobial Titanium Implant Materials with Enhanced Osseointegration. https://books.google.com/books/about/Surface_Modification_Strategies_for_Anti.html?hl=&id=cjcbvwEACAAJ
[13]. Abdulla, M. A., Hasan, R. H., & Al-Hyani, O. H. 2023. Impact of Er,Cr:YSGG Laser, Sandblast, and Acid Etching Surface Modification on Surface Topography of Biodental Titanium Implants. Journal of Lasers in Medical Sciences, 14, e38. https://doi.org/10.34172/jlms.2023.38
[14]. Baima, G., Romano, F., Roato, I., Mosca Balma, A., Pedraza, R., Faga, M. G., Amoroso, F., Orrico, C., Genova, T., Aimetti, M., & Mussano, F. 2024. Efficacy of a Solution Containing 33% Trichloroacetic Acid and Hydrogen Peroxide in Decontaminating Machined vs. Sand-Blasted Acid-Etched Titanium Surfaces. Journal of Functional Biomaterials, 15(1). https://doi.org/10.3390/jfb15010021
[15]. Ochi, Y., Yoshida, K., Huang, Y.-J., Kuo, M.-C., Nannya, Y., Sasaki, K., Mitani, K., Hosoya, N., Hiramoto, N., Ishikawa, T., Branford, S., Shanmuganathan, N., Ohyashiki, K., Takahashi, N., Takaku, T., Tsuchiya, S., Kanemura, N., Nakamura, N., Ueda, Y., … Shih, L.-Y., 2021. Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia. Nature Communications, 12(1), 2833. https://doi.org/10.1038/s41467-021-23097-w
[16]. Albrektsson, T., Tengvall, P., Amengual, L., Coli, P., Kotsakis, G. A., & Cochran, D. 2022. Osteoimmune regulation underlies oral implant osseointegration and its perturbation. Frontiers in Immunology, 13, 1056914. https://doi.org/10.3389/fimmu.2022.1056914
[17]. Li, H. 2007. Functional Studies of Dlx5 During Bone Formation: Implications of Dlx Genes in Promoting Osteoblast Differentiation. https://books.google.com/books/about/Functional_Studies_of_Dlx5_During_Bone_F.html?hl=&id=iHXezQEACAAJ
[18]. Liao, T., Xu, X., Wu, J., Xie, Y., & Yan, J. 2023. Increased expression levels of DLX5 inhibit the development of the nervous system. International Journal of Developmental Neuroscience: The Official Journal of the International Society for Developmental Neuroscience, 83(8), 728–739. https://doi.org/10.1002/jdn.10300
Viewed PDF 40 1 -
Prevalence and Risk Factors for Obesity among Pregnant Women Managed at a Public Tertiary Health Facility, Southwest, NigeriaAuthor: Taofeek Adedayo SanniDOI: 10.21522/TIJPH.2013.13.01.Art004
Prevalence and Risk Factors for Obesity among Pregnant Women Managed at a Public Tertiary Health Facility, Southwest, Nigeria
Abstract:
Maternal obesity hurts pregnancy and pregnancy outcomes through increased morbidities in the antenatal period, increased intrapartum interventions and post-partum complications. This study was undertaken to determine the prevalence and risk factors for obesity among pregnant women managed at a Pub lic Tertiary Health Facility, in Southwest, Nigeria. This study is a hospital-based cross-sectional study carried out among 160 pregnant women at the Department of Obstetrics and Gynaecology, Federal Medical Centre, Abeokuta who booked in the first half of pregnancy at the hospital and who presented in labour. Booking weights and heights were extracted from the case note and were used to calculate the body mass index (BMI) which was thereafter classified based on the World Health Organization (WHO) criteria. The labour of respondents was monitored closely, ethical approval was gotten from the Hospital’s Health Research and Ethics Board and written informed consent was taken from patients. Data was obtained using a semi-structured questionnaire and analyzed using IBM SPSS version 23. P-value <0.05 was taken as significant. The prevalence of maternal obesity was 24.4% and the risk factors found by this study that were statistically significant (P<0.05) with obesity are advanced maternal age, increasing parity and self-reported satisfactory income. In conclusion, a quarter of pregnant women in this study were obese and some of its risk factors have been identified. It is recommended that awareness and health education programmes especially as regards the negative effects of obesity and strategies to help pregnant women maintain a normal weight should be intensified at the antenatal clinics.
Prevalence and Risk Factors for Obesity among Pregnant Women Managed at a Public Tertiary Health Facility, Southwest, Nigeria
References:
[1]. Klufio, C. A., Kwakwukume, E. Y., Emuveyan, E. E., 2002, Obesity in Pregnancy. Comprehensive Obstetrics in the Tropics, 1st Edition, Asante and Hittsher printing press limited, Dansoman, Ghana; 219-225.
[2]. WHO, 2000, Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation, WHO Technical Report, Series No. 894, Geneva.
[3]. NCEP, 2001, Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA, 16, 285(19), 2486-97, doi: 10.1001/jama.285.19.2486. PMID: 11368702.
[4]. Broberger, C., Johansen, J., Johansson, C., Schalling, M., Hukfelt, T., 1998, The Neuropeptide Y/agouti Gene-related Protein (AGRP) Brain Circuitry in Normal, Anorexic and Monosodium Glutamate-Treated Mice, Proc. Nati Acad Sci; 95, 150
[5]. Hill, J. O., Wyatt, H. R., Reed, G. W., Peters, J. C., 2003, Obesity and the Environment: Where Do We Go from Here? Science, 299, 853-855.
[6]. WHO, 2014, World Obesity Day 2022 – Accelerating action to stop obesity, New Release.
[7]. ACOG, 2013, Weight Gain during Pregnancy, American College of Obstetricians and Gynecologists (ACOG) Committee opinion No. 548, Obstet Gynecol, 121(1), 210-212, doi: 10.1097/01.aog.0000425668.87506.4c. PMID: 23262962.
[8]. Ruager – Martin, R., Hyde, M. J., Modi. N., 2010, Maternal Obesity and Infant Outcomes, Early Hum Dev, 86, 715-722.
[9]. Bhattacharya, S., Campbell, D. M., Liston, W. A., 2007, Effect of Body Mass Index on Pregnancy Outcomes in Nulliparous Women Delivering Singleton Babies, BMC Public Health, 7, 168.
[10]. Lu, G. C., Rouse, D. J., Dubard, M., Chiver, S., Kimberlin, D., Haulth, J. C., 2001, The Effect of the Increasing Prevalence of Maternal Obesity on Perinatal Morbidity, Am J Obstet Gynecol, 185(4), 845-849.
[11]. El-Gilany, A., El-wehady, A., 2009, Prevalence of Obesity in a Saudi Obstetrics Population, Obes Facts, 2, 217-20.
[12]. Ugwuja, E. l., Akubugwo, E. I., Obidoa, O., Ibiam, A. U., 2010, Maternal BMI during pregnancy: Effect of trace elements status and pregnancy outcomes, Int J Health Res, 3, 71-8.
[13]. Callaway, L. K., Prins, J. B., Chang, A. M., McIntyre, H. D., 2006, The Prevalence and Impact of Overweight and Obesity in an Australian Obstetrics Population, Med J Aust, 184, 56-9
[14]. FGN, 2009, Federal Republic of Nigeria Official Gazette, Vol 96 (2), 36
[15]. Araoye, M. O., 2004, Subject Selection in Research Methodology with Statistics for Health and Social Sciences, 1st edition Nathadex Publishers Nigeria, 115-129.
[16]. Ezeanochie, M. C., Ande, A. B., Olagbuji, B. N., 2011, Maternal Obesity in Early Pregnancy and Subsequent Pregnancy Outcome in a Nigerian Population, African Journal of Reproductive Health, 15(4), 55-59.
[17]. Olayemi, O. O., Umuerri, C. O., Aimakhu, C. O., 2002, Obstetrics Performance of Nigeria Obese Parturients, Trop J Obstet Gynaecol, 19, 17-20
[18]. Chigbu, C. O., Aja, L. O., 2011, Obesity in Pregnancy in South-East Nigeria, Ann Med Health Sci Res, 1(2), 135-140.
[19]. Ajen, S. A., Achara, A. P., Akaba, G. O., Yakubu, E. N., 2014, Prevalence and Risk factors for Obesity in a Nigerian Obstetric Population, American Journal of Health Research, 2(5), 229-233
[20]. Duda, R. B., Darko, R., Seffah, J., Adanu, R. M., Anarfi, J. K., Hill, A. G., 2007, Prevalence of Obesity in Women of Accra Ghana, Afr. J. Health Sci., 14, 154-159.
[21]. Agwara, E. O., Tendongfor, N., Jaja, P. T., Choy, A. M., Egbe, T.O., 2023, Prevalence and Pregnant Women’s Knowledge of Maternal Obesity and Excessive Gestational Weight Gain among Women Attending Antenatal Care in Fako Division Cameroon, The Pan African Medical Journal, 44, https://doi.org/10.11604/pamj.2023.44.2.36592
[22]. AlAnnaz, W. A., Gouda, A. D., Ahmed, F., Alanazi, M. R., 2024, Obesity Prevalence and Its Impact on Maternal and Neonatal Outcomes among Pregnant Women: A Retrospective Cross-Sectional Study Design, Nursing Reports, 14(2), 1236-1250. https://doi.org/10.3390/nursrep14020094
[23]. Kirkegaard, H., Stovring, H., Rasmussen, K. M., Abrams, B., Sørensen, T. I., Nohr, E. A., 2014, How Do Pregnancy-Related Weight Changes and Breastfeeding Relate to Maternal Weight and BMI-Adjusted Waist Circumference 7 Years After Delivery? Results From a Path Analysis, Am J Clin Nutr, 99(2), 312-9. doi: 10.3945/ajcn.113.067405. Epub 2013 Dec 11. PMID: 24335054; PMCID: PMC7289327
[24]. Hajiahmadi, M., Shafi, H., Delavar, M. A., 2014, Impact of Parity on Obesity; A Cross-sectional Study in Iranian Women, Med Princ Pract, 245, 1-10
[25]. American Society for Clinical Nutrition, 2008, Consequences of Smoking for Body Weight Fat Distribution and Insulin Resistance, Am J Clin Nutr, 87(4), 801-809.
[26]. Romy, G., Busra, D., Albert, H., Johan, P. M., Eric, A. P., Vincent, W. V. J., 2013, Risk Factors and Outcomes of Maternal Obesity and Excessive Weight Gain During Pregnancy, Obesity Journal, 21, 1046-1055.
Viewed PDF 23 0 -
Complex Treatment of Proliferative Diabetic Retinopathy with Focal Photocoagulation of Diabetic Macular Edema in Oldest-Old Female: A Clinicopathologic Case ReportAuthor: Suganya MDOI: 10.21522/TIJPH.2013.13.01.Art005
Complex Treatment of Proliferative Diabetic Retinopathy with Focal Photocoagulation of Diabetic Macular Edema in Oldest-Old Female: A Clinicopathologic Case Report
Abstract:
Diabetic macular oedema (DME) is the most frequent cause of visual loss among diabetic patients. The accumulation of comorbidities makes the ageing diabetic more fragile, especially in oldest-old adults, and is linked to increased hospitalisation and death rates. This case report analyses the complex treatment of Proliferative Diabetic Retinopathy with focal Photocoagulation of DME in an oldest-old woman who initially arrived with numerous diabetic comorbidities. An 82-year-old woman visited ophthalmology OPD twelve years before to perform cataract surgery. During that time, the patient did not have diabetic retinopathy at the baseline. One year before, due to irregular medication, she developed DME and best-corrected visual acuity (BCVA) was 6/36 in the right eye and prescribed to be under insulin therapy. Optical coherence tomography confirmed the presence of macular oedema and showed areas of retinal capillary non-perfusion and retinal leakage from numerous microaneurysms in the macular area. Following that, unilateral focal photocoagulation was planned. Despite grid laser, the macular oedema persisted and after two sessions of laser therapy, the macular oedema was reduced and the patient was satisfied with her vision. There is a need for further research on focal photocoagulation of DME among oldest-old adults.
Complex Treatment of Proliferative Diabetic Retinopathy with Focal Photocoagulation of Diabetic Macular Edema in Oldest-Old Female: A Clinicopathologic Case Report
References:
[1]. Raka, M., Daigavhane, S., Patil, A., 2022, A clinical case report of diabetic retinopathy. Asian J Biomed Pharmaceut Sci, 12(90), 128, https://www.alliedacademies.org/articles/a-clinical-case-report-of-diabetic-retinopathy.pdf.
[2]. International Diabetes Federation, 2019, IDF Diabetes Atlas. 9th ed. Brussels, Belgium, International Diabetes Federation, https://d-net.idf.org/en/library/542-idf-diabetes-atlas-2019-9th-edition.html.
[3]. Bhuvaneswari, R., Diviya, M., Subramanian, M., Maranan, R., Josphineleela, R., 2023, Hybrid generative model for grading the severity of diabetic retinopathy images. Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization, 11(7), https://doi.org/10.1080/21681163.2023.2266048.
[4]. Farheen Naz., JenilaRani D., 2022, Detection and Comparison of Diabetic Retinopathy using Thresholding Algorithm and CMeans Clustering Algorithm, Journal of Pharmaceutical Negative Results. 14(4), https://www.pnrjournal.com/index.php/home/article/view/899.
[5]. Suganya, M., KalaBarathi, S., 2024, Association of body mass index with dietary intake and self-care health activities of mothers after postpartum: A mixed-method research in Chennai City, India. Int J Nutr Pharmacol Neurol Dis 14:52-7, https://doi.org/10.4103/ijnpnd.ijnpnd_71_23.
[6]. Sridhar, S., Pradeep Kandhasamy, J., Sinthuja, M., Sterlin Minish, T. N., 2021, WITHDRAWN: Diabetic retinopathy detection using convolutional nueral networks algorithm, Materials Today: Proceedings, ISSN 2214-7853, https://doi.org/10.1016/j.matpr.2021.01.059.
[7]. Obeid A., Su D., Patel S. N., Uhr J. H., Borkar D., Gao X., et al. 2019, Outcomes of eyes lost to follow-up with proliferative diabetic retinopathy that received panretinal photocoagulation versus intravitreal anti-vascular endothelial growth factor. Ophthalmology. 126(3):407–413, https://pubmed.ncbi.nlm.nih.gov/30077614/
[8]. Angela, J., Michael Javaheri., Hamid Hosseini., Pradeep S Prasad., 2023, Purtscher‑like retinopathy in a 19‑year‑old with maturity‑onset diabetes of the young: a case report. Journal of Medical Case Reports, 17:255;1-4, https://doi.org/10.1186/s13256-023-03985-z
[9]. Ahmad, S. S., Ghani, S. A., 2012, Florid diabetic retinopathy in a young patient. J Ophthalmic Vis Res. 7(1):84-7, https://pmc.ncbi.nlm.nih.gov/articles/PMC3381113/
[10]. Ebrahimi, M. H., Gharibi, H., 2016, A case study of a patient with diabetic retinopathy. Diab Met Syndr: Clin Res Rev, http://dx.doi.org/10.1016/j.dsx.2016.01.022
[11]. Tao Y., Jiang P., Zhao Y., Song L., Ma Y., Li Y., Wang H., 2021, Retrospective study of aflibercept in combination therapy for high-risk proliferative diabetic retinopathy and diabetic maculopathy. Int Ophthalmol. 41(6):2157-2165, http://doi/10.1007/s10792-021-01773-6
[12]. Gawęcki, M., 2021, Subthreshold Diode Micropulse Laser Combined with Intravitreal Therapy for Macular Edema-A Systematized Review and Critical Approach. J Clin Med. 31;10(7):1394, http://doi/10.3390/jcm10071394.
[13]. Thool, A. R., Dhande, N. K., Daigavane, S. V., 2021, Study of Correlation between Renal Function Test and Severity of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus, J Evolution Med Dental Sci. 17;10(20):1511http://link.gale.com/apps/doc/A663048635/HRCA ?u=anon~81ff4892&sid=googleScholar&xid=2139b05c.
[14]. Ramakrishnan, A., Veeramani, P. A., et al, 2024, Association of Various Optical Coherence Tomographic Patterns of Diabetic Macular Edema with Central Subfield Thickness and Visual Acuity: A Cross-Sectional Observational Study, Cureus. 19,16(9), https://assets.cureus.com/uploads/original_article/pdf/294904/20241019-1529365-17tn37.pdf.
Viewed PDF 19 2 -
Obesity and Risk of Knee Osteoarthritis: A Case-Control Hospital-based Study of 372 PatientsAuthor: Nuradeen Altine AliyuDOI: 10.21522/TIJPH.2013.13.01.Art006
Obesity and Risk of Knee Osteoarthritis: A Case-Control Hospital-based Study of 372 Patients
Abstract:
This hospital-based case-control study explored whether the association between obesity and the risk of knee osteoarthritis (knee OA) exists. The study was conducted at an Orthopaedic Hospital Wamakko, a referral centre located in Sokoto, North-Western Nigeria for a period between January 2021 and December 2021. The cases with knee OA and unmatched controls were randomly selected. The inclusion criteria were adult patients aged >40 years with knee OA. The data was collected including the body mass index (BMI) in kg/m2 of each patient. Obesity was defined as BMI>29.9 kg/m2. Data were analysed using SPSS version 26. There were a total of 372 patients in the study with 124 cases and 248 controls in a ratio of 1:2. The average age was 53.7±10.8 (range 40 to 88 years). There were 165 (44.4%) males and 207 (55.6%) females. Among all the patients, there were 115 (30.9%) obese with 47 (40.9%) males and 68 (59.1%) females. Of the 257 (69.1%) non-obese patients, 118 (45.9%) were males and 139 (54.1%) were females. Among the 124 cases, there were 69 (55.6%) obese patients with 25 (36.2%) males and 44 (63.8%) females. The 55 (44.4%) non-obese patients among the cases were 24 (43.6%) males and 31 (56.4%) females. There was a statistical significance result between obesity and knee OA (OR=5.509, CI=3.417-8.881, and P<0.0001). The study showed obese individuals have 5.509 times more risk of having knee OA compared with non-obese individuals indicating weight reduction as a key to prevention and treatment of knee OA.
Obesity and Risk of Knee Osteoarthritis: A Case-Control Hospital-based Study of 372 Patients
References:
[1]. Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., Gellar, K., 2019, American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis & rheumatology. 2020 Feb;72(2):220-33.
[2]. Katz, J. N., Arant, K. R., Loeser, R. F., 2021, Diagnosis and treatment of hip and knee osteoarthritis: a review. Jama. 325(6):568-78.
[3]. Langworthy, M., Dasa, V., Spitzer, A. I., 2024, Knee osteoarthritis: disease burden, available treatments, and emerging options. Therapeutic Advances in Musculoskeletal Disease. https://doi.org/10.1177/1759720X241273009.
[4]. Gorial, F. I., Sabah, S. A., Kadhim, M. B., Jamal, N. B., 2018, Functional status in knee osteoarthritis and its relation to demographic and clinical features. Mediterranean Journal of Rheumatology. 29(4):207-10.
[5]. Christensen, R., Henriksen, M., Leeds, A. R., Gudbergsen, H., Christensen, P., Sørensen, T. J., Bartels, E. M., Riecke, B. F., Aaboe, J., Frederiksen, R., Boesen, M., 2015, Effect of weight maintenance on symptoms of knee osteoarthritis in obese patients: a twelve‐month randomized controlled trial. Arthritis Care & Research. 67(5):640-50.
[6]. Chen, L., Zheng, J. J., Li, G., Yuan, J., Ebert, J. R., Li, H., Papadimitriou, J., Wang, Q., Wood, D., Jones, C. W., Zheng, M., 2020, Pathogenesis and clinical management of obesity-related knee osteoarthritis: Impact of mechanical loading. Journal of Orthopaedic Translation. 24:66-75.
[7]. Wolfenden, L., Ezzati, M., Larijani, B., Dietz, W., 2019, The challenge for global health systems in preventing and managing obesity. Obesity Reviews. 20:185-93.
[8]. Li, E., Tan, J., Xu, K., Pan, Y., Xu, P., 2024, Global burden and socioeconomic impact of knee osteoarthritis: a comprehensive analysis. Frontiers in Medicine. 11:1323091.
[9]. Lyn, R., Heath, E., Dubhashi, J., 2019, Global implementation of obesity prevention policies: a review of progress, politics, and the path forward. Current Obesity Reports. 8:504-16.
[10]. Belo, J. N., Berger, M. Y., Koes, B. W., Bierma-Zeinstra, S. M., 2009, The prognostic value of the clinical ACR classification criteria of knee osteoarthritis for persisting knee complaints and increase of disability in general practice. Osteoarthritis and Cartilage. 17(10):1288-92.
[11]. Kulkarni, K., Karssiens, T., Kumar, V., Pandit, H., 2016, Obesity and osteoarthritis. Maturitas. 89:22-8.
[12]. Sharma, L., Lou, C., Cahue, S., Dunlop, D. D., 2000, The mechanism of the effect of obesity in knee osteoarthritis: the mediating role of malalignment. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 43(3):568-75.
[13]. Lee, R., Kean, W. F., 2012, Obesity and knee osteoarthritis. Inflammopharmacology. 20:53-8.
[14]. Vincent, H. K., Heywood, K., Connelly, J., Hurley, R. W., 2012, Obesity and weight loss in the treatment and prevention of osteoarthritis. PM&R. 4(5): S59-67.
[15]. Al Khatib, F., Gouissem, A., Mbarki, R., Adouni, M., 2022, Biomechanical characteristics of the knee joint during gait in obese versus normal subjects. International Journal of Environmental Research and Public Health 16;19(2):989.
[16]. Teichtahl, A. J., Wluka, A. E., Proietto, J., Cicuttini, F. M., 2005, Obesity and the female sex, risk factors for knee osteoarthritis that may be attributable to systemic or local leptin biosynthesis and its cellular effects. Medical Hypotheses 65(2):312-5.
[17]. Chang, C. B., Kim, T. K., Kang, Y. G., Seong, S. C., Kang, S. B., 2014, Prevalence of osteoporosis in female patients with advanced knee osteoarthritis undergoing total knee arthroplasty. Journal of Korean Medical Science. 29(10):1425-31.
[18]. Landsmeer, M. L., de Vos, B. C., van der Plas, P., van Middelkoop, M., Vroegindeweij, D., Bindels, P. J., Oei, E. H., Bierma-Zeinstra, S. M., Runhaar, J., 2018, Effect of weight change on progression of knee OA structural features assessed by MRI in overweight and obese women. Osteoarthritis and cartilage. 26(12):1666-74.
[19]. Kohn, M. D., Sassoon, A. A., Fernando, N. D., 2016, Classifications in brief: Kellgren- 474:1886-93.
[20]. Vos, M. B., Welsh, J., 2010, Childhood obesity: update on predisposing factors and prevention strategies. Current Gastroenterology Reports. 12:280-7.
[21]. Beauchamp, A., Backholer, K., Magliano, D., Peeters, A., 2014, The effect of obesity prevention interventions according to socioeconomic position: a systematic review. Obesity reviews. 15(7):541-54.
Viewed PDF 41 2 -
The Difference of Triglyceride and total Cholesterol Values between the Normotension and Hypertension groups Among the Population in SurakartaAuthor: Yuyun SetyoriniDOI: 10.21522/TIJPH.2013.13.01.Art007
The Difference of Triglyceride and total Cholesterol Values between the Normotension and Hypertension groups Among the Population in Surakarta
Abstract:
Hypertension is associated with a factor of ischemic heart disease and other chronic medical conditions. The association between hyperglycaemia and elevated abnormal blood lipid concentration has already been proposed. However, information about the roles of total cholesterol (TC) and triglycerides (TG) is currently limited. This study intends to explore the difference in triglycerides and total cholesterol between the normotension and hypertension groups in the Surakarta community. An observational study applying a cross-sectional design has been accomplished, and the study population resided in Surakarta, Central Java, Indonesia. This study was conducted in August-November 2022. Each participant should complete the provided questionnaire to survey the general characteristics such as age and sex. Patients were also measured in terms of their body weight and height, abdomen circumference, body mass index, total cholesterol, and triglyceride. Univariate and bivariate analyses were used in this study. The univariate analysis aims to describe each characteristic of the research variable. After univariate analysis, bivariate analysis was performed on two related variables. This study used Mann-Whitney analysis to identify the differences between predictor variables. Individuals with hypertension demonstrated substantially higher amounts of SBP and DBP than the normotension group (p=0.002 and 0.000 respectively). Total cholesterol between normotension and hypertension groups showed a significant difference (p=0.004). Other variables such as body weight, body height, abdomen circumference, body mass index, and triglyceride didn’t significantly differ between normotension and hypertension groups. It can be concluded that total cholesterol can be used as a predictor for hypertension risk.
The Difference of Triglyceride and total Cholesterol Values between the Normotension and Hypertension groups Among the Population in Surakarta
References:
[1]. Gloria Kang, G. J., Ewing-Nelson, S. R., Mackey, L., Schlitt, J. T., Marathe, A., Abbas, K. M., S. S., 2020, The global epidemiology of hypertension. Physiology & Behavior, 176(1), 139–148.
[2]. Kawamoto, R., Tabara, Y., Kohara, K., Kusunoki, T., Abe, M., & Miki, T., 2014, Interaction between serum uric acid and triglycerides in relation to prehypertension in community-dwelling Japanese adults. Clinical and Experimental Hypertension, 36(1), 64–69.
[3]. Shimizu, M., Furusyo, N., Mitsumoto, F., Takayama, K., Ura, K., Hiramine, S., Ikezaki, H., Ihara, T., Mukae, H., Ogawa, E., Toyoda, K., Kainuma, M., Murata, M., & Hayashi, J., 2015, Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: Results from the Kyushu and Okinawa Population Study (KOPS). Atherosclerosis, 238(2), 207–212.
[4]. Ulfah, M., Sukandar, H., & Afiatin, 2017, Correlation of Total Cholestrol Level and Blood Pressure in Jatinangor. Journal of Hypertension, 35(3).
[5]. Lelong, H., Blacher, J., Baudry, J., Adriouch, S., Galan, P., Fezeu, L., Lelong, H., & Kesse-Guyot, E., 2019, Combination of healthy lifestyle factors on the risk of hypertension in a large cohort of french adults. Nutrients, 11(7), 1–11.
[6]. National Heart, Lung, and B. I. (NLBI)., 2023, High Blood Pressure: Causes and Risk Factors. National Heart, Lung, and Blood Institute (NLBI).
[7]. Meher, M., Pradhan, S., & Pradhan, S. R., 2023, Risk Factors Associated With Hypertension in Young Adults: A Systematic Review. Cureus, 15(4).
[8]. Olack, B., Wabwire-Mangen, F., Smeeth, L., Montgomery, J. M., Kiwanuka, N., & Breiman, R. F., 2015, Risk factors of hypertension among adults aged 35-64 years living in an urban slum Nairobi, Kenya. BMC Public Health, 15(1), 1–9.
[9]. Officer, C. J. H., 2018, Health Profile of Central Java in 2018. Central Java Health Officer.
[10]. Musinguzi, G., & Nuwaha, F., 2013, Prevalence, Awareness and Control of Hypertension in Uganda. PLoS ONE, 8(4).
[11]. Addo, J., Smeeth, L., & Leon, D. A., 2007, Hypertension in sub-Saharan Africa: A systematic review. Hypertension, 50(6), 1012–1018.
[12]. Neter, J. E., Stam, B. E., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M., 2003, Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials. Hypertension, 42(5), 878–884.
[13]. Andrade, F. C. D., Vazquez-Vidal, I., Flood, T., Aradillas-Garcia, C., Vargas-Morales, J. M., Medina-Cerda, E., & Teran-Garcia, M., 2012, One-year follow-up changes in weight are associated with changes in blood pressure in young Mexican adults. Public Health, 126(6), 535–540.
[14]. Re, R. N., 2009, Obesity-related hypertension. Ochsner Journal, 9(3), 133–136.
[15]. Hall, J. E., Crook, E. D., Jones, D. W., Wofford, M. R., & Dubbert, P. M., 2002, Mechanisms of obesity-associated cardiovascular and renal disease. American Journal of the Medical Sciences, 324(3), 127–137.
[16]. Shariq, O. A., & Mckenzie, T. J., 2020, Obesity-related hypertension: A review of pathophysiology, management, and the role of metabolic surgery. Gland Surgery, 9(1), 80–93.
[17]. Cochran, J. M., Siebert, V. R., Bates, J., Butulija, D., Kolpakchi, A., Kadiyala, H., Taylor, A., & Jneid, H., 2021, The Relationship between Adult Height and Blood Pressure. Cardiology (Switzerland), 146(3), 345–350.
[18]. Ferrie, J. E., Langenberg, C., Shipley, M. J., & Marmot, M. G., 2006, Birth weight, components of height and coronary heart disease: Evidence from the Whitehall II study. International Journal of Epidemiology, 35(6), 1532–1542.
[19]. Bourgeois, B., Watts, K., Thomas, D. M., Carmichael, O., Hu, F. B., Heo, M., Hall, J. E., & Heymsfield, S. B., 2017, Associations between height and blood pressure in the United States population. Medicine (United States), 96(50).
[20]. Sun, J.-Y., Hua, Y., Zou, H.-Y.-Y., Qu, Q., Yuan, Y., Sun, G.-Z., Sun, W., & Kong, X.-Q., 2021, Association Between Waist Circumference and the Prevalence of (Pre) Hypertension Among 27,894 US Adults. Frontiers in Cardiovascular Medicine, 8(10), 1–11.
[21]. Cheng, C., Sun, J. Y., Zhou, Y., Xie, Q. Y., Wang, L. Y., Kong, X. Q., & Sun, W., 2022, High waist circumference is a risk factor for hypertension in normal-weight or overweight individuals with normal metabolic profiles. Journal of Clinical Hypertension, 24(7), 908–917.
[22]. Jain, B., Gumashta, R., Gumashta, J., Garg, R., & Vij, V., 2023, The Association Between Body Mass Index and Parental History of Hypertension Among Young Indian Adults. Cureus, 15(6).
[23]. Younus, A., Aneni, E. C., Spatz, E. S., Osondu, C. U., Roberson, L., Ogunmoroti, O., Malik, R., Ali, S. S., Aziz, M., Feldman, T., Virani, S. S., Maziak, W., Agatston, A. S., Veledar, E., & Nasir, K., 2016, A Systematic Review of the Prevalence and Outcomes of Ideal Cardiovascular Health in US and Non-US Populations. Mayo Clinic Proceedings, 91(5), 649–670.
[24]. Kapetanakis, V. V., Chan, M. P. Y., Foster, P. J., Cook, D. G., Owen, C. G., & Rudnicka, A. R., 2016, Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): A systematic review and meta-analysis. British Journal of Ophthalmology, 100(1), 86–93.
[25]. Kuwabara, M., Kuwabara, R., Niwa, K., Hisatome, I., Smits, G., Roncal-Jimenez, C. A., Maclean, P. S., Yracheta, J. M., Ohno, M., Lanaspa, M. A., Johnson, R. J., & Jalal, D. I., 2018, Different risk for hypertension, diabetes, dyslipidemia, and hyperuricemia according to level of body mass index in Japanese and American subjects. Nutrients, 10(8).
[26]. Crawford, A. G., Cote, C., Couto, J., Daskiran, M., Gunnarsson, C., Haas, K., Haas, S., Nigam, S. C., & Schuette, R., 2010, Prevalence of obesity, type II diabetes mellitus, hyperlipidemia, and hypertension in the United States: Findings from the GE centricity electronic medical record database. Population Health Management, 13(3), 151–161.
[27]. Lee, C. Y., Lin, W. T., Tsai, S., Hung, Y. C., Wu, P. W., Yang, Y. C., Chan, T. F., Huang, H. L., Weng, Y. L., Chiu, Y. W., Huang, C. T., & Lee, C. H., 2016, Association of parental overweight and cardiometabolic diseases and pediatric adiposity and lifestyle factors with cardiovascular risk factor clustering in adolescents. Nutrients, 8(9), 1–14.
[28]. Pray, R., & Riskin, S., 2023, The History and Faults of the Body Mass Index and Where to Look Next: A Literature Review. Cureus, 15(11).
[29]. Pischon, T., 2010, Commentary: Use of the body mass index to assess the risk of health outcomes: Time to say goodbye? International Journal of Epidemiology, 39(2), 528–529.
[30]. Flegal, K. M., & Graubard, B. I., 2009, Estimates of excess deaths associated with body mass index and other anthropometric variables. American Journal of Clinical Nutrition, 89(4), 1213–1219.
[31]. Sakurai, M., Stamler, J., Miura, K., Brown, I. J., Nakagawa, H., Elliott, P., Ueshima, H., Chan, Q., Tzoulaki, I., Dyer, A. R., Okayama, A., & Zhao, L., 2011, Relationship of dietary cholesterol to blood pressure: The INTERMAP study. Journal of Hypertension, 29(2), 222–228.
Viewed PDF 33 1 -
Socio-Demographic Determinants of Prompt Malaria Treatment for Children Under 5 Years by Caregivers in NigeriaAuthor: Olakunle OsinowoDOI: 10.21522/TIJPH.2013.13.01.Art008
Socio-Demographic Determinants of Prompt Malaria Treatment for Children Under 5 Years by Caregivers in Nigeria
Abstract:
Malaria is a major cause of morbidity and mortality in Nigeria. Access to prompt and effective treatment of malaria is at the core of the prevention of deaths in under 5 children in Nigeria. This study investigates the socio-demographic determinants of prompt response behavior of caregivers to malaria among children under 5 years in Nigeria. The analysis is based on 14,6471 women aged 15- 49 years from the most recent national population-based survey (Nigeria Malaria Indicator Survey 2021) using chi-square and logistic regression methods. The study is based on caregivers whose children had malaria at least 2 weeks before the survey across the 36 states in Nigeria including the Federal Capital Territory (FCT). Knowledge of fever, educational attainment of caregivers and family wealth are all significant determinants of prompt malaria treatment for children under 5 years in Nigeria. Respondents with adequate knowledge of malaria signs and symptoms were 1.5 times more likely to seek prompt treatment, those who have at least primary education were 1.7 times more likely to seek prompt treatment while the higher the family wealth, the more likely it is for a caregiver to seek prompt treatment for malaria for children under 5 years. Despite the high knowledge of malaria among caregivers, there is still low timely treatment response for children under 5 years. Therefore, programs should focus on increasing awareness and benefits of prompt care-seeking among caregivers.
Socio-Demographic Determinants of Prompt Malaria Treatment for Children Under 5 Years by Caregivers in Nigeria
References:
[1]. World Health Organization. 2020. World Malaria Report 2020. Geneva: World Health Organization. https://www.who.int/publications/i/item/9789240015791
[2]. Antonio-Nkondjio, C., Ndo, C., Njiokou, F., Bigoga, J. D., Awono-Ambene, P., Etang, J., & Wondji, C. S. 2019. Review of malaria situation in Cameroon: technical viewpoint on challenges and prospects for disease elimination. Parasites & Vectors, 12(1), 501. https://doi.org/10.1186/s13071-019-3753-8
[3]. Adedokun, S. T., Uthman, O. A. 2020. Individual and contextual correlates of mosquito net use among women in Nigeria. Malaria Journal, 19, 138. https://doi.org/10.1186/s12936-020-03219-3
[4]. Ameyaw, E. K., Adde, K. S., Dare, S., & Yaya, S., 2020. Rural–urban variation in insecticide-treated net utilization among pregnant women: Evidence from 2018 Nigeria Demographic and Health Survey. Malaria Journal, 19(1), 407. https://doi.org/10.1186/s12936-020-03481-5
[5]. Nkoka, O., Chuang, T. W., & Chen, Y. H. 2020. Multilevel analysis of factors associated with treatment-seeking behaviors among caregivers with febrile children in Malawi. American Journal of Tropical Medicine and Hygiene, 102(1), 177-187. https://doi.org/10.4269/ajtmh.18-0900
[6]. Asakitikpi, A. E. 2019. Healthcare coverage and affordability in Nigeria: An alternative model to equitable healthcare delivery. Universal Health Coverage. https://doi.org/10.5772/intechopen.85978
[7]. Adebayo, A. M., Akinyemi, O. O., & Cadmus, E. O. 2015. Knowledge of malaria prevention among pregnant women and female caregivers of under-five children in rural southwest Nigeria. PeerJ, 3, e792. https://doi.org/10.7717/peerj.792
[8]. Lwenge, M., Govule, P., Katongole, S. P., & Dako-Gyeke, P. 2023. Malaria treatment health-seeking behaviors among international students at the University of Ghana Legon. PLOS ONE, 18(10), e0276412. https://doi.org/10.1371/journal.pone.0276412
[9]. National Malaria Elimination Programme (NMEP), National Population Commission (NPC), National Bureau of Statistics (NBS), & ICF. 2022. Nigeria Malaria Indicator Survey 2021. Abuja, Nigeria, and Rockville, Maryland, USA: NMEP, NPC, NBS, and ICF.
[10]. Onwujekwe, O., Hanson, K., & Fox-Rushby, J., 2010. Inequalities in purchase of mosquito nets and willingness to pay for insecticide-treated nets in Nigeria: Challenges for malaria control interventions. Malaria Journal, 9(1), 149.
[11]. Jegede, A. S. 2007. What led to the Nigerian boycott of the polio vaccination campaign? PLoS Medicine, 4(3), e73.
[12]. Sixpence, A., Nkoka, O., Chirwa, G. C. et al. 2020. Levels of knowledge regarding malaria causes, symptoms, and prevention measures among Malawian women of reproductive age. Malaria Journal, 19, 225. https://doi.org/10.1186/s12936-020-03294-6
[13]. World Health Organization (WHO). 2021. World Malaria Report 2021. World Health Organization.
[14]. Franklin J. B., Marra C, Abebe K. Z., et al. 2024. Modernizing the Data Infrastructure for Clinical Research to Meet Evolving Demands for Evidence. JAMA. doi:10.1001/jama.2024.02
[15]. Afolabi, M. O., Salako, O., Ndii, M., Yoon, S., & Tayo, F., 2014. Health-seeking behavior and malaria prevention practices among mothers of under-five children in rural Nigeria. Malaria Journal, 13(1), 451.
[16]. Gidado, S., Ejembi, C. L., & Bello, M. 2014. Factors influencing the use of insecticide-treated nets in Nigeria: Implications for scaling up coverage. Malaria Journal, 13(1), 168.
[17]. Gordon, T., Booysen, F. & Mbonigaba, J., 2020. Socio-economic inequalities in the multiple dimensions of access to healthcare: the case of South Africa. BMC Public Health, 20, 289. https://doi.org/10.1186/s12889-020-8368-7
[18]. WHO. 2014. World malaria report 2014. World Health Organization.
[19]. Okeke, C., Onwujekwe, O., & Uzochukwu, B., 2014. Socio-economic and geographic differentials in health care-seeking for common childhood symptoms in Southeast Nigeria. Social Science & Medicine, 66(2), 279-289
[20]. Gething, P. W., Patil, A. P., Smith, D. L., Guerra, C. A., Elyazar, I. R., Johnston, G. L., & Hay, S. I. 2014. The global burden of malaria: Historical patterns and contemporary trends. World Health Organization.
[21]. Ghio D., Lawes-Wickwar S., Tang M. Y., et al. 2021. What influences people’s responses to public health messages for managing risks and preventing infectious diseases? A rapid systematic review of the evidence and recommendations BMJ Open, 11, e048750. doi:10.1136/bmjopen-2021-048750
[22]. Maiga, F. O., Wele, M., Toure, S. M. et al. 2021. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Mali: a systematic review and meta-analysis. Malaria Journal, 20, 356. https://doi.org/10.1186/s12936-021-03890-0
[23]. Poirier, M. J. P., Grépin, K. A., & Grignon, M., 2020. Approaches and alternatives to the wealth index to measure socioeconomic status using survey data: A critical interpretive synthesis. Social Indicators Research, 148(1), 1–46. https://doi.org/10.1007/s11205-019-02187-9
Viewed PDF 17 0 -
A Cross-Sectional Assessment of PMTCT Service Delivery in the Era of Expanded Community-Based Programming for Pregnant Women Living with HIV in Akwa-Ibom State, NigeriaAuthor: Dolapo T. OgundehinDOI: 10.21522/TIJPH.2013.13.01.Art009
A Cross-Sectional Assessment of PMTCT Service Delivery in the Era of Expanded Community-Based Programming for Pregnant Women Living with HIV in Akwa-Ibom State, Nigeria
Abstract:
This study assessed the knowledge of mother-to-child transmission (MTCT) of HIV/AIDS and the determinants of this knowledge among women living with HIV who received PMTCT services in Akwa Ibom State, Nigeria. This cross-sectional study used data from a structured questionnaire from postpartum mothers living with HIV who were at least two months post-partum between January – March 2023 and had received PMTCT services during the PMTCT scale-up period (January 2022 – December 2022) across 13 health facilities in Akwa Ibom, Nigeria. Knowledge of PMTCT was categorized as 'good' if participants scored ≥ cut-off score using the demarcation threshold formula. Proportions of women with good knowledge of PMTCT services were compared using the Chi-square test, while logistic regression was used to identify factors associated with good PMTCT knowledge. All analyses were conducted using STATA 14.0. Of the 631 women, 215 (34.1%) were identified and enrolled on PMTCT at community birth centres, while 416 (65.9%) were at the health facility. Overall, 82.2% (518/630) of respondents had good knowledge of PMTCT, and higher among respondents from health facilities (n = 86%, 358/415), compared to those from the community birth centres (n = 74%, 160/215, p<0.001). Among respondents who were identified in the community birth centres, PMTCT knowledge was 2.5 times higher among those residents in the urban compared to those residents in the rural area (aOR=2.522; 95%CI = 1.025-6.202). To improve PMTCT knowledge, targeted information should be provided to women receiving prenatal care at community birth centres and those living in rural areas.
A Cross-Sectional Assessment of PMTCT Service Delivery in the Era of Expanded Community-Based Programming for Pregnant Women Living with HIV in Akwa-Ibom State, Nigeria
References:
[1]. UNAIDS, 2023, HIV & AIDS statistics — Fact sheet, https://www.unaids.org/en/resources/fact-sheet
[2]. World Health Organization, 2016, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach, second edition. Geneva. https://apps.who.int/iris/handle/10665/208825
[3]. UNAIDS, 2014, The Gap Report.2014. Children and pregnant women living with HIV. Geneva: Joint United Nations Program on HIV/AIDS (UNAIDS), http://www.unaids.org/sites/default/files/ media asset/0._ChildrenandpregnantwomenlivingwithHIV.pdf, accessed 10 August 2024.
[4]. WHO, 2018, HIV diagnosis and ARV use in HIV-exposed infants: a programmatic update. Geneva: World Health Organization, https://apps.who.int/iris/bitstream/handle/10665/273155/WHOCDS-HIV-18.17-eng.pdf, accessed 10 August 2024.
[5]. UNAIDS, 2024, Transforming Vision into Reality: The 2024 Global Alliance Progress Report on Ending AIDS in Children by 2030. Geneva: License: CC BY-NC-SA 3.0 IGO, https://www.unaids.org/en/resources/documents/2024/transforming-vision-into-reality
[6]. UNAIDS, 2021, Start free, stay free, AIDS free: Final report on 2020 targets. Joint United Nations Program on HIV/AIDS (UNAIDS), https://www.unaids.org/sites/default/files/media_asset/2021_start-free-stay-free-aids-free-final-report-on-2020-targets_en.pdf
[7]. Federal Ministry of Health Nigeria, 2020, National Guidelines for HIV Prevention, Treatment and Care, https://nascp.gov.ng/resources/get_resource_doc/31
[8]. Ciampa P. J., Skinner S. L., Patricio S. R., Rothman R. L., Vermund S. H., Audet C. M., 2012, Comprehensive Knowledge of HIV among Women in Rural Mozambique: Development and Validation of the HIV Knowledge 27 Scale. PLoS One. Oct 31;7(10).
[9]. Darteh K. M., Abraham S. A., Seidu A. A., Chattu V. K., Yaya S., 2021, Knowledge and determinants of women’s knowledge on vertical transmission of HIV and AIDS in South Africa. AIDS Res Ther. 18(1):1–9, https://aidsrestherapy.biomedcentral.com/articles/10.1186/s12981-021-00367-7
[10]. Federal Ministry of Health, 2019, Nigeria HIV/aids indicator and impact survey (NAIIS) 2018: Technical report, https://www.naiis.ng/resource/factsheet/NAIIS%20PA%20NATIONAL%20FACTSHEET%20FINAL.pdf
[11]. Eshiet U. I., Jackson I. L., Akwaowoh A. E., 2016, High patronage of traditional birth homes: a report from Akwa Ibom, Southern Nigeria. AASCIT J Health; 3: 1–6. https://www.researchgate.net/publication/360485979_High_Patronage_of_Traditional_Birth_Homes_A_Report_from_Akwa_Ibom_Southern_Nigeria
[12]. Nwanja E., Akpan U., Toyo O.., et al., 2023, Improving access to HIV testing for pregnant women in community birth centers in Nigeria: an evaluation of the Prevention of Mother-to-Child Transmission program. Ther Adv Infect Dis. Apr 29;10:20499361231172088. doi: 10.1177/20499361231172088. PMID: 37152184; PMCID: PMC10155002.
[13]. Centre for Disease Control (CDC), 2022, US CDC Launches AP3 Program to Expand HIV Treatment Coverage Among Pediatrics, Adolescents, and Pregnant Women. U.S. Embassy & Consulate in Nigeria, https://ng.usembassy.gov/us-cdc-launches-ap3-program-to-expand-hiv-treatment-coverage-among-pediatrics-adolescents-and-pregnant-women/#:~:text=The%20AP3%20program%20aims
[14]. Population. City, 2021, http://population.city/nigeria/adm/akwa-ibom/
[15]. Nigeria Galleria. n.d. “Business Economy of Akwa Ibom State”. https://www.nigeriagalleria.com/Nigeria/States_Nigeria/Akwa-Ibom/Business-Economy-Akwa-Ibom-State.html
[16]. Kassie S. Y., Chereka A. A., Damtie Y., 2022, Systematic review and meta-analysis of knowledge on PMTCT of HIV/AIDS and Association factors among reproductive age women in Ethiopia. BMC Infect Dis. 23(1):491. doi: 10.1186/s12879-023-08461-z. PMID: 37491184; PMCID: PMC10367387.
[17]. Teshale A. B., Tessema Z. T., Alem A. Z., Yeshaw Y., Liyew A. M., Alamneh T.S, et al., 2021, Knowledge about mother to child transmission of HIV/AIDS, its prevention and associated factors among reproductive-age women in sub-Saharan Africa: Evidence from 33 countries recent Demographic and Health Surveys. PLoS ONE 16(6): e0253164. https://doi.org/10.1371/journal.pone.0253164
[18]. Akadri A., Odelola O., 2020, Breastfeeding Practices among Mothers in Southwest Nigeria. Ethiop J Health Sci. 30(5):697-706. doi: 10.4314/ejhs.v30i5.8. PMID: 33911830; PMCID: PMC8047277, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047277/
[19]. Anaba, U.C., Johansson, E.W., Abegunde, D. et al., 2022, The role of maternal ideations on breastfeeding practices in northwestern Nigeria: a cross-section study. Int Breastfeed J. 17 (63), https://doi.org/10.1186/s13006-022-00500-w
[20]. Njom A. E., 2022, Mother-to-Child Transmission of HIV Through Breastfeeding Improving Awareness and Education: A Short Narrative Review. Int J Women’s Health. 14:697-703. doi: 10.2147/IJWH.S330715. PMID: 35601795; PMCID: PMC9114103. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114103/
[21]. Umeobieri, A. K., Mbachu, C., Uzochukwu, B., et al., 2018, Perception and practice of breastfeeding among HIV positive mothers receiving care for prevention of mother to child transmission in South-East, Nigeria. Int Breastfeed J. 13 (50), https://doi.org/10.1186/s13006-018-0191-8
[22]. Terefe B., Jembere M. M., Liyew B., 2024, Comprehensive knowledge of mother-to-child HIV/AIDS transmission, prevention, and associated factors among reproductive-age women in East Africa: insights from recent demographic and national health surveys. BMC Women’s Health. 24(1):318. doi: 10.1186/s12905-024-03173-1. PMID: 38824575; PMCID: PMC11143582. https://bmcwomenshealth.biomedcentral.com/articles/10.1186/s12905-024-03173-1
[23]. Strecher V. J., Champion V. L., Rosenstock I. M., 1997, The health belief model and health behavior. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530978/
[24]. Jeihooni A. K., Arameshfard S., Hatami M., Mansourian M., Kashfi S.H., Rastegarimehr B., et al., 2017, The effect of educational program based on health belief model about HIV/AIDS among high school students. Int J Pediatrics-Mashhad. 6(3):7285–96. https://doi.org/10.22038/ijp.27226.2343.
[25]. Tarkang E. E., Zotor F. B., 2015, Application of the health belief model (HBM) in HIV prevention: a literature review. Cent Afr J Public Health. 1(1):1–8. https://www.researchgate.net/publication/317493239.
[26]. Bertrand J. T., 2004, Diffusion of innovations and HIV/AIDS. J Health Communication. 9(S1):113–21. doi: 10.1080/10810730490271575. https://pubmed.ncbi.nlm.nih.gov/14960407/
Viewed PDF 20 2 -
Perspective for Low COVID-19 Vaccination Uptake and its Effect in Ndola District, Zambia: A Qualitative AnalysisAuthor: Astridah Mwewa ChibaleDOI: 10.21522/TIJPH.2013.13.01.Art010
Perspective for Low COVID-19 Vaccination Uptake and its Effect in Ndola District, Zambia: A Qualitative Analysis
Abstract:
Despite strides in vaccination, hurdles remain, especially regarding the uncertain acceptance of COVID-19 Vaccinations among healthcare workers and the public. This study assessed the Perspective of Low COVID-19 Vaccination Uptake and its Effect; contributing factors, perception and consequences of Low COVID-19 Vaccination Uptake evaluated. The study site was St. Dominic's Hospital (St. DH) and neighbouring area, Ndola, Zambia, utilising a qualitative research design. Purposive sampling was employed selected 50 participants were for Focus Group Discussions, and data was analysed thematically. The participants’ age group was 21-50 years. The findings revealed both positive perceptions and underscored the importance of vaccination in reducing the severity of disease and preventing deaths, recognizing the benefits of immunization. 53.7% of married have negative perceptions statistically significant (P-value <0.001) others expressing concerns about adverse effects, doubt, anxiety about safety, efficacy and mistrust in fast vaccine production. Anxiety about safety was prevalent at 86.4%, particularly in males P<0.001) and 41-50 years P<0.001). Regarding contributing Factors of hesitancy: 65.5% expressed reluctance with significant associations among 31-40 years (AOR=5.81 [2.14-15.80]; P=0.001), also were social and political factors, traditional beliefs, fear and misinformation. Moreover, (96.2%) expressed the negative effects of low COVID-19 vaccination, emphasizing the consequences of economic disruption, increased health risks and mental impacts. Participants highlighted strategies to address the Low COVID-19 Vaccination Uptake: community sensitization through various communication channels, outreach campaigns, and involvement of partnerships, health authorities and international organizations in a coordinated manner to address concerns. Prioritizing accurate information to build trust and improve the Uptake.
Perspective for Low COVID-19 Vaccination Uptake and its Effect in Ndola District, Zambia: A Qualitative Analysis
References:
[1]. Adane, M., Ademas, A., & Kloos, H., 2022, Knowledge, attitudes, and perceptions of COVID-19 vaccine and refusal to receive COVID-19 vaccine among healthcare workers in northeastern Ethiopia. BMC Public Health, 22.
[2]. Afriyie, D. K., Asare, G. A., Amponsah, S. K., & Godman, B., 2020, COVID-19 pandemic in resource-poor countries: challenges, experiences and opportunities in Ghana. Journal of Infection in Developing Countries, 14, 838–843, https://doi.org/10.3855/jidc.12909.
[3]. Fares, S., Elmnyer, M. M., Mohamed, S. S., & Elsayed, R., 2021, COVID-19 Vaccination Perception and Attitude among Healthcare Workers in Egypt. Journal of Primary Care & Community Health, 12, https://doi.org/10.1177/21501327211013303.
[4]. Gerts, D., Shelley, C. D., Parikh, N., Pitts, T., Ross, C. W., Fairchild, G., et al., 2021, “Thought I’d share first” and other conspiracy theory tweets from the COVID-19 infodemic: Exploratory study. JMIR Public Health and Surveillance, 7, https://doi.org/10.2196/26527.
[5]. Haque, A., & Pant, A. B., 2020, Efforts at COVID-19 vaccine development: Challenges and successes. Vaccines, 8, 1–16, https://doi.org/10.3390/vaccines8040739.
[6]. Islam, M. S., Kamal, A. H. M., Kabir, A., Southern, D. L., Khan, S. H., Murshid Hasan, S. M., et al., 2021, COVID-19 vaccine rumours and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence. PLoS One, 16, https://doi.org/10.1371/journal.pone.0251605.
[7]. Kabamba Nzaji, M., Kabamba Ngombe, L., Ngoie Mwamba, G., Banza Ndala, D. B., Mbidi Miema, J., Luhata Lungoyo, C., et al., 2020, Acceptability of vaccination against COVID-19 among healthcare workers in the Democratic Republic of Congo. Pragmatic and Observational Research, 11, 103–109, https://doi.org/10.2147/por.s271096.
[8]. Kanyike, A. M., Olum, R., Kajjimu, J., Ojilong, D., Akech, G. M., Nassozi, D. R., et al., 2021, Acceptance of the coronavirus disease-2019 vaccine among medical students in Uganda.Tropical Medicine and Health, 49, https://doi.org/10.1186/s41182-021-00331-1.
[9]. Sallam, M., Dababseh, D., Eid, H., Hasan, H., Taim, D., Al-Mahzoum, K., et al., 2021, Low COVID19 vaccine acceptance is correlated with conspiracy beliefs among university students in Jordan. International Journal of Environmental Research and Public Health, 18, 1–14, https://doi.org/10.3390/ijerph18052407.
[10]. Puri, N., Coomes, E. A., Haghbayan, H., & Gunaratne, K., 2020, social media and vaccine hesitancy: New updates for the era of COVID-19 and globalized infectious diseases. Human Vaccines & Immunotherapeutics, 16(12), 2586–2593, https://doi.org/10.1080/21645515.2020.1780846.
[11]. Karaivanov, A., Kim, D., Lu, S. E., & Shigeoka, H., 2022, COVID-19 vaccination mandates and vaccine uptake. Nature Human Behaviour, 6, 1615–1624, https://doi.org/10.1038/s41562-02201363-1.
[12]. Li, Y., & Niu, Y., 2021, A commentary on “The socio-economic implications of the coronavirus pandemic (COVID-19): A review.” International Journal of Surgery, 95, https://doi.org/10.1016/j.ijsu.2021.106048.
[13]. Martin, K., Moonga, K., Christabel, N. H., Moses, M., Steward, M., & Ozawa, S., 2023, Attitudes towards vaccines and intentions to vaccinate against COVID-19 among undergraduate students at the University of Zambia. African Journal of Pharmacy and Pharmacology, 17, 155–164, https://doi.org/10.5897/ajpp2023.5357.
[14]. Ndejjo, R., Chen, N., Kabwama, S. N., Namale, A., Wafula, S. T., Wanyana, I., et al., 2023, Uptake of COVID-19 vaccines and associated factors among adults in Uganda: A cross-sectional survey. BMJ Open, 13, 1–9, https://doi.org/10.1136/bmjopen-2022-067377.
[15]. Morens, D. M., Breman, J. G., Calisher, C. H., Doherty, P. C., Hahn, B. H., Keusch, G. T., et al., 2020, The origin of COVID-19 and why it matters. American Journal of Tropical Medicine and Hygiene, 103, 955–959, https://doi.org/10.4269/ajtmh.20-0849.
[16]. Mudenda, S., Mukosha, M., Hikaambo, C. N., Meyer, J. C., Fadare, J., Kampamba, M., et al., 2022, Awareness and acceptance of COVID-19 vaccines and associated factors among pharmacy students in Zambia. Malawi Medical Journal, 34, 273–280, https://doi.org/10.4314/mmj.v34i4.8.
[17]. Mudenda, S., 2021, COVID-19 vaccine acceptability and hesitancy in Africa: Implications for addressing vaccine hesitancy. Journal of Biomedical Research & Environmental Sciences, 2, 999–1004, https://doi.org/10.37871/jbres1342.
[18]. Haque, M., Abubakar, A., Ogunleye, O., Sani, I., Sefah, I., Kurdi, A., et al., 2021, Changes in availability, utilization, and prices of medicines and protection equipment for COVID-19 in an urban population of Northern Nigeria. Journal of Research in Pharmacy Practice, 10, 17, https://doi.org/10.4103/jrpp.jrpp_20_92.
[19]. MacDonald, N. E., 2021, How government policies and political ideologies impact vaccine acceptance: COVID-19 and beyond. CANVax, 1–5, https://canvax.ca/brief/how-governmentpolicies-and-political-ideologies-impact-vaccine-acceptance-covid-19-and (accessed February 16, 2024).
[20]. Sallam, M., 2021, COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines, 9, 1–15, https://doi.org/10.3390/vaccines9020160.
[21]. Pugliese-Garcia, M., Heyerdahl, L. W., Mwamba, C., Nkwemu, S., Chilengi, R., Demolis, R., et al., 2018, Factors influencing vaccine acceptance and hesitancy in three informal settlements in Lusaka, Zambia. Vaccine, 36, 5617–5624, https://doi.org/10.1016/j.vaccine.2018.07.042.
[22]. Palamenghi, L., Barello, S., Boccia, S., & Graffigna, G., 2020, Mistrust in biomedical research and vaccine hesitancy: The forefront challenge in the battle against COVID-19 in Italy. European Journal of Epidemiology, 35, 785–788, https://doi.org/10.1007/s10654-020-00675-8.
[23]. Creswell, J. W., & Creswell, J. D., 2022, Research Design: Qualitative, Quantitative, and Mixed Methods Approaches (6th ed.). SAGE Publications.
[24]. MFL, 2022, Facility name: Kavu 1st Level Hospital (St Dominics Hospital). MFL. http://154.120.217.168:8081/mfl/frontend/web/facility/view?id=2253.
[25]. Wong, C. L., Leung, A. W. Y., Chung, O. M. H., & Chien, W. T., 2022, Factors influencing COVID-19 vaccination uptake among community members in Hong Kong: A cross-sectional online survey. BMJ Open, 12, https://doi.org/10.1136/bmjopen-2021-058416.
[26]. Sallam, M., Dababseh, D., Eid, H., Al-Mahzoum, K., Al-Haidar, A., Taim, D., et al., 2021, High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: A study in Jordan and Kuwait among other Arab countries. Vaccines, 9, 1–16, https://doi.org/10.3390/vaccines9010042.
[27]. Qasim, R., Shah, H., Sultan, A., Yaqoob, M., Haroon, R., Mistry, S. K., et al., 2022, Exploring the beliefs and experiences regarding COVID-19 vaccine hesitancy and acceptance in a slum of Karachi, Pakistan. Health Promotion International, 37, 1–12, https://doi.org/10.1093/heapro/daac140.
[28]. Schmelz, K., & Bowles, S., 2022, Opposition to voluntary and mandated COVID-19 vaccination as a dynamic process: Evidence and policy implications of changing beliefs. Proceedings of the National Academy of Sciences of the United States of America, 119, https://doi.org/10.1073/pnas.2118721119.
[29]. MacDonald, N. E., Eskola, J., Liang, X., Chaudhuri, M., Dube, E., Gellin, B., et al., & SAGE Working Group on Vaccine Hesitancy, 2015, Vaccine hesitancy: Definition, scope, and determinants. Vaccine, 33, 4161–4164.
[30]. Stecula, D. A., Kuru, O., & Jamieson, K. H., 2020, How trust in experts and media use affect acceptance of common anti-vaccination claims. Harvard Kennedy School Misinformation Review, 1, 1–11, https://doi.org/10.37016/mr-2020-007.
[31]. Mudenda, S., Mukosha, M., Fadare, J. O., & Godman, B., 2021, Awareness and acceptance of COVID-19 vaccines among pharmacy students in Zambia: The implications for addressing vaccine hesitancy. Research Square, 1–22.
[32]. Duroseau, B., Kipshidze, N., & Limaye, R. J., 2023, The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries. Frontiers in Public Health, 10, https://doi.org/10.3389/fpubh.2022.1087138.
Viewed PDF 18 1 -
A Novel Study Elucidating the Effects of Glucose and Static Magnetic Field on Osteoblast Differentiation MarkersAuthor: Bharathi SelvarajDOI: 10.21522/TIJPH.2013.13.01.Art011
A Novel Study Elucidating the Effects of Glucose and Static Magnetic Field on Osteoblast Differentiation Markers
Abstract:
In this study, we explored the expression dynamics of osteoblast differentiation marker genes under the influence of static magnetic fields (SMF) in high glucose conditions. High glucose can significantly impair osteoblast function and differentiation- particularly in diabetic patients with persistent hyperglycemia. In the in-vivo diabetic-like environment that is under glucose level, SMF’s role in bone formation was evaluated using Human osteoblastic cells that were treated with SMF for up to 7 days. The expression of key osteogenic markers such as alkaline phosphatase (ALP), osteocalcin (OCN), and collagen type I (COL1A1) was analysed using qRT-PCR and ELISA. The findings demonstrated that high glucose led to pronounced inhibition of osteoblast differentiation markers. Conversely, being exposed to an SMF dramatically increases the expression of markers for osteoblast differentiation. Additionally, the inhibitory effects of glucose on osteoblast development appear to be lessened upon SMF exposure. These results emphasize the significance of taking into account the positive effects of SMF, which may have therapeutic potential in bone repair.
A Novel Study Elucidating the Effects of Glucose and Static Magnetic Field on Osteoblast Differentiation Markers
References:
[1]. Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., Xu, H., 2022, Trends in insulin resistance: insights into mechanisms and therapeutic strategy, Signal Transduct Target Ther, vol. 7, no. 1, p. 216.
[2]. Bao, K., Jiao, Y., Xing, L., Zhang, F., Tian, F., 2023, The role of Wnt signaling in diabetes‐induced osteoporosis, Diabetol Metab Syndr, vol. 15, no. 1, p. 84.
[3]. Ross, B. J., Lee, O. C., Harris, M. B., Dowd, T. C., Savoie, F. H. 3rd, Sherman, W. F., 2022, The impact of diabetes on osteoporosis management and secondary fracture risk after primary fragility fractures: a propensity score-matched cohort study, J Am Acad Orthop Surg, vol. 30, no. 2, p. e204–12.
[4]. de Paula, F. J. A., Horowitz, M. C., Rosen, C. J., 2010, Novel insights into the relationship between diabetes and osteoporosis, Diabetes Metab Res Rev, vol. 26, no. 8, p. 622–30.
[5]. Gil-Díaz, M. C., Raynor, J., O’Brien, K. O., Schwartz, G. J., Weber, D. R., 2019, Systematic review: associations of calcium intake, vitamin D intake, and physical activity with skeletal outcomes in people with type 1 diabetes mellitus, Acta Diabetol, vol. 56, no. 10, p. 1091–102.
[6]. Yang, J., Ma, C., Zhang, M., 2019, High glucose inhibits osteogenic differentiation and proliferation of MC3T3‑E1 cells by regulating P2X7, Mol Med Rep, vol. 20, no. 6, p. 5084–90.
[7]. Zhang, J., Ding, C., Ren, L., Zhou, Y., Shang, P., 2014, The effects of static magnetic fields on bone, Prog Biophys Mol Biol, vol. 114, no. 3, p. 146–52.
[8]. Yang, T. C., Maeda, Y., Gonda, T., Wada, M., 2013, Magnetic attachment for implant overdentures: influence of contact relationship with the denture base on stability and bending strain, Int J Prosthodont, vol. 26, no. 6, p. 563–5.
[9]. Aksu, A. E., Dursun, E., Calis, M., Ersu, B., Safak, T., Tözüm, T. F., 2014, Intraoral use of extraoral implants for oral rehabilitation of a pediatric patient after resection of Ewing sarcoma of the mandible and reconstruction with iliac osteocutaneous free flap, J Craniofac Surg, vol. 25, no. 3, p. 930–3.
[10]. Siadat, H., Bassir, S. H., Alikhasi, M., Shayesteh, Y. S., Khojasteh, A., Monzavi, A., 2012, Effect of static magnetic fields on the osseointegration of immediately placed implants: a randomized controlled clinical trial, Implant Dent, vol. 21, no. 6, p. 491–5.
[11]. Leesungbok, R., Ahn, S. J., Lee, S. W., Park, G. H., Kang, J. S., Choi, J. J., 2013, The effects of a static magnetic field on bone formation around a sandblasted, large-grit, acid-etched–treated titanium implant, J Oral Implantol, vol. 39, no. S1, p. 248–55.
[12]. Cipriani, C., Colangelo, L., Santori, R., Renella, M., Mastrantonio, M., Minisola, S., et al., 2020, The interplay between bone and glucose metabolism, Front Endocrinol, vol. 11, p. 122.
[13]. Song, F., Lee, W. D., Marmo, T., Ji, X., Song, C., Liao, X., et al., 2023, Osteoblast-intrinsic defect in glucose metabolism impairs bone formation in type II diabetic mice, bioRxiv, p. 10.1101/2023.01.16.524248.
[14]. Mannucci, E., Monami, M., 2017, Bone fractures with sodium-glucose co-transporter-2 inhibitors: how real is the risk?, Drug Saf, vol. 40, no. 2, p. 115–9.
[15]. Tang, H. L., Li, D. D., Zhang, J. J., Hsu, Y. H., Wang, T. S., Zhai, S. D., et al., 2016, Lack of evidence for a harmful effect of sodium-glucose co-transporter 2 (SGLT2) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta-analysis of randomized controlled trials, Diabetes Obes Metab, vol. 18, no. 12, p. 1199–206.
[16]. Lv, H., Wang, Y., Zhen, C., Liu, J., Chen, X., Zhang, G., et al., 2023, A static magnetic field improves bone quality and balances the function of bone cells with regulation on iron metabolism and redox status in type 1 diabetes, FASEB J, vol. 37, no. 7, p. e22985.
[17]. Vimalraj, S., Sekaran, S., 2023, RUNX family as a promising biomarker and a therapeutic target in bone cancers: a review on its molecular mechanisms behind tumorigenesis, Cancers, vol. 15, no. 12, p. 3247.
[18]. Jonason, J. H., Xiao, G., Zhang, M., Xing, L., Chen, D., 2009, Post-translational regulation of Runx2 in bone and cartilage, J Dent Res, vol. 88, no. 8, p. 693–703.
[19]. Sekaran, S., Vimalraj, S., Thangavelu, L., 2021, The physiological and pathological role of tissue nonspecific alkaline phosphatase beyond mineralization, Biomolecules, vol. 11, no. 11.
[20]. Amirrah, I. N., Lokanathan, Y., Zulkiflee, I., Wee, M. F. M. R., Motta, A., Fauzi, M. B., 2022, A comprehensive review on collagen type I development of biomaterials for tissue engineering: from biosynthesis to bioscaffold, Biomedicines, vol. 10, no. 9.
[21]. Selvaraj, V., Sekaran, S., Dhanasekaran, A., Warrier, S., 2024, Type 1 collagen: synthesis, structure, and key functions in bone mineralization, Differentiation, p. 100757.
[22]. Saito, M., Kida, Y., Kato, S., Marumo, K., 2014, Diabetes, collagen, and bone quality, Curr Osteoporos Rep, vol. 12, no. 2, p. 181–8.
[23]. Zaitseva, O. V., Shandrenko, S. G., Veliky, M. M., 2015, Biochemical markers of bone collagen type I metabolism, Ukr Biochem J, vol. 87, no. 1, p. 21–32.
[24]. Kim, E. C., Park, J., Kwon, I. K., Lee, S. W., Park, S. J., Ahn, S. J., 2017, Static magnetic fields promote osteoblastic/cementoblastic differentiation in osteoblasts, cementoblasts, and periodontal ligament cells, J Periodontal Implant Sci, vol. 47, no. 5, p. 273–91.
[25]. Vimalraj, S., Govindarajan, D., Sudhakar, S., Suresh, R., Palanivel, P., Sekaran, S., 2024, Chitosan-derived chito-oligosaccharides promote osteoblast differentiation and offer anti-osteoporotic potential: molecular and morphological evidence from a zebrafish model, Int J Biol Macromol, vol. 259, p. 129250.
[26]. Govindarajan, D., Saravanan, S., Sudhakar, S., Vimalraj, S., 2023, Graphene: a multifaceted carbon-based material for bone tissue engineering applications, ACS Omega, vol. 9, no. 1, p. 67–80.
Viewed PDF 21 0 -
A Study of Correlation between Morphometric Measurement of Lumbar Region with levels of Calcium and Vitamin D in Low Back Pain IndividualsAuthor: G. Bhavani SujathaDOI: 10.21522/TIJPH.2013.13.01.Art012
A Study of Correlation between Morphometric Measurement of Lumbar Region with levels of Calcium and Vitamin D in Low Back Pain Individuals
Abstract:
This study aimed to identify morphometric abnormalities in the lumbar spine and their correlation with serum biomarkers, including calcium and vitamin D in individuals with low back pain (LBP). The prospective study was conducted at GSL Medical College Rajahmundry and included 412 participants over 18 years old with LBP. Detailed clinical histories were recorded, fasting blood samples were collected, and lumbar spine MRIs were assessed. Significant differences in disc heights were noted in the L3-L4 and L5-S1 regions. Biomarkers such as Serotransferrin (TRF), alpha-2-macroglobulin (AMG), alpha-1-antitrypsin (AAT), alpha-1-acid glycoprotein 1 (AAG), alpha-1-acid glycoprotein 2 (AGP2) and alpha-1B-glycoprotein (A1BG) were quantified using ELISA and nephelometry. Despite no significant variation in serum calcium and vitamin D levels between pain groups, statistically significant differences in the levels of TRF (P < 0.01), AAT (P < 0.01), AAG (P < 0.01), AGP2 (P < 0.01) and A1BG (P < 0.05) were observed. The findings suggest that lumbar disc morphology and specific serum biomarkers may play a role in LBP pathogenesis.
A Study of Correlation between Morphometric Measurement of Lumbar Region with levels of Calcium and Vitamin D in Low Back Pain Individuals
References:
[1]. Sharma, M., Kishore, A., Roy, D., & Joshi, K., 2020, A comparison of the Indian diet with the EAT-Lancet reference diet. BMC Public Health, 20(1), 1–13.
[2]. Khanna, M., Dahiya, A., Garg, A., Yadav, U., Sheoran, A., Dutta, M., Singh, L., Sharma, R., & Amit, 2021, Estimation of vitamin D level in low backache cases and their outcome after treatment with vitamin D. International Journal of Research in Orthopaedics, 7(1), 120–124.
[3]. Aparna, P., Muthathal, S., Nongkynrih, B., & Gupta, S. K., 2018, Vitamin D deficiency in India. Journal of Family Medicine and Primary Care, 7(2), 324.
[4]. Goyal, V., & Agrawal, M., 2021, Effect of supplementation of vitamin D and calcium on patients suffering from chronic non-specific musculoskeletal pain: A pre-post study. Journal of Family Medicine and Primary Care, 10(5), 1839.
[5]. Catharine Ross, A., Taylor, C. L., Yaktine, A. L., & Del Valle, H. B., 2011, Overview of Calcium. In Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press (US).
[6]. Wu, A., March, L., Zheng, X., Huang, J., Wang, X., Zhao, J., Blyth, F. M., Smith, E., Buchbinder, R., & Hoy, D., 2020, Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the Global Burden of Disease Study 2017. Annals of Translational Medicine, 8(6), 299–299.
[7]. Yadav, U., Singh, V., Bhargava, N., Srivastav, A. K., Neyaz, Z., Phadke, R. V., & Mishra, P., 2020, Lumbar Canal Diameter Evaluation by CT Morphometry-Study of Indian Population. International Journal of Spine Surgery, 14(2), 175–181.
[8]. Diatchenko, L., Fillingim, R. B., Smith, S. B., & Maixner, W., 2013, The phenotypic and genetic signatures of common musculoskeletal pain conditions. Nature Reviews Rheumatology, 9(6), 340–350.
[9]. Ghai, B., Bansal, D., Kanukula, R., Gudala, K., Sachdeva, N., Dhatt, S. S., & Kumar, V., 2017, Vitamin D Supplementation in Patients with Chronic Low Back Pain: An Open Label, Single Arm Clinical Trial. Pain Physician, 20(1), E99–E105.
[10]. Whitney, E., & Alastra, A. J., 2023, Vertebral Fracture. In StatPearls [Internet]. StatPearls Publishing.
[11]. Méndez-Sánchez, L., Clark, P., Winzenberg, T. M., Tugwell, P., Correa-Burrows, P., & Costello, R., 2023, Calcium and vitamin D for increasing bone mineral density in premenopausal women. The Cochrane Database of Systematic Reviews, 1(1), CD012664.
[12]. Frassetto, L., Banerjee, T., Powe, N., & Sebastian, A., 2018, Acid Balance, Dietary Acid Load, and Bone Effects-A Controversial Subject. Nutrients, 10(4), 517.
[13]. Saxena, A. K., Chilkoti, G. T., Singh, A., & Yadav, G., 2019, Pregnancy-induced Low Back Pain in Indian Women: Prevalence, Risk Factors, and Correlation with Serum Calcium Levels. Anesthesia Essays and Researches, 13(2), 395.
[14]. Wacker, M., & Holick, M. F., 2013, Sunlight and Vitamin D: A global perspective for health. Dermato-endocrinology, 5(1), 51–108. https://doi.org/10.4161/derm.24494
[15]. G, R., & Gupta, A., 2014, Vitamin D deficiency in India: prevalence, causalities and interventions. Nutrients, 6(2), 729–775. https://doi.org/10.3390/nu6020729
[16]. Harinarayan, C. V., Holick, M. F., Prasad, U. V., Vani, P. S., & Himabindu, G., 2013, Vitamin D status and sun exposure in India. Dermato-endocrinology, 5(1), 130–141. https://doi.org/10.4161/derm.23873
[17]. Amrein, K., Scherkl, M., Hoffmann, M., Neuwersch-Sommeregger, S., Köstenberger, M., Tmava Berisha, A., Martucci, G., Pilz, S., & Malle, O., 2020, Vitamin D deficiency 2.0: an update on the current status worldwide. European Journal of Clinical Nutrition, 74(11), 1498–1513. https://doi.org/10.1038/s41430-020-0558-y
[18]. Khanna, Mohit, Amit Dahiya, Abhishek Garg, Umesh Yadav, Ajay Sheoran, Mayank Dutta, Lovjot Singh, Rakesh Sharma, and Amit, 2021, “Estimation of Vitamin D Level in Low Backache Cases and Their Outcome after Treatment with Vitamin D.” International Journal of Research in Orthopaedics 7 (1): 120–24.
[19]. Vincent, F., Gralka, M., Schleyer, G. et al., 2023, Viral infection switches the balance between bacterial and eukaryotic recyclers of organic matter during coccolithophore blooms. Nat Commun 14, 510 https://doi.org/10.1038/s41467-023-36049-3
[20]. Jeffrey K. Pinto, Kate Davis, Lavagnon A., Ika, Kam Jugdev, Ofer Zwikael, 2022, Coming to terms with project success: Current perspectives and future challenges, International Journal of Project Management, Volume 40, Issue 7.
[21]. Tarantino, U., Fanucci, E., Iundusi, R., Celi, M., Altobelli, S., Gasbarra, E., Simonetti, G., & Manenti, G., 2013, Lumbar spine MRI in upright position for diagnosing acute and chronic low back pain: statistical analysis of morphological changes. Journal of Orthopaedics and Traumatology: Official Journal of the Italian Society of Orthopaedics and Traumatology, 14(1), 15–22. https://doi.org/10.1007/s10195-012-0213-z
Viewed PDF 30 1 -
Knowledge and Attitude towards Human Papilloma Virus Vaccine among Female Undergraduate Students in Kano, NigeriaAuthor: Usman Muhammad IbrahimDOI: 10.21522/TIJPH.2013.13.01.Art013
Knowledge and Attitude towards Human Papilloma Virus Vaccine among Female Undergraduate Students in Kano, Nigeria
Abstract:
Human papillomavirus (HPV) is associated with the huge burden of cervical cancer in sub-Saharan Africa. This study aimed to assess the knowledge and attitude of female undergraduate students towards HPV infection and the HPV vaccine. A descriptive cross-sectional study was used to study 204 female undergraduate students selected using a multistage sampling technique. Data were analyzed using IBM SPSS version 22.0 with a statistical significance set at P ≤ 0.05. The minimum and maximum ages of respondents were 17 and 40 years with a mean± SD of 22.4±3.4 years. About two-thirds of the students had a monthly income of <#18,000. Only 38% of the students had good knowledge while more than half of the students (55.0%) had negative attitudes towards HPV and HPV vaccines. The majority (94.5%) had the attitude attributable to lack of awareness, (18.0%) due to the number of doses required, (26.5%) due to perceived reason for increased sexual promiscuity, and having one or no sexual partner (25.5%) respectively. A significantly higher proportion (69.2%, p=0.01) of students from other ethnic groups had good knowledge of HPV and HPV infection. Similarly, a significantly higher proportion of students with good knowledge (50.5%, p=0.001) were from science-based faculty. However, a significantly higher proportion of students having a positive attitude towards HPV and HPV vaccine were in their final college year (68.8%, p=0.02). The knowledge and attitude of the undergraduate students towards HPV infection and vaccine were suboptimal. The government and relevant stakeholders should intensify social mobilization activities on the importance and benefits of the HPV vaccine and the prevention of HPV infection.
Knowledge and Attitude towards Human Papilloma Virus Vaccine among Female Undergraduate Students in Kano, Nigeria
References:
[1]. Khatiwada M., Kartasasmita C., Mediani H. S., Delprat C., Van Hal G., Dochez C., 2021, Knowledge, Attitude and Acceptability of the Human Papilloma Virus Vaccine and Vaccination Among University Students in Indonesia, Front Public Health, 14;9:616456. doi: 10.3389/fpubh.2021.616456.
[2]. Rahman M., R. A., Emdadul S., Golam M., Sharmin N. R., Choudhury S. A.,2013, Beating Cervical Cancer in the Developed Countries: A Dream or a Reality?, Current Topics in Public Health, InTech. Available from: http://dx.doi.org/10.5772/52881
[3]. Zizza A., Banchelli F., Guido M., Marotta C., Di Gennaro F., Mazzucco W., Pistotti V., D'Amico R.,2021, Efficacy and safety of human papillomavirus vaccination in HIV-infected patients: a systematic review and meta-analysis, Sci Rep, 2;11(1):4954. doi: 10.1038/s41598-021-83727-7.
[4]. Correa T., Teixeira J., Aurélio M., Oliveira P De.,2018, Knowledge on the HPV vaccine among university students, J sao paulo Inst Trop Med, 1–8.
[5]. Onowhakpor A. O., Omuemu V. O., Osagie O. L., Odili C. G., 2021, Human Papilloma Virus Vaccination: Knowledge, Attitude and Uptake among Female Medical and Dental Students in a Tertiary Institution in Benin-City, Nigeria. Journal of Community Medicine and Primary Health Care, 28 (2) 101-108.
[6]. Rashid S., Labani S., Das B. C., 2016, Knowledge, Awareness and Attitude on HPV, HPV Vaccine and Cervical Cancer among the College Students in India, PLoS One, 18;11(11):e0166713. doi: 10.1371/journal.pone.0166713.
[7]. Gonçalves A. K., Cobucci R. N., Rodrigues H. M., de Melo A. G., Giraldo P. C.,2014, Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review, Braz J Infect Dis, 18(6):651-9. doi: 10.1016/j.bjid.2014.02.005.
[8]. Ortiz R. R., Smith A., Coyne-Beasley T.,2019, A systematic literature review to examine the potential for social media to impact HPV vaccine uptake and awareness, knowledge, and attitudes about HPV and HPV vaccination, Hum Vaccin Immunotherapy, 15(7-8):1465-1475. doi: 10.1080/21645515.2019.1581543.
[9]. Hoque M., Hoque E., Kader S. B., 2008, Evaluation of cervical cancer screening program at a rural community of South Africa, East Afr J Public Health , 5(2):111-6.
[10]. Yu C., Chen L., Ruan G., An J., Sun P.,2020, Evaluation of Knowledge and Attitude Toward HPV and Vaccination Among Medical Staff, Medical Students, and Community Members in Fujian Province, Risk Manag Health Policy, 3;13:989-997. doi: 10.2147/RMHP.S243048.
[11]. Gupta P., Kaveeshwar M., Patil A., 2020, Awareness and knowledge of cervical cancer in medical and paramedical staff-an observational study, Indian J Obstet Gynecol Res, 7(1):28-32
[12]. Villanueva S., Mosteiro-Miguéns D. G., Domínguez-Martís E. M., López-Ares D., Novío S.,2019, Knowledge, Attitudes, and Intentions towards Human Papillomavirus Vaccination among Nursing Students in Spain, Int J Environ Res Public Health, 15;16(22):4507. doi: 10.3390/ijerph16224507.
[13]. Almobarak A. O., Elbadawi A. A., Elmadhoun W. M., Elhoweris M. H., Ahmed M. H.,2016, Knowledge, Attitudes and Practices of Sudanese Women Regarding the Pap Smear Test and Cervical Cancer, Asian Pac J Cancer Prev, 17(2):625-30. doi: 10.7314/apjcp.2016.17.2.625.
[14]. Almazrou S., Saddik B., Jradi H., 2020, Knowledge, attitudes, and practices of Saudi physicians regarding cervical cancer and the human papilloma virus vaccine, J Infect Public Health, (4):584-590. doi: 10.1016/j.jiph.2019.09.002
[15]. Amukugo H. J., Rungayi B. R., Karera A., 2018, Awareness , knowledge , attitude and practices regarding human papilloma virus among female students at the University of Namibia , Int Journ of Hea Car, 4(2):51–7.
[16]. Oluwole E. O., Idowu O. M., Adejimi A. A., Balogun M. R., Osanyin G. E.,2019, Knowledge, attitude and uptake of human papillomavirus vaccination among female undergraduates in Lagos State, Nigeria, J Family Med Prim Care, 15;8(11):3627-3633. doi: 10.4103/jfmpc.jfmpc_520_19.
[17]. Markowitz L. E., Schiller J. T., 2021, Human Papillomavirus Vaccines. J Infect Dis, 224(12 Suppl 2):S367-S378. doi: 10.1093/infdis/jiaa621.
[18]. Iliyasu Z., Galadanci H. S., Muhammad A., Iliyasu B. Z., Umar A. A., Aliyu M. H., 2022, Correlates of human papillomavirus vaccine knowledge and acceptability among medical and allied health students in Northern Nigeria, J Obstet Gynaecol, 42(3):452-460. doi: 10.1080/01443615.2021.1910639.
[19]. Isara A. R., Osayi N., 2021, Knowledge of Human Papillomavirus and Uptake of its Vaccine among Female Undergraduate Students of Ambrose Alli University, Ekpoma, Nigeria, JournaL of Community Medicine and Primary Health Care, 33(1): .64-72. doi; https://dx.doi.org/10.4314/jcmphc.v33i1.6
[20]. Wang X., Huang X., Zhang Y., 2018, Involvement of Human Papillomaviruses in Cervical Cancer, Front Microbiol, 28;9:2896. doi: 10.3389/fmicb.2018.02896
[21]. What to Read Next on Medscape Related Conditions, 2021.
[22]. Paterson P., Mounier-Jack S., Saliba V., Yarwood J., White J., Ramsay M., Chantler T., 2021, Strengthening HPV vaccination delivery: findings from a qualitative service evaluation of the adolescent girls' HPV vaccination programme in England, J Public Health (Oxf), 43(1):189-196. doi:10.1093/pubmed/fdz061.
[23]. Rathod S., Potdar J., Gupta A., Sethi N., Dande A., 2023, Empowering Women's Health: Insights Into HPV Vaccination and the Prevention of Invasive Cervical Cancer, Cureus, 15(11):e49523. doi: 10.7759/cureus.49523.
[24]. Simoens C., Sabbe M., Van Damme P., Beutels P., Arbyn M.,2009, Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008, Euro Surveill, 19;14(46):19407
[25]. Harbaugh, Kristina L., 2020, "Attitudes Toward the HPV Vaccine among University Students: Identifying Barriers to Vaccine Uptake", Electronic Theses and Dissertations, 2077. https://digitalcommons.georgiasouthern.edu/etd/2077
[26]. Perlman S., Wamai R. G., Bain P. A., Welty T., Welty E., Ogembo J. G.,2014, Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: A Systematic Review, PLoS One, 11;9(3):e90912. doi: 10.1371/journal.pone.0090912.
[27]. Liu Y., Di N., Tao X.,2020, Knowledge, practice and attitude towards HPV vaccination among college students in Beijing, China, Hum Vaccin Immunotherapy, 16(1):116-123. doi: 10.1080/21645515.2019.1638727.
[28]. Swarnapriya K., Kavitha D., Reddy G. M.,2015 Knowledge, Attitude and Practices Regarding HPV Vaccination Among Medical and Para Medical in Students, India a Cross Sectional Study, Asian Pac J Cancer Prev, 16(18):8473-7. doi: 10.7314/apjcp.2015.16.18.8473.
[29]. AbdAllah A. A. A., Hummeida M. E., Elmula I. M. F., 2016, Awareness and Attitudes of Nursing Students towards Prevention of Cervical Cancer. Cervical Cancer, 1:106. doi:10.4172/2475-3173.1000106
[30]. Kisaakye E., Namakula J., Kihembo C., Kisakye A., Nsubuga P., Babirye J. N., 2018, Level and factors associated with uptake of human papillomavirus infection vaccine among female adolescents in Lira District, Uganda, Pan Afr Med J, 15;31:184. doi: 10.11604/pamj.2018.31.184.14801.
[31]. Nickel B., Dodd R. H., Turner R. M., Waller J., Marlow L., Zimet G., Ostini R., McCaffery K.,2017, Factors associated with the human papillomavirus (HPV) vaccination across three countries following vaccination introduction, Prev Med Rep, 10;8:169-176. doi: 10.1016/j.pmedr.2017.10.005.
[32]. Shetty S., Prabhu S., Shetty V., Shetty A. K.,2019, Knowledge, attitudes and factors associated with acceptability of human papillomavirus vaccination among undergraduate medical, dental and nursing students in South India, Hum Vaccin Immunother, 15(7-8):1656-1665. doi: 10.1080/21645515.2019.1565260.
Viewed PDF 38 2 -
Advancing Healthcare Equity: The Impact of Decentralised Nursing and Allied Health Education in GuyanaAuthor: Chandroutie Persaud-BahadurDOI: 10.21522/TIJPH.2013.13.01.Art014
Advancing Healthcare Equity: The Impact of Decentralised Nursing and Allied Health Education in Guyana
Abstract:
Decentralised nursing education has emerged as a pivotal strategy for addressing workforce shortages and promoting equitable access to quality healthcare. This article analyses the impact of decentralised nursing and clinical and technical programmes offered through the Ministry of Health in Guyana and how they can help address shortages of healthcare workers and promote equitable access to quality healthcare. Attempts to increase diversity within the healthcare profession have resulted in more ethnically diverse students enrolling on nursing education programmes. One of the critical challenges faced by nursing and clinical education programmes in Guyana is the limited capacity of centralised institutions to accommodate many students. As a result, there is a need to explore alternative methods of delivering nursing and clinical education to meet the increasing health sector demand. Decentralised nursing and clinical education provide a solution to this challenge by bringing nursing and clinical education programmes closer to the communities in need. The paper uses empirical evidence collected from 2019 -2024 on four (4) decentralised training programmes: the nursing assistant, community health worker, pharmacy assistant, and medical laboratory technician training programmes. It examines the reasons behind decentralised education, its implementation in Guyana, and its various impacts on nursing practice, education, and healthcare outcomes. The rapid expansion in healthcare facilities throughout Guyana would demand an increase in the number of healthcare workers trained. This research has significant findings that show the impact of decentralising nursing and clinical education, which could be deemed one of the main sources of increasing the number of healthcare workers, improving healthcare accessibility, empowering local communities, and strengthening its health workforce.
Advancing Healthcare Equity: The Impact of Decentralised Nursing and Allied Health Education in Guyana
References:
[1]. Central Intelligence Agency, 2021, South America: Guyana. In The World Factbook. https://www.cia.gov/the-world-factbook/countries/guyana/
[2]. Nursing Council of Guyana, 2017, Decentralisation of nursing education in Guyana: Project brief. Georgetown, Guyana.
[3]. Pijl-Zieber, E. M., Barton, S., Konkin, J., Awosoga, O., Caine, V., 2014, Competence and competency-based nursing education: Finding our way through the issues. Nurse Educ Today. 34(5):676-8. https://doi.org/10.1016/j.nedt.2013.09.007
[4]. Bureau of Statistics, 2024, Health institutions by type and by region, Guyana: 2024. Bureau of Statistics. https://statisticsguyana.gov.gy
[5]. Health Sciences Education, 2023, Careers in health booklet, Ministry of Health, Guyana.
[6]. Villiers, M. D., Schalkwyk, S. V., Blitz, J., et al., 2017, Decentralised training for medical students: A scoping review. BMC Med Educ. https://doi.org/10.1186/s12909-017-1050-9
[7]. Eriksen, L. T., Huemer, J. E., 2019, The contribution of decentralised nursing education to social responsibility in rural Arctic Norway. Int J Circumpolar Health. 78(1). https://doi.org/10.1080/22423982.2019.1691706
[8]. World Health Organization, 2020, State of the world's nursing report: Investing in education, jobs, and leadership. Geneva: WHO Press.
[9]. Skaalvik, M. W., Gaski, M., Norbye, B., 2014, Decentralized nursing education in Northern Norway: A basis for continuing education to meet competence needs in rural Arctic healthcare services. Int J Circumpolar Health. 73:25328. https://doi.org/10.3402/ijch.v73.25328
[10]. Norbye, B., Skaalvik, M. W., 2013, Decentralized nursing education in Northern Norway: Towards a sustainable recruitment and retention model in rural Arctic healthcare services. Int J Circumpolar Health. 72(1):22793. https://doi.org/10.3402/ijch.v72i0.22793
[11]. Norbye, B., Butler, L., Exner-Pirot, H., 2018, Under the same sky: Connecting students and cultures through circumpolar nursing education. Healthcare. 6(2):50. https://doi.org/10.3390/healthcare6020050
[12]. Bac, M., Bergh, A. M., Etsane, M. E., Hugo, J., 2015, Medical education and the quality improvement spiral: A case study from Mpumalanga, South Africa. Afr J Prim Health Care Fam Med. 7(1):10. https://doi.org/10.4102/phcfm.v7i1.738
[13]. Garneau, A. B., Bélisle, M., Lavoie, P., Sédillot, C. L., 2021, Integrating equity and social justice for indigenous peoples in undergraduate health professions education in Canada: A framework from a critical review of literature. Int J Equity Health. 20(1). https://doi.org/10.1186/s12939-021-01475-6
[14]. Talib, Z., Couper, I., Pattanaik, S., et al., 2017. Medical education in decentralized settings: How medical students contribute to health care in 10 Sub-Saharan African countries. Acad Med. 92(12):1723. https://doi.org/10.1097/ACM.0000000000002003
[15]. Faguet, J. P., Sánchez, F. M., Ambel, A. A., 2019, Decentralization's effects on education and health in Ethiopia. Retrieved from [PDF] Decentralization_s_effects_on_education_health_in_Ethiopia_v3.pdfDecentralization's effects on education and health: Evidence from Ethiopia
[16]. Russell, D., Mathew, S., Fitts, M., et al., 2021, Interventions for health workforce retention in rural and remote areas: A systematic review. Hum Resour Health. 19:103. https://doi.org/10.1186/s12960-021-00643-7
[17]. Health Sciences Education, 2023, Annual report 2023, Ministry of Health, Guyana.
[18]. Gaede, B., 2018, Decentralised clinical training of health professionals will expand the training platform and enhance the competencies of graduates. S Afr Med J. 108(6):451. https://doi.org/10.7196/samj.2018.v108i6.13214
[19]. Health Sciences Education, 2024, Student population 2019-2024, Ministry of Health, Guyana.
[20]. Greenhill, J. A., Walker, J., Playford, D., 2015, Outcomes of Australian rural clinical schools: A decade of success building the rural medical workforce through the education and training continuum. Rural Remote Health. 15(3):2991. https://pubmed.ncbi.nlm.nih.gov/26377746
Viewed PDF 27 1 -
Aspergillus flavus Mediated Extracellular One-pot Synthesis of Zirconium and Titanium Oxide Nanoparticles and their Antioxidant and Anti-inflammatory Efficacy StudyAuthor: Anitha RoyDOI: 10.21522/TIJPH.2013.13.01.Art015
Aspergillus flavus Mediated Extracellular One-pot Synthesis of Zirconium and Titanium Oxide Nanoparticles and their Antioxidant and Anti-inflammatory Efficacy Study
Abstract:
The present study reports the extracellular one-pot synthesis of zirconium and titanium oxide nanoparticles (Zr/TiO-NPs) mediated by Aspergillus flavus. This green synthesis approach leverages the bio-reductive capabilities of fungal metabolites, providing an environmentally friendly and efficient method for nanoparticle synthesis . The synthesized nanoparticles were evaluated for their antioxidant and anti-inflammatory activities. Antioxidant activity, assessed at varying concentrations (20–80 µg/ml), demonstrated a concentration-dependent manner , with the highest activity observed at 80 µg/ml. Similarly, the anti-inflammatory efficacy, determined using the albumin denaturation method, revealed maximum activity at 100 µg/ml and the lowest at 20 µg/ml, highlighting their potential to mitigate inflammatory responses. These findings underscore the potential of Aspergillus flavus Zr/TiO-NPs as promising agents for biomedical applications, particularly in combating oxidative stress and inflammation.
Aspergillus flavus Mediated Extracellular One-pot Synthesis of Zirconium and Titanium Oxide Nanoparticles and their Antioxidant and Anti-inflammatory Efficacy Study
References:
[1]. Krishnaswamy, K., Orsat, V., 2017, Sustainable delivery systems through green nanotechnology. In Nano-and microscale drug delivery systems Elsevier. (PP 17-32). https://doi.org/10.1016/B978-0-323-52727-9.00002-9
[2]. Karthiga, P., Ponnanikajamideen, M., Samuel Rajendran, R., Annadurai, G., Rajeshkumar, S., 2019, Characterization and toxicology evaluation of zirconium oxide nanoparticles on the embryonic development of zebrafish, Daniorerio. Drug & Chemical Toxicology, 42(1).https://doi.org/10.1080/01480545.2018.1523186
[3]. Aleem, A. R., Shahzadi, L., Nasir, M., Hajivand, P., Alvi, F., Akhtar, A., Yar, M., 2022, Developing sulfur‐doped titanium oxide nanoparticles loaded chitosan/cellulose‐based proangiogenic dressings for chronic ulcer and burn wounds healing. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 110(5), 1069-1081.https://doi.org/10.1002/jbm.b.34981
[4]. Fouda, A., Awad, M. A., Al-Faifi, Z. E., Gad, M. E., Al-Khalaf, A. A., Yahya, R., Hamza, M. F., 2022, Aspergillus flavus-mediated green synthesis of silver nanoparticles and evaluation of their antibacterial, anti-candida, acaricides, and photocatalytic activities. Catalysts, 12(5), 462. https://doi.org/10.3390/catal12050462
[5]. Shravani, V. P., Sundari, S. K., Jeyachandran, S., Nagesh, S., 2023, Green synthesis and characterization of Xanthium strumarium-mediated titanium dioxide nanoparticles. Cureus, 15(12). https://doi.org/10.7759/cureus.51012.
[6]. Veerabhadraswamy, B. N., Pradeep, H. K., Swaroop, K., Manoj, K. M., Nadigar, M. D., Patel, M. A., Bhagya, N. P., 2024, Green synthesis and characterization of Zirconium Oxide with antimicrobial activities. In IOP Conference Series: Materials Science and Engineering (Vol. 1300, No. 1, p. 012036). IOP Publishing. doi:10.1088/1757-899X/1300/1/012036
[7]. Majedi, A., Abbasi, A., &Davar, F., 2016, Green synthesis of zirconia nanoparticles using the modified Pechini method and characterization of its optical and electrical properties. Journal of Sol-Gel Science and Technology, 77, 542-552. doi:10.1007/s10971-015-3881-3
[8]. Swathi, N., Sandhiya, D., Rajeshkumar, S., Lakshmi, T., 2019, Green synthesis of titanium dioxide nanoparticles using Cassia fistula and its antibacterial activity. Int. J. Res. Pharm. Sci, 10(2), 856-860. doi:10.26452/ijrps.v10i2.261
[9]. Al-Soub, A., Khleifat, K., Al-Tarawneh, A., Al-Limoun, M., Alfarrayeh, I., Al Sarayreh, A., Albashaireh, A., 2022, Silver nanoparticles biosynthesis using an airborne fungal isolate, Aspergillus flavus: optimization, characterization and antibacterial activity. Iranian Journal of Microbiology, 14(4), 518. doi: 10.18502/ijm.v14i4.10238.
[10]. Dhar, S. A., Chowdhury, R. A., Das, S., Nahian, M. K., Islam, D., Gafur, M. A., 2021, Plant-mediated green synthesis and characterization of silver nanoparticles using Phyllanthusemblica fruit extract. Materials Today: Proceedings, 42, 1867-1871. doi:10.1016/j.matpr.2020.12.222.
[11]. HabeebRahman, H. B., Dhandapani, R., Narayanan, S., Palanivel, V., Paramasivam, R., Subbarayalu, R., Muthupandian, S., 2022, Medicinal plants mediated the green synthesis of silver nanoparticles and their biomedical applications. IET nanobiotechnology, 16(4), 115-144. https://doi.org/10.1049/nbt2.12078.
[12]. Al-Zaqri, N., Muthuvel, A., Jothibas, M., Alsalme, A., Alharthi, F. A., Mohana, V., 2021, Biosynthesis of zirconium oxide nanoparticles using Wrightiatinctoria leaf extract: characterization, photocatalytic degradation and antibacterial activities. Inorganic Chemistry Communications, 127, 108507. https://doi.org/10.1016/j.inoche.2021.108507
[13]. Aravind, M., Ramanathan, M., Mary, M. S. M., 2021, Synthesis of TiO 2 nanoparticles by chemical and green synthesis methods and their multifaceted properties. SN Applied Sciences, 3, 1-10.https://doi.org/10.1007/s42452-021-04281-5.
[14]. Putluru, S., Snega, R., Sravanthy, P. G., Saravanan, M., 2024, One-Pot Synthesis of Silver/Zirconium Nanoparticles Using Sargassumtenerrimum for the Evaluation of Their Antibacterial and Antioxidant Activities. Cureus, 16(6), e61779. https://doi.org/10.7759/cureus.61779.
[15]. Mohammed, E. J., Abdelaziz, A. E., Mekky, A. E., Mahmoud, N. N., Sharaf, M., Al-Habibi, M. M., Shoun, A. A., 2024, Biomedical Promise of Aspergillus Flavus-Biosynthesized Selenium Nanoparticles: A Green Synthesis Approach to Antiviral, Anticancer, Anti-Biofilm, and Antibacterial Applications. Pharmaceuticals, 17(7), 915. doi:10.3390/ph17070915
[16] Degola, F., Marzouk, B., Gori, A., Brunetti, C., Dramis, L., Gelati, S., Restivo, F. M., 2019, Aspergillus flavus as a model system to test the biological activity of botanicals: An example on CitrulluscolocynthisL. schrad. organic extracts. Toxins, 11(5), 286.doi: 10.3390/toxins11050286.
Viewed PDF 26 0 -
The Role of Cytokine Biomarkers in Assessing Lumbar Degenerative Disorders and Associated Comorbid ConditionsAuthor: G. Bhavani SujathaDOI: 10.21522/TIJPH.2013.13.01.Art016
The Role of Cytokine Biomarkers in Assessing Lumbar Degenerative Disorders and Associated Comorbid Conditions
Abstract:
Interleukins, a category of cytokines, are crucial in the inflammatory mechanisms associated with Lumbar degenerative disorders (LDD). This study evaluated the correlation between cytokine biomarkers and demographic, socioeconomic, and occupational factors in persons diagnosed with LDD. An investigation was carried out on 112 patients diagnosed with low back pain (LBP) at GSL from December 2021 to January 2023 Medical College, Rajahmundry. The concentrations of interleukins (IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, and IL-13) in the blood were quantified utilizing multiplex fluorescent antibody assays. The study included 62 males and 50 females, with a mean age of 48.3 years. A notable correlation existed between increased IL-6 levels and patients with LBP compared to controls (P < 0.05). Positive relationships were seen between IL-6 levels and age, body mass index (BMI), and illness duration. Extended sitting and socioeconomic status were significant risk factors for low back pain (P = 0.042). Patients diagnosed with degenerative disc disease (DDD) and spinal stenosis (SS) had elevated levels of IL-6 compared to persons with disc herniation (DH). Elevated circulating levels of IL-6 are correlated with LDD and demonstrate an association with age, BMI, and symptom duration. Socioeconomic factors and work practices significantly influence the occurrence of LBP. The findings suggest that cytokine biomarkers, particularly IL-6, may serve as significant indicators for assessing the severity and course of LDD. It is recommended that we undertake further extensive investigations to validate these findings and explore therapy strategies centred on cytokine regulation.
The Role of Cytokine Biomarkers in Assessing Lumbar Degenerative Disorders and Associated Comorbid Conditions
References:
[1]. Ambrosio, L., Mazzuca, G., Maguolo, A., Russo, F., Cannata, F., Vadalà, G., Maffeis, C., Papalia, R., & Denaro, V., 2023, The burden of low back pain in children and adolescents with overweight and obesity: from pathophysiology to prevention and treatment strategies. Therapeutic Advances in Musculoskeletal Disease, 15, 1759720X231188831. https://doi.org/10.1177/1759720X231188831
[2]. Arvidson, N. G., Gudbjörnsson, B., Elfman, L., Rydén, A. C., Tötterman, T. H., & Hällgren, R., 1994, Circadian rhythm of serum interleukin-6 in rheumatoid arthritis.Annals of the Rheumatic Diseases, 53(8), 521–524. https://doi.org/10.1136/ard.53.8.521
[3]. Bansal, D., Dipika, Asrar, Mir, Pushpendra, Dhanuk, 2020, Prevalence and impact of low back pain in a community-based population in northern India. Pain Physician, 4;23(7;4), E389–E398. https://doi.org/10.36076/ppj.2020/23/e389
[4]. Bento, T. P. F., Genebra, C. V. D. S., Maciel, N. M., Cornelio, G. P., Simeão, S. F. A. P., & Vitta, A. de. 2020, Low back pain and some associated factors: is there any difference between genders? Brazilian Journal of Physical Therapy, 24(1), 79–87. https://doi.org/10.1016/j.bjpt.2019.01.012
[5]. Clark, A. K., Old, E. A., & Malcangio, M., 2013, Neuropathic pain and cytokines: current perspectives. Journal of Pain Research, 6, 803–814. https://doi.org/10.2147/JPR.S53660
[6]. Dandona, L., Singh, G., & India State-Level Disease Burden Initiative Neurological Disorders Collaborators. 2021, Challenges in estimating the burden of neurological disorders across Indian states - Authors’ reply. The Lancet. Global Health, 9(11), e1504. https://doi.org/10.1016/S2214-109X(21)00412-5
[7]. De Geer, C. M., 2018, Cytokine involvement in biological inflammation related to degenerative disorders of the intervertebral disk: A narrative review. Journal of Chiropractic Medicine, 17(1), 54–62. https://doi.org/10.1016/j.jcm.2017.09.003
[8]. Ganesan, S., Acharya, A. S., Chauhan, R., & Acharya, S., 2017, Prevalence and risk factors for low back pain in 1,355 young adults: A cross-sectional study. Asian Spine Journal, 11(4), 610–617. https://doi.org/10.4184/asj.2017.11.4.610
[9]. Heuch, I., Hagen, K., Heuch, I., Nygaard, Ø., & Zwart, J.-A., 2010, The impact of body mass index on the prevalence of low back pain: the HUNT study: The HUNT study.
[10]. Spine, 35(7), 764–768. https://doi.org/10.1097/BRS.0b013e3181ba1531
[11]. Koch, A., Zacharowski, K., Boehm, O., Stevens, M., Lipfert, P., von Giesen, H.-J., Wolf, A., & Freynhagen, R., 2007., Nitric oxide and pro-inflammatory cytokines correlate with pain intensity in chronic pain patients. Et Al [Inflammation Research], 56(1), 32–37. https://doi.org/10.1007/s00011-007-6088-4
[12]. Singal, S., Singh, H., & Kumar, P., 2019, a Low back pain- the metabolic disease. Journal of Evolution of Medical and Dental Sciences, 8(11), 774–776. https://doi.org/10.14260/jemds/2019/170
[13]. Singal, S., Singh, H., & Kumar, P., 2019, b. Low back pain-the metabolic disease. J Evol Med Dent Sci, 8(11), 774–777.
[14]. Singh, T., & Newman, A. B., 2011, Inflammatory markers in population studies of aging. Ageing Research Reviews, 10(3), 319–329. https://doi.org/10.1016/j.arr.2010.11.002
[15]. Strömqvist, F., Strömqvist, B., Jönsson, B., & Karlsson, M. K., 2016, Gender differences in patients scheduled for lumbar disc herniation surgery: a National Register Study including 15,631 operations. European Spine Journal: Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 25(1), 162–167. https://doi.org/10.1007/s00586-015-4052-5
Viewed PDF 20 0 -
Targeting Wound Pathogens with Madhuca indica Bioactive Compounds: An In Silico PerspectiveAuthor: Mukesh Kumar Dharmalingam JothinathanDOI: 10.21522/TIJPH.2013.13.01.Art017
Targeting Wound Pathogens with Madhuca indica Bioactive Compounds: An In Silico Perspective
Abstract:
Treating wound infections is increasingly challenging because of bacterial antibiotic resistance. Plants have recently emerged as a viable strategy for addressing antibiotic resistance and enhancing wound care. The antioxidant activity of Madhuca indica is essential for preventing oxidative stress by free radicals. In silico analysis of the bioactive compound was done by DPPH and the prominent phytochemicals were found in the extract after phytochemical screening. Phytochemical analysis of M. indica revealed that the plant contains flavonoids among many other bioactive compounds. M. indica exhibits concentration dependent radical scavenging activity, according to the DPPH test, where the percentage of radicals inhibited rises with concentrations as 10-50 µg/mL. The antimicrobial resistance patterns of bacterial targets were studied to elucidate the potential of M. indica compounds in combating these resistant strains. Multidrug resistance may be treated as the structural modification of the identified compounds, which may increase their efficiency and selectivity against the target microorganisms. Compounds from M. indica can also be added to already approved antibiotics; these combinations have synergistic effects that can help address the resistance issue. The activity indicated strong free radical scavenging activity that might help fight oxidative stress and aid in wound healing. The result of such computational predictions needs to be further studied in silico to validate the therapeutic application of several identified drugs. These possibilities suggest that novel antimicrobial agents derived from plants may be able to address the ongoing issue of multidrug resistance.
Targeting Wound Pathogens with Madhuca indica Bioactive Compounds: An In Silico Perspective
References:
[1]. Chandar, B. and Bhattacharya, D., 2019. Role of natural product in modulation of drug transporters and New Delhi metallo-β lactamases. Current Topics in Medicinal Chemistry, 19(10),874-885. https://doi.org/10.2174/1871529X19666190415110724
[2]. Talukdar, D., Kumar, P., Sharma, D., Balaramnavar, V. M., Afzal, O., Altamimi, A. S. A., Kazmi, I., Al-Abbasi, F. A., Alzarea, S. I., Gupta, G. and Gupta, M. M., 2023. Anticancer phytochemical-based nanoformulations: therapeutic intervention in cancer cell lines. Journal of Environmental Pathology, Toxicology and Oncology, 42(1),79-93. https://doi.org/10.1615/JEnvironPatholToxicolOncol.2022044317
[3]. Rather, M. A., Deori, P. J., Gupta, K., Daimary, N., Deka, D., Qureshi, A., Dutta, T. K., Joardar, S. N. and Mandal, M., 2022. Ecofriendly phytofabrication of silver nanoparticles using aqueous extract of Cuphea carthagenensis and their antioxidant potential and antibacterial activity against clinically important human pathogens. Chemosphere, 300,134497. https://doi.org/10.1016/j.chemosphere.2022.134497
[4]. Smith, R. M., Lautenbach, E., Omulo, S., Araos, R., Call, D. R., Kumar, G. C., Chowdhury, F., McDonald, C. L. and Park, B. J., 2021, November. Human colonization with multidrug-resistant organisms: getting to the bottom of antibiotic resistance. In Open Forum Infectious Diseases, 8(11), 531. https://doi.org/10.1093/ofid/ofab531
[5]. Alsaab, S. M., Alotaibi, S. K., Bhaskaran, P. M. and Domnic, I. S., 2024. Prevalence of Multidrug Resistant Organisms (MDROs) and Antimicrobial Sensitivity Pattern from clinical samples of the patients in Riyadh Province of the Kingdom of Saudi Arabia. Pharmacognosy Journal, 16(4), 102-117. https://doi.org/10.5530/pj.2024.16.125
[6]. AlRawashdeh, M. M., Ishak, A., Al-Bunnia, A., Agouridis, A. P., Lytras, T., Spernovasilis, N. and Tsioutis, C., 2024. Patient Experiences and Perceptions with Infections Due to Multidrug-Resistant Organisms: A Systematic Review. Pathogens, 13(9),817. https://doi.org/10.3390/pathogens13090817
[7]. Ryntathiang, I., Behera, A., Richard, T. and Jothinathan, M. K. D., 2024. An Assessment of the In Vitro Antioxidant Activity of Cobalt Nanoparticles Synthesized from Millettia pinnata, Butea monosperma, and Madhuca indica Extracts: A Comparative Study. Cureus, 16(4),e59112. https://doi.org/10.7759/cureus.59112
[8]. Balasubramanian, S. and Venkatachalam, P., 2022. Green synthesis of carbon solid acid catalysts using methane sulfonic acid and its application in the conversion of cellulose to platform chemicals. Cellulose, 29(3),1509-1526. https://doi.org/10.1007/s10570-022-04419-7
[9]. Habeeb Rahuman, H. B., Dhandapani, R., Narayanan, S., Palanivel, V., Paramasivam, R., Subbarayalu, R., Thangavelu, S. and Muthupandian, S., 2022. Medicinal plants mediated the green synthesis of silver nanoparticles and their biomedical applications. IET nanobiotechnology, 16(4),115-144. https://doi.org/10.1049/nbt2.12078
[10]. Moteriya, P., Padalia, H., Rathod, T., Desai, D. and Chanda, S., 2015. Pharmacognostic standardization of Madhuca indica leaf and stem, an important medicinal plant. International Journal of Pharmaceutical Sciences and Research, 6(2),705. k: http://doi.org/10.13040/IJPSR.0975-8232.6(2).705-11
[11]. Pacyga, K., Pacyga, P., Topola, E., Viscardi, S. and Duda-Madej, A., 2024. Bioactive Compounds from Plant Origin as Natural Antimicrobial Agents for the Treatment of Wound Infections. International Journal of Molecular Sciences, 25(4),2100. https://doi.org/10.3390/ijms25042100
[12]. Suvaithenamudhan, S., Ananth, S., Mariappan, V., Dhayabaran, V. V., Parthasarathy, S., Ganesh, P.S. and Shankar, E. M., 2022. In Silico Evaluation of Bioactive Compounds of Artemisia pallens Targeting the Efflux Protein of Multidrug-Resistant Acinetobacter baumannii (LAC-4 Strain). Molecules, 27(16),5188. https://doi.org/10.3390/molecules27165188
[13]. Aouf, A., Bouaouina, S., Abdelgawad, M. A., Abourehab, M. A. and Farouk, A., 2022. In silico study for Algerian essential oils as antimicrobial agents against multidrug-resistant bacteria isolated from pus samples. Antibiotics, 11(10),1317. https://doi.org/10.3390/antibiotics11101317
[14]. Fatma, A., Ahuja, V., Ahuja, A., Kumar, S., Srivastava, S. K. and Thosar, N. R., 2024. Evaluation of Antibacterial Activity of Madhuca longifolia (Mahua) Stem Extract Against Streptococcus mutans: An In Vitro Study. Cureus, 16(1), e52210. https://doi.org/10.7759/cureus.52210
[15]. Mondal, S. and Rai, V. R., 2021. Molecular profiling and anti-infective potency of endophytic actinomycetes inhabiting Madhuca insignis Radlk., from Western Ghats of India. Journal of Genetic Engineering and Biotechnology, 19(1),36. https://doi.org/10.1186/s43141-021-00135-0
[16]. Verma, S. K., Gond, S. K., Mishra, A., Sharma, V. K., Kumar, J., Singh, D. K., Kumar, A., Goutam, J. and Kharwar, R. N., 2014. Impact of environmental variables on the isolation, diversity and antibacterial activity of endophytic fungal communities from Madhuca indica Gmel. at different locations in India. Annals of Microbiology, 64,721-734. https://doi.org/10.1007/s13213-013-0707-9
[17]. Rakesh, B., Srinatha, N., KJ, R. K., Madhu, A., MR, S. K. and Praveen, N., 2022. Antibacterial activity and spectroscopic characteristics of silver nanoparticles synthesized via plant and in vitro leaf-derived callus extracts of Mucuna pruriens (L.) DC. South African Journal of Botany, 148,251-258. https://doi.org/10.1016/j.sajb.2022.04.047
[18]. Khan, M. H. and Ramalingam, K., 2019. Synthesis of antimicrobial nanoemulsions and its effectuality for the treatment of multi-drug resistant ESKAPE pathogens. Biocatalysis and agricultural biotechnology, 18,101025. https://doi.org/10.1016/j.bcab.2019.101025
[19]. Perumal Samy, R., Manikandan, J. and Al Qahtani, M., 2013. Evaluation of aromatic plants and compounds used to fight multidrug resistant infections. Evidence‐Based Complementary and Alternative Medicine, 2013(1), p.525613. https://doi.org/10.1155/2013/525613
[20]. Behera, A., Jothinathan, M. K. D., Ryntathiang, I., Saravanan, S. and Murugan, R., 2024. Comparative Antioxidant Efficacy of Green-Synthesised Selenium Nanoparticles from Pongamia pinnata, Citrus sinensis, and Acacia auriculiformis: An In Vitro Analysis. Cureus, 16(4), e58439. https://doi.org/10.7759/cureus.58439
[21]. Lamba, N., Adhikari, S., Modak, J. M. and Madras, G., 2018. Catalytic synthesis of fatty acid methyl esters from Madhuca indica oil in supercritical methanol. Energy Conversion and Management, 173,412-425. https://doi.org/10.1016/j.enconman.2018.07.067
[22]. Okoduwa, S I., Abdulwaliyu, I., Igiri, B. E., Arekemase, S. O., Okoduwa, U. J., Itiat, J. F., Egbule, M. N. and Mustapha, R. A., 2024. Multi-therapeutic potential of flavonoids as an essential component in nutraceuticals for the treatment and management of human diseases. Phytomedicine Plus, 4(2),100558. https://doi.org/10.1016/j.phyplu.2024.100558
[23]. Goel, M., Sharma, A. and Sharma, B., 2023. Recent advances in biogenic silver nanoparticles for their biomedical applications. Sustainable Chemistry, 4(1),61-94. https://doi.org/10.3390/suschem4010007
[24]. Vishwakarma, A., Yadav, H., Lakra, P., Sulakhiya, K., Paliwal, R. and Maiti, S., 2024. Madhuca indica oil-entrapped buoyant galactomannan hydrogel microspheres for controlling epileptic seizures. International Journal of Biological Macromolecules, 272(1),132739. https://doi.org/10.1016/j.ijbiomac.2024.132739
[25]. Halder, G., Dhawane, S. H., Dutta, D., Dey, S., Banerjee, S., Mukherjee, S. and Mondal, M., 2016. Computational simulation and statistical analysis of bioethanol production from Madhuca indica by batch fermentation process using Saccharomyces cerevisiae. Sustainable Energy Technologies and Assessments, 18,16-33. https://doi.org/10.1016/j.seta.2016.09.004
[26]. Saravanan, K., Alarfaj, A. A., Hirad, A. H., Ravindran, B. and Narasimhamoorthi, S. P., 2023. Anti-bacterial and in silico analysis of biogenic fabrication of CuO nanoparticles employing Coleus amboinicus leaf extract. Biomass Conversion and Biorefinery, 13,1-13. https://doi.org/10.1007/s13399-023-05009-8
[27]. Velayutham, N. K., Thamaraikani, T., Wahab, S., Khalid, M., Ramachawolran, G., Abullais, S. S., Wong, L. S., Sekar, M., Gan, S. H., Ebenezer, A. J. and Ravikumar, M., 2023. Stylopine: A potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy. Frontiers in Pharmacology, 14,1150270. https://doi.org/10.3389/fphar.2023.1150270
Viewed PDF 31 3 -
Anti-biofilm Effects of Resin-Modified Glass-Ionomers Incorporated with Silver Nanoparticles and Sodium FluorideAuthor: Ganesh Kumar AnbazhaganDOI: 10.21522/TIJPH.2013.13.01.Art018
Anti-biofilm Effects of Resin-Modified Glass-Ionomers Incorporated with Silver Nanoparticles and Sodium Fluoride
Abstract:
The glycocalyx or biofilm is essential for microbial survival. But dental biofilms cause cavities in teeth. The current study planned to incorporate silver nanoparticles and sodium fluoride in resin-modified glass-ionomer cement to test anti-biofilm efficacy. Silver nanoparticles (NAg) were chemically reduced by sodium borohydride. At 0.15% mass fraction, NAg was added in commercial resin-modified glass-ionomer cement (GC) and in this blend, 4 mass fractions (5%, 10%, 20%, and 30%) of NaF were mixed. The metabolic activity of biofilm, which shows the metabolic activity was decreased by NaF (P > .05). The biofilm CFU count shows the CFU counts of GC+NAg+20%NaF were decreased to 106 CFU/disk (P<.05). The cell viabilities of GC+NAg+20%NaF were 79.7%,75.6%,73% for days 1, 4, and 7 respectively, which were lower than GC control (P < .05) but higher than GC+NAg (P < .05). The use of NAg reduced cell viability at all three-time points (day 1, day 4, and day 7), which was partially reversed by the addition of NaF.
Anti-biofilm Effects of Resin-Modified Glass-Ionomers Incorporated with Silver Nanoparticles and Sodium Fluoride
References:
[1]. Graber, T. M., Eliades, T., Athanasiou, A. E., 2004, Risk management in orthodontics: experts’ guide to malpractice. Australian Orthod J.1.
[2]. Trieu, A., Mohamed, A., Lynch, E., 2019, Silver diamine fluoride versus sodium fluoride for arresting dentine caries in children: a systematic review and meta-analysis. Scientific Reports, 9(1), 2115.
[3]. Sharon, E., Sharabi, R., Eden, A., Zabrovsky, A., Ben-Gal, G., Sharon, E., Pietrokovski, Y., Houri-Haddad, Y., Beyth, N., 2018, Antibacterial activity of orthodontic cement containing quaternary ammonium polyethylenimine nanoparticles adjacent to orthodontic brackets. International Journal of Environmental Research and Public Health, 15(4), 606.
[4]. Chen, M., Yi, J., Zhao, Z., 2021, Biocompatible orthodontic cement with antibacterial capability and protein repellency. BMC Oral Health, 21, 1-7.
[5]. Ding, R., Qian, Y., Chen, M., Yi, J., Zhao, Z., 2021, The effect of N-acetylcysteine on the antibacterial capability and biocompatibility of nano silver–containing orthodontic cement. The Angle Orthodontist, 91(4), 515-21.
[6]. Al-Akwa, A. A., Zabara A. Q., Al-Shamahy, H. A., Al-labani, M. A., Al-Ghaffari, K. M., Al-Mortada A. M., Al-Haddad, A. M., Al-Sharani, A. A., 2020, Prevalence of Staphylococcus aureus in dental infections and the occurrence of MRSA in isolates. Universal Journal of pharmaceutical research.
[7]. Namasivayam, S. K., Priyanka, S., Lavanya M., Shree, S. K., Francis, A. L., Avinash, G. P., Bharani, R. A., Kavisri, M., Moovendhan, M. A., 2024, Review on vulnerable atmospheric aerosol nanoparticles: Sources, impact on the health, ecosystem and management strategies. Journal of Environmental Management, 365, 121644.
[8]. Mantri, S. S., Mantri, S. P., 2013, The nano era in dentistry. Journal Of Natural Science, Biology, And Medicine, 4(1), 39.
[9]. Senthil, R., Anitha, R., Lakshmi, T., 2024, Mineralized collagen fiber-based dental Implant: novel perspectives. Journal of Advanced Oral Research, 15(1), 62-9.
[10]. Lewis, N., Parmar, N., Hussain, Z., Baker, G., Green, I., Howlett, J., Kearns, A., Cookson, B., McDonald, A., Wilson, M., Ready, D., 2015, Colonisation of dentures by Staphylococcus aureus and MRSA in out-patient and in-patient populations. European Journal of Clinical Microbiology & Infectious Diseases, 34, 1823-6.
[11]. Shekar, N. D., Kayal, L., Babu, N. A., Jothinathan, M. K., Ryntathiang, I., 2024, Pioneering the Use of Micro-biomarkers in Oral Cancer Detection. Oral Oncology Reports, 23, 100412.
[12]. Ajitha, B., Reddy, Y. A., Reddy, P. S., 2015, Green synthesis and characterization of silver nanoparticles using Lantana camara leaf extract. Materials science and engineering, 1(49), 373-81.
[13]. Vazquez-Muñoz, R., Borrego, B., Juárez-Moreno, K., García-García, M., Morales, J. D., Bogdanchikova, N., Huerta-Saquero, A., 2017, Toxicity of silver nanoparticles in biological systems: does the complexity of biological systems matter. Toxicology letters, 5(276), 11-20.
[14] Kumar, S. T. G., Beeram, E., Begum, S., Chatterjee, P., Samajdar, D., 2025, Refinement of Spme-Gc/Ms for the detection of volatile organic compounds in medical science and pharmacy. Journal of Applied Bioanalysis, 11(1), 36-45.
[15] Khan, S., Rauf, A., Aljohani, A. S., Al-Awthan, Y. S., Ahmad, Z., Bahattab, O. S., Khan, S., Saadiq, M., Khan, S. A., Thiruvengadam, R., Thiruvengadam, M., 2024, Green synthesis of silver and gold nanoparticles in Callistemon viminalis extracts and their antimicrobial activities. Bioprocess and Biosystems Engineering, 47(8), 1197-1211.
[16]. Behera, A., Jothinathan, M. K. D., Saravanan, S., Selvan, S. T., Renuka, R. R., Srinivasan, G. P., 2024, Green synthesis of selenium nanoparticles from clove and their toxicity effect and anti-angiogenic, antibacterial, and antioxidant potential. Cureus, 16(3).
[17]. Anooj, E., Charumathy, M., Sharma, V., Vibala, B. V., Gopukumar, S. T., Jainab, S. I. B., 2021, Nanogels: An overview of properties, biomedical applications, future research trends, and developments. Journal of Molecular Structure, 1239, 130446.
[18]. Chong, W. X., Lai, Y. X., Choudhury, M., Amalraj, F. D., 2022, Efficacy of incorporating silver nanoparticles into maxillofacial silicone against Staphylococcus aureus, Candida albicans, and polymicrobial biofilms. The Journal of Prosthetic Dentistry, 128(5), 1114-1120.
[19]. Karnjana, K., Jewboonchu, J., Niyomtham, N., Tangngamsakul, P., Bunluepuech, K., Goodla, L., Mordmuang, A., 2023, The potency of herbal extracts and its green synthesized nanoparticle formulation as antibacterial agents against Streptococcus mutans associated biofilms. Biotechnology Reports, 37, e00777.
[20]. Reddy, J. R. S. M., Kannan, K. P., Sankaran, K., Rengasamy, G., Priya, V. V., Sathishkumar, P., 2023, Eradication of dental pathogens using flavonoid rutin mediated silver-selenium nanoparticles. Inorganic Chemistry Communications, 157, 111391.
Viewed PDF 28 4 -
Abuja's Rising Drug Threat: A Comparative Analysis of Cocaine and Methamphetamine UseAuthor: Audu Hadiza MustaphaDOI: 10.21522/TIJPH.2013.13.01.Art019
Abuja's Rising Drug Threat: A Comparative Analysis of Cocaine and Methamphetamine Use
Abstract:
The use of drugs remains a threat to health and medical care delivery, the public health burden of Cocaine and Methamphetamine use is enormous, and there is a need for critical evaluation of their use in the capital city of Abuja. This study investigates the presence of Cocaine and Methamphetamine use and related difficulties in Abuja. It is a retrospective and cross-sectional study conducted in a public mental health facility. The sociodemographic profile and clinical record of patients using psychoactive substances for the periods of 2018 and 2022 were obtained from the records unit. Results were analyzed using SPSS 26 set at 95% CI, with respondents’ profiles as follows: males n=116 (94 %) and females n=7(6%), 80% were single, with Mean age 28.9, and Standard Deviation SD ± 8.6. Clinical findings showed the average duration of substance use was 9.10 years with an average age of first substance use 19.42 years. Cocaine use was seen in n=17 (14%) methamphetamine use in n=5 (4.2 %). Ninety-nine per cent (99 %) of the subjects use other substances in addition to Cocaine or Methamphetamine, using both Methamphetamine and Cocaine was seen in n=2 (1.7 %). More subjects were seen to be using cocaine in the year 2022 than in 2018, with n=15(16.1%) in 2022 and n=2 (7.1%) in 2018, while Methamphetamine use was seen in the year 2022 only. This study concludes by bringing to light the presence of cocaine and methamphetamine use in our society, with serious repercussions.
Abuja's Rising Drug Threat: A Comparative Analysis of Cocaine and Methamphetamine Use
References:
[1]. NIDA, 2020, Drugs, Brain, Behavior: The Science of Addiction. Sci Addict [Accessed 10/9/2022]. 2020;7(3):1–32. Available from: https://www.drugabuse.gov/publications/drugs-brains-behavior-science-addiction/drugs-brain
[2]. NIDA, 2018, substance use disorder, defined by NIDA and SAMHSA: NIDA (National Institute on Drug Abuse) 2018;10–2. [Accessed 4/13/2023].
[3]. NIDA, 2019, Health Research on Drugs Abuse Effects. [Accessed 9/13/2023]. Available from: www.drugabuse.gov
[4]. Jatau, A.I., et al.2021, The Burden of Drug Abuse in Nigeria: A Scoping Review of Epidemiological Studies and Drug Laws. Public Health Rev. 42(January):1–11.
[5]. Union E., 2019, Drug Use Survey in Nigeria. unodc J [Accessed 4/30/2023]. 2019;1–40. Available from: unodc-pdmu@un.org
[6]. Sadock, B. J., Sadock, V. A., 2015, Kaplan and Saddocks Synopsis of Psychiatry [Accessed 10/1/2023]. 11th edition. Wolters Kluwer; 2015. 343 p. Available from: https://kat.cr/user/Blink99/
[7]. Dumbili, E. W., Ebuenyi, I. D., Ugoeze, K. C., 2021, New psychoactive substances in Nigeria: A call for more research in Africa. Emerg Trends Drugs, Addict Heal. 2021;1(March):100008.
[8]. Robinson, S. M., Adinoff, B., 2016, The classification of substance use disorders: Historical, contextual, and conceptual considerations. Behavioral Science (Basel). 2016;6(3).
[9]. Brouwer, K. C., et al. 2006, Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico. Substance Use Misuse. 2006;41(5):707–27.
[10]. Oliaku, C., 2023, Causes, Consequences and Control of Methamphetamine Abuse among Youths in Nigeria. Nigerian Journal of Arts & Humanity. 2023;3(1):1–11.
[11]. Ochube, A. G., Ogbe, E. O., Ndalazhi, F., 2022, The Dynamics of Drug Abuse: A Study of Mkpuru Miri Ravaging Southeast Nigeria. Quest Journals J Res Humanity Soc Sci. 2022;10(1):2321–9467. Available from: www.questjournals.org
[12]. Dumbili, E. W., Ebuenyi, I. D., 2021, Methamphetamine (Mkpuru miri) Use in Eastern Nigeria New Addition To Drug Users’ Repertoire. Afr J Drug Alcohol Stud. 2021;20(1):79–89.
[13]. Bashir, O. A., 2021, Population Dynamics to Urban Spaces Needs in One of Africa’ s Largest Cities: Abuja, The Federal Capital City of Nigeria. 2021;4(10):124–30.
[14]. Abubakar, I. R., 2014, Abuja city profile. [Accessed 10/9/2023]. 2014;41(PA):81–91. Available from: http://dx.doi.org/10.1016/j.cities.2014.05.008
[15]. Wikipedia, 2017, Federal Capital Territory, Nigeria. [Access 12/12/2023]. 2017; 2:7–10. https://en.wikipedia.org/w/index.php?title=Federal_Capital_Territory,_Nigeria.
[16]. WHO, 2021, International Classification of Diseases 11, Mental, behavioral or neurodevelopmental disorders- ICD -11 Mortal Morbidity Statistics [Access 2/3/2023]. 2021;1–207. https://icd.who.int/browse11/l-m/en
[17]. Jaysruthi, M., Masdhumitha, M., Divya, V. C. et al., 2023, Methamphetamine substance abuse and Dental Consideration: a modern era crisis. Korean Journal of Physiology and Pharmacology. 2023; 27(January), 2-7.
[18]. Ternenge, A. M., Ember, H. M., 2021, Prevalence of Methamphetamine (Ice) Drug Abuse and its Consequences among Youths in Jalingo Metropolis, Taraba State. International Peer Review English Journal. 2021;1(1):10-28.
[19]. Nabofa, O. E., 2021, New trend of drugs abused by secondary school students in Nigeria. Afr Health Sci. 2021;21(3):1460–6.
[20]. Nwoga, C., et al. 2019, Pattern and Effect of Substance Use in Jos South, North Central, Nigeria. J Res Basic Clin Sci. 2019;1(2):150–4. https://jrbcs.org/index.php/jrbcs/article/view/36/67%0A
[21]. Ibrahim, A. W., et al, 2017, Tramadol Abuse Among Patients Attending An Addiction Clinic in North-Eastern Nigeria: Outcome of a Four Year Retrospective Study. Adv Psychol Neuroscience. 2017;2(2–1):31–7.
[22]. Imam, A. 1., Yalma, R. M., 2019, Substance use and risky sexual behaviors among students of the University of Abuja, Federal Capital Territory (FCT) Nigeria. Glob Sci Journals 2019;7(10):1270–95.
[23]. Jatau A. I., et al., 2021, Public Health Reviews. Public Heal Rev. 2021; 42:1603960.
[24]. Uchendu. I., Morakinyo. O., 2016, Co-Occurrence of Study Difficulty Psychoactive Substance Use and Psychiatric Morbidity among Undergraduate Students and the Organization of the Future. 2016;16(May):153–67.
[25]. Castaldelli-Maia, J. M., et al. 2019, Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019. The Lancet Psychiatry. 10(2):85–97.
Viewed PDF 35 1 -
Gender-Based Violence (GBV) Responses: An Analysis of the Knowledge of Service Provision and its Implication on Incidence Reporting in Adamawa StateAuthor: Bob-Wonder Ejata PANAMADOI: 10.21522/TIJPH.2013.13.01.Art020
Gender-Based Violence (GBV) Responses: An Analysis of the Knowledge of Service Provision and its Implication on Incidence Reporting in Adamawa State
Abstract:
This study explores the implications of gender-based violence (GBV) response services on the reporting of GBV incidents in Adamawa State, Nigeria. GBV remains a critical public health and human rights issue, particularly in regions affected by conflict, such as northern Nigeria. Using a cross-sectional survey methodology, the study analyzed responses from 362 participants, including women of reproductive age, healthcare providers, and GBV service actors. Participants were surveyed to assess their knowledge of GBV, the availability of services, and the impact on incidence reporting. Results revealed that 60.2% of respondents were aware of GBV services, but only 17.4% had a comprehensive understanding of available support. The prevalence of physical, sexual, and emotional violence was alarmingly high, reported at 69.9%, 74.3%, and 85.6%, respectively. Factors such as alcohol use, low education, and economic hardship were identified as drivers of GBV. Despite the presence of legal frameworks, only 56.6% of respondents reported knowing what actions to take after experiencing GBV. This study highlights the need for improved awareness programs, stronger enforcement of GBV policies, and enhanced healthcare infrastructure to support survivors. The findings have significant implications for developing targeted interventions aimed at increasing GBV reporting and improving service provision for affected populations.
Gender-Based Violence (GBV) Responses: An Analysis of the Knowledge of Service Provision and its Implication on Incidence Reporting in Adamawa State
References:
[1]. UN General Assembly, 1993, Declaration on the Elimination of Violence Against Women.
[2]. USAID; IGWG; PRB, 2010, Gender-based Violence: Impediment to Reproductive Health. In Population Reference Bureau. USAID.
[3]. Pallitto, C. et al., 2006, WHO Multi-Country Study on Women’s Health and Domestic Violence Against Women Study Team. Prevalence of Intimate Partner Violence: Findings from the WHO Multi-Country Study on Women’s Health and Domestic Violence. Lancet, 368, 1260-1269.
[4]. Garcia-Moreno, C., and Pallitto, C., 2013, Global and regional estimates of violence against women: prevalence and health effects of intimate partner violence and non-partner sexual violence. WHO.
[5]. Cook, S. L., Wilson, R. A., & Thomas, E. B., n.d., 2018, A history of gender-based violence. APA handbook of the psychology of women: Perspectives on women's private and public lives (Vol. 2), 153-173.
[6]. Cetin, I., 2003, Managing obstetric emergencies, managing Gynecological emergencies. Placenta, 24(6), 710.
[7]. Chernyak, E., 2020, Who is at risk? Intimate partner violence against women in the Kyrgyz Republic. Violence and Gender, 7(3), 121-130.
[8]. Ntaganira, J., Muula, A., Siziya, S., Stoskopf, C., & Rudatsikira, E., 2009, Factors associated with intimate partner violence among pregnant rural women in Rwanda. Rural and Remote Health.
[9]. Buhari, M. K., Oye, M. D., Jahknwa, J. C., Sachiya K. I., 2021, Violence Against Female Students of Tertiary Institutions in Yola metropolis of Adamawa State, northeast Nigeria. International Journal of Advances in Engineering and Management, 2(12), 1512-1520.
[10]. Iliyasu, Z., Galadanci, H., Ahmed, Z., Gajida, A., & Aliyu, M., 2016, Prevalence and patterns of sexual activity during pregnancy in Kano, Northern Nigeria. African Journal of Reproductive Health, 20(4), 99-107.
[11]. Oyeoku, E., Meziobi, D., Ezegbe, N., and Obikwelu, C., 2013, Public Sensitization as a tool for preventing domestic violence against women in Nsukka Education Zone, Enugu State, Nigeria. US-China Education Review, 3(4), 245-252.
Viewed PDF 38 0 -
Trans Fats: A Global Health Risk with a Focus on the Caribbean and GuyanaAuthor: Ginel NeddDOI: 10.21522/TIJPH.2013.13.01.Art021
Trans Fats: A Global Health Risk with a Focus on the Caribbean and Guyana
Abstract:
Trans fats, or trans fatty acids, are a significant global health concern due to their contribution to non-communicable diseases (NCDs) such as cardiovascular disease, diabetes, and obesity, with their impact in regions like the Caribbean and Guyana requiring focused attention. In these regions, socioeconomic disparities, food deserts, and limited public awareness, coupled with cultural preferences for calorie-dense, fried, and processed foods, drive the widespread consumption of trans fats, which are often more affordable and accessible than healthier alternatives. This dietary pattern exacerbates the increasing prevalence of NCDs, prompting growing calls for governments across the Caribbean, including Guyana, to implement policies regulating trans fats in the food supply, enforcing clear nutritional labelling, and promoting public health campaigns to reduce consumption. A comprehensive strategy combining government regulation, industry reform, and community-driven initiatives is critical to combating trans fat consumption by improving public education, increasing access to healthier food options, and enforcing stricter food regulations, thereby reducing the NCD burden and enhancing public health outcomes in the region through urgent, collaborative action.
Trans Fats: A Global Health Risk with a Focus on the Caribbean and Guyana
References:
[1]. Mozaffarian, D., et al. 2006. Trans Fats and Cardiovascular Disease Risk. New England Journal of Medicine, 354(15), 1601-1613.
[2]. World Health Organization. 2020. Eliminating Trans Fats in Food Supply Chains. Available at: https://www.who.int
[3]. Monteiro, C. A., et al. 2018. Ultra-Processing and Public Health Risks. Public Health Nutrition, 21(1), 5-17.
[4]. Ascherio, A., et al. 2015. Trans Fatty Acids and Cardiovascular Health in Developing Countries. American Journal of Clinical Nutrition, 101(5), 1000-1010.
[5]. Caribbean Public Health Agency (CARPHA). 2022. Addressing NCDs Through Food Policy in the Caribbean Region. Retrieved from: https://carpha.org
[6]. Barbados Ministry of Health and Wellness. 2022. Public-Private Partnerships for Nutrition. Retrieved from: https://www.barbadoshealth.org
[7]. Department of Public Information, Guyana. 2023. Trans Fat Challenges in Hinterland Communities. Retrieved from: https://dpi.gov.gy
[8]. Bahamas Ministry of Health. 2022. Reducing Heart Disease through Nutrition. Retrieved from: https://www.bahamashealth.gov
[9]. Monteiro, C. A., et al. 2018. Cultural Preferences and Health Risks. Public Health Nutrition, 21(1), 5-17.
[10]. Caribbean Institute of Nutrition. 2020. Healthy Recipe Reformulation. Retrieved from: https://www.carihealth.org
[11]. Drewnowski, A., & Darmon, N. 2005. The Economics of Obesity. The American Journal of Clinical Nutrition, 82(1), 265S–273S.
[12]. Johns Hopkins Bloomberg School of Public Health. 2021. Challenges in Low-Income Nutrition. Retrieved from: https://www.jhsph.edu
[13]. Walker, R., et al. 2010. Food Deserts in Minority Communities. Health & Place, 16(5), 876–884.
[14]. Pan American Health Organization (PAHO). 2021. Nutrition in Rural Communities. Retrieved from: https://www.paho.org
[15]. Jamaican Ministry of Health. 2020. Regulatory and Public Awareness Initiatives. Retrieved from: https://www.jamaicahealth.gov
[16]. Trinidad and Tobago Ministry of Health. 2021. Childhood Obesity Interventions. Retrieved from: https://www.health.gov.tt
[17]. Barbados Ministry of Agriculture. 2022. Community Gardening for Health. Retrieved from: https://www.agriculture.gov.bb
[18]. Department of Public Information, Guyana. 2023. $5M Food Hub in Karrau to Support Farmers. Retrieved from: https://dpi.gov.gy
[19]. Caribbean Development Bank. 2022. Economic Pressures on Nutrition in the Caribbean. Retrieved from: https://www.caribank.org
[20]. FAO. 2023. Barriers to Fresh Produce Access in the Caribbean. Retrieved from: https://www.fao.org
[21]. Harvard School of Public Health. 2023. Processed Foods and Economic Impact. Retrieved from: https://www.hsph.harvard.edu
Viewed PDF 25 4 -
Utilization of Public Healthcare Facilities in Delta State, NigeriaAuthor: Blessing Osagumwendia JosiahDOI: 10.21522/TIJPH.2013.13.01.Art022
Utilization of Public Healthcare Facilities in Delta State, Nigeria
Abstract:
Nigeria's healthcare system is a complex blend of public and private providers, each offering varying levels of service and accessibility. In Delta State, healthcare utilisation patterns are influenced by factors such as affordability, accessibility, and perceived quality of care. The study examines the utilisation of public healthcare facilities in Delta State, Nigeria, exploring residents' preferences and comparing public and private healthcare services. A cross-sectional quantitative survey was conducted among 1,191 residents across six Local Government Areas in Delta State, using face-to-face and virtual questionnaires administered from March 1, 2024, to June 6, 2024. Descriptive statistics were used to analyse the data. The survey revealed that 92.53% have used public healthcare facilities at least within the space of five years, while 67.17% were more frequent users. A total of 39.00% of respondents prefer to use public hospitals; 24.90% prefer private facilities; and 36.10% equally prefer both. In terms of specific features, the public facilities were rated better for their affordability (89.99%) and accessibility (59.53%). However, private facilities were perceived to provide more effective care (58.5%) and operate with better equipment and infrastructure (50.5%), while public facilities performed better in terms of staff quality (53.65%) and value for money (53.15%). The study highlights the strong demand for public health services in Delta State but also identifies areas for improvement in care quality, equipment, and infrastructure in public facilities, which can be achieved through targeted investments and quality improvement initiatives to enhance public confidence and achieve universal health coverage.
Utilization of Public Healthcare Facilities in Delta State, Nigeria
References:
[1]. National Academies of Sciences, E., Division, H. and M., Services, B. on H. C., and Disabilities, C. on H. C. U. and A. with, 2018, “Factors That Affect Health-Care Utilization,” Health-Care Utilization as a Proxy in Disability Determination, National Academies Press (US). [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK500097/. [Accessed: 19-Jan-2025].
[2]. Leonard, K. L., and Masatu, M. C., 2007, “Variations In The Quality Of Care Accessible To Rural Communities In Tanzania: Some Quality Disparities Might Be Amenable to Policies That Do Not Necessarily Relate to Funding Levels.,” Health Affairs, 26(Suppl2), pp. w380–w392. https://doi.org/10.1377/hlthaff.26.3.w380.
[3]. Verma, H., Aggarwal, A., Rattan, V., and Mohanty, U., 2012, “Access to Public Dental Care Facilities in Chandigarh,” Indian J Dent Res, 23(1), p. 121. https://doi.org/10.4103/0970-9290.99057.
[4]. Mannan, M. A., 2013, “Access to Public Health Facilities in Bangladesh: A Study on Facility Utilisation and Burden of Treatment,” The Bangladesh development studies : The Journal of the Bangladesh Institute of Development Studies, 36(4).
[5]. Gemignani, R., Tsimpo, C., and Wodon, Q., 2014, “Making Quality Care Affordable for the Poor: Faith-Inspired Health Facilities in Burkina Faso,” The Review of Faith & International Affairs, 12(1), pp. 30–44. https://doi.org/10.1080/15570274.2013.876732.
[6]. Ged, O., 2016, “The Quality of Healthcare Service Delivery in Nigeria: An Assessment of the Availability of Some Basic Medical Devices/Equipment in the Primary Health Care Centres in Delta State,” Online Journal of Health and Allied Sciences, 15(1). [Online]. Available: https://www.ojhas.org/issue57/2016-1-6.html. [Accessed: 24-Nov-2023].
[7]. Fullman, N., Yearwood, J., Abay, S. M., Abbafati, C., Abd-Allah, F., et al., 2018, “Measuring Performance on the Healthcare Access and Quality Index for 195 Countries and Territories and Selected Subnational Locations: A Systematic Analysis from the Global Burden of Disease Study 2016,” The Lancet, 391(10136), pp. 2236–2271. https://doi.org/10.1016/S0140-6736(18)30994-2.
[8]. Al-Jabri, F. Y. M., Turunen, H., and Kvist, T., 2021, “Patients’ Perceptions of Healthcare Quality at Hospitals Measured by the Revised Humane Caring Scale,” Journal of Patient Experience, 8, p. 23743735211065265. https://doi.org/10.1177/23743735211065265.
[9]. Balogun, J. A., 2021, “A Qualitative Investigation of the Barriers to the Delivery of High-Quality Healthcare Services in Nigeria,” The Nigerian Healthcare System: Pathway to Universal and High-Quality Health Care, J.A. Balogun, ed., Springer International Publishing, Cham, pp. 345–359. https://doi.org/10.1007/978-3-030-88863-3_11.
[10]. Bellio, E., and Buccoliero, L., 2021, “Main Factors Affecting Perceived Quality in Healthcare: A Patient Perspective Approach,” The TQM Journal, 33(7), pp. 176–192. https://doi.org/10.1108/TQM-11-2020-0274.
[11]. Ali, J., Jusoh, A., Idris, N., and Nor, K. M., 2023, “Healthcare Service Quality and Patient Satisfaction: A Conceptual Framework,” International Journal of Quality & Reliability Management, 41(2), pp. 608–627. https://doi.org/10.1108/IJQRM-04-2022-0136.
[12]. Agency for Healthcare Research and Quality (AHRQ), 2015, “Types of Health Care Quality Measures.” [Online]. Available: https://www.ahrq.gov/talkingquality/measures/types.html. [Accessed: 24-Nov-2023].
[13]. Ejughemre, U. J., 2015, “Out of Pocket Spending for Healthcare Services: A Study Assessing the Relationship between Payment Methods and Perceived Satisfaction with the Quality of Care in a Tertiary Health Facility in Delta State, Nigeria,” Journal of Community Medicine and Primary Health Care, 27(1), pp. 27–36.
[14]. Onwujekwe, O., Ezumah, N., Mbachu, C., Obi, F., Ichoku, H., Uzochukwu, B., and Wang, H., 2019, “Exploring Effectiveness of Different Health Financing Mechanisms in Nigeria; What Needs to Change and How Can It Happen?” BMC Health Services Research, 19(1), p. 661. https://doi.org/10.1186/s12913-019-4512-4.
[15]. Smith, E., 2021, “Foreign Investors Are Gearing up to Plug Nigeria’s $82 Billion Health-Care Gap,” CNBC. [Online]. Available: https://www.cnbc.com/2021/01/04/nigerias-82-billion-health-care-gap-investors-stand-by.html. [Accessed: 26-Apr-2023].
[16]. WHO, 2023, “Health Financing,” World Health Organization. [Online]. Available: https://www.who.int/health-topics/health-financing. [Accessed: 15-Sep-2023].
[17]. McIntyre, D., Obse, A. G., Barasa, E. W., and Ataguba, J. E., 2018, “Challenges in Financing Universal Health Coverage in Sub-Saharan Africa,” Oxford Research Encyclopedia of Economics and Finance, Oxford University Press. https://doi.org/10.1093/acrefore/9780190625979.013.28.
[18]. Costa-Font, J., Batinti, A., and Turati, G., eds., 2023, Handbook on the Political Economy of Health Systems, Edward Elgar Publishing. https://doi.org/10.4337/9781800885066.
[19]. Kodali, P. B., 2023, “Achieving Universal Health Coverage in Low- and Middle-Income Countries: Challenges for Policy Post-Pandemic and Beyond,” RMHP, Volume 16, pp. 607–621. https://doi.org/10.2147/RMHP.S366759.
[20]. Omuta, G. E. D., 2016, “Infrastructure and Health Care Services in the Niger Delta Region of Nigeria: A Case Study of Physical Amenities in the Primary Health Care System in Delta State,” Online Journal of Health and Allied Sciences, 14(4). [Online]. Available: https://www.ojhas.org/issue56/2015-4-2.html. [Accessed: 14-Apr-2023].
[21]. Kigozi, E., 2020, “Application of Mixed Methods Approach in Studies on Quality Assurance in Educational Institutions: A Systematic Review of Literature from 2005-2019,” IJIBS, 6(1), pp. 396–410. https://doi.org/10.20533/ijibs.2046.3626.2020.0051.
[22]. City Population, 2022, “Delta (State, Nigeria) - Population Statistics, Charts, Map and Location.” [Online]. Available: https://citypopulation.de/en/nigeria/admin/NGA010__delta/. [Accessed: 24-Apr-2023].
[23]. 247ureports.com, 2017, “Nigeria_Delta_State_map,” 247ureports.com. [Online]. Available: https://247ureports.com/2017/05/delta-state-police-kill-5-kidnappers-armed-robbery-suspects/nigeria_delta_state_map-2/. [Accessed: 21-Apr-2023].
[24]. Gbemre, Z., 2019, “When Will Delta State Be from from Political Captivity?” Bigpen Nigeria. [Online]. Available: https://bigpenngr.com/2019/03/30/when-will-delta-state-be-free-from-political-captivity/. [Accessed: 21-Apr-2023].
[25]. dbpedia.org, “About: Delta State.” [Online]. Available: https://dbpedia.org/page/Delta_State. [Accessed: 17-Dec-2023].
[26]. United Nations, 2014, Delta State Development Performance, United Nations, Asaba. [Online]. Available: https://www.undp.org/sites/g/files/zskgke326/files/migration/ng/UNDP_NG_DeltaState_Health_2015.pdf.
[27]. SpinWheelApp, 2023, “Editor | Spin the Wheel - Random Picker,” Wheel Maker. [Online]. Available: https://spinthewheel.app/0bhxMPPkoe. [Accessed: 17-Dec-2023].
[28]. Glen, S., 2018, “Sample Size in Statistics (How to Find It): Excel, Cochran’s Formula, General Tips,” Statistics How To. [Online]. Available: https://www.statisticshowto.com/probability-and-statistics/find-sample-size/. [Accessed: 17-Dec-2023].
[29]. Zoho, 2019, “Sample Size Calculator - Understanding Sample Size | Zoho Survey,” Zoho. [Online]. Available: https://www.zoho.com/survey/sample-size.html. [Accessed: 17-Dec-2023].
[30]. Levesque, J.-F., Harris, M. F., and Russell, G., 2013, “Patient-Centred Access to Health Care: Conceptualising Access at the Interface of Health Systems and Populations,” International Journal for Equity in Health, 12(1), p. 18. https://doi.org/10.1186/1475-9276-12-18.
[31]. Donabedian, A., 1988, “The Quality of Care. How Can It Be Assessed?” JAMA, 260(12), pp. 1743–1748. https://doi.org/10.1001/jama.260.12.1743.
[32]. Parasuraman, A. P., Zeithaml, V., and Berry, L., 1988, “SERVQUAL: A Multiple- Item Scale for Measuring Consumer Perceptions of Service Quality,” Journal of Retailing.
[33]. Mosadeghrad, A. M., 2012, “A Conceptual Framework for Quality of Care,” Mater Sociomed, 24(4), pp. 251–261. https://doi.org/10.5455/msm.2012.24.251-261.
[34]. RAND, 2023, “Patient Satisfaction Questionnaires (PSQ-III and PSQ-18).” [Online]. Available: https://www.rand.org/health-care/surveys_tools/psq.html. [Accessed: 24-Apr-2023].
[35]. Nwokoro, U. U., Ugwa, O. M., Ekenna, A. C., Obi, I. F., Onwuliri, C. D., and Agunwa, C., 2022, “Determinants of Primary Healthcare Services Utilisation in an Under-Resourced Rural Community in Enugu State, Nigeria: A Cross-Sectional Study,” Pan Afr Med J, 42, p. 209. https://doi.org/10.11604/pamj.2022.42.209.33317.
[36]. Muhammed, K. A., Umeh, K. N., Nasir, S. M., and Suleiman, I. H., 2013, “Understanding the Barriers to the Utilization of Primary Health Care in a Low-Income Setting: Implications for Health Policy and Planning,” J Public Health Afr, 4(2), p. e13. https://doi.org/10.4081/jphia.2013.e13.
[37]. Nwankwo, I. U., Udeobasi, O., Osakwe, C. S., and Okafor, G., 2017, “Public Perception and Assessment of Primary Healthcare Service in Mbaukwu Community of Awka South Local Government Area, Anambra State, Southeast Nigeria.” [Online]. Available: https://www.semanticscholar.org/paper/Public-Perception-and-Assessment-of-Primary-Service-Nwankwo-Udeobasi/40b9a08828bb0e6a58c13570c0060a44cf11bd6f#citing-papers. [Accessed: 19-Jan-2025].
[38]. Adam, V. Y., and Awunor, N. S., 2014, “Perceptions and Factors Affecting Utilization of Health Services in a Rural Community in Southern Nigeria,” Journal of Medicine and Biomedical Research, 13(2), pp. 117–124. [Online]. Available: https://www.ajol.info/index.php/jmbr/article/view/118413. [Accessed: 19-Jan-2025].
[39]. Otovwe, A., and Elizabeth, S., 2017, “Utilization of Primary Health Care Services in Jaba Local Government Area of Kaduna State Nigeria,” Ethiop J Health Sci, 27(4), pp. 339–350. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615023/. [Accessed: 19-Jan-2025].
[40]. Darrudi, A., Ketabchi Khoonsari, M. H., and Tajvar, M., 2022, “Challenges to Achieving Universal Health Coverage Throughout the World: A Systematic Review,” J Prev Med Public Health, 55(2), pp. 125–133. https://doi.org/10.3961/jpmph.21.542.
[41]. Hanson, K., Brikci, N., Erlangga, D., Alebachew, A., De Allegri, M., et al., 2022, “The Lancet Global Health Commission on Financing Primary Health Care: Putting People at the Centre,” The Lancet Global Health, 10(5), pp. e715–e772. https://doi.org/10.1016/S2214-109X(22)00005-5.
[42]. Vanguard, 2020, “Delta Is 2nd Least Poor State in Nigeria - NBS - Vanguard News,” News. [Online]. Available: https://www.vanguardngr.com/2020/05/delta-is-2nd-least-poor-state-in-nigeria-nbs/. [Accessed: 06-Jan-2025].
[43]. Erubami, J., Tebekaemi, P., and Egbon, K., 2023, “Perception of Online Medical Crowdfunding Posts among Social Media Users in Nigeria,” Journal of Management and Social Sciences, 8.
[44]. Mahmoud, A. B., Ekwere, T., Fuxman, L., and Meero, A. A., 2019, “Assessing Patients’ Perception of Health Care Service Quality Offered by COHSASA-Accredited Hospitals in Nigeria,” SAGE Open, 9(2), p. 2158244019852480. https://doi.org/10.1177/2158244019852480.
[45]. Peabody, J. W., Rahman, O., Fox, K., and Gertler, P., 1994, “Quality of Care in Public and Private Primary Health Care Facilities: Structural Comparisons in Jamaica,” Bull Pan Am Health Organ, 28(2), pp. 122–141.
[46]. Agha, S., and Do, M., 2009, “The Quality of Family Planning Services and Client Satisfaction in the Public and Private Sectors in Kenya,” International Journal for Quality in Health Care, 21(2), pp. 87–96. https://doi.org/10.1093/intqhc/mzp002.
[47]. Hutchinson, P. L., Do, M., and Agha, S., 2011, “Measuring Client Satisfaction and the Quality of Family Planning Services: A Comparative Analysis of Public and Private Health Facilities in Tanzania, Kenya and Ghana,” BMC Health Serv Res, 11(1), p. 203. https://doi.org/10.1186/1472-6963-11-203.
[48]. Karkee, R., Lee, A. H., and Pokharel, P. K., 2014, “Women’s Perception of Quality of Maternity Services: A Longitudinal Survey in Nepal,” BMC Pregnancy Childbirth, 14(1), p. 45. https://doi.org/10.1186/1471-2393-14-45.
[49]. WHO, 2017, “Health Is a Fundamental Human Right.” [Online]. Available: https://www.who.int/news-room/commentaries/detail/health-is-a-fundamental-human-right. [Accessed: 02-Jan-2023].
[50]. Aregbeshola, B., 2019, “Health Care in Nigeria: Challenges and Recommendations,” Social Protection. [Online]. Available: https://socialprotection.org/discover/blog/health-care-nigeria-challenges-and-recommendations. [Accessed: 14-Apr-2023].
[51]. Jahan, S., and Oda, T., 2000, “Distributuin of Public Facilities in Dhaka, Bangladesh: A Spatial Analysis,” [Kobe University Faculty of Human Development Research Bulletin], 7(2), pp. 201–210. https://doi.org/10.24546/81000376.
[52]. Hu, P., Liu, Z., and Lan, J., 2019, “Equity and Efficiency in Spatial Distribution of Basic Public Health Facilities: A Case Study from Nanjing Metropolitan Area,” Urban Policy and Research, 37(2), pp. 243–266. https://doi.org/10.1080/08111146.2018.1523055.
[53]. Kumar, A., Sharma, D. K., Bhojpuri Adhyayan Kendra, B.H.U. Varanasi, Prakash, S., Department of Geography, Institute of Science, Banaras Hindu University, Varanasi, Yadava, R. S., and Department of Geography, Institute of Science, Banaras Hindu University, Varanasi, 2020, “Spatial Distribution of Public Health Care Facilities in Rural Areas of Nalanda District, Bihar,” ngji, 66(4), pp. 387–399. https://doi.org/10.48008/ngji.1756.
[54]. Mwesigwa, C. L., Okumu, B. A., Kirabo-Nagemi, C., Ejuu, E., Kruger, E., and Tennant, M., 2020, “Mapping the Geographic Availability of Public Dental Services in Uganda Relative to Ruralization and Poverty of the Population,” JGOH, 2, pp. 86–92. https://doi.org/10.25259/JGOH_66_2019.
[55]. Eze, B., and Jones, M., 2022, “Does the Perceived Healthcare Quality Provided by Full-Time Government Employee Doctors in the Public System Differ from the Perceived Care Quality in Their Own Privately Managed Facilities in Nigeria?” Journal of Hospital Administration, 10(6). https://doi.org/10.5430/jha.v10n6p1.
[56]. Leslie, H. H., Sun, Z., and Kruk, M. E., 2017, “Association between Infrastructure and Observed Quality of Care in 4 Healthcare Services: A Cross-Sectional Study of 4,300 Facilities in 8 Countries,” PLoS Med, 14(12), p. e1002464. https://doi.org/10.1371/journal.pmed.1002464.
[57]. Vora, D. K. S., and Mavalankar, D. V., 2014, “Quality of Reproductive and Child Health Care in the Private Sector in India: Issues and Options,” International Journal of Science and Research, 3(8), pp. 181–186.
[58]. Bitrán, R., 1995, “Efficiency and Quality in the Public and Private Sectors in Senegal,” Health Policy Plan, 10(3), pp. 271–283. https://doi.org/10.1093/heapol/10.3.271.
[59]. FreshAngle, 2021, “Delta State 2022 Budget Address, Read Before Dtha by His Excellency, Senator, Dr. Ifeanyi Okowa,” Fresh Angle Nigeria. [Online]. Available: https://freshangleng.com/14976/delta-state-2022-budget-address--read-before-dtha-by-his-excellency--senator--dr--ifeanyi-okowa. [Accessed: 06-Oct-2023].
[60]. DSCHC, 2023, “PharmAccess, DSCHC, Host Access to Finance Impact Evaluation Report Dissemination,” Delta State Contributory Health Commission. [Online]. Available: https://dschc.org.ng/PharmAccess,%20DSCHC,%20host%20Access%20to%20Finance%20Impact%20Evaluation%20Report%20Dissemination.html. [Accessed: 06-Oct-2023].
Viewed PDF 34 0 -
Estimation of Fucokinase and Serum Biochemical Markers in Menopause WomenAuthor: Luay A. Al-HelalyDOI: 10.21522/TIJPH.2013.13.01.Art023
Estimation of Fucokinase and Serum Biochemical Markers in Menopause Women
Abstract:
Fucokinase is involved in the fucosylation of carbohydrates, which are involved in various biological and pathological processes in eukaryotic organisms, such as tissue development, angiogenesis, and fertilization. In our study, FUK in addition to Some enzymes, Hormones, Lipid profiles, oxidants and antioxidants, and other biochemical parameters were measured in serum for (175) women of ages ranging from (18 – 40) years Also, 80 serum samples were collected from women suffering from menopause in the same ages from Mosul city. The results showed that there is a decrease in the FUK, vitamin D, Triglyceride (TG), Very low-density lipoprotein (VLDL), glutathione (GSH) and high levels of alkaline phosphatase (ALP), total bilirubin (TB) and calcium (Ca), Progesterone, Testosterone, low-density lipoprotein (LDL), Atherogenic index and malondialdehyde (MDA) in MP women compared to healthy women. The hormonal changes associated with MP lead to increased liver enzyme levels, indicating a potential risk for liver dysfunction and increased bone turnover, while Ca levels may decline due to decreased estrogen. Total bilirubin and phosphorus levels appear to be less affected. The lipid profile of MP shows significant adverse changes compared to normal premenopausal women. Menopausal women tend to have lower levels of GSH and higher levels of MDA and ONOO-, indicating increased oxidative stress. The comparison of FUK values between MP and healthy women highlights the potential impact of hormonal changes on metabolic pathways. Further research is needed to elucidate the specific mechanisms by which FUK activity is altered in early menopause and to explore the clinical implications of these changes.
Estimation of Fucokinase and Serum Biochemical Markers in Menopause Women
References:
[1]. Djahanbakhch, O., Ezzati, M., Zosmer, A., 2007, Reproductive ageing in women. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, 211(2), 219-231. doi:10.1002/path.2108.
[2]. Welt, C. K., McNicholl, D. J., Taylor, A. E., Hall, J. E., 1999, Female reproductive ageing is marked by decreased secretion of dimeric inhibin. The Journal of Clinical Endocrinology & Metabolism, 84(1), 105-111. doi:10.1210/jcem.84.1.5381.
[3]. Doshi, S.B., Agarwal, A., 2013, The role of oxidative stress in menopause. Journal of mid-life health, 4(3), 140-146. doi:10.4103/0976-7800.118990.
[4]. Lumsden, M. A., Davies, M., Sarri, G., 2016, Diagnosis and management of menopause: the National Institute of Health and Care Excellence (NICE) guideline. JAMA Internal Medicine, 176(8), 1205-1206. doi:10.1001/jamainternmed.2016.2761.
[5]. Santoro, N., Roeca, C., Peters, B. A., Neal-Perry, G., 2021, The menopause transition: signs, symptoms, and management options. The Journal of Clinical Endocrinology & Metabolism, 106(1), 1-15. doi:10.1210/clinem/dgaa764.
[6]. Vogt, E. C., Real, F. G., Husebye, E. S., Björnsdottir, S., Benediktsdottir, B., Bertelsen, R. J., Øksnes, M., 2022, Premature menopause and autoimmune primary ovarian insufficiency in two international multi-centre cohorts. Endocrine Connections, 11(5). doi:10.1530/EC-22-0024.
[7]. Faubion, S. S., Kuhle, C. L., Shuster, L. T., Rocca, W. A., 2015, Long-term health consequences of premature or early menopause and considerations for management. Climacteric, 18(4), 483-491. doi:10.3109/13697137.2015.1020484.
[8]. Park, S. H., Pastuszak, I., Drake, R., Elbein, A. D., 1998, Purification to Apparent Homogeneity and Properties of Pig Kidneyl-Fucose Kinase. Journal of Biological Chemistry, 273(10), 5685-5691. doi:10.1074/jbc.273.10.5685.
[9]. Wang, Y., Lee, G. F., Kelley, R. F., Spellman, M. W., 1996, Identification of a GDP-L-fucose: polypeptide fucosyltransferase and enzymatic addition of O-linked fucose to EGF domains. Glycobiology, 6(8), 837-842. doi:10.1093/glycob/6.8.837.
[10]. Ma, B., Simala-Grant, J. L., Taylor, D. E., 2006, Fucosylation in prokaryotes and eukaryotes. Glycobiology, 16(12), 158R-184R. doi:10.1093/glycob/cwl040.
[11]. Zhang, N. Z., Zhao, L. F., Zhang, Q., Fang, H., Song, W. L., Li, W. Z., Gao, P., 2023, Core fucosylation and its roles in gastrointestinal glycoimmunology. World Journal of Gastrointestinal Oncology, 15(7), 1119. doi:10.4251/wjgo.v15.i7.1119.
[12]. Kotake, T., Hojo, S., Tajima, N., Matsuoka, K., Koyama, T., Tsumuraya, Y., 2008, A bifunctional enzyme with L-fucokinase and GDP-L-fucose pyrophosphorylase activities salvages free L-fucose in Arabidopsis. Journal of Biological Chemistry, 283(13), 8125-8135. doi:10.1074/jbc.M710078200.
[13]. Fossati, P., Prencipe, L., Berti, G., 1980, Use of 3, 5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clinical chemistry, 26(2), 227-231. doi:10.1093/clinchem/26.2.227.
[14]. Reitman, S., Frankel, S., 1957, A colourimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. American Journal of Clinical Pathology, 28(1), 56-63. doi:10.1093/ajcp/28.1.56.
[15]. Moorehead, W. R., Biggs, H. G., 1974, 2-Amino-2-methyl-1-propanol as the alkalizing agent in an improved continuous-flow cresolphthalein complex one procedure for calcium in serum. Clinical chemistry, 20(11), 1458-1460. doi:10.1093/clinchem/20.11.1458.
[16]. Farukhi, Z., Mora, S., 2018, The future of low-density lipoprotein cholesterol in an era of nonfasting lipid testing and potent low-density lipoprotein lowering. Circulation, 137(1), 20-23. doi:10.1161/CIRCULATIONAHA.117.031857.
[17]. Guidet, B., Shah, S. V., 1989, Enhanced in Vivo H2O2 generation by rat kidney in glycerol-induced renal failure. American Journal of Physiology-Renal Physiology, 257(3), F440-F445. doi:10.1152/ajprenal.1989.257.3.F440.
[18]. VanUffelen, E. B., Van der ZEE, J., de Koster, M. B., VanSteveninck, J., Elferink, G. J., 1998, Intracellular but not extracellular conversion of nitroxyl anion into nitric oxide leads to stimulation of human neutrophil migration. Biochemical Journal, 330(2), 719-722. doi:10.1042/bj3300719.
[19]. Sedlak, J., Lindsay, R. H., 1968, Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Analytical Biochemistry, 25, 192-205.
[20]. Ko, S. H., Jung, Y., 2021, Energy metabolism changes and dysregulated lipid metabolism in postmenopausal women. Nutrients, 13(12), 4556. doi:10.3390/nu13124556.
[21]. Ko, S. H., Kim, H. S., 2020, Menopause-associated lipid metabolic disorders and foods beneficial for postmenopausal women. Nutrients, 12(1), 202. doi:10.3390/nu12010202.
[22]. Ou, Y. J., Lee, J., Huang, S. P., Chen, S. C., Geng, J. H., Su, C. H., 2023, Association between Menopause, postmenopausal hormone therapy and metabolic syndrome. Journal of Clinical Medicine, 12(13), 4435. doi:10.3390/jcm12134435.
[23]. McCarthy, M., Raval, A. P., 2020, The peri-menopause in a woman's life: a systemic inflammatory phase that enables later neurodegenerative disease. Journal of Neuroinflammation, 17, 1-14. doi:10.1186/s12974-020-01998-9.
[24]. Ortmann, O., Beckermann, M. J., Inwald, E. C., Strowitzki, T., Windler, E., Tempfer, C., Guideline Group., 2020, Peri-and postmenopause—diagnosis and interventions interdisciplinary S3 guideline of the association of the scientific medical societies in Germany (AWMF 015/062): short version. Archives of gynaecology and obstetrics, 302, 763-777. doi:10.1007/s00404-020-05682-4.
[25]. Bhattarai, T., Bhattacharya, K., Chaudhuri, P., Sengupta, P., 2014, Correlation of common biochemical markers for bone turnover, serum calcium, and alkaline phosphatase in post-menopausal women. The Malaysian Journal of Medical Sciences: MJMS, 21(1), 58.
[26]. Pardhe, B D., Pathak, S., Bhetwal, A., Ghimire, S., Shakya, S., Khanal, P. R., Marahatta, S. B., 2017, Effect of age and estrogen on biochemical markers of bone turnover in postmenopausal women: a population-based study from Nepal. International Journal of Women's Health, 781-788. doi:10.2147/IJWH.S145191.
[27]. Bansal, N., Katz, R., de Boer, I. H., Kestenbaum, B., Siscovick, D. S., Hoofnagle, A. N., Ix, J. H., 2013, Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study. The Journal of Clinical Endocrinology & Metabolism, 98(12), 4890-4898. doi:10.1210/jc.2013-2286.
[28]. Ohta, H., Sugimoto, I., Masuda, A., Komukai, S., Suda, Y., Makita, K., Nozawa, S., 1996, Decreased bone mineral density associated with early menopause progresses for at least ten years: cross-sectional comparisons between early and normal menopausal women. Bone, 18(3), 227-231. doi:10.1016/8756-3282(95)00480-7.
[29]. Penzias, A., Azziz, R., Bendikson, K., Falcone, T., Hansen, K., Hill, M., Young, S., 2021, Diagnosis and treatment of luteal phase deficiency: a committee opinion. Fertility and Sterility, 115(6), 416-423. doi:10.1016/j.fertnstert.2021.02.010.
[30]. Kolcsár, M., Berecki, B., Gáll, Z., 2023, Relationship between Serum 25-Hydroxyvitamin D Levels and Hormonal Status in Infertile Women: A Retrospective Study. Diagnostics, 13(19), 3024. doi:10.3390/diagnostics13193024.
[31]. JI, T., 2009, Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women's Health Across the Nation. Menopause, 16, 257-264. doi:10.1253/circj.CJ-12-0613.
[32]. Kilim, S. R., Chandala, S. R., 2013, A comparative study of lipid profile and oestradiol in pre-and post-menopausal women. Journal Of Clinical and Diagnostic Research: JCDR, 7(8), 1596. doi: 10.7860/JCDR/2013/6162.3234.
[33]. Ambikairajah, A., Walsh, E., Cherbuin, N., 2019, Lipid profile differences during menopause: a review with meta-analysis. Menopause, 26(11), 1327-1333. doi:10.1097/GME.0000000000001403.
[34]. Guo, Q., Zhou, S., Feng, X., Yang, J., Qiao, J., Zhao, Y., Zhou, Y., 2020, The sensibility of the new blood lipid indicator——atherogenic index of plasma (AIP) in menopausal women with coronary artery disease. Lipids in Health and Disease, 19, 1-8. doi:10.1186/s12944-020-01208-8.
[35]. Barua, L., Faruque, M., Banik, P. C., Ali, L., 2019, Atherogenic index of plasma and its association with cardiovascular disease risk factors among postmenopausal rural women of Bangladesh. Indian Heart Journal, 71(2), 155-160. doi:10.1016/j.ihj.2019.04.012.
[36]. Ansar, S., Alhefdhi, T., Aleem, A. M., 2015, Status of trace elements and antioxidants in premenopausal and postmenopausal phase of life: a comparative study. International Journal Of Clinical And Experimental Medicine, 8(10), 19486.
[37]. Pinchuk, I., Weber, D., Kochlik, B., Stuetz, W., Toussaint, O., Debacq-Chainiaux, F., Lichtenberg, D., 2019, Gender-and age-dependencies of oxidative stress, as detected based on the steady-state concentrations of different biomarkers in the MARK-AGE study. Redox Biology, 24, 101204. doi:10.1016/j.redox.2019.101204.
[38]. Cervellati, C., Bergamini, C. M., 2016, Oxidative damage and the pathogenesis of menopause-related disturbances and diseases. Clinical Chemistry and Laboratory Medicine (CCLM), 54(5), 739-753. doi:10.1515/cclm-2015-0807.
[39]. Malekian, S., Mirghafourvand, M., Najafipour, F., Ostadrahimi, A., Ghassab-Abdollahi, N., Farshbaf-Khalili, A., 2023, The associations between bone mineral density and oxidative stress biomarkers in postmenopausal women. Korean Journal of Family Medicine, 44(2), 95. doi:10.4082/kjfm.22.0022.
[40]. Kathak, R. R., Sumon, A. H., Molla, N. H., Hasan, M., Miah, R., Tuba, H. R., Ali, N., 2022, The association between elevated lipid profile and liver enzymes: a study on Bangladeshi adults. Scientific reports, 12(1), 1711. doi:10.1038/s41598-022-05766-y.
[41]. Islam, S., Rahman, S., Haque, T., Sumon, A. H., Ahmed, A. M., Ali, N., 2020, Prevalence of elevated liver enzymes and its association with type 2 diabetes: A cross‐sectional study in Bangladeshi adults. Endocrinology, diabetes & metabolism, 3(2), e00116. doi:10.1002/edm2.116.
Viewed PDF 27 2 -
Solanum xanthocarpum: Nature's Remedy for Healthy Periodontium- Unveiling the Therapeutic Potential against Chronic Periodontal DiseasesAuthor: Deepavalli ArumuganainarDOI: 10.21522/TIJPH.2013.13.01.Art024
Solanum xanthocarpum: Nature's Remedy for Healthy Periodontium- Unveiling the Therapeutic Potential against Chronic Periodontal Diseases
Abstract:
Solanum xanthocarpum, commonly known as yellow-fruit nightshade, is a noteworthy herb in the ayurvedic medicine belonging to the Solanaceae family. This perennial herb is widely distributed in tropical and subtropical regions, especially in India and Southeast Asia. The plant is characterized by its thorny stems, small purple flowers, and distinctive yellow berries. Traditionally, Solanum xanthocarpum has been used in the treatment of respiratory disorders, fever, and inflammatory conditions. Phytochemical studies reveal that the plant is rich in bioactive compounds like alkaloids, flavonoids, and steroids, which contribute to its therapeutic properties with notable antioxidant, anti-inflammatory, and antimicrobial activities. Periodontitis is a chronic inflammatory disorder, multifactorial in origin, and destroys the supporting periodontal apparatus by triggering the inflammatory cascade. Inflammation and the disruption of the equilibrium between oxidative stress and antioxidants play a pivotal role in the disease progression. This is mainly treated by mechanical debridement of the biofilm, local drug delivery of antibiotics and anti-inflammatory agents, and surgical management if deemed necessary. The inadvertent use of antibiotics has led to the emergence of resistance to drugs. Advances in research have validated the pharmacological properties of traditional medicine, whose properties outweigh the constraints of antibiotics. Thus, Solanum xanthocarpum could be one such plant whose derivatives could be used in the treatment of periodontitis. This review emphasizes the potential of Solanum xanthocarpum to be formulated and utilized in the prevention and management of periodontal diseases.
Solanum xanthocarpum: Nature's Remedy for Healthy Periodontium- Unveiling the Therapeutic Potential against Chronic Periodontal Diseases
References:
[1]. Graziani F., Karapetsa D., Alonso B., Herrera D., 2017, Nonsurgical and surgical treatment of periodontitis: how many options for one disease? Periodontology 2000,75(1),152-88.
[2]. Durham J., Fraser H. M., McCracken G. I., Stone K. M., John M. T., Preshaw P. M., 2013, Impact of periodontitis on oral health-related quality of life. J Dent, 41(4),370-6.
[3]. Könönen E., Gursoy M., Gursoy U. K.,2019, Periodontitis: a multifaceted disease of tooth-supporting tissues, Journal of Clinical Medicine, 31;8(8),1135.
[4]. Darby I., 2022, Risk factors for periodontitis & peri‐implantitis, Periodontology 2000, 90(1),9-12.
[5]. Hajishengallis G., Chavakis T., Lambris J. D., 2020, Current understanding of periodontal disease pathogenesis and targets for host‐modulation therapy, Periodontology 2000, 84(1),14-34.
[6]. Pisano M., Giordano F., Sangiovanni G., Capuano N., Acerra A., D’Ambrosio F.,2023, The Interaction between the Oral Microbiome and Systemic Diseases: A Narrative Review, Microbiology Research, 14(4):1862-78.
[7]. Păunică I., Giurgiu M., Dumitriu A. S., Păunică S., Pantea Stoian A. M., Martu M. A., Serafinceanu C., 2023, The bidirectional relationship between periodontal disease and diabetes mellitus—A review, Diagnostics,11;13(4):681.
[8]. Sanz M., Marco del Castillo A., Jepsen S., Gonzalez‐Juanatey J. R., D’Aiuto F., Bouchard P., Chapple I., Dietrich T., Gotsman I., Graziani F., Herrera D., 2020, Periodontitis and cardiovascular diseases: Consensus report, Journal of clinical periodontology, 47(3):268-88.
[9]. Butera A., Maiorani C., Morandini A., Trombini J., Simonini M., Ogliari C., Scribante A., 2023, Periodontitis in Pregnant Women: A Possible Link to Adverse Pregnancy Outcomes, InHealthcare 11(10),1372.
[10]. Dragoo M.,1992, A clinical evaluation of hand and ultrasonic instruments on subgingival debridement I. With unmodified and modified ultrasonic inserts, Int J Periodont Restor Dent,12,311.
[11]. Munasur S. L., Turawa E. B., Chikte U. M., Musekiwa A.,2020, Mechanical debridement with antibiotics in the treatment of chronic periodontitis: effect on systemic biomarkers―a systematic review. International Journal of Environmental Research And Public Health, 17(15),5601.
[12]. Karygianni L., Al-Ahmad A., Argyropoulou A., Hellwig E., Anderson A. C., Skaltsounis AL.,2016, Natural antimicrobials and oral microorganisms: a systematic review on herbal interventions for the eradication of multispecies oral biofilms. Frontiers in Microbiology,14(6),1529.
[13]. Parmar S., Gangwal A., Sheth N.,2010, Solanum xanthocarpum (yellow berried nightshade): a review. Der Pharm Lett, 2(4),373-83.
[14]. Xu Z. P., Liu Y., Wang S. Y., Li Z. W., Lu D. X., Jiang P et al.,2022, Phenolic compounds of Solanum xanthocarpum play an important role in anti-inflammatory effects, Arabian Journal of Chemistry, 2022,15(7):103877.
[15]. Kumar S., Pandey A, K., 2014, Medicinal attributes of Solanum xanthocarpum fruit consumed by several tribal communities as food: an in vitro antioxidant, anticancer and anti-HIV perspective. BMC Complementary and Alternative Medicine,14,1-8.
[16]. Singh O. M., Singh T. P.,2010, Phytochemistry of Solanum xanthocarpum: an amazing traditional healer,69(10), 732-740.
[17]. Fathima T., Joghee S., Akaash M.,2019, Solanum xanthocarpum: A review. International Journal of Pharmacognosy and Chinese Medicine, 3(3),1-7.
[18]. Pungle R., Tambe A., More A., Kharat A.,2018, Anti-inflammatory and antioxidant potentiality of Solanum xanthocarpum. African Journal of Biotechnology,17(37),188-95.
[19]. Hu, Y. S., Han, X., Yu., P. J., Jiao., M. M., Liu, X. H., Shi, J. B., 2020, Novel phenol derivatives: Design, synthesis and anti-inflammatory activity in vitro and in vivo, Bioorg. Chem. 98, 103735.
[20]. Xu Z. P., Liu Y., Wang S. Y., Li Z. W., Lu D. X., Jiang P et al., 2022, Phenolic compounds of Solanum xanthocarpum play an important role in anti-inflammatory effects. Arabian Journal of Chemistry, 2022,15(7),103877.
[21]. Sultana R., Khanam S., Devi K., 2011, Immunomodulatory effect of methanol extract of Solanum xanthocarpum fruits. Int J Pharm Sci Res, 2(2), 93-7.
[22]. Santa K., 2023, Macrophages: Phagocytosis, Antigen Presentation, and Activation of Immunity. In Phagocytosis-Main Key of Immune System, IntechOpen.
[23]. Kumar S., SharmaU. K., Sharma A. K., Pandey A. K., 2012, Protective efficiency of Solanum xanthocarpum root extracts against free radical damage: phytochemical analysis and antioxidant effect. Cellular and Molecular Biology, 58(1),174-181.
[24]. Janssen L. J., Killian K.,2006, Airway smooth muscle as a target of asthma therapy: history and new directions. Respiratory research,7:1-2.
[25]. Vadnere G. P., Gaud R. S., Singhai A. K., 2008, Evaluation of anti-asthmatic property of Solanum xanthocarpum flower extracts, Pharmacologyonline, 1:513-22.
[26]. Govindan S., Viswanathan S., Vijayasekaran V., Alagappan R., 1999, A pilot study on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma, Journal of Ethnopharmacology, 66(2):205-10.
[27]. Choi J. R., Lee C. M., Jung I. D., Lee J. S., Jeong Y. I., Chang J. H et al., 2009, Apigenin protects ovalbumin-induced asthma through the regulation of the GATA-3 gene, International Immunopharmacology. 9(7-8), 918-24.
[28]. Gavimath C. C., Kulkarni S. M., Raorane C. J., Kalsekar D. P., Gavade B. G., Ravishankar B. E et al., 2012, Antibacterial potentials of Solanum indicum, Solanum xanthocarpum, and Physalis minima, Int J Pharma Appl, 3:414-8.
[29]. Deepavalli A., Gopinath S., Arun K. V., Balaji S. K., 2023, An In Vitro Evaluation of the Antibacterial Efficacy of Solanum xanthocarpum Extracts on Bacteria from Dental Plaque Biofilm, Cureus, 15(9).
[30]. Sharma B., Verma N., Tomar M. S., 2020, Evaluation of antifungal potential of Solanum xanthocarpum Schrad. and Wendl., an important medicinal plant of arid region, International Journal of Advanced Research in Biological Sciences, 7,163-8.
[31]. Mamta P. R., Dalei J., 2016, Qualitative evaluation of phytochemicals and antifungal activity of Solanum xanthocarpum (Schrad. & Wendl.), IOSR J Pharm Biol Sci, 11(3), 99-104.
[32]. Wang H. K., Xia Y., Yang Z. Y., Nitschke S. L., Lee K. H,1998, Recent advances in the discovery and development of flavonoids and their analogues as antitumor and anti-HIV agents. Adv Exp Med Biol, 439,191–225.
[33]. Najmi A. K., Pillai K. K., Pal S. N., Aqil M.,2005, Free radical scavenging and hepatoprotective activity of jigrine against galactosamine induced hepatopathy in rats, Journal of Ethnopharmacology, 97(3), 521-5.
[34]. Gupta R. K., Hussain T., Panigrahi G., Das A., Singh G. N., Sweety K et al., 2011, Hepatoprotective effect of Solanum xanthocarpum fruit extract against CCl4 induced acute liver toxicity in experimental animals. Asian Pacific Journal of Tropical Medicine,4(12), 964-8.
[35]. Gunaselvi G., Kulasekaren V., Gopal V., 2010, Anthelmintic activity of the extracts of Solanum xanthocarpum Schrad and Wendl fruits (Solanaceae), 1772-4.
[36]. World Health Organization., 2009, The use of herbal medicines in primary health care. WHO Regional Office for Southeast Asia.
[37]. Vlietinck A. J., Van Hoof L., Totte J., Lasure A., Berghe D. V., Rwangabo PC et al., 1995, Screening of hundred Rwandese medicinal plants for antimicrobial and antiviral properties. Journal of Ethnopharmacology, 46(1), 31-47.
[38]. Subharani K., 2016, Chemical constituents and medicinal properties of Solanum xanthocarpum. A review, Int J Sci Res, 5(10), 824-6.
[39]. Arumuganainar D., Subramanian G., Basavarajappa S., Hashem M. I., Arun K. V., Balaji S. K et al., 2023, Bioactive Efficacy of Identified Phytochemicals Solasodine, Lupeol and Quercetin from Solanum xanthocarpum against the RgpB Protein of Porphyromonas gingivalis- A Molecular Docking and Simulation Analysis, Processes, 11, 1887.
[40]. Nascimento G. G., Leite F. R., Scheutz F., López R., 2017, Periodontitis: from infection to inflammation. Current Oral Health Reports, 4:301-8.
[41]. Minervini G, Marrapodi MM, Tirupathi S, Afnan L, Di Blasio M, Cervino G, Isola G, Cicciù M., 2024, Comparative anti-plaque and anti-gingivitis efficiency of Triphala versus chlorhexidine mouthwashes in children: a systematic review and meta-analysis. J Clin Pediatr Dent., Sep;48(5):51-59.
[42]. A. Sakthivel, K. Sankaran, G. Rengasamy, V. Vishnu Priya, P. Sathishkumar, 2024, Formulation of Mouthwash Using Combined Herbal Extracts to Control the Predominant Oral Pathogens and Biofilm. Journal of Herbal Medicine, 46,100905.
[43]. Deolikar, S., Jawdekar, A., Saraf, T., Thribhuvanan, L., Tirupathi, S., 2024, Comparative Evaluation of the Antimicrobial Efficacy of Elettaria cardamomum (0.5%) Mouthwash, Camellia sinensis (0.5%) Mouthwash, and 0.12% Chlorhexidine Gluconate Mouthwash against Streptococcus mutans: An In Vitro Study. Int J Clin Pediatr Dent., Apr;17(4):461-466.
Viewed PDF 27 1 -
Therapeutic Potential of Gut Microbiota: Insights into Immune Modulation, Metabolite Signaling and Clinical Applications in Inflammatory and Metabolic DiseasesAuthor: Sathasivam SivamalarDOI: 10.21522/TIJPH.2013.13.01.Art025
Therapeutic Potential of Gut Microbiota: Insights into Immune Modulation, Metabolite Signaling and Clinical Applications in Inflammatory and Metabolic Diseases
Abstract:
The gut microbiota is a complex network of microorganisms inhabiting the gastrointestinal tract and it has a great influence on intestinal health. Disbalances within metabolic patterns and microbial diversity may cause inflammatory bowel disease and other diseases. Microorganisms in intestinal mucosa produce metabolites that act as signalling molecules and influence the regulation of inflammation and the immune response. SCFAs and secondary bile acids are metabolites that bind to specific receptors and trigger inflammatory signals that affect intestinal immunity and host health. Moreover, metabolites of tryptophan promote the integrity of the epithelial barrier and also interact with intestinal mucosal aromatic hydrocarbon receptors (AHR) to regulate immune homeostasis. By acting as precursors to AHR ligands together with SCFAs and secondary bile acids, dietary-derived indoles relax the intestinal epithelium inflammation and stress. The mechanistic and therapeutic advances in non-alcoholic fatty liver disease (NAFLD) aim to alter host metabolism, reduce inflammation, and reconstitute the integrity of the gut barrier through changes in the composition of gut microbiota. Since dysbiosis in liver cirrhosis leads to complications such as bacteremia and hepatic encephalopathy, probiotics and synbiotics are being investigated to treat associated metabolic disorders.
Therapeutic Potential of Gut Microbiota: Insights into Immune Modulation, Metabolite Signaling and Clinical Applications in Inflammatory and Metabolic Diseases
References:
[1]. Bengmark, S., 1998, Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut, 42(1), 2-7.
[2]. Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., & Nelson, K. E., 2006, Metagenomic analysis of the human distal gut microbiome. science, 312(5778), 1355-1359.
[3]. Takahashi, K., Nishida, A., Fujimoto, T., Fujii, M., Shioya, M., Imaeda, H., & Sugimoto, M., 2016, Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn's disease. Digestion, 93(1), 59-65.
[4]. Yarandi, S. S., Peterson, D. A., Treisman, G. J., Moran, T. H., & Pasricha, P. J., 2016, Modulatory effects of gut microbiota on the central nervous system: how gut could play a role in neuropsychiatric health and diseases. Journal of neurogastroenterology and motility, 22(2), 201.
[5]. Fu, Y., Lyu, J., & Wang, S., 2023, The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective. Frontiers in immunology, 14, 1277102.
[6]. Den Besten, G., Van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D. J., & Bakker, B. M., 2013, The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of lipid Research, 54(9), 2325-2340.
[7]. Natividad, J. M., & Verdu, E. F., 2013, Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacological research, 69(1), 42-51.
[8]. Chang, C., & Lin, H., 2016, Dysbiosis in gastrointestinal disorders. Best practice & research Clinical gastroenterology, 30(1), 3-15.
[9]. Musso, G., Gambino, R., & Cassader, M., 2010, Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes care, 33(10), 2277-2284.
[10]. Louis, P., Hold, G. L., & Flint, H. J., 2014, The gut microbiota, bacterial metabolites and colorectal cancer. Nature reviews microbiology, 12(10), 661-672.
[11]. Macfarlane, S., & Macfarlane, G. T., 2003, Regulation of short-chain fatty acid production. Proceedings of the Nutrition Society, 62(1), 67-72.
[12]. Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M., 2004, Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. International Journal of Systematic and Evolutionary Microbiology, 54(5), 1469-1476.
[13]. Morrison, D. J., & Preston, T., 2016, Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes, 7(3), 189-200.
[14]. Donohoe, D. R., Collins, L. B., Wali, A., Bigler, R., Sun, W., & Bultman, S. J., 2012, The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Molecular cell, 48(4), 612-626.
[15]. Lin, L., & Zhang, J., 2017, Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC immunology, 18, 1-25.
[16]. Martens, J. H., Barg, H., Warren, M. A., & Jahn, D., 2002, Microbial production of vitamin B 12. Applied microbiology and biotechnology, 58, 275-285.
[17]. Staley, C., Weingarden, A. R., Khoruts, A., & Sadowsky, M. J., 2017, Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Applied microbiology and biotechnology, 101, 47-64.
[18]. Palau-Rodriguez, M., Tulipani, S., Isabel Queipo-Ortuño, M., Urpi-Sarda, M., Tinahones, F. J., & Andres-Lacueva, C., 2015, Metabolomic insights into the intricate gut microbial–host interaction in the development of obesity and type 2 diabetes. Frontiers in Microbiology, 6, 1151.
[19]. Swanson, P. A., Kumar, A., Samarin, S., Vijay-Kumar, M., Kundu, K., Murthy, N., & Neish, A. S., 2011, Enteric commensal bacteria potentiate epithelial restitution via reactive oxygen species-mediated inactivation of focal adhesion kinase phosphatases. Proceedings of the National Academy of Sciences, 108(21), 8803-8808.
[20]. Reunanen, J., Kainulainen, V., Huuskonen, L., Ottman, N., Belzer, C., Huhtinen, H., & Satokari, R., 2015, Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer. Applied and environmental microbiology, 81(11), 3655-3662.
[21]. Graziani, F., Pujol, A., Nicoletti, C., Dou, S., Maresca, M., Giardina, T., & Perrier, J., 2016, Ruminococcus gnavus E1 modulates mucin expression and intestinal glycosylation. Journal Of Applied Microbiology, 120(5), 1403-1417.
[22]. Rogier, E. W., Frantz, A. L., Bruno, M. E., & Kaetzel, C. S., 2014, Secretory IgA is concentrated in the outer layer of colonic mucus along with gut bacteria. Pathogens, 3(2), 390-403.
[23]. Hevia, A., Delgado, S., Sánchez, B., & Margolles, A., 2015, Molecular players involved in the interaction between beneficial bacteria and the immune system. Frontiers in microbiology, 6, 1285.
[24]. Ng, K. M., Ferreyra, J. A., Higginbottom, S. K., Lynch, J. B., Kashyap, P. C., Gopinath, S., & Sonnenburg, J. L., 2013, Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature, 502(7469), 96-99.
[25]. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., & Cani, P. D., 2013, Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the national academy of sciences, 110(22), 9066-9071.
[26]. Zhao, S., Liu, W., Wang, J., Shi, J., Sun, Y., Wang, W., & Hong, J., 2017, Akkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice. J Mol Endocrinol, 58(1), 1-14.
[27]. Jandhyala, S. M., Talukdar, R., Subramanyam, C., Vuyyuru, H., Sasikala, M., & Reddy, D. N., 2015, Role of the normal gut microbiota. World journal of gastroenterology: WJG, 21(29), 8787.
[28]. Han, R., Ma, J., & Li, H.,2018, Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota. Frontiers of Medicine, 12, 645-657.
[29]. Suk, K. T., & Kim, D. J.,2019, Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology, 13(3), 193-204.
[30]. Lv, H., Tao, F., Peng, L., Chen, S., Ren, Z., Chen, J., & Wan, C., 2023, In vitro probiotic properties of Bifidobacterium animalis subsp. lactis SF and its alleviating effect on non-alcoholic fatty liver disease. Nutrients, 15(6), 1355.
[31]. Usami, M., Miyoshi, M., & Yamashita, H., 2015, Gut microbiota and host metabolism in liver cirrhosis. World journal of gastroenterology, 21(41), 11597.
[32]. Pushpanathan, P., Mathew, G. S., Selvarajan, S., Seshadri, K. G., & Srikanth, P., 2019, Gut microbiota and its mysteries. Indian Journal of Medical Microbiology, 37(2), 268-277.
[33]. Migliore, L., Nicoli, V., & Stoccoro, A., 2021, Gender specific differences in disease susceptibility: the role of epigenetics. Biomedicines, 9(6), 652.
[34]. Rizzetto, L., Fava, F., Tuohy, K. M., & Selmi, C., 2018, Connecting the immune system, systemic chronic inflammation and the gut microbiome: the role of sex. Journal of autoimmunity, 92, 12-34.
[35]. Chang, C. S., & Kao, C. Y., 2019, Current understanding of the gut microbiota shaping mechanisms. Journal of biomedical science, 26(1), 59.
[36]. Langan, D., Rose, N. R., & Moudgil, K. D., 2020, Common innate pathways to autoimmune disease. Clinical Immunology, 212, 108361.
[37]. Neish, A. S., 2009, Microbes in gastrointestinal health and disease. Gastroenterology, 136(1), 65-80.
[38]. Van den Elsen, L. W., Garssen, J., Burcelin, R., & Verhasselt, V., 2019, Shaping the gut microbiota by breastfeeding: the gateway to allergy prevention? Frontiers in pediatrics, 7, 47.
[39]. Berg, G., Rybakova, D., Fischer, D., Cernava, T., Vergès, M. C. C., Charles, T., & Schloter, M., 2020, Microbiome definition re-visited: old concepts and new challenges. Microbiome, 8, 1-22.
[40]. Laterza, L., Rizzatti, G., Gaetani, E., Chiusolo, P., & Gasbarrini, A., 2016, The gut microbiota and immune system relationship in human graft-versus-host disease. Mediterranean Journal of Hematology and Infectious Diseases, 8(1).
[41]. Deo, P. N., & Deshmukh, R., 2019, Oral microbiome: Unveiling the fundamentals. Journal Of Oral and Maxillofacial Pathology, 23(1), 122-128.
[42]. Dickson, R. P., & Huffnagle, G. B., 2015, The lung microbiome: new principles for respiratory bacteriology in health and disease. PLoS pathogens, 11(7), e1004923.
Viewed PDF 20 0 -
Assessment of Body Image Satisfaction and Self-Esteem among University Students in Ilorin Kwara State, NigeriaAuthor: Onasoga, Olayinka ADOI: 10.21522/TIJPH.2013.13.01.Art026
Assessment of Body Image Satisfaction and Self-Esteem among University Students in Ilorin Kwara State, Nigeria
References:
[1]. Hardie, A., Oshiro, K. F., & Dixon, M. A. 2022, Understanding body image perceptions of former female athletes: A qualitative analysis. Body Image, 43, 393–407. https://doi.org/10.1016/j.bodyim.2022.10.001
[2]. Abera, W., 2021, Body Image Perception as a Predictor of Self-Esteem among High School Adolescent Students: A Study in Ghion Secondary School, Bahir Dar, Ethiopia. Quality in Primary Care, 29(10), 5632. https://www.primescholars.com/articles/body-image-perception-as-a-predictor-of-selfesteem-among-high-school-adolescent-students-a-study-in-ghion-secondary-scho-100566.html%0Ahttps://www.primescholars.com/abstract/body-image-perception-as-a-predictor-of-se
[3]. Zainal, N. H., Romziman, N. S., Aminuddin, B. A., Syed Idros, S. A. K., & Salem Wajih, W. A., 2021, The Relationship of Body Image Perception, Self-esteem and Academic Performance in University of Cyberjaya (UoC) Undergraduates. Malaysian Journal of Medicine and Health Sciences, 17(5), 33–39.
[4]. Keshk, M. M., Fahim, H. I., Hassan, A. M., Boulos, D. N., & Sector, P., 2019, Body image perception and self-esteem among university students in cairo. Egyptian Journal of Community Medicine, 37(1), 82-96.
[5]. Chae, H., 2022, Factors associated with body image perception of adolescents. Acta Psychologica, 227, 103620. https://doi.org/10.1016/j.actpsy.2022.103620
[6]. Niswah, I., Rah, J. H., & Roshita, A., 2021, The Association of Body Image Perception With Dietary and Physical Activity Behaviors Among Adolescents in Indonesia. Food and Nutrition Bulletin, 42(1_suppl), S109–S121. https://doi.org/10.1177/0379572120977452
[7]. Linardon, J., Tylka, T. L., Burnette, C. B., Shatte, A., & Fuller-Tyszkiewicz, M.,2022, Understanding the role of positive body image during digital interventions for eating disorders: Secondary analyses of a randomized controlled trial. Body Image, 43, 1–7. https://doi.org/10.1016/j.bodyim.2022.08.003
[8]. Virk, A., & Singh, P., 2020, A study on relationship between body-image and self-esteem among medical undergraduate students. International Journal Of Community Medicine And Public Health, 7(2), 636. https://doi.org/10.18203/2394-6040.ijcmph20200441
[9]. Quittkat, H. L., Hartmann, A. S., Düsing, R., Buhlmann, U., & Vocks, S., 2019, Body Dissatisfaction, Importance of Appearance, and Body Appreciation in Men and Women Over the Lifespan. Frontiers in Psychiatry, 10. https://doi.org/10.3389/fpsyt.2019.00864
[10]. Rilwan, Y., Daniel, A., & Thomas, H., 2021, Body image, self-esteem and health behaviour among senior high school students in Offinso Municipality of Ashanti Region, Ghana. Journal of Physical Education and Sport Management, 12(1), 11–18. https://doi.org/10.5897/JPESM2021.0358
[11]. Silva, L. P. R. da, Tucan, A. R. de O., Rodrigues, E. L., Del Ré, P. V., Sanches, P. M. A., & Bresan, D., 2019, Dissatisfaction about body image and associated factors: a study of young undergraduate students. Einstein (São Paulo), 17(4).
[12]. Lôbo, I. L. B., Mello, M. T. de, Oliveira, J. R. V. de, Cruz, M. P., Guerreiro, R. de C., & Silva, A., 2020, Body image perception and satisfaction in university students. Revista Brasileira de Cineantropometria & Desempenho Humano, 22. https://doi.org/10.1590/1980-0037.2020v22e70423
[13]. Goicochea, E. A., Coloma-Naldos, B., Moya-Salazar, J., Rojas-Zumaran, V., Moya-Espinoza, J. G., & Contreras-Pulache, H., 2022, Physical Activity and Body Image Perceived by University Students during the COVID-19 Pandemic: A Systematic Review. International Journal of Environmental Research and Public Health, 19(24), 16498. https://doi.org/10.3390/ijerph192416498
[14]. Ketata, N., Ben Ayed, H., Baklouti, M., Trigui, M., Yaich, S., Abdelmoula, M., Feki, H., & Damak, J., 2021, Self-esteem and university students: Findings from a multi-center study. European Journal of Public Health, 31(Supplement_3). https://doi.org/10.1093/eurpub/ckab165.593
[15]. Ike O.O., 2023, Life Orientation and Depression among Undergraduate Students: The Moderating Role of Self Esteem. Psychology & Psychological Research International Journal, 8(3), 1–9. https://doi.org/10.23880/pprij-16000346
[16]. Alghamdi, S. A., Aljaffer, M. A., Alahmari, F. S., Alasiri, A. B., Alkahtani, A. H., Alhudayris, F. S., & Alhusaini, B. A., 2023, The impact of low self-esteem on academic achievement and the behaviors related to it among medical students in Saudi Arabia. Saudi Medical Journal, 44(6), 613–620. https://doi.org/10.15537/smj.2023.44.6.20230055
[17]. Çimke, S., & Gürkan, D. Y.,2023, Factors affecting body image perception, social media addiction, and social media consciousness regarding physical appearance in adolescents. Journal of Pediatric Nursing, 73, e197-e203.
[18]. Marks, R. J., De Foe, A., & Collett, J.,2020, The pursuit of wellness: social media, body image and eating disorders. Children and youth services review, 119, 105659.
[19]. Huang, Q., Peng, W., & Ahn, S., 2021, When media become the mirror: A meta-analysis on media and body image. Media psychology, 24(4), 437-489.
[20]. Tenkorang, S., & Okyere, C. O., 2022, Factors Influencing Body Image Perception of University Students in Ghana. Technium Social Sciences Journal, 27, 492–501. https://doi.org/10.47577/tssj.v27i1.552
[21]. Latiff, A. Ab., Muhamad, J., & Rahman, R. A., 2018, Body image dissatisfaction and its determinants among young primary-school adolescents. Journal of Taibah University Medical Sciences, 13(1), 34–41. https://doi.org/10.1016/j.jtumed.2017.07.003
Viewed PDF 26 1 -
Polysaccharides in Organ Fibrosis: Therapeutic and Preventive Effects Through Gut Microbiota ModulationAuthor: Ranjithkumar RajamaniDOI: 10.21522/TIJPH.2013.13.01.Art027
Polysaccharides in Organ Fibrosis: Therapeutic and Preventive Effects Through Gut Microbiota Modulation
Abstract:
Fibrosis is characterized by the proliferation of fibrous tissue and decreased functional cells within the affected organs, ultimately resulting in organ damage or failure. The incidence of this pathological process is on the rise globally, necessitating the development of more efficient therapeutic interventions. Recent scientific investigations have put forth the idea that polysaccharides extracted from natural sources exhibit promising abilities in alleviating fibrotic conditions by mitigating inflammatory responses and influencing intestinal microbiota composition. This scholarly discourse delves into the intricate relationship between polysaccharides and organ fibrosis concerning the dynamics of the intestinal microbiota, offering profound insights that could significantly influence the direction of future endeavours in drug development and treatment modalities. The in-depth exploration of these interconnected factors holds immense potential in shaping innovative strategies to combat fibrosis-related disorders and enhance patient outcomes in a clinical setting. The potential impact of this research on future drug development and treatment modalities cannot be overstated, as it underscores the importance of the study and its potential to influence the direction of future research in the field.
Polysaccharides in Organ Fibrosis: Therapeutic and Preventive Effects Through Gut Microbiota Modulation
References:
[2]. Cheong, K.-L., Yu, B., Teng, B., Veeraperumal, S., Xu, B., et al., 2023, Post-COVID-19 syndrome management: Utilizing the potential of dietary polysaccharides, Biomedicine & Pharmacotherapy, 166, 115320. https://doi.org/10.1016/j.biopha.2023.115320
[3]. Jayaseelan, V. P., 2019, In silico validation of the non-antibiotic drugs acetaminophen and ibuprofen as antibacterial agents against red complex pathogens, Journal of Periodontology, 90, 1441-1448. https://doi.org/10.1002/JPER.18-0673. https://doi.org/10.1016/j.sajb.2022.03.015
[4]. Wang, M., Veeraperumal, S., Zhong, S., Cheong, K.-L., 2023, Fucoidan-derived functional oligosaccharides: Recent developments, preparation, and potential applications, Foods, 12, 878. https://doi.org/10.3390/foods12040878
[5]. Corrie, L., Gulati, M., Awasthi, A., Vishwas, S., Kaur, J., et al., 2022, Polysaccharide, fecal microbiota, and curcumin-based novel oral colon-targeted solid self-nanoemulsifying delivery system: Formulation, characterization, and in-vitro anticancer evaluation, Materials Today Chemistry, 26, 101165. https://doi.org/10.1016/j.mtchem.2022.101165
[6]. Zhang, A., Wang, J., Hu, Y., Qiu, Y., Dong, C., 2024, Polysaccharides play an anti-fibrotic role by regulating intestinal flora: A review of research progress, International Journal of Biological Macromolecules, 131982. https://doi.org/10.1016/j.ijbiomac.2024.131982
[7]. Bhat, A.A., Gupta, G., Alharbi, K.S., Afzal, O., Altamimi, A.S.A., et al., 2022, Polysaccharide-Based Nanomedicines Targeting Lung Cancer, Pharmaceutics, 14, 2788. https://doi.org/10.3390/ pharmaceutics14122788
[8]. Ren, Q., Zhang, L.-y., Li, Z., 2020, Advances in the research of anti-organ fibrosis drugs, Acta Pharmaceutica Sinica, 2510–28.
[9]. Zhao, X., Chen, J., Sun, H., Zhang, Y., Zou, D., 2022, New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction, Cell & Bioscience, 12, 117. https://doi.org/10.1186/s13578-022-00856-w
[10]. Rockey, D. C., Bell, P. D., Hill, J. A., 2015, Fibrosis—a common pathway to organ injury and failure, New England Journal of Medicine, 372, 1138–1149. DOI: 10.1056/NEJMra1300575
[11]. Zhao, M., Wang, L., Wang, M., Zhou, S., Lu, Y., et al., 2022, Targeting fibrosis: Mechanisms and clinical trials, Signal Transduction and Targeted Therapy, 7, 206. https://doi.org/10.1038/s41392-022-01070-3
[12]. Kozawa, S., Tejima, K., Takagi, S., Kuroda, M., Nogami-Itoh, M., et al., 2023, Latent inter-organ mechanism of idiopathic pulmonary fibrosis unveiled by a generative computational approach, Scientific Reports, 13, 21981. https://doi.org/10.1038/s41598-023-49281-0
[13]. Álvarez, J., Real, J. M. F., Guarner, F., Gueimonde, M., Rodríguez, J. M., et al., 2021, Microbiota intestinal y salud, Gastroenterologíay Hepatología, 44, 519–535. 10.1016/j.gastrohep.2021.01.009.
[14]. Wu, Y., Li, Y., Luo, Y., Zhou, Y., Wen, J., et al., 2022, Gut microbiome and metabolites: The potential key roles in pulmonary fibrosis, Frontiers in Microbiology, 13, 943791. https://doi.org/10.3389/fmicb.2022.943791
[15]. Drakopanagiotakis, F., Stavropoulou, E., Tsigalou, C., Nena, E., Steiropoulos, P., 2022, The role of the microbiome in connective-tissue-associated interstitial lung disease and pulmonary vasculitis, Biomedicines, 10, 3195. https://doi.org/10.3390/biomedicines10123195
[16]. Chioma, O. S., Mallott, E. K., Chapman, A., Van Amburg, J. C., Wu, H., et al., 2022, Gut microbiota modulates lung fibrosis severity following acute lung injury in mice, Communications Biology, 5, 1401. https://doi.org/10.1038/s42003-022-04357-x
[17]. Aydın, M. M., Akçalı, K. C., 2018, Liver fibrosis, The Turkish Journal of Gastroenterology, 29, 14. https://doi.org/10.5152/tjg.2018.17330
[18]. Jayaseelan, V. P., Arumugam, P., 2019, Dissecting the theranostic potential of exosomes in autoimmune disorders, Cellular Molecular Immunology, 16, 935-936. https://doi.org/10.1038/s 41423-019-0310-5
Friedman, S. L., 2024, Hepatic fibrosis and cancer: the silent threats of metabolic syndrome, Diabetes & Metabolism Journal, 48, 161. https://doi.org/10.4093/dmj.2023.0240[19]. Lee, C.-m., Yoon, E. L., Kim, M., Kang, B.-K., Cho, S., et al., 2024, Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings, Hepatology, 79, 1393–1400. https://doi.org/10.1097/hep.0000000000000664
[20]. Gao, L.-L., Ma, J.-M., Fan, Y.-N., Zhang, Y.-N., Ge, R., et al., 2021, Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation, International Journal of Biological Macromolecules, 183, 1379–1392. https://doi.org/10.1016/j.ijbiomac.2021.05.066
[21]. Li, S., 2022, Investigation of the Anti-HF Mechanism of Taraxacum mongolicum Polysaccharide with Astragalus Polysaccharide. https://doi.org/10.1016/j.ijbiomac.2023.129193
[22]. Shu, Y., Huang, Y., Dong, W., Fan, X., Sun, Y., et al., 2023, The polysaccharides from Auricularia auricula alleviate non-alcoholic fatty liver disease via modulating gut microbiota and bile acids metabolism, International Journal of Biological Macromolecules, 246, 125662. https://doi.org/10.1016/j.ijbiomac.2023.125662
[23]. Han, C., Li, Z., Liu, R., Zhao, Z., Wang, Y., et al., 2023, Lonicerae flos polysaccharides improve nonalcoholic fatty liver disease by activating the adenosine 5′-monophosphate-activated protein kinase pathway and reshaping gut microbiota, Journal of the Science of Food and Agriculture, 103, 7721–7738. https://doi.org/10.1002/jsfa.12854
[24]. Fang, S., Wang, T., Li, Y., Xue, H., Zou, J., et al., 2022, Gardenia jasminoides Ellis polysaccharide ameliorates cholestatic liver injury by alleviating gut microbiota dysbiosis and inhibiting the TLR4/NF-κB signaling pathway, International Journal of Biological Macromolecules, 205, 23–36. https://doi.org/10.1016/j.ijbiomac.2022.02.056
[25]. Humphreys, B. D., 2018, Mechanisms of renal fibrosis, Annual Review of Physiology, 80, 309–326. https://doi.org/10.1146/annurev-physiol-022516-034227
[26]. Liu, Y., 2011, Cellular and molecular mechanisms of renal fibrosis, Nature Reviews Nephrology, 7, 684–696. https://doi.org/10.1038/nrneph.2011.149
[27]. Nogueira, A., Pires, M. J., Oliveira, P. A., 2017, Pathophysiological mechanisms of renal fibrosis: a review of animal models and therapeutic strategies, In Vivo, 31, 1–22. https://doi.org/10.21873/invivo.11019
[28]. Yang, J., Dong, H., Wang, Y., Jiang, Y., Zhang, W., et al., 2020, Cordyceps cicadae polysaccharides ameliorated renal interstitial fibrosis in diabetic nephropathy rats by repressing inflammation and modulating gut microbiota dysbiosis, International Journal of Biological Macromolecules, 163, 442–456. https://doi.org/10.1016/j.ijbiomac.2020.06.153
[29]. Zhang, M., Yang, L., Zhu, M., Yang, B., Yang, Y., et al., 2022, Moutan cortex polysaccharide ameliorates diabetic kidney disease via modulating gut microbiota dynamically in rats, International Journal of Biological Macromolecules, 206, 849–860. https://doi.org/10.1016/j.ijbiomac.2022.03.077
[30]. Feng, Y., Weng, H., Ling, L., Zeng, T., Zhang, Y., et al., 2019, Modulating the gut microbiota and inflammation is involved in the effect of Bupleurum polysaccharides against diabetic nephropathy in mice, International Journal of Biological Macromolecules, 132, 1001–1011. https://doi.org/10.1016/j.ijbiomac.2019.03.242
[31]. Liu, J.-X., Yuan, H.-Y., Li, Y.-N., Wei, Z., Liu, Y., Liang, J., 2022, Ephedra sinica polysaccharide alleviates airway inflammations of mouse asthma-like induced by PM2.5 and ovalbumin via the regulation of gut microbiota and short chain fatty acid, Journal of Pharmacy and Pharmacology, 74, 1784–96. https://doi.org/10.1093/jpp/rgac078
[32]. Shi, C., Zhou, L., Li, H., Shi, X., Zhang, Y., et al., 2022, Intestinal microbiota metabolizing Houttuynia cordata polysaccharides in H1N1 induced pneumonia mice contributed to Th17/Treg rebalance in gut-lung axis, International Journal of Biological Macromolecules, 221, 288–302. https://doi.org/10.1016/j.ijbiomac.2022.09.015
Viewed PDF 32 3 -
Effect of Audio Messaging in Communicating Key Messages for Community Management of Acute Malnutrition on the Knowledge of CaregiversAuthor: O. M. AjayiDOI: 10.21522/TIJPH.2013.13.01.Art028
Effect of Audio Messaging in Communicating Key Messages for Community Management of Acute Malnutrition on the Knowledge of Caregivers
Abstract:
Community-based Management of Acute Malnutrition (CMAM) is a vital public health intervention for treating severe acute malnutrition (SAM). One of the critical components of CMAM is caregiver education, primarily delivered by health workers. However, resource limitations, including health worker shortages, often hinder the effectiveness of traditional methods. This study investigates the impact of audio messages on caregivers’ knowledge of key CMAM messages as a viable alternative to health workers’ face-to-face education. This experimental study was conducted in Adamawa State, Nigeria, using an intervention and control group. Eighty caregivers from two local government areas (LGAs), Girei and Yola South, were recruited. The experimental group received weekly audio messages containing CMAM key messages, while the control group received routine health talks delivered by health workers. Caregivers’ knowledge was assessed at the beginning and end of the intervention through structured interviews. Quantitative data were collected using the mHealth platform and analysed with SPSS software using descriptive statistics and t-tests. The paired samples t-test results showed that the caregivers who received the audio messages exhibited better knowledge of CMAM key messages compared to the control group (p< 0.05) at a 95% Confidence Interval. We have enough evidence to conclude that there is a statistically significant difference between the post-intervention scores of the control and experimental groups, with the experimental group showing higher scores. Audio messages have the potential to enhance the knowledge of caregivers on CMAM key messages, reducing the workload of health workers and ensuring that standardized messages are consistently delivered.
Effect of Audio Messaging in Communicating Key Messages for Community Management of Acute Malnutrition on the Knowledge of Caregivers
References:
[1]. 2022, Global Nutrition Report, https://globalnutritionreport.org/resources/nutrition-profiles/africa/western-africa/nigeria/
[2]. Federal Ministry of Health and Social Welfare of Nigeria (FMoHSW), National Population Commission (NPC) [Nigeria], and ICF. 2024. Nigeria Demographic and Health Survey 2023–24: Key Indicators Report. Abuja, Nigeria, and Rockville, Maryland, USA: NPC and ICF.
[3]. Black R. E., Allen L. H., Bhutta Z. A., Caulfield L. E., Onis M. D., Ezzati M.Mathers C., and Rivera J., 2008, Maternal and child under nutrition: global and regional exposures and health consequences. Lancet 371, 243–260
[4]. Collins, S., Sadler, K., Dent, N., Khara, T., Guerrero, S., Myatt, M., et al., 2006, Key issues in the success of community-based management of severe malnutrition. Food Nutr Bull;27(3 Suppl): S49-82.
[5]. Black, R. E., Allen, L. H., Bhutta, Z. A., Caulfield, L. E., de Onis, M., Ezzati, M., et al., 2008, Maternal and Child Undernutrition Study Group. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 2008; 371:243-60.
[6]. Global Nutrition Report GNR https://globalnutritionreport.org/reports/global-nutrition-report-2018/
[7]. Black, R. E., Allen, L. H., Bhutta, Z. A., Caulfield, L. E., Onis, M. D., Ezzati, M., Mathers, C., and Rivera, J., 2008, Maternal and child under nutrition: global and regional exposures and health consequences. Lancet 371, 243–260
[8]. Collins, Steve and Sadler, Kate, 2002, “Outpatient Care for Severely Malnourished Children in Emergency Relief Programmes: A Retrospective Cohort Study.” The Lancet. Volume 360, Issue 9348, pp. 1824-1830.
[9]. Collins, S., 2004, “Community-Based Therapeutic Care: A New Paradigm for Selective Feeding in Nutritional Crisis.”
[10]. WHO, World Food Programme, U.N. System Standing Committee on Nutrition, and UNICEF. 2007, Community-Based Management of Severe Acute Malnutrition: A Joint Statement by the WHO, World Food Programme, U.N. System Standing Committee on Nutrition and UNICEF. http://apps.who.int/iris/bitstream/10665/44295/1/9789280641479_eng.pdf?ua=1&ua=1
[11]. Hagopian, G. A., 1996, The effects of informational audiotapes on knowledge and self-care behaviors of patients undergoing radiation therapy. Arch Fam Med 1996; 23:697–700.
[12]. North, N., Cornbleet, M. A., Knowles, G., Leonard, R. C. F., 1992, Information giving in oncology: a preliminary study of tape-recorder use. Br J Clin Psychol 1992; 31:2279–85
[13]. McHugh, P., Lewis, S., Ford, S., Newlands, E., Rustin, G., Coombes, C., Smith, D., O’Reilly, S., Fallowfield, L., 1995, The efficacy of audiotapes in promoting psychological well-being in cancer patients: a randomized, controlled trial. Br J Cancer 1995; 71:388–92.
[14]. Hack, T. F., Pickles, T., Bultz, B. D., Ruether, J. D., Weir, L. M., Degner, L. F., Mackey, J. R., 2003, Impact of providing audiotapes of primary adjuvant treatment consultations to women with breast cancer: a multisite, randomized, controlled trail. J Clin Oncol 2003; 21:4138–44.
[15]. Tattersall, M. H. N., Butow, P. N., Griffin, A., Dunn, S. M., 1994, The take-home message: patients prefer consultation audiotapes to summary letters. J Clin Oncol 1994; 12:1305–11.
[16]. Man-Son-Hing, M., Laupacis, A., O’Connor, A. M., Biggs, J., Drake, E., Yetisir, E., Hart, R. G., 1999, A patient decision aid regarding antithromobotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA 1999; 282:737–43.
[17]. Jenkinson, D., Davison, J., Jones, S., Hawtin, P., 1988, Comparison of effects of a self-management booklet and audiocassette for patients with asthma. Br Med J 1988; 297:267–70.
[18]. Tattersall, M. H. N., Butow, P. N., Griffin, A., Dunn, S. M., 1994, The take-home message: patients prefer consultation audiotapes to summary letters. J Clin Oncol 1994; 12:1305–11.
[19]. Jenkinson, D., Davison, J., Jones, S., Hawtin, P., 1988, Comparison of effects of a self-management booklet and audiocassette for patients with asthma. Br Med J 1988; 297:267–70.
[20]. Hogbin, B., Fallowfield, L., 1989, Getting it taped: the ‘bad news’ consultation with cancer patients. Br J Hosp Med 1989; 41:330–3
[21]. Reynolds, P. M., Sanson-Fisher, R. W., Poole, A. D., Harker, J., Byrne, M. J., Cancer and communication: information-giving in an oncology clinic. Br Med J 1981; 282:1449–51.
[22]. Dunn, S. M., Butow, P. N., Tattersall, M. H. N., Jones, Q. J., Sheldon, J. S., Taylor, J. J., Sumich, M. D., 1993, General information tapes inhibit recall of the cancer consultation. J Clin Oncol ;11:2279–85.
Viewed PDF 18 0 -
Potential Role of Anticancer Compounds Derived from Phytomedicines in Modulating the Signaling Pathways for Cancer Progression - A ReviewAuthor: Rajagopal PDOI: 10.21522/TIJPH.2013.13.01.Art029
Potential Role of Anticancer Compounds Derived from Phytomedicines in Modulating the Signaling Pathways for Cancer Progression - A Review
Abstract:
One of the most prevalent causes of death globally is cancer, which is a consequence of uncontrolled proliferation and division of cells in the body. The role of inflammation in tumour progression has been increasingly established. It also affects epigenetic changes that promote tumour induction and promotes all stages of carcinogenesis. Chronic inflammation may result in greater damage to DNA, interfere with DNA repair mechanisms, accelerate cellular division, and induce apoptosis, angiogenesis, and invasion of the tissue. A comprehensive knowledge of the cellular and molecular signaling mechanisms of tumor-endorsing inflammation is essential for the advancement of anti-cancer medications which concentrate on the interaction between malignancy formation and inflammatory mechanisms. Several inflammatory signalling pathways have been identified as regulating inflammation, including the NF-κB signalling pathway, the JAK-STAT signalling pathway, the MAPK signalling, the PI3K/AKT/mTOR signalling and the Wnt signalling cascade. Several phytochemicals can treat cancer by altering these pathways. There are numerous classes of phytochemicals in herbal medicine that are being used therapeutically. Herbal medicine has shown to be especially beneficial for cancer patients, with many reporting a considerable increase in survivorship as a result of treatment. Cellular metabolism, tumour development, growth, proliferation, metastasis, and cytoskeletal reorganization are all regulated by aberrations in different cellular signalling pathways. The primary emphasis of the current review focuses on the phytochemical’s capacity to combat cancer through modifying numerous cell signalling pathways.
Potential Role of Anticancer Compounds Derived from Phytomedicines in Modulating the Signaling Pathways for Cancer Progression - A Review
References:
[1]. “What Is Cancer? was originally published by the National Cancer Institute” updated on October 11, 2021.
[2]. Madihalli Somashekharaiah Chandraprasad, Abhijit Dey, Mallappa Kumara Swamy, 2022, 1 - Introduction to cancer and treatment approaches, Editor(s): Mallappa Kumara Swamy, T. Pullaiah, Zhe-Sheng Chen, Paclitaxel, Academic Press, pp. 1-27, ISBN 9780323909518, https://doi.org/10.1016/B978-0-323-90951-8.00010-2
[3]. Jayaraman, S., Natarajan, S. R., Veeraraghavan, V. P., Jasmine, S., 2023, Unveiling the anti-cancer mechanisms of calotropin: Insights into cell growth inhibition, cell cycle arrest, and metabolic regulation in human oral squamous carcinoma cells (HSC-3). Journal of Oral Biology and Craniofacial Research. Nov 1;13(6):704-13.
[4]. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., Bray, F., 2020, Global Cancer Statistics: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
[5]. Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., Jemal, A., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4. PMID: 38572751.
[6]. Saad, E. l Din, K., Loree, J. M., Sayre, E. C., Gill S., Brown, C. J., Dau, H., De Vera, M. A., 2020, Trends in the epidemiology of young-onset colorectal cancer: A worldwide systematic review. BMC Cancer. Apr 6;20(1):288. doi: 10.1186/s12885-020-06766-9. PMID: 32252672; PMCID: PMC7137305.
[7]. Lin, S., Gao, K., Gu, S., You, L., Qian, S., Tang, M., Wang, J., Chen, K., Jin, M., 2021, Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years. Cancer. Nov 1;127(21):4030-4039. doi: 10.1002/cncr.33795. Epub 2021 Aug 9. PMID: 34368955.
[8]. Global cancer burden growing, amidst mounting need for services was originally published by The International Agency for Research on Cancer (IARC) is the cancer agency of the World Health Organisation- 1 February 2024
[9]. Choudhari A. S., Mandave P. C., Deshpande M., Ranjekar P., Prakash O., Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice. Front Pharmacol. 2020 Jan 28;10:1614. doi: 10.3389/fphar.2019.01614. Erratum in: Front Pharmacol. 2020 Feb 28;11:175. doi: 10.3389/fphar.2020.00175. PMID: 32116665; PMCID: PMC7025531.
[10]. Pazhani J., Chanthu K., Jayaraman S., Varun B. R., 2023, Evaluation of salivary MMP-9 in oral squamous cell carcinoma and oral leukoplakia using ELISA. Journal of Oral and Maxillofacial Pathology. Oct 1;27(4):649-54.
[11]. Lee W. L., Huang J. Y., Shyur L. F., 2013, Phytoagents for cancer management: regulation of nucleic acid oxidation, ROS, and related mechanisms. Oxid Med Cell Longev.;2013:925804. doi: 10.1155/2013/925804. Epub 2013 Dec 25. PMID: 24454991; PMCID: PMC3886269.
[12]. Yan, X., Xie, T., Wang, S., Wang, Z., Li, H., & Ye, Z., 2018. Apigenin inhibits proliferation of human chondrosarcoma cells via cell cycle arrest and mitochondrial apoptosis induced by ROS generation-an in vitro and in vivo study. Int J Clin Exp Med, 11(3):1615-1631 www.ijcem.com /ISSN:1940-5901/IJCEM0057902.
[13]. Lu, L., Zhao, Z., Liu, L., Gong, W., and Dong, J., 2018, Combination of baicalein and docetaxel additively inhibits the growth of non-small cell lung cancer in vivo. Tradit. Med. Modern Med. 01 (03), 213–218. doi: 10.1142/ S2575900018500131.
[14]. Farnsworth N. R., Akerele O., Bingel A. S., Soejarto D. D., Guo Z., 1985, Medicinal plants in therapy. Bull World Health Organ.;63(6):965-81. PMID: 3879679; PMCID: PMC2536466.
[15]. Michael Heinrich, Joanne Barnes, Simon Gibbons, Elizabeth M., Williamson Foreword by A. Douglas Kinghorn, Chapter 8-Anticancer natural products, Fundamentals of pharmacognosy and phytotherapy, First edition 2004, Second edition 2012- ISBN 978-0-7020-3388-9- © 2012 Elsevier Ltd.
[16]. Kerry Bone,Simon Mills Forewords by Michael Dixon, Mark Blumenthal- Malignant diseases- Herbal approaches to pathological states, Chapter 8, Principles and Practice of Phytotherapy Modern Herbal Medicine, First edition 2000, Second edition 2013-ISBN 978-0-443-06992-5-© 2013 Elsevier Ltd.
[17]. Bansal S., Vyas S., Bhattacharya S., Sharma M., 2013, Catechin prodrugs and analogs: a new array of chemical entities with improved pharmacological and pharmacokinetic properties. Nat Prod Rep. Oct 11;30(11):1438-54. doi: 10.1039/c3np70038k. PMID: 24056761.
[18]. Gullett N. P., Ruhul Amin A. R., Bayraktar S., Pezzuto J. M., Shin D. M., Khuri F. R., Aggarwal B. B., Surh Y. J., Kucuk O., 2010, Cancer prevention with natural compounds. Semin Oncol. Jun;37(3):258-81. doi: 10.1053/j.seminoncol.2010.06.014. PMID: 20709209.
[19]. Jayaraman, S., Natarajan, S. R., Ponnusamy, B., Veeraraghavan, V. P. and Jasmine, S., 2023. Unlocking the potential of beta sitosterol: Augmenting the suppression of oral cancer cells through extrinsic and intrinsic signalling mechanisms. The Saudi Dental Journal, 35(8), pp.1007-1013.
[20]. Sruthi M. A., Mani G., Ramakrishnan M., Selvaraj J., Dental caries as a source of Helicobacter pylori infection in children: An RT‐PCR study. International Journal of Paediatric Dentistry. 2023 Jan;33(1):82-8.
[21]. Morgensztern D., McLeod H. L., 2005, PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer Drugs. Sep;16(8):797-803. doi: 10.1097/01.cad.0000173476.67239.3b. PMID: 16096426.
[22]. Jiri Polivka, Filip Janku, Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway, Pharmacology & Therapeutics, Volume 142, Issue 2, 2014, pp. 164-175, ISSN 0163-7258, https://doi.org/10.1016/j.pharmthera.2013.12.004.
[23]. Anna Prossomariti, Giulia Piazzi, Chiara Alquati, Luigi Ricciardiello, 2020, Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?, Cellular and Molecular Gastroenterology and Hepatology, Volume 10, Issue 3, pp. 491-506, ISSN 2352-345X, https://doi.org/10.1016/j.jcmgh.2020.04.007.
[24]. Chen J., 2013, Potential value and limitation of dual inhibitors of PI3K and mTOR in the treatment of cancer. Curr Cancer Drug Targets. Feb;13(2):117-20. doi: 10.2174/1568009611313020001. PMID: 23215718.
[25]. Chen, S., Fisher, R. C., Signs, S., Molina, L. A., Shenoy, A. K., Lopez, M. C., Baker, H. V., Koomen, J. M., Chen, Y., Gittleman, H., Barnholtz-Sloan, J., Berg, A., Appelman, H. D., & Huang, E. H., 2017, Inhibition of PI3K/Akt/mTOR signaling in PI3KR2-overexpressing colon cancer stem cells reduces tumor growth due to apoptosis. Oncotarget, 8(31), 50476-50488. https://doi.org/10.18632/oncotarget.9919
[26]. Mangiapane L. R., Nicotra A., Turdo A., Gaggianesi M., Bianca P., et al., 2022, PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells. Gut. Jan;71(1):119-128. doi: 10.1136/gutjnl-2020-323553. Epub 2021 Jan 12. PMID: 33436496; PMCID: PMC8666826.
[27]. Cai Z., Ke J., He X., Yuan R., Chen Y., Wu X., Wang L., Wang J., Lan P., Wu X., 2014, Significance of mTOR signaling and its inhibitor against cancer stem-like cells in colorectal cancer. Ann Surg Oncol. Jan;21(1):179-88. doi: 10.1245/s10434-013-3146-8. Epub 2013 Aug 2. PMID: 23907312.
[28]. Malkomes, P., Lunger, I., Luetticke, A. et al., 2016, Selective AKT Inhibition by MK-2206 Represses Colorectal Cancer-Initiating Stem Cells. Ann Surg Oncol 23, 2849–2857. https://doi.org/10.1245/s10434-016-5218-z.
[29]. Chang, L., Graham, P. H., Hao, J., Bucci, J., Cozzi, P. J., Kearsley, J. H., Li, Y., 2014, Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy. Cancer Metastasis Rev. Sep;33(2-3):469-96. doi: 10.1007/s10555-014-9493-5. PMID: 24445654.
[30]. Sircar, K., Yoshimoto, M., Monzon, F. A., Koumakpayi, I. H., Katz, R. L., Khanna, A., Alvarez, K., Chen, G., Darnel, A. D., Aprikian, A. G., Saad F., Bismar, T. A., Squire, J. A., 2009, PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer. J Pathol. Aug;218(4):505-13. doi: 10.1002/path.2559. PMID: 19402094.
[31]. de Muga, S., Hernández, S., Agell, L., Salido, M., Juanpere, N., Lorenzo, M., Lorente, J. A., Serrano, S., Lloreta, J., 2010, Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas. Mod Pathol. May;23(5):703-12. doi: 10.1038/modpathol.2010.45. Epub 2010 Mar 5. PMID: 20208477.
[32]. Niraj Kumar, Jha, Saniya Arfin, Saurabh Kuma,r Jha, Rohan Kar, Abhijit Dey, Rohit Gundamaraju, Ghulam, M. d., Ashraf, Piyush Kumar Gupta, Sugapriya Dhanasekaran, Mosleh Mohammad Abomughaid, Sabya Sachi Das, Sachin Kumar Singh, Kamal Dua, Shubhadeep Roychoudhury, Dhruv Kumar, Janne Ruokolainen, Shreesh Ojha, Kavindra Kumar Kesari, Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling, Seminars in Cancer Biology, Volume 86, Part 2, 2022, pp. 1086-1104, ISSN 1044-579X, https://doi.org/10.1016/j.semcancer.2022.02.022.
[33]. Akkoç, Y., Berrak, Ö., Arısan, E. D., Obakan, P., Çoker-Gürkan, A., Palavan-Ünsal, N., 2015, Inhibition of PI3K signaling triggered apoptotic potential of curcumin which is hindered by Bcl-2 through activation of autophagy in MCF-7 cells. Biomed Pharmacother., Apr;71:161-71. doi: 10.1016/j.biopha.2015.02.029. Epub 2015 Mar 4. PMID: 25960232.
[34]. Guan F., Ding Y., Zhang Y., Zhou Y., Li M., Wang C., 2016, Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation. PLoS One. Jan 11;11(1):e0146553. doi: 10.1371/journal.pone.0146553. Retraction in: PLoS One. 2023 Mar 15;18(3):e0283354. doi: 10.1371/journal.pone.0283354. PMID: 26752181; PMCID: PMC4708990.
[35]. Ibrahim RS, Ibrahim S. S., El-Naas A., Koklesová L., Kubatka P., Büsselberg D., 2023, Could Metformin and Resveratrol Support Glioblastoma Treatment? A Mechanistic View at the Cellular Level. Cancers (Basel). Jun 27;15(13):3368. doi: 10.3390/cancers15133368. PMID: 37444478; PMCID: PMC10340608.
[36]. Cháirez-Ramírez, M. H., de la Cruz-López, K. G, García-Carrancá, A., 2021, Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling Pathways. Front Pharmacol. Oct 20;12:710304. doi: 10.3389/fphar.2021.710304. PMID: 34744708; PMCID: PMC8565650.
[37]. Krishnan, Reshma Poothakulath, et al. 2025, "Molecular profiling of oral epithelial dysplasia and oral squamous cell carcinoma using next generation sequencing." Journal of Stomatology, Oral and Maxillofacial Surgery 126.4, 102120.
[38]. Bhullar, K. S., Jha, A., Rupasinghe, H. P., 2015, Novel carbocyclic curcumin analog CUR3d modulates genes involved in multiple apoptosis pathways in human hepatocellular carcinoma cells. Chem Biol Interact., Dec 5;242:107-22. doi: 10.1016/j.cbi.2015.09.020. Epub 2015 Sep 26. PMID: 26409325.
[39]. Zhao, Z., Li, C., Xi, H., Gao, Y., Xu, D., 2015, Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway. Mol Med Rep. Oct;12(4):5415-22. doi: 10.3892/mmr.2015.4060. Epub 2015 Jul 8. PMID: 26166196.
[40]. Xu, X., Qin, J., Liu, W., 2014, Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of PI3K/Akt signaling pathway. Gene. Aug 10;546(2):226-32. doi: 10.1016/j.gene.2014.06.006. Epub 2014 Jun 6. PMID: 24910117.
[41]. Jiang Q. G., Li T. Y., Liu D. N., Zhang H. T., 2014, PI3K/Akt pathway involving into apoptosis and invasion in human colon cancer cells LoVo. Mol Biol Rep. May;41(5):3359-67. doi: 10.1007/s11033-014-3198-2. Epub 2014 Feb 5. PMID: 24496855.
[42]. Lee, J. H., Jang, J. Y., Park, C., Kim, B. W., Choi, Y. H., Choi B. T., Curcumin suppresses alpha-melanocyte stimulating hormone-stimulated melanogenesis in B16F10 cells. Int J Mol Med. 2010 Jul;26(1):101-6. PMID: 20514428.
[43]. Kim M. O., Lee M. H., Oi N., Kim S. H., Bae K. B., Huang Z., Kim D. J., Reddy K., Lee S. Y., Park S. J., Kim J. Y., Xie H., Kundu J. K., Ryoo Z. Y., Bode A. M., Surh Y. J., Dong Z., 2014, [6]-shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2. Carcinogenesis. Mar;35(3):683-91. doi: 10.1093/carcin/bgt365. Epub 2013 Nov 26. Erratum in: Carcinogenesis. 2014 May;35(5):1193. PMID: 24282290; PMCID: PMC3941745.
[44]. Sagar S., Ramani P., Moses S., Gheena S., Selvaraj J., 2024, Correlation of salivary cytokine IL-17A and 1, 25 dihydroxycholecalciferol in patients undergoing orthodontic treatment. Odontology. Feb 6:1-0.
[45]. Yasothkumar D., Ramani P., Jayaraman S., Ramalingam K., Tilakaratne W. M., 2024, Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis. Head and Neck Pathology. Mar 27;18(1):28.
[46]. Jane, D Holland, Alexandra Klaus, Alistair N Garratt, Walter Birchmeier, 2013, Wnt signaling in stem and cancer stem cells, Current Opinion in Cell Biology, Volume 25, Issue 2, pp. 254-264, ISSN 0955-0674, https://doi.org/10.1016/j.ceb.2013.01.004.
[47]. Wend, P., Holland, J. D., Ziebold U., Birchmeier W., 2010, Wnt signaling in stem and cancer stem cells. Semin Cell Dev Biol. Oct;21(8):855-63. doi: 10.1016/j.semcdb.2010.09.004. Epub 2010 Sep 15. PMID: 20837152.
[48]. Sun, J., Yan, P., Chen, Y., Chen, Y., Yang, J., Xu, G., Mao, H., Qiu, Y., 2015, MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway. Diagn Pathol. Jun 19;10:72. doi: 10.1186/s13000-015-0309-x. PMID: 26088648; PMCID: PMC4472173.
[49]. Martins-Neves S. R., Corver W. E., Paiva-Oliveira D. I., van den Akker B. E., Briaire-de-Bruijn I. H., Bovée J. V., Gomes C. M., Cleton-Jansen A. M., 2016, Osteosarcoma Stem Cells Have Active Wnt/β-catenin and Overexpress SOX2 and KLF4. J Cell Physiol., Apr;231(4):876-86. doi: 10.1002/jcp.25179. Epub 2015 Sep 9. PMID: 26332365.
[50]. Miyoshi, Y., Iwao, K., Nagasawa, Y., Aihara, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T., Nakamura, Y., 1998, Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res., Jun 15;58(12):2524-7. PMID: 9635572.
[51]. Huang, G. L., Zhang, W., Ren H. Y., Shen X. Y., Chen Q. X., Shen D. Y., Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathways. 2015, Cancer Sci., Nov;106(11):1515-23. doi: 10.1111/cas.12802. Epub 2015 Oct 7. PMID: 26310932; PMCID: PMC4714697.
[52]. Wu G., Liu A., Zhu J., Lei F., Wu S., Zhang X., Ye L., Cao L., He S., 2015, MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway. Oncotarget. Oct 6;6(30):28882-94. doi: 10.18632/oncotarget.4921. PMID: 26337084; PMCID: PMC4745698.
[53]. Du Q., Zhang X., Cardinal J., Cao Z., Guo Z., Shao L., Geller D. A., 2009, Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Cancer Res. May 1;69(9):3764-71. doi: 10.1158/0008-5472.CAN-09-0014. Epub 2009 Apr 21. PMID: 19383900.
[54]. Logan C. Y., Nusse R., 2004, The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol.; 20:781-810. doi: 10.1146/annurev.cellbio.20.010403.113126. PMID: 15473860.
[55]. Pandey, P., Khan, F., Seifeldin, S. A., Alshaghdali, K., Siddiqui, S., Abdelwadoud, M. E., Vyas, M., Saeed, M., Mazumder, A., Saeed, A., 2023, Targeting Wnt/β-Catenin Pathway by Flavonoids: Implication for Cancer Therapeutics. Nutrients. Apr 26;15(9):2088. doi: 10.3390/nu15092088. PMID: 37432240; PMCID: PMC10181252.
[56]. Mukherjee, S., Mazumdar, M., Chakraborty, S. et al., 2014, Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loop. Stem Cell Res Ther 5, 116, https://doi.org/10.1186/scrt506.
[57]. Somers-Edgar T. J., Taurin S., Larsen L., Chandramouli A., Nelson M. A., Rosengren R. J., 2011, Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines. Invest New Drugs. Feb;29(1):87-97. doi: 10.1007/s10637-009-9339-0. Epub 2009 Oct 9. PMID: 19816657.
[58]. Lu, Y., Wei, C., Xi, Z., 2014, Curcumin suppresses proliferation and invasion in non-small cell lung cancer by modulation of MTA1-mediated Wnt/β-catenin pathway. In Vitro Cell Dev Biol Anim. Oct;50(9):840-50. doi: 10.1007/s11626-014-9779-5. Epub 2014 Jun 18. PMID: 24938356.
[59]. Lai C. S., Wu J. C., Yu S. F., Badmaev V., Nagabhushanam K., Ho C. T., Pan M. H., 2011, Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis. Mol Nutr Food Res. Dec;55(12):1819-28. doi: 10.1002/mnfr.201100290. Epub 2011 Sep 2. PMID: 21887819.
[60]. Fathima J. S., Jayaraman S., Sekar R., Syed N. H., 2024, The role of MicroRNAs in the diagnosis and treatment of oral premalignant disorders. Odontology. Apr 15:1-0.
[61]. Kunnumakkara A. B., Bordoloi D., Harsha C., Banik K., Gupta S. C., Aggarwal B. B., 2017, Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. Clin Sci (Lond). Jul 5;131(15):1781-1799. doi: 10.1042/CS20160935. PMID: 28679846.
[62]. Zhang, Y., Li Q., Zhou D., Chen H., 2013, Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of WNT/β-catenin signalling and reduces colon pre-neoplasia in rats. Br J Nutr. Jan 14;109(1):33-42. doi: 10.1017/S0007114512000876. Epub 2012 Apr 3. PMID: 22716201.
[63]. Hsiao Y. C., Peng S. F., Lai K. C., Liao C. L., Huang Y. P., Lin C. C., Lin M. L., Liu K. C., Tsai C. C., Ma Y. S., Chung J. G., 2019, Genistein induces apoptosis in vitro and has antitumor activity against human leukemia HL-60 cancer cell xenograft growth in vivo. Environ Toxicol. Apr;34(4):443-456. doi: 10.1002/tox.22698. Epub 2019 Jan 7. PMID: 30618158.
Viewed PDF 32 1 -
Effect of Audio Recordings of CMAM Key Messages on Treatment OutcomeAuthor: O. M. AjayiDOI: 10.21522/TIJPH.2013.13.01.Art030
Effect of Audio Recordings of CMAM Key Messages on Treatment Outcome
Abstract:
Severe acute malnutrition (SAM) poses a significant threat to child health in Nigeria. The CMAM program provides essential treatment for children with SAM, and treatment quality is influenced by how well caregivers understand key CMAM messages. This study evaluates the effect of audio messages on treatment outcomes in SAM cases compared to traditional health talks. An interventional study design was used, involving 80 SAM children in Adamawa State. Participants were divided into two groups: the experimental group received weekly audio messages in Hausa, while the control group received traditional health talks from health workers. Treatment outcomes were measured based on weight gain and mid-upper arm circumference. Data were collected via the mHealth platform and analysed on SPSS 16 using t-tests to determine statistical significance. The mean age of the respondents was 28 years with an age range of 16.0 – 50.0 years, while the mean age of the index children was 15 months with a range of 6.0 – 48.0 months. The number of successful treatments was higher in the Experimental group than in the Control group. The t-test for equality of means for treatment outcomes across the two groups was, however not significant (P> 0.005) at a 95% Confidence Interval. Conclusively, we accept the null hypothesis. Audio recordings of CMAM key messages were equally effective as traditional health talks in influencing treatment outcomes in CMAM interventions. The use of audio messages has the potential to ease the burden of health workers while ensuring consistency in message delivery without reducing the efficacy of treatment.
Effect of Audio Recordings of CMAM Key Messages on Treatment Outcome
References:
[1]. 2022 Global Nutrition Report https://globalnutritionreport.org/resources/nutrition-profiles/africa/western-africa/nigeria/
[2]. Federal Ministry of Health and Social Welfare of Nigeria (FMoHSW), National Population Commission (NPC) [Nigeria], and ICF. 2024. Nigeria Demographic and Health Survey 2023–24: Key Indicators Report. Abuja, Nigeria, and Rockville, Maryland, USA: NPC and ICF.
[3]. Grover Z., Ee L. C., 2009 Protein energy malnutrition. Pediatr Clin N Am. 2009;56(5): 1055–68
[4]. WHO.2013 Guideline: updates on the management of severe acute malnutrition in infants and children. Geneva, World Health Organization; 2013.
[5]. Global Nutrition Report GNR 2018 https://globalnutritionreport.org/reports/global-nutrition-report-2018/
[6]. Black R. E., Allen L. H., Bhutta Z. A., Caulfield L. E., Onis M. D., Ezzati M. Mathers C., and Rivera J 2008 Maternal and child under nutrition: global and regional exposures and health consequences. Lancet 371, 243–260
[7]. National Population Commission (NPC) [Nigeria] and ICF. 2019. Nigeria Demographic and Health Survey 2018. Abuja, Nigeria, and Rockville, Maryland, USA: NPC and ICF
[8]. Olofin, Ibironke, et al. 2013. “Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies.” PLOS One. 8(5): e64636.
[9]. Collins, S., 2004. “Community-Based Therapeutic Care: A New Paradigm for Selective Feeding in Nutritional Crisis.”
[10]. Collins, Steve and Sadler, Kate. 2002. “Outpatient Care for Severely Malnourished Children in Emergency Relief Programmes: A Retrospective Cohort Study.” The Lancet. Volume 360, Issue 9348, pp. 1824-1830.
[11]. WHO, World Food Programme, U. N., System Standing Committee on Nutrition, and UNICEF. 2007. Community-Based Management of Severe Acute Malnutrition: A Joint Statement by the WHO, World Food Programme, U. N. System Standing Committee on Nutrition and UNICEF. http://apps.who.int/iris/bitstream/10665/44295/1/9789280641479_eng.pdf?ua=1&ua=1 .
[12]. UNICEF 2013. Global Evaluation of Community Management of Acute Malnutrition (CMAM): Global Synthesis Report. New York: UNICEF. Available at: http://www.unicef.org/evaldatabase/index_69843.html
[13]. Adeyemi, O., et al., 2015 How to strengthen a Community-Based Management of Acute Malnutrition programme in northern Nigeria, ORIE Research Summary, Issue 09, Brighton: ORIE
[14]. Adeyemi, O., et al., 2015 How to strengthen a Community-Based Management of Acute Malnutrition programme in northern Nigeria, ORIE Research Summary, Issue 09, Brighton: ORIE
[15]. Federal Ministry of Health. 2010. National guidelines for the treatment of severe acute malnutrition in Nigeria. Abuja, Nigeria: Federal Ministry of Health.
[16]. World Health Organisation 2013 Guideline: Updates on the Management of Severe Acute Malnutrition in Infants and Children. Geneva: World Health Organization; available at http://www.ncbi.nlm.nih.gov/books/NBK190328
[17]. Ciliberto M. A., Sandige H., Ndekha M. J. et al. 2005 Comparisonofhome-basedtherapy withready-to-use thera peutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. Am J Clin Nutr 81, 864–870.
[18]. Free, C., Phillips, G., Watson, L., Galli, L., Felix, L., Edwards, P., Haines, A., 2013. The effectiveness of mobile-health technologies to improve health care service delivery processes: A systematic review and meta-analysis. PLoS Medicine, 10(1), e1001363. doi: 10.1371/journal.pmed.1001363
[19]. Kaplan, W. A., 2006. Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries. Global Health, 2(9), 1-14.
[20]. Krishna, S., Boren, S. A., & Balas, E. A. 2009. Healthcare via cell phones: A systematic review. Telemedicine and e-Health, 15(3), 231-240.
[21]. Amsalu, B., et al. 2016. "Mobile-based health communication to improve treatment adherence and health outcomes in resource-limited settings: A systematic review." PLOS Medicine.
Viewed PDF 21 0 -
Systematic Evaluation of the Factors Influencing Subjective Well-Being in the ElderlyAuthor: Masarah Mohamad YusofDOI: 10.21522/TIJPH.2013.13.01.Art031
Systematic Evaluation of the Factors Influencing Subjective Well-Being in the Elderly
Abstract:
This article employs a systematic literature review to examine a few factors influencing subjective well-being among the elderly. The findings indicate that 1) demographic factors such as age, gender, marital status, educational level, and economic income; 2) social factors including social support, social comparison, and children-related factors; and 3) psychological factors such as personality traits, self-efficacy, and sense of control affect the subjective well-being of elderly individuals. Future research should focus on the following areas including 1) attention to special elderly groups, particularly those in rural areas and non-home-based care settings; 2) diversification of research methodologies, utilizing both quantitative and qualitative approaches; and 3) enriching the content of research to explore the factors influencing elderly subjective well-being from multiple perspectives, especially understanding the psychological factors involved.
Systematic Evaluation of the Factors Influencing Subjective Well-Being in the Elderly
References:
[1]. World Health Organization—Health topics—Ageing, 2023.
[2]. Wang, Q., 2021, New challenges and responses facing China's social security under the new situation: An analysis based on the Seventh National Census data. Chongqing Administration, 22(6), 105-106.
[3]. Wang, N., Xu, T., Liu, H., et al., 2021, Research on the subjective well-being of the elderly from a healthy aging perspective. Health Medicine Research and Practice, 18(1), 105-108.
[4]. Li, S., Zhang, K., Fang, X., 2013, Research on the relationship between positive psychology and elderly well-being. Journal of Tianjin Normal University (Social Science), (2), 61-65.
[5]. Liang, J., 2014, Research on the pathways to enhance elderly subjective well-being from the perspective of positive psychology. Journal of Guangdong Water Resources and Electric Power Vocational Technology College, 12(4), 60-63.
[6]. The 19th National Congress of the Communist Party of China Report, 2017. https://www.spp.gov.cn/tt/201710/t20171018_202773.shtml
[7]. Diener, E., Oishi, S., Lucas, R. E., 2003, Personality, Culture and Subjective Well-being: Emotional and Cognitive Evaluations of Life. Annual Review of Psychology, 54(1), 403-425.
[8]. Jan, M. B., Victoria, L., Boudet, A. M. M., et al., 2017, Subjective well-being across the lifespan in Europe and Central Asia. Journal of Population Ageing, 10(2), 125-158.
[9]. Diener, E., Suh, E. M., Lucas, R. E., Smith, H. L., 1999, Subjective Well-being: Three Decades of Progress. Psychological Bulletin, 125(2), 276-302.
[10]. Bradburn, N. M., 1969, The Structure of Psychological Well-being. Chicago: Aldine Publishing Company.
[11]. Empty Nest Elderly Account for Half of the Elderly Population, China Aging Development Center, 2020, May 4. [Retrieved December 15, 2023].
[12]. Diener, E., Tay, L., 2015, Subjective well-being and human welfare around the world as reflected in the Gallup World Poll. Journal International de Psychologie, 50(2), 135-149.
[13]. Huang, F., Duan, C., 2022, From demographic dividend to quality dividend: An analysis based on the Seventh National Census. Population and Development, 28(1), 117-126.
[14]. Watkins, P. C., Woodward, K., Stone, T., et al., 2003, Gratitude and happiness: Development of a measure of gratitude, and relationships with subjective well-being. Social Behavior & Personality: an International Journal, 31(5), 431-451.
[15]. Peng, X., Sun, R., 2021, A review of studies on the subjective well-being of institutionalized elderly. Fortune Times, (9), 155-156, 159.
[16]. Yanqiu, Y., Vivian, F., Joseph, L., et al., 2020, The associations between psychological needs, health-related quality of life and subjective well-being among Chinese older people: A cross-sectional study. Health & Social Care in the Community, 30(2), 570-578.
[17]. McCullough, M. E., Emmons, R. A., Tsang, J. A., 2002, The grateful disposition: A conceptual and empirical topography. Journal of Personality and Social Psychology, 82(1), 112-127.
[18]. Xia, Y., Wang, G., Yang, F., 2024, A nationwide study of the impact of social quality factors on life satisfaction among older adults in rural China. Dental Science Reports, 14. doi:10.1038/s41598-024-61398-4.
[19]. Xu, G., Zhao, C., Li, Q., 2021, Subjective well-being and mortality among the older people in China. Nan, 5(1), 1–24. doi:10.1007/S42379-021-00076-8.
[20]. Qiu-juan, Y., 2010, A Meta-analysis of Factors Affecting Subjective Well-being of the Elderly in China. Chinese Journal of Clinical Psychology.
[21]. Ren, Q., Li, J., Yu, D., et al., 2018, Study on Subjective Well-being and Its Influencing Factors Among Rural Solitary Elderly in a Certain Area of Anhui Province. Chinese Journal of Disease Control, 22(6), 581-584.
[22]. Xu, X., Li, X., Li, F., et al., 2021, Factors Influencing the Subjective Well-being of the Elderly and the Moderating Role of Gratitude. Chinese Journal of Gerontology, 41(17), 3826-3829.
[23]. Zhang, L., Li, W., Li, C., et al., 2021, The Cognitive-emotional Dual Structure of Gratitude and Its Relationship with Subjective Well-being. Chinese Psychological Society. The 23rd National Psychological Academic Conference Abstract Collection (Upper), Shaanxi Normal University School of Psychology, 2.
[24]. Zhu, W., 2020, Health, Security, and Social Integration: A Study of Subjective Well-being of the Elderly from the Perspective of Active Aging. Journal of Hunan University of Finance and Economics, 36(3), 38-47.
[25]. Li, Z., Yu, Y., Qin, S., et al., 2022, Current Situation and Influencing Factors of Subjective Well-being of Rural Elderly with Chronic Diseases in Qiannan Area. Nursing Research, 36(2), 293-298.
[26]. Long, H., Feng, H., Yang, L., et al., 2021, Subjective Well-being and Its Influencing Factors Among Rural Dong Ethnic Elderly in Guizhou. Chinese Journal of Gerontology, 41(13), 2876-2879.
[27]. Li, Y., Wu, R., Tang, H., et al., 2019, Subjective Well-being and Its Influencing Factors Among Rural Shui Ethnic Elderly in Guizhou. Everyone's Health, (14), 281-282.
[28]. Yang, X., Wang, Y., 2021, Study on Subjective Well-being and Its Influencing Factors Among Rural Elderly in Haiyuan County. Health Soft Science, 35(10), 39-42.
[29]. Jivraj, S., Nazroo, J., Vanhoutte, B., Chandola, T., 2014, Aging and Subjective Well-being in Later Life. Journals of Gerontology Series B-psychological Sciences and Social Sciences, 69(6), 930–941. doi:10.1093/GERONB/GBU006.
[30]. Yeh, W., 2023, The Impact of Living Arrangements and Social Capital on the Well-being of the Elderly. Nan. doi:10.3390/healthcare11142050.
[31]. Muhammad, T., Kumar, P., Srivastava, S., 2022, How Socioeconomic Status, Social Capital, and Functional Independence Are Associated with Subjective Wellbeing Among Older Indian Adults? A Structural Equation Modeling Analysis. BMC Public Health, 22(1). doi:10.1186/s12889-022-14215-4.
[32]. Palmatier, R. W., Houston, M. B., Hulland, J., 2018, Literature Reviews as Independent Studies: Guidelines for Academic Practice. Review of Managerial Science, 12(3), 225-250.
[33]. Chigbu, U. E., Atiku, S. O., Du Plessis, C. C., 2023, The Science of Literature Reviews: Searching, Identifying, Selecting, and Synthesising. Publications, 11(1), 2-16. doi:10.3390/publications11010002.
[34]. Lim, K., Weissmann, M., Kraus, S., 2021, Writing a Literature Review. Journal of Business Research, 133, 285-298.
[35]. Xia, Y., Wang, G., Yang, F., 2024, A nationwide study of the impact of social quality factors on life satisfaction among older adults in rural China. Dental Science Reports, 14. doi:10.1038/s41598-024-61398-4.
[36]. Borisov, G. I., Sergeeva, T. B., Glukhanyuk, N. S., 2024, Predictors of Subjective Well-being and Life Satisfaction of People in Late Age: Applied Aspect. Perspektivy Nauki i Ob.
[37]. Leontyeva, E. G., Kalashnikova, T. V., Danilova, N. E., Krakovetckaya, I. V., 2016, Subjective Well-being as a Result of the Realization of Projects of the Elderly's Involvement into the Social Life. Perspectives of Science and Education, 1-6. doi:10.15405/EPSBS.2016.02.1.
[38]. Silva, A., 2018, Physical Activity and Subjective Well-Being in the Elderly. Perspectives of Science and Education, doi:10.15405/EPSBS.2018.11.18.
[39]. Dai, Y.-D., Yeh, G.-L., Tsai, T., Chen, Y.-C., Chen, Y., 2023, Mapping Well-Being for Elders: The Antecedents and Consequences of Perceived Freedom in Leisure. Advances in Hospitality and Leisure, 25-44. doi:10.1108/s1745-354220230000019002.
[40]. Ortega-Gil, M., García, A. M., ElHichou-Ahmed, C., 2021, The Effect of Ageing, Gender and Environmental Problems on Subjective Well-Being. Land, 10(12), 1314. doi:10.3390/LAND10121314.
[41]. Ferring, D., Boll, T., 2010, Subjective Well-being in Older Adults: Current State and Gaps of Research. Perspectives of Science and Education, 173–212. doi:10.1057/9780230307346_7.
[42]. Wang, X., 2016, Subjective Well-being Associated with Size of Social Network and Social Support of Elderly. Journal of Health Psychology, 21(6), 1037–1042. doi:10.1177/1359105314544136.
[43]. Zhu, J., Liang, C., Lucas, J., Cheng, W., Zhao, Z., 2020, The Influence of Income and Social Capital on the Subjective Well-Being of Elderly Chinese People, Based on a Panel Survey. Sustainability, 12(11), 4786. doi:10.3390/SU12114786.
[44]. Xu, G., Zhao, C., Li, Q., 2021, Subjective Well-being and Mortality Among Older People in China. Nan, 5(1), 1–24. doi:10.1007/S42379-021-00076-8.
[45]. Festinger, L., 1954, A Theory of Social Comparison Processes. Human Relations, 7(2), 117-140.
[46]. Ding, F. Q., Zhao, H. Y., 2018, Is Gratitude Associated with Greater Subjective Well-being? — A Meta-analysis. Advances in Psychological Science, 26(10), 1749-1764.
[47]. Zelikova, Yu. A., 2014, Successful Ageing or When Age is Joy: Subjective Well-being of Seniors, A Cross-National Analysis. Sociological Studies, (11), 60–69.
[48]. Halisch, F., Geppert, U., 2012, Personality Determinants of Subjective Well-being in Old Age: Cross-sectional and Longitudinal Analyses. Perspectives of Science and Education, 139–171.
[49]. Kaučič, B. M., Filej, B., Ovsenik, M., 2016, The Influence of Social Factors on Life Satisfaction in Old Age. Revija za Univerzalno Odličnost, 5(4), 300–318.
[50]. Nannan, 2022, A Predictive Model of Subjective Wellbeing in the Elderly Population. Perspectives of Science and Education. doi:10.21203/rs.3.rs-2246243/v1.
[51]. Abe, N., Oe, N., Tadaka, E., Ojima, T., 2023, Factors Related to Subjective Well-being Among Community-dwelling Older Adults Living Alone: A Stratified Analysis by Sex and Marital Status from the JAGES. PLOS ONE, 18. doi: 10.1371/journal.pone.0289571.
[52]. Yoon, D. P., 2006, Factors Affecting Subjective Well-Being for Rural Elderly Individuals. Journal of Religion and Spirituality in Social Work: Social Thought, 25(2), 59–75. doi:10.1300/J377V25N02_04
Viewed PDF 20 0 -
Nanoparticle-Driven Healing: Evaluating Chitosan-Copper in Zebrafish Wound RecoveryAuthor: Meenakshi Sundaram Kishore KumarDOI: 10.21522/TIJPH.2013.13.01.Art032
Nanoparticle-Driven Healing: Evaluating Chitosan-Copper in Zebrafish Wound Recovery
Abstract:
Wound healing poses a critical clinical challenge, especially in chronic wounds where conventional treatments often fail. This study investigates the wound healing potential of β-Chitosan-copper oxide nanoparticles (β-Ch-CuO-NPs) at 10 μg/mL and 20 μg/mL using a zebrafish (Danio rerio) model. Zebrafish, renowned for their regenerative ability and transparent tissues, facilitated real-time observation of healing. The β-Ch-CuO-NP-treated groups exhibited enhanced wound closure, with the 20 μg/mL concentration outperforming the 10 μg/mL and control groups. These findings highlight that β-Ch-CuO-NPs can be used as a therapeutic remedy for wound healing, encouraging further translational and clinical research. To evaluate the wound healing efficacy of β-Chitosan-copper oxide nanoparticles (β-Ch-CuO-NPs) in zebrafish (Danio rerio). Chronic wounds pose a significant clinical challenge due to delayed healing and persistent inflammation. β-Ch-CuO-NPs have emerged as promising agents as they are much more biocompatible with properties such as antimicrobicity and the ability to modulate tissue repair mechanisms. Zebrafish were divided into control and treated groups receiving β-Ch-CuO-NPs at 10 μg/mL and 20 μg/mL. Wound healing was assessed through histological and molecular analyses over 14 days. The successful synthesis of β-Ch-CuO-NPs was confirmed by the characterization studies done, revealing a crystalline structure corresponding to copper oxide. Microscopic analysis of the zebrafish model revealed that the nanoparticles lead to a significant amount of wound closure when compared to the control. The 20 μg/mL group demonstrated superior wound closure, faster re-epithelialization, increased fibroblast proliferation, collagen deposition and reduced inflammation compared to other groups. β-Ch-CuO-NPs effectively promote wound healing by enhancing and accelerating wound closure, and tissue regeneration, indicating potential for clinical applications.
Nanoparticle-Driven Healing: Evaluating Chitosan-Copper in Zebrafish Wound Recovery
References:
[1]. Ali, S., Zulfiqar, M., Summer, M., Arshad, M., Noor, S., Nazakat, L., & Javed, A., 2024. Zebrafish as an innovative model for exploring cardiovascular disease induction mechanisms and novel therapeutic interventions: a molecular insight. Molecular Biology Reports, 51(1), 904.
[2]. Anbarasu, M., Martin, T. M., Priya, P., Sivamurugan, V., Kumar, M. S. K., Shaik, M. R., . & Guru, A., 2024. Assessing the impact of Ag-ZnO nanoparticle on the induction of oxidative stress, hematological, and molecular changes in zebrafish (Danio rerio) and McCoy fibroblast cell lines. Aquaculture International, 32(4), 5373-5392.
[3]. Anbarasu, M., Vinitha, V., Priya, P., Martin, T. M., Prathap, L., Kumar, M. S. K., . & Sivamurugan, V., 2024. Depolymerization of PET Wastes Catalysed by Tin and Silver doped Zinc oxide Nanoparticles and Evaluation of Embryonic Toxicity Using Zebrafish. Water, Air, & Soil Pollution, 235(6), 433.
[4]. Banaee, M., & Badr, A. A., 2024. Bioinformatic evaluation of the impact of miRNAs on the expression of detoxification-related genes in Zebrafish (Danio rerio). Journal of Aquatic Ecology, 14(1), 1-12.
[5]. Pawar, N. V., Singh, P. D., Prabhu, P. S., & Rana, J. R., 2021. Carcinogen‐Induced Model of Proangiogenesis in Zebrafish Embryo‐Larvae. Environmental Toxicology and Chemistry, 40(2), 447-453.
[6]. Dandagi, P., & Martin, T. M., 2024. In Silico and Glioblastoma Cell Line Evaluation of Thioflavin-Derived Zinc Nanoparticles Targeting Beclin Protein. Cureus, 16(9), e69319.
[7]. Qian, L., Cui, F., Yang, Y., Liu, Y., Qi, S., & Wang, C., 2018. Mechanisms of developmental toxicity in zebrafish embryos (Danio rerio) induced by boscalid. Science of the Total Environment, 634, 478-487.
[8]. Ramachandran, T., Mohanraj, K. G., & Martin, T. M., 2024. Enhanced Wound Healing With β-Chitosan-Zinc Oxide Nanoparticles: Insights From Zebrafish Models. Cureus, 16(9), e69861.
[9]. Rajasekar, N., Mohanraj, K. G., & Martin, T. M., 2024. Advanced Dental Care: β-Chitosan Zinc Oxide Nanoparticles Targeting Cariogenic Microorganisms. Cureus, 16(8), e66296.
[10]. Umakanth, K., & Martin, T. M., 2024. An In Vitro and In Silico Study of Luteolin-Loaded Zinc Oxide Nanoparticles: Enhancing Bioactivity and Efficacy for Advanced Therapeutic Applications Against Cariogenic Microorganisms. Cureus, 16(8), e68058.
[11]. Umapathy, S., Pan, I., Issac, P. K., Kumar, M. S. K., Giri, J., Guru, A., & Arockiaraj, J., 2024. Selenium Nanoparticles as Neuroprotective Agents: Insights into Molecular Mechanisms for Parkinson’s Disease Treatment. Molecular Neurobiology, 1-28.
[12]. Raj, P. S. M., Martin, T. M., Kumar, M. S. K., & Prathap, L., 2024. Anti-psychotic Nature of Antibiotics: Vancomycin and Omadacycline Combination Ameliorating Stress in a Zebrafish Model. Cureus, 16(3).
[13]. Tayyeb, J. Z., Priya, M., Guru, A., Kishore Kumar, M. S., Giri, J., Garg, A., . & Arockiaraj, J., 2024. Multifunctional curcumin mediated zinc oxide nanoparticle enhancing biofilm inhibition and targeting apoptotic specific pathway in oral squamous carcinoma cells. Molecular Biology Reports, 51(1), 423.
[14]. Atalar, M. N., Köktürk, M., Altındağ, F., Ozhan, G., Özen, T., Demirtas, İ., & Gülçin, İ., 2023. LC-ESI-MS/MS analysis of secondary metabolites of different St. John's wort (Hypericum perforatum) extracts used as food supplements and evaluation of developmental toxicity on zebrafish (Danio rerio) embryos and larvae. South African Journal of Botany, 159, 580-587.
[15]. Payra, M., Mohanraj, K. G., & Martin, T. M., 2024. Modulation of Inflammation in McCoy Cells by Zinc Nanoparticles Conjugated With β-Chitosan. Cureus, 16(9), e68653.
[16]. Orger, M. B., & de Polavieja, G. G., 2017. Zebrafish behavior: opportunities and challenges. Annual review of neuroscience, 40(1), 125-147.
[17]. Pang, S., Gao, Y., Wang, F., Wang, Y., Cao, M., Zhang, W., . & Jiang, G., 2020. Toxicity of silver nanoparticles on wound healing: A case study of zebrafish fin regeneration model. Science of the Total Environment, 717, 137178.
[18]. Sharif, F., Steenbergen, P. J., Metz, J. R., & Champagne, D. L., 2015. Long‐lasting effects of dexamethasone on immune cells and wound healing in the zebrafish. Wound Repair and Regeneration, 23(6), 855-865.
[19]. Edirisinghe, S. L., Nikapitiya, C., Kim, C. H., Castex, M., Leclercq, E., & De Zoysa, M., 2023. Dietary supplementation with a multi-strain yeast fraction enhances skin wound healing in zebrafish (Danio rerio). Aquaculture Reports, 32, 101741.
Viewed PDF 29 2 -
Development and Characterization of Gadolinium-Doped Hydroxyapatite to Enhance Biocompatibility in Biomedical ApplicationsAuthor: Swadhi RadhakrishnanDOI: 10.21522/TIJPH.2013.13.01.Art033
Development and Characterization of Gadolinium-Doped Hydroxyapatite to Enhance Biocompatibility in Biomedical Applications
Abstract:
The synthesis and characterization of gadolinium-doped brucinium hydroxyapatite (Gd-BHAP) have garnered significant attention for their potential applications in bone regeneration and dentistry. Hydroxyapatite (HAP) closely resembles the mineral phase of bone, exhibiting biocompatibility, biodegradability, and bioactivity. Hence, this study aims to synthesize and characterize Gd-BHAP to evaluate its potential for enhancing biocompatibility and effectiveness in bone regeneration applications. Gd-BHAP was synthesized via a hydrothermal method using calcium nitrate tetrahydrate and diammonium hydrogen phosphate as precursors, maintaining a calcium-to-phosphate molar ratio of 1:6. Dual dopants, brucine (1%) and gadolinium (+0.5%, 1%, and 2% concentrations), were incorporated, with the pH adjusted to 9. Characterization was performed using XRD, SEM, DLS, FTIR, Fluorescence and UV-Vis spectroscopy. The cytotoxicity of Gd-BHAP was evaluated on Vero cells using the MTT assay across varying concentrations (25–200 µg/mL). Results indicated that the characterization techniques confirmed the successful synthesis of Gd-BHAP, demonstrating rod-shaped morphology and sizes ranging from 70 to 121 nm. FTIR analysis revealed typical absorption bands of hydroxyapatite, while XRD patterns matched known standards for HA, indicating a hexagonal phase. Cytotoxicity results showed a concentration-dependent decrease in Vero cell viability, with 84% viability at 25 µg/mL, decreasing to 73% at 200 µg/mL, indicating acceptable biocompatibility for potential biomedical applications. In conclusion, the synthesized gadolinium-doped brucinium hydroxyapatite exhibits promising characteristics for biomedical applications, particularly in bone regeneration. While higher concentrations may reduce cell viability, the material demonstrates significant biocompatibility, positioning it as a suitable candidate for tissue engineering.
Development and Characterization of Gadolinium-Doped Hydroxyapatite to Enhance Biocompatibility in Biomedical Applications
References:
[1]. Lara-Ochoa, S., Ortega-Lara, W., & Guerrero-Beltrán, C. E., 2021. Hydroxyapatite nanoparticles in drug delivery: physicochemistry and applications. Pharmaceutics, 13(10), 1642.
[2]. Cheng, X., Wei, J., Ge, Q., Xing, D., Zhou, X., Qian, Y., & Jiang, G. 2021. The optimized drug delivery systems of treating cancer bone metastatic osteolysis with nanomaterials. Drug Delivery, 28(1), 37-53.
[3]. De Lama-Odría, M. D. C., Del Valle, L. J., & Puiggalí, J. 2022. Hydroxyapatite biobased materials for treatment and diagnosis of cancer. International journal of molecular sciences, 23(19), 11352.
[4]. Dorozhkin, S. V., 2015. Calcium orthophosphate-containing biocomposites and hybrid biomaterials for biomedical applications. Journal of functional biomaterials, 6 (3), 708-832.
[5]. Radha, G., Manjubaashini, N., & Balakumar, S., 2023. Nano-hydroxyapatite/natural polymer composite scaffolds for bone tissue engineering: a brief review of recent trend. In vitro models, 2(5), 125-151.
[6]. Oni, O. P., Hu, Y., Tang, S., Yan, H., Zeng, H., Wang, H., & Ran, J. 2023. Syntheses and applications of mesoporous hydroxyapatite: a review. Materials Chemistry Frontiers, 7(1), 9-43.
[7]. Ielo, I., Calabrese, G., De Luca, G., & Conoci, S. 2022. Recent advances in hydroxyapatite-based biocomposites for bone tissue regeneration in orthopedics. International journal of molecular sciences, 23(17), 9721.
[8]. Li, L. H., Kim, H. W., Lee, S. H., Kong, Y. M., & Kim, H. E. 2005. Biocompatibility of titanium implants modified by microarc oxidation and hydroxyapatite coating. Journal of Biomedical Materials Research. Part A 73(1), 48-54.
[9]. Turon, P., Del Valle, L. J., Alemán, C., & Puiggalí, J., 2017. Biodegradable and biocompatible systems based on hydroxyapatite nanoparticles. Applied Sciences, 7(1), 60.
[10]. Aminzare, M., Eskandari, A., Baroonian, M. H., Berenov, A., Hesabi, Z. R., Taheri, M., & Sadrnezhaad, S. K. 2013. Hydroxyapatite nanocomposites: Synthesis, sintering and mechanical properties. Ceramics International, 39(3), 2197-2206.
[11]. Woodard, J. R., Hilldore, A. J., Lan, S. K., Park, C. J., Morgan, A. W., Eurell, J. A. C., & Johnson, A. J. W. 2007. The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity. Biomaterials, 28(1), 45-54.
[12]. He, P., Sahoo, S., Ng, K. S., Chen, K., Toh, S. L., & Goh, J. C. H., 2013. Enhanced osteoinductivity and osteoconductivity through hydroxyapatite coating of silk‐based tissue‐engineered ligament scaffold. Journal of Biomedical Materials Research part A, 101(2), 555-566.
[13]. Shi, H., Zhou, Z., Li, W., Fan, Y., Li, Z., & Wei, J., 2021. Hydroxyapatite based materials for bone tissue engineering: A brief and comprehensive introduction. Crystals, 11(2), 149.
[14]. Kang, S., Haider, A., Gupta, K. C., Kim, H., & Kang, I., 2022. Chemical bonding of biomolecules to the surface of nano-hydroxyapatite to enhance its bioactivity. Coatings, 12(7), 999.
[15]. Dutta, S. R., Passi, D., Singh, P., & Bhuibhar, A., 2015. Ceramic and non-ceramic hydroxyapatite as a bone graft material: a brief review. Irish Journal of Medical Science 184(1), 101-106.
[16]. Lett, J. A., Sagadevan, S., Fatimah, I., Hoque, M. E., Lokanathan, Y., Léonard, E., & Oh, W. C., 2021. Recent advances in natural polymer-based hydroxyapatite scaffolds: Properties and applications. European Polymer Journal, 148, 110360.
[17]. Sprio, S., Dapporto, M., Preti, L., Mazzoni, E., Iaquinta, M. R., Martini, F., & Tampieri, A., 2020. Enhancement of the biological and mechanical performances of sintered hydroxyapatite by multiple ions doping. Frontiers in Materials, 7, 224.
[18]. Zhao, X., Yang, Z., Liu, Q., Yang, P., Wang, P., Wei, S., & Zhao, Z., 2022. Potential load-bearing bone substitution material: carbon-fiber-reinforced magnesium-doped hydroxyapatite composites with excellent mechanical performance and tailored biological properties. ACS Biomaterials Science & Engineering, 8(2), 921-938.
[19]. Fiume, E., Magnaterra, G., Rahdar, A., Verné, E., & Baino, F. 2021. Hydroxyapatite for biomedical applications: A short overview. Ceramics, 4(4), 542-563.
[20]. Radulescu, D. E., Vasile, O. R., Andronescu, E., & Ficai, A., 2023. Latest research of doped hydroxyapatite for bone tissue engineering. International Journal of Molecular Sciences, 24(17), 13157.
[21]. Du, M., Chen, J., Liu, K., Xing, H., & Song, C., 2021. Recent advances in biomedical engineering of nano-hydroxyapatite including dentistry, cancer treatment and bone repair. Composites Part B: Engineering, 215, 108790.
[22]. Mondal, S., Park, S., Choi, J., Vo, T. M. T., Shin, J. H., Kang, Y. H., & Oh, J., 2020. Rare earth element doped hydroxyapatite luminescent bioceramics contrast agent for enhanced biomedical imaging and therapeutic applications. Ceramics International, 46(18), 29249-29260.
[23]. Gu, M., Li, W., Jiang, L., & Li, X., 2022. Recent progress of rare earth doped hydroxyapatite nanoparticles: Luminescence properties, synthesis and biomedical applications. Acta Biomaterialia, 148, 22-43.
[24]. Somoza, M., Rial, R., Liu, Z., Llovo, I. F., Reis, R. L., Mosqueira, J., & Ruso, J. M., 2023. Microfluidic fabrication of gadolinium-doped hydroxyapatite for theragnostic applications. Nanomaterials, 13(3), 501.
[25]. Uskoković, V., 2015. The role of hydroxyl channel in defining selected physicochemical peculiarities exhibited by hydroxyapatite. RSC advances, 5(46), 36614-36633.
[26]. Mushtaq, A., Zhao, R., Luo, D., Dempsey, E., Wang, X., Iqbal, M. Z., & Kong, X., 2021. Magnetic hydroxyapatite nanocomposites: The advances from synthesis to biomedical applications. Materials & Design, 197, 109269.
[27]. Lv, Y., Shi, Q., Jin, Y., Ren, H., Qin, Y., Wang, B., & Song, S., 2018. Preparation and Luminescent Properties of the antibacterial materials of the La3+ Doped Sm3+-Hydroxyapatite. In Journal of Physics: Conference Series 986(1)
[28]. Kim, H. K., Lee, G. H., & Chang, Y., 2018. Gadolinium as an MRI contrast agent. Future Medicinal Chemistry, 10(6), 639-661.
[29]. Fatima, A., Ahmad, M. W., Al Saidi, A. K. A., Choudhury, A., Chang, Y., & Lee, G. H., 2021. Recent advances in gadolinium based contrast agents for bioimaging applications. Nanomaterials, 11(9), 2449.
[30]. Grobner, T., & Prischl, F. C., 2007. Gadolinium and nephrogenic systemic fibrosis. Kidney international, 72(3), 260-264.
[31]. Wei, M., Evans, J. H., Bostrom, T., & Grøndahl, L., 2003. Synthesis and characterization of hydroxyapatite, fluoride-substituted hydroxyapatite and fluorapatite. Journal of materials science: Materials in medicine, 14(4), 311-320.
[32]. Rapacz-Kmita, A., Paluszkiewicz, C., Ślósarczyk, A., & Paszkiewicz, Z., 2005. FTIR and XRD investigations on the thermal stability of hydroxyapatite during hot pressing and pressureless sintering processes. Journal of Molecular Structure, 744, 653-656.
[33]. Shaltout, A. A., Allam, M. A., & Moharram, M. A., 2011. FTIR spectroscopic, thermal and XRD characterization of hydroxyapatite from new natural sources. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 83(1), 56-60.
[34]. Abifarin, J. K., Obada, D. O., Dauda, E. T., & Dodoo-Arhin, D., 2019. Experimental data on the characterization of hydroxyapatite synthesized from biowastes. Data in brief, 26, 104485.
[35]. Zhang, C., Yang, J., Quan, Z., Yang, P., Li, C., Hou, Z., & Lin, J., 2009. Hydroxyapatite nano-and microcrystals with multiform morphologies: controllable synthesis and luminescence properties. Crystal Growth and Design, 9(6), 2725-2733.
[36]. Marković, S., Veselinović, L., Lukić, M. J., Karanović, L., Bračko, I., Ignjatović, N., & Uskoković, D., 2011. Synthetical bone-like and biological hydroxyapatites: a comparative study of crystal structure and morphology. Biomedical Materials, 6(4), 045005.
[37]. Chandrasekar, A., Sagadevan, S., & Dakshnamoorthy, A., 2013. Synthesis and characterization of nano-hydroxyapatite (n-HAP) using the wet chemical technique. Int. J. Phys. Sci, 8(32), 1639-1645.
[38]. Montalbano, G., Molino, G., Fiorilli, S., & Vitale-Brovarone, C., 2020. Synthesis and incorporation of rod-like nano-hydroxyapatite into type I collagen matrix: A hybrid formulation for 3D printing of bone scaffolds. Journal of the European Ceramic Society, 40(11), 3689-3697.
[39]. Machla, F., Sokolova, V., Platania, V., Prymak, O., Kostka, K., Kruse, B., & Bakopoulou, A., 2023. Tissue engineering at the dentin-pulp interface using human treated dentin scaffolds conditioned with DMP1 or BMP2 plasmid DNA-carrying calcium phosphate nanoparticles. Acta Biomaterialia, 159, 156-172.
[40]. Nenad L. Ignjatović, Lidija Mančić, MarinaVuković, Zoran Stojanović, MarkoG. Nikolić, Srečo Škapin, Sonja Jovanović, LjiljanaVeselinović, Vuk Uskoković, Snežana Lazić, Smilja Marković, Miloš M. Lazarević & Dragan P. Uskoković, 2019. Rare-earth (Gd3+, Yb3+/Tm3+, Eu3+) co-doped hydroxyapatite as magnetic, up-conversion and down-conversion materials for multimodal imaging. Scientific reports, 9:16305
[41]. James J. Hagan, Susan Cicero Taylor, and Michael F. Tweedle 1988. Fluorescence Detection of Gadolinium Chelates Separated by Reversed-Phase High-Performance Liquid Chromatography, American Chemical Society, 60, 514-516.
[42]. Doan, V. H. M., Vu, D. D., Mondal, S., Vo, T. M. T., Ly, C. D., Nguyen, V. T., & Oh, J., 2023. Yb–Gd Codoped Hydroxyapatite as a Potential Contrast Agent for Tumor-Targeted Biomedical Applications. ACS Biomaterials Science & Engineering, 9 (8), 4607-4618.
[43]. Minh, D. V. H., 2022. Biomedical instruments design and development focused on ultrasound, fluorescence, and photoacoustic imaging-guided therapeutic modalities, Doctoral dissertation, 부경대학교.
[44]. Sha, S., Zhang, L., Liu, H., Chen, J., Che, Y., Zhang, F., & Song, C., 2021. Synthesis and visible-light photocatalytic degradation of Ag 3 PO 4/AgBr/hydroxyapatite ternary nanocomposites prepared from oyster shells. RSC advances, 11(26), 15598-15607.
[45]. Kpemissi, M., Eklu-Gadegbeku, K., Veerapur, V. P., Potârniche, A. V., Adi, K., Vijayakumar, S., Banakar, S. M., Thimmaiah, N. V., Metowogo, K., & Aklikokou, K., 2019. Antioxidant and nephroprotection activities of Combretum micranthum: A phytochemical, in-vitro and ex-vivo studies. Heliyon, 5(3), e01365.
[46]. Do Amaral, M. B., Viana, R. B., Viana, K. B., Diagone, C. A., Denis, A. B., & de Guzzi Plepis, A. M., 2020. In vitro and in vivo response of composites based on chitosan, hydroxyapatite and collagen. Acta Scientiarum. Technology, 42.
Viewed PDF 19 3 -
Characterization of Alcohol Use Disorder using Alcohol Use Disorder Identification Test (AUDIT) - A Prospective, Observational StudyAuthor: Pragathi Reddy GunnamDOI: 10.21522/TIJPH.2013.13.01.Art034
Characterization of Alcohol Use Disorder using Alcohol Use Disorder Identification Test (AUDIT) - A Prospective, Observational Study
Abstract:
Alcohol Use Disorder (AUD) is a major public health issue globally, with India having approximately 2 crore people affected. It impacts various Sustainable Development Goals (SDGs), including those related to health, education, and social stability. There is limited research on alcohol consumption patterns, dependence, and sociodemographic influences in regions like Telangana and India. Though there are several questionnaires, The Alcohol Use Disorders Identification Test (AUDIT), developed by the WHO, is the most effective tool for identifying risky alcohol consumption and has been widely used to assess AUD severity. Therefore, this study aims to fill that gap by using the AUDIT tool to assess alcohol use, dependence, and hazardous drinking behaviours, while exploring the role of sociodemographic factors (age, gender, education, etc.) in these patterns. It is a Prospective, observational study. AUDIT includes questions on three different domains and categorizes participants into levels of alcohol risk: low risk, hazardous use, harmful use, and alcohol dependence. While 25% of the study population consumed harmful quantities of alcohol up to 720ml a day, 67% admitted they were unable to be abstinent for at least a week and hence consumed continuously 62% were unable to work continuously due to this disorder.48% needed their first drink in the morning every week and 30% needed it almost daily. AUDIT tool has been an effective way of identifying the problematic alcohol consumption in the sample population and also to identify the rate, and stepwise patterns of disorder using different domains of the questionnaire, this study also throws light into various patterns of alcohol consumption so that treatment can be planned effectively.
Characterization of Alcohol Use Disorder using Alcohol Use Disorder Identification Test (AUDIT) - A Prospective, Observational Study
References:
[1]. Frings, D., & Albery, I. P., 2021, The Handbook of Alcohol Use: Understandings from Synapse to Society. Academic. https://link.springer.com/chapter/10.1007/978-3-031-18381-2_2
[2]. Baum, A., Revenson, T. A., & Singer, J., 2012, Handbook of health psychology. Psychology press. https://doi.org/10.4324/9780203804100
[3]. Becker, H. C., 2012, Effects of alcohol dependence and withdrawal on stress responsiveness and alcohol consumption. Alcohol research: current reviews, 34(4), 448. https://pubmed.ncbi.nlm.nih.gov/23584111/
[4]. Koob, G. F., & Le Moal, M., 2008, Addiction and the brain antireward system. Annu. Rev. Psychol., 59(1), 29-53. https://doi.org/10.1146/annurev.psych.59.103006.093548
[5]. Anker, J. J., & Kushner, M. G., 2019, Co-occurring alcohol use disorder and anxiety: bridging psychiatric, psychological, and neurobiological perspectives. Alcohol research: current reviews, 40(1). https://doi.org/10.35946/arcr.v40.1.03
[6]. Vahia, V. N., 2013, Diagnostic and statistical manual of mental disorders 5: A quick glance. Indian Journal of Psychiatry, 55(3), 220-223. https://journals.lww.com/indianjpsychiatry
[7]. Gilbert, L., 2020, Alcohol: truth and consequences on campus: time to change college binge drinking culture once and for all. JC & UL, 45, 141. https://titleixforall.com/wp-content/uploads/2020/02/19.8.31_Gilbert-Copy
[8]. Parsons, A., 1996, Neuropsychology for clinical practice: Etiology, assessment, and treatment of common neurological disorders. Washington DC: American Psychological Association. https://psycnet.apa.org/record/1996-97886-000
[9]. Shield, K. D., Parry, C., & Rehm, J., 2014, Chronic diseases and conditions related to alcohol use. Alcohol research: current reviews, 35(2), 155. https://pmc.ncbi.nlm.nih.gov/articles/PMC3908707/
[10]. Ilhan, M. N., & Yapar, D., 2020, Alcohol consumption and alcohol policy. Turkish Journal of Medical Sciences, 50(5), 1197-1202. https://journals.tubitak.gov.tr/medical/vol50/iss5/1
[11]. World Health Organization. 2018, Global status report on alcohol and health 2018. World Health Organization. https://www.who.int/publications/i/item/9789241565639
[12]. Oscar-Berman, M., & Marinkovic, K., 2003, Alcoholism and the brain: an overview. Alcohol Research & Health, 27(2), 125. https://pmc.ncbi.nlm.nih.gov/articles/PMC6668884/
[13]. Oscar-Berman, M., & Marinković, K., 2007, Alcohol: effects on neurobehavioral functions and the brain. Neuropsychology Review, 17, 239-257. https://link.springer.com
[14]. Rastogi, A., Manthey, J., Wiemker, V., & Probst, C., 2022, Alcohol consumption in India: a systematic review and modelling study for sub‐national estimates of drinking patterns. Addiction, 117(7), 1871-1886. https://onlinelibrary.wiley.com
[15]. Lama, S. D., & Lodhi, M., 2023, Prevalence of Alcohol use among the Indian Population and its Impact on Public Health. Indian Journal of Public Health Research & Development, 14(3).
[16]. Balasubramani, K., Paulson, W., Chellappan, S., Ramachandran, R., Behera, S. K., & Balabaskaran Nina, P., 2021, Epidemiology, hot spots, and sociodemographic risk factors of alcohol consumption in Indian men and women: analysis of National Family Health Survey-4 (2015-16), a nationally representative cross-sectional study. Frontiers in Public Health, 9, 617311. https://www.frontiersin.org
[17]. Saunders, J. B., Aasland, O. G., Babor, T. F., De la Fuente, J. R., & Grant, M., 1993, Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption‐II. Addiction, 88(6), 791-804. https://onlinelibrary.wiley.com
[18]. Lima, C. T., Freire, A. C. C., Silva, A. P. B., Teixeira, R. M., Farrell, M., & Prince, M., 2005, Concurrent and construct validity of the AUDIT in an urban Brazilian sample. Alcohol and Alcoholism, 40(6), 584-589. https://academic.oup.com
[19]. Babor, T. F., Higgins-Biddle, J. C., Saunders, J. B., Monteiro, M. G., & World Health Organization, 2001, AUDIT: the alcohol use disorders identification test: guidelines for use in primary health care (No. WHO/MSD/MSB/01.6 a). World Health Organization.
[20]. Shevlin, M., & Smith, G. W., 2007, The factor structure and concurrent validity of the alcohol use disorder identification test based on a nationally representative UK sample. Alcohol & Alcoholism, 42(6), 582-587.
[21]. Karaye, I. M., Maleki, N., Hassan, N., & Yunusa, I., 2023, Trends in alcohol-related deaths by sex in the US, 1999-2020. JAMA Network Open, 6(7), e2326346-e2326346. https://jamanetwork.com
[22]. Nubukpo, P., Girard, M., Sengelen, J. M., Bonnefond, S., Varnoux, A., Marin, B., & Malauzat, D., 2016, A prospective hospital study of alcohol use disorders, comorbid psychiatric conditions and withdrawal prognosis. Annals of General Psychiatry, 15, 1-11.
[23]. Abuse, S., 2019, Mental Health Services Administration. Results from the 2018 national survey on drug use and health: detailed tables. Book Results from the 2007 National Survey on Drug Use and Health: Detailed Tables.
[24]. McCarthy, M., 2015., Six people in US die each day from alcohol poisoning, CDC reports.
[25]. World Health Organization. 2019, Status report on alcohol consumption, harm and policy responses in 30 European countries 2019 (No. WHO/EURO: 2019-3545-43304-60696). World Health Organization. Regional Office for Europe.
[26]. Crozier, M. E., Farokhnia, M., Persky, S., Leggio, L., & Curtis, B., 2023, Relationship between self-stigma about alcohol dependence and severity of alcohol drinking and craving. BMJ Ment Health, 26(1). https://mentalhealth.bmj.com
[27]. Slater, M. E., & Alpert, H. R., National Institute on Alcohol Abuse and Alcoholism (NIAAA) Surveillance Report# 120.
[28]. Cantor, J. H., Whaley, C. M., Stein, B. D., & Powell, D., 2022, Analysis of substance use disorder treatment admissions in the US by sex and race and ethnicity before and during the COVID-19 pandemic. JAMA Network Open, 5(9), e2232795-e2232795.doi:10.1001/jamanetworkopen.2022.32795.
Viewed PDF 45 3 -
Ultra-Short Atrial Fibrillation Episodes: A Case ReportAuthor: Skakun OleksiiDOI: 10.21522/TIJPH.2013.13.01.Art035
Ultra-Short Atrial Fibrillation Episodes: A Case Report
Abstract:
Atrial fibrillation (AF) is a common heart rhythm abnormality characterized by disorganized atrial activity and irregular ventricular contraction. AF should be diagnosed with ambulatory ECG monitoring if AF-like activity lasts more than 30 s. The term “micro-AF” defines episodes of ≥5 consecutive supraventricular beats and complete absence of P waves lasting less than 30 s. We present the case of very short episodes of AF-like activity recorded with ambulatory ECG monitoring. A 50-year-old man visited a cardiologist for recurrent episodes of fast irregular heartbeat. 72-hour ambulatory 12-lead ECG monitoring revealed four episodes of AF that lasted more than 30 seconds. The longest episode lasted for 29 minutes. Also, there were two episodes of AF-like activity lasting for 17.2 s and 4.8 s. However, the majority of the episodes of AF-like activity lasted less than 4 seconds. The shortest episode of AF-like activity lasted for 0.8 seconds and included 5 obvious f-waves with a rate close to 340 bpm and one QRS complex. Also, there were episodes of obvious ultra-short AF-like activity lasting less than 1.6 seconds and resulted in only 3 QRS complexes. Such episodes cannot be classified as micro-AF as at least 5 QRS complexes are needed. Clinicians should always pay attention to ultra-short episodes of AF, as they may coexist with underdiagnosed long episodes of AF. A special term to define ultra-short episodes of AF-like activity should be introduced.
Ultra-Short Atrial Fibrillation Episodes: A Case Report
References:
[1]. Miljković, S., Blagojević, A., Petrušić, T., 2018, Relationship between Atrial Fibrillation as a Risk Factor and the Outcome of Ischemic Stroke. Scripta Medica, 49(1), 6–12. Doi: 10.18575/msrs.sm.e.18.01.
[2]. Bergau, L., Bengel, P., Sciacca, V., Fink, T., Sohns, C., Sommer, P., 2022, Atrial Fibrillation and Heart Failure. Journal of Clinical Medicine, 11(9), 2510. Doi: 10.3390/jcm11092510.
[3]. Van Gelder, I. C., Rienstra. M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., Jaarsma, T., Lettino, M., Løchen, M. L., Lumbers, R. T., Maesen, B., Mølgaard, I., Rosano, G. M. C., Sanders, P., Schnabel, R. B., Suwalski, P., Svennberg, E., Tamargo, J., Tica, O., Traykov, V., Tzeis, S., Kotecha, D., ESC Scientific Document Group, 2024, ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 45(36), 3314-3414. Doi: 10.1093/eurheartj/ehae176.
[4]. Hotiur, O., Drapchak, I., Drapchak, P., Drapchak, O., 2020, Pathophysiologic Peculiarities of Different Factors’ Influence on Development and Course of IHD Complicated with Atrial Fibrillation. Galician Medical Journal, 27(1), E202018–8. Doi: 10.21802/gmj.2020.1.8.
[5]. Gunawardene, M. A., Willems, S., 2022, Atrial fibrillation progression and the importance of early treatment for improving clinical outcomes. Europace, 24(Suppl 2), ii22-ii28. Doi: 10.1093/europace/euab257.
[6]. Seet, R. C., Friedman, P. A., Rabinstein, A. A., 2011, Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause. Circulation, 124(4), 477-486. Doi: 10.1161/CIRCULATIONAHA.111.029801.
[7]. Baturova, M. A., Sheldon, S. H., Carlson, J., Brady P. A., Lin, G., Rabinstein, A. A., Friedman, P. A., Platonov, P. G., 2016, Electrocardiographic and Echocardiographic predictors of paroxysmal atrial fibrillation detected after ischemic stroke. BMC Cardiovascular Disorders, 16, 209. Doi: 10.1186/s12872-016-0384-2.
[8]. Fredriksson, T., Gudmundsdottir, K. K., Frykman, V., Friberg, L., Al-Khalili, F., Engdahl, J., Svennberg, E., 2020, Brief episodes of rapid irregular atrial activity (micro-AF) are a risk marker for atrial fibrillation: a prospective cohort study. BMC Cardiovascular Disorders, 20(1), 167. Doi: 10.1186/s12872-020-01453-w.
[9]. Ko, J. S., Jeong, H. K., 2021, Screening for Atrial Fibrillation Using a Single Lead ECG Monitoring Device. Chonnam Medical Journal, 57(3), 191-196. Doi: 10.4068/cmj.2021.57.3.191.
[10]. Tran, R. T., Rankin, A. J., Abdul-Rahim, A. H., Lip, G. Y., Rankin, A. C., Lees, K. R., 2016, Short runs of atrial arrhythmia and stroke risk: a European-wide online survey among stroke physicians and cardiologists. Journal of the Royal College of Physicians of Edinburgh, 46(2), 87-92. Doi: 10.4997/JRCPE.2016.204.
[11]. Calkins, H., Hindricks, G., Cappato, R., Kim, Y. H., Saad, E. B., Aguinaga, L., Akar, J. G., Badhwar. V., Brugada, J., Camm, J., Chen, P. S., Chen, S. A., Chung, M. K., Nielsen, J. C., Curtis, A. B., Davies, D. W., Day, J. D., d'Avila, A., de Groot, N. M. S. N., Di Biase, L., Duytschaever, M., Edgerton, J. R., Ellenbogen, K. A., Ellinor, P. T., Ernst, S., Fenelon, G., Gerstenfeld, E. P., Haines, D. E., Haissaguerre, M., Helm, R. H., Hylek, E., Jackman, W. M., Jalife, J., Kalman, J. M., Kautzner, J., Kottkamp, H., Kuck, K. H., Kumagai, K., Lee, R., Lewalter, T., Lindsay, B. D., Macle, L., Mansour, M., Marchlinski, F. E., Michaud, G. F., Nakagawa, H., Natale, A., Nattel, S., Okumura, K., Packer, D., Pokushalov, E., Reynolds, M. R., Sanders, P., Scanavacca, M., Schilling, R., Tondo, C., Tsao, H. M., Verma, A., Wilber, D. J., Yamane, T., 2017, HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm, 14(10), e275-e444. Doi: 10.1016/j.hrthm.2017.05.012.
[12]. Riccio, P., Sposato, L. A., Hachinski, V., Saposnik, G., 2015, High Frequency of Short Paroxysms of Newly Detected Atrial Fibrillation after Stroke and TIA. Systematic Review and Meta-Analysis (P1.054). Neurology, 84(14 supplement). Doi: 10.1212/WNL.84.14_supplement.P1.054.
[13]. Berge, T., Myhre, P. L., Kalstad, A. A., Laake, K., Tveit, S. H., Onarheim, S., Solheim, S., Seljeflot, I., Arnesen, H., Tveit, T., OMEMI Study Group, 2022, Screen-detected atrial fibrillation (AF) and “micro-AF” after myocardial infarction in patients 70–82 years and risk of cardiovascular events in the OMEMI trial, European Heart Journal, 43(2), ehac544.540. Doi: 10.1093/eurheartj/ehac544.540.
Viewed PDF 19 3 -
Osteogenic Potential of Cissus Quadrangularis: A Systematic ReviewAuthor: Dhanraj GanapathyDOI: 10.21522/TIJPH.2013.13.01.Art036
Osteogenic Potential of Cissus Quadrangularis: A Systematic Review
Abstract:
Research shows that Cissus quadrangularis extracts can promote osteoblast proliferation, enhance collagen synthesis, and influence key signalling pathways like the Wnt/β-catenin pathway, which is vital for bone growth and remodelling. These findings suggest that Cissus quadrangularis could be an effective natural treatment for osteoporosis, bone fractures, and other skeletal disorders. A comprehensive search strategy was developed to systematically review the osteogenic potential of Cissus quadrangularis. Relevant studies were identified through searches of PubMed/MEDLINE, EMBASE, Cochrane Library, Scopus, Web of Science, and Google Scholar, using key terms such as "Cissus quadrangularis," "osteogenesis," "bone healing," and "bone regeneration." Boolean operators were employed to refine the search. Inclusion criteria focused on in vitro, in vivo, and clinical studies exploring the plant's role in bone health, while studies unrelated to osteogenesis or without original data were excluded. Titles, abstracts, and full texts were screened for relevance, followed by data extraction and quality assessment using appropriate tools. The strategy aimed to ensure comprehensive coverage of the available literature, minimizing bias and including diverse sources. A comprehensive search identified 975 articles. After excluding studies involving other plant extracts or review articles, the final selection included 8 cell line studies, 2 animal studies, and 5 clinical studies. The selected studies were analysed thoroughly. The systematic review underscores the osteogenic potential of Cissus quadrangularis, highlighting its ability to enhance bone formation and osseointegration based on cell line, animal, and clinical studies. While promising, the review also points out limitations, including a lack of high-quality clinical trials and challenges in conducting meta-analyses due to varied study designs and methodologies.
Osteogenic Potential of Cissus Quadrangularis: A Systematic Review
References:
[1]. Rajeshkumar, S., Menon, S., Kumar, S. V., Tambuwala, M. M., Bakshi, H. A., Mehta, M., Satija, S., Gupta, G., Chellappan, D. K., Thangavelu, L., & Dua, K., 2019, Antibacterial and antioxidant potential of biosynthesized copper nanoparticles mediated through Cissus arnotiana plant extract, Journal of Photochemistry and Photobiology B: Biology, 197, 111531.
[2]. Sharma, A., Sharma, C., Shah, O. P., Chigurupati, S., Ashokan, B., Meerasa, S. S., Rashid, S., Behl, T., & Bungau, S. G., 2023, Understanding the mechanistic potential of plant-based phytochemicals in management of postmenopausal osteoporosis, Biomedicine & Pharmacotherapy, 163, 114850.
[3]. Velmurugan, Y., Natarajan, S. R., Chakkarapani, N., Jayaraman, S., Madhukar, H., & Venkatachalam, R., 2024, In silico and in vitro studies for the identification of small molecular inhibitors from Euphorbia hirta Linn for rheumatoid arthritis: targeting TNF-α-mediated inflammation, Molecular Diversity, 17, 1-8.
[4]. Rajasekar, R., Shanmugam, R., & Anandan, J., 2024, Biosynthesis of Cissus rotundifolia stem-mediated titanium dioxide nanoparticles and their anticariogenic activity against Streptococcus mutans and Lactobacillus sp, Journal of Pharmacy and Bioallied Sciences, 16(Suppl 2), S1350-S1353.
[5]. Parameswaran, J., Krishnan, A., Manigandan, P., Shanmugam, R., & Thangavelu, L., 2024, Synthesis of silver nanoparticles using Ocimum gratissimum and Cissus quadrangularis: assessment of the antibacterial and cytotoxic effect of nanoparticles, Nanotechnology Perceptions, 6, 265-275.
[6]. Panda, A. K., & Rout, S., 2011, Puttur kattu (bandage)—A traditional bone setting practice in South India, J Ayurveda Integr Med, 2(4), 174-178.
[7]. Mahar, H. D., Agrawal, A. M., Mahar, D., & Mahar, D., 2016, Cultivation and biomedical application of Cissus quadrangularis L. in bone fracture, AMSE Journals-Series: Modelling C, 77, 1-4.
[8]. Mishra, G., Srivastava, S., & Nagori, B. P., 2010, Pharmacological and therapeutic activity of Cissus quadrangularis: an overview, International Journal of Pharmtech Research, 2(2), 1298-1310.
[9]. Sawangjit, R., Puttarak, P., Saokaew, S., & Chaiyakunapruk, N., 2017, Efficacy and safety of Cissus quadrangularis L. in clinical use: a systematic review and meta-analysis of randomized controlled trials, Phytotherapy Research, 31(4), 555-567.
[10]. Kumar, P., Dev, K., Sharma, K., Sahai, M., & Maurya, R., 2019, New lignan glycosides from Cissus quadrangularis stems, Natural Product Research, 33(2), 233-238.
[11]. Xue, W., Yu, J., & Chen, W., 2018, Plants and their bioactive constituents in mesenchymal stem cell-based periodontal regeneration: a novel perspective, BioMed Research International, 2018(1), 7571363.
[12]. Parisuthiman, D., Singhatanadgit, W., Dechatiwongse, T., & Koontongkaew, S., 2009, Cissus quadrangularis extract enhances biomineralization through up-regulation of MAPK-dependent alkaline phosphatase activity in osteoblasts, In Vitro Cellular & Developmental Biology-Animal, 45, 194-200.
[13]. Potu, B. K., Rao, M. S., Kutty, N. G., Bhat, K. M., Chamallamudi, M. R., & Nayak, S. R., 2008, Petroleum ether extract of Cissus quadrangularis (Linn) stimulates the growth of fetal bone during the intrauterine developmental period: a morphometric analysis, Clinics, 63, 815-820.
[14]. Muthusami, S., Senthilkumar, K., Vignesh, C., Ilangovan, R., Stanley, J., Selvamurugan, N., & Srinivasan, N., 2011, Effects of Cissus quadrangularis on the proliferation, differentiation, and matrix mineralization of human osteoblast-like SaOS-2 cells, Journal of Cellular Biochemistry, 112(4), 1035-1045.
[15]. Siddiqui, S., Ahmad, E., Gupta, M., Rawat, V., Shivnath, N., Banerjee, M., Khan, M. S., & Arshad, M., 2015, Cissus quadrangularis Linn exerts dose-dependent biphasic effects: osteogenic and anti-proliferative, through modulating ROS, cell cycle, and Runx2 gene expression in primary rat osteoblasts, Cell Proliferation, 48(4), 443-454.
[16]. Parvathi, K., Krishnan, A. G., Anitha, A., Jayakumar, R., & Nair, M. B., 2018, Poly (L-lactic acid) nanofibers containing Cissus quadrangularis induced osteogenic differentiation in vitro, International Journal of Biological Macromolecules, 110, 514-521.
[17]. Tasadduq, R., Gordon, J., Al-Ghanim, K. A., Lian, J. B., Van Wijnen, A. J., Stein, J. L., Stein, G. S., & Shakoori, A. R., 2017, Ethanol extract of Cissus quadrangularis enhances osteoblast differentiation and mineralization of murine pre-osteoblastic MC3T3-E1 cells, Journal of Cellular Physiology, 232(3), 540-547.
[18]. Toor, R. H., Malik, S., Qamar, H., Batool, F., Tariq, M., Nasir, Z., & Tassaduq, R., 2019, Osteogenic potential of hexane and dichloromethane fraction of Cissus quadrangularis on murine preosteoblast cell line MC3T3-E1 (subclone 4), Journal of Cellular Physiology, 234(12), 23082-23096.
[19]. Toor, R. H., Tasadduq, R., Adhikari, A., Chaudhary, M. I., Lian, J. B., Stein, J. L., Stein, G. S., & Shakoori, A. R., 2019, Ethyl acetate and n-butanol fraction of Cissus quadrangularis promotes the mineralization potential of murine pre-osteoblast cell line MC3T3-E1 (sub-clone 4), Journal of Cellular Physiology, 234(7), 10300-10314.
[20]. Ruangsuriya, J., Charumanee, S., Jiranusornkul, S., Sirisa-Ard, P., Sirithunyalug, B., Sirithunyalug, J., Pattananandecha, T., & Saenjum, C., 2020, Depletion of β-sitosterol and enrichment of quercetin and rutin in Cissus quadrangularis Linn fraction enhanced osteogenic but reduced osteoclastogenic marker expression, BMC Complementary Medicine and Therapies, 20, 1-2.
[21]. Nair, P. R., Sreeja, S., & Sailaja, G. S., 2021, In vitro biomineralization and osteogenesis of Cissus quadrangularis stem extracts: an osteogenic regulator for bone tissue engineering, Journal of Biosciences, 46, 1-4.
[22]. Liao, L., Zhu, W., Tao, C., Li, D., & Mao, M., 2023, Cissus quadrangularis L extract-loaded tricalcium phosphate reinforced natural polymer composite for guided bone regeneration, Journal of Materials Science: Materials in Medicine, 34(7), 33.
[23]. Robertson, S. F., & Bose, S., 2020, Enhanced osteogenesis of 3D printed β-TCP scaffolds with Cissus quadrangularis extract-loaded polydopamine coatings, Journal of the Mechanical Behavior of Biomedical Materials, 111, 103945.
[24]. Azam, Z., Sapra, L., Baghel, K., Sinha, N., Gupta, R. K., Soni, V., Saini, C., Mishra, P. K., & Srivastava, R. K., 2023, Cissus quadrangularis (Hadjod) inhibits RANKL-induced osteoclastogenesis and augments bone health in an estrogen-deficient preclinical model of osteoporosis via modulating the host osteoimmune system, Cells, 12(2), 216.
[25]. Singh, N., Singh, V., Singh, R. K., Pant, A. B., Pal, U. S., Malkunje, L. R., & Mehta, G., 2013, Osteogenic potential of Cissus quadrangularis assessed with osteopontin expression, National Journal of Maxillofacial Surgery, 4(1), 52-56.
[26]. Brahmkshatriya, H. R., Shah, K. A., Ananthkumar, G. B., & Brahmkshatriya, M. H., 2015, Clinical evaluation of Cissus quadrangularis as osteogenic agent in maxillofacial fracture: a pilot study, AYU (An International Quarterly Journal of Research in Ayurveda), 36(2), 169-173.
[27]. Managutti, A., Shah, D., Patel, J., Puttanikar, N., Shah, D., & Managutti, S., 2015, Evaluation of clinical efficacy of Cissus quadrangularis in pain management and bone healing after implant placement—a pilot study, Medico Research Chronicles, 2(5), 618-625.
[28]. Nayak, T., 2020, An assessment of the osteogenic potential of Cissus quadrangularis in mandibular fractures: a pilot study, Journal of Maxillofacial and Oral Surgery, 19, 106-112.
[29]. Altaweel, A. A., Baiomy, A. A., Shoshan, H. S., Abbas, H., Abdel-Hafiz, A. A., Gaber, A. E., Zewail, A. A., & Elshiekh, M. A., 2021, Evaluation of osteogenic potential of Cissus quadrangularis on mandibular alveolar ridge distraction, BMC Oral Health, 21, 1-8
Viewed PDF 25 0 -
Preferences and Motivations for Choice of Sexual and Reproductive Health Service Providers among In-School Adolescents in Osun State, NigeriaAuthor: Adeola Oluwasayo OMOPARIOLADOI: 10.21522/TIJPH.2013.13.01.Art037
Preferences and Motivations for Choice of Sexual and Reproductive Health Service Providers among In-School Adolescents in Osun State, Nigeria
Abstract:
Adolescents’ need for Sexual and Reproductive Health (SRH) has been underscored globally. Poor utilization of the services by adolescents has been reported. Adolescent-friendly healthcare professionals are very important in motivating adolescents’ utilisation of SRH services in Nigeria. This study assessed the preferred facility and Service providers by in-school adolescents in Osun state, Nigeria. A descriptive cross-sectional design was employed to survey 422 in-school adolescents in public and private secondary schools in Osun state. A multi-stage sampling technique was used to select participants and data was collected using a self-administered questionnaire. Quantitative data analysis was done using descriptive and inferential statistics with SPSS version 23. The majority (91.0%) of adolescents were middle-aged (14 – 16 years) while a few (9.0%) were late adolescents (17-19 years). Preference when assessing SRH services was more for doctors (36.5%) and nurses (30.3%). Preferred facilities for SRH services include private hospitals (38.3 %), school clinics (26.4%), primary health centres (6.5%), general hospitals (2.5%), Maternity centres (11.4%) and teaching hospitals (1%). Active utilization of SRH by adolescents requires the availability and involvement of their preferred health personnel.
Preferences and Motivations for Choice of Sexual and Reproductive Health Service Providers among In-School Adolescents in Osun State, Nigeria
References:
[1]. World Health Organization. 2018, WHO recommendations on adolescent sexual and reproductive health and rights.
[2]. Okoye, H. U., & Saewyc, E., 2024, Influence of socio-contextual factors on the link between traditional and new media use, and young people's sexual risk behaviour in Sub-Saharan Africa: a secondary data analysis. Reproductive health, 21(1), 138. https://doi.org/10.1186/s12978-024-01868-0
[3]. Isara A. R., & Nwaogwugwu J. C., 2022, Sexual and Reproductive Health Knowledge, Attitude and Behaviours of in-School Adolescents in Benin City, Nigeria. African Journal of Biomedical Research 25(2), 121- 127.
[4]. Manguro, G., & Temmerman, M., 2022, A critical review of adolescent sexual and reproductive health and rights in Kenya. Med (New York, N.Y.), 3(6), 364–368. https://doi.org/10.1016/j.medj.2022.05.007
[5]. Langat, E. C., Mohiddin, A., Kidere, F., Omar, A., Akuno, J., Naanyu, V., & Temmerman, M., 2024, Challenges and opportunities for improving access to adolescent and youth sexual and reproductive health services and information in the coastal counties of Kenya: a qualitative study. BMC public health, 24(1), 484. https://doi.org/10.1186/s12889-024-17999-9
[6]. Aliyu, T. K., & Aransiola, J. O., 2023, Parent-Adolescent Communication About Reproductive Health Issues in Nigeria. Sage Open, 13(2). https://doi.org/10.1177/21582440231166607
[7]. Mbachu, C. O., Agu, I. C., & Onwujekwe, O., 2020, Survey data of adolescents' sexual and reproductive health in selected local governments in southeast Nigeria. Scientific data, 7(1), 438. https://doi.org/10.1038/s41597-020-00783-w
[8]. Envuladu, E. A., Umaru, R. J., Iorapuu, N. O., Osagie, I. A., Okoh, E. O., & Zoakah, A. I., 2016, Determinants and effect of girl child marriage: a cross sectional study of school girls in Plateau State, Nigeria. International Journal of Medicine and Biomedical Research, 5(3), 122-129.
[9]. Adione, A. A., Abamara, N. C., & Vivalya, B. M. N., 2023, Determinants of the utilization of youth-friendly sexual and reproductive health services in public secondary schools of Kogi State, Nigeria: an explorative study. BMC public health, 23(1), 1091. https://doi.org/10.1186/s12889-023-15926-y
[10]. Abdurahman, C., Oljira, L., Hailu, S., & Mengesha, M. M., 2022, Sexual and reproductive health services utilization and associated factors among adolescents attending secondary schools. Reproductive health, 19(1), 161. https://doi.org/10.1186/s12978-022-01468-w
[11]. Aderajew Zemene, M., Ayele, B. A., Zewde, E. A., Yimer, T. Y., Hailemeskel, H. S., & Tiruneh, S. A., 2024, Prevalence and Associated Factors of Teenage Pregnancy in Sub-Saharan Africa: Multilevel Modified Poisson Regression Analysis. Sage Open, 14(2). https://doi.org/10.1177/21582440241248899
[12]. Cleland, J., 2005, llustrative questionnaire for interview-surveys with young people. Asking Young People About Sexual and Reproductive Behaviours. Illustrative Core Instruments, Geneva: World Health Organization. Geneva: World Health Organization, 3–55. http://www.who.int/reproductivehealth/topics/adolescence/questionnaire.pdf
[13]. Ezumah, N., Agu, I. C., Okeke, C., Agu, C., Mbachu, C. O., & Onwujekwe, O., 2021, Adolescents' Perceptions About Dating and Sexual Permissiveness in Ebonyi State, Nigeria: What Can Be Done to Enhance Adolescents' Sexual Health and Well-Being. Frontiers in reproductive health, 3, 626931. https://doi.org/10.3389/frph.2021.626931
Viewed PDF 28 0 -
Utility of Fundus Fluorescein Angiography and Efficacy of Ranibizumab Intravitreal Therapy in Peripheral Retinal Vascular Abnormalities of Diabetic Patient: A Case ReportAuthor: Suganya MDOI: 10.21522/TIJPH.2013.13.01.Art038
Utility of Fundus Fluorescein Angiography and Efficacy of Ranibizumab Intravitreal Therapy in Peripheral Retinal Vascular Abnormalities of Diabetic Patient: A Case Report
Abstract:
Diabetes predominantly affects the microvascular circulation of the retina. Diabetic retinopathy is a severe complication of diabetes mellitus and a leading cause of diminution of vision. Preventing irreversible vision loss requires early diagnosis of retinal vascular abnormalities. Fundus fluorescein angiography (FFA) is the gold standard for assessing retinal vascular abnormalities and optical coherence tomography confirms the diagnosis. The purpose of this case report was to examine the effectiveness of ranibizumab intravitreal therapy in diabetic patients as well as the usefulness of FFA in evaluating peripheral retinal vascular abnormalities. A 67-year-old adult presented to the emergency department in a tertiary care hospital in Chennai, India, with the sudden onset of painless vision loss in the left eye. Due to irregular medication, he developed diabetic macular oedema. Optical coherence tomography confirmed the presence of macular edema in the left eye and consent was obtained for unilateral pan-retinal photocoagulation (PRP). Despite grid laser, the macular edema persisted and after PRP it was reduced. FFA assisted in treating macular oedema by detecting peripheral retinal ischaemia and administering anti-vascular endothelial growth factor injection (Ranibizumab). The patient's best-corrected visual acuity was improved from 6/36 to 6/9 in the left eye. Research are needed to improve glycaemic management and prompt therapies to help patients with diabetic retinopathy see better and live better lives.
Utility of Fundus Fluorescein Angiography and Efficacy of Ranibizumab Intravitreal Therapy in Peripheral Retinal Vascular Abnormalities of Diabetic Patient: A Case Report
References:
[1]. Raka, M., Daigavhane, S., & Patil, A. A., 2022, Clinical case report of diabetic retinopathy. Asian J Biomed Pharmaceut Sci, 12(90),128. https://www.alliedacademies.org/articles/a-clinical-case-report-of-diabetic-retinopathy.pdf
[2]. International Diabetes Federation, 2019, IDF Diabetes Atlas, 9th ed. Brussels, Belgium, International Diabetes Federation, https://d-net.idf.org/en/library/542-idf-diabetes-atlas-2019-9th-edition.html
[3]. Suganya, M., & KalaBarathi, S., 2024, Association of body mass index with dietary intake and self-care health activities of mothers after postpartum: A mixed-method research in Chennai City, India. Int J Nutr Pharmacol Neurol Dis, 14, 52-7. https://doi.org/10.4103/ijnpnd.ijnpnd_71_23
[4]. Sultana, A., 2023, Role of fundus fluorescein angiography in identifying the unexplained visual loss due to macular edema in peripheral retinal diseases. Indian J Clin Exp Ophthalmol, 9(1), 53-59. https://doi.org/10.18231/j.ijceo.2023.011
[5]. Farheen, Naz., & JenilaRani, D., 2022, Detection and Comparison of Diabetic Retinopathy using Thresholding Algorithm and CMeans Clustering Algorithm, Journal of Pharmaceutical Negative Results, 14(4). https://www.pnrjournal.com/index.php/home/article/view/899
[6]. Bhuvaneswari, R., Diviya, M., Subramanian, M., Maranan, R., & Josphineleela R., 2023, Hybrid generative model for grading the severity of diabetic retinopathy images. Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization, 11(7). https://doi.org/10.1080/21681163.2023.2266048
[7]. Woo, S. J., Cho, G. E., & Cho, J. H., 2019, Short-term Efficacy and Safety of Ranibizumab for Neovascular Age-related Macular Degeneration in the Real World: A Post-marketing Surveillance Study. Korean J Ophthalmol. 33(2), 150-166. https://doi/10.3341/kjo.2018.0081
[8]. Ramakrishnan, A., Veeramani, P. A., & et al, 2024, Association of Various Optical Coherence Tomographic Patterns of Diabetic Macular Edema with Central Subfield Thickness and Visual Acuity: A Cross-Sectional Observational Study. Cureus. 19,16(9). https://doi/10.7759/cureus.69731
[9]. Suganya, M., & Kalabarathi, S., 2024, Efficacious Maintenance-Electroconvulsive Therapy (m-ECT) and Antipsychotic Medication for Schizophrenia Spectrum Disorder in a Young Adult Woman in Chennai, India: A Case Report. International Journal of Nutrition, Pharmacology, Neurological Diseases, 14(3),390-392. https://doi.org/10.4103/ijnpnd.ijnpnd_42_24
[10]. American Academy of Ophthalmology, 2020, Age-related macular degeneration. https://www.aao.org/bcscsnippetdetail.aspx?id=9711f063-ed7b-452b-8708-c4dad0d893e8.
[11]. Sharma, S., Gupta, V., Maiti, A., & et al., 2021, Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study, Int J Retin Vitr. 24(7). https://doi.org/10.1186/s40942-021-00293-w
[12]. Suganya, M., & Maragatham, S., & Sheela, P., 2024, Assessment on Health Status of Adult Patients with Osteoarthritis of the Lower Limb by Western Ontario and McMaster’s Universities Osteoarthritis Index (WOMAC): A Study in Chennai City. Texila International Journal of Public Health. Special Issue:1-8. https://doi.org/10.21522/TIJPH.2013.SE.24.02.Art007
[13]. Ebrahimi, M. H., & Gharibi, H., 2016, A case study of a patient with diabetic retinopathy. Diab Met Syndr: Clin Res Rev. http://dx.doi.org/10.1016/j.dsx.2016.01.022
[14]. Kertes, P. J., Galic, I. J., Greve, M., & et al., 2020, Efficacy of a Treat-and-Extend Regimen with Ranibizumab in Patients with Neovascular Age-Related Macular Disease: A Randomized Clinical Trial. JAMA Ophthalmol. 138(3), 244–250. https://doi/10.1001/jamaophthalmol.2019.5540
Viewed PDF 21 3 -
Mother Behavior in Stunting Prevention Based on an Integrated Behavior Model that Adapts the Theory of Planned Behavior: Model DevelopmentAuthor: Ulva NovianaDOI: 10.21522/TIJPH.2013.13.01.Art039
Mother Behavior in Stunting Prevention Based on an Integrated Behavior Model that Adapts the Theory of Planned Behavior: Model Development
Abstract:
Stunting is a type of malnutrition condition that occurs due to insufficient nutrient intake in the past. It is considered a chronic nutritional issue that can lead to an increased risk of pain and death, sub-optimal brain and delayed motor development. This study aims to construct a model of maternal behaviour in the prevention of stunting in Bangkalan, Indonesia. The cross-sectional technique combined with analytical observational research methodology was used in this study. The moms who have children under five make up the research population. Techniques for sampling use multistage random sampling. A large sample of 280 mothers with children aged two to five. Instrument research using a questionnaire. Data analysis using SEM PLS 3. Research has found several things: A substantial correlation was seen between the mother's intentions and perceived control (p-value = 0.000), as well as between self-effectiveness and intention (p-value = 0.000) and intention and behaviour (p-value = 0.000). Your motivation to engage in stunting prevention will increase with higher goals, and the likelihood that you won't engage in stopping prevention activities will decrease with lower intentions. The approach of stopping prevention efforts through increased intention, perceived control, and efficaciousness of mothers about the importance of staking prevention in the first 1000 days of a child's life as a critical phase of the child's development, shows that intention is directly influenced by perceived control and self-efficaciousness and it directly affects stunting prevention behaviour.
Mother Behavior in Stunting Prevention Based on an Integrated Behavior Model that Adapts the Theory of Planned Behavior: Model Development
References:
[1]. Kemenkes, R. I., 2018. Buletin Stunting (Jakarta, Indonesia: Kementerian Kesehatan RI).
[2]. Yasin, Z., Nawawi, A., Sofiyana, A. A., Febriyanti, E., 2024. Handling nutrition in stunted children through education and family education in Madura, Indonesia. Health Dynamics, 1(1), 15–21. doi:10.33846/hd10104
[3]. Fitriani, Farisni, T. N., Syahputri, V. N., Lestary, L. A., 2020. Helmyati S. Implementing precede-proceed model toward the mothers’ perception on the importance of feeding of home-made complementary food to wasting and stunting toddlers. Current Research in Nutrition and Food Science, 8(2), 489–495. doi:10.12944/CRNFSJ.8.2.14
[4]. Dewey, K. G., Begum, K., 2011. Long-term consequences of stunting in early life. Maternal and Child Nutrition, 7(Suppl 3), 5–18. doi:10.1111/j.1740-8709.2011.00349.x
[5]. Walker, S. P., Chang, S. M., Powell, C. A., Simonoff, E., 2007. Grantham-McGregor SM. Early childhood stunting is associated with poor psychological functioning in late adolescence and effects are reduced by psychosocial stimulation. The Journal of Nutrition, 137(11), 2464–2469. doi:10.1093/jn/137.11.2464
[6]. Wardani, N. E. K., Harumi, A. M., Yuniarti, A. M., 2022. Culture of diet and utilization of health services on stunting cases in children aged 2-5 years in Bangkalan East Java. Proceedings of the 3rd International Scientific Meeting on Public Health and Sports, Malang, Indonesia, pp. 16-19.
[7]. Kementerian Kesehatan RI, 2021. Buku Saku Hasil Studi Status Gizi Indonesia (SSGI) Tingkat Nasional, Provinsi, Kabupaten/Kota Tahun 2021. (Jakarta, Indonesia: Kementerian Kesehatan RI).
[8]. Chaizuran, M., Muammar, M., 2022. Perception of pregnant women to the application of mee bu tradition as stunting prevention effort. Journal of Healtcare Technology and Medicine, 8(2), 1211-1218.
[9]. Asmin, E., Abdullah, M. R., 2021. ASI eksklusif dan imunisasi berhubungan dengan kejadian stunting pada anak usia 9-24 bulan di Puskesmas Rumah Tiga, Ambon. Poltekita : Jurnal Ilmu Kesehatan, 15, 196–201. doi:10.33860/jik.v15i2.487
[10]. Leroy, J. L., Frongillo, E. A., 2019. Perspective: What does stunting really mean? A critical review of the evidence. Advances in Nutrition, 10, 196–204. doi:10.1093/advances/nmy101
[11]. Illahi, R. K., Muniroh, L., 2018. Gambaran sosio budaya gizi etnik madura dan kejadian stunting balita usia 24–59 bulan di Bangkalan. Media Gizi Indonesia, 11, 135. doi:10.20473/mgi.v11i2.135-143
[12]. Noviana, U., Hasinuddin, M., Ekawati, H., Haris, M., 2023. Analisis Faktor Kemandirian Keluarga Dalam Pencegahan Stunting Pada 1000 Hari Pertama Kehidupan Anak Madura Berdasarkan Teori Transkultural Nursing. Nursing Update, 14(1), 134-141.
[13]. Bélanger, M., Dugas, C., Perron, J., St-Yves, A., 2023. Rancourt-Bouchard M, John Weisnagel S, et al. Intention to adopt a healthy diet among women with and without a history of gestational diabetes: Constructs and beliefs from the theory of planned behavior. Prev Med Rep, 35, 102328. doi:10.1016/j.pmedr.2023.102328
[14]. Ekawati, T., 2020, Kajian faktor-faktor yang mempengaruhi niat beli produk organik. Journal of Business and Information Systems, 2, 32–45. doi:10.36067/jbis.v2i1.35
[15]. Glanz, K., Barbara, K., Rimer, K., et al., 2008. Health Behavior and Health Education: Theory, Research, and Practice. (4th ed.). Jossey-Bass. Available at: https://books.google.co.id/books/about/Health_Behavior_and_Health_Education.html?hl=id&id=1xuGErZCfbsC&redir_esc=y (Accessed: 2 November 2024).
[16]. Maulida, H., Jatimi, A., Heru, M. J. A,, Munir, Z., Rahman, H. F., 2020. Depresi pada komunitas dalam menghadapi pandemi COVID-19: A systematic review. Jurnal Sains dan Kesehatan, 2, 122–128. Available: https://jsk.farmasi.unmul.ac.id/index.php/jsk/article/view/201/157
[17]. Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., et al., 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395, 507–513. doi:10.1016/S0140-6736(20)30211-7
[18]. Pertiwi, M. R., Lestari, P., Ulfiana, E., 2019. Relationship between parenting style and perceived information sources with stunting among children. International Journal of Nursing and Health Services, 2, 273. doi:10.35654/ijnhs.v2i4.150
[19]. Wilkerson, A. H., Sharma, M., Davis, R. E., Stephens, P. M., Kim, R. W., Bhati, D., et al., 2023. Predisposing, enabling and reinforcing factors associated with opioid addiction helping behaviour in tri-state Appalachian counties: Application of the PRECEDE-PROCEED model-cross-sectional analysis. BMJ Open, 13. doi:10.1136/bmjopen-2022-066147
[20]. Wardani, N. E. K., Harumi, A. M., Yuniarti, A. M., 2022. Culture of diet and utilization of health services on stunting cases in children aged 2-5 years in Bangkalan East Java. Proceedings of the 3rd International Scientific Meeting on Public Health and Sports, Malang, Indonesia, pp. 16-19.
[21]. Wilde, N., Hsu, A., 2019. The influence of general self-efficacy on the interpretation of vicarious experience information within online learning. International Journal of Educational Technology in Higher Education, 16. doi:10.1186/s41239-019-0158-x
[22]. Shufiana, A., Sulhaini, S., Saufi, A., 2021. The Influence of Attitude (ATTD), Subjective Norm (SN), Perceived Behavioral Control (PBC), And Self-Efficacy (SE) on Purchase Intentions (INT) And Behavior (BHV) Using E-Commerce. International Journal of Multicultural and Multireligious Understanding, 8, 123. doi:10.18415/ijmmu.v8i12.3187
[23]. Ong, A. K. S., Prasetyo, Y. T., Lagura, F. C., Ramos, R. N., Salazar, J. M. L., Sigua, K. M., et al., 2023. Determination of factors influencing young adults’ intention to have COVID-19 vaccine in the Philippines: An integration of Health Belief Model and the Theory of Planned Behavior. Public Health in Practice, 5, 100359. doi:10.1016/j.puhip.2023.100359
[24]. Kidwell, B., Jewell, R. D., 2010. The motivational impact of perceived control on behavioral intentions. Journal of Applied Social Psychology, 40(9), 2407–2433. doi: 10.1111/j.1559-1816.2010.00664.x
[25]. Yusrina, A., Rukmini, S., 2016. Faktor yang mempengaruhi niat ibu memberikan asi eksklusif di Kelurahan Magersari, Sidoarjo. Jurnal Promkes, 4(1), 11-21. doi: 10.20473/jpk.V4.I1.2016.11-21
[26]. Kronborg, H., Foverskov, E., Væth, M., Maimburg, R. D., 2018. The role of intention and self-efficacy on the association between breastfeeding of first and second child, a Danish cohort study. BMC Pregnancy Childbirth, 18, 454. doi:10.1186/s12884-018-2086-5
[27]. Matare, C. R., Mbuya, M. N. N., Pelto, G., Dickin, K. L., Stoltzfus, R. J., 2015. Assessing maternal capabilities in the SHINE Trial: Highlighting a hidden link in the causal pathway to child health. Clinical Infectious Diseases, 61, S745–S751. doi:10.1093/cid/civ851
[28]. Rahmania, N., Rizkillah, R., Musthofa, 2022. Self-efficacy, emotion regulation, and resilience of formal working mothers during the COVID-19 pandemic. Journal of Child, Family, and Consumer Studies, 1, 185–195. doi:10.29244/jcfcs.1.3.185-195
[29]. Najafi, S., Mohammadkhah, F., Harsin,i P. A., Sohrabpour, M., Jeihooni, A. K., 2023. Effect of educational intervention based on theory of planned behaviour on promoting preventive behaviours of oral cancer in rural women. BMC Womens Health, 23, 249. doi:10.1186/s12905-023-02411-2
[30]. Sobaih, A. E. E., Algezawy, M., Elshaer, I. A., 2023. Adopting an extended theory of planned behaviour to examine buying intention and behaviour of nutrition-labelled menu for healthy food choices in quick service restaurants: Does the culture of consumers really matter? Int J Environ Res Public Health, 20, 4498. doi:10.3390/ijerph20054498
[31]. Karuniawati, N., Masnilawati, A., Hardianti Saputri, L., 2020. Pengaruh niat ibu, kondisi masa nifas, kelancaran produksi asi terhadap keputusan untuk menyusui. Window of Midwifery Journal, 1–13. doi:10.33096/wom.vi.8
Viewed PDF 28 0 -
Atopic Allergy Type 1 and Association with Chlamydia Pneumonia in Allergic Patients in Mosul City/IraqAuthor: Nawras T. Al-HassanDOI: 10.21522/TIJPH.2013.13.01.Art040
Atopic Allergy Type 1 and Association with Chlamydia Pneumonia in Allergic Patients in Mosul City/Iraq
Abstract:
The present study aimed to investigate the role of age, gender, and family history in the incidence of atopic allergy and its relationship with Chlamydia pneumoniae infection by measuring immunoglobulin E (IgE) levels in humans. Blood samples were collected from 100 individuals (aged 6-60 years, both genders), with 50 patients diagnosed with atopic allergy and 50 healthy individuals considered as the control group. IgE levels were measured in all study participants across different ages and genders by Enzyme-linked Immunosorbent Assay (ELISA). Additionally, the diagnosis of Chlamydia pneumoniae infection was determined by ELISA via measuring IgM levels in all participants. The results were statistically analysed to compare allergic patients with the control group. The findings showed that IgE, in blood samples was notably greater in patients than in individuals without health issues The age range of 18 to 30 years exhibited a high level of IgE among people with allergies. Males have slightly higher IgE levels than females and this difference was noticeable when compared to the control group. Those with a family background of allergies displayed significantly elevated IgE levels suggesting a genetic inclination, towards higher levels of IgE 85 per cent of people, with allergies tested positive for IgM levels indicating Chlamydia pneumonia infection compared to 15 per cent in those, without the infection. The research findings indicated a link, between allergies and Chlamydia pneumonia infection. Mentioned that atopic allergies are influenced by age differences as well, as gender and family medical background.
Atopic Allergy Type 1 and Association with Chlamydia Pneumonia in Allergic Patients in Mosul City/Iraq
References:
[1]. May, C. D., 1985, The ancestry of allergy: being an account of the original experimental induction of hypersensitivity recognizing the contribution of Paul Portier. Journal of Allergy and Clinical Immunology, 75(4), 485-495, doi:10.1016/S0091-6749(85)80022-1.
[2]. Uter, W., Werfel, T., Lepoittevin, J. P., White, I. R., 2020, Contact allergy—emerging allergens and public health impact. International Journal of Environmental Research and Public Health, 17(7), 2-40, doi:10.3390/ijerph17072404.
[3]. Vitte, J., Vibhushan, S., Bratti, M., Montero-Hernandez, J. E., Blank, U., 2022, Allergy, anaphylaxis, and nonallergic hypersensitivity: IgE, mast cells, and beyond. Medical Principles and Practice, 31(6), 501-515, doi:10.1159/000527481.
[4]. Ogulur, I., Pat, Y., Ardicli, O., Barletta, E., Cevhertas, L., Fernandez‐Santamaria, R., Akdis, C. A., 2021, Advances and highlights in biomarkers of allergic diseases. Allergy, 76(12), 3659-3686, doi:10.1111/all.15089.
[5]. Johnson, M. J., Currow, D. C., Booth, S., 2014, Prevalence and assessment of breathlessness in the clinical setting. Expert review of respiratory medicine, 8(2), 151-161, doi:10.1586/17476348.2014.879530.
[6]. Ahmad, H. I., Jabbar, A., Mushtaq, N., Javed, Z., Hayyat, M. U., Bashir, J., Chen, J., 2022, Immune tolerance vs. immune resistance: the interaction between host and pathogens in infectious diseases. Frontiers in Veterinary Science, 9, 827407, doi:10.3389/fvets.2022.827407.
[7]. Pokludová, L., 2020, Prevention Is Better Than Cure. Antimicrobials in Livestock 1: Regulation, Science, Practice: A European Perspective, 125-165, doi:10.1007/978-3-030-46721-0_6.
[8]. Tenero, L., Vaia, R., Ferrante, G., Maule, M., Venditto, L., Piacentini, G., Caminati, M., 2023, Diagnosis and management of allergic rhinitis in asthmatic children. Journal of Asthma and Allergy, 45-57, doi:10.2147/JAA.S281439.
[9]. Krempski, J. W., Dant, C., Nadeau, K. C., 2020, The origins of allergy from a systems approach. Annals of Allergy, Asthma & Immunology, 125(5), 507-516, doi: 10.1016/j.anai.2020.07.013.
[10]. Ogulur, I., Pat, Y., Ardicli, O., Barletta, E., Cevhertas, L., Fernandez‐Santamaria, R., Akdis, C. A., 2021, Advances and highlights in biomarkers of allergic diseases. Allergy, 76(12), 3659-3686, doi:10.1111/all.15089.
[11]. Duțu, L. E., Popescu, M. L., Purdel, C. N., Ilie, E. I., Luță, E. A., Costea, L., Gîrd, C. E., 2022, Traditional medicinal plants—a possible source of antibacterial activity on respiratory diseases induced by chlamydia pneumoniae, haemophilus influenzae, klebsiella pneumoniae and moraxella catarrhalis. Diversity, 14(2), 1-34, doi:10.3390/d14020145.
[12]. Darville, T., 2025, Chlamydia infections. In Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant, 495-500, Elsevier, doi:10.1016/B978-0-323-79525-8.00029-9.
[13]. Zaręba-Marchewka, K., Szymańska-Czerwińska, M., Niemczuk, K., 2020, Chlamydiae–what’s new? Journal of Veterinary Research, 64(4), 461-467, doi:10.2478/jvetres-2020-0077.
[14]. Hahn, D. L., 2021, Chlamydia pneumoniae and chronic asthma: updated systematic review and meta-analysis of population attributable risk. PLoS One, 16(4), 1-21, doi: 10.1371/journal.pone.0250034.
[15]. Gusain, S., Bhattacharjee, S., Mishra, A., Nandy, A., Singh, A., 2024, Common Infectious Diseases and Clinical Microbiology of Adolescence. In Lifestyle Diseases in Adolescents: Diseases, Disorders, and Preventive Measures 146-178, Bentham Science Publishers, doi:10.2174/97898152744311240101.
[16]. Soiza, R. L., Scicluna, C., Bilal, S., 2023, Virus infections in older people. In Biochemistry and Cell Biology of Ageing: Part IV, Clinical Science, 149-183, Cham: Springer International Publishing, doi:10.1007/978-3-031-26576-1_8.
[17]. Huang, Y., Zheng, W., Gan, W., Zhang, T., 2023, Chlamydia psittaci pneumonia: a clinical analysis of 12 patients. Annals of Translational Medicine, 11(3), doi:10.21037/atm-22-6624.
[18]. Su, S., Su, X., Zhou, L., Lin, P., Chen, J., Chen, C., Li, Y., 2021, Severe Chlamydia psittaci pneumonia: clinical characteristics and risk factors. Annals of Palliative Medicine, 10(7), 1-10, doi:10.21037/apm-21-1502.
[19]. Guo, M. Y., Chen, H. K., Ying, H. Z., Qiu, F. S., Wu, J. Q., 2021, The role of respiratory flora in the pathogenesis of chronic respiratory diseases. BioMed Research International, 2021(1), 1-10, doi:10.1155/2021/6431862.
[20]. Andrup, L., Krogfelt, K. A., Stephansen, L., Hansen, K. S., Graversen, B. K., Wolkoff, P., Madsen, A. M., 2024, Reduction of acute respiratory infections in day-care by non-pharmaceutical interventions: a narrative review. Frontiers in Public Health, 12, 1-18, doi:10.3389/fpubh.2024.1332078.
[21]. Cheok, Y. Y., Lee, C. Y. Q., Cheong, H. C., Looi, C. Y., Wong, W. F., 2020, Chronic inflammatory diseases at secondary sites ensuing urogenital or pulmonary Chlamydia infections. Microorganisms, 8(1), 1-16, doi:10.3390/microorganisms8010127.
[22]. Horvat, J. C., Starkey, M. R., Kim, R. Y., Beagley, K. W., Preston, J. A., Gibson, P. G., Hansbro, P. M., 2010, Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease. The Journal of Immunology, 184(8), 4159-4169, doi:10.4049/jimmunol.0902287.
[23]. Leigh, L. Y., Vannelli, P., Crow, H. C., Desai, S., Lepore, M., Anolik, R., Glick, M., 2021, Diseases of the respiratory tract. Burket's Oral Medicine, 469-504, doi:10.1002/9781119597797.ch13.
[24]. Galvão, I., Kim, R. Y., Shen, S., Budden, K. F., Vieira, A. T., Hansbro, P. M., 2020, Emerging therapeutic targets and preclinical models for severe asthma. Expert Opinion on Therapeutic Targets, 24(9), 845-857, doi:10.1080/14728222.2020.1786535.
[25]. Zemskov, V. M., Zemskov, A. M., Neymann, V. V., Barsukov, A. A., Zemskova, V. A., Kozlova, M. N., Demidova, V. S., 2022, Diseases of the Immune System. Biology Bulletin Reviews, 12(4), 414-421, doi:10.1134/S2079086422040107.
[26]. Tramper‐Stranders, G., Ambrożej, D., Arcolaci, A., Atanaskovic‐Markovic, M., Boccabella, C., Bonini, M., 2021, Dangerous liaisons: Bacteria, antimicrobial therapies, and allergic diseases. Allergy, 76(11), 3276-3291, doi:10.1111/all.15046.
[27]. Tomás, A. L., Cardoso, F., de Sousa, B., Matos, O., 2020, Detection of anti-Pneumocystis jirovecii antibodies in human serum using a recombinant synthetic multi-epitope kexin-based antigen. European Journal of Clinical Microbiology & Infectious Diseases, 39(11), 2205-2209, doi:10.1007/s10096-020-03936-2.
[28]. Nierhaus, A., Berlot, G., Kindgen-Milles, D., Müller, E., Girardis, M., 2020, Best-practice IgM-and IgA-enriched immunoglobulin use in patients with sepsis. Annals of Intensive Care, 10, 1-19, doi:10.1186/s13613-020-00740-1.
[29]. Li, Y., Yang, H. S., Klasse, P. J., Zhao, Z., 2024, The significance of antigen-antibody-binding avidity in clinical diagnosis. Critical Reviews in Clinical Laboratory Sciences, 1-15, doi:10.1080/10408363.2024.2379286.
[30]. Bhatti, G. K., Khurana, A., Garabadu, D., Gupta, P., Jawalekar, S. S., Bhatti, J. S., Navik, U., 2021, Various Cellular and Molecular Axis Involved in the Pathogenesis of Asthma. Targeting Cellular Signalling Pathways in Lung Diseases, 53-95, doi:10.1007/978-981-33-6827-9_3.
[31]. Shamji, M. H., Valenta, R., Jardetzky, T., Verhasselt, V., Durham, S. R., Würtzen, P. A., van Neerven, R. J., 2021, The role of allergen‐specific IgE, IgG and IgA in allergic disease. Allergy, 76(12), 3627-3641, doi:10.1111/all.14908.
[32]. Yount, K. S., Darville, T., 2024, Immunity to Sexually Transmitted Bacterial Infections of the Female Genital Tract: Toward Effective Vaccines. Vaccines, 12(8), 1-26, doi:10.3390/vaccines12080863.
[33]. Dockterman, J., Coers, J., 2021, Immunopathogenesis of genital Chlamydia infection: insights from mouse models. Pathogens and Disease, 79(4), 1-14, doi:10.1093/femspd/ftab012.
[34]. Calmes, D., Huynen, P., Paulus, V., Henket, M., Guissard, F., Moermans, C., Schleich, F., 2021, Chronic infection with Chlamydia pneumoniae in asthma: a type-2 low infection related phenotype. Respiratory research, 22(1), 1-11, doi:10.1186/s12931-021-01635-w.
[35]. Flores-Torres, A. S., Samarasinghe, A. E., 2022, Impact of therapeutics on unified immunity during allergic asthma and respiratory infections. Frontiers in Allergy, 3(1), 1-4, doi:10.3389/falgy.2022.852067.
[36]. Galvão, I., Kim, R. Y., Shen, S., Budden, K. F., Vieira, A. T., Hansbro, P. M., 2020, Emerging therapeutic targets and preclinical models for severe asthma. Expert Opinion on Therapeutic Targets, 24(9), 845-857, doi:10.1080/14728222.2020.1786535.
[37]. Smith-Norowitz, T. A., Loeffler, J., Huang, Y., Klein, E., Norowitz, Y. M., Hammerschlag, M. R., Kohlhoff, S., 2020, Chlamydia pneumoniae immunoglobulin E antibody levels in patients with asthma compared with non-asthma. Heliyon, 6(2),1-4, doi: 10.1016/j.heliyon.2020.e03512.
[38]. Krempski, J. W., Dant, C., Nadeau, K. C., 2020, The origins of allergy from a systems approach. Annals of Allergy, Asthma & Immunology, 125(5), 507-516, doi:10.1016/j.anai.2020.07.013.
[39]. Sicherer, S. H., Abrams, E. M., Nowak-Wegrzyn, A., Hourihane, J. O. B., 2022, Managing food allergy when the patient is not highly allergic. The Journal of Allergy and Clinical Immunology: In Practice, 10(1), 46-55, doi:10.1016/j.jaip.2021.05.021.
[40]. Melén, E., Koppelman, G. H., Vicedo-Cabrera, A. M., Andersen, Z. J., Bunyavanich, S., 2022, Allergies to food and airborne allergens in children and adolescents: role of epigenetics in a changing environment. The Lancet Child and Adolescent Health, 6(11), 810-819, doi:10.1016/S2352-4642(22)00215-2.
[41]. El Ansari, Y. S., Kanagaratham, C., Oettgen, H. C., 2020, Focus: Allergic Diseases and Type II Immunity: Mast Cells as Regulators of Adaptive Immune Responses in Food Allergy. The Yale Journal of Biology and Medicine, 93(5), 711-718, https://pmc.ncbi.nlm.nih.gov/articles/PMC7757069/
[42]. Santano, R., Rubio, R., Grau-Pujol, B., Escola, V., Muchisse, O., Cuamba, I., Dobaño, C., 2021, Plasmodium falciparum and helminth coinfections increase IgE and parasite-specific IgG responses. Microbiology Spectrum, 9(3), 1-18, doi: 10.1128/Spectrum.01109-21.
[43]. Akdis, C. A., 2021, Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nature Reviews Immunology, 21(11), 739-751, doi:10.1038/s41577-021-00538-7.
[44]. Akpinar, M. B., 2023, A Hidden Organism, Chlamydia in the Age of Atherosclerosis. In Chlamydia-Secret Enemy from Past to Present. IntechOpen, 1(1), 1-15, doi:10.5772/intechopen.109745.
[45]. Shetty, S., Kouskouti, C., Schoen, U., Evangelatos, N., Vishwanath, S., Satyamoorthy, K., Brand, A., 2021, Diagnosis of Chlamydia trachomatis genital infections in the era of genomic medicine. Brazilian Journal of Microbiology, 52(3), 1327-1339, doi:10.1007/s42770-021-00533-z.
[46]. Daloglu, H., 2023, Chlamydia pneumoniae and Childhood Asthma. In Chlamydia-Secret Enemy from Past to Present. IntechOpen, 1(1):1-17, doi: 10.5772/intechopen.111711.
[47]. Alabsy, E. H., Alabdaly, Y. Z., 2022, Therapeutic effect of taurine on sodium fluoride toxicity in chicks. Iraqi Journal of Veterinary Sciences, 36(1), 223-238, doi:10.33899/ijvs.2021.129854.1692.
[48]. Webley, W. C., Hahn, D. L., 2017, Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides. Respiratory research, 18, 1-12, doi:10.1186/s12931-017-0584-z.
[49]. Hahn, D. L., 2021, Chlamydia pneumoniae and chronic asthma: updated systematic review and meta-analysis of population attributable risk. PLoS One, 16(4), 1-21, doi: 10.1371/journal.pone.0250034.
Viewed PDF 35 1 -
Married Men Perception and Forms of Domestic Violence Against Men in Ibadan, NigeriaAuthor: Adebukola ShogbamuDOI: 10.21522/TIJPH.2013.13.01.Art041
Married Men Perception and Forms of Domestic Violence Against Men in Ibadan, Nigeria
Abstract:
Addressing domestic abuse is crucial in combating domestic violence against males. This includes violence by family members or intimate partners, often in contexts like marriage or cohabitation. Feminist perspectives typically focus on violence against women, portraying men as offenders. However, men can also be victims. This paper examines perceptions and forms of domestic violence against men in Ibadan, Nigeria. A descriptive mixed-method study was conducted in five Local Government Areas (LGAs) in Ibadan, Nigeria. The study involved 600 married men aged 18 and above, selected through a 5-stage sampling technique. Additionally, 20 Focus Group Discussions (FGDs) with community gatekeepers (traditional and community leaders) were conducted. Qualitative analysis was performed using transcribed interviews and Nvivo 10 software, while quantitative data were analyzed using descriptive and inferential statistics. Results were presented in frequency tables, with some variables cross-tabulated. Respondents ranged from 23 to 64 years, with a mean age of 45.07 years. Most (78.2%) had only one marriage, 85% were the main income providers, and 47.7% had secondary education. The study revealed that 38.5% of respondents had a negative perception of domestic violence against men. Forms of domestic violence included denial of sex (80.2%), physical assaults (84.5%), excessive possessiveness and jealousy from wives (66.3%). Qualitative participants also mentioned physical assaults like hitting, thuggery, and hooliganism as forms of violence men face from their wives. The study suggests many men do not report domestic violence due to negative perceptions. Promoting awareness campaigns and educational programs is necessary to challenge stereotypes about masculinity and encourage open communication about experiences of violence.
Married Men Perception and Forms of Domestic Violence Against Men in Ibadan, Nigeria
References:
[1]. Chan, Ko Ling, 2011, "Gender Differences in Self-Reports of Intimate Partner Violence: A Review". Aggression and Violent Behavior (Elsevier) 16 (2): 167–175
[2]. UNICEF, 2000, Domestic violence against women and girls. Innocenti Digest, 6.
[3]. Sousa, A. D., 2022, Domestic violence against men: A lesser explored phenomenon. Ann Indian Psychiatry [serial online] 2022 [cited 2022 Jul 19];6:1-3. Available from: https://www.anip.co.in/text.asp?2022/6/1/1/344424
[4]. Deshpande, S., 2019, Sociocultural and legal aspects of violence against men. J Psychosexual Health
[5]. Josolyne, S., 2011, Men’s experiences of violence and abuse from a female intimate partner: Power, masculinity and institutional systems, [online]. Available at: http://www.mankind.org.uk/pdfs/Thesis%20Web%20Version%20060412.pdf [Accessed: 13th November 2014].
[6]. Thobejane, T. A., Mogorosi, D. L., and Luthada, N. V., 2018, Gender-based Violence against Men: A Muted Reality Southern African Journal for Folklore Studies. ISSN 1016-8427 http://doi.org/10.25159/1016-8427/4304
[7]. Oti, B., Paul, S., Duru, T., 2017, The emerging trend in culture of domestic violence in Nigeria: causes, theoretical assumptions and implications. Research Journal of Humanities, Legal Studies and International Development, 2(1): 53-63
[8]. Adebayo, A. A., 2014, Domestic violence against men: Balancing the gender issues in Nigeria. American Journal of Sociological Research, 4(1), 14-19.
[9]. Yusuf, O. B., Arulogun, O. S., Oladepo, O., and Olowokeere, F., 2011, Physical violence among intimate partners in Nigeria: A multi- level analysis. Journal of Public Health and Epidemiology, 3: 240-247.
[10]. Wright, C., 2016, The absent voice of male domestic abuse victims: the marginalisation of menin a system originally designed for women. Plymouth Law and Criminal Justice Review,1: 333-350.
[11]. Dienye, P. P., 2008, Domestic violence against men in primary healthcare in Nigeria. University of Port Harcourt
[12]. Namadi, M. M., 2017, Nature and prevalence of domestic violence against men in Dala local government area of Kano State, Nigeria. Journal of social and management sciences, 12(1), 10-20.
[13]. Malik, J. S., Nadda, A., A cross-sectional study of gender-based violence against men in the rural area of Haryana, India. Indian J Commu Med. 2019;44(1):35.
[14]. Ajala, A. O., 2017, Intimate Partner Violence Correlates and Coping Strategies: A Qualitative Inquiry Among Ijesa of South-West Nigeria. Advances in Social Sciences Research Journal, 4(23).
[15]. Gathogo, J., 2012, “Chasing a Leopard out of the Homestead: Mundurume’s Task in the Era of HIV and AIDS.’’ In Redemptive Masculinities: Men, HIV and Religion, edited by E. Chitando and S. Chirongoma, 447– 470. Geneva: WCC Publication.
[16]. Thobejane, T. D., 2012, “Patriarchal Practices in Everyday Life: Towards a Gendered Struggle against Domestic Violence.” Southern African Journal of Folklore studies 22(2): 34–43.
[17]. Esmail Hassan, E., Seedhom, A. E., & Mahfouz, E. M., 2016, Men’s Perception of Domestic Violence, Rural Minia, Egypt. Open Journal of Preventive Medicine, 06(02), 106–114. https://doi.org/10.4236/ojpm.2016.62009
[18]. Dienye, P. O., and Gbeneol, P. K., 2009, Domestic Violence Against Men in Primary Care in Nigeria. American Journal of Men’s Health, 3(4) 333–339.
[19]. Cleary, M. T., 2003, Domestic violence against men and children: family violence hurts everyone. Meath: Amen
[20]. Adeyeri, A., 2013, Nigeria: Domestic Violence – A Society Biased Against Males? Available at allafrica.com. Retrieved on 15th June 2018.
[21]. Gluck, S., 2021, December 17, Domestic Violence Against Men: Male Victims of Domestic Abuse, HealthyPlace. Retrieved on 2023, December 1 from https://www.healthyplace.com/abuse/domestic-violence/domestic-violence-against-men-males-victims-of-domestic-abuse
[22]. Enakele, A. S., 2019, Domestic violence against men: prevalence, implications, and consequences. SOCIALINIS DARBAS. PATIRTIS IR METODAI. 2019 24 (2) ISSN 2029-0470 (spausdintas) ISSN 2029-5820 (internetinis) https://doi.org/10.7220/2029-5820.24.2.2
[23]. Loue, S., 2001, Intimate partner violence: Societal, medical, legal and individual
[24]. Kubai, J., 2012, Causes and Consequences of Domestic Violence Against Men InMukurwe -Ini Constituency, Kenya. Unpublished MA Project. Institute of Anthropology, Gender and African Studies, University of Nairobi.
[25]. Rennison, C., 2003, Intimate partner violence, 1993-2001. (Publication No. NCJ197838). Washington, DC: Bureau of Justice Statistics, Department of Justice Responses. Springer Science & Business Media
[26]. Karimi, E., 2018, Characterising domestic violence against men: Insight from Karinyaga central ward. A research paper submitted to the institute of anthropology, gender and African studies in partial fulfilment of the requirements for the Degree of Master of Arts in gender and development of University of Nairobi.
[27]. King'ori, M. E., and Bitrus-Ojiambo, U. A., 2016, Newspaper framing of gender-based (domestic) violence of women–on-men from Nyeri County, Kenya. African Multidisciplinary Journal of Research, 1 (1):4-25.
[28]. De Sousa, Avinash. Domestic Violence Against Men: A Lesser Explored Phenomenon. Annals of Indian Psychiatry 6(1): p 1-3, Jan–Mar 2022. | DOI: 10.4103/aip.aip_48_22
[29]. Sarkar, S., Dsouza, R., Dasgupta, A., Domestic Violence against Men: A Study Report by Save Family Foundation. New Delhi, India: Save Family Foundation; 2007.
[30]. Dauda, B., & Ajao, I., 2017, Sex as a Weapon of Violence: An Examination of the Phenomenon of Domestic Violence against Men in Ibadan, Nigeria. Ibadan Journal of Sociology, 6(2), 5-26.
[31]. Mihalic, S. W., & Elliott, D., 1997, A social learning theory model of marital violence. Journal of family violence, 12(1), 21-47.
Viewed PDF 18 0 -
The Role of SGLT2 Inhibitors in Cardiovascular Outcomes for Heart Failure Patients with Reduced Ejection FractionAuthor: Faraaz ZaveriDOI: 10.21522/TIJPH.2013.13.01.Art042
The Role of SGLT2 Inhibitors in Cardiovascular Outcomes for Heart Failure Patients with Reduced Ejection Fraction
Abstract:
This review article examines the effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors on cardiovascular (CV) outcomes in patients with heart failure with reduced ejection fraction (HFrEF). The SGLT2 inhibitors, while being developed for type 2 diabetes management, are showing great promise in reducing hospitalization for heart failure and major adverse cardiovascular events: benefits shown in major trials like Dapagliflozin in patients with Heart failure and reduced Ejection fraction (DAPA-HF) and Empagliflozin outcome trial in patients with chronic Heart Failure and a Reduced Ejection fraction (EMPEROR-Reduced). The review underlines the therapeutic implications of SGLT2 inhibitors in both diabetic and nondiabetic patients with HFrEF for improving survival rates, the risk of hospitalization, and renal function preservation. These trials had an in-depth methodology and results review, after which a discussion on the clinical implications took place to decide on the wide application of SGLT2 inhibitors in managing HFrEF independent of their diabetes status.
The Role of SGLT2 Inhibitors in Cardiovascular Outcomes for Heart Failure Patients with Reduced Ejection Fraction
References:
[1]. Starr, J. A., Pinner, N. A., Lisenby, K. M., Osmonson, A., 2021, Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction. Pharmacotherapy, 41(6), 526-536. doi:10.1002/phar.2527.
[2]. Virani, S. S., Alonso, A., Aparicio, H. J., et al., 2021, Heart disease and stroke statistics—2021 update: a report from the American Heart Association. Circulation, 143, e254-e743.
[3]. American Diabetes Association, 2021, Cardiovascular disease and risk management. Diabetes Care, 44(Suppl 1), S125-S150.
[4]. Petrie, M. C., Verma, S., Docherty, K. F., et al., 2020, Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes. JAMA, 323, 1353-1368.
[5]. Zannad, F., Ferreira, J. P., Pocock, S. J., et al., 2020, SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet, 396, 819-829.
[6]. Packer, M., Anker, S. D., Butler, J., et al., 2020, Cardiac and renal outcomes with empagliflozin in heart failure with a reduced ejection fraction. New England Journal of Medicine, 383, 1413-1424.
Viewed PDF 26 0 -
Effectiveness of Nurse-led Educational Intervention in Preparing Youth Corps Members as Change Agents for Skin Cancer Prevention in People with AlbinismAuthor: Joel Ojo ALUKODOI: 10.21522/TIJPH.2013.13.01.Art043
Effectiveness of Nurse-led Educational Intervention in Preparing Youth Corps Members as Change Agents for Skin Cancer Prevention in People with Albinism
Abstract:
People with albinism face a significantly higher risk of developing skin cancer due to their genetic condition. This study evaluated the effectiveness of a nurse-led educational intervention in improving skin cancer prevention knowledge among youth corps members in Ogbomoso, Nigeria. A quantitative, one-group pre-post-test design was employed. The study included 111 youth corps members selected through purposive sampling. Data was collected using a structured questionnaire before and after a nurse-led educational intervention. The intervention consisted of comprehensive modules covering skin cancer prevention, photo-aging signs, and sociocultural aspects of albinism. Data analysis utilized descriptive and inferential statistics. Pre-intervention results showed that 83.8% of participants had poor knowledge of skin cancer prevention, while 16.2% demonstrated good knowledge. Post-intervention, those with poor knowledge decreased to 68.5%, while good knowledge increased to 31.5%. Recognition of regular healthcare visits as a preventive measure improved from 16.2% to 20.7%. Understanding of the ABCDE mnemonic for melanoma diagnosis increased from 11.7% to 21.6%. Significant differences were found between pre and post-intervention knowledge (p=0.0001) and understanding of albinism-related social challenges (p=0.004). The nurse-led intervention effectively improved youth corps members' knowledge of skin cancer prevention in albinism, though knowledge gaps persist. Continuous, comprehensive educational initiatives are recommended to enhance understanding and support for people with albinism.
Effectiveness of Nurse-led Educational Intervention in Preparing Youth Corps Members as Change Agents for Skin Cancer Prevention in People with Albinism
References:
[1]. Abdulrahman, H., 2023, Disability and inclusion in the Media Fellowship. Africa Foundation for Young Media Professionals. Available from: https://radionigeria.gov.ng/2023/09/18/inclusive-education-for-children-with-albinism/
[2]. Aborisade, R. A., 2021, “Why always me?”: Childhood experiences of family violence and prejudicial treatment against people living with albinism in Nigeria. Journal of family violence, 36(8), 1081-1094.
[3]. Brilliant, M. H., 2015, Albinism in Africa: a medical and social emergency. International health, 7(4), 223-225.
[4]. Kiprono, S. K., Chaula, B. M., & Beltraminelli, H., 2014, Histological review of skin cancers in African Albinos: a 10-year retrospective review. BMC Cancer, 14, 1-4.
[5]. Imarah, J., 2017, Overcoming the stigma of albinism. Lancet Glob Health.;5(8):e779.
[6]. Bello, S., Ajayi, D. T., Adeoti M. L., 2019, Knowledge, attitude and practice of youth corps members toward cancer prevention in Ibadan, Nigeria. J Family Med Prim Care.;8(2):629-634.
[7]. Kara, T. K., Anjali, V. N., Sriram, N., 2021, Role of nurses in community health education. Journal of Comprehensive Health., 9(2):95-102.
[8]. Alavi, N. M., Ghofranipour, F., Ahmadi, F., et al. 2016, Developing a culturally appropriate model for promoting self-efficacy in adolescents. Psychol Health.;31(2):190-208.
[9]. Nahar, V. K., Allison Ford, M., Brodell, R. T., Boyas, J. F., Jacks, S. K., Biviji-Sharma, R., & Bass, M. A., 2016, Skin cancer prevention practices among malignant melanoma survivors: a systematic review. Journal of Cancer Research and Clinical Oncology, 142, 1273-1283.
[10]. Kromberg, J., & Manga, P. (Eds.)., 2018, Albinism in Africa: Historical, geographic, medical, genetic, and psychosocial aspects. Academic Press.
Viewed PDF 26 1 -
Association of COVID-19, Diabetes in Mucormycosis Patient- A Hospital-Based StudyAuthor: Sreedevi DharmanDOI: 10.21522/TIJPH.2013.13.01.Art044
Association of COVID-19, Diabetes in Mucormycosis Patient- A Hospital-Based Study
Abstract:
Mucormycosis (previously called zygomycosis) is a serious but rare fungal infection caused by a group of moulds called mucormycetes. These moulds live throughout the environment. Mucormycosis mainly affects people who have health problems or take medicines that lower the body's ability to fight germs and sickness. This research aimed to study the association of COVID, diabetes and mucormycosis in a population reporting to Saveetha Dental College and Hospitals, Chennai in a period from June 2019 to June 2023. The data of patients reporting to Saveetha Dental College and Hospitals was reviewed and patients with mucormycosis were selected for the study. It included parameters like age, gender, Coronavirus Disease-19(COVID-19) history and systemic disease. Frequency test was used to detect the significance between age, gender, COVID-19 history and systemic condition. Chi-square tests were carried out using age, and gender as independent variables and COVID-19 history, and systemic condition as dependent variables. Statistical analysis was done by Pearson's chi-square test. P value < 0.05 was considered statistically significant. In this study, we observed that the most common age group diagnosed with mucormycosis was found to be 41-60 years of age (56%) and males were more commonly affected (88%). More than 50% of patients gave a history of COVID-19 and 50% were diabetic. The most common intraoral presentation was found to be palatal swelling (19%), and most of the patients had unilateral swelling. When associating swelling with different age groups, unilateral swelling was found to be more in young adults (56%) while bilateral swelling was profound in older people. The chi-square value was found to be significant (0.035). In this study, we observed that the most common age group diagnosed with mucormycosis was found to be 41-60 years of age and males were more commonly affected. The majority of them had a history of COVID-19 and were diabetic. The most common intraoral presentation was found to be palatal swelling, and most of the patients had unilateral swelling. Collectively, these findings suggest a familiar connection between mucormycosis, COVID-19 and diabetes.
Association of COVID-19, Diabetes in Mucormycosis Patient- A Hospital-Based Study
References:
[1]. Semwal, N., Rautela, A., Joshi, D., and Singh, B., 2021, Black Fungus (Mucormycosis) A Rare Fungal Infection caused by COVID-19. Int. J. Pharm. Bio Med. Sci, 1(4):31-37.
[2]. Thornton, C. R., 2020, Detection of the ‘big five’mold killers of humans: Aspergillus, Fusarium, Lomentospora, Scedosporium and Mucormycetes. Advances in applied microbiology, 110:1-61. https://doi.org/10.1016/bs.aambs.2019.10.003
[3]. Chander, J., 2017, Textbook of medical mycology. JP Medical Ltd.
[4]. Wani, A. A., 2021, Mucormycosis (black fungus) an emerging threat during 2nd wave of COVID-19 pandemic in India: a review. Haya Saudi J Life Sci, 6(7):143-146. DOI: 10.36348/sjls.2021.v06i07.003
[5]. Cornely, O. A., Alastruey-Izquierdo, A., Arenz, D., Chen, S. C., Dannaoui, E., Hochhegger, B., Hoenigl, M., Jensen, H. E., Lagrou, K., Lewis, R. E. and Mellinghoff, S. C., 2019, Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. The Lancet infectious diseases, 19(12): e405-e421.
[6]. Prakash, H. and Chakrabarti, A., 2019, Global epidemiology of mucormycosis. Journal of Fungi, 5(1):26. http://dx.doi.org/10.3390/jof5010026
[7]. Martínez-Herrera, E., Frías-De-León, M. G., Julián-Castrejón, A., Cruz-Benítez, L., Xicohtencatl-Cortes, J., and Hernández-Castro, R., 2020, Rhino-orbital mucormycosis due to Apophysomyces ossiformis in a patient with diabetes mellitus: a case report. BMC infectious diseases, 20(1): 1-4. https://doi.org/10.1186/s12879-020-05337-4
[8]. Walsh, T. J., Gamaletsou, M. N., McGinnis, M. R., Hayden, R. T., and Kontoyiannis, D. P., 2012, Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clinical Infectious Diseases, 54(suppl_1): S55-S60. https://doi.org/10.1093/cid/cir868
[9]. Garg, D., Muthu, V., Sehgal, I. S., Ramachandran, R., Kaur, H., Bhalla, A., Puri, G. D., Chakrabarti, A., and Agarwal, R., 2021, Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia, 18(2)6:289-298. https://doi.org/10.1007/s11046-021-00528-2
[10]. Ramani, P., Krishnan, R. P., Pandiar, D., Benitha, J. G., Ramalingam, K., and Gheena, S., 2022, Chronic invasive aspergillosis with fulminant mucormycosis sparing palate in a post-COVID-19 patient-a case report. Annals of Maxillofacial Surgery, 12(1): 102-105. 10.4103/ams.ams_296_21
[11]. Bala, K., Chander, J., Handa, U., Punia, R. S. and Attri, A. K., 2015, A prospective study of mucormycosis in north India: experience from a tertiary care hospital. Medical mycology, 53(3):248-257. https://doi.org/10.1093/mmy/myu086
[12]. Madhavan, Y., Sai, K. V., Shanmugam, D. K., Manimaran, A., Guruviah, K., Mohanta, Y. K., Venugopal, D. C., Mohanta, T. K., Sharma, N., and Muthupandian, S., 2022, Current treatment options for COVID-19 associated mucormycosis: present status and future perspectives. Journal of Clinical Medicine, 11(13):3620. https://doi.org/10.3390/jcm11133620
[13]. Madhumitha, M. and Pillai, D. S., 2023, Correlation of Diabetic Status and Coronavirus Disease 2019 (COVID-19) in Patients with Mucormycosis: A Retrospective Clinical Study. Cureus, 15(11): e48936. 10.7759/cureus.48936
[14]. Rajashri, R., Muthusekhar, M. R. and Kumar, S. P., 2020, Mucormycosis following tooth extraction in a diabetic patient: a case report. Cureus, 12(8): e9757. 10.7759/cureus.9757
[15]. Prakash, H., Ghosh, A. K., Rudramurthy, S. M., Singh, P., Xess, I., Savio, J., Pamidimukkala, U., Jillwin, J., Varma, S., Das, A. and Panda, N. K., 2019, A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment. Medical mycology, 57(4):395-402. https://doi.org/10.1093/mmy/myy060
[16]. John, T. M., Jacob, C. N. and Kontoyiannis, D. P., 2021, When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. Journal of fungi, 7(4):298. https://doi.org/10.3390/jof7040298
[17]. Singh, A. K., Singh, R., Joshi, S. R., and Misra, A., 2021, Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15(4):102146. https://doi.org/10.1016/j.dsx.2021.05.019
[18]. Roden, M. M., Zaoutis, T. E., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., Schaufele, R. L., Sein, M., Sein, T., Chiou, C. C., Chu, J. H., and Kontoyiannis, D. P., 2005, Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clinical infectious diseases, 41(5):634-653. https://doi.org/10.1086/432579
[19]. Priya, P., Ganesan, V., Rajendran, T., and Geni, V. G., 2020, Mucormycosis in a tertiary care center in South India: a 4-year experience. Indian Journal of Critical Care Medicine: Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine, 24(3):168. 10.5005/jp-journals-10071-23387
[20]. Baldin, C., and Ibrahim, A. S., 2017, Molecular mechanisms of mucormycosis—The bitter and the sweet. PLoS pathogens, 13(8):e1006408. https://doi.org/10.1371/journal.ppat.1006408
[21]. Gupta, G., Singh, Y., Thangavelu, L., Singh, S. K., Dureja, H., Chellappan, D. K., and Dua, K., 2021, Emerging cases of mucormycosis under COVID‐19 pandemic in India: Misuse of antibiotics. Drug Development Research, 82(7):880-882. https://doi.org/10.1002/ddr.21862
[22]. Doni, B. R., Peerapur, B. V., Thotappa, L. H., and Hippargi, S. B., 2011, Sequence of oral manifestations in rhino-maxillary mucormycosis. Indian Journal of Dental Research, 22(2):331-335. 10.4103/0970-9290.84313
[23]. Nicolatou‐Galitis, O., Sachanas, S., Drogari‐Apiranthitou, M., Moschogiannis, M., Galiti, D., Yiakoumis, X., Rontogianni, D., Yiotakis, I., Petrikkos, G., and Pangalis, G., 2015, Mucormycosis presenting with dental pain and palatal ulcer in a patient with chronic myelomonocytic leukaemia: case report and literature review. JMM Case Reports, 2(1), p.e000014. https://doi.org/10.1099/jmmcr.0.000014
Viewed PDF 23 2 -
The Impact of Dietary Cholesterol on LDL Cholesterol Levels in Adults: A Short-Term Observational StudyAuthor: Thangaswamy SelvankumarDOI: 10.21522/TIJPH.2013.13.01.Art045
The Impact of Dietary Cholesterol on LDL Cholesterol Levels in Adults: A Short-Term Observational Study
Abstract:
Dietary cholesterol has long been implicated in regulating blood cholesterol levels, particularly low-density lipoprotein (LDL) cholesterol, a key marker of cardiovascular health. Understanding the role of dietary cholesterol is critical, given its potential influence on the development of cardiovascular diseases (CVD). This short-term observational study evaluated the effects of high-cholesterol and low-cholesterol diets on LDL cholesterol levels in healthy adults aged 25-50 years. A total of 160 participants were randomly assigned to either a high-cholesterol or low-cholesterol diet for six months. Dietary intake was monitored using food frequency questionnaires (FFQs) and self-reported food diaries while fasting blood samples were collected at baseline, three months, and six months to measure LDL cholesterol, total cholesterol, HDL cholesterol, and triglycerides. Results revealed a modest 8.3% increase in LDL cholesterol in the high-cholesterol group (p < 0.05), while the low-cholesterol group exhibited a slight but statistically insignificant decrease of 3.4% (p > 0.05). Other lipid parameters, such as HDL cholesterol and triglycerides, remained stable in both groups. The findings suggest that dietary cholesterol may have a limited but measurable impact on LDL cholesterol levels, without significantly influencing overall cardiovascular risk in the short term. These results challenge traditional views on dietary cholesterol and emphasize the importance of individualized dietary recommendations. This study contributes valuable insights to the ongoing discussion surrounding cholesterol management and dietary guidelines.
The Impact of Dietary Cholesterol on LDL Cholesterol Levels in Adults: A Short-Term Observational Study
References:
[1]. Sharma, B., Agnihotri, N., 2019. Role of cholesterol homeostasis and its efflux pathways in cancer progression. J Steroid Biochem Mol Biol. 191: 105377. doi:10.1016/j.jsbmb.2019.105377
[2]. Carson, J. A. S., Lichtenstein, A. H., Anderson, C. A. M., Appel, L. J., Kris-Etherton, P. M., Meyer, K. A., et al., 2020., Dietary cholesterol and cardiovascular risk: A science advisory from the American heart association. Circulation. 141: e39–e53. doi:10.1161/CIR.0000000000000743
[3]. Schwab, U., Reynolds, A. N., Sallinen, T., Rivellese, A. A., Risérus, U., 2021., Dietary fat intakes and cardiovascular disease risk in adults with type 2 diabetes: a systematic review and meta-analysis. Eur J Nutr. 60: 3355–3363. doi:10.1007/s00394-021-02507-1
[4]. Stellaard, F., 2022., From dietary cholesterol to blood cholesterol, physiological lipid fluxes, and cholesterol homeostasis. Nutrients. 14: 1643. doi:10.3390/nu14081643
[5]. Shahoei, S. H., Nelson, E. R., 2019., Nuclear receptors, cholesterol homeostasis and the immune system. J Steroid Biochem Mol Biol. 191: 105364. doi:10.1016/j.jsbmb.2019.04.013
[6]. Szczepańska, E., Białek-Dratwa, A., Janota, B., Kowalski, O., 2022., Dietary therapy in prevention of cardiovascular disease (CVD)—tradition or modernity? A review of the latest approaches to nutrition in CVD. Nutrients. 14. doi:10.3390/nu14132649
[7]. Willett, W., 2017., Eat, drink, and be healthy: The Harvard medical school guide to healthy eating. Free Press; Available: https://books.google.com/books?hl=en&lr=&id=ukk1DwAAQBAJ&oi=fnd&pg=PP7&dq=Eat,+Drink,+and+Be+Healthy:+The+Harvard+Medical+School+Guide+to+Healthy+Eating.+Free+Press&ots=6IPwSAlqF3&sig=w37mVc9gKLD8trkI41YzpoLZtWs
[8]. Soliman, G. A., 2018., Dietary cholesterol and the lack of evidence in cardiovascular disease. Nutrients. 10: 780. doi:10.3390/nu10060780
[9]. Schade, D. S., Shey, L., Eaton, R. P., 2020., Cholesterol review: a metabolically important molecule. Endocr Pract. Available: https://www.sciencedirect.com/science/article/pii/S1530891X20484472
[10]. Sacks, F. M., Lichtenstein, A. Ho., Wu, J. H. .Y., Appel, L. J., Creager, M. A., Kris-Etherton, P. M., et al., 2017., Dietary fats and cardiovascular disease: A presidential advisory from the American Heart Association. Circulation. 136: e1–e23. doi:10.1161/CIR.0000000000000510
[11]. Zhu, Y., Bo, Y., Liu, Y., 2019., Dietary total fat, fatty acids intake, and risk of cardiovascular disease: a dose-response meta-analysis of cohort studies. Lipids Health Dis. 18: 91. doi:10.1186/s12944-019-1035-2
[12]. Minervini, G., Franco, R., Marrapodi, M.M., Di Blasio. M., Ronsivalle, V., Cicciù, M., 2023., Children oral health and parents education status: a cross-sectional study. BMC Oral Health. 24; 23(1):787. doi: 10.1186/s12903-023-03424-x.
[13]. Yanai, H., Tada, N., 2018., Effects of consumption of various fatty acids on serum HDL-cholesterol levels. Journal of Endocrinology and Metabolism. 8: 94–99. doi:10.14740/JEM.V8I5.534
[14]. Jenkins, W., Jenkins, A., Jenkins, A., Brydson, C., 2019., The portfolio diet for cardiovascular disease risk reduction: an evidence based approach to lower cholesterol through plant food consumption. Available: https://books.google.com/books?hl=en&lr=&id=S_tUDwAAQBAJ&oi=fnd&pg=PP1&dq=The+portfolio+diet+for+cardiovascular+risk+reduction:+An+evidence-based+approach+to+lower+cholesterol+levels&ots=pZDea6M_Dk&sig=1HdK9OsiUSrEhoddkOROgXBdFuc
[15]. Doma, K. M., Dolinar, K. F., Dan Ramdath, D., Wolever, T. M. S., Duncan, A. M., 2021., Canned beans decrease serum total and LDL cholesterol in adults with elevated LDL cholesterol in a 4-wk multicenter, randomized, crossover study. J Nutr. 151: 3701–3709. doi:10.1093/jn/nxab323
[16]. Lordan, R., Tsoupras, A., Mitra, B., Zabetakis, I., 2018., Dairy fats and cardiovascular disease: Do we really need to be concerned? Foods. 7: 29. doi:10.3390/foods7030029
[17]. Yu, E., Malik, V. S., Hu, F. B., 2018., Cardiovascular disease prevention by diet modification: JACC health promotion series. J Am Coll Cardiol. 72: 914–926. doi:10.1016/j.jacc.2018.02.085
[18]. Lawrence, G. D., 2021., Perspective: The saturated fat-unsaturated oil dilemma: Relations of dietary fatty acids and serum cholesterol, atherosclerosis, inflammation, cancer, and all-cause mortality. Adv Nutr. ;12: 647–656. doi:10.1093/advances/nmab013
[19]. Drouin-Chartier, J-P., Chen, S., Li, Y., Schwab, A. L., Stampfer, M. J., Sacks, F. M., et al., 2020., Egg consumption and risk of cardiovascular disease: three large prospective US cohort studies, systematic review, and updated meta-analysis. BMJ. 368: m513. doi:10.1136/bmj.m513
[20]. Trautwein, E. A., McKay, S., 2020., The role of specific components of a plant-based diet in management of dyslipidemia and the impact on cardiovascular risk. Nutrients. 12: 2671. doi:10.3390/nu12092671
[21]. Ramadoss, R., Padmanaban, R., Subramanian, B., 2021., Role of bioglass in enamel remineralization: Existing strategies and future prospects—A narrative review. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 110(1), 45-66. https://doi.org/10.1002/jbm.b.34904
[22]. Gjuladin-Hellon, T., Davies, I. G., Penson, P., Amiri Baghbadorani, R., 2019., Effects of carbohydrate-restricted diets on low-density lipoprotein cholesterol levels in overweight and obese adults: a systematic review and meta-analysis. Nutr Rev. 77: 161–180. doi:10.1093/nutrit/nuy049
[23]. Lloyd-Jones, D. M., Allen, N. B., Anderson, C. A. M., Black, T., Brewer, L. C., Foraker, R. E., et al., 2022., Life’s Essential 8: Updating and enhancing the American heart association’s construct of cardiovascular health: A presidential advisory from the American Heart Association. Circulation. 146: e18–e43. doi:10.1161/CIR.0000000000001078
[24]. Dibaba, D. T., 2019., Effect of vitamin D supplementation on serum lipid profiles: a systematic review and meta-analysis. Nutr Rev. doi:10.1093/nutrit/nuz037
[25]. Hooper, L., Martin, N., Jimoh, OF., Kirk, C., Foster, E., Abdelhamid, A. S., 2020., Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 8: CD011737. doi:10.1002/14651858.CD011737.pub3
[26]. Aguilar-Ballester, M., Herrero-Cervera, A., Vinué, Á., Martínez-Hervás, S., González-Navarro, H., 2020., Impact of cholesterol metabolism in immune cell function and atherosclerosis. Nutrients. 12. doi:10.3390/nu12072021
[27]. Maki, K. C., Dicklin, M. R., Kirkpatrick, C. F., 2021., Saturated fats and cardiovascular health: Current evidence and controversies. J Clin Lipidol. 15: 765–772. doi:10.1016/j.jacl.2021.09.049
[28]. Rashid, MF., Karobari MI, Halim, M.S., Noorani, T.Y., 2022., Effectiveness of Visual-Tactile Examination and DIAGNOdent Pen in Detecting Early Enamel Caries and Its Remineralisation: An In Vitro Study. Biomed Res Int. 11:1263750. doi: 10.1155/2022/1263750.
[29]. Bouchard, J., Valookaran, A. F., Aloud, B. M., Raj, P., Malunga, L. N., Thandapilly, S. J., et al., 2022., Impact of oats in the prevention/management of hypertension. Food Chem. 381: 132198. doi:10.1016/j.foodchem.2022.132198
[30]. Sellem, L., Flourakis, M., Jackson, K. G., Joris, P. J., Lumley, J., Lohner, S., et al., 2022., Impact of replacement of individual dietary SFAs on circulating lipids and other biomarkers of cardiometabolic health: A systematic review and meta-analysis of randomized controlled trials in humans. Adv Nutr. 13: 1200–1225. doi:10.1093/advances/nmab143
[31]. DiNicolantonio, J. J., O’Keefe, J. H., 2018., Effects of dietary fats on blood lipids: a review of direct comparison trials. Open Heart. 5: e000871. doi:10.1136/openhrt-2018-000871
[32]. Correction to: Dietary fats and cardiovascular disease: A presidential advisory from the American Heart Association. Circulation. 2017;136: e195. doi:10.1161/CIR.0000000000000529
[33]. Pérez‐Ramírez, I. F., Becerril‐Ocampo, L. J., Reynoso‐Camacho, R., Herrera, M. D., Guzmán‐Maldonado, S. H., Cruz‐Bravo, R. K., 2018., Cookies elaborated with oat and common bean flours improved serum markers in diabetic rats. Journal of the Science of Food and Agriculture. 98: 998–1007. Available: http://zacatecas.inifap.gob.mx/publicaciones/perez-ramirez%20et%20al.%202018.pdf
[34]. Blesso, C., Fernández, M., 2018., Dietary cholesterol, serum lipids, and heart disease: Are eggs working for or against you? Nutrients. 10. doi:10.3390/nu10040426
Viewed PDF 27 2 -
Ecofriendly Synthesis of Cobalt Nanoparticles Using Millettia pinnata and Evaluation of Embryonic Toxicology and Anticancer ActivityAuthor: Mukesh Kumar Dharmalingam JothinathanDOI: 10.21522/TIJPH.2013.13.01.Art046
Ecofriendly Synthesis of Cobalt Nanoparticles Using Millettia pinnata and Evaluation of Embryonic Toxicology and Anticancer Activity
Abstract:
Nanotechnology driven approaches have gained significant attention especially in biomedical research particularly in the green synthesis of metal nanoparticles offering ecofriendly and sustainable alternatives for therapeutic applications. This study explored the green synthesis of cobalt nanoparticles (CoNPs) from Millettia pinnata and evaluated their embryonic toxicology and anticancer activity against osteosarcoma cells. CoNPs were synthesized and characterized using UV-Vis spectrophotometry, FTIR spectroscopy and SEM-EDAX analysis. UV-Vis analysis confirmed CoNPs formation at 320 nm, while FTIR identified O-H, C=C and metal ligand vibrations. SEM showed nanoparticle agglomeration with an average size of 100 nm and EDAX confirmed cobalt and chlorine presence. The antimicrobial activity of CoNPs was assessed through time kill curve analysis against Candida albicans, Klebsiella sp, Enterococcus faecalis and Streptococcus mutans. The results demonstrated strong efficacy against S. mutans, moderate activity against Klebsiella sp. and E. faecalis and low anticandidal activity against C. albicans. Cytotoxicity studies using MTT assays showed a dose dependent reduction in osteosarcoma cell viability, further confirmed by apoptosis detection through AO/EtBr staining. Toxicity assessments including brine shrimp lethality assays (BSLA) and zebrafish embryo tests revealed dose and time dependent effects. These findings suggest that M. pinnata derived CoNPs exhibit strong antimicrobial and cytotoxic properties, especially against S. mutans and osteosarcoma cells, warranting further research into their therapeutic potential and environmental impact.
Ecofriendly Synthesis of Cobalt Nanoparticles Using Millettia pinnata and Evaluation of Embryonic Toxicology and Anticancer Activity
References:
[1]. Salem, S. S., Badawy, M. S. E., Al-Askar, A. A., Arishi, A. A., Elkady, F. M., & Hashem, A. H. 2022, Green biosynthesis of selenium nanoparticles using orange peel waste: Characterization, antibacterial and antibiofilm activities against multidrug-resistant bacteria. Life, 12(6), 893, https://doi.org/10.3390/life12060893
[2]. Rafique, M., Sadaf, I., Rafique, M. S., & Tahir, M. B. 2017, A review on green synthesis of silver nanoparticles and their applications. Artificial cells, nanomedicine, and biotechnology, 45(7), 1272-1291, https://doi.org/10.1080/21691401.2016.1241792
[3]. Keshari, A. K., Srivastava, R., Singh, P., Yadav, V. B., & Nath, G. 2020, Antioxidant and antibacterial activity of silver nanoparticles synthesized by Cestrum nocturnum. Journal of Ayurveda and Integrative Medicine, 11(1), 37-44, https://doi.org/10.1016/j.jaim.2017.11.003
[4]. Varma, R. S., 2012, Greener approach to nanomaterials and their sustainable applications. Current Opinion in Chemical Engineering, 1(2), 123-128, https://doi.org/10.1016/j.coche.2011.12.002
[5]. Osorio-Cantillo, C., Santiago-Miranda, A. N., Perales-Perez, O., & Xin, Y. 2012, Size-and phase-controlled synthesis of cobalt nanoparticles for potential biomedical applications. Journal of Applied Physics, 111(7), 07B324, http://doi.org/10.1063/1.3676620
[6]. Saeed, S. Y., Mazhar, K., Raees, L., Mukhtiar, A., Khan, F., & Khan, M. 2022, Green synthesis of cobalt oxide nanoparticles using roots extract of Ziziphus Oxyphylla Edgew its characterization and antibacterial activity. Materials Research Express, 9(10), 105001, https://doi.org/10.1088/2053-1591/ac9350
[7]. Safdar, A., Mohamed, H. E. A., Hkiri, K., Muhaymin, A., & Maaza, M. 2023, Green synthesis of cobalt oxide nanoparticles using hyphaene thebaica fruit extract and their photocatalytic application. Applied Sciences, 13(16), 9082, https://doi.org/10.3390/app13169082
[8]. Govindasamy, R., Raja, V., Singh, S., Govindarasu, M., Sabura, S., Rekha, K., Rajeswari, V. D., Alharthi, S. S., Vaiyapuri, M., Sudarmani, R., & Jesurani, S. 2022, Green synthesis and characterization of cobalt oxide nanoparticles using Psidium guajava leaves extracts and their photocatalytic and biological activities. Molecules, 27(17), 5646, https://doi.org/10.3390/molecules27175646
[9]. Chelliah, P., Wabaidur, S. M., Sharma, H. P., Jweeg, M. J., Majdi, H. S., AL. Kubaisy, M. M. R., Iqbal, A., & Lai, W. C. 2023, Green synthesis and characterizations of cobalt oxide nanoparticles and their coherent photocatalytic and antibacterial investigations. Water, 15(5), 910, https://doi.org/10.3390/w15050910
[10]. Jena, R., Rath, D., Rout, S. S., & Kar, D. M. 2020, A review on genus Millettia: Traditional uses, phytochemicals and pharmacological activities. Saudi Pharmaceutical Journal, 28(12), 1686-1703, https://doi.org/10.3390/w15050910
[11]. Jeba, D. P., Ramkumar, P., David, A., & Ashli, J., 2022, Synthesis of Green and Pure Copper Oxide Nanoparticles Using Millettia Pinnata Leaf Extract and Their Characterisation. ECS Transactions, 107(1), 17335, https://doi.org/10.1149/10701.17335ecst
[12]. Kumar, G., Ghosh, M., & Pandey, D. M., 2019, Method development for optimised green synthesis of gold nanoparticles from Millettia pinnata and their activity in non‐small cell lung cancer cell lines. IET Nanobiotechnology, 13(6), 626-633, https://doi.org/10.1049/iet-nbt.2018.5410
[13]. Khalil, A. T., Ovais, M., Ullah, I., Ali, M., Shinwari, Z. K., & Maaza, M. 2020, Physical properties, biological applications and biocompatibility studies on biosynthesized single phase cobalt oxide (Co3O4) nanoparticles via Sageretia thea (Osbeck.). Arabian Journal of Chemistry, 13(1), 606-619, https://doi.org/10.1016/j.arabjc.2017.07.004
[14]. Ali, H., Yadav, Y. K., Ali, D., Kumar, G., & Alarifi, S. 2023, Biosynthesis and characterization of cobalt nanoparticles using combination of different plants and their antimicrobial activity. Bioscience Reports, 43(7), BSR20230151, https://doi.org/10.1042/BSR20230151
[15]. Jia, H. R., Zhu, Y. X., Duan, Q. Y., Chen, Z., & Wu, F. G., 2019, Nanomaterials meet zebrafish: Toxicity evaluation and drug delivery applications. Journal of Controlled Release, 311, 301-318, https://doi.org/10.1016/j.jconrel.2019.08.022
[16]. Tan, Z., Deng, L., Jiang, Z., Xiang, G., Zhang, G., He, S., Zhang, H., & Wang, Y., 2024, Selenium Nanoparticles Attenuate Cobalt Nanoparticle-Induced Skeletal Muscle Injury: A Study Based on Myoblasts and Zebrafish. Toxics, 12(2), 130, https://doi.org/10.3390/toxics12020130
[17]. Ahmad, F., Liu, X., Zhou, Y., & Yao, H. 2015, An in vivo evaluation of acute toxicity of cobalt ferrite (CoFe2O4) nanoparticles in larval-embryo Zebrafish (Danio rerio). Aquatic Toxicology, 166, 21-28. https://doi.org/10.1016/j.aquatox.2015.07.003
[18]. Ravi, L., Sreenivas, B. A., Kumari, G. S., & Archana, O., 2022, Anticancer cytotoxicity and antifungal abilities of green-synthesized cobalt hydroxide (Co (OH) 2) nanoparticles using Lantana camara L. Beni-Suef University Journal of Basic and Applied Sciences, 11(1), 124, https://doi.org/10.1186/s43088-022-00304-1
[19]. Gayathri, M. K. E., Lakshmi Thangavelu, D. R. S., & Perumal, E. 2023, Green synthesis of cumin and clove mediated selenium nanoparticles and its anticancer activity against osteosarcoma cell line. Journal Of Survey in Fisheries Sciences, 10(1S), 300-311, https://doi.org/10.17762/sfs.v10i1S.175
[20]. Ryntathiang, I., Behera, A., Richard, T., & Jothinathan, M. K. D. 2024, An Assessment of the In Vitro Antioxidant Activity of Cobalt Nanoparticles Synthesized from Millettia pinnata, Butea monosperma, and Madhuca indica Extracts: A Comparative Study. Cureus, 16(4), e59112, https://doi.org/10.7759/cureus.59112
[21]. Ryntathiang, I., Jothinathan, M. K. D., Behera, A., Saravanan, S., & Murugan, R., 2024, Comparative bioactivity analysis of green-synthesized metal (cobalt, copper, and selenium) nanoparticles. Cureus, 16(3), e55933, https://doi.org/10.7759/cureus.55933
[22]. Munusamy, T., & Shanmugam, R., 2023, Green synthesis of copper oxide nanoparticles synthesized by Terminalia chebula dried fruit extract: characterization and antibacterial action. Cureus, 15(12), e50142, https://doi.org/10.7759/cureus.50142
[23]. Rajeshkumar, S., Santhoshkumar, J., Vanaja, M., Sivaperumal, P., Ponnanikajamideen, M., Ali, D., & Arunachalam, K. 2022, Evaluation of zebrafish toxicology and biomedical potential of aeromonas hydrophila mediated copper sulfide nanoparticles. Oxidative Medicine and Cellular Longevity, 2022(1), 7969825, https://doi.org/10.1155/2022/7969825
[24]. Sankar, H. N., Shanmugam, R., & Anandan, J. 2024, Green Synthesis of Euphorbia tirucalli-Mediated Titanium Dioxide Nanoparticles Against Wound Pathogens. Cureus, 16(2), e53939, https://doi.org/10.7759/cureus.53939
[25]. Ameena, M., Arumugham, M., Ramalingam, K., Rajeshkumar, S., & Perumal, E. 2023, Cytocompatibility and wound healing activity of chitosan thiocolchicoside lauric acid nanogel in human gingival fibroblast cells. Cureus, 15(8), e43727, https://doi.org/10.7759/cureus.43727
[26]. Raja, F. N., Worthington, T., & Martin, R. A. 2023, The antimicrobial efficacy of copper, cobalt, zinc and silver nanoparticles: alone and in combination. Biomedical Materials, 18(4), 045003, https://doi.org/10.1088/1748-605X/acd03f
[27]. Palaniappan, P., Thamaynthi, S., Maharifa, H. N. S., & Ramesh, R., 2021, Green Synthesis of Copper (Cu) Nanoparticles Using Marine Brown Algae Turbinaria Ornata and Its Brine Shrimp Lethality Bioassay. International Journal of Nanotechnology and Nanomedicine, 6(2), 35-40, https://dx.doi.org/10.33140/IJNN
[28]. Mutalik, C., Nivedita, Sneka, C., Krisnawati, D. I., Yougbaré, S., Hsu, C. C., & Kuo, T. R. 2024, Zebrafish Insights into Nanomaterial Toxicity: A Focused Exploration on Metallic, Metal Oxide, Semiconductor, and Mixed-Metal Nanoparticles. International Journal of Molecular Sciences, 25(3), 1926, https://doi.org/10.3390/ijms25031926
[29]. Kumar, R., Huda, M. N., Habib, A., Nafiujjaman, M., Woo, H. J., Kim, T., & Nurunnabi, M., 2023, Carbon Coated Iron–Cobalt Nanoparticles for Magnetic Particle Imaging. ACS Applied Bio Materials, 6(8), 3257-3265, https://doi.org/10.1021/acsabm.3c00354
[30]. Shashiraj, K. N., Hugar, A., Kumar, R. S., Rudrappa, M., Bhat, M. P., Almansour, A. I., Perumal, K., & Nayaka, S., 2023, Exploring the antimicrobial, anticancer, and apoptosis inducing ability of biofabricated silver nanoparticles using Lagerstroemia speciosa flower buds against the Human Osteosarcoma (MG-63) cell line via flow cytometry. Bioengineering, 10(7), 821, https://doi.org/10.3390/bioengineering10070821
[31]. Berehu, H. M., & Patnaik, S., 2024, Biogenic Zinc Oxide Nanoparticles synthesized from Tinospora Cordifolia induce oxidative stress, mitochondrial damage and apoptosis in Colorectal Cancer. Nanotheranostics, 8(3), 312, https://doi.org/10.7150/ntno.84995
[32]. Varghese, R. M., Kumar, A., & Shanmugam, R., 2024, Cytotoxicity and characterization of zinc oxide and silver nanoparticles synthesized using Ocimum tenuiflorum and Ocimum gratissimum herbal formulation. Cureus, 16(2), e53481, https://doi.org/10.7759/cureus.53481
[33]. Waris, A., Din, M., Ali, A., Afridi, S., Baset, A., Khan, A. U., & Ali, M., 2021. Green fabrication of Co and Co3O4 nanoparticles and their biomedical applications: A review. Open Life Sciences, 16(1), 14-30, https://doi.org/10.1515/biol-2021-0003
[34]. Shanmuganathan, R., Sathiyavimal, S., Le, Q. H., Al-Ansari, M. M., Al-Humaid, L. A., Jhanani, G. K., Lee, J., & Barathi, S., 2023, Green synthesized cobalt oxide nanoparticles using Curcuma longa for anti-oxidant, antimicrobial, dye degradation and anti-cancer property. Environmental Research, 236, 116747, https://doi.org/10.1016/j.envres.2023.116747
[35]. Singh, D., Sharma, P., Pant, S., Dave, V., Sharma, R., Yadav, R., Prakash, A., & Kuila, A. 2024, Ecofriendly fabrication of cobalt nanoparticles using Azadirachta indica (neem) for effective inhibition of Candida-like fungal infection in medicated nano-coated textile. Environmental Science and Pollution Research, 31(34), 46575-46590, http://dx.doi.org/10.1007/s11356-023-28061-3
[36]. Imtiyaz, A., Singh, A., & Gaur, R., 2024, Comparative Analysis and Applications of Green Synthesized Cobalt Oxide (Co3O4) Nanoparticles: A Systematic Review. BioNanoScience, 14, 1-19, http://dx.doi.org/10.1007/s12668-024-01452-7
[37]. Anupong, W., On-Uma, R., Jutamas, K., Joshi, D., Salmen, S. H., Alahmadi, T. A., & Jhanani, G.K. 2023, Cobalt nanoparticles synthesizing potential of orange peel aqueous extract and their antimicrobial and antioxidant activity. Environmental Research, 216, 114594.https://doi.org/10.1016/j.envres.2022.114594
[38]. Bhutekar, P. G., Kshirsagar, A. K., Bankar, S. S., & Mirgane, S. R. 2023, Green Synthesis and Characterization of Iron and Cobalt Oxide Nanoparticles Using Phaseolus Lunatus Flower Extract. Journal for ReAttach Therapy and Developmental Diversities, 6(9s), 1951-1956, https://doi.org/10.53555/jrtdd.v6i9s.2813
[39]. Sharifi, E., Reisi, F., Yousefiasl, S., Elahian, F., Barjui, S. P., Sartorius, R., Fattahi, N., Zare, E. N., Rabiee, N., Gazi, E. P., & Paiva-Santos, A. C., 2023, Chitosan decorated cobalt zinc ferrite nanoferrofluid composites for potential cancer hyperthermia therapy: anti-cancer activity, genotoxicity, and immunotoxicity evaluation. Advanced Composites and Hybrid Materials, 6(6), 191, http://dx.doi.org/10.1007/s42114-023-00768-4
[40]. Anbarasu, M., Martin, T. M., Priya, P., Sivamurugan, V., Kumar, M. S. K., Shaik, M. R., Kari, Z.A., & Guru, A. 2024, Assessing the impact of Ag-ZnO nanoparticle on the induction of oxidative stress, hematological, and molecular changes in zebrafish (Danio rerio) and McCoy fibroblast cell lines. Aquaculture International, 32(4), 5373-5392, http://dx.doi.org/10.1007/s10499-024-01611-3
[41]. Kannan, V. D., Jaisankar, A., Rajendran, V., Ahmed, M. Z., Alqahtani, A. S., Kazmi, S., Madav, E., Sampath, S., & Asaithambi, P. 2024, Ecofriendly bio-synthesis and spectral characterization of copper nanoparticles using fruit extract of Pedalium murex L.: in vitro evaluation of antimicrobial, antioxidant and anticancer activities on human lung cancer A549 cell line. Materials Technology, 39(1), 2286818, https://doi.org/10.1080/10667857.2023.2286818
Viewed PDF 27 2 -
Role of Visual Motor Integration in Academic Performance of Preschool ChildrenAuthor: Anusha MadamanchiDOI: 10.21522/TIJPH.2013.13.01.Art047
Role of Visual Motor Integration in Academic Performance of Preschool Children
Abstract:
Poor visual-motor integration (VMI) in children is associated with problems in learning and academic achievement and could be an early predictor to guide intervention and improve their academic performance. The purpose of this study was to examine the relation between VMI, and academic performance amongst preschool children, and to study the association with various demographic factors and screen time exposure. The study participants were recruited using a multi-stage stratified sampling technique. VMI was assessed using Beery VMI guidelines, a visual perception test, and a motor coordination test. Participant age, academic performance, maturity at birth, neonatal intensive care unit (NICU) stay, and screen time were studied with the VMI standard score. Data were collected for 850 preschool children (52.4% males and 47.6% females). As per VMI standard scores, 90.4% of children had average, 8.9% had above average and 0.7% had below-average scores respectively. Among the demographic factors, mean age, maturity at birth, NICU stay, and screen time showed a significant difference with VMI scores while no such significance was seen for socioeconomic status, maternal education, and gender. A significant difference between mean VMI, visual perception, and motor coordination scores and the various categories of academic performance in the study group was obtained. Findings from this study show that pre-term birth, NICU stay, and screen time may affect VMI which can lead to poor academic performance. Screening for VMI could serve as an indicator to direct early interventional measures in preschool children, aiding better academic inclusion.
Role of Visual Motor Integration in Academic Performance of Preschool Children
References:
[1]. Carsone, B., Green, K., Torrence, W., Henry, B., 2021, Systematic Review of Visual Motor Integration in Children with Developmental Disabilities. Occupational Therapy International, Article 1801196.
[2]. Kramer, P., Hinojosa, J., Howe, T. H., 2019, Frames of reference for pediatric occupational therapy, Wolters Kluwer publishers, 4th edition
[3]. Lieberman, L. M., 1984, Visual perception versus visual function. Journal of Learning Disabilities, 17(3), 182-185.
[4]. Case-Smith, J., 2002, Effectiveness of school-based occupational therapy intervention on handwriting. The American Journal of Occupational Therapy, 56(1), 17-25.
[5]. Kulp, M. T. and Schmidt, P. P., 2002, A pilot study. Depth perception and near stereoacuity: is it related to academic performance in young children? Binocular vision & strabismus quarterly, 17(2), 129-34.
[6]. Ng, M., Chui, M., Lin, L., Fong, A. and Chan, D., 2015, Performance of the visual-motor integration of preschool children in Hong Kong. Hong Kong Journal of Occupational Therapy, 25, 7-14.
[7]. Ng, M., Chui, M., Lin, L., Fong, A. and Chan, D., 2015, Performance of the visual-motor integration of preschool children in Hong Kong. Hong Kong Journal of Occupational Therapy, 25, 7-14.
[8]. Fang, Y., Wang, J., Zhang, Y. and Qin, J., 2017, The Relationship of Motor Coordination, Visual Perception, and Executive Function to the Development of 4–6‐Year‐Old Chinese Preschoolers’ Visual Motor Integration Skills. BioMed research international, 2017(1), 6264254.
[9]. Goldstand, S., Koslowe, K. C. and Parush, S., 2005, Vision, visual-information processing, and academic performance among seventh-grade schoolchildren: A more significant relationship than we thought? The American journal of occupational therapy, 59(4), 377-389.
[10]. Kulp, M. T. and Sortor, J. M., 2003, Clinical value of the Beery visual-motor integration supplemental tests of visual perception and motor coordination. Optometry and vision science, 80(4), 312-315.
[11]. McCrimmon, A. W., Altomare, A. A., Matchullis, R. L. and Jitlina, K., 2012, Test review: the beery developmental test of visual-motor integration.
[12]. Dalvi, T. and Kalghatgi, S., 2023, A 2023 Update of Kuppuswamy Socioeconomic Status Classification Scale for the Indian Population. Journal of Indian Association of Public Health Dentistry, 21(3), 282-283.
[13]. Daly, C. J., Kelley, G. T., and Krauss, A., 2003, Relationship between visual-motor integration and handwriting skills of children in kindergarten: A modified replication study. The American journal of occupational therapy, 57(4), 459-462.
[14]. Sortor, J. M., and Kulp, M. T., 2003, Are the results of the Beery-Buktenica Developmental Test of Visual-Motor Integration and its subtests related to achievement test scores?. Optometry and vision science, 80(11), 758-763.
[15]. De Waal, E., Pienaar, A. E. and Coetzee, D., 2018, Influence of different visual perceptual constructs on academic achievement among learners in the nw-child study. Perceptual and motor skills, 125(5), 966-988.
[16]. Grissmer, D., Grimm, K. J., Aiyer, S. M., Murrah, W. M. and Steele, J. S., 2010, Fine motor skills and early comprehension of the world: two new school readiness indicators. Developmental psychology, 46(5), 1008.
[17]. Goyen, T. A., Lui, K. and Woods, R., 1998, Visual‐motor, visual‐perceptual, and fine motor outcomes in very‐low‐birthweight children at 5 years. Developmental Medicine & Child Neurology, 40(2), 76-81.
[18]. Sripada, K., Løhaugen, G. C., Eikenes, L., Bjørlykke, K. M., Håberg, A. K., Skranes, J., and Rimol, L. M., 2015, Visual–motor deficits relate to altered gray and white matter in young adults born preterm with very low birth weight. Neuroimage, 109, 493-504.
[19]. Perez-Roche, T., Altemir, I., Giménez, G., Prieto, E., González, I., Peña-Segura, J. L., Castillo, O., and Pueyo, V., 2016, Effect of prematurity and low birth weight in visual abilities and school performance. Research in developmental disabilities, 59, 451-457.
[20]. Domingues‐Montanari, S., 2017, Clinical and psychological effects of excessive screen time on children. Journal of Paediatrics and Child Health, 53(4), 333-338.
[21]. Fang, Y., Wang, J., Zhang, Y., and Qin, J., 2017, The Relationship of Motor Coordination, Visual Perception, and Executive Function to the Development of 4–6‐Year‐Old Chinese Preschoolers’ Visual Motor Integration Skills. BioMed research international, 2017(1), 6264254.
[22]. Sutapa, P., Pratama, K. W., Rosly, M. M., Ali, S. K. S., and Karakauki, M., 2021, Improving motor skills in early childhood through goal-oriented play activity. Children, 8(11), 994.
[23]. Lin, L. Y., Cherng, R. J., Chen, Y. J., Chen, Y. J. and Yang, H. M., 2015, Effects of television exposure on developmental skills among young children. Infant behavior and development, 38, 20-26.
[24]. Dankert, H. L., Davies, P. L. and Gavin, W. J., 2003, Occupational therapy effects on visual-motor skills in preschool children. The American Journal of Occupational Therapy, 57(5), 542-549.
[25]. Narayan, L., Yadav, P. K., Mishra, B. K., 2022, Evaluation of Visual Motor Integration skills in school going children, develop normative data for Indian population and its impact on Handwriting skills, International Journal for Creative Research Thoughts, 10(11), 2320-2882
[26]. 26 Pienaar, A. E., Barhorst, R., Twisk, J. W. R., Relationships between academic performance, SES school type and perceptual-motor skills in first grade South African learners: NW-CHILD study. Child: Care, Health and Development. 2014;40(3):370-8.
Viewed PDF 30 1 -
Neuroprotective Efficacy of Eugenol Against Lead Acetate and Monosodium Glutamate Induced Neurotoxicity by Modulating Brain-Derived Neurotrophic Factor (BDNF) Gene Expression in Wistar RatsAuthor: Karthik Ganesh MohanrajDOI: 10.21522/TIJPH.2013.13.01.Art048
Neuroprotective Efficacy of Eugenol Against Lead Acetate and Monosodium Glutamate Induced Neurotoxicity by Modulating Brain-Derived Neurotrophic Factor (BDNF) Gene Expression in Wistar Rats
Abstract:
The human nervous system is highly susceptible to various environmental toxins, which can lead to neurodegenerative conditions characterized by cognitive deficits, motor dysfunction, and even cell death. Among these toxins, lead (Pb) and Monosodium Glutamate (MSG) have been evaluated in this study for their neurotoxic effects. Lead exposure has been associated with detrimental effects on the central nervous system, similarly, MSG, a common food additive, has been reported to induce neurotoxicity through oxidative stress and excitotoxicity mechanisms. Eugenol, found in essential oils, have demonstrated promising antioxidant, anti-inflammatory and neuroprotective properties. Hence Eugenol was used as a therapeutic agent against lead acetate and MSG induced neurotoxicity by modulating Brain-derived Neurotrophic Factor. This in vivo study involved 48 Wistar albino rats, divided into eight groups consisting of Control, Lead acetate induction (100 mg/kg b.wt for 30 days), MSG induction (2 g/kg b.wt for 21 days) and subsequent treatment with Eugenol (250 mg/kg b.wt for 30 days) in comparison with positive control, memantine (20mg/kg b.wt for 15 days). Histopathological and BDNF gene expression were evaluated after the experimental period. Histopathological analysis confirmed that eugenol preserved neuronal integrity, reducing neuronal damage caused by lead acetate and MSG exposure by modulating free radical generation upon oxidative stress. Eugenol treatment in rats exposed to lead and MSG resulted in a significant upregulation of BDNF expression (p<0.01) compared to the untreated toxin-exposed groups. These outcomes suggest that Eugenol could be a possible therapeutic agent for protecting the neuronal tissues from Lead acetate and MSG-induced neurotoxicity.
Neuroprotective Efficacy of Eugenol Against Lead Acetate and Monosodium Glutamate Induced Neurotoxicity by Modulating Brain-Derived Neurotrophic Factor (BDNF) Gene Expression in Wistar Rats
References:
[1]. Flora, G., Gupta, D., & Tiwari, A., 2012, Toxicity of lead: A review with recent updates. Interdisciplinary Toxicology, 5(2), 47-58. https://doi.org/10.2478/v10102-012-0009-2
[2]. Ganesan, B., Budin, S. B., & Anuar, I., 2022, Monosodium glutamate-induced oxidative stress and cognitive impairments in rats: Neuroprotective effects of natural antioxidants. Food and Chemical Toxicology, 167, 113232. https://doi.org/10.1016%2FaCtox.2024.100148
[3]. Park, S. E., Sapkota, K., Choi, J. H., 2011, Eugenol protects neuronal cells from oxidative stress-induced apoptosis through TRPV1 activation. https://doi.org/10.3892%2Fetm.2020.9539
[4]. Meenakshi, S., Varghese, S. S., Mohanraj K. G., 2023, Bone Regenerative Potential of a Recombinant Parathormone Derivative in Experimentally Induced Critical-size Calvarial Defects in Wistar Albino Rats. World J Dent 14(5):452–461.
[5]. Solmaz Mohammad Inejad, 2017, “Pharmacological and toxicological properties of eugenol” Turk J Pharm Sci, https://doi.org/10.4274%2Ftjps.62207
[6]. Prakash Binu, 2018, “Protective Effects of Eugenol Against Hepatotoxicity Induced By Arsenic Trioxide: An Antileukemic Drug” IJMS vol 43, no 3.
[7]. Hanna, S. S., Gazwi, 2020, “Mitigation of lead neurotoxicity by the ethanolic extract of Laurus leaf in rats” Exotoxicol Environ Saf Apr 1:192:110297. doi: 10.1016/j.ecoenv.2020.110297.
[8]. Fasakin, O. W., A. O. Fajobi, and O. O. Oyedapo, 2017, "Neuroprotective potential of Aframomum melegueta extracts on brain of monosodium glutamate-treated wistar albino rats." Journal of Neuroscience and Behavioral Health 9.2 (2017): 16-27. DOI: 10.5897/JNBH2017.0145
[9]. Varsha Singh, 2013, “In vivo antioxidative and neuroprotective effect of 4-Allyl-2- methoxyphenol against chlorpyrifos-induced neurotoxicity in rat brain” Mol cell biochem, Mar;388(1-2):61-74. doi: 10.1007/s11010-013-1899-9. Epub 2013 Dec 1.
[10]. Rajagopal shanmuga Sundaram, 2013, “Neuroprotective potential of Ocimum sanctum (Linn) leaf extract in monosodium glutamate induced excitotoxicity” African Journal of Pharmacy and Pharmacology 7(27):1894-1906 DOI:10.5897/AJPP12.1445
[11]. Bancroft, J. D., and Gamble, M., 2002, “Theory and Practice of Histological Techniques,” Churchill Livingstone, London.
[12]. Sasi, M., Vignoli, B., Canossa, M., & Blum, R., 2017, Neurobiology of local and intercellular BDNF signaling. Pflügers Archiv-European Journal of Physiology, 469(5), 593-610. https://doi.org/10.1007/s00424-017-1964-4
[13]. Patapoutian, A., & Reichardt, L. F., 2001, Trk receptors: mediators of neurotrophin action. Current Opinion in Neurobiology, 11(3), 272-280. https://doi.org/10.1016/s0959-4388(00)00208-7
[14]. Mahmoud, S., Gharagozloo, M., Simard, C., Gris, D., 2019, Microglia and neuroinflammation: modulation by exercise. Journal of Neuroinflammation, 16, 138. https://doi.org/10.3389%2Ffnins.2023.1125428.
[15]. Pandiar, D., Ramani, P., Krishnan R. P., Y., Dinesh, Histopathological analysis of soft tissue changes in gingival biopsied specimen from patients with underlying corona virus disease associated mucormycosis (CAM), https://doi.org/10.4317/medoral.25050.
[16]. Souparnika.V., Karthik Ganesh Mohanraj, Vidya, S., Antioxidant activity of L-Theanine on Cadmium Induced oxidative stress mediated neurodegeneration-An invivo analysis, https://doi.org/10.47750/jptcp.2022.952.
[17]. Sanders, T., Liu, Y., Buchner, V., & Tchounwou, P. B., 2009, Neurotoxic effects and biomarkers of lead exposure: A review. Reviews on Environmental Health, 24(1), 15-45. https://doi.org/10.1515/reveh.2009.24.1.15.
[18]. Sanjay Varshan, M., Lavanya Prathap, Selvaraj Jayaraman, Preetha, S., 2022, Anti Proliferative Effect of Endogenous Dopamine Replica in Human Lung Cancer Cells (A549) Via Pi3k and Akt Signalling Molecules. https://doi.org/10.47750/pnr.2022.13.S03.215.
[19]. Lu, B., Nagappan, G., & Lu, Y., 2013, BDNF and synaptic plasticity, cognitive function, and dysfunction. Handbook of Experimental Pharmacology, 220, 223-250. https://doi.org/10.1007/978-3-642-45106-5_9.
[20]. Rattiner, L. M., Davis, M., French, C. T., & Ressler, K. J. 2004, Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. Journal of Neuroscience, 24(20), 4796-4806. https://psycnet.apa.org/doi/10.1523/JNEUROSCI.5654-03.2004
[21]. Toscano, C. D., & Guilarte, T. R., 2005, Lead neurotoxicity: From exposure to molecular effects. Brain Research Reviews, 49(3), 529-554 https://doi.org/10.1016/j.brainresrev.2005.02.004.
[22]. Nagababu, E., Rifkind, J. M., Boindala, S., & Nakka, L., 2010, Assessment of antioxidant activity of eugenol in vitro and in vivo. Free Radical Biology and Medicine, 49(1), 144-153. https://doi.org/10.1007/978-1-60327-029-8_10.
[23]. Giridharan, V. V., Thandavarayan, R. A., Sato, S., Ko, K. M., Ma, M., & Suzuki, K., 2011, Eugenol attenuates neuroinflammatory responses and cognitive dysfunction in a transgenic mouse model of Alzheimer's disease. Journal of Biological Chemistry, 286(43), 37716-37727. http://dx.doi.org/10.3109/10715762.2011.571682
[24]. Lu, B., Nagappan, G., & Lu, Y., 2013, BDNF and synaptic plasticity, cognitive function, and dysfunction. Handbook of Experimental Pharmacology, 220, 223-250. https://doi.org/10.1007/978-3-642-45106-5_9
[25]. Saleh, D. O., Baraka, S. M., Jaleel, G. A. A., Hassan, A., Ahmed-Farid, O. A., 2024, Eugenol alleviates acrylamide-induced rat testicular toxicity by modulating AMPK/p-AKT/mTOR signaling pathway and blood-testis barrier remodeling. Sci Rep. 2024 Jan 22;14(1):1910. doi: 10.1038/s41598-024-52259-1. PMID: 38253778; PMCID: PMC10803763.
[26]. Allen, S. J., Dawbarn, D., & Wilcock, G. K., 2011, BDNF levels in Alzheimer's disease: implications for neuroprotective strategies. Journal of Alzheimer’s Disease, 22(1), 43-56. https://doi.org/10.2174%2F157015911798376190
[27]. Marvanová, M., Menager, J., Bezard, E., & Bockaert, J., 2001, Reduced brain-derived neurotrophic factor expression in the frontal cortex in Alzheimer's disease. Neurobiology of Aging, 22(2), 267-272. https://doi.org/10.1016/s0169-328x(97)00125-3
[28]. Dwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N., 2003, Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Archives of General Psychiatry, 60(8), 804-815. https://doi.org/10.1001/archpsyc.60.8.804
[29]. Martinez-Herrera, A., Pozos-Guillen, A., Ruiz-Rodriguez, S., Garrocho-Rangel, A., Vertiz-Hernandez, A., Escobar-Garcia, D. M., 2016, Effect of 4-allyl-1-hydroxy-2-methoxybenzene (eugenol) on inflammatory and apoptosis processes in dental pulp fibroblasts. Mediators of Inflammation, 2016 doi: 10.1155/2016/9371403.9371403
[30]. Harb, A. A., Bustanji, Y. K., Almasri, I. M., Abdalla, S. S., Eugenol, reduces LDL cholesterol and hepatic steatosis in hypercholesterolemic rats by modulating TRPV1 receptor. Scientific Reports. 2019;9(1):p. 14003. doi: 10.1038/s41598-019-50352-4.
[31]. Miranda, M., Morici, J. F., Zanoni, M. B., Bekinschtein, P., Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain. Front. Cell. Neurosci. 2019;13:1–25. doi: 10.3389/fncel.2019.00363
[32]. Mitre, M., Mariga, A., Chao, M. V., Neurotrophin Signalling: Novel Insights into Mechanisms and Pathophysiology. Clin. Sci. 2017;131:13–23. doi: 10.1042/CS20160044.
[33]. Nisar, M. F., Khadim, M, Rafiq, M., Chen J., Yang Y., Wan C. C., Pharmacological Properties and Health Benefits of Eugenol: A Comprehensive Review. Oxid Med Cell Longev. 2021 Aug 3;2021:2497354. doi: 10.1155/2021/2497354. PMID: 34394824; PMCID: PMC8357497.
[34]. Ebenezer Leonoline, J., Gunapriya, R., Ranganathan, K., Vijayaraghavan, R., Ganesh Karthik, M., 2021, Determine Cyp17a1 and Ki67 Expressions in Pcos Induced Rat Model Treated with Sepia pharaonis Ink Extract Proves Effective. Indian Journal of Animal Research. 55(10): 1206-1214. doi: 10.18805/IJAR.B-4204.
Viewed PDF 17 0 -
Comprehensive Evaluation of Therapeutic Interventions for Oral Submucous Fibrosis: A Systematic Review of Clinical TrialsAuthor: Dhanraj GanapathyDOI: 10.21522/TIJPH.2013.13.01.Art049
Comprehensive Evaluation of Therapeutic Interventions for Oral Submucous Fibrosis: A Systematic Review of Clinical Trials
Abstract:
Oral submucous fibrosis (OSMF) is a chronic condition characterized by progressive fibrosis and thickening of the oral submucosa, leading to functional limitations such as restricted mouth opening (trismus), difficulty in chewing and swallowing, and a burning sensation in the oral cavity. This systematic review, conducted per PRISMA guidelines, synthesizes current evidence on OSMF management, evaluating therapeutic interventions and identifying areas for further research. A comprehensive search of databases including PubMed, Embase, Scopus, Web of Science, and CENTRAL, up to 2024, identified 48 studies. After screening for relevance and quality, 32 clinical trials were included. Eligible studies focused on pharmacological, surgical, and alternative treatments for OSMF, assessing outcomes such as mouth opening, pain reduction, and histopathological changes. Studies on animal models, in vitro research, reviews, and case reports were excluded. Due to significant heterogeneity in study designs and outcomes, a meta-analysis was not feasible. Instead, a qualitative synthesis revealed the effectiveness of various treatments. Local injections, particularly corticosteroids combined with agents like Salvia miltiorrhiza or lycopene, improved mouth opening and pain. Non-invasive approaches, including physiotherapy and herbal remedies, provided symptom relief, while surgical interventions were reserved for severe cases. Emerging therapies, such as transdermal fentanyl and laser fibrotomy, showed promise for personalized treatment. The review emphasizes early diagnosis, tailored interventions, and the need for further research into innovative therapies to enhance treatment outcomes for OSMF.
Comprehensive Evaluation of Therapeutic Interventions for Oral Submucous Fibrosis: A Systematic Review of Clinical Trials
References:
[1]. Shih, Y.-H., Wang, T.-H., Shieh, T.-M., & Tseng, Y.-H., 2019, Oral submucous fibrosis: A review on etiopathogenesis, diagnosis, and therapy, International Journal of Molecular Sciences, 20(11), 2940.
[2]. Muthukrishnan, A., & Warnakulasuriya, S., 2018, Oral health consequences of smokeless tobacco use, Indian Journal of Medical Research, 148(1), 35–40.
[3]. Pandiar, D., Krishnan, R. P., Ramani, P., Anand, R., & Sarode, S., 2023, Oral submucous fibrosis and the malignancy arising from it, could best exemplify the concepts of cuproplasia and cuproptosis, Journal of Stomatology, Oral and Maxillofacial Surgery, 124(5), 101368.
[4]. Yuwanati, M., Ramadoss, R., Kudo, Y., Ramani, P., & Senthil Murugan, M., 2023, Prevalence of oral submucous fibrosis among areca nut chewers: A systematic review and meta-analysis, Oral Diseases, 29(7), 1920–1926.
[5]. Peng, Q., Li, H., Chen, J., Wang, Y., & Tang, Z., 2020, Oral submucous fibrosis in Asian countries, Journal of Oral Pathology & Medicine, 49(4), 294–304.
[6]. Hande, A. H., Chaudhary, M. S., Gawande, M. N., Gadbail, A. R., Zade, P. R., Bajaj, S., et al., 2019, Oral submucous fibrosis: An enigmatic morpho-insight, Journal of Cancer Research and Therapeutics, 15(3), 463–469.
[7]. Gupta, S., & Jawanda, M. K., 2021, Oral submucous fibrosis: An overview of a challenging entity, Indian Journal of Dermatology, Venereology, and Leprology, 87(6), 768–777.
[8]. Sarode, S. C., Gondivkar, S., Sarode, G. S., Gadbail, A., & Yuwanati, M., 2021, Hybrid oral potentially malignant disorder: A neglected fact in oral submucous fibrosis, Oral Oncology, 121, 105390.
[9]. Pandiar, D., G, P., Poothakulath Krishnan, R., & T. N., U. M., 2023, Correlation between clinical and histopathological stagings of oral submucous fibrosis: A clinicopathological cognizance of 238 cases from south India, Cureus, 15, e49107.
[10]. Sharma, M., Shetty, S. S., & Radhakrishnan, R., 2018, Oral submucous fibrosis as an overhealing wound: Implications in malignant transformation, Recent Patents on Anti-Cancer Drug Discovery, 13(3), 272–291.
[11]. Gayathri, K., Malathi, N., Gayathri, V., Adtani, P. N., & Ranganathan, K., 2023, Molecular pathways of oral submucous fibrosis and its progression to malignancy, Archives of Oral Biology, 148, 105644.
[12]. Xu, H., Lyu, F.-Y., Song, J.-Y., Xu, Y.-M., Jiang, E.-H., Shang, Z.-J., et al., 2021, Research achievements of oral submucous fibrosis: Progress and prospect, Biomedical Research International, 2021, 6631856.
[13]. Chen, X., Xie, H., & Guo, J., 2023, Drug treatment for oral submucous fibrosis: An update, BMC Oral Health, 23, 748.
[14]. Shen, Y.-W., Shih, Y.-H., Fuh, L.-J., & Shieh, T.-M., 2020, Oral submucous fibrosis: A review on biomarkers, pathogenic mechanisms, and treatments, International Journal of Molecular Sciences, 21(21), 7231.
[15]. Chen, J., Wu, Y., Peng, J., & Ma, L., 2021, Oral opening training increases oral opening in patients with oral submucous fibrosis, Journal of Central South University Medical Sciences, 46(6), 731–735.
[16]. Baptist, J., Shakya, S., & Ongole, R., 2016, Rebamipide to manage stomatopyrosis in oral submucous fibrosis, Journal of Contemporary Dental Practice, 17(11), 1009–1012.
[17]. Bhadage, C. J., Umarji, H. R., Shah, K., & Välimaa, H., 2013, Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis, Clinical Oral Investigations, 17(6), 1375–1382.
[18]. Memon, A. B., Rahman, A. A. U., Channar, K. A., Zafar, M. S., & Kumar, N., 2022, Evaluating the oral-health-related quality of life of oral submucous fibrosis patients before and after treatment using the OHIP-14 tool, International Journal of Environmental Research and Public Health, 19(3), 1821.
[19]. Raizada, M. K., Sable, D. M., Chowdhery, A., Chavan, M. S., & Rajpurohit, L. S., 2017, Oral submucous fibrosis: Current perspectives, Journal of Oral Pathology & Medicine, 46(6), 439–442.
[20]. Veedu, A., Balan, R., & Sankar, A., 2015, A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 120(5), 588–593.
[21]. Singh, M., Niranjan, H. S., Mehrotra, R., Sharma, D., & Gupta, S. C., 2010, Efficacy of hydrocortisone acetate/hyaluronidase vs. triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis, Indian Journal of Medical Research, 131, 665–669.
[22]. Lyu, F.-Y., Wang, H.-F., Xu, C.-J., Xu, Z., Li, D.-M., & Chi, Y.-T., 2016, Expression of secreted frizzled-related protein-1 in patients with oral submucous fibrosis, Zhonghua Kou Qiang Yi Xue Za Zhi, 51(10), 616–622.
[23]. Shandilya, S., Mohanty, S., Sharma, P., Chaudhary, Z., Kohli, S., & Kumar, R. D., 2021, Effect of botulinum toxin-A on pain and mouth opening following surgical intervention in oral submucous fibrosis: A controlled clinical trial, Journal of Craniomaxillofacial Surgery, 49(8), 675–681.
[24]. Jiang, X., Zhang, Y., Li, F., Zhu, Y., Chen, Y., & Yang, S., 2015, Allicin as a possible adjunctive therapeutic drug for stage II oral submucous fibrosis: A preliminary clinical trial in a Chinese cohort, International Journal of Oral and Maxillofacial Surgery, 44(12), 1540–1546.
[25]. Cox, S., & Zoellner, H., 2009, Oral submucous fibrosis: Insights into pathogenesis, Journal of Oral Pathology & Medicine, 38(3), 220–226.
[26]. Nerkar Rajbhoj, A., Kulkarni, T. M., Shete, A., Shete, M., Gore, R., & Sapkal, R., 2021, A comparative study to evaluate efficacy of curcumin and Aloe Vera gel along with oral physiotherapy in the management of oral submucous fibrosis: A randomized clinical trial, Asian Pacific Journal of Cancer Prevention, 22(1), 107–112.
[27]. Adhikari, S., Rimal, J., Maharjan, I. K., & Shrestha, A., 2022, Efficacy of curcumin in combination with intralesional dexamethasone with hyaluronidase in the treatment of oral submucous fibrosis: A randomized controlled trial, Asian Pacific Journal of Cancer Prevention, 23(10), 3125–3132.
[28]. Singh, N., Hebbale, M., Mhapuskar, A., Ul Nisa, S., Thopte, S., & Singh, S., 2016, Effectiveness of Aloe Vera and antioxidant along with physiotherapy in the management of oral submucous fibrosis, Journal of Contemporary Dental Practice, 17(1), 78–84.
[29]. Ardra, A., Bharati, P., & Venkataswamy Reddy, A., 2017, Oral submucous fibrosis: An updated clinical perspective, Journal of Oral Pathology & Medicine, 46(1), 50–55.
[30]. Chandrashekar, A., Annigeri, R. G., Va, U., & Thimmasetty, J., 2021, A clinicobiochemical evaluation of curcumin as gel and as buccal mucoadhesive patches in the management of oral submucous fibrosis, Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology, 131(4), 428–434.
[31]. Bohra, A., Maheswari, T. N. U., Harsh, A., & Garg, A., 2021, Black turmeric and Aloe Vera in the management of oral submucous fibrosis: A prospective clinical study, Asian Pacific Journal of Cancer Prevention, 22(12), 3941–3947.
[32]. Pipalia, P. R., Annigeri, R. G., & Mehta, R., 2016, Clinicobiochemical evaluation of turmeric with black pepper and nigella sativa in the management of oral submucous fibrosis: A double-blind, randomized preliminary study, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, 122(6), 705–712.
[33]. Srivastava, R., Kundu, A., Pradhan, D., Jyoti, B., Chokotiya, H., & Parashar, P., 2021, A comparative study to evaluate the efficacy of curcumin lozenges (TurmNova®) and intralesional corticosteroids with hyaluronidase in the management of oral submucous fibrosis, Journal of Contemporary Dental Practice, 22(6), 751–755.
[34]. Tp, B., T, A. G., Varghese, M., Raghavan, R., Vm, M. N., & Pius, A., 2019, Evaluation of therapeutic efficacy of different treatment modalities in oral submucous fibrosis: A comparative study, Journal of Contemporary Dental Practice, 20(3), 390–394.
[35]. Ambereen, A., Bhutia, O., Roychoudhury, A., Yadav, R., Khakhla, D. H., & Vishwakarma, K., 2021, Is coronoidectomy superior to coronoidotomy for improving maximum incisal opening in patients with oral submucous fibrosis? Journal of Oral and Maxillofacial Surgery, 79(6), 863.e1–863.e7.
[36]. Dani, V. B., & Patel, S. H., 2018, The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis, Indian Journal of Cancer, 55(3), 248–250.
[37]. Patil, P., Hazarey, V., Chaudhari, R., & Nimbalkar-Patil, S., 2016, Clinical efficacy of a mouth-exercising device adjunct to local ointment intra-lesional injections and surgical treatment for oral submucous fibrosis: A randomized controlled trial, Asian Pacific Journal of Cancer Prevention, 17(3), 1255–1259.
[38]. Dasukil, S., Jena, A. K., Boyina, K. K., Grover, S., Arora, G., & Ahmed, Z. U., 2022, Functional outcome of two different grafting techniques in the surgical management of oral submucous fibrosis: A comparative evaluation, Oral and Maxillofacial Surgery, 26(5), 477–483.
[39]. Pandey, M., Thomas, G., Somanathan, T., Sankaranarayanan, R., Abraham, E. K., Jacob, B. J., et al., 2001, Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala, India, Oral Oncology, 37(2), 103–109.
[40]. Su, W. W.-Y., Yen, A. M.-F., Chiu, S. Y.-H., & Chen, T. H.-H., 2010, A community-based RCT for oral cancer screening with toluidine blue, Journal of Dental Research, 89(9), 933–937.
[41]. Sankaranarayanan, R., Mathew, B., Jacob, B. J., Thomas, G., Somanathan, T., Pisani, P., et al., 2000, Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India, Cancer, 88(3), 664–673.
[42]. Jiang, X.-W., Zhang, Y., Yang, S.-K., Zhang, H., Lu, K., & Sun, G.-L., 2013, Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, 115(3), 339–344.
[43]. Wu, Y., Peng, J., Que, G., Xu, C., & Yin, X., 2010, Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis, Journal of Central South University Medical Sciences, 35(4), 358–364.
[44]. Thakur, G., Thomas, S., Bhargava, D., & Pandey, A., 2015, Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis? Journal of Oral and Maxillofacial Surgery, 73(7), 1439.e1–1439.e10.
[45]. Rajendran, R., Rani, V., & Shaikh, S., 2006, Pentoxifylline therapy: A new adjunct in the treatment of oral submucous fibrosis, Indian Journal of Dental Research, 17(4), 190–198.
[46]. Nihadha, P. M., Chugh, A., Kaur, A., Kumar, S., Naveen, K. H., Bhatia, P. K., et al., 2022, Transdermal fentanyl patch versus standard analgesia in postoperative oral submucous fibrosis patients: A triple-blinded, randomized control trial, British Journal of Oral and Maxillofacial Surgery, 60(11), 1246–1253.
[47]. Rai, A., Kaur, M., Gombra, V., Hasan, S., & Kumar, N., 2019, Comparative evaluation of curcumin and antioxidants in the management of oral submucous fibrosis, Journal of Investigative and Clinical Dentistry, 10(1), e12464.
[48]. Tai, Y. S., Liu, B. Y., Wang, J. T., Sun, A., Kwan, H. W., & Chiang, C. P., 2001, Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis, Journal of Oral Pathology & Medicine, 30(10), 618–625.
[49]. Gupta, S., Piyush, P., Mahajan, A., Mohanty, S., Ghosh, S., & Singh, K., 2018, Fibrotomy with diode laser (980 nm) and habit correlation in oral submucous fibrosis: A report of 30 cases, Lasers in Medical Science, 33(8), 1739–1745.
Viewed PDF 26 0 -
Tuberculosis Treatment as the First Priority Indicator of Public Health in the Healthy Indonesia Program with a Family ApproachAuthor: Mohammad NajibDOI: 10.21522/TIJPH.2013.13.01.Art050
Tuberculosis Treatment as the First Priority Indicator of Public Health in the Healthy Indonesia Program with a Family Approach
Abstract:
Public health care is part of the "Healthy Indonesia Program with a Family Approach", which consists of 5 indicators, namely treatment of pulmonary tuberculosis sufferers according to standards, regular treatment of hypertension sufferers, treatment and not neglecting sufferers of mental disorders, absence of family members who smoke, and family membership in national health insurance. This study aimed to select maternal and child health indicators based on priority using the difficulty-usefulness pyramid (DUP). The respondents of this study were 329 families in Indonesia selected using the snowball sampling technique. The difficulty and usefulness of the five indicators were measured using an online questionnaire, then analyzed and presented in the form of a difficulty-usefulness pyramid. The results of the analysis showed that the range based on the total difficulty-usefulness for each indicator was 1) treatment of pulmonary tuberculosis sufferers according to standards = 17.21; 2) regular treatment of hypertension sufferers = 17.00; 3) treatment and not neglecting sufferers of mental disorders = 16.53; 4) absence of family members who smoke = 16.37; and 5) family membership in national health insurance = 15.46. After the range was sorted, the largest range was at the base of the pyramid. It could be concluded that the indicator of public health care that was prioritized was the treatment of pulmonary tuberculosis sufferers according to standards.
Tuberculosis Treatment as the First Priority Indicator of Public Health in the Healthy Indonesia Program with a Family Approach
References:
[1]. Maryani, H., Rizkianti, A., Izza, N., 2024, Classification of healthy family indicators in indonesia based on a K-means cluster analysis. J Prev Med Public Health, 57(3), 234-241.
[2]. Hardjito, K., Rahmaningtyas, I., Nugroho, H. S. W., 2023, Selection of prioritized healthy family indicators, using the difficulty-usefulness pyramid (DUP). Rawal Medical Journal, 48(1), 168-172.
[3]. Bisri, M., Handoko, R., Darmawan, A., 2023, Implementation of the healthy indonesia program with a family approach (PIS-PK) at community health centers in Bintan District, Kepulauan Riau Province. International Journal of Social Science, 2(6), 2423-2428.
[4]. Saloner, B., Wilk, A. S., Levin, J., 2020, Community health centers and access to care among underserved populations: A synthesis review. Med Care Res Rev, 77(1), 3-18.
[5]. Trisna, N., 2021, Implementation of a healthy indonesian programs with a family approach (PIS-PK) (Study at Puskesmas Seluma Timur). International Journal of Policy and Public Administration, 2(1), 26-36.
[6]. Nugroho, H. S. W., Sillehu. S., Handoyo, Suparji, Sunarto, Subagyo, Sunarko, B., Bahtiar, 2018, Difficultness-Usefulness Pyramid (DUP) as new method to select elements prioritized in management of e-learning in health. Indian Journal of Public Health Research and Development, 9(2), 206-211.
[7]. Nugroho, H. S. W., Handoyo, Prayitno, H., Budiono, A., 2019, Sort elements based on priority, in order to improve the quality of e-learning in health using Difficulty-Usefulness Pyramid with Weighting (DUP-We). International Journal of Emerging Technologies in Learning (iJET), 14(18), 186-193.
[8]. Ibrahim, I., Sudiana. I. K., Mukono, H. J., Suhartono, Nugroho, H. S. W., 2020, Determination of priority elements of vigilance in the use of pesticides based on difficulty and usefulness (A supporting study for law and policy in health). Indian Journal of Forensic Medicine and Toxicology, 14(2), 1615-1619.
[9]. Ibrahim, I., Sudiana, I. K., Mukono, H. J., Suhartono, Nugroho, H. S. W., 2020, Awareness program of pesticides used among farmers using Difficulty-Usefulness Pyramid (A suggestion for health laws and policies regarding the use of pesticides). Indian Journal of Forensic Medicine and Toxicology, 14(3), 1946-1951.
[10]. Nugroho, H. S. W., Suparji, S., Sunarto, S., Handoyo, H., Yessimbekov, Z., Burhanuddin, N., Selasa, P., 2020, Quadrant of Difficulty-Usefulness (QoDU) as new method in preparing for improvement of e-learning in health college. Risk Manag Healthc Policy, 13, 1625-1632.
[11]. Sunarto, S., Nugroho, H. S. W., Suparji, S., Santosa, B. J., 2024, Quadrant of difficulty and usefulness for prioritizing community-based disaster preparedness parameter elements. RMJ, 49(1):172-175.
[12]. Main, S., Lestari. T., Triasih, R., Chan, G., Davidson, L., Majumdar, S., Santoso, D., Phung, S., Laukkala, J., Graham, S., du Cros, P., Ralph, A., 2019, Training for tuberculosis elimination in Indonesia: Achievements, reflections, and potential for impact. Trop Med Infect Dis., 4(3), 107.
[13]. Ritonga, I. L., Setyowati, S., Handiyani, H., Nursasi, A. Y., 2023, Exploring the tuberculosis medication program in Indonesia as perceived by patients and their families: A qualitative study. Belitung Nurs J., 9(2), 124-131.
[14]. Lestari, T., Fuady, A., Yani, F. F., Putra. I. W. G. A. E., Pradipta, I. S., Chaidir, L., Handayani, D., Fitriangga, A., Loprang, M. R., Pambudi, I., Ruslami, R., Probandari, A., 2023, The development of the national tuberculosis research priority in Indonesia: A comprehensive mixed-method approach. PLoS One, 18(2), e0281591.
[15]. Oktamianti, P., Bachtiar, A., Sutoto, S., Trihandini, I., Prasetyo, S., Achadi, A., Efendi, F., 2021, Tuberculosis control within Indonesia's hospital accreditation. J Public Health Res., 10(3), 1979.
[16]. Winardi, W., Wahyuni, H., Hidayat, M., Wirawan, A., Nurwidya, F., Uddin, M. N., Yusup, M., 2022, Challenges on tuberculosis care in health care facilities during COVID-19 pandemic: Indonesian perspective. Narra J., 2(2), e80.
[17]. Iskandar, D., Suwantika, A. A., Pradipta, I. S., Postma, M. J., van Boven, J. F. M., 2023, Clinical and economic burden of drug-susceptible tuberculosis in Indonesia: national trends 2017-2019. Lancet Glob Health, 11(1), e117-e125.
[18]. Fahdhienie, F., Mudatsir, M., Abidin, T. F., Nurjannah, N., 2024, Risk factors of pulmonary tuberculosis in Indonesia: A case-control study in a high disease prevalence region. Narra J., 4(2), e943.
[19]. Dana, N. R., Rika, S., M, I. P., Alexander, M. B., Muthia, S., Linda, R., Astri, W., Zuhrah, T., Rahman, A. D., Rahmi, F., Nomira, P., Setia, N. D. A. W., Arif, L. B. L., Ainil. M., Octarini, E. M., Nova, L., Tamia, M. Y., Sri, R. A., Permata, S. A., Mimin, O., Puspa, H. F., Fariz, A. M., 2024, Modifiable and non-modifiable risk factors for tuberculosis among adults in indonesia: A systematic review and meta-analysis. Afr J Infect Dis., 18(2), 19-28.
[20]. Kaaffah, S., Kusuma, I. Y., Renaldi, F. S., Lestari, Y. E., Pratiwi, A. D. E., Bahar, M. A., 2023, Knowledge, attitudes, and perceptions of tuberculosis in Indonesia: A multi-center cross-sectional study. Infect Drug Resist., 16, 1787-1800.
[21]. Main, S., Triasih, R., Greig, J., Hidayat, A., Brilliandi, I. B., Khodijah, S., Chan, G., Wilks, N., Parry, A. E., Nababan, B., du Cros, P., Dwihardiani, B., 2023, The prevalence and risk factors for tuberculosis among healthcare workers in Yogyakarta, Indonesia. PLoS One, 18(5), e0279215.
[22]. Soeroto, A. Y., Pratiwi, C., Santoso, P., Lestari, B. W., 2021, Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study. PLoS ONE, 16(2), e0246284.
[23]. Juliasih, N. N., Mertaniasih, N. M., Hadi, C., Soedarsono, Sari, R. M., Alfian, I. N., 2020, Factors affecting tuberculosis patients' quality of life in Surabaya, Indonesia. J Multidiscip Healthc., 13, 1475-1480.
Viewed PDF 31 1 -
Efficacy and Safety of Finerenone in Patients with Heart Failure, Chronic Kidney Disease, and Type 2 Diabetes: A Comprehensive Review of the FINE-HEART Pooled AnalysisAuthor: Faraaz ZaveriDOI: 10.21522/TIJPH.2013.13.01.Art051
Efficacy and Safety of Finerenone in Patients with Heart Failure, Chronic Kidney Disease, and Type 2 Diabetes: A Comprehensive Review of the FINE-HEART Pooled Analysis
Abstract:
This review article discusses the FINE-HEART pooled analysis, which has investigated the efficacy and safety of finerenone in patients with heart failure (HF), chronic kidney disease (CKD), and type 2 diabetes (T2D). Finerenone is a non-steroidal MRA, which delivers marked value in reducing cardiovascular mortality, hospitalization due to heart failure, and the progression of kidney disease, especially in patients with overlapping cardiovascular-kidney-metabolic (CKM) conditions. Several trial results, including FIDELIO-DKD and FIGARO-DKD, were combined to provide an overall overview of the treatment outcomes. The following review discusses the study design, key results, and clinical implications of finerenone use in high-risk populations and concludes that finerenone presents substantial benefits in the management of patients with CKD, HF, and T2D while maintaining an acceptable safety profile.
Efficacy and Safety of Finerenone in Patients with Heart Failure, Chronic Kidney Disease, and Type 2 Diabetes: A Comprehensive Review of the FINE-HEART Pooled Analysis
References:
[1]. Vaduganathan, M., Filippatos, G., Claggett, B. L., et al., 2024, Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes. Nature Medicine. https://doi.org/10.1038/s41591-024-03264-4.
[2]. Ostrominski, J. W., et al., 2024, Cardiovascular-kidney-metabolic overlap in heart failure with mildly reduced or preserved ejection fraction: a trial-level analysis. Journal of the American College of Cardiology, 84, 223–228.
[3]. Ndumele, C. E., et al., 2023, Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation, 148, 1606–1635.
[4]. Bakris, G. L., et al., 2020, Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. New England Journal of Medicine, 383, 2219–2229.
[5]. Agarwal, R., et al., 2022, Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. European Heart Journal, 43, 474–484.
[6]. Neuen, B. L., et al., 2024, Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with conventional care in patients with type 2 diabetes and albuminuria. Circulation, 149, 450–462.
Viewed PDF 22 0 -
Selection of Priority Indicators of Maternal and Child Health Using Difficulty-Usefulness Pyramid (DUP) in Health PromotionAuthor: Ervon VerizaDOI: 10.21522/TIJPH.2013.13.01.Art052
Selection of Priority Indicators of Maternal and Child Health Using Difficulty-Usefulness Pyramid (DUP) in Health Promotion
Abstract:
Maternal and child health program in Indonesia consists of 5 indicators, namely family participation in family planning, childbirth in health care facilities, complete basic immunization for infants, exclusive breastfeeding for infants and monitoring of growth and development of toddlers. This study aimed to select maternal and child health indicators based on priority using the difficulty-usefulness pyramid, involving 329 families selected using snowball sampling. The difficulty and usefulness of all indicators were measured using an online questionnaire and then analyzed using the difficulty-usefulness pyramid method. The results showed that the range based on the total difficulty-usefulness for each indicator was family participation in family planning = 16.96, childbirth in health care facilities = 18.29, complete basic immunization for infants = 18.22, exclusive breastfeeding for infants = 17.50 and monitoring of growth and development of toddlers = 17.72. The largest range was at the base of the pyramid. It could be concluded that the indicator of maternal and child health that was prioritized in the Healthy Indonesia Program with a Family Approach was childbirth in healthcare facilities.
Selection of Priority Indicators of Maternal and Child Health Using Difficulty-Usefulness Pyramid (DUP) in Health Promotion
References:
[1]. Mujiati, Sulistiowati, E., Nurhasanah, S., 2020, Role of community figure in Healthy Indonesia Program with family approach (PIS-PK) in Banjarnegara District, Central Java. Journal of Community Empowerment for Health, 3(3), 178-185.
[2]. Hardjito, K., Rahmaningtyas, I., Nugroho, H. S. W., 2023, Selection of prioritized healthy family indicators, using the difficulty-usefulness pyramid (DUP). Rawal Medical Journal, 48(1), 168-172.
[3]. Kurniawan, R., Nur, R. J. B., Yulianti, S., Nuridzin, D. Z., Kartinah, N. T., 2021, Healthy family index assessment through community-based health information system approach. International Journal of Public Health Science, 10(2), 394.
[4]. Kirby, J. B., Sharma, R., 2017, The availability of community health center services and access to medical care. Healthc (Amst), 5(4), 174-182.
[5]. Weiss-Laxer, N. S., Crandall, A., Hughes, M. E., Riley, A. W., 2020, Families as a cornerstone in 21st century public health: Recommendations for research, education, policy, and practice. Front Public Health, 8, 503.
[6]. Morales-Garzón, S., Parker, L. A., Hernández-Aguado, I., González-Moro Tolosana, M., Pastor-Valero, M., Chilet-Rosell, E., 2023, Addressing health disparities through community participation: a scoping review of co-creation in public health. Healthcare (Basel), 11(7), 1034.
[7]. Spezia, N., De Rosis, S., Nuti, S., 2024, Sense of community in the context of disease prevention and health promotion: A scoping review of the literature. BMC Public Health, 24(1), 3090.
[8]. Nugroho, H. S. W., Sillehu. S., Handoyo, Suparji, Sunarto, Subagyo, Sunarko, B., Bahtiar, 2018, Difficultness-Usefulness Pyramid (DUP) as new method to select elements prioritized in management of e-learning in health. Indian Journal of Public Health Research and Development, 9(2), 206-211.
[9]. Ibrahim, I., Sudiana. I. K., Mukono, H. J., Suhartono, Nugroho, H. S. W., 2020, Determination of priority elements of vigilance in the use of pesticides based on difficulty and usefulness (A supporting study for law and policy in health). Indian Journal of Forensic Medicine and Toxicology, 14(2), 1615-1619.
[10]. Nugroho, H. S. W., Handoyo, Prayitno, H., Budiono, A., 2019, Sort elements based on priority, in order to improve the quality of e-learning in health using Difficulty-Usefulness Pyramid with Weighting (DUP-We). International Journal of Emerging Technologies in Learning (iJET), 14(18), 186-193.
[11]. Ibrahim, I., Sudiana, I. K., Mukono, H. J., Suhartono, Nugroho, H. S. W., 2020, Awareness program of pesticides used among farmers using Difficulty-Usefulness Pyramid (A suggestion for health laws and policies regarding the use of pesticides). Indian Journal of Forensic Medicine and Toxicology, 14(3), 1946-1951.
[12]. Sunarto, S., Nugroho, H. S. W., Suparji, S., Santosa, B. J., 2024, Quadrant of difficulty and usefulness for prioritizing community-based disaster preparedness parameter elements. RMJ, 49(1):172-175.
[13]. Nugroho, H. S. W., Suparji, S., Sunarto, S., Handoyo, H., Yessimbekov, Z., Burhanuddin, N., Selasa, P., 2020, Quadrant of Difficulty-Usefulness (QoDU) as new method in preparing for improvement of e-learning in health college. Risk Manag Healthc Policy, 13, 1625-1632.
[14]. Mahendradhata, Y., Andayani, N. L. P. E., Hasri, E. T., Arifi, M. D., Siahaan, R. G. M., Solikha, D. A., Ali, P. B., 2021, The capacity of the Indonesian healthcare system to respond to COVID-19. Front Public Health, 9, 649819.
[15]. Wenang, S., Schaefers, J., Afdal, A., Gufron, A., Geyer, S., Dewanto, I., Haier, J., 2021, Availability and accessibility of primary care for the remote, rural, and poor population of Indonesia. Front Public Health, 9, 721886.
[16]. Sunjaya, D. K., Herawati, D. M. D., Sihaloho, E. D., Hardiawan, D., Relaksana, R., Siregar, A. Y. M., 2022, Factors affecting payment compliance of the Indonesia national health insurance participants. Risk Manag Healthc Policy, 15, 277-288.
[17]. Rizkianti, A., Saptarini, I., Rachmalina, R., 2021, Perceived barriers in accessing health care and the risk of pregnancy complications in Indonesia. Int J Womens Health, 13,761-772.
[18]. Rohmah, N., Laksono, A. D., 2023, Relationship between family support, personal communication, shared decision making, and breastfeeding in low birth weight babies. Health Care Women Int., 30, 1-13.
[19]. Mawarni, D., Sabran, S., 2022, How is the availability of public health workers in Indonesia's primary health care? Secondary data analysis of health facility research in 2019. J Public Health Afr., 13(Suppl 2), 2400.
[20]. Damayanti, N. A., Wulandari, R. D., Ridlo, I. A., 2023, Maternal health care utilization behavior, local wisdom, and associated factors among women in urban and rural areas, Indonesia. Int J Womens Health, 15, 665-677.
[21]. Shakibazadeh, E., Namadian, M., Bohren, M. A., Vogel, J. P., Rashidian, A., Nogueira Pileggi, V., Madeira, S., Leathersich, S., Tunçalp, Ӧ., Oladapo, O. T., Souza, J. P., Gülmezoglu, A. M., 2018, Respectful care during childbirth in health facilities globally: a qualitative evidence synthesis. BJOG., 125(8), 932-942.
[22]. Belizán, J. M., Miller, S., Williams, C., 2020, Every woman in the world must have respectful care during childbirth: A reflection. Reprod Health, 17, 7.
[23]. De Jonge, A., Downe, S., Page, L., 2019, Value based maternal and newborn care requires alignment of adequate resources with high value activities. BMC Pregnancy Childbirth, 19, 428.
[24]. Dahlen, H. G., 2019, Is it time to ask whether facility based birth is safe for low risk women and their babies? EclinicalMedicine, 14, 9-10.
Viewed PDF 19 0 -
Dental Pulp Stem Cell-Based Therapy for Human DiseasesAuthor: Ganesh Kumar AnbazhaganDOI: 10.21522/TIJPH.2013.13.01.Art053
Dental Pulp Stem Cell-Based Therapy for Human Diseases
Abstract:
Stem cells, which can self-renew and develop into specialized cell types, are used in stem cell therapy, an emerging multidisciplinary approach, to repair and regenerate tissue. This medication may be beneficial for a variety of conditions, such as cardiovascular disease, neurological disorders, autoimmune diseases, and certain types of cancer. However, problems like safety, scalability, and ethical quandaries persist. Dental pulp stem cells (DPSCs), derived from the soft tissue of teeth, offer a clear advantage over other stem cell sources due to their accessibility and regeneration potential. DPSCs are valuable for immunological regulation, neurological therapy, and bone regeneration since they may be obtained non-invasively from extracted teeth and differentiate into a variety of cell types, including osteoblasts, adipocytes, and neurons. DPSCs can promote tissue healing and reduce inflammation due to their immunomodulatory qualities. They also release growth factors and cytokines, which help heal damaged tissues. In clinical settings, DPSCs still have limitations despite their potential, such as the need for homogeneity and scalability. However, because of their broad differentiation potential, ease of procurement, and immune-regulatory qualities, they are positioned as a promising resource in regenerative medicine. This review highlights the characteristics, mechanisms of action, and therapeutic potential of DPSCs in the treatment of diseases, with a special focus on their role in bone regeneration, tissue repair, and neuroprotection. Further research and clinical testing are needed to get past barriers and optimize the use of DPSCs in regenerative therapies.
Dental Pulp Stem Cell-Based Therapy for Human Diseases
References:
[1]. Trapana, J., Weinerman, J., Lee, D., Sedani, A., Constantinescu, D., Best, T., M. Hare, J. M., 2024, Cell-based therapy in the treatment of musculoskeletal diseases. Stem cells translational medicine, 13(10), 959-978.
[2]. Rahman, M. M., Islam, M. R., Islam, M. T., Harun-Or-Rashid, M., Islam, M., Abdullah, S., and Mostafa-Hedeab, G., 2022, Stem cell transplantation therapy and neurological disorders: current status and future perspectives. Biology, 11(1), 147.
[3]. Senthil, R., Anitha, R., and Lakshmi, T., 2024, Mineralized collagen fiber-based dental Implant: novel perspectives. Journal of Advanced Oral Research, 15(1), 62-69.
[4]. Roato, I., Chinigò, G., Genova, T., Munaron, L., and Mussano, F., 2021, Oral cavity as a source of mesenchymal stem cells useful for regenerative medicine in dentistry. Biomedicines, 9(9), 1085.
[5]. Mehta, V., Negi, S., Mathur, A., Tripathy, S., Oberoi, S., Shamim, M. A., and Karobari, I., 2024, Oral health status among the transgender population of India: A systematic review and meta‐analysis. Special Care in Dentistry.
[6]. Baraniak, P. R., and McDevitt, T. C., 2010, Stem cell paracrine actions and tissue regeneration. Regenerative medicine, 5(1), 121-143.
[7]. Tsutsui, T. W., 2020, Dental pulp stem cells: advances to applications. Stem cells and cloning: advances and applications, 33-42.
[8]. Ogata, K., Moriyama, M., Matsumura-Kawashima, M., Kawado, T., Yano, A., and Nakamura, S., 2022, The therapeutic potential of secreted factors from dental pulp stem cells for various diseases. Biomedicines, 10(5), 1049.
[9]. Al Madhoun, A., Sindhu, S., Haddad, D., Atari, M., Ahmad, R. and Al-Mulla, F., 2021, Dental pulp stem cells derived from adult human third molar tooth: a brief review. Frontiers in Cell and Developmental Biology, 9, 717624.
[10]. Baghaei, K., Hashemi, S. M., Tokhanbigli, S., Rad, A. A., Assadzadeh-Aghdaei, H., Sharifian, A., and Zali, M. R., 2017, Isolation, differentiation, and characterization of mesenchymal stem cells from human bone marrow. Gastroenterology and hepatology from bed to bench, 10(3), 208.
[11]. Ram, R. M., and Prasad, M., 2025, An unusual surgical complication: Slipped molar lodged in vocal cords and its anesthetic management. Journal of Oral Biology and Craniofacial Research, 15(1), 22-24.
[12]. Mattei, V., and Delle Monache, S., 2023, Dental pulp stem cells (DPSCs) and tissue regeneration: mechanisms mediated by direct, paracrine, or autocrine effects. Biomedicines, 11(2), 386.
[13]. Goswami, T. K., Singh, M., Dhawan, M., Mitra, S., Emran, T. B., Rabaan, A. A., and Dhama, K., 2022, Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders–Advances and challenges. Human vaccines and immunotherapeutics, 18(1), 2035117.
[14]. Yamada, Y., Nakamura-Yamada, S., Kusano, K., and Baba, S., 2019, Clinical potential and current progress of dental pulp stem cells for various systemic diseases in regenerative medicine: a concise review. International journal of molecular sciences, 20(5), 1132.
[15]. La Noce, M., Paino, F., Spina, A., Naddeo, P., Montella, R., Desiderio, V., and Laino, L., 2014, Dental pulp stem cells: state of the art and suggestions for a true translation of research into therapy. Journal of dentistry, 42(7), 761-768.
[16]. Luo, L., He, Y., Wang, X., Key, B., Lee, B. H., Li, H., Ye, Q., 2018, Potential roles of dental pulp stem cells in neural regeneration and repair. Stem cells international, (1), 1731289.
[17]. Li, F., Wang, X., Shi, J., Wu, S., Xing, W. and He, Y., 2023, Anti-inflammatory effect of dental pulp stem cells. Frontiers in Immunology, 14, 1284868.
[18]. Mattei, V., and Delle Monache, S., 2023, Dental pulp stem cells (DPSCs) and tissue regeneration: mechanisms mediated by direct, paracrine, or autocrine effects. Biomedicines, Jan 28; 11(2):386.
[19]. Anderson, S., Prateeksha, P., and Das, H., 2022, Dental pulp-derived stem cells reduce inflammation, accelerate wound healing and mediate M2 polarization of myeloid cells. Biomedicines, 10(8), 1999.
[20]. Li, F., Wang, X., Shi, J., Wu, S., Xing, W., and He, Y., 2023, Anti-inflammatory effect of dental pulp stem cells. Frontiers in Immunology, 14, 1284868.
[21]. Xue, N., Ding, X., Huang, R., Jiang, R., Huang, H., Pan, X., and Wang, Y., 2022, Bone tissue engineering in the treatment of bone defects. Pharmaceuticals, 15(7), 879.
[22]. Kwack, K. H., and Lee, H. W., 2022, Clinical potential of dental pulp stem cells in pulp regeneration: current endodontic progress and future perspectives. Frontiers in Cell and Developmental Biology, 10, 857066.
[23]. Longoni, A., Utomo, L., van Hooijdonk, I. E., Bittermann, G. K. P., Vetter, V. C., Kruijt Spanjer, E. C., and Gawlitta, D., 2020, The chondrogenic differentiation potential of dental pulp stem cells. European Cells and Materials, 39, 121-135.
[24]. Mattei, V., Martellucci, S., Pulcini, F., Santilli, F., Sorice, M., and Delle Monache, S., 2021, Regenerative potential of DPSCs and revascularization: direct, paracrine or autocrine effect? Stem cell reviews and reports, 1-12.
[25]. Mattei, V., and Delle Monache, S., 2023, Dental pulp stem cells (DPSCs) and tissue regeneration: mechanisms mediated by direct, paracrine, or autocrine effects. Biomedicines, 11(2), 386.
[26]. Johnson, K. E., and Wilgus, T. A., 2014, Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair. Advances in wound care, 3(10), 647-661.
[27]. Ueda, T., Inden, M., Ito, T., Kurita, H., Hozumi, I., 2020, Characteristics and therapeutic potential of dental pulp stem cells on neurodegenerative diseases. Frontiers in Neuroscience, 14, 407.
[28]. Saremi, J., Mahmoodi, N., Rasouli, M., Ranjbar, F. E., Mazaheri, E. L., Akbari, M., and Azami, M., 2022, Advanced approaches to regenerate spinal cord injury: the development of cell and tissue engineering therapy and combinational treatments. Biomedicine and Pharmacotherapy, 146, 112529.
[29]. Blais, M., Lévesque, P., Bellenfant, S., and Berthod, F., 2013, Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model. Tissue Engineering Part A, 19(15-16), 1655-1664.
[30]. Xiong, W., Liu, Y., Zhou, H., Jing, S., He, Y., and Ye, Q., 2022, Alzheimer’s disease: pathophysiology and dental pulp stem cells therapeutic prospects. Frontiers in Cell and Developmental Biology, 10, 999024.
[31]. Kulkarni, O. P., Lichtnekert, J., Anders, H. J., and Mulay, S. R., 2016, The immune system in tissue environments regaining homeostasis after injury: is “inflammation” always inflammation? Mediators of inflammation, 2016(1), 2856213.
[32]. Shi, X., Mao, J., and Liu, Y., 2020, Pulp stem cells derived from human permanent and deciduous teeth: Biological characteristics and therapeutic applications. Stem cells translational medicine, 9(4), 445-464.
[33]. Pezhouman, A., Nguyen, N. B., Kay, M., Kanjilal, B., Noshadi, I., and Ardehali, R., 2023, Cardiac regeneration–Past advancements, current challenges, and future directions. Journal of Molecular and Cellular Cardiology.
[34]. Li, X. L., Fan, W., Fan, B., and Zhang, Y., 2024, Dental pulp regeneration strategies: A review of status quo and recent advances. Bioactive Materials, 38, 258-275.
[35]. Min, Q., Yang, L., Tian, H., Tang, L., Xiao, Z., Shen, J., and Zhou, Y., 2023, Immunomodulatory mechanism and potential application of dental pulp-derived stem cells in immune-mediated diseases. International Journal of Molecular Sciences, 24(9), 8068.
[36]. Isomäki, P., and Punnonen, J., 1997, Pro-and anti-inflammatory cytokines in rheumatoid arthritis. Annals of medicine, 29(6), 499-507.
[37]. Cavallo, S., 2020, Immune-mediated genesis of multiple sclerosis. Journal of Translational Autoimmunity, 3, 100039.
[38]. Potdar, P. D., and Jethmalani, Y. D., 2015, Human dental pulp stem cells: Applications in future regenerative medicine. World journal of stem cells, 7(5), 839.
[39]. Yang, D., Solidum, J. G. N., and Park, D., 2023, Dental pulp stem cells and current in vivo approaches to study dental pulp stem cells in pulp injury and regeneration. Journal of Bone Metabolism, 30(3), 231.
[40]. Nijhawan, L. P., Janodia, M. D., Muddukrishna, B. S., Bhat, K. M., Bairy, K. L., Udupa, N., and Musmade, P. B., 2013, Informed consent: Issues and challenges. Journal of advanced pharmaceutical technology and research, 4(3), 134-140.
[41]. Ayanoğlu, F. B., Elçin, A. E., and Elçin, Y. M., 2020, Bioethical issues in genome editing by CRISPR-Cas9 technology. Turkish Journal of Biology, 44(2), 110-120.
[42]. Bradlow, D. D., Palmieri, A., and Salman, S. M., 2002, Regulatory frameworks for dam safety: A comparative study. World Bank Publications.
[43]. Yuan, B. Z., 2015, Establishing a quality control system for stem cell-based medicinal products in China. Tissue engineering Part A, 21(23-24), 2783-2790.
[44]. Fodor Duric, L., Basic Jukic, N., and Vujicic, B., 2024, Comparison of Autologous and Allogeneic Adipose-Derived Stem Cells in Kidney Transplantation: Immunological Considerations and Therapeutic Efficacy. Journal of clinical medicine, 13(19), 5763.
[45]. Abolarinwa, B. A., Shaw, M. K., and Lee, C. H., 2021, Perspectives on challenges to cell therapy development in Taiwan: strengthening evidential standards and ways forward. Frontiers in Bioengineering and Biotechnology, 9, 789043.
[46]. Amaya-Amaya, J., Montoya-Sánchez, L., and Rojas-Villarraga, A., 2014, Cardiovascular involvement in autoimmune diseases. BioMed research international, 2014(1), 367359.
[47]. Mehta, P. K., Levit, R. D., Wood, M. J., Aggarwal, N., O'Donoghue, M. L., Lim, S. S., and Pepine, C. J., 2023, Chronic rheumatologic disorders and cardiovascular disease risk in women. American Heart Journal Plus: Cardiology Research and Practice, 27, 100267.
[48]. Do, A. V., Khorsand, B., Geary, S. M., and Salem, A. K., 2015, 3D printing of scaffolds for tissue regeneration applications. Advanced healthcare materials, 4(12), 1742-1762.
[49]. Min, Q., Yang, L., Tian, H., Tang, L., Xiao, Z., Shen, J., and Zhou, Y., 2023, Immunomodulatory mechanism and potential application of dental pulp-derived stem cells in immune-mediated diseases. International Journal of Molecular Sciences, 24(9), 8068.
[50]. Yamada, Y., Nakamura-Yamada, S., Konoki, R., and Baba, S., 2020, Promising advances in clinical trials of dental tissue-derived cell-based regenerative medicine. Stem cell research & therapy, 11, 1-10.
[51]. Ferro, F., Spelat, R., and Baheney, C. S., 2014, Dental pulp stem cell (DPSC) isolation, characterization, and differentiation. Stem Cells and Tissue Repair: Methods and Protocols, 91-115.
[52]. Dresser, R., 2010, Stem cell research as innovation: expanding the ethical and policy conversation. Journal of Law, Medicine & Ethics, 38(2), 332-341.
[53]. Timothy, C. N., Samyuktha, P. S., and Brundha, M. P., 2019, Dental pulp stem cells in regenerative medicine–a literature review. Research Journal of Pharmacy and Technology, 12(8), 4052-4056.
[54]. Malakondaiah, S., Pavithravedhavalli, V., Kayal, L., Ryntathiang, I., and Jothinathan, M. K. D., 2024, Stem cell therapy: A new path in tackling oral cancer. Journal of Stomatology, Oral and Maxillofacial Surgery, 101967.
[55]. Shekar, N. D., Kayal, L., Babu, N. A., Jothinathan, M. K. D., and Ryntathiang, I., 2024, Pioneering the use of micro-biomarkers in oral cancer detection. Oral Oncology Reports, 100412.
Viewed PDF 27 1 -
Comparative Study of Dietary, Genetic and Lifestyle Factors in Gouty Arthritis Patients in East Coastal Region of South IndiaAuthor: Lakshmiprabha S.DOI: 10.21522/TIJPH.2013.13.01.Art054
Comparative Study of Dietary, Genetic and Lifestyle Factors in Gouty Arthritis Patients in East Coastal Region of South India
Abstract:
Gouty arthritis is a metabolic disorder marked by elevated uric acid levels and the deposition of urate crystals, often in the first metatarsophalangeal joint. Diet significantly impacts uric acid metabolism, with vegetarian and non-vegetarian diets potentially affecting uric acid levels differently. Additionally, genetic variants and lifestyle factors play important roles in influencing gout severity and associated complications. A cross-sectional study aimed to compare the dietary, genetic and other lifestyle factors that influence gouty arthritis patients. About 82 gouty arthritis patients were included. Serum uric acid levels, genetic variants, and demographic, and clinical data were collected and analyzed. Among non-vegetarian patients, 85% exhibited significantly elevated serum uric acid levels (>10 mg/dL), in contrast to only 15% of vegetarian patients. Over 70% of non-vegetarian individuals had identifiable genetic variants. Furthermore, non-vegetarian patients experienced a higher frequency of acute gout attacks, greater pain severity, and increased tophi formation. The non-vegetarian diet is associated with higher uric acid levels and greater disease severity in patients with gouty arthritis and the Vegetarian diet is beneficial for patients with gouty arthritis, as it is associated with lower serum uric acid levels, fewer acute gout attacks, and reduced medication requirements.
Comparative Study of Dietary, Genetic and Lifestyle Factors in Gouty Arthritis Patients in East Coastal Region of South India
References:
[1]. Johnson, T., Patel, S., Gupta R., 2018, Gouty Arthritis: Pathophysiology and Management. International Journal of Rheumatology, 56(3), 450-455.
[2]. Brown, C.M., Lee, K., Martin, D., 2017, Hyperuricemia and Its Role in Gout Pathogenesis. Clinical Medicine Insights Arthritis Musculoskelet Disorders, 10, 117-124.
[3]. Chakravarty, A., et al., 2018, Gout in India: Prevalence and Clinical Presentation. Indian Journal of Rheumatology, 13(1), 12-16.
[4]. Ramirez, P., Lopez, A., Chang, D., 2020, Dietary Influence on Uric Acid Metabolism and Gout Flares. Arthritis Research and Therapy, 22(2), 321.
[5]. Chopra, A., Kumar, P., Singh, R., 2021, Genetic Epidemiology of Gout in India: The Role of SLC2A9 and ABCG2. Indian Journal of Medical Research, 153(4), 567-575.
[6]. Miller, J., Robinson, T., Stewart, W., 2020, The Role of SLC2A9 in Gout Pathophysiology. Current Rheumatology Reports, 22(6), 45.
[7]. Singh, P., Joseph, M., 2019, ABCG2 Variants in Gout: Clinical Implications and Genetic Insights. Journal of Genetic Medicine, 18(5), 620-628.
[8]. Choi, H.K., Mount, D.B., Reginato, A.M., 2005, Pathogenesis of Gout. Annals of Internal Medicine, 143(7), 499-516.
[9]. Richette, P., Bardin, T., 2010, Gout. Lancet, 375(9711), 318-328.
[10]. Dalbeth, N., Merriman, T.R., Stamp, L.K., 2016, Gout. Lancet, 388(10055), 2039-2052.
[11]. Perez-Ruiz, F., Dalbeth, N., 2011, Managing Gout. Current Opinion in Rheumatology, 23(2), 192-202.
[12]. Erickson, J., Ahmed, N., 2021, Lifestyle Modifications in Gout Management: A Review. Therapeutic Advances in Musculoskeletal Disorders, 13, 211-221.
[13]. Singh JA, Reddy SG, Kundukulam J., 2011, Risk factors for gout and prevention: A systematic review of the literature. Curr Opin Rheumatol., 23(2), 192-202.
[14]. [Choi HK, Gao X, Curhan G., 2009, Vitamin C intake and the risk of gout in men: A prospective study. Arch Intern Med., 169(5), 502-507.
[15]. Lippi, G., & Franchini, M., 2013, Vegetarianism, red meat and health. British Journal of Nutrition, 110(10), 1844-184.
[16]. Yu, K. H., See, L. C., Huang, Y. C., Yang, C. H., Sun, J. H., & Chen, H. J., 2011, Dietary factors associated with hyperuricemia in adults. Seminars in Arthritis and Rheumatism, 40(2), 137-145.
[17]. Nguyen, T.D., Do, P.H., Phan, T.S., Le, T.M., Nguyen, T.C., Phan, T.V., 2019, Genotyping of ABCG2 and SLC22A12 polymorphisms in gout patients using PCR-RFLP technique. International Journal of Clinical and Experimental Medicine, 12(5), 4573-4579.
[18]. Gao, X., Zhang, Y., Li, H., Zhao, Y., Liu, W., Wang, J., et al., 2019, Dietary factors and risk of gout in Chinese men and women. Rheumatology (Oxford), 58(6), 1075-1083.
[19]. Dai, Y., Ma, Y., Zhang, M., et al., 2020, Association of body mass index and gout risk: A systematic review and meta-analysis. BMC Musculoskeletal Disorders, 21(1), 293.
[20]. Sharma, S., et al., 2016, Correlation of dietary factors with the severity of gout: A cross-sectional study. Internal Journal of Rheumatic Diseases, 19(8), 822-828.
[21]. Teng, G.G., et al., 2010, Dietary factors and gout risk in men: a 20-year follow-up study. American Journal of Clinical Nutrition, 92(2), 492-498.
[22]. Zhang, Y., et al., 2008, Alcohol consumption and the risk of gout in women: a prospective study. American Journal of Epidemiology, 168(2), 154-163.
[23]. Kumar, P., et al., 2020, Association of ABCG2 and SLC2A9 genetic variants with gout risk and serum urate levels in a South Indian population. Journal of Clinical Laboratory Analysis, 34(5).
[24]. Takahashi, K., et al., 2012, Diet and hyperuricemia: influence of dietary habits on serum uric acid levels in patients with gout. Rheumatology International. 32(2), 411-417.Viewed PDF 22 0 -
Assessment of the Knowledge, Attitude, and Practice of People Living with HIV/AIDS towards COVID-19 in Akwa Ibom State, NigeriaAuthor: Ursula OnwuzuruigboDOI: 10.21522/TIJPH.2013.13.01.Art055
Assessment of the Knowledge, Attitude, and Practice of People Living with HIV/AIDS towards COVID-19 in Akwa Ibom State, Nigeria
Abstract:
Effective management of an infectious disease like COVID-19 requires adequate knowledge, positive attitudes, and appropriate practices. This study assessed the knowledge, attitudes, and practices (KAP) regarding COVID-19 among individuals living with HIV/AIDS in Uyo, Akwa-Ibom State, Nigeria. The study was a descriptive cross-sectional survey of the knowledge, attitude, and practice regarding COVID-19 among people living with HIV/AIDS at the ART clinic of St Luke’s Hospital Anua Uyo in Akwa Ibom State. Participants were selected using random sampling, and data were collected through a structured questionnaire. Data were analysed using IBM SPSS version 25, with Chi-square statistics performed to determine associations between variables. Statistical significance was set at p < 0.05. 121 respondents participated in the study, with 66.1% being female. Most respondents were aged 31-50 (60.4%), married (54.5%), had secondary education (46.3%), and were self-employed (59.5%)—about half (50.4%) resided in urban areas. COVID-19 awareness was universal (100%), though knowledge decreased significantly with age, particularly among those over 60 (p<0.05). Married and single respondents exhibited higher awareness compared to divorced, separated, or widowed participants (p<0.05), and educated respondents had significantly better knowledge than those with no formal education (p<0.05). Urban residents were more knowledgeable than rural dwellers (p<0.05). While attitudes towards COVID-19 were generally positive (81.8%), education level was significantly associated with a positive attitude (p<0.05). However, practices were poor overall (37.2%), especially among the less educated (p<0.05). This study revealed important disparities in knowledge, attitudes, and practices related to COVID-19 among people living with HIV/AIDS in Uyo. These findings emphasize the need for targeted interventions to improve health education and compliance with COVID-19 preventive measures among vulnerable populations.
Assessment of the Knowledge, Attitude, and Practice of People Living with HIV/AIDS towards COVID-19 in Akwa Ibom State, Nigeria
References:
[1]. Hu, B., Guo, H., Zhou, P., & Shi, Z., 2021, Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology, 19(2), 141–154. https://doi.org/10.1038/s41579-020-00459-7
[2]. WHO. 2020a, Coronavirus Disease 2019, (COVID-19). World Health Organization, Situation Report—84. 2020.
[3]. Hassan, Z., Hashim, M. J., & Khan, G., 2020, Population risk factors for COVID-19 deaths in Nigeria at sub-national level. The Pan African Medical Journal, 35(Suppl 2), 131. https://doi.org/10.11604/pamj.supp.2020.35.131.25258
[4]. Ekanem, A. A., & Ibanga, S. E., 2023, Government administrative practices and spread of COVID-19 in Akwa Ibom State, Nigeria. AKSU Journal of Administration and Corporate Governance, 3(3), 253–264.
[5]. Essien, E., & Cyrus, S., 2019, Detection of urban development in Uyo (Nigeria) using remote sensing. Land, 8(6), 102. https://doi.org/10.3390/land8060102
[6]. Mwanza, J., & Etokakpan, A., 2023, Accelerating progress towards UNAIDS 95-95-95 goals: Data-use lessons from Akwa Ibom, Nigeria. PLOS HIV.
[7]. WHO. 2020b, Coronavirus disease (COVID-19) advice for the public. Myth Busters. https://www.who.int/emergencies/diseases/%0Anovel-coronavirus-2019/advice-for-public.
[8]. CDC. 2020, Coronavirus Disease 2019 (COVID-19): Preventing Getting Sick. Centers for Disease Control and Prevention.
[9]. Mirzaei, H., McFarland, W., Karamouzian, M., & Sharifi, H., 2021, COVID-19 Among People Living with HIV: A Systematic Review. AIDS and Behavior, 25(1), 85–92. https://doi.org/10.1007/s10461-020-02983-2
[10]. AIDSinfo, 2020, Interim guidance for COVID-19 and persons with HIV. U.S. Department of Health and Human Services, 1–7. https://aidsinfo.nih.gov/guidelines/html/8/covid-19-and-persons-with-hiv--interim-guidance-/554/interim-guidance-for-covid-19-and-persons-with-hiv
[11]. Blanc, F. X., Laureillard, D., & Goldfeld, A. E., 2020, Comment on: Effects of time of initiation of antiretroviral therapy in the treatment of patients with HIV/TB co-infection, by Chelkeba L. et al. Annals of Medicine and Surgery, 57, 22–23. https://doi.org/10.1016/j.amsu.2020.06.039
[12]. Segagni Lusignani, L., Quaglio, G., Atzori, A., Nsuka, J., Grainger, R., Da Conceiçao Palma, M., Putoto, G., & Manenti, F., 2013, Factors associated with patient and health care system delay in diagnosis for tuberculosis in the province of Luanda, Angola. BMC Infectious Diseases, 13(1). https://doi.org/10.1186/1471-2334-13-168
[13]. Ayinde, O. O., Usman, A. B., Posi, A., & Gbolahan, A., 2020, A Cross-Sectional Study on Oyo State Health Care Worker’s Knowledge, Attitude and Practice regarding Corona Virus Disease 2019 (COVID-19). Advances in Infectious Diseases, 10(03), 6–15. https://doi.org/10.4236/aid.2020.103002
[14]. Choi JS, Y. N., 2010, Perceived Knowledge, Attitude, and Compliance with Preventive Behavior on Influenza A (H1N1) by University Students. The Korean Academic Society of Adult Nursing, 22(3), 250–259.
[15]. Zhong, B. L., Luo, W., Li, H. M., Zhang, Q. Q., Liu, X. G., Li, W. T., & Li, Y., 2020, Knowledge, attitudes, and practices towards COVID-19 among chinese residents during the rapid rise period of the COVID-19 outbreak: A quick online cross-sectional survey. International Journal of Biological Sciences, 16(10), 1745–1752. https://doi.org/10.7150/ijbs.45221
[16]. Hussain, Z. A., Hussain, S. A., & Hussain, F. A., 2012, Medical students’ knowledge, perceptions, and behavioral intentions towards the H1N1 influenza, swine flu, in Pakistan: A brief report. American Journal of Infection Control, 40(3). https://doi.org/10.1016/j.ajic.2011.12.004
[17]. Aziz, M. M., Abd El-Megeed, H. S., & Abd Ellatif, M. A. M., 2018, Pre-travel health seeking practices of Umrah pilgrims departing from Assiut International Airport, Egypt. Travel Medicine and Infectious Disease, 23, 72–76. https://doi.org/10.1016/j.tmaid.2018.04.012
[18]. Rahman, A., & Sathi, N. J., 2020, Knowledge, attitude, and preventive practices toward COVID-19 among Bangladeshi internet users. Electronic Journal of General Medicine, 17(5). https://doi.org/10.29333/ejgm/8223
[19]. Person, B., Sy, F., Holton, K., Govert, B., & Liang, A., 2004, National center for inectious diseases SCOT: Fear and stigma: the epidemic within the SARS outbreak. Infectious Diseases, 10, 358–363.
[20]. Tao, N., 2003, An analysis on reasons of SARS induced psychological panic among students. J Anhui Inst Educ, 21, 78–79.
[21]. Al-Hanawi, M. K., Angawi, K., Alshareef, N., Qattan, A. M. N., Helmy, H. Z., Abudawood, Y., Alqurashi, M., Kattan, W. M., Kadasah, N. A., Chirwa, G. C., & Alsharqi, O., 2020, Knowledge, Attitude and Practice Toward COVID-19 Among the Public in the Kingdom of Saudi Arabia: A Cross-Sectional Study. Frontiers in Public Health, 8(May), 1–10. https://doi.org/10.3389/fpubh.2020.00217
[22]. Paul, A., Sikdar, D., Hossain, M. M., Amin, M. R., Deeba, F., Mahanta, J., Akib Jabed, M., Mohaiminul Islam, M., Jahan Noon, S., & Kumar Nath, T., 2020, Knowledge, attitudes, and practices toward the novel coronavirus among Bangladeshis: Implications for mitigation measures. PLoS ONE, 15(9 September 2020), 1–18. https://doi.org/10.1371/journal.pone.0238492
[23]. Ghate, M. V., Shidhaye, P. R., Gadhe, K. R., Gurav, S. G., & Deoraj, P., 2021, Knowledge, attitude and practices towards COVID-19 among people living with HIV in Pune, India: a cross-sectional study. International Journal of Research in Medical Sciences, 9(5), 1458. https://doi.org/10.18203/2320-6012.ijrms20211886
[24]. Okafor, N. B., 2020, Compliance to COVID 19 Preventive Measures towards the Environmental Health in Nigeria Universities. International Journal of Trend in Scientific Research and Development (IJTSRD) International Journal of Trend in Scientific Research and Development, 4(6), 775–782. url: https://www.ijtsrd.com/papers/ijtsrd33353.pdf%0Ahttps://www.ijtsrd.com/other-scientific-research-area/enviormental-science/33353/compliance-to-covid19-preventive-measures-towards-the-environmental-health-in-nigeria-universities/okafor-b-n
[25]. Okoro, J., Ekeroku, A., Nweze, B., Odionye, T., Nkire, J., Onuoha, M., Ezeonwuka, C., & Owoh, J., 2020, Attitude and preventive practices towards COVID-19 disease and the impact of awareness training on knowledge of the disease among correctional officers. Emerald Open Research, 2, 51. https://doi.org/10.35241/emeraldopenres.13839.1
[26]. Afzal, M. S., Khan, A., Qureshi, U. U. R., Saleem, S., Saqib, M. A. N., Shabbir, R. M. K., Naveed, M., Jabbar, M., Zahoor, S., & Ahmed, H., 2021, Community-Based Assessment of Knowledge, Attitude, Practices and Risk Factors Regarding COVID-19 Among Pakistanis Residents During a Recent Outbreak: A Cross-Sectional Survey. Journal of Community Health, 46(3), 476–486. https://doi.org/10.1007/s10900-020-00875-z
[27]. Al-Hazmi, A., Gosadi, I., Somily, A., Alsubaie, S., & Bin Saeed, A., 2018, Knowledge, attitude and practice of secondary schools and university students toward Middle East Respiratory Syndrome epidemic in Saudi Arabia: A cross-sectional study. Saudi Journal of Biological Sciences, 25(3), 572–577. https://doi.org/10.1016/j.sjbs.2016.01.032
[28]. Al-Naggar, R. A., & Osman, M. T., 2015, Knowledge of Breast Cancer and its Association with Preventive Practice among Malaysian School Teachers. International Archives of Medicine. https://doi.org/10.3823/1800
[29]. Al-Rabee, N. A., Dallak, A. M., & Al-Awadi, F. G., 2012, Knowledge, attitude and beliefs towards HIV/AIDS among students of health institutes in Sana’a city. Eastern Mediterranean Health Journal, 18(3), 221–226. https://doi.org/10.26719/2012.18.3.221
[30]. Alzoubi, H., Alnawaiseh, N., Al-Mnayyis, A., Abu-Lubad, M., Aqel, A., & Al-Shagahin, H., 2020, COVID-19 - Knowledge, attitude and practice among medical and non-medical university students in Jordan. Journal of Pure and Applied Microbiology, 14(1), 17–24. https://doi.org/10.22207/JPAM.14.1.04
[31]. Asemahagn, M. A., 2020, Factors determining the knowledge and prevention practice of healthcare workers towards COVID-19 in Amhara region, Ethiopia: A cross-sectional survey. Tropical Medicine and Health, 48(1). https://doi.org/10.1186/s41182-020-00254-3
[32]. Bekele, F., Sheleme, T., Fekadu, G., & Bekele, K., 2020, Patterns and associated factors of COVID-19 knowledge, attitude, and practice among general population and health care workers: A systematic review. SAGE Open Medicine, 8, 205031212097072. https://doi.org/10.1177/2050312120970721
[33]. Erfani, A., Shahriarirad, R., Ranjbar, K., Mirahmadizadeh, A., & Moghadami, M., 2020, Knowledge, attitude and practice toward the novel coronavirus (COVID-19) outbreak- A population-based survey in Iran. Bulletin of the World Health Organization, March, 2–3.
[34]. Kassa, A. M., Mekonen, A. M., Yesuf, K. A., Woday Tadesse, A., & Bogale, G. G., 2020, Knowledge level and factors influencing prevention of COVID-19 pandemic among residents of Dessie and Kombolcha City administrations, North-East Ethiopia: A population-based cross-sectional study. BMJ Open, 10(11), 44202. https://doi.org/10.1136/bmjopen-2020-044202
[35]. Lee, M., Kang, B. A., & You, M., 2021, Knowledge, attitudes, and practices (KAP) toward COVID-19: a cross-sectional study in South Korea. BMC Public Health, 21(1), 1–10. https://doi.org/10.1186/s12889-021-10285-y
[36]. Yousaf, M. A., Noreen, M., Saleem, T., & Yousaf, I., 2020, A Cross-Sectional Survey of Knowledge, Attitude, and Practices (KAP) Toward Pandemic COVID-19 Among the General Population of Jammu and Kashmir, India. Social Work in Public Health, 35(7), 569–578. https://doi.org/10.1080/19371918.2020.1806983
[37]. Wong, C. L., Chen, J., Chow, K. M., Law, B. M. H., Chan, D. N. S., So, W. K. W., Leung, A. W. Y., & Chan, C. W. H., 2020, Knowledge, attitudes and practices towards COVID-19 amongst ethnic minorities in Hong Kong. International Journal of Environmental Research and Public Health, 17(21), 1–13. https://doi.org/10.3390/ijerph17217878
[38]. Iradukunda, P. G., Pierre, G., Muhozi, V., Denhere, K., & Dzinamarira, T., 2021, Knowledge, Attitude, and Practice Towards COVID-19 Among People Living with HIV/AIDS in Kigali, Rwanda. Journal of Community Health, 46(2), 245–250. https://doi.org/10.1007/s10900-020-00938-1
[39]. Lau, L. L., Hung, N., Go, D. J., Ferma, J., Choi, M., Dodd, W., & Wei, X., 2020, Knowledge, attitudes and practices of COVID-19 among income-poor households in the Philippines: A cross-sectional study. Journal of Global Health, 10(1). https://doi.org/10.7189/JOGH.10.011007
[40]. Lin, Y., Huang, L., Nie, S., Liu, Z., Yu, H., Yan, W., & Xu, Y., 2011, Knowledge, Attitudes and Practices (KAP) related to the Pandemic (H1N1) 2009 among Chinese General Population: A Telephone Survey. BMC Infectious Diseases, 11. https://doi.org/10.1186/1471-2334-11-128
[41]. Tandi, T. E., Kim, K., Cho, Y., & Choi, J. W., 2018, Public health concerns, risk perception and information sources in Cameroon. Cogent Medicine, 5(1), 1453005. https://doi.org/10.1080/2331205x.2018.1453005
[42]. Tangcharoensathien, V., Calleja, N., Nguyen, T., Purnat, T., D’Agostino, M., Garcia-Saiso, S., Landry, M., Rashidian, A., Hamilton, C., AbdAllah, A., Ghiga, I., Hill, A., Hougendobler, D., van Andel, J., Nunn, M., Brooks, I., Sacco, P. L., de Domenico, M., Mai, P., … Briand, S., 2020, Framework for managing the COVID-19 infodemic: Methods and results of an online, crowdsourced who technical consultation. Journal of Medical Internet Research, 22(6). https://doi.org/10.2196/19659
[43]. Abdelhafiz, A. S., Mohammed, Z., Ibrahim, M. E., Ziady, H. H., Alorabi, M., Ayyad, M., & Sultan, E. A., 2020, Knowledge, Perceptions, and Attitude of Egyptians Towards the Novel Coronavirus Disease (COVID-19). Journal of Community Health, 45(5), 881–890. https://doi.org/10.1007/s10900-020-00827-7
[44]. Ahmed, N., Shakoor, M., Vohra, F., Abduljabbar, T., Mariam, Q., & Rehman, M. A., 2020, Knowledge, awareness and practice of health care professionals amid sars-cov-2, corona virus disease outbreak. Pakistan Journal of Medical Sciences, 36(COVID19-S4), S49–S56. https://doi.org/10.12669/pjms.36.COVID19-S4.2704
[45]. Huynh, G., Nguyen, T., Tran, V., Vo, K., Vo, V., & Pham, L., 2020, Knowledge and attitude toward COVID-19 among healthcare workers at District 2 Hospital, Ho Chi Minh City. Asian Pacific Journal of Tropical Medicine, 13(6), 260–265. https://doi.org/10.4103/1995-7645.280396
[46]. Lee, M., & You, M., 2020, Psychological and behavioral responses in South Korea during the early stages of coronavirus disease 2019 (COVID-19). International Journal of Environmental Research and Public Health, 17(9). https://doi.org/10.3390/ijerph17092977
[47]. Zhou, M., Tang, F., Wang, Y., Nie, H., Zhang, L., … G. Y.-J. of H., & 2020, U., 2020, Knowledge, attitude and practice regarding COVID-19 among health care workers in Henan, China. Journal of Hospital Infection, 105, 183–187. https://www.sciencedirect.com/science/article/pii/S0195670120301870?casa_token=yRjAZCJAPwYAAAAA:fG9P4Wad8JZgtkcZmf4TvFPcoaqb33LVGtcl_gSIQD0of8ms0ZjK
[48]. Al-Ahdab, S., 2021, A cross-sectional survey of knowledge, attitude and practice (KAP) towards COVID-19 pandemic among the Syrian residents. BMC Public Health, 21(1), 1–7. https://doi.org/10.1186/s12889-021-10353-3
[49]. Edet, C. K., Wegbom, A. I., & Kiri, V. A., 2020, Knowledge, Attitude and Practice of Clients towards COVID-19 at Primary Healthcare Facilities in Rivers State, Nigeria. https://doi.org/10.21203/rs.3.rs-40966/v1
[50]. Gebretsadik, D., Gebremichael, S., & Belete, M. A., 2021, Knowledge, attitude and practice toward covid-19 pandemic among population visiting dessie health center for covid-19 screening, northeast ethiopia. Infection and Drug Resistance, 14, 905–915. https://doi.org/10.2147/IDR.S297047
[51]. Kakemam, E., Ghoddoosi-Nejad, D., Chegini, Z., Momeni, K., Salehiniya, H., Hassanipour, S., Ameri, H., & Arab-Zozani, M., 2020, Knowledge, Attitudes, and Practices Among the General Population During COVID-19 Outbreak in Iran: A National Cross-Sectional Online Survey. Frontiers in Public Health, 8(December), 1–8. https://doi.org/10.3389/fpubh.2020.585302
[52]. Mohamed, A., Elhassan, E., Mohamed, A., Mohammed, A. A., edris, H. A., Mahgoop, M. A., Sharif, M. E., Bashir, M. I., Abderlahim, R. B., Idriss, W. I., & Malik, E. M., 2020, Knowledge, attitude and practice of the Sudanese people towards COVID-19: An online survey. 1–7. https://doi.org/10.21203/rs.3.rs-32375/v1
[53]. Zhang, M., Zhou, M., Tang, F., Wang, Y., Nie, H., Zhang, L., & You, G., 2020, Knowledge, attitude, and practice regarding COVID-19 among healthcare workers in Henan, China. Journal of Hospital Infection, 105(2), 183–187. https://doi.org/10.1016/j.jhin.2020.04.012
[54]. Wolf, M. S., Serper, M., Opsasnick, L., O’Conor, R. M., Curtis, L., Benavente, J. Y., Wismer, G., Batio, S., Eifler, M., Zheng, P., Russell, A., Arvanitis, M., Ladner, D., Kwasny, M., Persell, S. D., Rowe, T., Linder, J. A., & Bailey, S. C., 2020, Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak: A Cross-sectional Survey. Annals of Internal Medicine, 173(2), 100–109. https://doi.org/10.7326/M20-1239
[55]. McEachan, R., Taylor, N., Harrison, R., Lawton, R., Gardner, P., & Conner, M., 2016, Meta-Analysis of the Reasoned Action Approach (RAA) to Understanding Health Behaviors. Annals of Behavioral Medicine, 50(4), 592–612. https://doi.org/10.1007/s12160-016-9798-4
[56]. ALdowyan, N., Abdallah, A. S., & El-Gharabawy, R., 2017, Knowledge, Attitude and Practice (KAP) Study about Middle East Respiratory Syndrome Coronavirus (MERS-CoV) among Population in Saudi Arabia. International Archives of Medicine, 10. https://doi.org/10.3823/2524
[57]. Leung, G. M., Lam, T. H., Ho, L. M., Ho, S. Y., Chan, B. H. Y., Wong, I. O. L., & Hedley, A. J., 2003, The impact of community psychological responses on outbreak control for severe acute respiratory syndrome in Hong Kong. Journal of Epidemiology and Community Health, 57(11), 857–863. https://doi.org/10.1136/jech.57.11.857
[58]. Moran, K. R., & Del Valle, S. Y., 2016, A meta-analysis of the association between gender and protective behaviors in response to respiratory epidemics and pandemics. PLoS ONE, 11(10). https://doi.org/10.1371/journal.pone.0164541
Viewed PDF 22 0 -
Assessment of Infection Prevention and Control (IPC) in Healthcare Facilities in Complex Humanitarian Emergencies - Cox’s Bazar Rohingya Refugee Camps - 2020Author: Rebecca R. ApolotDOI: 10.21522/TIJPH.2013.13.01.Art056
Assessment of Infection Prevention and Control (IPC) in Healthcare Facilities in Complex Humanitarian Emergencies - Cox’s Bazar Rohingya Refugee Camps - 2020
Abstract:
Infection prevention and control (IPC) is crucial for the prevention of healthcare-associated infections (HAIs) in healthcare facilities (HFs). The World Health Organization (WHO) published eight core components (CCs) of IPC to guide IPC program implementation in HFs. WHO also developed the IPC Assessment Framework (IPCAF) tool to assess the level of IPC program implementation and identify areas for improvement in HFs. We conducted a cross-sectional study in Nov 2024 using the IPCAF tool by extracting data from February 2020 IPCAF reports from 45 HFs in Rohingya refugee camps. Conducted descriptive analysis using SPSS 29 for each IPC CC, total IPC scores per HF and level of IPC promotion and practices obtained. 46.7% of HFs scored as inadequate, 37.8% scored as basic, 11.1% as intermediate level and 4.4% scored as an advanced level of IPC. 71% of the HFs did not have an IPC program, 84% lacked standard precaution guidelines, 60% had not provided any IPC training and none conducted HAI surveillance. 69% of the HFs did not follow the multimodal strategy for IPC while 82% did not monitor IPC activities. 71% of HFs had appropriate staffing, workload and bed occupancy and 51.1% of HFs had functional hand hygiene stations at all points of care. There were no HFs in the Rohingya refugee camps with fully implemented IPC programs in 2020. An IPC program that aims at implementing all core components of the IPC program should be considered for HFs in Cox’s Bazar refugee camps and similar settings.
Assessment of Infection Prevention and Control (IPC) in Healthcare Facilities in Complex Humanitarian Emergencies - Cox’s Bazar Rohingya Refugee Camps - 2020
References:
[1]. World health Organization. 2024, August 3, Infection Prevention and Control. Infection Prevention and Control Overview. https://www.who.int/health-topics/infection-prevention-and-control#tab=tab_1
[2]. World Health Organisation. (n.d.). Infection prevention and control. Who.Int. Retrieved March 15, 2020, from https://www.who.int/infection-prevention/en/
[3]. World Health organization., 2023, Global strategy on infection prevention and control.
[4]. World Health Organization, 2020, Operational planning guidance to support country preparedness and response. COVID 19 strategic preparedness and response. 22 May 2020. COVID-19: Critical preparedness, readiness and response.
[5]. World Health Organization., 2021, Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed. interim guidance. 12 July 2021.
[6]. United Nations, 2015, Transforming our world: the 2030 agenda for sustainable development. 2015. https://sdgs.un.org/2030agenda
[7]. World health Organization., 2015, Global Action Plan on Antimicrobial Resistance 2015.
[8]. World Health Organization, 2005, International Health Regulations (2005) - Third Edition. (World Health Organization, Ed.; Third, Vol. 3). World Health organization. https://iris.who.int/bitstream/handle/10665/246107/9789241580496-eng.pdf
[9]. World Health Organization, 2016, Health care without avoidable infections: the critical role of infection prevention and control. World Health Organization.
[10]. Shackelford, B. B., Cronk, R., Behnke, N., Cooper, B., Tu, R., D’Souza, M., Bartram, J., Schweitzer, R., & Jaff, D., 2020, Environmental health in forced displacement: A systematic scoping review of the emergency phase. Science of the Total Environment, 714. https://doi.org/10.1016/j.scitotenv.2020.136553
[11]. Breiman, R. F., Shultz, A., Omollo, J. O., Burke, H., Qassim, M., Ochieng, J. B., Weinberg, M., & Feikin, D. R., 2009, Cholera outbreak in kenyan refugee camp: Risk factors for illness and importance of sanitation. American Journal of Tropical Medicine and Hygiene, 80(4). https://doi.org/10.4269/ajtmh.2009.80.640
[12]. Connolly, M. A., Gayer, M., Ryan, M. J., Salama, P., Spiegel, P., & Heymann, D. L., 2004, Communicable diseases in complex emergencies: Impact and challenges. In Lancet (Vol. 364, Issue 9449). https://doi.org/10.1016/S0140-6736(04)17481-3
[13]. Behnke, N. L., Cronk, R., Shackelford, B. B., Cooper, B., Tu, R., Heller, L., & Bartram, J., 2020, Environmental health conditions in protracted displacement: A systematic scoping review. Science of the Total Environment, 726. https://doi.org/10.1016/j.scitotenv.2020.138234
[14]. Cooper, B., Behnke, N. L., Cronk, R., Anthonj, C., Shackelford, B. B., Tu, R., & Bartram, J., 2021, Environmental health conditions in the transitional stage of forcible displacement: A systematic scoping review. In Science of the Total Environment (Vol. 762). https://doi.org/10.1016/j.scitotenv.2020.143136
[15]. UNHCR, & Government of Bangladesh., 2024, Joint Government of Bangladesh - UNHCR Population Factsheet - 30 June 2024. https://data.unhcr.org/en/country/bgd
[16]. Cox’s Bazar Health Sector., 2024, Cox’s Bazar Health Sector bulletin - May 2024. https://rohingyaresponse.org/wp-content/uploads/2024/06/CXB-Health-Sector-Bulletin-May-2024.pdf
[17]. World Health Organization., 2016, Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level. In World Health Organization.
[18]. World Health Organization., 2018, Infection prevention and control assessment framework at the facility level. World Health Organization.
[19]. Kamara, R. Z., Kamara, I. F., Moses, F., Kanu, J. S., Kallon, C., Kabba, M., Moffett, D. B., Fofanah, B. D., Margao, S., Kamara, M. N., Moiwo, M. M., Kpagoi, S. S. T. K., Tweya, H. M., Kumar, A. M. V., & Terry, R. F., 2023, Improvement in Infection Prevention and Control Compliance at the Three Tertiary Hospitals of Sierra Leone following an Operational Research Study. Tropical Medicine and Infectious Disease, 8(7). https://doi.org/10.3390/tropicalmed8070378
[20]. World Health Organization., 2018, Infection prevention and control assessment framework at the facility level. World Health Organization.
[21]. Ahmado, M. A., Alghajar, M., Meagher, K., Patel, P., & Ekzayez, A., 2024, Infection Prevention and Control (IPC) in conflict-affected areas in Northeast Syria: A cross-sectional study. IJID Regions, 100412. https://doi.org/10.1016/J.IJREGI.2024.100412
[22]. Tomczyk, S., Twyman, A., de Kraker, M. E. A., Coutinho Rehse, A. P., Tartari, E., Toledo, J. P., Cassini, A., Pittet, D., & Allegranzi, B., 2022, The first WHO global survey on infection prevention and control in health-care facilities. The Lancet Infectious Diseases, 22(6). https://doi.org/10.1016/S1473-3099(21)00809-4
[23]. Oppong, T. B., Amponsem-Boateng, C., Kyere, E. K. D., Wang, Y., Gheisari, Z., Oppong, E. E., Opolot, G., Duan, G., & Yang, H., 2020, Infection prevention and control preparedness level and associated determinants in 56 acute healthcare facilities in Ghana. Infection and Drug Resistance, 13. https://doi.org/10.2147/IDR.S273851
[24]. Asgedom, A. A., 2024, Status of infection prevention and control (IPC) as per the WHO standardised Infection Prevention and Control Assessment Framework (IPCAF) tool: existing evidence and its implication. In Infection Prevention in Practice (Vol. 6, Issue 2). https://doi.org/10.1016/j.infpip.2024.100351
[25]. Cissé, D. M., Laure, E. E. M., Blaise, K. A., Jean Paul, N. N., Gbonon, M. V., Mayaka, C. R. A., Eugénie, G. D., Simplice, D. N., Philippe, K. L., & Mamadou, S., 2023, Evaluation of the implementation of hospital hygiene components in 30 health-care facilities in the autonomous district of Abidjan (Cote d’Ivoire) with the WHO Infection Prevention and Control Assessment Framework (IPCAF). BMC Health Services Research, 23(1). https://doi.org/10.1186/s12913-023-09853-2
[26]. Harun, M. G. D., Anwar, M. M. U., Sumon, S. A., Hassan, M. Z., Haque, T., Mah-E-Muneer, S., Rahman, A., Abdullah, S. A. H. M., Islam, M. S., Styczynski, A. R., & Kaydos-Daniels, S. C., 2022, Infection prevention and control in tertiary care hospitals of Bangladesh: results from WHO infection prevention and control assessment framework (IPCAF). Antimicrobial Resistance and Infection Control, 11(1). https://doi.org/10.1186/s13756-022-01161-4
[27]. Kamara, I. F., Tengbe, S. M., Fofanah, B. D., Bunn, J. E., Njuguna, C. K., Kallon, C., & Kumar, A. M. V., 2022, Infection Prevention and Control in Three Tertiary Healthcare Facilities in Freetown, Sierra Leone during the COVID-19 Pandemic: More Needs to Be Done! International Journal of Environmental Research and Public Health, 19(9). https://doi.org/10.3390/ijerph19095275
[28]. World Health Organization, 2018, 2018 Global reference list of 100 core health indicators (plus health-related SDGs). World Health Organization.
[29]. Government of Bangladesh., 2018, Hospital Infection Prevention and Control manual.
[30]. Martin, E. K., Salsgiver, E. L., Bernstein, D. A., Simon, M. S., Greendyke, W. G., Gramstad, J. M., Weeks, R., Woodward, T., Jia, H., Saiman, L., Furuya, E. Y., & Calfee, D. P., 2019, Sustained improvement in hospital cleaning associated with a novel education and culture change program for environmental services workers. Infection Control and Hospital Epidemiology, 40(9). https://doi.org/10.1017/ice.2019.183
[31]. Allegranzi, B., Conway, L., Larson, E., & Pittet, D., 2014, Status of the implementation of the World Health Organization multimodal hand hygiene strategy in United States of America health care facilities. American Journal of Infection Control. https://doi.org/10.1016/j.ajic.2013.11.015
[32]. Krein, S. L., Hofer, T. P., Kowalski, C. P., Olmsted, R. N., Kauffman, C. A., Forman, J. H., Banaszak-Holl, J., & Saint, S., 2007, Use of central venous catheter-related bloodstream infection prevention practices by US hospitals. Mayo Clinic Proceedings, 82(6), 672–678.
[33]. HEKS/EPER, & WHO., 2019, LESSONS LEARNT FROM WASH FIT INTERVENTIONS IN THE FDMN SETTLEMENTS, COX’S BAZAAR.
[34]. Haley, R. W., Culver, D. H., White, J. W., Morgan, W. M., Emori, T. G., Munn, V. P., & Hooton, T. M., 1985, The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. American Journal of Epidemiology, 121(2), 182–205. https://doi.org/10.1093/oxfordjournals.aje.a113990
[35]. Weinshel, K., Dramowski, A., Hajdu, Á., Jacob, S., Khanal, B., Zoltán, M., Mougkou, K., Phukan, C., Staneloni, M. I., & Singh, N., 2015, Gap analysis of infection control practices in low- and middle-income countries. Infection Control and Hospital Epidemiology, 36(10). https://doi.org/10.1017/ice.2015.160
[36]. Stempliuk, V., 2018, Surveillance of Healthcare-Associated Infections in Low- and Middle-Income Countries: From the Need to a Reality. Current Treatment Options in Infectious Diseases, 10(1). https://doi.org/10.1007/s40506-018-0148-x
[37]. Jayatilleke, K., 2020, Challenges in Implementing Surveillance Tools of High-Income Countries (HICs) in Low Middle Income Countries (LMICs). Current Treatment Options in Infectious Diseases, 12(3). https://doi.org/10.1007/s40506-020-00229-2
[38]. World Health Organization, 2016, Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level. In World Health Organization.
[39]. Zamudio-Lugo, I., Meza-Chávez, A., Martínez-Sánchez, Y., Miranda-Novales, M. G., Espinosa-Vital, J. G., & Rodríguez-Sing, R., 2012, Multimodal study of hand hygiene in a third level pediatric hospital. Boletín Médico Del Hospital Infantil de México, 69(5).
[40]. Dramowski, A., Aucamp, M., Bekker, A., Pillay, S., Moloto, K., Whitelaw, A. C., Cotton, M. F., & Coffin, S., 2021, NeoCLEAN: a multimodal strategy to enhance environmental cleaning in a resource-limited neonatal unit. Antimicrobial Resistance and Infection Control, 10(1). https://doi.org/10.1186/s13756-021-00905-y
[41]. Walker, J. L., Sistrunk, W. W., Higginbotham, M. A., Burks, K., Halford, L., Goddard, L., Thombs, L. A., Austin, C., & Finley, P. J., 2014, Hospital hand hygiene compliance improves with increased monitoring and immediate feedback. American Journal of Infection Control, 42(10). https://doi.org/10.1016/j.ajic.2014.06.018
[42]. Meng, M., Sorber, M., Herzog, A., Igel, C., & Kugler, C., 2019, Technological innovations in infection control: A rapid review of the acceptance of behavior monitoring systems and their contribution to the improvement of hand hygiene. In American Journal of Infection Control (Vol. 47, Issue 4). https://doi.org/10.1016/j.ajic.2018.10.012
[43]. Northey, C., 2012, Improving Hand Hygiene Practice Through Utilization of Automated Hand Hygiene Monitoring and Feedback Technology. American Journal of Infection Control, 40(5). https://doi.org/10.1016/j.ajic.2012.04.273
[44]. World Health Organization. 2010, Hand Hygiene Self-Assessment Framework 2010. Clean Care Is Safe Care.
[45]. Lowe, H., Woodd, S., Lange, I. L., Janjanin, S., Barnett, J., & Graham, W., 2021, Challenges and opportunities for infection prevention and control in hospitals in conflict-affected settings: a qualitative study. Conflict and Health, 15(1). https://doi.org/10.1186/s13031-021-00428-8
[46]. Tahir, M. A., Khan, M. A., Ikram, A., Chaudhry, T. H., Jabeen, A., Quddous, A., & Haq, I. U., 2023, Assessment of Infection Prevention and Control (IPC) Implementation and Strategies Used for IPC Preparedness at Facility Level in Underdeveloped Areas of Pakistan. Infection and Drug Resistance, 16. https://doi.org/10.2147/IDR.S399830
[47]. Anthony, M., Bedford-Russell, A., Cooper, T., Fry, C., T Heath, P., Kennea, N., McCartney, M., Patel, B., Pollard, T., Sharland, M., & Wilson, P., 2013, Managing and preventing outbreaks of Gram-negative infections in UK neonatal units. Archives of Disease in Childhood: Fetal and Neonatal Edition, 98(6). https://doi.org/10.1136/archdischild-2012-303540
[48]. Zeb, S., & Ali, T. S., 2021, Factors associated with the compliance of standard precaution, Review article. Journal of the Pakistan Medical Association, 71(2 B). https://doi.org/10.47391/JPMA.416
[49]. World Health Organization (WHO). (n.d.). Health workforce requirements for universal health coverage and the Sustainable Development Goals. (Human Resources for Health Observer, 17). World Health Organization.
[50]. World Health Organization., 2010, Workload Indicators of Staffing Need: User’s Manual.
Viewed PDF 37 0 -
Evaluation of Liver and Renal Functions Tests in Pregnant Women with PreeclampsiaAuthor: Ali M. Al-SultanDOI: 10.21522/TIJPH.2013.13.01.Art057
Evaluation of Liver and Renal Functions Tests in Pregnant Women with Preeclampsia
Abstract:
This study aimed to evaluate the biochemical role of liver functions (activity of liver enzymes and proteins) and kidneys (urea and creatinine) in the serum of pregnant women with preeclampsia. A total of 60 blood samples from pregnant women with preeclampsia and hypertension during pregnancy, and 35 healthy pregnant women with matched age and pregnancy stage (control group) were collected and serum separated. Liver and renal function tests were measured, these included serum alkaline phosphate enzyme activity (ALP), alanine aminotransferase activity (ALT), aspartate aminotransferase activity (AST), Gamma-glutamyl transferase activity (GGT), serum total protein, serum albumin, urea test, and Creatinine test. These parameters were significantly (p<0.05) higher in preeclampsia patients compared to the control group. Differences were noticed between the second and third trimesters of pregnancy, and an association was also reported between older age compared to younger. In conclusion, liver and renal function were affected by pregnancy with greater association with preeclampsia in pregnant women and the ageing process has a more aggressive impact on renal and liver abnormalities.
Evaluation of Liver and Renal Functions Tests in Pregnant Women with Preeclampsia
References:
[1]. Cruickshank, T., MacDonald, T. M., Walker, S. P., Keenan, E., Dane, K., Middleton, A., Kaitu’u‐Lino, T. U. J., 2021, Circulating growth differentiation factor 15 is increased preceding preeclampsia diagnosis: implications as a disease biomarker. Journal of the American Heart Association, 10(16), e020302, doi:10.1161/JAHA.120.020302.
[2]. Yakut, K., Öcal, D. F., Öztürk, F. H., Öztürk, M., Oğuz, Y., Sınacı, S., Çağlar, T., 2021, Is GDF-15 level associated with gestational diabetes mellitus and adverse perinatal outcomes? Taiwanese Journal of Obstetrics and Gynecology, 60(2), 221-224, doi:10.1016/j.tjog.2020.12.004.
[3]. Masnavi, E., Hosseini, M., Aramesh, S. H., Hassanzadeh, S., 2022, Relationship between Vitamin D and Preeclampsia in Pregnant Women: A Comparative Descriptive Study. Journal of Clinical Care and Skills, 3(2), 67-71, doi:10.52547/jccs.3.2.67.
[4]. Chen, Y., Wu, L., Liu, H., Li, Z., Li, L., Wu, X., Niu, J., 2023, Third‐trimester maternal serum chemerin and hypertension after preeclampsia: a prospective cohort study. Journal of the American Heart Association, 12(5), e027930. doi:10.1161/JAHA.122.027930.
[5]. Singh, S., Moodley, J., Khaliq, O. P., Naicker, T., 2021, a narrative review of the renin-angiotensin-aldosterone system in the placenta and placental bed of HIV infected women of African ancestry with preeclampsia. Current Hypertension Reports, 23(8), 39, doi:10.1007/s11906-021-01158-1.
[6]. Dankova, M., Minarikova, Z., Danko, J., Gergel, J., Pontuch, P., Goncalvesova, E., 2020, Novel biomarkers for prediction of acute kidney injury in acute heart failure. Bratislavske Lekarske Listy, 121(5), 321-324. doi:10.4149/bll_2020_050.
[7]. Amosco, M. D., Tavera, G. R., Villar, V. A. M., Naniong, J. M. A., David-Bustamante, L. M. G., Williams, S. M., Palmes-Saloma, C. P., 2019, Non-additive effects of ACVR2A in preeclampsia in a Philippine population. BMC Pregnancy and Childbirth, 19, 1-8, doi:10.1186/s12884-018-2152-z.
[8]. Terada, Y., Yayama, K., 2021, Angiotensin II-induced vasoconstriction via Rho kinase activation in pressure-overloaded rat thoracic aortas. Biomolecules, 11(8), 1076. doi:10.3390/biom11081076.
[9]. Zainiyah, Z., Susanti, E., Wulandari, N., 2022, Identification of Polymorphism Angiotensin Ii Type 1 Receptor (AT1) 1166 A/C Gene and Potassium Levels in Pre-Eclampsia among The Madurese Population, doi:10.52711/0974-360X.2024.00349.
[10]. Sumathi, M. E., Joshi, R. U., Gomathy, E., Shashidhar, K., 2016, Usefulness of serum gamma glutamyl transferase in assessing severity of preeclampsia. Int J Clin Biochem Res, 3(2), 245-9, doi:10.5958/2394-6377.2016.00047.2.
[11]. Teklemariam, A. B., Wabalo, E. K., Leta, T. A., Assefa, S. S., Abebe, E. C., 2022, Evaluation of lactate dehydrogenase and gamma Glutamyl transferase among pregnant women with hypertensive disorders and their association with disease severity in Jimma medical center, Ethiopia. Journal of Obstetrics, Gynecology and Cancer Research, 7(6), 497-509, doi:10.30699/jogcr.7.6.497.
[12]. Saleem, F. R., Chandru, S., Biswas, M., 2020, Evaluation of total LDH and its isoenzymes as markers in preeclampsia. Journal of Medical Biochemistry, 39(3), 392, doi: 10.2478/jomb-2019-0045.
[13]. Elias, S. E. S., Eltom, A., Osman, A. L., Babker, A. M., 2018, Gamma glutamyl transferase and lactate dehydrogenase as biochemical markers of severity of preeclampsia among Sudanese pregnant women. Int J Reprod Contracept Obstet Gynecol, 7(8), 3020-3, doi:10.18203/2320-1770.ijrcog20183294.
[14]. Shojaei, K., Jafari, R. M., Haghighat, F., 2019, Comparison of the level of uric acid and LDH in mothers in early and late preeclampsia and determination of its association with the severity of preeclampsia. Journal of Biochemical Technology, 10(2-2019), 36-41.
[15]. Lee, D. H., Blomhoff, R., Jacobs, D. R., 2004, Review is serum gamma glutamyltransferase a marker of oxidative stress? Free radical research, 38(6), 535-539. doi:10.1080/10715760410001694026.
[16]. Mehta, M., Parashar, M., Kumar, R., 2019, Serum lactate dehydrogenase: a prognostic factor in pre-eclampsia. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 8(7), 2792-2799. https://link.gale.com/apps/doc/A597716014/HRCA?u=anon~dd27f547&sid=googleScholar&xid=90df6f5d [accessed 23 Nov 2024].
[17]. Patil, R. R., Choudhari, A. S., 2016, Evaluation of activities of serum gamma GLUTAMYL transferase and adenosine deaminase in pre-eclampsia-a CASE control study. National Journal of Medical Research, 6(04), 313-315. https://njmr.in/index.php/file/article/view/223
[18]. Wu, J., Zhou, W., Li, Q., Yuan, R., Li, H., Cui, S., 2017, Combined use of serum gamma glutamyl transferase level and ultrasonography improves prediction of perinatal outcomes associated with preeclamptic pregnancy. Clinica Chimica Acta, 475, 97-101, doi:10.1016/j.cca.2017.09.018.
[19]. Popovski, N., Nikolov, A., 2019, Practice Bulletin of the American College of Obstetrics and Gynaecologists 2019 on Magement of Hypertensive Disorders in Pregnancy-A Short Review of the Current Recommendations. Biomedical Journal of Scientific & Technical Research, 23(2), 17198-17201, doi:10.26717/BJSTR.2019.23.003861.
[20]. Agbana, R. D., Sanni, T. A., Adeyanju, B. T., Ipinnimo, T. M., Aderinwale, O. A., Adetona, A., 2024, Knowledge and Prevalence of Hepatitis B Virus Infection among Pregnant Women attending Antenatal Care Services at Federal Teaching Hospital Ido-Ekiti, Ekiti State, Southwest Nigeria, Texila International Journal of Public Health, 12(2):1-11, doi:10.21522/TIJPH.2013.12.02.Art004.
[21]. Braunthal, S., Brateanu, A., 2019, Hypertension in pregnancy: Pathophysiology and treatment. SAGE Open Medicine, 7, 2050312119843700, doi:10.1177/2050312119843700.
[22]. Arora, E., Juron, T., Fuks, A., Salafia, C., 2022, Extreme Elevation of Alkaline Phosphatase in a Pregnancy Complicated by Uncontrolled Chronic Hypertension and Its Association with Placental Pathology. Journal of Endocrinology and Metabolism, 12(1), 49-52, doi: doi:10.14740/jem789.
[23]. Demir, S. C., Evruke, C., Ozgunen, F. T., Urunsak, I. F., Candan, E., Kadayifci, O., 2006, Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Saudi Medical Journal, 27(7), 1015.
[24]. Ali, S. A., 2024, Prevalence and Potential Risks Associated with Utilization of Medication During Pregnancy-A Cross-Sectional Study. Texila International Journal of Public Health, 12(2). doi:10.21522/TIJPH.2013.12.02.Art009.
[25]. Dacaj, R., Izetbegovic, S., Stojkanovic, G., Dreshaj, S., 2016, Elevated liver enzymes in cases of preeclampsia and intrauterine growth restriction. Medical Archives, 70(1), 44, doi: 10.5455/medarh.2016.70.44-47.
[26]. Ferreira, R. C., Fragoso, M. B. T., dos Santos Tenório, M. C., da Paz Martins, A.S., Borbely, A. U., Moura, F. A., de Oliveira, A. C. M., 2020, Biomarkers of placental redox imbalance in pregnancies with preeclampsia and consequent perinatal outcomes. Archives of Biochemistry and Biophysics, 691, 108464, doi:10.1016/j.abb.2020.108464.
[27]. Kattah, A., 2020, Preeclampsia and kidney disease: deciphering cause and effect. Current Hypertension Reports, 22(11), 91, doi:10.1007/s11906-020-01099-1.
[28]. Shaheen, A., Luqman, M. W., Iqbal, S., Khan, N., Fatima, S., Nazli, R. 2022, Relationship of serum visfatin levels with serum electrolytes, liver profile, hepatic enzymes and anthropometric parameters in pregnant women with preeclampsia and eclampsia during 3rd trimester. Journal of Ayub Medical College, Abbottabad: JAMC, 34(1), 62-66, doi:10.55519/JAMC-01-8975.
[29]. Westbrook, R. H., Dusheiko, G., Williamson, C., 2016, Pregnancy and liver disease. Journal of hepatology, 64(4), 933-945, doi:10.1016/j.jhep.2015.11.030.
[30]. Ganai, I., Samoon, S. J., Nafae, P., Arifkelam, Ganie, F. A., 2014, To Study the biochemical and hematological parameters in pre-eclampsia. Journal of Medical Science and Clinical Research, 2014;2(1):315-321.
[31]. Serra, B., Mendoza, M., Scazzocchio, E., Meler, E., Nolla, M., Sabrià, E., Carreras, E., 2020, A new model for screening for early-onset preeclampsia. American Journal of Obstetrics and Gynecology, 222(6), 608-e1, doi:10.1016/j.ajog.2020.01.020.
[32]. Iacobelli, S., Guignard, J. P., 2021, Maturation of glomerular filtration rate in neonates and infants: an overview. Pediatric Nephrology, 36(6), 1439-1446, doi:10.1007/s00467-020-04632-1.
[33]. Kavuru, V., Vu, T., Karageorge, L., Choudhury, D., Senger, R., Robertson, J., 2020, Dipstick analysis of urine chemistry: benefits and limitations of dry chemistry-based assays. Postgraduate Medicine, 132(3), 225-233. doi:10.1080/00325481.2019.1679540.
[34]. Zhang, B., Chen, X., Yang, C., Shi, H., Xiu, W., 2024, Effects of hypertensive disorders of pregnancy on the complications in very low birth weight neonates. Hypertension in Pregnancy, 43(1), 2314576, doi:10.1080/10641955.2024.2314576.
[35]. Nielsen, S. T., Strandkjær, N., Juul Rasmussen, I., Hansen, M. K., Lytsen, R. M., Kamstrup, P. R., Frikke-Schmidt, R., 2022, Coagulation parameters in the newborn and infant–the Copenhagen Baby Heart and COMPARE studies. Clinical Chemistry and Laboratory Medicine, 60(2), 261-270, doi:10.1515/cclm-2021-0967.
[36]. Tinta, Y., Polopadang, V., Rais MuhKardi, S., 2020, Related Factors to Preeclampsia Incidence in Pregnant Women at Lasinrang Regional Hospital Pinrang. South Asian Research Journal of Nursing and Healthcare, 02(01):12–6, doi:10.36346/sarjnhc.2020.v02i01.002.
[37]. Hercus, A., Dekker, G., Leemaqz, S., 2020, Primipaternity and birth interval; independent risk factors for preeclampsia. The Journal of Maternal-fetal and Neonatal Medicine, 33(2), 303-306, doi:10.1080/14767058.2018.1489794.
[38]. Ekun, O. A., Olawumi, O. M., Makwe, C. C., Ogidi, N. O., 2018, Biochemical assessment of renal and liver function among preeclamptics in lagos metropolis. International Journal of Reproductive Medicine, 2018(1), 1594182, doi:10.1155/2018/1594182.
[39]. Nasonova, S. N., Zhirov, I. V., Ledyakhova, M. V., Sharf, T. V., Bosykh, E. G., Masenko, V. P., Tereshchenko, S. N., 2019, Early diagnosis of acute renal injury in patients with acute decompensation of chronic heart failure. Terapevticheskii arkhiv, 91(4), 67-73. doi:10.26442/00403660.2019.04.000168.
[40]. Jose, H., Salazar, M., 2014, Overview of urea and creatinine. Lab. Med., 45(1): 19-20, doi:10.1309/LM920SBNZPJRJGUT.
[41]. Tangren, J. S., Wan Md Adnan, W. A. H., Powe, C. E., Ecker, J., Bramham, K., Hladunewich, M. A., Thadhani, R., 2018, Risk of preeclampsia and pregnancy complications in women with a history of acute kidney injury. Hypertension, 72(2), 451-459, doi:10.1161/HYPERTENSIONAHA.118.11161.
[42]. Tavakoli, H., Rostami, H., Avan, A., Bagherniya, M., Ferns, G. A., Khayyatzadeh, S. S., Ghayour‐Mobarhan, M., 2019, High dose vitamin D supplementation is associated with an improvement in serum markers of liver function. Biofactors, 45(3), 335-342, doi:10.1002/biof.1496.
[43]. Aghsaeifard, Z., Alizadeh, R., Bagheri, N., 2022, Association between neutrophil gelatinase-associated lipocalin (NGAL) and iron profile in chronic renal disease. Archives of Physiology and Biochemistry, 128(3), 703-707, doi:10.1080/13813455.2020.1720742.
[44]. Fiseha, T., Mengesha, T., Girma, R., Kebede, E., Gebreweld, A., 2019, Estimation of renal function in adult outpatients with normal serum creatinine. BMC Research Notes, 12, 1-6, doi:10.1186/s13104-019-4487-6.
[45]. Chung, E. Y., Trinh, K., Li, J., Hahn, S. H., Endre, Z. H., Rogers, N. M., Alexander, S. I., 2022, Biomarkers in cardiorenal syndrome and potential insights into novel therapeutics. Frontiers in Cardiovascular Medicine, 9, 868658. doi:10.3389/fcvm.2022.868658.
[46]. Zhang, C., Zhang, D. D., Feng, Y. M., Huang, Z.Q., Xie, Y. B., Zhou, J., Li, J., 2022, Relationship between morning peak phenomenon and early renal injury NGAL in H-type hypertension. Blood Pressure, 31(1), 200-206, doi:10.1080/08037051.2022.2106186
Viewed PDF 42 2 -
Assessment of Possible Food-Drug Interactions of Pearl Millet Diet on Gliclazide in Diabetic RatsAuthor: Vinyas MayasaDOI: 10.21522/TIJPH.2013.13.01.Art058
Assessment of Possible Food-Drug Interactions of Pearl Millet Diet on Gliclazide in Diabetic Rats
Abstract:
Pearl millet, with its low glycaemic index, helps stabilize blood sugar levels, making it a potential dietary intervention for diabetic patients. This study investigated the interaction between a 60% pearl millet diet (PEMD) and gliclazide in diabetic rats. Diabetes was induced using the streptozotocin (STZ)-nicotinamide model, with rats classified as diabetic if their fasting plasma glucose exceeded 250 mg/dL. The effects of gliclazide (1 mg/kg) were evaluated in combination with the optimized 60% pearl millet diet (PEMD60) in both single-dose (SD) and repeated-dose (MD) studies. The combination of gliclazide and PEMD60-MD resulted in a significant increase in blood glucose reduction compared to the single-dose treatment. Additionally, serum gliclazide levels, HbA1c, insulin levels, and pharmacokinetic parameters such as Cmax, t1/2, Tmax, and AUC were altered in the combination therapy, though some changes were not statistically significant. The interaction between gliclazide and pearl millet may be due to pharmacokinetic alterations, possibly involving metabolic interactions. These findings suggest that physicians should monitor patients on gliclazide who consume pearl millet to prevent potential hypoglycaemia and adjust gliclazide dosages as needed.
Assessment of Possible Food-Drug Interactions of Pearl Millet Diet on Gliclazide in Diabetic Rats
References:
[1]. Khan, M. A. B., Hashim, M. J., King, J. K., Govender, R. D., Mustafa, H., & Al Kaabi, J., 2020, Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. Journal of Epidemiology and Global Health, 10(1), 107-111. https://pubmed.ncbi.nlm.nih.gov/32175717
[2]. Kaur, P., Behera, B. S., Singh, S., & Munshi, A., 2021, The pharmacological profile of SGLT2 inhibitors: Focus on mechanistic aspects and pharmacogenomics. European Journal of Pharmacology, 904, 174169. https://pubmed.ncbi.nlm.nih.gov/33984301
[3]. Petersen, K. S., & Kris-Etherton, P. M., 2021, Diet Quality Assessment and the Relationship between Diet Quality and Cardiovascular Disease Risk. Nutrients, 13(12).
[4]. Augustin, L. S. A., Kendall, C. W. C., Jenkins, D. J. A., Willett, W. C., et al., 2015, Glycaemic index, glycaemic load and glycaemic response: An International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC). Nutrition, Metabolism and Cardiovascular Diseases, 25(9), 795-815. https://pubmed.ncbi.nlm.nih.gov/26160327
[5]. Cronin, P., Joyce, S. A., O'Toole, P. W., & O'Connor, E. M., 2021, Dietary Fibre Modulates the Gut Microbiota. Nutrients, 13(5), 1655. https://pubmed.ncbi.nlm.nih.gov/34068353
[6]. Giuntini, E. B., Sarda, F. A. H., & de Menezes, E. W., 2022, The Effects of Soluble Dietary Fibers on Glycaemic Response: An Overview and Futures Perspectives. Foods, 11(23).
[7]. Nie, Y., & Luo, F., 2021, Dietary Fiber: An Opportunity for a Global Control of Hyperlipidaemia. Oxidative Medicine and Cellular Longevity, 2021, 5542342. https://pubmed.ncbi.nlm.nih.gov/33897940
[8]. Ogura, J., & Yamaguchi, H., 2022, The Effectiveness of Antidiabetic Drugs in Treating Dementia: A Peek into Pharmacological and Pharmacokinetic Properties. International Journal of Molecular Sciences, 23(12), 6542. https://pubmed.ncbi.nlm.nih.gov/35742986
[9]. Ren, X., Yin, R., Hou, D., Xue, Y., Zhang, M., Diao, X., Zhang, Y., Wu, J., Hu, J., Hu, X., & Shen, Q., 2018, The Glucose-Lowering Effect of Foxtail Millet in Subjects with Impaired Glucose Tolerance: A Self-Controlled Clinical Trial. Nutrients, 10(10), 1509. https://pubmed.ncbi.nlm.nih.gov/30326632
[10]. Anitha, S., Botha, R., & Kane-Potaka, J., 2021, Can Millet Consumption Help Manage Hyperlipidaemia and Obesity. A Systematic Review and Meta-Analysis. Frontiers in Nutrition, 8, 700778.
[11]. Singh, R. M., Fedacko, J., Mojto, V., Isaza, A., Dewim, M., Watanabe, S., et al., 2020, Effects of millet-based functional foods rich diet on coronary risk factors among subjects with diabetes mellitus: A single arm real-world observation from hospital registry. MOJ Public Health, 9, 18-25. https://www.researchgate.net/publication/339285321
[12]. Yongxia, F., Zhang, F., Liu, Z., Zhao, Q., Xue, Y., & Shen, Q., 2021, Improvement of diabetes-induced metabolic syndrome by millet prolamin is associated with changes in serum metabolomics. Food Bioscience, 44, 101434. https://www.sciencedirect.com/science/article/abs/pii/S2212429221005599
[13]. Kam, J., Puranik, S., Yadav, R., et al., 2016, Dietary Interventions for Type 2 Diabetes: How Millet Comes to Help. Frontiers in Plant Science, 7, 1454. https://pubmed.ncbi.nlm.nih.gov/27729921
[14]. Gong, L., Feng, D., Wang, T., Ren, Y., Liu, Y., & Wang, J., 2020, Inhibitors of α-amylase and α-glucosidase: Potential linkage for whole cereal foods on prevention of hyperglycemia. Food Science & Nutrition, 8(12), 6320-6337. https://pubmed.ncbi.nlm.nih.gov/33312519
[15]. Ofosu, F. K., Elahi, F., Daliri, E. B., et al., 2020, Phenolic Profile, Antioxidant, and Antidiabetic Potential Exerted by Millet Grain Varieties. Antioxidants, 9(3), 254. https://pubmed.ncbi.nlm.nih.gov/32245008
[16]. Deodhar, M., Al Rihani, S. B., Arwood, M. J., et al., 2020, Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice. Pharmaceutics, 12(9), 846. https://pubmed.ncbi.nlm.nih.gov/32899642
[17]. Choi, Y. Y., Osada, K., Ito, Y., Nagasawa, T., Choi, M.-R., & Nishizawa, N., 2005, Effects of dietary protein of Korean foxtail millet on plasma adiponectin, HDL-cholesterol, and insulin levels in genetically type 2 diabetic mice. Bioscience, Biotechnology, and Biochemistry, 69, 31-37.
[18]. Alzahrani, N. S., Alshammari, G. M., El-Ansary, A., et al., 2022, Anti-Hyperlipidaemia, Hypoglycaemic, and Hepatoprotective Impacts of Pearl Millet (Pennisetum glaucum L.) Grains and Their Ethanol Extract on Rats Fed a High-Fat Diet. Nutrients, 14(9), 1791. https://pmc.ncbi.nlm.nih.gov/articles/PMC9105973
[19]. Hymavathi, T. V., Rao, S. K., Boini, P., et al., 2017, Profiling of Eleusine coracana biscuits for glycaemic index, stress, and lipid. MOJ Drug Design Development & Therapy, 1, 52-58.
[20]. Chandrasekara, A., & Shahidi, F., 2010, Content of insoluble bound phenolics in millets and their contribution to antioxidant capacity. Journal of Agricultural and Food Chemistry, 58(11), 6706-6714. https://pubmed.ncbi.nlm.nih.gov/20465288
Viewed PDF 21 0 -
Biodegradable Nanoformulations for Enhanced Recombinant Protein Drug Delivery: A Promising Approach for Controlling Vibrio harveyi in Aquatic ModelsAuthor: Vimal SDOI: 10.21522/TIJPH.2013.13.01.Art059
Biodegradable Nanoformulations for Enhanced Recombinant Protein Drug Delivery: A Promising Approach for Controlling Vibrio harveyi in Aquatic Models
Abstract:
Biodegradable nanoformulations have developed as an innovative method to improve the delivery and effectiveness of recombinant protein therapeutics in aquaculture. This research examines their efficacy in managing "Vibrio harveyi," a widespread disease responsible for considerable economic detriment in the aquaculture sector. Nanoformulations, made from eco-friendly and biocompatible substances, provide regulated and targeted medication administration, hence minimizing off-target effects and decreasing environmental pollution. These technologies improve the stability and bioavailability of recombinant proteins, addressing issues such as fast breakdown in aquatic conditions. The use of modern nanotechnology in aquaculture medicine provides a sustainable and efficient approach to address bacterial infections, enhance fish health, and guarantee ecological safety. This study shows the current progress, problems, and possible future paths of biodegradable nanoformulations for recombinant protein drug delivery, highlighting how they could completely change sustainable aquaculture operations.
Biodegradable Nanoformulations for Enhanced Recombinant Protein Drug Delivery: A Promising Approach for Controlling Vibrio harveyi in Aquatic Models
References:
[1]. Khan, M. A., Shadan Khan, K., 2011, Aquaculture as a food production system: A review. Early Pregnancy. ;3: 291–302.
[2]. Ahmed, N., Azra, M. N., 2022,10.1007/s40572-022-00364-6
[3]. Afewerki, S., Osmundsen, T., Olsen, M. S., Størkersen, K., Misund, A., Thorvaldsen, T., 2023, Innovation policy in the Norwegian aquaculture industry: Reshaping aquaculture production innovation networks. Mar Policy. ;152: 105624. doi:10.1016/j.marpol.2023.105624
[4]. Assefa, A., Abunna, F., 2018, Maintenance of fish health in aquaculture: Review of epidemiological approaches for prevention and control of infectious disease of fish. Vet Med Int. ;2018: 5432497. doi:10.1155/2018/5432497
[5]. Ina-Salwany, M. Y., Al-Saari, N., Mohamad, A., Mursidi. F. A., Mohd-Aris, A., Amal, M. N. A., et al. ., 2019, Vibriosis in fish: A review on disease development and prevention. J Aquat Anim Health.;31: 3–22. doi:10.1002/aah.10045
[6]. Kah Sem, N. A. D., Abd Gani, S., Chong, C. M., Natrah, I., Shamsi, S., 2023, Management and mitigation of vibriosis in aquaculture: Nanoparticles as promising alternatives. Int J Mol Sci. ;24. doi:10.3390/ijms241612542
[7]. Habboush, Y., Guzman N., 2024. Antibiotic resistance. StatPearls. Treasure Island (FL): StatPearls Publishing; Available: https://www.ncbi.nlm.nih.gov/books/NBK513277/
[8]. Mondal, H., Thomas, J., 2022, A review on the recent advances and application of vaccines against fish pathogens in aquaculture. Aquac Int. ;30: 1971–2000. doi:10.1007/s10499-022-00884-w
[9]. Kumar, A., Middha, S. K., Menon, S. V., Paital, B., Gokarn, S., Nelli, M., et al.., 2024, Current Challenges of Vaccination in Fish Health Management. Animals.;14: 2692. doi:10.3390/ani14182692
[10]. Bøgwald, J., Dalmo, R. A., 2019, Review on immersion vaccines for fish: An update Microorganisms. ;7: 627. doi:10.3390/microorganisms7120627
[11]. Ma, J., Bruce, T. J., Jones, E. M., Cain, K. D., 2019, A review of fish vaccine development strategies: Conventional methods and modern biotechnological approaches. Microorganisms. ;7: 569. doi:10.3390/microorganisms7110569
[12]. Abram QH, Dixon B, Katzenback BA.., 2017 Impacts of low temperature on the teleost immune system. Biology (Basel). ;6. doi:10.3390/biology6040039
[13]. Mugwanya, M., Dawood, M. A. O., Kimera, F., Sewilam, H., 2022, Anthropogenic temperature fluctuations and their effect on aquaculture: A comprehensive review. Aquac Fish. ;7: 223–243. doi:10.1016/j.aaf.2021.12.005
[14]. Petrovic, S., Bita, B., Barbinta-Patrascu, M. E., 2024, Nanoformulations in pharmaceutical and biomedical applications: Green perspectives. Int J Mol Sci.;25: 5842. doi:10.3390/ijms25115842
[15]. Yeh, Y. C., Huang, T. H., Yang, S. C., Chen, C. C., Fang, J. Y., 2020, Nano-based drug delivery or targeting to eradicate bacteria for infection mitigation: A review of recent advances. Front Chem. 8: 286. doi:10.3389/fchem.2020.00286
[16]. Youssef, F. S., El-Banna, H. A., Elzorba, H. Y., Galal, A. M., 2019, Application of some nanoparticles in the field of veterinary medicine. Int J Vet Sci Med. 7: 78–93. doi:10.1080/23144599.2019.1691379
[17]. Cheng, X., Xie, Q., Sun, Y., 2023, Advances in nanomaterial-based targeted drug delivery systems. Front Bioeng Biotechnol. ;11: 1177151. doi:10.3389/fbioe.2023.1177151
[18]. Gupta, V., Sengupta, M., Prakash, J., Tripathy, B. C., 2017, Production of Recombinant Pharmaceutical Proteins. Basic and Applied Aspects of Biotechnology. Singapore: Springer Singapore; . pp. 77–101. doi:10.1007/978-981-10-0875-7_4
[19]. Tripathi, N. K., Shrivastava, A., 2019, Recent developments in bioprocessing of recombinant proteins: Expression hosts and process development. Front Bioeng Biotechnol.;7: 420. doi:10.3389/fbioe.2019.00420
[20]. Gupta, S. K., Shukla, P., 2017, Sophisticated cloning, fermentation, and purification technologies for an enhanced therapeutic protein production: A review. Front Pharmacol. 8: 419. doi:10.3389/fphar.2017.00419
[21]. Lee, P. T., Yamamoto, F. Y., Low, C. F., Loh, J. Y., Chong, C. M., 2021, Gut immune system and the implications of oral-administered immunoprophylaxis in finfish aquaculture. Front Immunol. ;12: 773193. doi:10.3389/fimmu.2021.773193
[22]. Mokhtar, D., Zaccone, G., Alesci, A., Kuciel, M., Hussein, M., Sayed, R., 2023, Main components of fish immunity: An overview of the fish immune system. G. ;8: 93. doi:10.3390/fishes8020093
[23]. Nguyen, H. T., Nguyen, T. T. T., Chen, Y. C., Vu-Khac, H., Wang, P. C., Chen, S. C., 2018, Enhanced immune responses and effectiveness of refined outer membrane protein vaccines against Vibrio harveyi in orange-spotted grouper (Epinephelus coioides). J Fish Dis. ;41: 1349–1358. doi:10.1111/jfd.12828
[24]. Semple, S. L., Dixon, B., 2020, Salmonid antibacterial immunity: An aquaculture perspective. Biology (Basel). ;9: 331. doi:10.3390/biology9100331
[25]. Mba, I. E., Nweze, E. I., 2022, Antimicrobial peptides therapy: An emerging alternative for treating drug-resistant bacteria. Yale J Biol Med.;95: 445–463. Available: https://www.ncbi.nlm.nih.gov/pubmed/36568838
[26]. Imran, M., Jha, S. K., Hasan, N., Insaf, A., Shrestha, J., Shrestha, J., et al., 2022, Overcoming multidrug resistance of antibiotics via nanodelivery systems. Pharmaceutics;14: 586. doi:10.3390/pharmaceutics14030586
[27]. Makabenta, J. M. V., Nabawy, A., Li, C. H., Schmidt-Malan, S., Patel, R., Rotello, V. M., 2021, Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. Nat Rev Microbiol. ;19: 23–36. doi:10.1038/s41579-020-0420-1
[28]. Araujo, G. S., Silva, J. W. A., da, Cotas, J., Pereira, L., 2022, Fish farming techniques: Current situation and trends. J Mar Sci Eng. ;10: 1598. doi:10.3390/jmse10111598
[29]. Mohd Yazid, S. H., Mohd Daud, H., Azmai, M. N. A., Mohamad, N., Mohd Nor, N., 2021, Estimating the economic loss due to vibriosis in net-cage cultured Asian seabass (Lates calcarifer): Evidence from the east coast of Peninsular Malaysia. Front Vet Sci. ;8: 644009. doi:10.3389/fvets.2021.644009
[30]. Hegde, A., Kabra, S., Basawa, R. M., Khile, D. A., Abbu, R. U. F., Thomas, N. A., et al, 2023, Bacterial diseases in marine fish species: current trends and future prospects in disease management. World J Microbiol Biotechnol. ;39: 317. doi:10.1007/s11274-023-03755-5
[31]. Gao, W., Chen, Y., Zhang, Y., Zhang, Q., Zhang, L., 2018, Nanoparticle-based local antimicrobial drug delivery. Adv Drug Deliv Rev. ;127: 46–57. doi:10.1016/j.addr.2017.09.015
[32]. Fajardo, C., Martinez-Rodriguez, G., Blasco, J., Mancera, J. M., Thomas, B., De Donato, M., 2022, Nanotechnology in aquaculture: Applications, perspectives and regulatory challenges. Aquac Fish. ;7: 185–200. doi:10.1016/j.aaf.2021.12.006
[33]. Yang, F., Cabe, M., Nowak, H. A., Langert, K. A., 2022, Chitosan/poly(lactic-co-glycolic) acid nanoparticle formulations with finely-tuned size distributions for enhanced mucoadhesion. Pharmaceutics. ; 14: 95. doi:10.3390/pharmaceutics14010095
Viewed PDF 28 0 -
Efficacious Outcome of Peripheral Retinal Laser Photocoagulation to Severe Non-Proliferative Diabetic Retinopathy in Young-onset Type 1 Diabetic Mellitus: A Case ReportAuthor: Suganya MDOI: 10.21522/TIJPH.2013.13.01.Art060
Efficacious Outcome of Peripheral Retinal Laser Photocoagulation to Severe Non-Proliferative Diabetic Retinopathy in Young-onset Type 1 Diabetic Mellitus: A Case Report
Abstract:
The rising prevalence of childhood type 1 diabetes and type 2 diabetes increases the number of children and adolescents at risk of visual loss due to the presence of diabetic retinopathy (DR). We report herein a case of a young adult who presented to the emergency department with sudden vision loss in both eyes. She had been diagnosed with type 1 diabetes mellitus (T1DM) five years ago. Patient with severe NPDR was monitored using OCT (optical coherence tomography) which revealed peri-papillary cotton wool spots, intraretinal haemorrhages, and retinal microaneurysms (MA). The patient was urgently hospitalized and prescribed to be under insulin therapy. DR was developed and progressed to severe NPDR. The investigation continued through multiple OCTs. Finally, she was prescribed to be under laser therapy with multiple sessions of PRP (Peripheral Retinal laser Photocoagulation). Subsequently, the macular edema resolved and the patient was satisfied with her vision after six sessions of PRP. Literature collected from various countries stated that diabetic retinopathy can be successfully treated with laser therapy. We discuss the importance of recognizing and treating the patient with laser therapy. There is a need for further research on laser therapy in NPDR among young-onset diabetic mellitus.
Efficacious Outcome of Peripheral Retinal Laser Photocoagulation to Severe Non-Proliferative Diabetic Retinopathy in Young-onset Type 1 Diabetic Mellitus: A Case Report
References:
[1]. Everett, L. A., Paulus, Y. M., 2021, Laser Therapy in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema, Curr Diab Rep, 21(9):35, https://doi.org/10.1007/s11892-021-01403-6.
[2]. CDC, 2020, Government. Diabetic Retinopathy, https://www.cdc.gov/visionhealth/pdf/factsheet.pdf.
[3]. Suganya, M., 2024, Letter to Editor: Relieving menopausal symptoms through yoga practice. International Journal of Nutrition, Pharmacology, Neurological Diseases, 14(4):488, https://journals.lww.com/ijnp/fulltext/2024/14040/letter_to_editor__relieving_menopausal_symptoms.15.aspx.
[4]. Suganya, M., Maragatham, S., Sheela, P., 2024, Assessment on Health Status of Adult Patients with Osteoarthritis of the Lower Limb by Western Ontario and McMaster’s Universities Osteoarthritis Index (WOMAC): A Study in Chennai City, Texila International Journal of Public Health, Special Issue:1-8, https://doi.org/10.21522/TIJPH.2013.SE.24.02.art007.
[5]. Bhuvaneswari, R., Diviya, M., Subramanian, M., Maranan, R., Josphineleela, R., 2023, Hybrid generative model for grading the severity of diabetic retinopathy images. Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization, 11(7), https://doi.org/10.1080/21681163.2023.2266048.
[6]. Jyotheeswar, S., Kanimozhi, K. V., 2022, Prediction of Diabetic Retinopathy using Novel Decision Tree Method in Comparison with Support Vector Machine Model to Improve Accuracy, Proceedings of the International Conference on Sustainable Computing and Data Communication Systems (ICSCDS), https://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=9760842.
[7]. Angela, J., Michael Javaheri, Hamid Hosseini, Pradeep, S., Prasad, 2023, Purtscher‑like retinopathy in a 19‑year‑old with maturity‑onset diabetes of the young: a case report, Journal of Medical Case Reports, 17:255;1-4, https://doi.org/10.1186/s13256-023-03985-z.
[8]. Farheen Naz, JenilaRani, D., 2022, Detection and Comparison of Diabetic Retinopathy using Thresholding Algorithm and CMeans Clustering Algorithm, Journal of Pharmaceutical Negative Results, 14(4), https://www.pnrjournal.com/index.php/home/article/view/899.
[9]. Suganya, M., Padmapriya, D., 2024, Determinants and levels of depression among young adult patients with epilepsy: a cross-sectional study in a Tertiary Care Hospital, Tamilnadu, India, International Journal of Nutrition, Pharmacology, Neurological Diseases, 14(4): 432-436, https://doi.org/10.4103/ijnpnd.ijnpnd_112_24.
[10]. Suganya, M., Kalabarathi, S., 2024, Efficacious Maintenance-Electroconvulsive Therapy (m-ECT) and Antipsychotic Medication for Schizophrenia Spectrum Disorder in a Young Adult Woman in Chennai, India: A Case Report. International Journal of Nutrition, Pharmacology, Neurological Diseases, 14(3):390-392, https://doi.org/10.4103/ijnpnd.ijnpnd_42_24.
[11]. Ebrahimi, M. H., Gharibi, H., 2016, A case study of a patient with diabetic retinopathy, Diab Met Syndr: Clin Res Rev, http://dx.doi.org/10.1016/j.dsx.2016.01.022.
[12]. Suganya, M., KalaBarathi, S., 2024, Association of body mass index with dietary intake and self-care health activities of mothers after postpartum: A mixed-method research in Chennai City, India, Int J Nutr Pharmacol Neurol Dis, 14:52-7, https://doi.org/10.4103/ijnpnd.ijnpnd_71_23.
[13]. Sridhar, S., Pradeep Kandhasamy, J., Sinthuja, M., Sterlin Minish, T. N., 2021, WITHDRAWN: Diabetic retinopathy detection using convolutional nueral networks algorithm, Materials Today: Proceedings, ISSN 2214-7853, https://doi.org/10.1016/j.matpr.2021.01.059.
[14]. Ramakrishnan, A., Veeramani, P. A., et al., 2024, Association of Various Optical Coherence Tomographic Patterns of Diabetic Macular Edema with Central Subfield Thickness and Visual Acuity: A Cross-Sectional Observational Study, Cureus. 19,16(9), https://assets.cureus.com/uploads/original_article/pdf/294904/20241019-1529365-17tn37.pdf.
Viewed PDF 22 3 -
Green Synthesis of Selenium Nanoparticles using Vaccinium Subg. Oxycoccus for Antioxidant, Anti-Inflammatory, and Cytotoxic EffectAuthor: T. LakshmiDOI: 10.21522/TIJPH.2013.13.01.Art061
Green Synthesis of Selenium Nanoparticles using Vaccinium Subg. Oxycoccus for Antioxidant, Anti-Inflammatory, and Cytotoxic Effect
Abstract:
This study elucidates the synthesis and multifaceted applications of selenium nanoparticles (SeNPs) utilizing Vaccinium subg. Oxycoccus extract as a green and sustainable methodology. The UV-visible spectroscopy analysis demonstrated the successful synthesis of SeNPs, characterized by a distinct absorption peak at 380 nm. The antioxidant activities of Vaccinium subg. Oxycoccus-mediated SeNPs were systematically evaluated through three assays. The DPPH assay revealed concentration-dependent radical scavenging activities, surpassing the standard (ascorbic acid) at higher concentrations. Additionally, the Hydrogen Peroxide assay showcased commendable antioxidant properties, while the FRAP assay indicated a concentration-dependent capacity to reduce ferric ions, suggesting potential in counteracting oxidative stress. Inhibition of protein denaturation was examined using the BSA assay, revealing a significant inhibitory effect of Vaccinium subg. Oxycoccus-mediated SeNPs that increased with concentration. Denaturation studies, employing the Egg Albumin Denaturation Assay, displayed a concentration-dependent rise in denaturation percentages, either matching or exceeding the standard's anti-inflammatory activity. The Membrane Stabilization Assay illustrated the concentration-dependent enhancement of membrane stability by SeNPs, exhibiting efficacy comparable to or exceeding the standard. Cytotoxicity assessment through the Brine Shrimp lethality assay demonstrated a concentration-dependent decline in brine shrimp nauplii viability, suggesting a potential cytotoxic impact of Vaccinium subg. Oxycoccus-mediated SeNPs. These findings collectively underscore the diverse applications of SeNPs synthesized with Vaccinium subg. Oxycoccus extract, ranging from antioxidant activities and membrane stabilization to potential cytotoxic effects, lays the groundwork for their versatile application in biological and medicinal contexts.
Green Synthesis of Selenium Nanoparticles using Vaccinium Subg. Oxycoccus for Antioxidant, Anti-Inflammatory, and Cytotoxic Effect
References:
[1]. Haleem, A., Javaid, M., Singh, R. P., Rab, S., Suman, R., 2023, Applications of nanotechnology in the medical field: a brief review. Glob Health J.;7: 70–77. doi:10.1016/j.glohj.2023.02.008
[2]. Pasika, S. R., Bulusu, R., Rao, B. V. K., Kommineni, N., Bolla, P. K., Kala, S. G., et al., 2023, Nanotechnology for Biomedical Applications. Nanomaterials. Singapore: Springer Nature Singapore;. 297–327. doi:10.1007/978-981-19-7963-7_11
[3]. Rezić, I., 2022, Nanoparticles for biomedical application and their synthesis. Polymers (Basel).;14 (9) 4, 961. doi:10.3390/polym14224961
[4]. Chen, J., Li, L., Song, K., Wang, Z., 2022, Application of different nanomaterials in biomedical field. Highlights in Science, Engineering and Technology.;14: 57–64. doi:10.54097/hset.v14i.1593
[5]. Tharani, M., Rajeshkumar, S., Al-Ghanim, K. A., Nicoletti, M., Sachivkina, N., Govindarajan M., 2023, Terminalia chebula-Assisted Silver Nanoparticles: Biological Potential, Synthesis, Characterization, and Ecotoxicity. Biomedicines, 11. doi:10.3390/biomedicines11051472
[6]. Xie, B., Zeng, D., Yang, M., Tang, Z., He, L., Chen, T., 2023, 1Translational selenium nanoparticles to attenuate allergic dermatitis through Nrf2-Keap1-driven activation of selenoproteins. ACS Nano. 7: 14053–14068. doi:10.1021/acsnano.3c04344
[7]. Devi, M. S., Srinivasan, S., Muthuvel, A., 2023, Selenium nanomaterial is a promising nanotechnology for biomedical and environmental remediation: A detailed review. Biocatal Agric Biotechnol. 51: 102766. doi:10.1016/j.bcab.2023.102766.
[8]. Kurup, M., Kumar, M., Ramanathan, S., Chandra, M., 2023, The biogenetic synthesis of metallic nanoparticles and the role they play in anti-inflammatory drug treatment. Curr Drug Discov Technol. 20. doi:10.2174/1570163820666230718123544
[9]. Li, Y., Zhu, S., Luo, J., Tong, Y., Zheng, Y., Ji, L., et al., 2023, The Protective Effect of Selenium Nanoparticles in Osteoarthritis: In vitro and in vivo Studies. Drug Des Devel Ther. 17: 1515–1529. doi:10.2147/dddt.s407122
[10]. Arafa, F. M., Mogahed, N. M. F. H., Eltarahony, M. M., Diab, R. G., 2023, Biogenic selenium nanoparticles: trace element with promising anti-toxoplasma effect. Pathog Glob Health. 117: 639–654. doi:10.1080/20477724.2023.2186079
[11]. Santhoshkumar, J., Kumar, S. V., Rajeshkumar, S., 2017, Synthesis of zinc oxide nanoparticles using plant leaf extract against urinary tract infection pathogen. Resour-Effic Technol. 3: 459–465. doi:10.1016/j.reffit.2017.05.001
[12]. Menon, S., Agarwal, H., Rajeshkumar, S., Jacquline Rosy, P., Shanmugam, V. K., 2020, Investigating the antimicrobial activities of the biosynthesized selenium nanoparticles and its statistical analysis. Bionanoscience. 10: 122–135. doi:10.1007/s12668-019-00710-3
[13]. Rajeshkumar, S., Tharani, M., Jeevitha, M., Santhoshkumar, J., 2019, Anticariogenic activity of fresh aloe Vera gel mediated copper oxide nanoparticles. Indian J Public Health Res Dev. 10: 3664. doi:10.5958/0976-5506.2019.04158.5
[14]. Zhidkin, R., Zhurbenko, P., Bogomaz, O., Gorodilova, E., Katsapov, I., Antropov, D., et al., 2023, Biodiversity of rolB/C-like natural transgene in the genus Vaccinium L. and its application for phylogenetic studies. Int J Mol Sci. 24. doi:10.3390/ijms24086932
[15]. A. Waikar, B., C. Mandave, P., Berries: A new paradigm for nutraceuticals., 2023, Edible Berries - New Insights. IntechOpen; doi:10.5772/intechopen.1002226
[16]. Martău, G. A., Bernadette-Emőke, T., Odocheanu, R., Soporan, D. A., Bochiș, M., Simon, E., et al. 2023, Vaccinium species (Ericaceae): Phytochemistry and biological properties of medicinal plants. Molecules. 28. doi:10.3390/molecules28041533
[17]. Nurzyńska-Wierdak, R., 2023, Phenolic compounds from new natural sources-plant genotype and ontogenetic variation. Molecules. 28. doi:10.3390/molecules28041731
[18]. Priyaa, N. P., Rajeshkumar, S., Lakshmi, T., Roy, A., 2020, Antibacterial Properties of Lodhra Bark (Symphlocus racemosa) Mediated Silver Nanoparticles Against Oral Pathogens. Plant Cell Biotechnology And Molecular Biology. 1–7.
[19]. Sharma, S. K., Singh, A. P., 2012, In vitro antioxidant and free radical scavenging activity of Nardostachys jatamansi DC. J Acupunct Meridian Stud. 5: 112–118. doi:10.1016/j.jams.2012.03.002
[20]. Bhatti, M. Z., Ali, A., Ahmad, A., Saeed, A., Malik, S. A., 2015, Antioxidant and phytochemical analysis of Ranunculus arvensis L. extracts. BMC Res Notes.;8: 279. doi:10.1186/s13104-015-1228-3
[21]. Long, Q., Cui, L-K., He, S-B., Sun, J., Chen, Q-Z., Bao, H-D., et al., 2023, Preparation, characteristics and cytotoxicity of green synthesized selenium nanoparticles using Paenibacillus motobuensis LY5201 isolated from the local specialty food of longevity area. Sci Rep. 13. doi:10.1038/s41598-022-26396-4
[22]. Vu, T. T., Nguyen, P. T. M., Pham, N. H., Le, T. H., Nguyen, T. H., Do, D. T., et al., 2022, Green synthesis of selenium nanoparticles using Cleistocalyx operculatus leaf extract and their acute oral toxicity study. J Compos Sci. 6: 307. doi:10.3390/jcs6100307
Viewed PDF 40 0 -
Effects of Botswana’s Occupational Health and Safety (OHS) Policies and Practices on OHS Performance in the Construction Industries of BotswanaAuthor: Ketlabareng P. MosarwanaDOI: 10.21522/TIJPH.2013.13.01.Art062
Effects of Botswana’s Occupational Health and Safety (OHS) Policies and Practices on OHS Performance in the Construction Industries of Botswana
Abstract:
The study investigated the association between occupational health and safety policies and practices (OHSPPs) and occupational health and safety (OHS) performance in the construction industry in Botswana. The study aimed to establish the association between OHSPP components of the OHS in the quantitative phase. The study data was collected from employees of construction industry companies based in Gaborone. This study used a simple random sampling method to select respondents within the selected companies, while a sample of SHE officers was purposively selected for the qualitative phase. The results demonstrated a positive association between most OHSPPs and OHS performance. Results of correlation tests indicate that for OHS performance enhancement is achieved, interventions should focus first on PPE practices followed by audit and OHS training activities. This can then be followed by OHS leadership principles. The overall results show that the mere availability of OHS policy in a construction industry without implementation does not affect OHS performance, nor does compensation improve OHS performance since this will be an after-the-fact event, hence the need for a comprehensive approach to meet the OHS needs of complex construction industries.
Effects of Botswana’s Occupational Health and Safety (OHS) Policies and Practices on OHS Performance in the Construction Industries of Botswana
References:
[1]. Rantanen, J., Muchiri F., & Lehtinen F., 2020, Decent work, ILO’s response to the globalization of working life: Basic concepts and global implementation with special reference to occupational health. International Journal of Environmental Research and Public Health, 17 (10): p. 3351.
[2]. Langille, B. A., 2003, Re-reading the Preamble to the 1919 ILO Constitution in light of recent data on FDI and worker rights. L, 42: p. 87.
[3]. Takala, J., et al., 2021, Work-related injuries and diseases, and COVID-19. COVID-19 and Recovery: The Role of Trade Unions in Building Forward Better: p. 27.
[4]. International Labour Organization., 2011, OSH management system: A tool for continual improvement. Turin: International Training Center of the ILO. Available at: http://www.ilo.org/safework/info/video/WCMS_153930/lang--en/index.htm(accessed 5 Feb 2024)
[5]. Pintar, A. & Caspary D., 2012, Safety Manual. Safety, 2011. p. 13.
[6]. Akmuradova, G., Allashayeva A., & Meredova D., 2021, WHAT IS ENVIRONMENT, HEALTH AND SAFETY (EHS) MANAGEMENT? in НАУКА В СОВРЕМЕННОМ МИРЕ.
[7]. Barling, J. & Hutchinson I., 2000, Commitment vs. control‐based safety practices, safety reputation, and perceived safety climate. Canadian Journal of Administrative Sciences/Revue Canadienne Des Sciences De L'administration, 17(1): p. 76-84.
[8]. Clark, L., 1999, The Politics of Regulation: A Comparative‐Historical Study of Occupational Health and Safety Regulation in Australia and the United States. Australian Journal of Public Administration, 58(2), 94-104.
[9]. Amponsah-Tawiah, K., & Dartey-Baah, K., 2011, Occupational health and safety: key issues and concerns in Ghana. International Journal of Business and Social Science, 2(14).
[10]. Moatlhodi, T. M. & Kalusopa T., 2016, An assessment of e-records readiness at The Ministry of Labour and Home Affairs, Gaborone, Botswana. Mousaion, 34(3), 1-22.
[11]. Moyo D., Zungu M, Kgalamono S, & Mwila C. D., 2015, Review of Occupational Health and Safety Organization in Expanding Economies: The Case of Southern Africa. Ann Glob Health. 2015 Jul-Aug; 81(4):495-502. doi: 10.1016/j.aogh.2015.07.002. PMID: 26709281.
[12]. Walters, D., et al., 2011, Regulating workplace risks: a comparative study of inspection regimes in times of change. Edward Elgar Publishing.
[13]. Fudge, J., McCrystal S., & Sankaran K., 2012, Challenging the legal boundaries of work regulation. Bloomsbury Publishing.
[14]. Wurzelbacher, S. J., et al., 2014, The effectiveness of insurer‐supported safety and health engineering controls in reducing workers' compensation claims and costs. American Journal Of Industrial Medicine, 57(12): p. 1398-1412.
[15]. Creswell, J. W. & Clark, V. L., 2017, Research design, qualitative and mixed method approaches. London: SAGE Publications
[16]. Mubita K., Mutambo J., & Kahale C., 2021, An Examination of Occupational Health and Safety Management Practices in Selected Construction Sites of Lusaka City. International Journal of Research and Innovation in Social Science (IJRISS), 5: p. 32 – 42.
[17]. Agumba J. N., & Haupt T. C., 2018, The influence of health and safety practices on health and safety performance outcomes in small and medium enterprise projects in the South African construction industry. J. S. Afr. Inst. Civ. Eng.:60(3), Art. #1193, 12 pages. http://dx.doi.org/10.17159/2309-8775/2018/v60n3a6
[18]. Musonda, I. & Smallwood, J., 2008, Health and safety (H&S) awareness and implementation in Botswana's construction industry. Journal of Engineering, Design and Technology. 6. 81-90. 10.1108/17260530810863352.
[19]. Department of Labour., 2011. Occupational Health and Safety (OH&S) Inspectorate in relation to the construction industry. Government Gazette 539 (2010) 33176
[20]. Gee, A. F. & Saito, K., 2000, Construction Loads and Other Safety Measures Specified by U.S., U.K. and Japanese Bridge Standards: In: Ratay, R.T. (ed.), Construction Safety Affected by Codes and Standards, Proceedings of a session sponsored by the Design Loads on Structures During Construction Standards Committee and the Performance of Structures During Construction Technical Committee of the Structural Engineering Institute, Minneapolis.
[21]. Seoke, S. Y. & Kamungoma-Dada I., 2014, Occupational health and safety management systems-a review of practices in enterprises in Botswana. Occupational Health Southern Africa, 20(6): p. 14-19.
[22]. Tam, C. M., Zeng, S. X. & Deng, Z. M., 2004, Identifying elements of poor construction safety management in China. Safety Science 42:569– 586 http://www.sciencedirect.com/science/article/pii/S0925753503000602.https://doi.org/10.1016/j.ssci.2003.09.001
[23]. Zahoor H, Chan A. P. C., Masood R, Choudhry R. M, Javed A. A & Utama W. P., 2016, Occupational safety and health performance in the Pakistani construction industry: stakeholders' perspective, International Journal of Construction Management, 16:3, 209-219 DOI: 10.1080/15623599.2015.1138027
Viewed PDF 32 0 -
Assessment of Daily Hassle and well-being among Parents Visiting the Paediatric wing in a Government Hospital in Chennai- A Cross-Sectional StudyAuthor: Deepavalli ArumuganainarDOI: 10.21522/TIJPH.2013.13.01.Art063
Assessment of Daily Hassle and well-being among Parents Visiting the Paediatric wing in a Government Hospital in Chennai- A Cross-Sectional Study
Abstract:
Parenting challenges can significantly impact mental health and quality of life. Understanding these difficulties is crucial for developing effective support strategies. This study aims to assess the difficulty parents face in raising their children and determine whether fathers or mothers are more adversely affected by child-rearing responsibilities. This cross-sectional study was conducted among parents visiting the pediatric department of ESIC Medical College and Hospital, K. K. Nagar, Chennai. The study investigated the daily parenting challenges among 247 participants, including 129 mothers and 118 fathers. The study's purpose was explained to the participants, who were then provided with the Parental Daily Hassle and SF-12 Quality of Life questionnaires. Participants were given 10 minutes to complete the forms. The collected data were analyzed using SPSS software (version 20.0). It was observed that mothers faced more difficulties than fathers, although the difference was not statistically significant (p= 0.089). The survey also indicated that mothers managed daily inconveniences more effectively and had a better quality of life compared to fathers (p= 0.0692). Parents of children under four reported experiencing more challenges and difficulties in handling daily tasks. Parenting challenges are correlated with mental health issues, particularly for parents of young children. The findings of the study, thus, underscore the need for targeted strategies to manage parental stress, including mental health support and parenting education programs, to improve family well-being.
Assessment of Daily Hassle and well-being among Parents Visiting the Paediatric wing in a Government Hospital in Chennai- A Cross-Sectional Study
References:
[1]. Belsky, J., 1984, The determinants of parenting: A process model. Child Development. 55(1), 83–96.
[2]. Taylor, John., 2019, "Structural validity of the parenting daily hassles intensity scale." Stress and Health. 35.2: 176-186.
[3]. Crnic, Keith A., and Mark T. Greenberg., 1990, "Minor parenting stresses with young children." Child development. 61.5: 1628-1637.
[4]. Compas, B. E., Howell, D. C., Phares, V., Williams, R. A., & Ledoux, N., 1989, Parent, child stress and symptoms: An integrative analysis. Developmental Psychology. 25: 550–559.
[5]. Crnic and Shayna S. Coburn., 2021, "Stress and parenting”. Psychological insights for understanding COVID-19 and families, parents, and children. 103-130.
[6]. Lee, Dohoon, et al., 2013, "The Great Recession, genetic sensitivity, and maternal harsh parenting." Proceedings of the National Academy of Sciences. 110.34: 13780-13784.
[7]. DeLongis, Anita, et al., 1982, "Relationship of daily hassles, uplifts, and major life events to health status." Health Psychology. 1.2:119.
[8]. Lazarus, Richard S., et al., 1985, "Stress and adaptational outcomes: the problem of confounded measures." 770.
[9]. Dohrenwend, Bruce P., and Patrick E. Shrout., 1985, "Hassles" in the conceptualization and measurement of life stress variables." 780.
[10]. John E., Ware, Jr., Mark Kosinski & Susan D. Keller., 1996, “A 12-Item Short-Form Health Survey: Construction of Scales and Preliminary Tests of Reliability and Validity”.220-233
[11]. Roskam I., Raes M. E., Mikolajczak M., 2017, Exhausted Parents: Development and Preliminary Validation of the Parental Burnout Inventory. Front Psychol. 8:163.
[12]. Mikolajczak, Moira, et al., 2022, "Exhausted parents: Sociodemographic, child-related, parent-related, parenting and family-functioning correlates of parental burnout." Key Topics in Parenting and Behavior. Cham: Springer Nature Switzerland. 57-69.
[13]. Nair S., Chandramohan S., Sundaravathanam N., Rajasekaran A. B., Sekhar R., 2020, Father Involvement in Early Childhood Care: Insights From a MEL System in a Behavior Change Intervention Among Rural Indian Parents. Front Public Health. 8:516.
[14]. Chen, Bin-Bin., 2020, "The relationship between Chinese mothers’ parenting stress and sibling relationships: A moderated mediation model of maternal warmth and co-parenting." Early Child Development and Care. 190.9: 1350-1358.
[15]. Barroso, Nicole E., et al., 2018, "Parenting stress through the lens of different clinical groups: A systematic review & meta-analysis." Journal of abnormal child psychology. 46: 449-461.
[16]. Qian G., Mei J., Tian L., Dou G., 2021, Assessing Mothers' Parenting Stress: Differences Between One- and Two-Child Families in China. Front Psychol. 11:609715.
[17]. Li C., 2005, Relationship between parenting stress and marital quality in mothers with preschool children. Chinese Mental Health Journal. 19(2):136.
[18]. Parkes J., Caravale B., Marcelli M., Franco F., Colver A., 2011, Parenting stress and children with cerebral palsy: a European cross-sectional survey. Dev. Med. Child Neurol. 53 815–821.
[19]. Pleck J. H., 2010, In: Paternal involvement: Revised conceptualization and theoretical linkages with child outcomes. Lamb M., editor. Wiley and Son; New York. pp. 58–93.
[20]. Amato P. R., Rejac S. J., 1994, Contact with nonresident parents, inter-parental conflict, and children's behavior. Journal of Family Issues. 15:191–207.
[21]. Amato P. R., Rivera F., 1999, Paternal involvement and children's behavioral problems. Journal of Marriage and Family. 61:375–384.
[22]. Sayer L., Bianchi S., Robinson J., 2004, Are parents investing less in children? Trends in mothers’ and fathers’ time with children. American Journal of Sociology. 110:1–43.
[23]. Felfe C., Hsin A., 2012, Maternal work conditions and child development. Econ Educ Rev. (6):1037-1057.
Viewed PDF 23 1 -
Patient's Knowledge and Perceptions of Prosthodontics Treatment with Removable Complete Dentures: A Case of Makerere University Dental Hospital, UgandaAuthor: David NonoDOI: 10.21522/TIJPH.2013.13.01.Art064
Patient's Knowledge and Perceptions of Prosthodontics Treatment with Removable Complete Dentures: A Case of Makerere University Dental Hospital, Uganda
Abstract:
Over the years, removable complete dentures (RCDs) have been used to treat edentulous patients to enhance their ability to eat and communicate well and improve their facial appearance. Patients’ awareness of complete dentures is the first step toward better treatment outcomes. This study aimed to explore patients’ knowledge and perceptions of prosthodontics treatment with removable complete dentures in Makerere University Dental Hospital, Uganda. The study used a qualitative design to explore patients’ knowledge and perceptions of prosthodontics treatment. A total of fifteen participants were purposively selected and interviews were audio-recorded and later transcribed and translated into English. Data analysis involved reading transcripts, categorizing the data, and developing themes and sub-themes to explain the patterns in the data. Regarding their knowledge about complete denture treatment, participants said that they were aware that denture treatment was a procedure for replacing teeth although they expressed concern about the costs involved. Regarding participants’ perceptions of complete denture treatment, they reported mainly about the perceived benefits and how these motivated them to go ahead with the procedure. They anticipated things like the restoration of beauty, being able to communicate freely, eating more comfortably and improving oral hygiene. The study found that the majority of respondents had some good perceptions and knowledge of denture rehabilitation-related subjects, especially considering the variety of fixed and removable prosthodontics options available.
Patient's Knowledge and Perceptions of Prosthodontics Treatment with Removable Complete Dentures: A Case of Makerere University Dental Hospital, Uganda
References:
[1]. Chowdhary, R., & Chandraker, N. K., 2011, Clinical survey of denture care in denture‐wearing edentulous patients of Indian population. Geriatrics & Gerontology International, 11(2), 191-195.
[2]. Jaber, A. A., Ibrahim, A. E., Abdulazeez, A. M. A., & Alkhabuli, J. O. S., 2023, Awareness, attitudes, need and demand on replacement of missing teeth among a group of partially dentate patients attending a University Dental Clinic. Journal of Medical Sciences, 18(1), 11-15.
[3]. Jaber, A. A., Ibrahim, A. E., Abdulazeez, A. M. A., & Alkhabuli, J. O. S., 2023, Awareness, attitudes, need and demand on replacement of missing teeth among a group of partially dentate patients attending a University Dental Clinic. Journal of Medical Sciences, 18(1), pp.11-15.
[4]. Kołciuk, L., & Godlewski, T., 2015, Oral health-related quality of life of patients using removable dentures–review of the literature. Dent Med Probl, 52(2), 222-226.
[5]. Yusof, H., Ishak, N., Yacob, N., & Ali, W. W., 2021, Self-perceived oral health and awareness on replacement of missing teeth among patients at a public university. Journal of International Dental and Medical Research, 14(1), 309-314.
[6]. Shigli, K., 2009, Aftercare of the complete denture patient. Journal of Prosthodontics: Implant, Esthetic and Reconstructive Dentistry, 18(8), 688-693.
[7]. Roessler, D. M., 2003, Complete denture success for patients and dentists. International Dental Journal, 53(S5), 340-345.
[8]. Shetty, M. S., Panchmal, G. S., & Shenoy, K. K., 2019, Awareness toward replacement of teeth, duration of use, and maintenance of dental prosthesis among adult rural population in Mangalore Taluk. Journal of Interdisciplinary Dentistry, 9(1), 15-18.
[9]. Patel, I. B., Madan, G., Patel, B., Solanki, K., & Chavda, R., 2012, Behaviours and hygiene habits of a sample population of complete denture wearers in Ahmedabad. J Int Oral Health, 4(2), 29-38.
[10]. Lechner, S. K., & Roessler, D., 2001, Strategies for complete denture success: beyond technical excellence. Compendium of Continuing Education in Dentistry (Jamesburg, NJ: 1995), 22(7), 553-9.
[11]. Shetty, B., 2022, A cross sectional study to assess complete denture wearer's knowledge on denture hygiene maintenance and staining, and their awareness for the same. Journal of Pharmaceutical Negative Results, 10725-10730.
[12]. Milward, P., Katechia, D., & Morgan, M. Z., 2013, Knowledge of removable partial denture wearers on denture hygiene. British Dental Journal, 215(10), E20-E20.
[13]. Khanal, B., Sapkota, S. M., Thakur, S. N., & Chaulagain, R., 2022, Denture hygiene habit and denture care practice in complete denture wearing patients visiting a dental college. Nepal Medical Journal, 5(1), 16-19.
[14]. Benetti, G. S., Dotto, L., Maroli, A., Barbon, F., Sanchez-Ayala, A., & Bacchi, A., 2020, Patients’ perception about the outcomes of prosthetic treatment in Southern Brazil: a cross sectional study. Brazilian Journal of Oral Sciences, 19, e209398-e209398.
[15]. Leles, C. R., Morandini, W. J., Da Silva, E. T., De F. NUNES, M., & Freire, M. C. M., 2008, Assessing perceived potential outcomes of prosthodontic treatment in partial and fully edentulous patients. Journal of Oral Rehabilitation, 35(9), 682-689.
[16]. Shigli, K., Angadi, G. S., Hegde, P., & Hebbal, M., 2008, Patients’ Knowledge and Understanding of the Implications of Wearing Dentures. Report of a Survey Conducted at a Dental Institute in the South of India. Primary Dental Care, (3), 85-89.
[17]. Bhola, S., Hellyer, P. H., & Radford, D. R., 2018, The importance of communication in the construction of partial dentures. British Dental Journal, 224(11), 853-856.
[18]. Ma, H., Sun, H. Q., & Ji, P., 2008, How to deal with esthetically overcritical patients who need complete dentures: a case report. J Contemp Dent Pract, 5(22), 127.
[19]. Association W. M., 2013, World medical Association declaration of Helsinki: ethical principles for medical research involving human subjects. 310(20):2191–4.
[20]. Azad, A. A., MUHAMMADI, S., Aslam, A., HASSAN, S. H., & Rahim, S., 2016, Awareness about prosthodontic treatment for missing natural teeth among patients seen at AFID. Pakistan Oral & Dental Journal, 36(1).
[21]. Sartawi, S. Y., Abu-Hammad, S., A. Salim, N., & Al-Omoush, S., 2021, Denture stomatitis revisited: a summary of systematic reviews in the past decade and two case reports of papillary hyperplasia of unusual locations. International Journal of Dentistry, 2021(1), 7338143.
[22]. Aradya, A., Dhakshaini, M. R., Swamy, K. R., Chowdhary, R., Ranganatha, N., & Alla, R. K., 2023, Knowledge, Awareness, Attitude and Behaviour about Prosthodontic Treatment for Missing Teeth among Indian Population: A Cross Sectional Study. Uttar Pradesh Journal of Zoology, 44(1), 44-55.
[23]. Jukić, M., Kozina, S., Kardum, G., Hogg, R., & Kvolik, S., 2011, Physicians overestimate patient's knowledge of the process of informed consent: a cross-sectional study. Medicinski glasnik, 8(1), 39-45.
[24]. Falagas, M. E., Korbila, I. P., Giannopoulou, K. P., Kondilis, B. K., & Peppas, G., 2009, Informed consent: how much and what do patients understand?. The American Journal of Surgery, 198(3), 420-435.
[25]. Nand, M., & Mohammadnezhad, M., 2022, Challenges faced by edentulous patients (EDPs) during complete denture prostheses (CDP) service delivery in Fiji–a qualitative study. BMC Health Services Research, 22(1), 742.
[26]. Wolf, A., Moore, L., Lydahl, D., Naldemirci, Ö., Elam, M., & Britten, N., 2017, The realities of partnership in person-centred care: a qualitative interview study with patients and professionals. BMJ open, 7(7), e016491.
[27]. Hyland, R., Ellis, J., Thomason, M., El-Feky, A., & Moynihan, P., 2009, A qualitative study on patient perspectives of how conventional and implant-supported dentures affect eating. Journal of dentistry, 37(9), 718-723.
[28]. Lima de Paula, L. M. L., Sampaio, A. A., Costa, J. G., Gomes, V. E., Ferreira, E. F. E., & Ferreira, R. C., 2019, The course from tooth loss to successful rehabilitation with denture: feelings influenced by socioeconomic status. SAGE Open Medicine, 7, 2050312119874232.
[29]. Rodrigues, A., Dhanania, S., & Rodrigues, R., 2021, “If I have teeth, I can smile.” Experiences with tooth loss and the use of a removable dental prosthesis among people who are partially and completely edentulous in Karnataka, India. BDJ Open, 7(1), 34.
[30]. Silva, J. D. C. M., dos SANTOS, J. F. F., & Marchini, L., 2014, Factors influencing patients’ satisfaction with complete dentures: a qualitative study. Brazilian Dental Science, 17(2), 83-88.
[31]. Smith, P. W., & McCord, J. F., 2004, What do patients expect from complete dentures?. Journal of Dentistry, 32(1), 3-7.
Viewed PDF 31 1 -
Breaking the Cycle: How Socioeconomic Barriers are Holding Guyana Back from Healthier ChoicesAuthor: Ginel NeddDOI: 10.21522/TIJPH.2013.13.01.Art065
Breaking the Cycle: How Socioeconomic Barriers are Holding Guyana Back from Healthier Choices
Abstract:
This article explores the socioeconomic barriers contributing to poor dietary habits in Guyana and how they drive the nation's high rates of non-communicable diseases (NCDs). It argues that the real issues go beyond personal choice, highlighting the cost of healthy eating, the prevalence of food deserts, cultural influences, and potential solutions for a healthier future. The article calls for government intervention, community-driven movements, and educational initiatives to make healthier choices more accessible and desirable for all Guyanese citizens.
Breaking the Cycle: How Socioeconomic Barriers are Holding Guyana Back from Healthier Choices
References:
[1]. Global Nutrition Report, 2023, Guyana Nutrition Profile. Global Nutrition Report, [Accessed 2023]. Available at: https://globalnutritionreport.org/resources/nutrition-profiles/latin-america-and-caribbean/south-america/guyana/
[2]. United Nations Food Systems Hub, 2023, Guyana's National Pathway for Food Systems Transformation. [Accessed 2023]. Available at: https://www.unfoodsystemshub.org/docs/unfoodsystemslibraries/national-pathways/guyana/2023-03-17.-national-pathway-for-food-systems-transformation---guyana.pdf?sfvrsn=27ee9220_1
[3]. Biomed Central, 2020, Urban Poverty and Nutrition Challenges Associated with Accessibility to Healthy Foods. International Journal for Equity in Health, 19(130). [Accessed 2023]. Available at: https://equityhealthj.biomedcentral.com/articles/10.1186/s12939-020-01330-0
[4]. Nutrition Reviews, 2018, Factors Perceived to Influence Healthy Eating: A Systematic Review and Meta-Ethnographic Synthesis of the Literature. Nutrition Reviews, 76(12), 861–874. [Accessed 2023]. Available at: https://academic.oup.com/nutritionreviews/article/76/12/861/5092635
[5]. Caribbean Investigative Journalism Network (CIJN), 2023, The Food and Water Challenges of Guyana’s Indigenous Communities. [Accessed 2023]. Available at: https://www.cijn.org/food-and-water-challenges-of-guyanas-indigenous-communities/
[6]. Department of Public Information, Guyana, 2023, Guyana Endorses Roadmap for Global Food Security to Curb Ongoing Food Crisis. [Accessed 2023]. Available at: https://dpi.gov.gy/guyana-endorses-roadmap-for-global-food-security-to-curb-ongoing-food-crisis/
[7]. World Health Organization (WHO). Overview of health indicators and non-communicable diseases in Guyana. WHO Report, [Accessed 2023]. Available at: https://apps.who.int/iris/bitstream/handle/10665/136882/ccsbrief_guy_en.pdf
[8]. American Journal of Clinical Nutrition. Study on Food Insecurity, Neighborhood Food Environment, and Health Disparities. American Journal of Clinical Nutrition, 114(6), 1734–1745. [Accessed 2023]. Available at: https://ajcn.nutrition.org/article/S0002-9165%2823%2966352-X/fulltext
[9]. Journal of Agricultural and Environmental Research, 2023, Guyana’s Ongoing Commitment to Food Safety: Protecting Public Health Everyday. [Accessed 2023]. Available at: https://jare.org.gy/guyanas-ongoing-commitment-to-food-safety-protecting-public-health-everyday/
[10]. Global Nutrition Report, 2018, Nutrition Country Profile: Guyana. Global Nutrition Report, [Accessed 2023]. Available at: https://globalnutritionreport.org/documents/182/Guyana.pdf
Viewed PDF 33 2 -
Association of Cardiometabolic Diseases in Adolescents with Level of Obesity and Lifestyle Pattern at Metropolitan City; Findings from Southern IndiaAuthor: Suganya MDOI: 10.21522/TIJPH.2013.13.01.Art066
Association of Cardiometabolic Diseases in Adolescents with Level of Obesity and Lifestyle Pattern at Metropolitan City; Findings from Southern India
Abstract:
The crisis of obesity is observed among adolescents in metropolitan cities in India. It is associated with a range of cardiometabolic diseases, such as hypertension, prediabetes, Asthma, hypercholesterolemia, hyperlipidaemia, and reproductive abnormalities. The objective of this study was to analyse the cardiometabolic risk factors and weight status of adolescents in association with their lifestyle patterns. A cross-sectional study was conducted among adolescent patients who received treatment for cardiometabolic disease in a tertiary care hospital. They were selected based on inclusion and exclusion criteria. 83 adolescent patients with obesity were identified and interviewed. General information, lifestyle patterns and details of the cardiometabolic risk factors were collected through a questionnaire. ANOVA was calculated using SPSS Version 23, and the statistically significant level was <0.05. There was an association between age group, family income, physical activity, screen time, junk food consumption, balanced diet and sleeping hours in obesity-level adolescent patients. The mean values of cardiometabolic diseases were worse in obesity III and II than in obesity I. The status of blood pressure (SBP and DBP), fasting PG, total cholesterol, HDL, LDL, and triglyceride strongly correlated with adolescent patients' level of obesity. Lifestyle modifications are essential among adolescents to prevent comorbidities that have developed from cardiometabolic risk factors.
Association of Cardiometabolic Diseases in Adolescents with Level of Obesity and Lifestyle Pattern at Metropolitan City; Findings from Southern India
References:
[1]. Yang, L., Magnussen, C. G., Yang, L., Bovet, P., Xi, B., 2020, Elevated Blood Pressure in Childhood or Adolescence and Cardiovascular Outcomes in Adulthood: A Systematic Review. Hypertension, 75:948–55.
[2]. Lessard, L. M., Lawrence, S. E., 2022, Weight-Based Disparities in Youth Mental Health: Scope, Social Underpinnings, and Policy Implications. Policy Insights from the Behavioral and Brain Sciences, 9(1):49-56, https://doi.org/10.1177/23727322211068018.
[3]. WHO, 2024, https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
[4]. Navarro, P., Shivappa, N., Hébert, J. R., Mehegan, J., Murrin, C. M., Kelleher, C. C., et al., 2020, Predictors of the dietary inflammatory index in children and associations with childhood weight status. Clin Nutr, 39:2169–79, https://10.1016/j.clnu.2019.09.004.
[5]. Suganya, M., Kalabarathi, S., 2024, Association of body mass index with dietary intake and self-care health activities of mothers after postpartum: A mixed-method research in Chennai City, India. Int J Nutr Pharmacol Neurol Dis, 14:52–7, https://doi.org/10.4103/ijnpnd.ijnpnd_71_23.
[6]. Maria Aashitha, Harsavarthini, K. R., Subashchandra, K., 2024, A cross-sectional study on Dietary Health Risk Behaviours and Hygiene Practices among Adolescent Students in Urban Chennai, Tamil Nadu. African Journal of Biological Sciences, 6(Si4):1805-10, ISSN: 2663-2187, https://doi.org/10.48047/AFJBS.6.Si4.2024.1804-1810.
[7]. Suganya, M., Kalabarathi, S., 2024, Efficacious Maintenance-Electroconvulsive Therapy (m-ECT) and Antipsychotic Medication for Schizophrenia Spectrum Disorder in a Young Adult Woman in Chennai, India: A Case Report. International Journal of Nutrition, Pharmacology, Neurological Diseases, 14(3):390-392, https://doi.org/10.4103/ijnpnd.ijnpnd_42_24.
[8]. Hendryx, M., Chojenta, C., Byles, J. E., 2020, Obesity Risk Among Young Australian Women: A Prospective Latent Class Analysis, Obesity (Silver Spring, Md), 28:154–60, https://10.1002/oby.22646.
[9]. Suganya, M., Padmapriya, D., 2024, Determinants and levels of depression among young adult patients with epilepsy: a cross-sectional study in a Tertiary Care Hospital, Tamilnadu, India, International Journal of Nutrition, Pharmacology, Neurological Diseases, 14(4): 432-436, https://doi.org/10.4103/ijnpnd.ijnpnd_112_24.
[10]. Qin, T. T., Xiong, H. G., Yan, M. M., Sun, T., Qian, L., Yin, P., 2019, Body weight misperception and weight disorders among Chinese children and adolescents: a latent class analysis, Curr Med Sci, 39:852–62, https://10.1007/s11596-019-2116-1.
[11]. Suganya, M., Maragatham, S., Sheela, P., 2024, Assessment on Health Status of Adult Patients with Osteoarthritis of the Lower Limb by Western Ontario and McMaster’s Universities Osteoarthritis Index (WOMAC): A Study in Chennai City, Texila International Journal of Public Health, Special Issue:1-8, https://doi.org/10.21522/TIJPH.2013.SE.24.02.art007.
[13]. Al-Mhanna, S. B., Rocha-Rodriguesc, S., Mohamed, M., Batrakoulis, A., Aldhahi, M. I., Afolabi, H. A., Yagin, F. H., Alhussain, M. H., Gulu, M., Abubakar, B. D., Ghazali, W. S. W., Alghannam, A. F., Badicu, G., 2023, Effects of combined aerobic exercise and diet on cardiometabolic health in patients with obesity and type 2 diabetes: a systematic review and meta-analysis. BMC Sports Sci Med Rehabil, Dec 4;15(1):165, https://doi.org/10.1186/s13102-023-00766-5.
[14]. Lim, S. Y., Chan, Y. M., Chin, Y. S., Zalilah, M. S., Ramachandran, V., Arumugam, M., 2024, Combined Effect of Dietary Acid Load and Cardiometabolic Syndrome on Bone Resorption Marker among Post-Menopausal Women in Malaysia. Malays J Med Sci, 31(2):113-129, https://doi.org/10.21315/mjms2024.
Viewed PDF 18 4 -
The Harmony of Iron Regulating Genes and Genes of Antioxidant Enzymes in Thalassaemia PatientsAuthor: Mohammed K. J. AlnoriDOI: 10.21522/TIJPH.2013.13.01.Art067
The Harmony of Iron Regulating Genes and Genes of Antioxidant Enzymes in Thalassaemia Patients
Abstract:
The purpose of this work was to investigate the expression of iron-regulating genes and their relationship to enzymatic antioxidant genes in thalassaemic patients, as well as to detect distinct forms of thalassaemia using an RT-PCR technique using a presence/absence protocol. This study included 50 patients who were admitted to Mosul's Al-Hadba'a Hospital. Ten healthy subjects and forty thalassaemic patients were aged eight to seventeen years. Freshly blood samples were collected using EDTA for molecular processes, as gene expression and genomic identification of thalassaemia types. The outcomes indicated that the foxO1 gene was significantly upregulated in thalassaemic patients compared to healthy participants, but hepcidin expression was non-significantly downregulated. Similarly, the enzymatic antioxidant gene GSH-Px1 demonstrated significant downstream regulation expression in thalassaemic participants compared to healthy ones, even though the expression of SOD1 and CAT antioxidant enzyme genes did not differ across investigated patients. Catalase expression is associated inversely with foxO1 expression. The presence/absence approach showed that 8.4% and 5.1% of individuals had positive α-thalassaemia based on α1 and α2 mutations in their gDNA samples, respectively, compared to healthy patients. Furthermore, 33.6%, 36.5%, and 16.4% of blood samples with an unknown type of thalassaemia tested positive for ß-thalassaemia because their gDNA samples had codon8/9, codon 41/42, and IVS-I-5 mutations, respectively. Our findings suggest that the RT-PCR approach is the most effective for studying gene expression and molecular identification of thalassaemia types.
The Harmony of Iron Regulating Genes and Genes of Antioxidant Enzymes in Thalassaemia Patients
References:
[1]. Britton, R. S., Leicester, K. L., Bacon, B. R., 2002, Iron toxicity and chelation therapy. International journal of hematology, 76, 219-228, doi: 10.1007/bf02982791.
[2]. Papanikolaou, G., Tzilianos, M., Christakis, J. I., Bogdanos, D., Tsimirika, K., MacFarlane, J., Nemeth, E., 2005, Hepcidin in iron overload disorders. Blood, 105(10), 4103-4105, doi: 10.1182/BLOOD-2004-12-4844.
[3]. Barisani, D., Pelucchi, S., Mariani, R., Galimberti, S., Trombini, P., Fumagalli, D., Piperno, A., 2008, Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload. Journal of hepatology, 49(1), 123-133, doi: 10.1016/J.JHEP.2008.03.011.
[4]. Latour, C., Kautz, L., Besson‐Fournier, C., Island, M. L., Canonne‐Hergaux, F., Loréal, O., Roth, M. P., 2014, Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin. Hepatology, 59(2), 683-694, doi: 10.1002/hep.26648.
[5]. Roth, M. P., Meynard, D., Coppin, H., 2019, Regulators of hepcidin expression. Vitamins and hormones, 110, 101-129, doi: 10.1016/BS.VH.2019.01.005.
[6]. Kassab-Chekir, A., Laradi, S., Ferchichi, S., Khelil, A. H., Feki, M., Amri, F., Miled, A., 2003, Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clinica Chimica Acta, 338(1-2), 79-86, doi: 10.1016/j.cccn.2003.07.010.
[7]. Meral, A., Tuncel, P., Sürmen-Gür, E., Özbek, R., Öztürk, E., GÜnay, Ü., 2000, Lipid peroxidation and antioxidant status in ß-thalassemia. Pediatric hematology and oncology, 17(8), 687-693, doi: 10.1080/08880010050211402.
[8]. Kattamis, C., Lazaropoulou, C., Delaporta, P., Apostolakou, F., Kattamis, A., Papassotiriou, I., 2011, Disturbances of biomarkers of iron and oxidant-antioxidant homeostasis in patients with beta-thalassemia intermedia. Pediatric endocrinology reviews: PER, 8, 256-262.
[9]. Nemeth, E., Ganz, T., 2023, Hepcidin and iron in health and disease. Annual review of medicine, 74(1), 261-277. https://doi.org/10.1146/annurev-med-043021-032816.
[10]. Dolai, T. K., Nataraj, K. S., Sinha, N., Mishra, S., Bhattacharya, M., Ghosh, M. K., 2012, Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. Indian Journal of Hematology and Blood Transfusion, 28, 7-9, doi: 10.1007/S12288-011-0088-9/METRICS.
[11]. Rahman, M., Irshadullah, N. M., Ahmed, M., Kabir, A. L., Begum, M., Mostafa, A. G., Khan, A. H., 2014, Prevalence of iron deficiency in thalassemia trait: a study in BSMMU, Dhaka. Bangladesh Journal of Medicine, 25(1), 13-16, doi: 10.3329/BJMED.V25I1.25072.
[12]. Tantiworawit, A., Khemakapasiddhi, S., Rattanathammethee, T., Hantrakool, S., Chai-Adisaksopha, C., Rattarittamrong, E., Fanhchaksai, K., 2021, Correlation of hepcidin and serum ferritin levels in thalassemia patients at Chiang Mai University Hospital. Bioscience Reports, 41(2), BSR20203352, doi: 10.1042/BSR20203352.
[13]. Haghpanah, S., Esmaeilzadeh, M., Honar, N., Hassani, F., Dehbozorgian, J., Rezaei, N., Karimi, M., 2015, Relationship between serum hepcidin and ferritin levels in patients with thalassemia major and intermedia in Southern Iran. Iranian Red Crescent Medical Journal, 17(7), doi: 10.5812/ircmj.17(5)2015.28343.
[14]. Susanah, S., Rakhmilla, L. E., Ghozali, M., Trisaputra, J. O., Moestopo, O., Sribudiani, Y., Maskoen, A. M., 2021, Iron Status in Newly Diagnosed β‐Thalassemia Major: High Rate of Iron Status due to Erythropoiesis Drive. BioMed Research International, 2021(1), 5560319, doi: 10.1155/2021/5560319.
[15]. Eshagh Hossaini, S. K., Haeri, M. R., 2019, Association between serum levels of hepcidin and ferritin in patients with thalassemia major and intermedia, the role of iron chelator. Journal of Hematopathology, 12, 143-147, doi: 10.1007/S12308-019-00363-X/FIGURES/4.
[16]. Lim, W. F., Muniandi, L., George, E., Sathar, J., Teh, L. K., Lai, M. I., 2015, HbF in HbE/β-thalassemia: A clinical and laboratory correlation. Hematology, 20(6), 349-353, doi: 10.1179/1607845414Y.0000000203.
[17]. Voskou, S., Aslan, M., Fanis, P., Phylactides, M., Kleanthous, M., 2015, Oxidative stress in β-thalassaemia and sickle cell disease. Redox biology, 6, 226-239, doi: 10.1016/J.REDOX.2015.07.018.
[18]. Rifkind, J. M., Mohanty, J. G., Nagababu, E., 2015, The pathophysiology of extracellular hemoglobin associated with enhanced oxidative reactions. Frontiers in physiology, 5, 500, doi: 10.3389/FPHYS.2014.00500/BIBTEX.
[19]. Johnson, R. M., Ho, Y. S., Yu, D. Y., Kuypers, F. A., Ravindranath, Y., Goyette, G. W., 2010, The effects of disruption of genes for peroxiredoxin-2, glutathione peroxidase-1, and catalase on erythrocyte oxidative metabolism. Free Radical Biology and Medicine, 48(4), 519-525, doi: 10.1016/J.FREERADBIOMED.2009.11.021.
[20]. Nagababu, E., Mohanty, J. G., Friedman, J. S., Rifkind, J. M., 2013, Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress. Free radical research, 47(3), 164-171, doi: 10.3109/10715762.2012.756138.
[21]. Homma, T., Okano, S., Lee, J., Ito, J., Otsuki, N., Kurahashi, T., Fujii, J., 2015, SOD1 deficiency induces the systemic hyperoxidation of peroxiredoxin in the mouse. Biochemical and biophysical research communications, 463(4), 1040-1046, doi: 10.1016/J.BBRC.2015.06.055.
[22]. Al-Allawi, N., Al Allawi, S., Jalal, S. D., 2021, Genetic epidemiology of hemoglobinopathies among Iraqi Kurds. Journal of Community Genetics, 12(1), 5-14, doi: 10.1007/s12687-020-00495-z.
[23]. Suwannakhon, N., Pangeson, T., Seeratanachot, T., Mahingsa, K., Pingyod, A., Bumrungpakdee, W., Sanguansermsri, T., 2019, Noninvasive prenatal screening test for compound heterozygous beta thalassemia using an amplification refractory mutation system real-time polymerase chain reaction technique. Hematology Reports, 11(3), doi: 10.4081/hr.2019.8124.
[24]. Al-Allawi, N. A., Puehringer, H., Raheem, R. A., Oberkanins, C., 2015, Genetic modifiers in β-thalassemia intermedia: a study on 102 Iraqi Arab patients. Genetic testing and molecular biomarkers, 19(5), 242-247, doi: 10.1089/gtmb.2014.0310.
[25]. Kho, S. L., Chua, K. H., George, E., Tan, J.A.M. A., 2015, A novel gap-PCR with high resolution melting analysis for the detection of α-thalassaemia Southeast Asian and Filipino β0-thalassaemia deletion. Scientific Reports, 5, doi: 10.1038/srep13937.
[26]. Lazarte, S. S., Mónaco, M. E., Haro, A. C., Jiménez, C. L., Ledesma Achem, M. E., Issé, B. A., 2014, Molecular characterization and phenotypical study of β-thalassemia in Tucumán, Argentina. Hemoglobin, 38(6), 394-401, doi: 10.3109/03630269.2014.968784.
[27]. Saud, A. M., 2012, Molecular and biochemical study on β-thalassemia patients in Iraq. University of Baghdad.pdf
[28]. Marashi, S. J., Eshkoor, S. A., saed Mirinargesi, M., Sarookhani, M. R., Rahmat, A. B., Ismail, P. B., 2012, Detection of eight common [beta]-globin gene mutation in thalassemia major patients using real time polymerase chain reaction (PCR)-high resolution melting and EvaGreen (TM) dye. African Journal of Biotechnology, 11(2), 448, doi: 10.5897/ajb10.1167.
[29]. Al-Allawi, N. A., Badi, A. I., Imanian, H., Nikzat, N., Jubrael, J. M., Najmabadi, H., 2009, Molecular characterization of α-thalassemia in the Dohuk region of Iraq. Hemoglobin, 33(1), 37-44, doi: 10.1080/03630260802626053.
[30]. Pornprasert, S., Phusua, A., Suanta, S., Saetung, R., Sanguansermsri, T., 2008, Detection of alpha‐thalassemia‐1 Southeast Asian type using real‐time gap‐PCR with SYBR Green1 and high resolution melting analysis. European journal of haematology, 80(6), 510-514, doi: 10.1111/j.1600-0609.2008.01055.x.
[31]. Gaafar, T. M., ELBeshlawy, A. M., Aziz, M. I., Abdelrazik, H. N., 2006, Rapid screening of β-Globin gene mutations by Real-Time PCR in Egyptian thalassemic children. African Journal of Health Sciences, 13(3), 70-77, doi: 10.4314/ajhs.v13i3.30839.
[32]. Al-Allawi, N. A., Jubrael, J. M., Hughson, M., 2006, Molecular characterization of β-thalassemia in the Dohuk region of Iraq. Hemoglobin, 30(4), 479-486, doi: 10.1080/03630260600868097.
[33]. Sun, C. F., Lee, C. H., Cheng, S. W., Lin, M. H., Wu, T. L., Tsao, K. C., Chu, D. C., 2001, Real‐time quantitative PCR analysis for α‐thalassemia‐1 of Southeast Asian type deletion in Taiwan. Clinical genetics, 60(4), 305-309, doi: 10.1034/j.1399-0004.2001.600409.x.
[34]. Oron‐Karni, V., Filon, D., Oppenheim, A., Rund, D., 1998, Rapid detection of the common Mediterranean α‐globin deletions/rearrangements using PCR. American journal of hematology, 58(4), 306-310, doi: 10.1002/(SICI)1096-8652(199808)58:4<306::AID-AJH10>3.0.CO;2-5.
[35]. Chang, J. G., Liu, H. J., Huang, J. M., Yang, T. Y., Chang, C. P., 1997, Multiplex mutagenically separated PCR: diagnosis of β-thalassemia and hemoglobin variants. Biotechniques, 22(3), 520-527, doi: 10.2144/97223rr03.
[36]. Rosnah, B., Rosline, H., Zaidah, A. W., Noor Haslina, M. N., Marini, R., Shafini, M. Y., Nurul Ain, F. A., 2012, Detection of Common Deletional Alpha‐Thalassemia Spectrum by Molecular Technique in Kelantan, Northeastern Malaysia. International Scholarly Research Notices, 2012(1), 462969, doi: 10.5402/2012/462969.
[37]. Farra, C., Badra, R., Fares, F., Muwakkit, S., Dbaibo, G., Dabbous, I., Abboud, M. R., 2015, Alpha thalassemia allelic frequency in Lebanon. Pediatric Blood & Cancer, 62(1), 120-122, doi: 10.1002/PBC.25242.
[38]. Hadavi, V., Taromchi, A. H., Malekpour, M., Gholami, B., Law, H. Y., Almadani, N., Najmabadi, H., 2007, Elucidating the spectrum of α-thalassemia mutations in Iran. haematologica, 92(7), 992-993, doi: 10.3324/HAEMATOL.10658.
[39]. Adekile, A., Sukumaran, J., Thomas, D., D’Souza, T., Haider, M., 2020, Alpha thalassemia genotypes in Kuwait. BMC Medical Genetics, 21, 1-5, doi: 10.1186/S12881-020-01105-Y/TABLES/4.
[40]. Baysal, E., 2011, α-Thalassemia syndromes in the United Arab Emirates. Hemoglobin, 35(5-6), 574-580, doi: 10.3109/03630269.2011.634698.
Viewed PDF 39 0 -
Chemotherapy-Induced Neutropenic Enterocolitis in Acute Myeloid Leukaemia Patient: A Case ReportAuthor: Maghimaa MDOI: 10.21522/TIJPH.2013.13.01.Art068
Chemotherapy-Induced Neutropenic Enterocolitis in Acute Myeloid Leukaemia Patient: A Case Report
Abstract:
This case report details a 53-year-old woman with newly diagnosed acute myelogenous leukaemia (AML) who developed neutropenic enterocolitis (typhlitis) following induction chemotherapy. Initially presenting with mild respiratory symptoms and blood abnormalities, her condition worsened after chemotherapy, leading to severe gastrointestinal issues and pancytopenia. Diagnostic imaging and blood cultures confirmed neutropenic enterocolitis caused by Escherichia coli. The patient was successfully treated with broad-spectrum antibiotics, G-CSF, blood transfusions, and supportive care, resulting in a full recovery. This case highlights the importance of early diagnosis and prompt treatment of neutropenic enterocolitis in AML patients undergoing chemotherapy to improve outcomes and reduce mortality.
Chemotherapy-Induced Neutropenic Enterocolitis in Acute Myeloid Leukaemia Patient: A Case Report
References:
[1]. Gorschlüter, M., Mey, U., Strehl, J., Ziske, C., Schepke, M., Schmidt‐Wolf, I. G., Sauerbruch, T., and Glasmacher, A., 2005, Neutropenic enterocolitis in adults: systematic analysis of evidence quality. European journal of Haematology, 75(1), pp.1-13. https://doi.org/10.1111/j.1600-0609.2005.00442.x
[2]. Rodrigues, F. G., Dasilva, G., and Wexner, S. D., 2017, Neutropenic enterocolitis. World journal of Gastroenterology, 23(1), p.42. doi: 10.3748/wjg.v23.i1.42.
[3]. Kondoh, D., Kamikawa, A., Sasaki, M., and Kitamura, N., 2017, Localization of α1-2 fucose glycan in the mouse olfactory pathway. Cells Tissues Organs, 203(1), pp.20-28. doi:10.1159/000447009.
[4]. Döhner, H., Weisdorf, D. J., and Bloomfield, C. D., 2015, Acute myeloid leukaemia. New England Journal of Medicine, 373(12), pp.1136-1152. doi:10.1056/NEJMra1406184.
[5]. Langebrake, C., Creutzig, U., Dworzak, M., Hrusak, O., Mejstrikova, E., Griesinger, F., Zimmermann, M., and Reinhardt, D., 2006, Residual disease monitoring in childhood acute myeloid leukaemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group. Journal of Clinical Oncology, 24(22), pp.3686-3692. https://doi.org/10.1200/JCO.2005.05.4312.
[6]. Becker, E. C., Tafader, A., and Bath, R. K., 2022, Neutropenic Enterocolitis in a Patient With Acute Myeloid Leukemia. Cureus, 14(7). doi: 10.7759/cureus.26712.
[7]. Borgstedt-Bendixen, S. E., Abrahamsson, J., Ha, S. Y., Koskenvuo, M., Lausen, B., Palle, J., Zeller, B., Hasle, H., and Løhmann, D. J., 2022, Abdominal complications during treatment for pediatric acute myeloid leukaemia. Journal of pediatric hematology/oncology, 44(5), pp.220-229. DOI: 10.1097/MPH.0000000000002281.
[8]. Portugal, R., and Nucci, M., 2017, Typhlitis (neutropenic enterocolitis) in patients with acute leukemia: a review. Expert review of hematology, 10(2), pp.169-174. https://doi.org/10.1080/17474086.2017.1280389.
[9]. Abu-Sbeih, H., Ali, F. S., Chen, E., Mallepally, N., Luo, W., Lu, Y., Foo, W. C., Qiao, W., Okhuysen, P. C., Adachi, J. A., and Hachem, R. Y., 2020, Neutropenic enterocolitis: clinical features and outcomes. Diseases of the Colon & Rectum, 63(3), pp.381-388. DOI: 10.1097/DCR.0000000000001548.
[10]. Bertozzi, G., Maiese, A., Passaro, G., Tosoni, A., Mirijello, A., Simone, S. D., Baldari, B., Cipolloni, L., and La Russa, R., 2021, Neutropenic enterocolitis and sepsis: towards the definition of a pathologic profile. Medicina, 57(6), p.638. https://doi.org/10.3390/medicina57060638.
[11]. Cartoni, C., Dragoni, F., Micozzi, A., Pescarmona, E., Mecarocci, S., Chirletti, P., Petti, M. C., Meloni, G., and Mandelli, F., 2001, Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography. Journal of Clinical Oncology, 19(3), pp.756-761. https://doi.org/10.1200/JCO.2001.19.3.756.
[12]. Davila, M. L., 2007, Neutropenic enterocolitis: current issues in diagnosis and management. Current infectious disease reports, 9(2), pp.116-120. https://doi.org/10.1007/s11908-007-0006-3.
[13]. Cross, S. J., Patel, J. R., and Wolf, J., 2022, Diagnosis and management of typhlitis and neutropenic enterocolitis in children with cancer. The Pediatric Infectious Disease Journal, 41(8), pp.e326-e328. DOI: 10.1097/INF.0000000000003556.
[14]. Saritha, P., Arunprakash, S., Srinivasan, P., Selvankumar, T., Aldawood, S., Kim, W., & Song, K. S., 2024, Synthesis of Luminescent Copper Nanoparticles Using Couroupita guianensis Flower Extract: Evaluation of Antibacterial and Anticancer Activities. Luminescence, 39(10), e4913.
[15]. Abareethan, M., Sathiyapriya, R., Pavithra, M. E., Parvathy, S., Thirumalaisamy, R., Selvankumar, T., & Almoallim, H. S., 2024, Biogenic silver nanoparticles from Solanum trilobatum leaf extract and assessing their antioxidant and antimicrobial potential. Chemical Physics Impact, 9, 100771.
[16]. Jaganathan, R., Kumaradhas, P., 2024, Structural insights into Furin enzyme inhibition to block SARS-CoV-2 spike protein cleavage: an in-silico approach. 3 Biotech, 14(9), 213.
[17]. Muthuvel, R., Jagannathan, S., Pariyapurath, N. K., Pachamuthu, R. G., Mathanmohun, M., & Sagadevan, S., 2024, Harnessing Nutritional Powerhouse: Millets and Probiotics in Anticancer Therapy. Current Pharmacology Reports, 1-8.
[18]. Pariyapurath, N. K., Jagannathan, S., Mathanmohun, M., Pillai, S. B., Dhandapani, K., Pachamuthu, R. G., & Namassivayam, H., 2024,. Targeted Immunization Strategies and Designing Vaccine against Indian Nipah Virus Strain (NiV B) and Malaysian Variant (NiV M). International Journal of Pharmaceutical Investigation, 14(4).
Viewed PDF 26 3 -
Extraction, Characterization and Antioxidative Potential of a Bioactive Polymeric Material from the Cuttlebone of Sepia brevimanaAuthor: Pasiyappazham RamasamyDOI: 10.21522/TIJPH.2013.13.01.Art069
Extraction, Characterization and Antioxidative Potential of a Bioactive Polymeric Material from the Cuttlebone of Sepia brevimana
Abstract:
This study aimed to extract and characterize a functional polymeric chemical from Sepia brevimana cuttlebone and explore its potential to inhibit oxidative processes. Cuttlebone waste is widely available and frequently discarded, making it an excellent source for extracting beneficial bioactive chemicals. The isolation process involved solvent extraction, precipitation, and purification to produce a pure polymeric material. Several analytical techniques, including Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and scanning electron microscopy (SEM), were employed to characterize the isolated polymeric material. The study revealed that the isolated material possesses a unique polymeric structure with functional groups associated with antioxidant activity. The bioactivity of the substance was assessed by evaluating its efficiency in inhibiting oxidative processes in a model system. The material demonstrated excellent antioxidant activity by inhibiting the generation of reactive oxygen species (ROS) and scavenging free radicals. The presence of antioxidant moieties and the polymeric nature of the structure contributed to this activity. In conclusion, a bioactive polymeric material with strong antioxidant capabilities was successfully extracted and characterized from Sepia brevimana cuttlebone. The findings highlight the potential of cuttlebone waste as a rich source of bioactive chemicals, offering a sustainable pathway for producing natural antioxidants for applications in the culinary, cosmetic, and pharmaceutical industries. Further research is needed to comprehensively analyze its bioactivities and understand the underlying mechanisms of action.
Extraction, Characterization and Antioxidative Potential of a Bioactive Polymeric Material from the Cuttlebone of Sepia brevimana
References:
[1]. Kim, K. W., Thomas, R. L., 2007, Antioxidative activity of chitosans with varying molecular weights. Food chemistry, 101(1), 308-313.
[2]. Ambika, N., Sudha, G., Prasanna, R., Krishnamoorthyn, A. S., Sathianarayanan, S., Baskar, V., Muthu, T., Maksim, R., Mohammad, A. S., Jose, M. L., Miran, P., 2022, Antioxidant, antitumor, and anticoagulant activities of polysaccharide from Calocybe indica (APK2). Antioxidants. 11(9), 1694.
[3]. Xie, W., Xu, P., Liu, Q., 2001, Antioxidant activity of water-soluble chitosan derivatives. Bioorganic & Medicinal Chemistry Letters, 11(13), 1699-1701.
[4]. Lin, S. B., Chen, S. H., Peng, K. C., 2009, Preparation of antibacterial chito‐oligosaccharide by altering the degree of deacetylation of β‐chitosan in a Trichoderma harzianum chitinase‐hydrolysing process. Journal of the Science of Food and Agriculture, 89(2), 238-244.
[5]. Onsøyen, E., Skaugrud, O., 1990, Metal recovery using chitosan. Journal of Chemical Technology and biotechnology (Oxford, Oxfordshire: 1986), 49(4), 395-404.
[6]. Hirano, S., Zhang, M., Chung, B. G., Kim, S. K., 2000, The N-acylation of chitosan fibre and the N-deacetylation of chitin fibre and chitin–cellulose blended fibre at a solid state. Carbohydrate Polymers, 41(2), 175-179.
[7]. Subash, H. A., Santhosh, K., Kannan, K., and Pitchiah, S., 2024, Extraction of Keratin degrading enzyme from marine Actinobacteria of Nocardia sp. and their antibacterial potential against oral pathogens. Oral Oncology Reports, 9, p.100184.
[8]. Meyer, A. S., Isaksen, A., 1995, Application of enzymes as food antioxidants. Trends in Food Science & Technology, 6(9), 300-304.
[9]. Kobayashi, M., Watanabe, T., Suzuki, S., Suzuki, M., 1990, Effect of N-acetylchitohexaose against Candida albicans infection of tumor-bearing mice. Microbiology and Immunology, 34(5), 413-426.
[10]. Tokoro, A., Kobayashi, M., Tatewaki, N., Suzuki, K., Okawa, Y., Mikami, T., Suzuki, M., 1989, Protective effect of N-acetyl chitohexaose on Listeria monocytogenes infection in mice. Microbiology and immunology, 33(4), 357-367.
[11]. Kanner, J., German, J. B., Kinsella, J. E., Hultin, H. O., 1987, Initiation of lipid peroxidation in biological systems. Critical Reviews in Food Science & Nutrition, 25(4), 317-364.
[12]. Velioglu, Y., Mazza, G., Gao, L., Oomah, B. D., 1998, Antioxidant activity and total phenolics in selected fruits, vegetables, and grain products. Journal of agricultural and food chemistry, 46(10), 4113-4117.
[13]. Ramasubburayan, R., Senthilkumar, N., Kanagaraj, K., Basumatary, S., Kathiresan, S., Manjunathan, J., Revathi, M., Selvaraj, M., Prakash, S., 2023, Environmentally benign, bright luminescent carbon dots from IV bag waste and chitosan for antimicrobial and bioimaging applications. Environmental Research, 238, 117182.
[14]. Xing, R., Yu, H., Liu, S., Zhang, W., Zhang, Q., Li, Z., Li, P., 2005, Antioxidant activity of differently regioselective chitosan sulfates in vitro. Bioorganic & medicinal chemistry, 13(4), 1387-1392.
[15]. Dong, F., Xue, Q., Liu, J., Guo, Z., Zhong, H., Sun, H., 2009, The influence of amino and hydroxyl of chitosan on hydroxyl radical scavenging activity. In 2009 3rd International Conference on Bioinformatics and Biomedical Engineering, 1-4, IEEE.
[16]. Bersuder, P., Hole, M., Smith, G., 1998, Antioxidants from a heated histidine-glucose model system. I: Investigation of the antioxidant role of histidine and isolation of antioxidants by high-performance liquid chromatography. Journal of the American Oil Chemists' Society, 75(2), 181-187.
[17]. Xing, R., Liu, S., Yu, H., Zhang, Q., Li, Z., Li, P., 2004, Preparation of low-molecular-weight and high-sulfate-content chitosans under microwave radiation and their potential antioxidant activity in vitro. Carbohydrate research, 339(15), 2515-2519.
[18]. Tolaimate, A., Desbrieres, J., Rhazi, M., Alagui, A., 2003, Contribution to the preparation of chitins and chitosans with controlled physico-chemical properties. Polymer, 44(26), 7939-7952.
[19]. Jothi, N., Nachiyar, R. K., 2013, Identification and isolation of chitin and chitosan from cuttle bone of Sepia prashadi Winckworth, 1936. Global Journal of Biotechnology & Biochemistry, 8(2), 33-39.
[20]. Karthik, R., Manigandan, V., Saravanan, R., Rajesh, R. P., Chandrika, B., 2016, Structural characterization and in vitro biomedical activities of sulfated chitosan from Sepia pharaonis. International Journal of Biological Macromolecules, 84, 319-328.
[21]. Varma, R., Vasudevan, S., 2020, Extraction, characterization, and antimicrobial activity of chitosan from horse mussel Modiolus modiolus. ACS omega, 5(32), 20224-20230.
[22]. Varun, T. K., Senani, S., Jayapal, N., Chikkerur, J., Roy, S., Tekulapally, V. B., Kumar, N., 2017, Extraction of chitosan and its oligomers from shrimp shell waste, their characterization and antimicrobial effect. Veterinary world, 10(2), 170.
[23]. Subhapradha, N., Ramasamy, P., Shanmugam, V., Madeswaran, P., Srinivasan, A., Shanmugam, A., 2013, Physicochemical characterisation of β-chitosan from Sepioteuthis lessoniana gladius. Food chemistry, 141(2), 907-913.
[24]. Jeffery, R. S., Morris, R. W., Denham, R. A., 1991, Coronal alignment after total knee replacement. The Journal of Bone & Joint Surgery British Volume, 73(5), 709-714, https://doi.org/10.1302/0301-620X.73B5.1894655
[25]. Rasti, H., Parivar, K., Baharara, J., Iranshahi, M., Namvar, F., 2017, Chitin from the mollusc chiton: extraction, characterization and chitosan preparation. Iranian journal of pharmaceutical research: IJPR, 16(1), 366.
[26]. Sudatta, B. P., Sugumar, V., Varma, R., Nigariga, P., 2020, Extraction, characterization and antimicrobial activity of chitosan from pen shell, Pinna bicolor. International Journal of Biological Macromolecules, 163, 423-430.
[27]. Vino, A. B., Ramasamy, P., Shanmugam, V., Shanmugam, A., 2012, Extraction, characterization and in vitro antioxidative potential of chitosan and sulfated chitosan from Cuttlebone of Sepia aculeata Orbigny, 1848. Asian Pacific journal of tropical biomedicine, 2(1), S334-S341.
[28]. Al Sagheer, F. A., Al-Sughayer, M. A., Muslim, S., Elsabee, M. Z., 2009, Extraction and characterization of chitin and chitosan from marine sources in Arabian Gulf. Carbohydrate polymers, 77(2), 410-419.
[29]. Yen, M. T., Tseng, Y. H., Li, R. C., Mau, J. L., 2007, Antioxidant properties of fungal chitosan from shiitake stipes. LWT-Food Science and Technology, 40(2), 255-261.
[30]. Rajalakshmi, A., Krithiga, N., Jayachitra, A., 2013, Antioxidant activity of the chitosan extracted from shrimp exoskeleton. Middle East J. Sci. Res, 16(10), 1446-1451.
Viewed PDF 25 2 -
In-silico Analysis of Single Nucleotide Polymorphisms (SNPs) in Human Pten GeneAuthor: T. GovardhanDOI: 10.21522/TIJPH.2013.13.01.Art070
In-silico Analysis of Single Nucleotide Polymorphisms (SNPs) in Human Pten Gene
Abstract:
Phosphatase Tensin Homolog deleted on Chromosome 10 is a tumour suppressor gene frequently inactivated in human cancers. Single Nucleotide Polymorphisms (SNPs) are the substitution of one DNA nucleotide base with another and a commonly occurring genomic alteration. This study involved analyzing various missense SNPs of the PTEN gene using five different bioinformatics tools -SIFT, POLYPHEN, CADD, META LR, and MUTATION ASSESSOR to identify the tolerated from intolerant ones. String analysis of PTEN protein-protein interactions was also done using the STRING database. A total of 8298 missense SNPs were retrieved and analyzed using the five bioinformatics tools. Out of 8298 missense SNPs analyzed, SIFT categorized 5281 SNPs as deleterious, while POLYPHEN identified 4490 as damaging. CADD showed that 909 were disease-causing SNPs. META LR identified 2995 as damaging, and the MUTATION ASSESSOR identified 897 high-risk missense SNPs. This study shows that the various in silico tools are a good preliminary approach to identifying the harmful missense SNPs.
In-silico Analysis of Single Nucleotide Polymorphisms (SNPs) in Human Pten Gene
References:
[1]. Garcia, F. A., de O., de Andrade, E. S., & Palmero, E. I., 2022, Insights on variant analysis in silico tools for pathogenicity prediction. Frontiers in Genetics, 13, 1010327. https://doi.org/10.3389/fgene.2022.1010327
[2]. Weng, L. P., Smith, W. M., Dahia, P. L., Ziebold, U., Gil, E., Lees, J. A., & Eng, C., 1999, PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Cancer Research, 59(22), 5808–5814.
[3]. Fusco, N., Sajjadi, E., Venetis, K., Gaudioso, G., Lopez, G., Corti, C., Rocco, E. G., Criscitiello, C., Malapelle, U., & Invernizzi, M., 2020, PTEN alterations and their role in cancer management: Are we making headway on precision medicine? Genes, 11(7), 719. https://doi.org/10.3390/genes11070719
[4]. Liu, T., Wang, Y., Wang, Y., & Chan, A. M., 2019, Multifaceted regulation of PTEN subcellular distributions and biological functions. Cancers, 11(9), 1247. https://doi.org/10.3390/cancers11091247
[5]. Hopkins, B. D., Hodakoski, C., Barrows, D., Mense, S. M., & Parsons, R. E., 2014, PTEN function: the long and the short of it. Trends in Biochemical Sciences, 39(4), 183–190. https://doi.org/10.1016/j.tibs.2014.02.006
[6]. Chen, C.-Y., Chen, J., He, L., & Stiles, B. L., 2018, PTEN: Tumor suppressor and metabolic regulator. Frontiers in Endocrinology, 9, 338. https://doi.org/10.3389/fendo.2018.00338
[7]. Luongo, F., Colonna, F., Calapà, F., Vitale, S., Fiori, M. E., & De Maria, R., 2019, PTEN tumor-suppressor: The dam of stemness in cancer. Cancers, 11(8), 1076. https://doi.org/10.3390/cancers11081076
[8]. Ngeow, J., & Eng, C., 2020, PTEN in hereditary and sporadic cancer. Cold Spring Harbor Perspectives in Medicine, 10(4), a036087. https://doi.org/10.1101/cshperspect.a036087
[9]. Nero, C., Ciccarone, F., Pietragalla, A., & Scambia, G., 2019, PTEN and gynecological cancers. Cancers, 11(10), 1458. https://doi.org/10.3390/cancers11101458
[10]. Choi, S. W., Lee, Y., Shin, K., Koo, H., Kim, D., Sa, J. K., Cho, H. J., Shin, H.-M., Lee, S. J., Kim, H., Chung, S., Shin, J., Lee, C., & Nam, D.-H., 2021, Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma. Cell Death & Disease, 12(4), 374. https://doi.org/10.1038/s41419-021-03657-0
[11]. Wang, J., Zhang, S., Zhang, J., Zhang, Z., Ma, Q., Fu, W., Chen, X., Zhao, D., Zhao, M., Di, C., & Xie, X., 2023, A novel PTEN mutant caused by polymorphism in cis-regulatory elements is involved in chemosensitivity in breast cancer. American journal of cancer research, 13(1), 86–104.
[12]. Deng, N., Zhou, H., Fan, H., & Yuan, Y., 2017, Single nucleotide polymorphisms and cancer susceptibility. Oncotarget, 8(66), 110635–110649. https://doi.org/10.18632/oncotarget.22372
[13]. Ng, P. C., & Henikoff, S., 2003, SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Research, 31(13), 3812–3814. https://doi.org/10.1093/nar/gkg509
[14]. Behairy, M. Y., Soltan, M. A., Adam, M. S., Refaat, A. M., Ezz, E. M., Albogami, S., Fayad, E., Althobaiti, F., Gouda, A. M., Sileem, A. E., Elfaky, M. A., Darwish, K. M., & Alaa Eldeen, M., 2022, Computational analysis of deleterious SNPs in NRAS to assess their potential correlation with carcinogenesis. Frontiers in Genetics, 13, 872845. https://doi.org/10.3389/fgene.2022.872845
[15]. Ajith, A., & Subbiah, U., 2023, In silico screening of non-synonymous SNPs in human TUFT1 gene. Journal, Genetic Engineering & Biotechnology, 21(1), 95. https://doi.org/10.1186/s43141-023-00551-4
[16]. Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J., & Kircher, M., 2019, CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Research, 47(D1), D886–D894. https://doi.org/10.1093/nar/gky1016
[17]. Liu, X., Wu, C., Li, C., & Boerwinkle, E., 2016, DbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice-site SNVs. Human Mutation, 37(3), 235–241. https://doi.org/10.1002/humu.22932
[18]. Khan, I., Ansari, I. A., Singh, P., & Dass J, F. P., 2017, Prediction of functionally significant single nucleotide polymorphisms in PTEN tumor suppressor gene: An in-silico approach. Biotechnology and Applied Biochemistry, 64(5), 657–666. https://doi.org/10.1002/bab.1483
[19]. Naidu, C. K., & Suneetha, Y., 2016, Prediction and analysis of breast cancer related deleterious non-synonymous single nucleotide polymorphisms in the PTEN gene. Asian Pacific Journal of Cancer Prevention: APJCP, 17(4), 2199–2203. https://doi.org/10.7314/apjcp.2016.17.4.2199
[20]. Song, D.-D., Zhang, Q., Li, J.-H., Hao, R.-M., Ma, Y., Wang, P.-Y., & Xie, S.-Y., 2017, Single nucleotide polymorphisms rs701848 and rs2735343 in PTEN increases cancer risks in an Asian population. Oncotarget, 8(56), 96290–96300. https://doi.org/10.18632/oncotarget.22019
[21]. Han, M., Wu, G., Sun, P., Nie, J., Zhang, J., & Li, Y., 2015, Association of genetic polymorphisms in PTEN and additional interaction with alcohol consumption and smoking on colorectal cancer in Chinese population. International Journal of Clinical and Experimental Medicine, 8(11), 21629–21634
[22]. Andreassen, K. E., Kristiansen, W., Karlsson, R., Aschim, E. L., Dahl, O., Fosså, S. D., Adami, H.-O., Wiklund, F., Haugen, T. B., & Grotmol, T., 2013, Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor. Human Reproduction (Oxford, England), 28(7), 1995–2002. https://doi.org/10.1093/humrep/det127
Viewed PDF 25 0 -
Estimating the Rate and Quantifying the Reasons for HIV Retesting in Previously Diagnosed People Living with HIV, A Cross-Sectional Study in CameroonAuthor: Tse Kingsly NkwohDOI: 10.21522/TIJPH.2013.13.01.Art071
Estimating the Rate and Quantifying the Reasons for HIV Retesting in Previously Diagnosed People Living with HIV, A Cross-Sectional Study in Cameroon
Abstract:
HIV Testing Services remain critical as the entry point into HIV prevention and treatment programs. However, retesting of people who already know their HIV-positive status can waste test kits, personnel time, and laboratory resources and pose a retention problem. We estimated retesting rates, reasons, strategies, and re-engagement approaches. We conducted a cross-sectional study in 15 high-volume Health Facilities in Cameroon's West Region, sampling clients aged 15+ who tested HIV positive from April to August 2024. Data collection involved interviews, electronic medical records, and focus groups. Quantitative data was analyzed with SPSS 26; qualitative data with NVivo 14.23.3. A total of 520 adult clients tested HIV positive and 98% consented (n = 509. The mean age was 39 and 58.90% were female (n = 300). This study found a retesting rate of 42.24% (n = 215, p = 0.001). The true positivity rate dropped from 2.44% to 1.43% after we deduplicated the known positives. The most common reason cited was the need to confirm the test results in 87 cases (40.5% p = 0.044). After receiving traditional treatment (30 cases, 14% p = 0.044), some patients returned for repeat testing, while others did so following healing prayers (27 cases, 12.6% p = 0.044). Reengagement in the care of known HIV-positive testers was 95.10%. We found a high rate of retesting, potentially biasing the yearly new HIV diagnoses. HIV testing programs could serve as gateways for re-engaging PLHIV who interrupt treatment, improving care continuity.
Estimating the Rate and Quantifying the Reasons for HIV Retesting in Previously Diagnosed People Living with HIV, A Cross-Sectional Study in Cameroon
References:
[1]. Joint United Nations Programme on HIV/AIDS, 2023, The path that ends AIDS: UNAIDS Global AIDS Update 2023 (p. 196). Joint United Nations Programme on HIV/AIDS.
[2]. Cameroon Population-based HIV Impact Assessment., 2017-2018, CAMPHIA Report. https://phia.icap.columbia.edu/wp-content/uploads/2021/09/53059-CAMPHIA-Report_EN_WEB_August1.pdf
[3]. Profil des estimations et projections en matière de VIH/SIDA au Cameroun., 2022, RAPPORT NARRATIF SPECTRUM 2021. http://onsp.minsante.cm/sites/default/files/publications/284/RAPPORT%20NARRATIF%20SPECTRUM%202021.pdf
[4]. Cameroon National AIDS Control Report., 2022, https://www.cnls-senegal.org/wp-content/uploads/2001/01/Rapport-Annuel-CNLS-2022.pdf
[5]. Olislagers, Q., van Leth, F., Shabalala, F., et al., 2023, Reasons for, and factors associated with, positive HIV retesting: A cross-sectional study in Eswatini. AIDS Care, 35(9), 1346-1353. https://doi.org/10.1080/09540121.2022.2142930
[6]. Myer, L., Dunning, L., & Bekker, L. G., 2018, Impact of repeat testing on HIV prevalence estimates in a national HIV testing program in South Africa. The Lancet HIV, 5(5), e239-e247. https://doi.org/10.1016/S2352-3018(18)30089-0
[7]. Nguefack, T., & Bilong, C., 2020, On estimating the number of people with known HIV positive status. BMC Research Notes. https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-020-04957-y
[8]. Smith, J., & Doe, A., 2021, HIV diagnosis and treatment trends in 2020. The Lancet, 398(10304), 1156-1167. https://doi.org/10.xxxx/lancet.2021.01.12345
[9]. Pogue, S. D., et al., 2024, HIV retesting among people living with HIV in Lesotho in 2022. International Journal of STD & AIDS. https://doi.org/9564624241289984
[10]. Hakim, A. J., Mukasa, B., Hundley, L., et al., 2019, Correlates of undiagnosed HIV infection and retesting among voluntary HIV testing clients at Mildmay Clinic, Uganda. AIDS Behavior, 23(4), 820-834. https://doi.org/10.1007/s10461-018-2343-x
[11]. Nardell, M. F., Hedt-Gauthier, B., Earnshaw, V. A., et al., 2022, Understanding repeat positive HIV testing in South Africa under changing treatment guidelines. AIDS Behavior, 26(5), 1366-1376. https://doi.org/10.1007/s10461-022-03641-7
[12]. Muinde, R., et al., 2023, Optimizing HIV case identification: Investigating client characteristics predictive of HIV positivity from provider-initiated testing (PITC) in central Kenya. BMC Health Services Research, 23(1), 1005. https://doi.org/10.1186/s12913-023-09651-9
[13]. Telfer, M., Kamali, A., & Ssembajja, F., 2017, HIV testing in sub-Saharan Africa: The role of repeat testing in reporting positivity rates. Journal of Global Health, 7(1), 010405. https://doi.org/10.7189/jogh.07.010405
[14]. Atanga, P. N., Harrison, T. N., Eric, A. A., Henry, D. M., Michael, H., & Arne, K., 2017, Retention in care and reasons for discontinuation of lifelong antiretroviral therapy in a cohort of Cameroonian pregnant and breastfeeding HIV-positive women initiating ‘Option B+’ in the South West Region. Tropical Medicine & International Health, 22(2), 161-170. https://doi.org/10.1111/tmi.12816
[15]. Ajeh, R. A., et al., 2021, Determinants of retention in HIV antiretroviral treatment (ART) in the Cameroon International Epidemiology Database to Evaluate AIDS (IeDEA) study clinics: The context of the HIV treat-all strategy in Cameroon. Journal of Global Health, 11(2), 12-23.
[16]. Chemutai, R. J., 2018, Factors associated with retention in care among HIV-positive adults attending Pumwani Comprehensive Care Centre in Nairobi County, Kenya. (Doctoral dissertation, JKUAT-COHES).
[17]. Odiachi, A., et al., 2018, HIV status disclosure to male partners among rural Nigerian women along the prevention of mother-to-child transmission of HIV cascade: A mixed methods study. Reproductive Health, 15(1), 36. https://doi.org/10.1186/s12978-018-0502-4
[18]. Tiamiyu, A. B., et al., 2020, HIV status disclosure by Nigerian men who have sex with men and transgender women living with HIV: A cross-sectional analysis at enrollment into an observational cohort. BMC Public Health, 20(1), N.PAG. https://doi.org/10.1186/s12889-020-09315-y
[19]. Nshom, E., et al., 2020, Retesting of patients receiving antiretroviral treatment at HIV care and treatment and prevention of mother-to-child HIV transmission sites in Cameroon. Journal of HIV & AIDS.
[20]. Ding, X.-B., et al., 2020, Analysis of reexamination and conclusive tests for 1,954 HIV antibody positive serums in Yantai from 2014 to 2018. Journal of Tropical Medicine (Guangzhou), 20(3), 414-416.
[21]. Fan Wei, F. W., & Yan QingLi, Y. Q., 2016, Retest and confirmation results of HIV screening positive samples in Huai'an, 2015. Modern Preventive Medicine, 43(17), 3210-3212.
[22]. Simoncini, G. M., et al., 2016, Reducing false-positive HIV diagnosis in Niger: A women's issue. Journal of the International Association of Providers of AIDS Care, 15(1), 15-18.
[23]. Fonner, V. A., et al., 2020, Country adherence to WHO recommendations to improve the quality of HIV diagnosis: A global policy review. BMJ Global Health, 5(5). https://doi.org/10.1136/bmjgh-2020-003446
[24]. Eaton, J. W., et al., 2017, The cost of not retesting: Human immunodeficiency virus misdiagnosis in the antiretroviral therapy "Test-and-Offer" era. Clinical Infectious Diseases, 65(3), 522-525. https://doi.org/10.1093/cid/cix322
[25]. Johnson, C. C., et al., 2017, To err is human, to correct is public health: A systematic review examining poor quality testing and misdiagnosis of HIV status. Journal of the International AIDS Society, 20(Suppl 6), 21755. https://doi.org/10.7448/IAS.20.6.21755
[26]. Dupwa, B., et al., 2019, Retesting for verification of HIV diagnosis before antiretroviral therapy initiation in Harare, Zimbabwe: Is there a gap between policy and practice? Transactions of the Royal Society of Tropical Medicine and Hygiene, 113(10), 610-616. https://doi.org/10.1093/trstmh/trz057
[27]. Shodell, D., et al., 2018, Low and decreasing prevalence and rate of false positive HIV diagnosis - Chokwe District, Mozambique, 2014-2017. MMWR. Morbidity and Mortality Weekly Report, 67(49), 1363-1368.
[28]. Horter, S., Thabede, Z., Dlamini, V., et al, 2017, "Life is so easy on ART, once you accept it": Acceptance, denial and linkage to HIV care in Shiselweni, Swaziland. Social Science & Medicine, 176, 52-59. https://doi.org/10.1016/j.socscimed.2017.01.025
[29]. Meka, A. F. Z., et al., 2020, Challenges and barriers to HIV service uptake and delivery along the HIV care cascade in Cameroon. The Pan African Medical Journal, 36, 37. https://doi.org/10.11604/pamj.2020.36.37.2286
[30]. Giguère, K., Eaton, J. W., Marsh, K., et al., 2021, Trends in knowledge of HIV status and efficiency of HIV testing services in sub-Saharan Africa, 2000–2020: A modelling study using survey and HIV testing programme data. The Lancet HIV, 8(5), e284–e293. https://doi.org/10.1016/S2352-3018(21)00047-1
[31]. Adayonfo, E. O., & Selo-Ojeme, C. O., 2014, "Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) delusional disorder" - A Case Report. Journal of Medicine and Biomedical Research, 13(2), 34-37.
Viewed PDF 32 0 -
Impact of Multi-Month Dispensation of Antiretroviral Therapy on Retention among People Living with HIV in ZambiaAuthor: Boyd KalikiDOI: 10.21522/TIJPH.2013.13.01.Art072
Impact of Multi-Month Dispensation of Antiretroviral Therapy on Retention among People Living with HIV in Zambia
Abstract:
HIV/AIDS continues to be a global public health concern. At the end of 2019, an estimated 38 million people were living with HIV globally of which 87% knew their HIV status, 67% were on antiretroviral therapy and 59% had achieved HIV viral load suppression with no risk of infecting others. WHO recommends multi-month dispensing of ART for up to 6 months in patients who are clinically stable due to the positive effects of reducing the burden on health systems, and saving time and opportunity costs for patients. The study was a retrospective cohort study based on secondary data collected routinely from health facilities with a sampling frame covering the entire country extracted from SmartCare. Both adults and children who had received ART between 1st January 2015 and 30th June 2020 were included in the study and were tracked through to 30th June 2021. This study revealed that HIV-positive patients on ART and receiving multi-month dispensation are more likely to be retained in HIV care and treatment compared to those on the standard of care dispensation. In conclusion, this study has revealed that a multi-month dispensation of ART is an effective intervention to improve retention among people living with HIV. Therefore, there is a need to continue scaling up multi-month dispensation for all stable patients on ART in Zambia.
Impact of Multi-Month Dispensation of Antiretroviral Therapy on Retention among People Living with HIV in Zambia
References:
[1]. Bekolo, C. E., Diallo, A., Philips, M., Yuma, J. D., Di Stefano, L., Drèze, S., Mouton, J., Koita, Y., Tiomtore, O. W., 2017, Six-monthly appointment spacing for clinical visits as a model for retention in HIV Care in Conakry-Guinea: a cohort study. BMC Infect Dis 17, 766. https://doi.org/10.1186/s12879-017-2826-6
[2]. Centers for Disease Control and Prevention (CDC), 2020, Global HIV Fact Sheet, https://www.cdc.gov/globalhivtb/images/DGHT-HIV-Factsheet.pdf
[3]. Fatti, G., Ngorima-Mabhena, N., Mothibi, E., Muzenda, T., Choto, R., Kasu, T., Tafuma, T. A., Mahachi, N., Takarinda, K. C., Apollo, T., Mugurungi, O., Chasela, C., Hoffman, R. M., & Grimwood, A., 2020, Outcomes of Three- Versus Six-Monthly Dispensing of Antiretroviral Treatment (ART) for Stable HIV Patients in Community ART Refill Groups: A Cluster-Randomized Trial in Zimbabwe. Journal of Acquired Immune Deficiency Syndromes (1999), 84(2), 162–172. https://doi.org/10.1097/QAI.0000000000002333
[4]. Faturiyele, I. O., Appolinare, T., Ngorima-Mabhena, N., Fatti, G., Tshabalala, I., Tukei, V. J., & Pisa, P. T., 2018, Outcomes of community-based differentiated models of multi-month dispensing of antiretroviral medication among stable HIV-infected patients in Lesotho: a cluster randomised non-inferiority trial protocol. BMC public health, 18(1), 1069. https://doi.org/10.1186/s12889-018-5961-0
[5]. Heestermans, T., Browne, J. L., Aitken, S. C., Vervoort, S. C., & Klipstein-Grobusch, K., 2016, Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review. BMJ global health, 1(4), e000125. https://doi.org/10.1136/bmjgh-2016-000125
[6]. Kim, M. H., Wanless, R. S., Caviness, A. C., Golin, R., Amzel, A., Ahmed, S., Mhango, J., Damba, D., Kayabu, A., Chodota, M., Dlamini, S., Chidah, N., Mokhali, M., Calles, N. R., & Abrams, E. J., 2018, Multimonth Prescription of Antiretroviral Therapy Among Children and Adolescents: Experiences From the Baylor International Pediatric AIDS Initiative in 6 African Countries. Journal of Acquired Immune Deficiency Syndromes (1999), 78 Suppl 2(Suppl 2), S71–S80. https://doi.org/10.1097/QAI.0000000000001730
[7]. Mabunda, K., Ngamasana, E. L., Babalola, J. O., Zunza, M., & Nyasulu, P., 2019, Determinants of poor adherence to antiretroviral treatment using a combined effect of age and education among human immunodeficiency virus infected young adults attending care at Letaba Hospital HIV Clinic, Limpopo Province, South Africa. The Pan African Medical Journal, 32, 37. https://doi.org/10.11604/pamj.2019.32.37.17722
[8]. Mody, A., Roy, M., Sikombe, K., Savory, T., Holmes, C., Bolton-Moore, C., Padian, N., Sikazwe, I., & Geng, E., 2018, Improved Retention With 6-Month Clinic Return Intervals for Stable Human Immunodeficiency Virus-Infected Patients in Zambia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(2), 237–243, https://doi.org/10.1093/cid/cix756
[9]. Mutasa-Apollo, T., Ford, N., Wiens, M., Socias, M. E., Negussie, E., Wu, P., Popoff, E., Park, J., Mills, E. J., Kanters, S., 2017, Effect of frequency of clinic visits and medication pick-up on antiretroviral treatment outcomes: a systematic literature review and meta-analysis. J Int AIDS Soc., 20(Suppl 4):21647. doi: 10.7448/IAS.20.5.21647. PMID: 28770599; PMCID: PMC6192466.
[10]. PEPFAR. PEPFAR, 2020, Country Operational Plan Guidance for all PEPFAR Countries, 2020, Available from: https://www.differentiatedcare.org/Portals/0/adam/Content/O96KuQNWiUC0Y_fizRa6NQ/File/COP20-Guidance_Final-
[11]. Prust, M. L., Banda, C. K., Nyirenda, R., Chimbwandira, F., Kalua, T., Jahn, A., Eliya, M., Callahan, K., Ehrenkranz, P., Prescott, M. R., McCarthy, E. A., Tagar, E., & Gunda, A., 2017, Multi-month prescriptions, fast-track refills, and community ART groups: results from a process evaluation in Malawi on using differentiated models of care to achieve national HIV treatment goals. Journal of the International AIDS Society, 20(Suppl 4), 21650. https://doi.org/10.7448/IAS.20.5.21650
[12]. Risa, M. H., Crispin, M., Kelvin, T. B., Zumbe, S., Julie, H., Ashley, B., Matthew, P. F., Gift, K., Thokozani, K., Mwiza, N., Kathryn, D., Paula, M. C., Chi-Hong, T., Pedro, T. P., Refiloe, C., Sundeep, G., Mariet, B., Lawrence, L., Thembi, X., Ian, S., Sydney, R., 2021, Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trial. The Lancet Global Health, v9, issue 5, e628-e638. https://doi.org/10.1016/S2214-109X(21)00039-5
[13]. The Joint United Nations Programme on HIV/AIDS, 2020, 90–90-90 An ambitious treatment target to help end the AIDS epidemic. Available from https://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf
[14]. Senkungu, J., Ware, N. C., Emenyonu, N., & Weiser, S. D., 2010, Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS and behavior, 14(4), 778–784. https://doi.org/10.1007/s10461-009-9533-2
[15]. United Nations Joint Programme on HIV/AIDS (UNAIDS), 2014, 90-90-90 An ambitious treatment target to help end the AIDS epidemic. Available from: https://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf
[16]. United Nations Joint Programme on HIV/AIDS (UNAIDS), 2020, Fact Sheet—World AIDS Day 2017 Geneva, Switzerland. Available from: http://www.unaids.org/en/resources/fact-sheet.
[17]. World Health Organization (WHO), 2016, Clinical guidelines: antiretroviral therapy. Available from https://www.who.int/hiv/pub/arv/chapter4.pdf
[18]. World Health Organisation (WHO), 2013, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. WHO Guidelines.
[19]. World Health Organization (WHO), 2016, Consolidated Guidelines on prevention, diagnosis, treatment and care for key populations.
[20]. Zambia Demographic and Health Survey, 2013, Central Statistical Office (CSO), Ministry of Health (MOH), Tropical Diseases Research Centre (TDRC), University of Zambia, and Macro International Inc. 2009. Calverton, Maryland, USA: CSO and Macro International Inc., ZDHS.
Viewed PDF 20 0 -
Comparative Analysis between Vaccinated and Non-Vaccinated Sickle Cell Clients under 12 years against Influenzae and Pneumococcal Infections at Mulago National Referral Hospital, Kampala, UgandaAuthor: Kasirye Elizabeth OmaginoDOI: 10.21522/TIJPH.2013.13.01.Art073
Comparative Analysis between Vaccinated and Non-Vaccinated Sickle Cell Clients under 12 years against Influenzae and Pneumococcal Infections at Mulago National Referral Hospital, Kampala, Uganda
Abstract:
Sickle cell disease (SCD) is a group of inherited disorders characterized by the production of abnormal haemoglobin, known as haemoglobin S, leading to the distortion of red blood cells into a crescent shape. This disease significantly impairs the oxygen-carrying capacity of blood and results in recurrent vaso-occlusion, hemolytic anaemia, and organ damage. SCD patients are particularly vulnerable to infections due to complications such as functional asplenia, which weakens the immune system and heightens the risk of severe. Vaccination plays a crucial role in preventing infections in SCD patients, with recommended vaccines including those for pneumococcal, influenza, and meningococcal diseases. However, adherence to vaccination schedules remains a challenge, which can impact the health outcomes of these patients. This study investigated the incidence of influenza and pneumococcal infections among sickle cell disease (SCD) patients under 12 years old at Mulago National Referral Hospital in Uganda, assessing the effectiveness of current vaccination programs and identifying barriers to vaccine uptake. The study included 354 SCD patients, with 50% vaccinated and 50% non-vaccinated. Results indicate that vaccinated patients had a higher incidence of influenza (87.9%) compared to non-vaccinated patients (69.2%). However, hospitalization rates were higher among vaccinated patients, with 67.8% hospitalized for influenza. Pneumococcal infections were less frequent but still more common in vaccinated patients (11.3%) compared to non-vaccinated (5.1%). Despite this, vaccinated patients had significantly fewer hospital admissions and infections post-vaccination. Barriers to vaccine uptake were primarily due to knowledge gaps (89.3%), with fewer patients reporting issues like missed appointments or parental refusal.
Comparative Analysis between Vaccinated and Non-Vaccinated Sickle Cell Clients under 12 years against Influenzae and Pneumococcal Infections at Mulago National Referral Hospital, Kampala, Uganda
References:
[1]. Rees David, C., Williams Thomas, N., and Gladwin Mark, T., 2010,"Sickle-cell disease," The Lancet, vol. 376, pp. 2018-2031, 2010.
[2]. Yawn Barbara, P., Buchanan George, R., Afenyi-Annan Araba, N., Ballas Samir, K., Hassell Kathryn, L., James Andra, H., et al., 2014,"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members," Jama, vol. 312, pp. 1033-1048, 2014.
[3]. Bundy David, G., Muschelli John, Clemens Gwendolyn, D., Strouse John, J., Thompson Richard, E., Casella James, F., et al., 2016,"Preventive care delivery to young children with sickle cell disease," Journal of pediatric hematology/oncology, vol. 38, pp. 294-300, 2016.
[4]. Advisory Committee on Immunization Practices, 2017,"Recommended immunization schedule for children and adolescents aged 18 years or younger, United States, 2017," ed: US Department of Health and Human Services, CDC, Atlanta, GA.
[5]. Adamkiewicz Thomas, V., Silk Benjamin, J., Howgate James, Baughman Wendy, Strayhorn Gregory, Sullivan Kevin, et al., 2008,"Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life," Pediatrics, vol. 121, pp. 562-569, 2008.
[6]. Quinn Charles, T., Rogers Zora, R., Mccavit Timothy, L., and Buchanan George, R., 2010,"Improved survival of children and adolescents with sickle cell disease," Blood, The Journal of the American Society of Hematology, vol. 115, pp. 3447-3452, 2010.
[7]. Beverung Lauren, M., Brousseau David, Hoffmann Raymond, G., Yan, Ke, and Panepinto Julie, A., 2014,"Ambulatory quality indicators to prevent infection in sickle cell disease," American Journal of Hematology, vol. 89, pp. 256-260, 2014.
[8]. Weatherall David, J., 2010,"The inherited diseases of hemoglobin are an emerging global health burden," Blood, The Journal of the American Society of Hematology, vol. 115, pp. 4331-4336, 2010.
[9]. Weatherall David, J., 2011,"The challenge of haemoglobinopathies in resource‐poor countries," British Journal of Haematology, vol. 154, pp. 736-744, 2011.
[10]. Mcgann Patrick, T., 2014,"Sickle cell anemia: an underappreciated and unaddressed contributor to global childhood mortality," The Journal of Pediatrics, vol. 165, pp. 18-22, 2014.
[11]. Piel Frédéric, B., Patil Anand, P., Howes Rosalind, E., Nyangiri Oscar, A., Gething Peter, W., Dewi Mewahyu, et al., 2013,"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates," The Lancet, vol. 381, pp. 142-151, 2013.
[12]. Piel Frederic, B., Hay Simon, I., Gupta Sunetra, Weatherall David, J., and Williams Thomas, N., 2013,"Global burden of sickle cell anaemia in children under five, 2010–2050: modelling based on demographics, excess mortality, and interventions," PLoS medicine, vol. 10, p. e1001484, 2013.
[13]. Grosse Scott, D., Odame Isaac, Atrash Hani, K., Amendah Djesika, D., Piel Frédéric, B., and Williams Thomas, N., 2011,"Sickle cell disease in Africa: a neglected cause of early childhood mortality," American journal of preventive medicine, vol. 41, pp. S398-S405, 2011.
[14]. Diallo Dapa, A., and Guindo Aldiouma, 2014,"Sickle cell disease in sub-Saharan Africa: stakes and strategies for control of the disease," Current opinion in hematology, vol. 21, pp. 210-214, 2014.
[15]. Lehmann Hermann, and Raper Alan, B., 1949,"Distribution of the sickle-cell trait in Uganda, and its ethnological significance," Nature, vol. 164, pp. 494-495, 1949.
[16]. John, A. B., Ramlal, A., Jackson, H., Maude, G. H., Sharma, A., Waight, and Serjeant, G.R., 1984,"Prevention of pneumococcal infection in children with homozygous sickle cell disease," Br Med J (Clin Res Ed), vol. 288, pp. 1567-1570, 1984.
[17]. Hsu, Lewis, Nnodu, Obiageli E., Brown, Biobele J., Tluway, Furahini, King, Shonda, Dogara, Livingstone G., et al., 2018,"White paper: pathways to progress in newborn screening for sickle cell disease in sub-Saharan Africa," Journal of tropical diseases & public health, vol. 6, 2018.
[18]. Schembri Stuart, Morant Steve, Winter John, H., and Macdonald Thomas, M., 2009,"Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD," Thorax, vol. 64, pp. 567-572, 2009.
[19]. Who. (2016, Uganda Prioritizes response to Sickle Cell Disease. Available: https://www.afro.who.int/news/uganda-prioritizes-response-sickle-cell-disease
[20]. Sobota, Amy, Sabharwal, Vishakha, Fonebi, Gwendoline, and Steinberg, Martin, 2015,"How we prevent and manage infection in sickle cell disease," British Journal of Haematology, vol. 170, pp. 757-767, 2015.
[21]. Jarovsky Daniel, Bastos Phillipe Romanzini, De Matos Samantha Faria, Almeida Flávia Jacqueline, Sáfadi Marco Aurélio Palazzi, Hegg Izabella Campos Oliveira, et al., 2022,"Vaccination in pediatric patients with sickle-cell disease: uptake report and mini-review," Journal of Tropical Pediatrics, vol. 68, p. fmac034, 2022.
[22]. Oligbu, G., Fallaha, M., Pay, L., and Ladhani, S., 2019,"Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature," Br J Haematol, vol. 185, pp. 743-751, May 2019.
[23]. Gomes, L. M., Vieira, M. M., Reis, T. C., Barbosa, T. L., and Caldeira, A. P., 2011,"Knowledge of family health program practitioners in Brazil about sickle cell disease: a descriptive, cross-sectional study," BMC Fam Pract, vol. 12, p. 89, Aug 19 2011.
[24]. Vardavas, C., Nikitara, K., Aslanoglou, K., Lagou, I., Marou, V., Phalkey, R., et al., 2023,"Social determinants of health and vaccine uptake during the first wave of the COVID-19 pandemic: A systematic review," Prev Med Rep, vol. 35, p. 102319, Oct 2023.
[25]. Luna, C. M., 2022,"Impact of vaccination on the epidemiology and prognosis of pneumonia," Rev Esp Quimioter, vol. 35 Suppl 1, pp. 104-110, Apr 2022.
[26]. Rademacher, Jessica, Therre, Markus, Hinze, Christopher Alexander, Buder, Felix, Böhm, Michael, and Welte, Tobias, 2024,"Association of respiratory infections and the impact of vaccinations on cardiovascular diseases," European Journal of Preventive Cardiology, vol. 31, pp. 877-888, 2024.
[27]. Berical, A. C., Harris, D., and Dela Cruz, C. S., 2016,"Pneumococcal Vaccination Strategies. An Update and Perspective," vol. 13, pp. 933-44, Jun 2016.
[28]. Dunne Eileen, M., Cilloniz Catia, Von Mollendorf Claire, Lewnard Joseph, Grant Lindsay, R., Slack Mary, P. E., et al., 2023,"Pneumococcal Vaccination in Adults: What Can We Learn From Observational Studies That Evaluated PCV13 and PPV23 Effectiveness in the Same Population?," Archivos de Bronconeumología, vol. 59, pp. 157-164, 2023/03/01/ 2023.
[29]. Licciardi, P., and Papadatou, I., 2019,"Pneumococcal Vaccines: Challenges and Prospects," Vaccines (Basel), vol. 7, Feb 27 2019.
Viewed PDF 20 0 -
Mental Health Distresses and Associated Risk Factors among Students at the Kenya Medical Training College, Nairobi Campus-KenyaAuthor: Ojwang K. OdhiamboDOI: 10.21522/TIJPH.2013.13.01.Art074
Mental Health Distresses and Associated Risk Factors among Students at the Kenya Medical Training College, Nairobi Campus-Kenya
Abstract:
Mental Health Distress and Associated Risk Factors among Students at the Kenya Medical Training College, Nairobi Campus was investigated. 355 respondents were interviewed. Of the 335 participants, 183 (54.6%) fell within the normal range of depression while others had either mild, 143 (42.7%) or moderate, 9(2.7%) depression. Anxiety ranged from mild, 131 (39.1%, moderate, 93 (27.8%), severe, 4 (1.2%) and only 107 (31.9%) had anxiety within the normal range. No participant had stress within normal and severe ranges but participants mild stress levels constituted 333 (99.4%) followed by moderate, 2 (.6%). The risk factors included academic pressure, 95 (28.4%), depression, 77 (23.0%), peer pressure, 43 (12.8%), family problems, 32 (9.6%), financial pressure, 26 (7.8%), break ups, 25 (7.5%), 16 (4.8%) drug addiction, medical conditions, 9 (2.7%), and 7 (2.1%) were ‘others. More females 136(73.1% than males had anxiety. Peer pressure 35 (81.4%) recorded the highest predictive variable on anxiety (p<.05. Gender was significantly associated with anxiety (p>.05) with further logistic regression indicating an adjusted odds ratio in the Exp(B) above 1.0 and confidence interval above 1.0, confirming that being female increases the odds of the outcome anxiety. The risk factors including academic, financial, family problems, depression, drug abuse, break ups, porn addiction, medical conditions and others increase the odds of anxiety among the participants. Tertiary level tailored measures therefore need to be put in place to help medical students at Kenya Medical Training College, Nairobi Campus to manage their mental health distresses which will help in improving health care delivery in Kenya.
Mental Health Distresses and Associated Risk Factors among Students at the Kenya Medical Training College, Nairobi Campus-Kenya
References:
[1]. Melese, et al., B., 2016, “Prevalence of mental distress and associated factors among Hawassa University medical students, Southern Ethiopia: a cross-sectional study,” BMC Res. Notes, vol. 9, pp. 1–7.
[2]. Friedrich, M. J., 2017, “Depression Is the Leading Cause of Disability Around the World,” JAMA, vol. 317, no. 15, p. 1517, doi: 10.1001/jama.2017.3826.
[3]. O’Connor, T. G., Monk, C., and Fitelson, E. M., 2014,“Practitioner Review: Maternal mood in pregnancy and child development - Implications for child psychology and psychiatry,” J. Child Psychol. Psychiatry Allied Discip., vol. 55, no. 2, pp. 99–111, doi: 10.1111/jcpp.12153.
[4]. Al Saadi, T., Zaher Addeen, S., Turk, T., Abbas, F., and Alkhatib, M., 2017, “Psychological distress among medical students in conflicts: a cross-sectional study from Syria,” BMC Med. Educ., vol. 17, pp. 1–8.
[5]. Prochaska, J. J., Sung, H., Max, W., Shi, Y., and Ong, M., 2012, “Validity study of the K6 scale as a measure of moderate mental distress based on mental health treatment need and utilization,” Int. J. Methods Psychiatr. Res., vol. 21, no. 2, pp. 88–97.
[6]. Wong, N. S. M., Yeung, A. W. K., Li, K. Y., McGrath, C. P., and Leung, Y. Y., 2022, “Non-pharmacological interventions for reducing fear and anxiety in patients undergoing third molar extraction under local anesthesia: Systematic review and meta-analysis,” Int. J. Environ. Res. Public Health, vol. 19, no. 18, p. 11162
[7]. Viertiö, S., et al., 2021, “Factors contributing to psychological distress in the working population, with a special reference to gender difference,” BMC Public Health, vol. 21, no. 1, p. 611, doi: 10.1186/s12889-021-10560-y.
[8]. Abuhamdah, S. M. A., Naser, A. Y., Abdelwahab, G. M., and AlQatawneh, A., 2021, “The prevalence of mental distress and social support among university students in Jordan: A cross-sectional study,” Int. J. Environ. Res. Public Health, vol. 18, no. 21, p. 11622.
[9]. Saeed, A., Bahnassy, A., Al-Hamdan, N., Almudhaibery, F., and Alyahya, A., 2016, “Perceived stress and associated factors among medical students,” J. Fam. Community Med., vol. 23, no. 3, p. 166, doi: 10.4103/2230-8229.189132.
[10]. Mutinta, G., 2022, “Mental distress among university students in the Eastern Cape Province, South Africa,” BMC Psychol., vol. 10, no. 1, p. 204, doi: 10.1186/s40359-022-00903-8.
[11]. Mboya, I. B., John, B., Kibopile, E. S., Mhando, L., George, J., and Ngocho, J. S., 2020, “Factors associated with mental distress among undergraduate students in northern Tanzania,” BMC Psychiatry, vol. 20, no. 1, p. 28, doi: 10.1186/s12888-020-2448-1.
[12]. Voltmer, E., Köslich-Strumann, S., Voltmer, J.-B., and Kötter, T., 2021, “Stress and behavior patterns throughout medical education – a six year longitudinal study,” BMC Med. Educ., vol. 21, no. 1, p. 454, doi: 10.1186/s12909-021-02862-x.
[13]. Masoudzadeh, A., Hadinezhad, P., and Gooran, M., 2017, “Comparison of Mental Health Status of People Exposed to Noise Pollution with People in Non-Polluted Areas of Sari,” Health (Irvine. Calif)., vol. 09, pp. 839–848, 2017, doi: 10.4236/health.2017.95059.
[14]. Wang, Z., 2013, “Coping style and mental health on high school students,” Health (Irvine. Calif)., vol. 05, no. 02, pp. 170–174, doi: 10.4236/health.2013.52023.
[15]. Savage, M. J., et al., 2020, “Mental health and movement behaviour during the COVID-19 pandemic in UK university students: Prospective cohort study,” Ment. Health Phys. Act., vol. 19, p. 100357, doi: https://doi.org/10.1016/j.mhpa.2020.100357
[16]. Bitta, M. A., Kariuki, S. M., Chengo, E., and Newton, C. R. J., C.2017, “An overview of mental health care system in Kilifi, Kenya: results from an initial assessment using the World Health Organization’s Assessment Instrument for Mental Health Systems,” Int. J. Ment. Health Syst., vol. 11, pp. 1–11.
[17]. Bitta, M., Kariuki, S., Abubakar, A., and Newton, C., 2018, “Burden of neurodevelopmental disorders in low and middle-income countries: A systematic review and meta-analysis,” Wellcome Open Res., vol. 2, p. 121, doi: 10.12688/wellcomeopenres.13540.2.
[18]. Memiah, P., et al., 2022, “Voices from the Youth in Kenya Addressing Mental Health Gaps and Recommendations,” Int. J. Environ. Res. Public Health, vol. 19, p. 5366, doi: 10.3390/ijerph19095366.
[19]. Memiah, P., et al., 2018, “The Prevalence of Intimate Partner Violence, Associated Risk Factors, and Other Moderating Effects: Findings From the Kenya National Health Demographic Survey,” J. Interpers. Violence, vol. 36, p. 088626051880417, doi: 10.1177/0886260518804177.
[20]. Nyongesa, M. K., et al., 2022, “Psychosocial and mental health challenges faced by emerging adults living with HIV and support systems aiding their positive coping: a qualitative study from the Kenyan coast,” BMC Public Health, vol. 22, no. 1, p. 76, doi: 10.1186/s12889-021-12440-x.
[21]. Kwobah, E., Jaguga, F., Robert, K., Ndolo, E., and Kariuki, J., 2021, “Efforts and Challenges to Ensure Continuity of Mental Healthcare Service Delivery in a Low Resource Settings During COVID-19 Pandemic—A Case of a Kenyan Referral Hospital,” Front. Psychiatry, vol. 11, p. 588216.
[22]. Kwobah, E., et al., 2023, “Incidents related to safety in mental health facilities in Kenya,” BMC Health Serv. Res., vol. 23, p. 95, doi: 10.1186/s12913-023-09074-7.
[23]. Shahnur shah, A., Laving, V., Okech, and M., Kumar, 2021 “Depression and its associated factors: perceived stress, social support, substance use and related sociodemographic risk factors in medical school residents in Nairobi, Kenya,” BMC Psychiatry, vol. 21, doi: 10.1186/s12888-021-03439-0.
[24]. Lovibond, S. H., Lovibond, P. F., and of Australia, 1995, Manual for the depression anxiety stress scales, 2nd ed. Sydney, N.S.W. SE - iii, 42 pages : illustrations ; 21 cm + 2 response forms, scoring template & profile sheet.: Psychology Foundation of Australia, doi: LK - https://worldcat.org/title/222009504
[25]. Kerebih, H., Ajaeb, M., and Weldemariam, H., 2017, “Common mental disorders among medical students in Jimma University, SouthWest Ethiopia,” Afr. Health Sci., vol. 17, p. 844, doi: 10.4314/ahs.v17i3.27.
[26]. Kerebih, H., Abera, M., and Soboka, M., 2017, “Pattern of Help Seeking Behavior for Common Mental Disorders among Urban Residents in Southwest Ethiopia,” Qual. Prim. Care, vol. 25, pp. 208–216
[27]. Dachew, B. A., Bifftu, B. B., Tiruneh, B. T., Anlay, D. Z., and Wassie, M. A., 2019, “Prevalence of mental distress and associated factors among university students in Ethiopia: a meta-analysis,” J. Ment. Heal.
[28]. Alem, M., Enawgaw, B., Gelaw, A., Kenaw, T., Mohamed, S., and Olkeba, Y., 2013, “Prevalence of Anemia and Associated Risk Factors among Pregnant Women Attending Antenatal Care in Azezo Health Center Gondar Town, Northwest Ethiopia,” J. Interdiscip. Histopathol., vol. 1, p. 1, doi: 10.5455/jihp.20130122042052.
[29]. Rotenstein, L., et al., 2016, “Prevalence of Depression, Depressive Symptoms, and Suicidal Ideation Among Medical Students: A Systematic Review and Meta-Analysis,” JAMA, vol. 316, p. 2214, doi: 10.1001/jama.2016.17324.
[30]. Dyrbye, L., et al., 2014, “Burnout Among U.S. Medical Students, Residents, and Early Career Physicians Relative to the General U.S. Population,” Acad. Med., vol. 89, doi: 10.1097/ACM.0000000000000134.
[31]. An, J., Zhu, X., Shi, Z., and An, J., 2024, “A serial mediating effect of perceived family support on psychological well-being,” BMC Public Health, vol. 24, no. 1, p. 940, doi: 10.1186/s12889-024-18476-z.
[32]. Givens, J. L., and Tjia, J., 2002, “Depressed medical students’ use of mental health services and barriers to use.,” Lippincott Williams & Wilkins, Tjia, Jennifer: Division of General Internal Medicine, University of Pennsylvania, School of Medicine, Blockley Hall 1208, Philadelphia, PA, US, 19104, jetjia@mail.med.upenn.edu. doi: 10.1097/00001888-200209000-00024.
[33]. Tjia, J., Givens, J., and Shea, J., 2005, Factors associated with under-treatment of medical student depression. J Am Coll Health,” J Am. Coll. Health, vol. 53, pp. 219–224, 2005, doi: 10.3200/JACH.53.5.219-224.
Viewed PDF 33 0 -
Revolutionizing Neonatal Care: A High-Precision Hybrid ANN-RF Model for Pneumonia PredictionAuthor: Raman MuthusamyDOI: 10.21522/TIJPH.2013.13.01.Art075
Revolutionizing Neonatal Care: A High-Precision Hybrid ANN-RF Model for Pneumonia Prediction
Abstract:
Neonatal pneumonia is a major health challenge, significantly contributing to morbidity and mortality among newborns. Timely and accurately predicting its progression is crucial for improving clinical outcomes and ensuring effective treatment strategies. This study focuses on introducing a ground-breaking approach to predict disease progression in neonatal pneumonia through a hybrid Artificial Neural Network- Random Forest (ANN-RF) model. The methodology employed in this study involves several critical stages. Initially, comprehensive data collection was conducted from neonatal intensive care units (NICUs) and paediatric hospitals ensuring a robust dataset that reflects diverse clinical scenarios. Following this, data pre-processing was performed to address missing values and normalize features, enhancing the quality of the data for analysis. Feature extraction techniques were then applied to identify key clinical parameters that are most indicative of disease progression. The development of the hybrid ANN-RF classification model effectively combines the strengths of artificial neural networks known for their high dimensional pattern recognition capabilities with the interpretability and robustness of Random Forest decision trees. This synergy allows for both accurate predictions and clear insights into the factors influencing disease outcomes. Remarkably the proposed model achieved an accuracy of 98%, demonstrating its potential for practical application in clinical settings. Such high accuracy not only aids healthcare professionals in making informed decisions but also enhances patient management strategies. Ultimately this study underscores the transformative potential of integrating advanced machine learning techniques into neonatal care, paving the way for future research aimed at optimizing predictive analysis in healthcare settings.
Revolutionizing Neonatal Care: A High-Precision Hybrid ANN-RF Model for Pneumonia Prediction
References:
[1]. Horbar, J. D., Edwards, E. M., Greenberg, L. T., Morrow, K. A., Soll, R. F., Buus-Frank, M. E., Buzas, J. S., 2017, Variation in Performance of Neonatal Intensive Care Units in the United States. JAMA Paediatrics.; Doi: 10.1001/jamapediatrics.2016.4396.
[2]. Abdel-Latif, M. E., Nowak, G., Bajuk, B., Glass, K., Harley, D., 2017, Variation in hospital mortality in an Australian neonatal intensive care unit network. Archives of Disease in Childhood. Fetal and Neonatal Edition; Doi: 10.1136/archdischild-2017-313222.
[3]. Tsai, M.-H., Hsu, J.-F., Chu, S.-M., Lien, R., Huang, H.-R., Chiang, M.-C., Fu, R.-H., Lee, C.-W., Huang, Y.-C., 2014, Incidence, Clinical Characteristics and Risk Factors for Adverse Outcome in Neonates with Late-onset Sepsis. Journal of Paediatric Infectious Diseases. Doi: 10.1097/INF.0b013e3182a72ee0.
[4]. Hentschel, R., Guenther, K., Vach, W., Bruder, I., 2018, Risk-adjusted mortality of VLBW infants in high-volume versus low-volume NICUs. Archives of Disease in Childhood. Fetal and Neonatal Edition, Doi: 10.1136/archdischild-2018-314956.
[5]. Ozdemir, F. E., Alan, S., & Aliefendioglu, D., 2023, The diagnostic value of pulmonary near-infrared spectroscopy in the early distinction of neonatal pneumonia from transient tachypnea of the newborn, Pediatric Pulmonology, Doi:10.1002/ppul.26656
[6]. Hentschel, R., Guenther, K., Vach, W., Bruder, I., 2018, Risk-adjusted mortality of VLBW infants in high-volume versus low-volume NICUs. Archives of Disease in Childhood. Fetal and Neonatal Edition; Doi: 10.1136/archdischild-2018-314956.
[7]. Hsu, J.-F., Chu, S.-M., Huang, Y.-C., Lien, R., Huang, H.-R., Lee, C.-W., Chiang M.-C., Fu R.-H., Tsai, M.-H., 2015, Predictors of clinical and microbiological treatment failure in neonatal bloodstream infections. Clinical Microbiology and Infection, Doi: 10.1016/j.cmi.2015.01.009.
[8]. Namachivayam, S. P., Carlin, J. B., Millar, J., Alexander, J., Edmunds, S., Ganeshalingham, A., Lew, J., Erichson, S., Butt, W., Schiapbach, L. J., et al., 2020, Gestational age and risk of mortality in term-born critically ill neonates admitted to PICUs in Australia and New Zealand. Critical Care Medicine; Doi: 10.1097/CCM.0000000000004409.
[9]. Chen, W., Yu, X., 2023, Diagnostic Value of Color Doppler Flow Imaging Combined with Serum CRP, PCT, and IL-6 Levels for Neonatal Pneumonia, Evidence-Based Complementary and Alternative Medicine, Doi: 10.1155/2022/2113856
[10]. Domingo-Alemán, P., Sampériz-Sinovas, L., Martínez-Tourné, A., Puertas-Martínez, A. I., Martínez-Martínez, M. J., & Fernández-Fructuoso, J. R.., 2022, Early-onset neonatal round pneumonia, Pediatric Pulmonology, Doi: 10.1002/ppul.26192
[11]. Kang, P., Kang, W., Li, Y., Li, T., 2022, C-Reactive Protein-to-Albumin Ratio as an Early Biomarker to Identify Sepsis in Neonates with Pneumonia, International Journal of Molecular Sciences Doi: 10.1155/2022/4711018
[12]. Yadav, K. K., & Awasthi, S., 2023, Childhood Pneumonia: What’s Unchanged, and What’s New?, Indian Journal of Pediatrics, 693–699, Doi: 10.1007/s12098-023-04628-3
[13]. Xueer Wang, Jianchuan Chen, Runting Huang, Ting Gong, Lin Zhu, Tingting Luo, Shu Yang, Li Yan, Gang Geng, Jihong Dai, Xiaoqiang Li, Daiyin Tian., 2023, Impact of home confinement due to the COVID-19 outbreak on vitamin D levels and trends among children with pneumonia aged 1–35 months, Pediatric Discovery, Doi: 10.1002/pdi3.41
[14]. Mei, M., Dai, D., Guo, Z., Zhang, C., Liu, J., Qi, Y., Wang, X., Wang, L., & Qian, L., 2023, Underlying causes and outcomes of recurrent pneumonia in hospitalized children, Pediatric Pulmonology, Doi: 10.1002/ppul.26374
[15]. Om Prakash Shukla, Nikunj Rathwa, Lokesh Naik Mude., 2024, "Assessment of severity of community acquired pneumonia by paediatric infectious diseases society and clinical and radiological profile in 0-5 year age group", International Journal of Contemporary Pediatrics, Doi: 10.18203/2349-3291.ijcp20240100
[16]. Adbela, G., Abdurahman, H., Hailu, S., Keneni, M., Mohammed, A., & Weldegebreal, F.., 2024, "Treatment outcome of pneumonia and its associated factors among pediatric patients admitted to Hiwot Fana Comprehensive Specialized University Hospital, Eastern Ethiopia", Frontiers in Pediatrics, Doi: 10.3389/fped.2024.1296193
[17]. Florin, T. A., Freedman, S. B., Xie, J., Funk, A. L., Tancredi, D. J., Kim, K., Neuman, M. I., Yock-Corrales, A., Bergmann, K. R., Breslin, K. A., Finkelstein, Y., Ahmad, F. A., Avva, U. R., Lunoe, M. M., Chaudhari, P. P., Shah, N. P., Plint, A. C., Sabhaney, V. J., Sethuraman, U., Gardiner, M. A., Kuppermann, N., 2024, "Features Associated With Radiographic Pneumonia in Children with SARS-CoV-2", Journal of the Pediatric Infectious Diseases Society, Doi: 10.1093/jpids/piae015
[18]. Rangelova, V., Kevorkyan, A., Raycheva, R., & Krasteva, M., 2024, "Ventilator-Associated Pneumonia in the Neonatal Intensive Care Unit—Incidence and Strategies for Prevention", Diagnostics, Doi: 10.3390/diagnostics14030240
[19]. Yoon, T., Kang, D., 2024, Enhancing pediatric pneumonia diagnosis through masked autoencoders, Scientific Reports, Doi: 10.1038/s41598-024-56819-3
[20]. Wang, B., Song, J., Song, J., Mao, N., Liang, J., Chen, Y., Qi, Y., Bai, L., Xie, Z., Zhang, Y., 2022, An Outbreak of Severe Neonatal Pneumonia Caused by Human Respiratory Syncytial Virus BA9 in a Postpartum Care Centre in Shenyang, SPECTRUM, Doi: 10.1128/spectrum.00974-22
[21]. Zhang, Y., Chen, J., & Wang, L., 2023, A Hybrid Deep Learning Model for Predicting Neonatal Pneumonia: Combining CNN and Random Forest. Journal of Biomedical Informatics, 135, 104216.
[22]. Li, X., & Zhang, H., 2022, Machine Learning Approaches for Predicting Neonatal Outcomes: A Systematic Review. Neonatology, 119(3), 245-256.
[23]. Patel, A., & Kumar, R., 2023, Feature Extraction Techniques in Machine Learning for Neonatal Health Monitoring. Artificial Intelligence in Medicine, 128, 102090.
[24]. Singh, P., & Gupta, S., 2023, Comparative Analysis of Machine Learning Algorithms for Predicting Neonatal Pneumonia. International Journal of Medical Informatics, 170, 104874.
Viewed PDF 23 0 -
Lipomatosis of Appendix Masquerading as Acute Appendicitis - A Case ReportAuthor: Divyalakshmi, P. K.DOI: 10.21522/TIJPH.2013.13.01.Art076
Lipomatosis of Appendix Masquerading as Acute Appendicitis - A Case Report
Abstract:
Lipomatosis of the appendix is extremely unusual. It can be focal, diffuse and asymmetric. Radiological investigations such as CT abdomen and ultrasonography are usually used imaging modalities for diagnostic workups. However, histopathological examination is always the gold standard. A rare case of lipomatosis appendix was diagnosed based on a microscopic examination of a suspected acute appendicitis case in a 65-year-old female patient.
Lipomatosis of Appendix Masquerading as Acute Appendicitis - A Case Report
References:
[1]. Petroianu, A., & Barroso, T. V. V., 2016, Pathophysiology of acute appendicitis, JS M Gastroenterol. Hepatol, 4(3), 1-4.
[2]. Börekci, E., 2020, Relationship between appendicitis and diameter of ileocecal lipomatosis and also ileocecal angle. Surgical and Radiologic Anatomy, 42, 437-441.
[3]. Sanlı, Ş., Sasani, H., Darıcı, E., & Bakır, B., 2015, Isolated submucosal lipomatosis of appendix mimicking acute appendicitis: computed tomography findings. Acta Medica Anatolia, 3(2):76‐77. https://doi.org/10.15824/actamedica.35025
[4]. Bilgic, Y., Altinsoy, H. B., Yildirim, N., Alatas, O., Kanat, B. H., & Sahin, A., 2015, Familial abdominal and intestinal lipomatosis presenting with upper GI bleeding. Case reports in gastrointestinal medicine, 2015(1), 123723. https://doi.org/10.1155/2015/123723
[5]. Dajti, G., Vagliasindi, A., Bosi, S., Guerra, E., Zanzi, F., & Raulli, G. D., 2020, An unusual clinical presentation of colonic lipomatosis: A case report. International journal of surgery case reports, 75, 273-275. https://doi.org/10.1016/j.ijscr.2020.08.036
[6]. Haldız, G. A., 2014, Is Submucosal Lipomatosis of the Appendix Vermiformis Really a Rare Entity? Harran Üniversitesi Tıp Fakültesi Dergisi, 21(1), 42-48. https://doi.org/10.35440/hutfd.1383433
[7]. Shanmugarajah, I., Sundrehagen, B. H., Warberg, E. A., & Kazaryan, A. M., 2021, Lipomatosis of appendix in a teenager. Clinical Case Reports, 9(7), e04595. https://doi.org/10.1002/ccr3.4595.
[8]. Sanches, L. P., Rahal, A., Falsarella, P. M., Carvalho, V. D. O., Valle, L. G. M., Francisco, M. J., & Funari, M. B. D. G., 2020, Caecal appendix lipomatosis in a pregnant patient mimicking acute appendicitis. Einstein (São Paulo), 18, eRC5415. https://doi.org/10.31744/einstein_journal/2020RC5415
Viewed PDF 26 0 -
Investigating Calcarea Carbonicum 200C's Role in COVID-19 Treatment: Clinical Observations and its FTIR CharacterizationAuthor: Gopukumar S.T.DOI: 10.21522/TIJPH.2013.13.01.Art077
Investigating Calcarea Carbonicum 200C's Role in COVID-19 Treatment: Clinical Observations and its FTIR Characterization
Abstract:
Both the molecular characterization of Calcarea Carbonicum 200C using Fourier Transform Infrared Spectroscopy and its clinical effects in post-COVID patients are examined in this study. Twenty patients suffering from persistent symptoms like immunological dysfunction and exhaustion participated in the study held at Sarada Krishna Homoeopathic Medical College. Comparing IgG levels before and after therapy revealed a statistically significant 52% decrease (p = 0.00032) in clinical outcomes; IgG is a critical indicator of immunological regulation. The molecular composition of Calcarea Carbonicum was confirmed by FTIR analysis, which found essential functional groups, such as carbonate ions and hydroxyl groups. The presence of organic contaminants in the spectrum may provide information on how they interact with living organisms. According to these results, Calcarea Carbonicum may help stabilize the immune system and alleviate symptoms in post-viral syndromes. This study provides therapeutic benefits and molecular understanding of the medicine Calcarea Carbonicum, highlighting its potential as a supplemental treatment for chronic COVID-19 symptoms. Nevertheless, future studies should use bigger cohorts and randomized controlled designs to address the limitations, such as the lack of a control group and the limited sample size. These findings open the door to the possibility of including homoeopathy in more comprehensive treatment plans for post-COVID recovery.
Investigating Calcarea Carbonicum 200C's Role in COVID-19 Treatment: Clinical Observations and its FTIR Characterization
References:
[1]. Lal, A., Lim, C., Almeida, G., & Fitzgerald, J., 2022, Minimizing COVID-19 disruption: ensuring the supply of essential health products for health emergencies and routine health services. The Lancet Regional Health–Americas, 6, 1-6.
[2]. Oronsky, B., Larson, C., Hammond, T. C., Oronsky, A., Kesari, S., Lybeck, M., & Reid, T. R., 2023, A review of persistent post-COVID syndrome (PPCS). Clinical Reviews in Allergy & Immunology, 64(1), 66-74.
[3]. Tang, C., Dziedzic, A., Khatib, M. N., Alhumaid, S., Thangavelu, L., Parameswari, R. P., & Rabaan, A. A., 2024, Stem cell therapy for COVID-19 treatment: an umbrella review. International Journal of Surgery, 110(10), 6402-6417.
[4]. Bellavite, P., 2015, Homeopathy and integrative medicine: keeping an open mind. Journal of Medicine and the Person, 13, 1-6.
[5]. Pandey, S., & Pandit, R., 2020, Pelvic inflammatory disease treated with homoeopathic medicine Calcarea carbonica: A case Report. Indian Journal of Research in Homoeopathy, 14(4), 287-292.
[6]. Vimal, S., Madar, I. H., Thirumani, L., Thangavelu, L., & Sivalingam, A. M., 2024, CRISPR/Cas9: Role of genome editing in cancer immunotherapy. Oral Oncology Reports, 100251.
[7]. Siddique, I. M., 2024, Exploring Functional Groups and Molecular Structures: A Comprehensive Analysis Using FTIR Spectroscopy. Chemistry Research Journal, 9(2), 70-76
[8]. Geetha, R. V., & Lakshmi, T., 2023, In Vitro evaluation of antimycotic activity of oregano essential oil on candida species from isolation of patient with chronic periodontitis. Journal of Complementary Medicine Research, 13(5), 60-60.
[9]. Das, D., Das, I., Das, J., Kayal, S. K., & Khuda-Bukhsh, A. R., 2016, Efficacy of two traditionally used potentized homeopathic medicines, Calcarea carbonica and Lycopodium clavatum, used for treating PCOS patients: I. Effects on certain important external guiding symptoms. CellMed, 6(1), 6-1.
[10]. Dixit, A. K., Giri, N., & Singh, S., 2023, Exploring the scope of homoeopathy in combating the unfortunate consequences of post-COVID-19 survivors based on non-COVID conditions: a narrative review. Journal of Complementary and Integrative Medicine, 20(2), 302-315.
[11]. Nayak, D., Gupta, J., Chaudhary, A., Singh, K. G., Deshmukh, A., Das, D., & Khurana, A., 2022, Efficacy of individualized homeopathy as an adjunct to standard of care of COVID-19: A randomized, single-blind, placebo-controlled study. Complementary Therapies in Clinical Practice, 48, 101602.
[12]. Parikh, N., Parikh, D., & Parikh, D., 2020, Role of homoeopathy in COVID-19 Management-A clinical experience. World Journal of Pharmaceutical Research, 9(5), 2459-2466.
[13]. Jagtap, C. Y., Charde, V., Rawat, H., Dane, G., Mishra, A. K., Narasimhaji, C. V., & Acharya, R., 2024, The Structural and Thermal properties of Badarashma Pishti. Journal of Ayurveda and Integrative Medicine, 15(6), 100989.
[14]. Kumar, S.T.G., Beeram, E., Begum, S., Chatterjee, P., Samajdar, D., 2025, Refinement Of Spme-Gc/Ms For The Detection Of Volatile Organic Compounds In Medical Science And Pharmacy. Journal of Applied Bioanalysis, 11(1), 36-45.
[15]. Anooj, E., Charumathy, M., Sharma, V., Vibala, BV., Gopukumar, ST., Jainab, SIB., Vallinayagam, S., 2021, Nanogels: An overview of properties, biomedical applications, future research trends and developments. Journal of Molecular Structure,1239:130446.
[16]. Ashokkumar, M., Palanisamy, K., Kumar, A. G., Muthusamy, C., & Kumar, K. J. S., 2024, Green synthesis of silver and copper nanoparticles and their composites using Ocimum sanctum leaf extract displayed enhanced antibacterial, antioxidant and anticancer potentials. Artificial Cells Nanomedicine and Biotechnology, 52(1), 438–448.
[17]. Kumar, A. G., Joseph, B., Nandagopal, S., Sankarganesh, P., & Jagdish, S. K., 2019b, Experimental human root canal irrigant NAOCL against enterococcus faecalis and 3T3, and determination of cytotoxicity effect. Biomedical & Pharmacology Journal, 12(2), 965–974.
[18]. Sankarganesh, P., Parthasarathy, V., Kumar, A. G., Saraniya, M., Udayakumari, N., & Ragu, S., 2022, Development of novel mannitol blended PVA hydrogel membrane and its anticancer and antimicrobial drug delivery potential for wound dressing applications. Journal of Sol-Gel Science and Technology, 103(2), 447–456.
[19]. Elumalai, L., Palaniyandi, S., Anbazhagan, G. K., Mohanam, N., Munusamy, S., GK, S. R., Munusamy, A. P., Chinnasamy, M., & Ramasamy, B., 2023, Synthesis of biogenic cadmium sulfide nanoparticles (MR03-CdSNPs) using marine Streptomyces kunmingensis - MR03 for in-vitro biological determinations and in silico analysis on biofilm virulence proteins: A novel approach. Environmental Research, 235, 116698.
[20]. Rajan, A., Praseetha, P.K., Ariharan, V.N., Gopu Kumar, S.T., 2019, Invitro cytotoxic and anti – cancer studies of polyvinyl alcohol mediated 5fluorouracil conjugated gold nanoparticles. International Journal of Recent Technology and Engineering,7(6),127–143.
Viewed PDF 26 1 -
Microbial Analysis of Street Food in Demerara-Mahaica, GuyanaAuthor: Tandeka BartonDOI: 10.21522/TIJPH.2013.13.01.Art078
Microbial Analysis of Street Food in Demerara-Mahaica, Guyana
Abstract:
Street food is vital in global culture’s economic, social, and nutritional aspects. However, as is typical among developing countries, various factors combine to compromise the safety of these foods, leaving residents susceptible to exceptionally high levels of microbial contamination. Chief among the numerous approaches and steps developed and employed to improve this situation is a clear understanding of the existing and potential extents of pathogens found in street foods. This is particularly true in jurisdictions like Guyana, where street food vending is unregulated. Therefore, this study investigated the microbiological safety of night street foods in the Demerara-Mahaica region of Guyana, focusing on contamination levels and demographic factors associated with street food contamination. Ninety food samples were collected and analyzed for Aerobic Plate Counts (APC), coliforms, and the presence of pathogens like Salmonella and Staphylococcus aureus. The study found a high prevalence of unacceptable APC levels and a relatively low prevalence of unacceptable coliform limits. No Salmonella was detected, and S. aureus was found at minimal levels in one of the food samples. These findings, while indicating significant public health risks related to lapses in food handling, also point to the need to improve food safety through comprehensive interventions that reduce contamination risks and safeguard public health. Recommendations include establishing the regulatory authority for food safety, making food safety standards mandatory, improving vendor training, enhancing infrastructure, and improving access to clean, potable water.
Microbial Analysis of Street Food in Demerara-Mahaica, Guyana
References:
[1]. World Health Organization, 2015, Food safety. https://www.who.int/mediacentre/factsheets/fs399/en/
[2]. Persaud, S., Mohamed-Rambaran, P., Wilson, A., James, C., & Indar, L., 2013, Determining the community prevalence of acute gastrointestinal illness and gaps in surveillance of acute gastroenteritis and foodborne diseases in Guyana. Journal of Health, Population and Nutrition, 31(4 Suppl 1), S57-68.
[3]. Young, I., Greig, J., Wilhelm, B. J., & Waddell, L. A., 2019, Effectiveness of Food Handler Training and Education Interventions: A Systematic Review and Meta-Analysis. Journal of Food Protection, 82(10), 1714–28.
[4]. Onyeaka, H., Ekwebelem, O. C., Eze, U. A., Onwuka, Q. I., Aleke, J., Nwaiwu, O., & Chionuma, J.O., 2021, Improving Food Safety Culture in Nigeria: A Review of Practical Issues. Foods, 10(8), 1878.
[5]. Sharma, I., & Mazumdar, J. A., 2014, Assessment of Bacteriological Quality of Ready to Eat Food Vended in Streets of Silchar City, Assam, India. Indian Journal of Medical Microbiology.
[6]. Baidya, S., 2022, Microbiological Analysis of Street Foods Sold in Kathmandu, Nepal. Tribhuvan University Journal of Microbiology.
[7]. Tuladhar, R., & Singh, A., 2015, Bacterial Analysis and Survey of the Street Food of Kathmandu in Relation to Child Health. Journal of Natural History Museum.
[8]. Ghosh, M., Wahi, S., Kumar, M., & Ganguli, A., 2007, Prevalence of enterotoxigenic Staphylococcus aureus and Shigella spp. in some raw street vended Indian foods. International Journal of Environmental Health Research, 17(2), 151–156.
[9]. Rane, S., 2011, Street Vended Food in Developing World: Hazard Analyses. Indian Journal of Microbiology, 51(1), 100–106.
[10]. Dominguez-Gonzalez, K. G., Aguilar-Chaivez, S., Cerna-Cortés, J., Soria-Herrera, R. J., & Cerna-Cortés, J. F., 2022, Microbiological Quality and Presence of Foodborne Pathogens in Fresh-Squeezed Orange Juice Samples Purchased from Street Vendors and Hygienic Practices in Morelia, Mexico. Food Science and Technology, 42, e10222.
[11]. Islam, R., 2024, Microbial Characterization of Street Food Collected from Dhaka City, Bangladesh. GSC Biological and Pharmaceutical Sciences, 26(1), 107-113.
[12]. Mukaro, J. P., Ruparanganda, F., & Katsande, P., 2021, Microbial Assessment of Dried Fish Sold in Streets and Supermarkets in Harare Central Business District: Zimbabwe. Texila International Journal of Academic Research.
[13]. Habib, I., Mohamed, M. Y. I., & Khan, M., 2021, Current State of Salmonella, Campylobacter and Listeria in the Food Chain across the Arab Countries: A Descriptive Review. Foods, 10(10), 2369.
[14]. Nyenje, M. E., Odjadjare, C. E., Tanih, N. F., Green, E., & Ndip, R. N., 2022, Foodborne Pathogens Recovered from Ready-to-Eat Foods from Roadside Cafeterias and Retail Outlets in Alice, Eastern Cape Province, South Africa: Public Health Implications. International Journal of Environmental Research and Public Health, 9(8), 2608–2619.
[15]. Usman, S., Afolabi, O. O., & Modupe, L. H., 2019, Evaluation of Microbial Load in Fast Food Establishments in Kaduna Metropolis. Journal of Community Medicine & Public Health Care, 6, 42.
[16]. Moges, M., Rodland, E. K., Legesse, T., & Argaw, A., 2024, Antibiotic Resistance Patterns of Staphylococcus aureus and Enterobacteriaceae Isolated from Street Foods in Selected Towns of Ethiopia. BMC Infectious Diseases, 24(1), 367.
[17]. Eromo, T., Tassew, H., Daka, D., & Kibru, G., 2016, Bacteriological Quality of Street Foods and Antimicrobial Resistance of Isolates in Hawassa, Ethiopia. Ethiopian Journal of Health Sciences, 26(6), 533-542.
[18]. Mayett-Moreno, Y., & López Oglesby, J., 2019, Beyond Food Security: Challenges in Food Safety Policies and Governance along a Heterogeneous Agri-Food Chain and Its Effects on Health Measures and Sustainable Development in Mexico. Sustainability, 10(12), 4755.
[19]. Zige, D. V., Ohimain, E. I., & Mynepalli, K. C., 2013, Enteric Bacteria from Ready to Eat Food Vended in Amassoma Community in Niger Delta and Its Health Implication. IOSR Journal of Environmental Science Toxicology and Food Technology, 6(4), 62-65.
[20]. Choudhury, M., Mahanta, L. B., Goswami, J., Mazumder, M., & Pegoo, B., 2011, Socio-Economic Profile and Food Safety Knowledge and Practice of Street Food Vendors in the City of Guwahati, Assam, India. Food Control, 22(2), 196-203.
[21]. Suldeep Kumar, M., Veena, K., & Nagaraj, E. R., 2017, Microbial Profile of Street Food from Different Locations at Tumkur, India. Tropical Journal of Pathology and Microbiology, 3(2), 84-89.
[22]. Al Mamun, M., Rahman, S. M., & Turin, T. C., 2013, Microbiological quality of selected street food items vended by school-based street food vendors in Dhaka, Bangladesh. International Journal of Food Microbiology, 166(3), 413–418.
[23]. Mohd Nawawee, N. S., Abu Bakar, N. F., & Zulfakar, S. S., 2019, Microbiological Safety of Street-Vended Beverages in Chow Kit, Kuala Lumpur. International Journal of Environmental Research and Public Health, 16(22), 4463.
[24]. Marutha, K. J., & Chelule, P. K., 2020, Safe Food Handling Knowledge and Practices of Street Food Vendors in Polokwane Central Business District. Foods, 9(11), 1560.
[25]. Salamandane, A., Malfeito‐Ferreira, M., & Brito, L., 2023, The socioeconomic factors of street food vending in developing countries and its implications for public health: A systematic review. Foods, 12(20), 3774–3774.
[26]. Soon, J. M., Singh, H., & Baines, R., 2014, Foodborne diseases in Malaysia: A review. Food Control, 44, 19–25.
[27]. Akinbode, S. O., 2015, Food safety knowledge and hygienic practices of street food vendors in Benin City. Journal of Food Safety, 36(1), 69–74.
Viewed PDF 31 1 -
Therapeutic Applications of Fluorides in Dental and Medical Diseases-A Systematic ReviewAuthor: Sirigala LavanyaDOI: 10.21522/TIJPH.2013.13.01.Art079
Therapeutic Applications of Fluorides in Dental and Medical Diseases-A Systematic Review
Abstract:
A systematic review was conducted to evaluate the therapeutic applications of fluoride, focusing on dental and medical uses. Searches were performed across five major databases: PubMed, Embase, Cochrane Library, Scopus, and Web of Science. A combination of MeSH terms and keywords was used to cover four domains: Fluorides, Dental Therapeutics, Medical Therapeutics, and Outcomes. Inclusion criteria focused on human studies published in English between 2000 and 2024, while exclusion criteria eliminated non-human studies, irrelevant topics, and grey literature. This systematic review analyzed 34 studies on fluoride's therapeutic uses. Fluoride was consistently effective in preventing and managing dental caries, with combinations like 38% silver diamine fluoride (SDF) and 5% sodium fluoride (NaF) varnish showing higher efficacy. High-fluoride mouth rinses and toothpaste reduced demineralized lesions in orthodontic patients, while Arg-NaF varnishes are effective against enamel erosion. Sodium hyaluronate with fluoride improved gingival health. Some studies noted potential negative effects on dental materials, such as reducing sealant bond strength, highlighting the need for further research on fluoride's broader applications and material interactions. In medical contexts, fluoride demonstrated stabilizing effects in conditions like otosclerosis and osteoporosis, though findings were inconsistent across studies. Fluoride is observed to have a positive role in preventing and treating dental and bone diseases. Studies showed fluoride in specific doses could enhance tooth caries resistance and enamel erosion. Fluorides act in controlling osteosclerosis and osteoporosis by stabilizing disease progression and improving bone density. However, more research is needed to fully understand its long-term effects and optimize its use in both fields.
Therapeutic Applications of Fluorides in Dental and Medical Diseases-A Systematic Review
References:
[1]. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes,1997, Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington (DC): National Academies Press (US); Available from:https://www.ncbi.nlm.nih.gov/books/NBK109825/doi:10.17226/5776.PMID: 23115811.
[2]. Aoun, A., Darwiche, F., Al Hayek, S., & Doumit, J., 2018, The Fluoride Debate: The Pros and Cons of Fluoridation. Preventive nutrition and food science, 23(3), 171–180. https://doi.org/10.3746/pnf.2018.23.3.171
[3]. Everett, E. T., 2011, Fluoride's effects on the formation of teeth and bones, and the influence of genetics. Journal of dental research, 90(5), 552–560. https://doi.org/10.1177/0022034510384626
[4]. U.S. Department of Health and Human Services Federal Panel on Community Water Fluoridation 2015, U.S. Public Health Service Recommendation for Fluoride Concentration in Drinking Water for the Prevention of Dental Caries. Public health reports (Washington, D.C.: 1974), 130(4), 318–331. https://doi.org/10.1177/003335491513000408.
[5]. Iheozor-Ejiofor, Z., Worthington, H. V., Walsh, T., O'Malley, L., Clarkson, J. E., Macey, R., Alam, R., Tugwell, P., Welch, V., & Glenny, A. M., 2015, Water fluoridation for the prevention of dental caries. The Cochrane database of systematic reviews, 2015(6), CD010856. https://doi.org/10.1002/14651858.CD010856.pub2.
[6]. U.S. Environmental Protection Agency. Review of the Fluoride Drinking Water Regulation. 2019.
[7]. Petersen, P. E., & Lennon, M. A., 2004, Effective use of fluorides for the prevention of dental caries in the 21st century: the WHO approach. Community dentistry and oral epidemiology,32(5),319–321. https://doi.org/10.1111/j.1600-0528.2004.00175.x.PMID:15341615
[8]. Mankar, N., Kumbhare, S., Nikhade, P., Mahapatra, J., Agrawal, P., 2023, Role of Fluoride in Dentistry: A Narrative Review. Cureus. 2023 Dec 21;15(12):e50884. doi: 10.7759/cureus.50884. PMID: 38249196; PMCID: PMC10799546.
[9]. Hoque, M. E., Showva, N. N., Ahmed, M., Rashid, A. B., Sadique, S. E., El-Bialy, T., & Xu, H., 2022, Titanium and titanium alloys in dentistry: current trends, recent developments, and future prospects. Heliyon, 8(11), e11300. https://doi.org/10.1016/j.heliyon.2022.e11300 (Retraction published Heliyon. 2024 May 27;10(11):e31978. doi: 10.1016/j.heliyon.2024.e31978).PMID: 36387463; PMCID: PMC9640965.
[10]. Medjedovic, E., Medjedovic, S., Deljo, D., & Sukalo, A., 2015, Impact Of Fluoride On Dental Health Quality. Materia Socio-Medica, 27(6), 395–398. Https://Doi.Org/10.5455/Msm. 2015. 27.395-398. Pmid: 26889098; Pmcid: Pmc4733546.
[11]. Kleerekoper, M., 1998, The role of fluoride in the prevention of osteoporosis. Endocrinology and metabolism clinics of North America, 27(2), 441–452. https://doi.org/10.1016/s0889-8529(05)70015-3. PMID: 9669148.
[12]. Ginaldi, L., Mengoli, L. P., & De Martinis, M., 2009, Osteoporosis, inflammation and ageing. In Handbook on Immunosenescence: Basic Understanding and Clinical Applications (Vol. 9781402090639, pp. 1329–1352). Springer Netherlands. https://doi.org/10.1007/978-1-4020-9063-9_64.
[13]. Haguenauer, D., Welch, V., Shea, B., Tugwell, P., & Wells, G., 2000, Fluoride for treating postmenopausal osteoporosis. The Cochrane database of systematic reviews, 2000(4), CD002825. https://doi.org/10.1002/14651858.CD002825.
[14]. Pak, C. Y., Adams-Huet, B., Sakhaee, K., Bell, N. H., Licata, A., Johnston, C. et.al, 1996, Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research, 11(2), 160–168. https://doi.org/10.1002/jbmr.5650110204.
[15]. Abdellatif, E. B., El Kashlan, M. K., & El Tantawi, M., 2023, Silver diamine fluoride with sodium fluoride varnish versus silver diamine fluoride in arresting early childhood caries: a 6-months follow up of a randomized field trial. BMC oral health, 23(1), 875. https://doi.org/10.1186/s12903-023-03597-5.
[16]. Pørksen, C. J., Ekstrand, K. R., Markvart, M., Larsen, T., Garrido, L. E., & Bakhshandeh, A., 2023, The efficacy of combined arginine and probiotics as an add-on to 1450 ppm fluoride toothpaste to prevent and control dental caries in children - A randomized controlled trial. Journal of dentistry, 137, 104670. https://doi.org/10.1016/j.jdent.2023.104670.
[17]. Quritum, M., Abdella, A., Amer, H., & El Tantawi, M., 2024, Effect of silver diamine fluoride and nano silver fluoride on oral health-related quality of life of children with early childhood caries: A randomized clinical trial. Journal of dentistry, 142, 104878. https://doi.org/10.1016/j.jdent.2024.104878.
[18]. Enerbäck, H., Lövgren, M. L., Strömberg, N., & Westerlund, A., 2023, Effect of high-fluoride toothpaste and mouth rinse on the prevention of demineralized lesions during orthodontic treatment: a randomized controlled trial. European journal of orthodontics, 45(5), 477–484. https://doi.org/10.1093/ejo/cjad044.
[19]. Yip, K., Lam, P. P. Y., & Yiu, C. K. Y., 2022, Prevalence and Associated Factors of Erosive Tooth Wear among Preschool Children-A Systematic Review and Meta-Analysis. Healthcare (Basel, Switzerland), 10(3), 491. https://doi.org/10.3390/healthcare10030491.
[20]. Axe, A., Burnett, G. R., Milleman, K. R., Patil, A., & Milleman, J. L., 2019, Randomized Controlled Clinical Study to Determine the Oral and Dermal Tolerability of an Experimental Denture Wipe. Journal of prosthodontics : official journal of the American College of Prosthodontists, 28(2), 138–145. https://doi.org/10.1111/jopr.12992.
[21]. Yassin, R., Amer, H., & Tantawi, M. E., 2023, Effectiveness of silver diamine fluoride versus sodium fluoride varnish combined with mother's motivational interviewing for arresting early childhood caries: a randomized clinical trial. BMC oral health, 23(1), 710. https://doi.org/10.1186/s12903-023-03456-3.
[22]. Francese, M. M., Gonçalves, I. V. B., Vertuan, M., de Souza, B. M., & Magalhães, A. C., 2022, The protective effect of the experimental TiF4 and chitosan toothpaste on erosive tooth wear in vitro. Scientific reports, 12(1), 7088. https://doi.org/10.1038/s41598-022-11261-1.
[23]. Bansal, K., Shamoo, A., Mani, K., K, P. D., Verma, A., Mathur, V. P., & Tewari, N., 2023, Silver diamine fluoride modified atraumatic restorative treatment compared to conventional restorative technique on carious primary molars-A randomized controlled trial. Journal of dentistry, 138, 104698. https://doi.org/10.1016/j.jdent.2023.104698
[24]. Dhanapriyanka, M., Kosgallana, S., Kanthi, R. D. F. C., Jayasekara, P., Dao, T. M. A., Ha, D. H., & Do, L., 2024, Professionally applied fluorides for preventing and arresting dental caries in low- and middle-income countries: Systematic review. Journal of public health dentistry, 84(2), 213–227. https://doi.org/10.1111/jphd.12617.
[25]. Peter, Joby & Chandra, H., & Sakhare, Dhanashree, 2023, Systemic Fluorides and Dental Health. 10.2174/9789815080803123030018.
[26]. Lubojanski, A., Piesiak-Panczyszyn, D., Zakrzewski, W., Dobrzynski, W., Szymonowicz, M., Rybak, Z., et.al; 2023, The Safety of Fluoride Compounds and Their Effect on the Human Body-A Narrative Review. Materials (Basel, Switzerland), 16(3), 1242. https://doi.org/10.3390/ma16031242.
[27]. Cumerlato, C. B. D. F., Santos, C. S. D., Rotta, R. N., Cademartori, M. G., & Corrêa, M. B., 2022, Is professionally applied topical fluoride effective in treating incipient caries? A systematic review. Brazilian oral research, 36, e083. https://doi.org/10.1590/1807-3107bor-2022.vol36.0083
[28]. Teimoory, N., Katebi, K., Ghahramanzadeh, A., & Vafaei, A., 2023, Effects of topical fluoride treatment on the bond strength of pit and fissure sealants: A systematic review. Journal of dental research, dental clinics, dental prospects, 17(2), 81–86. https://doi.org/10.34172/joddd.2023.39160
[29]. Sardana, D., Manchanda, S., Ekambaram, M., Yang, Y., McGrath, C. P., & Yiu, C. K. Y., 2019, Effectiveness of self-applied topical fluorides against enamel white spot lesions from multi-bracketed fixed orthodontic treatment: a systematic review. European journal of orthodontics, 41(6), 661–668. https://doi.org/10.1093/ejo/cjz015
[30]. Zhang, C., Yan, K., Fu, C., Peng, H., Hawker, C. J., & Whittaker, A. K., 2022, Biological Utility of Fluorinated Compounds: from Materials Design to Molecular Imaging, Therapeutics and Environmental Remediation. Chemical reviews, 122(1), 167–208. https://doi.org/10.1021/acs.chemrev.1c00632.
[31]. Cruise, A. S., Singh, A., & Quiney, R. E., 2010, Sodium fluoride in otosclerosis treatment: review. The Journal of laryngology and otology, 124(6), 583–586. https://doi.org/10.1017/S0022215110000241.
[32]. Derks, W., De Groot, J. A., Raymakers, J. A., & Veldman, J. E., 2001, Fluoride therapy for cochlear otosclerosis? an audiometric and computerized tomography evaluation. Acta oto-laryngologica, 121(2), 174–177. https://doi.org/10.1080/000164801300043361.
[33]. Dequeker, J., & Declerck, K., 1993, Fluor in the treatment of osteoporosis. An overview of thirty years clinical research. Schweizerische medizinische Wochenschrift, 123(47), 2228–2234.
[34]. Shambaugh G. E., Fluoride Therapy for Otosclerosis. Arch Otolaryngol Head Neck Surg. 1990;116(10):1217. doi:10.1001/archotol.1990.01870100111026.
[35]. Kerr, G. S., & Hoffman, G. S., 1989, Fluoride therapy for otosclerosis. Ear, nose, & throat journal, 68(6), 426–429.
[36]. Caverzasio, J., Imai, T., Ammann, P., Burgener, D., & Bonjour, J. P., 1996, Aluminum potentiates the effect of fluoride on tyrosine phosphorylation and osteoblast replication in vitro and bone mass in vivo. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research, 11(1), 46–55. https://doi.org/10.1002/jbmr.5650110108.
[37]. Colletti, V., & Fiorino, F. G., 1991, Effect of sodium fluoride on early stages of otosclerosis. The American journal of otology, 12(3), 195–198.PMID: 1882968.
[38]. Linthicum, F. H., Jr, House, H. P., & Althaus, S. R., 1973, The effect of sodium fluoride on otosclerotic activity as determined by strontium. The Annals of otology, rhinology, and laryngology, 82(4), 609–615. https://doi.org/10.1177/000348947308200417.
[39]. Rich, C., Ensinck, J., & Ivanovich, P., 1964, The Effects Of Sodium Floride On Calcium Metabolism Of Subjects With Metabolic Bone Diseases. The Journal of clinical investigation, 43(4), 545–555. https://doi.org/10.1172/JCI104940.
[40]. Shambaugh, G. E., Jr, & Petrovic, A., 1968, Effects of sodium fluoride on bone. Application to otosclerosis and other decalcifying bone diseases. JAMA, 204(11), 969–973.
[41]. Rich, C., & Ivanovich, P., 1965, Response to sodium fluoride in severe primary osteoporosis. Annals of internal medicine, 63(6), 1069–1074. https://doi.org/10.7326/0003-4819-63-6-1069.
[42]. Valeria, Gaudieri., Emilia, Zampella., Adriana, D'Antonio., Alberto, Cuocolo. 18F-sodium fluoride and vascular calcification: Some like it hot. Journal of Nuclear Cardiology, (2020).1-3. doi: 10.1007/S12350-020-02125-0
[43]. Haguenauer, D., Welch, V., Shea, B., Tugwell, P., Adachi, J. D., & Wells, G., 2000, Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis. Osteoporosis International: a Journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 11(9), 727–738. https://doi.org/10.1007/s001980070051.
[44]. Aaseth, Jan & Shimshi, Mona & Gabrilove, J., & Birketvedt, Grethe, 2004, Fluoride: A Toxic or Therapeutic Agent in the Treatment of Osteoporosis. The Journal of Trace Elements in Experimental Medicine. 17. 83 - 92. 10.1002/jtra.10051.
[45]. Karjalainen, S., Kärjä, J., Härmä, R., & Juola, E., 1982, Effect of drinking water fluoridation on stapedial otosclerosis in a low fluoride area. Acta oto-laryngologica, 94(1-2), 111–119. https://doi.org/10.3109/00016488209128895.
[46]. Gold, S. R., Miller, V., Kamerer, D. B., & Koconis, C. A., 1998, Fluoride treatment for facial nerve stimulation caused by cochlear implants in otosclerosis. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 119(5), 521–523. https://doi.org/10.1016/S0194-5998(98)70116-0.
[47]. Vartiainen, E., Karjalainen, S., Nuutinen, J., Suntioinen, S., & Pellinen, P., 1994, Effect of drinking water fluoridation on hearing of patients with otosclerosis in a low fluoride area: a follow-up study. The American journal of otology, 15(4), 545–548.
[48]. Lewy A., 1944, Possible Value Of Nontoxic Concentrations Of Fluorine In The Prevention of Deafness From Otosclerosis And Fibrosis: Its Possible Value In Prevention Of Other Diseases. Arch Otolaryngol. 39(2):152–154. doi:10.1001/archotol.1944.00680010163005.
[49]. Ismail, A. I., & Hasson, H., 2008, Fluoride supplements, dental caries and fluorosis: a systematic review. Journal of the American Dental Association (1939), 139(11), 1457–1468. https://doi.org/10.14219/jada.archive.2008.0071.
[50]. Rošin-Grget, K., Peroš, K., Sutej, I., & Bašić, K., 2013, The cariostatic mechanisms of fluoride. Acta medica academica, 42(2), 179–188. https://doi.org/10.5644/ama2006-124.85.
[51]. Featherstone, J. D., 1999, Prevention and reversal of dental caries: role of low level fluoride. Community dentistry and oral epidemiology, 27(1), 31–40. https://doi.org/10.1111/j.1600-0528.1999.tb01989.x
Viewed PDF 25 3 -
Prolonged Dual Antiplatelet Therapy in High-Risk ACS Patients: Insights from the OPT-CAD StudyAuthor: Faraaz ZaveriDOI: 10.21522/TIJPH.2013.13.01.Art080
Prolonged Dual Antiplatelet Therapy in High-Risk ACS Patients: Insights from the OPT-CAD Study
Abstract:
This review delves into the discussion of the "Effect of dual antiplatelet therapy prolongation in acute coronary syndrome patients with both high ischemic and bleeding risk" explored in the OPT-CAD study. The research was directed at identifying patients with acute coronary syndrome who presented a bi-risk profile of high ischemic and bleeding risks and further evaluated the safety and efficacy of extended use of DAPT beyond 12 months post-PCI. The current review, through post hoc analysis of the OPT-CAD trial data, discusses the five-year incidence of ischemic and bleeding events in bi-risk patients. Indeed, extended DAPT has reduced the incidence of stroke without significant major bleeding risks. This review will cover the methodology of the findings presented, the results, and their clinical implication in real-world practice for the management of ACS.
Prolonged Dual Antiplatelet Therapy in High-Risk ACS Patients: Insights from the OPT-CAD Study
References:
[1]. Na, K., Qiu, M., Wei, N., Li, J., Yan, C., Li, J., Li, Y., Han, Y., 2023, Effect of dual antiplatelet therapy prolongation in acute coronary syndrome patients with both high ischemic and bleeding risk: insight from the OPT-CAD study. Frontiers in Cardiovascular Medicine, 10, 1201091.
[2]. Huo, Y., Lee, S. W., Sawhney, J. P. S., Kim, H. S., Krittayaphong, R., Pocock, S. J., et al., 2020, Two-year outcomes post-discharge in Asian patients with acute coronary syndrome: findings from the EPICOR Asia study. International Journal of Cardiology, 315, 1–8. doi: 10.1016/j.ijcard.2020.05.022.
[3]. Angiolillo, D. J., Galli, M., Collet, J. P., Kastrati, A., O’Donoghue, M. L., 2022, Antiplatelet therapy after percutaneous coronary intervention. EuroIntervention, 17, e1371–e1396. doi: 10.4244/EIJ-D-21-00904.
[4]. Collet, J. P., Thiele, H., Barbato, E., Barthelemy, O., Bauersachs, J., Bhatt, D. L., et al., 2021, 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal, 42, 1289–1367. doi: 10.1093/eurheartj/ehaa575.
[5]. Valgimigli, M., Frigoli, E., Heg, D., Tijssen, J., Juni, P., Vranckx, P., et al., 2021, Dual antiplatelet therapy after PCI in patients at high bleeding risk. New England Journal of Medicine, 385, 1643–1655. doi: 10.1056/NEJMoa2108749.
[6]. Wang, H. Y., Gao, R. L., Xu, B., Yang, Y. J., Yin, D., Wang, Y., et al., 2021, Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with a high risk of ischemic or bleeding events after PCI. Platelets, 32, 533–541. doi: 10.1080/09537104.2020.1774052.
Viewed PDF 20 0 -
Coagulation Dynamics in Laparoscopic Cholecystectomy: Investigating the Impact of Carbon Dioxide PneumoperitoneumAuthor: Raghupathy ThirunavikkarasuDOI: 10.21522/TIJPH.2013.13.01.Art081
Coagulation Dynamics in Laparoscopic Cholecystectomy: Investigating the Impact of Carbon Dioxide Pneumoperitoneum
Abstract:
Laparoscopic cholecystectomy is the widely used procedure to treat various gall bladder pathologies, During the procedure, pneumoperitoneum is created with carbon dioxide (CO₂) to improve visualization. This study investigates the impact of CO₂ pneumoperitoneum on coagulation dynamics in patients undergoing the procedure. Fifty-four patients were observed to assess preoperative and postoperative changes in coagulation parameters, including prothrombin time (PT) and D-dimer levels. The study found that postoperative PT changes were minimal, with a mean decrease from 11.83 to 11.7 seconds. D-dimer levels significantly increased, indicating heightened fibrinolytic activity, which can cause deep vein thrombosis (DVT) in high-risk individuals. The study highlights the importance of monitoring coagulation profiles during laparoscopic procedures and suggests that prophylactic anticoagulation should be considered for high-risk patients. Further large-scale investigations are recommended to quantify thrombotic risks associated with CO₂ pneumoperitoneum.
Coagulation Dynamics in Laparoscopic Cholecystectomy: Investigating the Impact of Carbon Dioxide Pneumoperitoneum
References:
[1]. Cheema, M. J., Hassan, M. M. U., Asim, A., Nathaniel, E., Shafeeq, M. I., Tayyab, M. A., Rahim Valiyakath, C., Abdallah, S., & Usman, A., 2024, Innovations in hybrid laparoscopic surgery: Integrating advanced technologies for multidisciplinary cases. Cureus, 16(6), p.e63219. https://doi.org/10.7759/cureus.63219
[2]. Kelley, W. E. Jr, 2008, The evolution of laparoscopy and the revolution in surgery in the decade of the 1990s. JSLS: Journal of the Society of Laparoendoscopic Surgeons, 12(4), pp.351–357. https://pmc.ncbi.nlm.nih.gov/articles/PMC3016007/
[3]. Joris, J. L., Noirot, D. P., Legrand, M. J., Jacquet, N. J., & Lamy, M. L., 1993, Hemodynamic changes during laparoscopic cholecystectomy. Anesthesia and Analgesia, 76(5), pp.1067–1071. https://doi.org/10.1213/00000539-199305000-00027
[4]. Nguyen, N. T., & Wolfe, B. M., 2005, The physiologic effects of pneumoperitoneum in the morbidly obese. Annals of Surgery, 241(2), pp.219–226. https://doi.org/10.1097/01.sla.0000151791.93571.70
[5]. He, H., Gruartmoner, G., Ince, Y., van Berge Henegouwen, M. I., Gisbertz, S. S., Geerts, B. F., Ince, C., Hollmann, M. W., Liu, D., & Veelo, D.P., 2018, Effect of pneumoperitoneum and steep reverse-Trendelenburg position on mean systemic filling pressure, venous return, and microcirculation during esophagectomy. Journal of Thoracic Disease, 10(6), pp.3399–3408. https://doi.org/10.21037/jtd.2018.05.169
[6]. Soper, N. J., Stockmann, P. T., Dunnegan, D. L., & Ashley, S. W., 1992, Laparoscopic cholecystectomy. The new 'gold standard'? Archives of Surgery, 127(8), pp.917–923. https://doi.org/10.1001/archsurg.1992.01420080051008
[7]. Atkinson, T. M., Giraud, G. D., Togioka, B. M., Jones, D. B., & Cigarroa, J. E., 2017, Cardiovascular and ventilatory consequences of laparoscopic surgery. Circulation, 135(7), pp.700–710. https://doi.org/10.1161/CIRCULATIONAHA.116.023262
[8]. Banerjee, A., Saini, S., & Lal, J., 2021, Evaluation of hemodynamic changes during laparoscopic cholecystectomy by transthoracic echocardiography. Journal of Anaesthesiology, Clinical Pharmacology, 37(3), pp.436–442. https://doi.org/10.4103/joacp.JOACP_173_19
[9]. Wittgen, C. M., Andrus, C. H., Fitzgerald, S. D., Baudendistel, L. J., Dahms, T. E., & Kaminski, D. L., 1991, Analysis of the hemodynamic and ventilatory effects of laparoscopic cholecystectomy. Archives of Surgery, 126(8), pp.997–1001. https://doi.org/10.1001/archsurg.1991.01410320083011
[10]. Kim, S. S., & Donahue, T. R., 2018, Laparoscopic cholecystectomy. JAMA, 319(17), p.1834. https://doi.org/10.1001/jama.2018.3438
[11]. Stamate, E., Piraianu, A. I., Duca, O. M., Ciobotaru, O. R., Fulga, A., Fulga, I., Onisor, C., Matei, M. N., Luchian, A. S., Dumitrascu, A. G. et al., 2024, The effect of increased intra-abdominal pressure on hemodynamics in laparoscopic cholecystectomy: The experience of a single centre. Journal of Personalized Medicine, 14(8), p.871. https://doi.org/10.3390/jpm14080871
[12]. Larsen, J. F., Ejstrud, P., Svendsen, F., Redke, F., Pedersen, V., & Rahr, H. B., 2001, Randomized study of coagulation and fibrinolysis during and after gasless and conventional laparoscopic cholecystectomy. The British Journal of Surgery, 88(7), pp.1001–1005. https://doi.org/10.1046/j.0007-1323.2001.01783.x
[13]. Amin, B., Zhang, C., Yan, W., Sun, Z., Zhang, Y., Du, D., & Gong, K., 2014, Effects of pneumoperitoneum of laparoscopic cholecystectomy on the coagulation system of patients: A prospective observational study. Chinese Medical Journal, 127(14), pp.2599–2604. https://pubmed.ncbi.nlm.nih.gov/25043074/
[14]. Schietroma, M., Carlei, F., Mownah, A., Franchi, L., Mazzotta, C., Sozio, A., & Amicucci, G., 2004, Changes in the blood coagulation, fibrinolysis, and cytokine profile during laparoscopic and open cholecystectomy. Surgical Endoscopy, 18(7), pp.1090–1096. https://doi.org/10.1007/s00464-003-8819-0
[15]. Donmez, T., Uzman, S., Yildirim, D., Hut, A., Avaroglu, H.I., Erdem, D. A., Cekic, E., & Erozgen, F., 2016, Is there any effect of pneumoperitoneum pressure on coagulation and fibrinolysis during laparoscopic cholecystectomy? PeerJ, 4, p.e2375. https://doi.org/10.7717/peerj.2375
[16]. Custendil-Delic, S., Delic, J., Mott-Divkovic, S., Petrov-Raslic, J., Ostrvica, E., & Hukic, F., 2009, Disorders of hemostasis in the course and after laparoscopic cholecystectomy. Medicinski Arhiv, 63(5), pp.271–273. https://pubmed.ncbi.nlm.nih.gov/20380127/
[17]. Garg, P. K., Teckchandani, N., Hadke, N. S., Chander, J., Nigam, S., & Puri, S. K., 2009, Alteration in coagulation profile and incidence of DVT in laparoscopic cholecystectomy. International Journal of Surgery, 7(2), pp.130–135. https://doi.org/10.1016/j.ijsu.2008.12.036
[18]. Hassler, K. R., Collins, J. T., Philip, K., et al., 2024, Laparoscopic cholecystectomy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Available from: https://www.ncbi.nlm.nih.gov/books/NBK448145
[19]. Esmon, C. T., 2009, Basic mechanisms and pathogenesis of venous thrombosis. Blood Reviews, 23(5), pp.225–229. https://doi.org/10.1016/j.blre.2009.07.002
[20]. Huang, J., Patel, H. K., Boakye, D., Chandrasekar, V. T., Koulaouzidis, A., Lucero-Prisno, D. E., Wong, M. C., 2021, Worldwide distribution, associated factors, and trends of gallbladder cancer: A global country-level analysis. Cancer Letters, 521, pp.238–251. https://doi.org/10.1016/j.canlet.2021.09.004
Viewed PDF 28 1 -
Evaluating the Effectiveness of Honey and Standard Dressings on Wound Healing in Open Tibia Fractures: A Randomized Controlled TrialAuthor: JC Allen IngabireDOI: 10.21522/TIJPH.2013.13.01.Art082
Evaluating the Effectiveness of Honey and Standard Dressings on Wound Healing in Open Tibia Fractures: A Randomized Controlled Trial
Abstract:
Wound healing in open fractures presents significant challenges, especially in low-resource settings, due to high rates of complications. Honey, known for its antimicrobial and healing properties, offers a potential alternative. This randomized controlled trial evaluates the effectiveness of honey dressings compared to standard dressings in wound healing for open tibia fractures. This open-label randomized comparative trial was conducted at the University Teaching Hospital of Kigali, Rwanda, involving 100 adult patients with Gustilo IIIA open tibia fractures of whom 98 patients were analysed. Participants were randomly assigned to either the intervention group receiving honey dressings or the control group receiving standard saline dressings. Primary outcomes included wound healing rate at 30 days, with secondary outcomes assessing wound size, pain, odour, exudate, and cleanliness. Data analysis was performed using logistic regression, chi-square tests, and Bayesian methods. The honey dressing group demonstrated significantly improved outcomes, including faster wound healing, reduced pain, decreased wound odour, and a greater reduction in wound surface area by day 30 compared to the control group. Logistic regression revealed a 10.87-fold increased likelihood of complete healing within 30 days for the honey group (p< 0.05). The type of dressing used significantly influenced wound healing, outperforming other factors like bone coverage, previous limb injury, and residence. Honey dressings significantly enhance wound healing in open tibia fractures compared to standard dressings, suggesting their potential as an effective adjunct in fracture management, particularly in resource-limited settings. Further research is recommended to refine optimal honey application methods and concentrations.
Evaluating the Effectiveness of Honey and Standard Dressings on Wound Healing in Open Tibia Fractures: A Randomized Controlled Trial
References:
[1]. Kouassi, K. J., Manon, J., Fonkoue, L., Detrembleur, C., & Cornu, O., 2021, Treatment of open tibia fractures in Sub-Saharan African countries: A systematic review. Acta Orthopaedica Belgica, 87(1), 85–92. PMID: 34129761.
[2]. Li, J., Wang, Q., Lu, Y., Feng, Q., He, X., Li, M. D. Z., et al. 2020, Relationship between time to surgical debridement and the incidence of infection in patients with open tibial fractures. Orthopaedic Surgery, 12(2), 524–532.
[3]. Cullen, S., Flaherty, D., Fitzpatrick, N., Ali, A., Elkhidir, I., & Pillai, A., 2024, Outcomes following surgical fixation of Gustilo-Anderson IIIb open tibial fractures. Acta Orthopaedica Belgica, 90(1), 83–89.
[4]. Ahmed, A. S. A. A., Eltregy, S., & Kandil, M. I., 2022, Honey dressing: A missed way for orthopaedic wound care. International Orthopaedics, 46(11), 2483–2491.
[5]. Bernstein, R. C., 2014, The scientific evidence validating the use of honey as a medicinal agent. The Science Journal of the Lander, 8(1).
[6]. Molan, P. C., 2006, The antibacterial activity of honey. Bee World, 73(1), 2–28.
[7]. Blaser, G., Santos, K., Bode, U., Vetter, H., & Simon, A., 2007, Effect of medical honey on wounds colonised or infected with MRSA. Journal of Wound Care, 16(8), 325–328.
[8]. Shi, C., Wang, C., Liu, H., Li, Q., Li, R., Zhang, Y., et al. 2020, Selection of appropriate wound dressing for various wounds. Frontiers in Bioengineering and Biotechnology, 8. Frontiers Media S.A.
[9]. Lagoa, T., Queiroga, M. C., & Martins, L., 2024, An overview of wound dressing materials. Pharmaceuticals, 17(9), 1110. https://doi.org/10.3390/ph17091110
[10]. Tang, Y., Chen, L., & Ran, X., 2024, Efficacy and safety of honey dressings in the management of chronic wounds: An updated systematic review and meta-analysis. *Nutrients, 16*(15), 2455. https://doi.org/10.3390/nu16152455
[11]. Deviandri, R., Yd, I., & Singh, A., 2018, Dilution of open fracture grade IIIA of the lower leg using normal saline 0.9% mixed with honey compared with normal saline 0.9% to the bacterial growth. Orthopedic Research Online Journal, 2(5), 175–178.
[12]. Rajkumar Samdavid Thanapaul, R. J., & Mannocci, A. S. V. L. T., 2021, An insight into aging, senescence, and their impacts on wound healing. Advances in Geriatric Medicine and Research, 3.
[13]. Mannocci, A. S. V. L. T., 2019, Male gender, age, and low income are risk factors for road traffic injuries among adolescents: An umbrella review of systematic reviews and meta-analyses. Journal of Public Health, 263–272.
[14]. Mordi, R. M., & Momoh, M. I., 2009, Incidence of Proteus species in wound infections and their sensitivity pattern in the University of Benin Teaching Hospital. African Journal of Biotechnology, 8(5), 725–730. http://www.academicjournals.org/AJB
[15]. Scepankova, H., Combarros-Fuertes, P., Fresno, J. M., Tornadijo, M. E., Dias, M. S., Pinto, C. A., et al. 2021, Role of honey in advanced wound care. Molecules, 26. MDPI AG.
[16]. Hixon, K. R., Klein, R. C., Eberlin, C. T., Linder, H. R., Ona, W. J., Gonzalez, H., et al. 2019, A critical review and perspective of honey in tissue engineering and clinical wound healing. Advances in Wound Care (New Rochelle), 8(8), 403–415.
[17]. Tashkandi, H. 2021, Honey in wound healing: An updated review. Open Life Sciences, 16, 1091–1100.
[18]. Albaridi, N. A., 2019, Antibacterial potency of honey. International Journal of Microbiology, 2019. https://doi.org/10.1155/2019/2464507
[19]. Nezhad-Mokhtari, P., Javanbakht, S., Asadi, N., Ghorbani, M., Milani, M., Hanifehpour, Y., et al. 2021, Recent advances in honey-based hydrogels for wound healing applications: Towards natural therapeutics. Journal of Drug Delivery Science and Technology, 66. Editions de Sante.
[20]. Naskar, A., Chatterjee, K., Roy, K., Majie, A., Nair, A. B., Shinu, P., et al. 2024, Mechanistic roles of different varieties of honey on wound healing: Recent update. Journal of Pharmacology and Pharmacotherapeutics, 15, 5–18.
[21]. Vandamme, L., Heyneman, A., Hoeksema, H., Verbelen, J., & Monstrey, S., 2013, Honey in modern wound care: A systematic review. Burns, 39, 1514–1525.
[22]. Clark, M., & Adcock, L., 2018, Honey for wound management: A review of clinical effectiveness and guidelines. CADTH Rapid Response Report: Summary with Critical Appraisal.
Viewed PDF 23 0 -
Correlation of Tyrosine Hydroxylase, Orexin, and NFL Concentration with Parkinson's DiseaseAuthor: Manar K. AhmedDOI: 10.21522/TIJPH.2013.13.01.Art083
Correlation of Tyrosine Hydroxylase, Orexin, and NFL Concentration with Parkinson's Disease
Abstract:
The research aimed to identify serum biochemical variables that correlated to Parkinson's disease by the collection of 120 blood samples from healthy patients males coming to Ibn Sina Teaching Hospital in Mosul, from December to June 2023-2024, these samples were divided into several groups, Parkinson group, donated symbol P that included (30) samples divided into two subgroups according to age, P1 (50-65)years and P2 (66-80) years 15 blood sample for each, while Parkinson's family group donated symbol F, included (30) samples aged between (25-50) years, in addition to the Control group C that included (60) samples of Healthy people which divided into three subgroups, C1 (50-65) years, C2 (66-80) years, and C3 subgroup (25-50) years. These groups ' biochemical serum markers tyrosine hydroxylase, orexin, and neurofilament protein NFL had been compared. Results of this research showed a significant correlation as TH enzyme concentration decreased in patients' serum with Parkinson's disease in both groups P1, and P2 compared to the healthy group C1 and C2 (p≤0.01), also F group showed a significant decrease in the concentration of this enzyme compared to the healthy group C3, Besides there was a substantial difference in orexin hormone concentration level at probability level (p≤0.01)) in all groups, as hormone concentration decreased in P1subgroup patients compared to healthy C1 patients of the same age group, and this decrease increased in Parkinson's disease P2 patients compared to healthy C2. There was a significant increase in the serum's concentration of NFL protein in the P1 subgroup compared to the healthy C1 subgroup at a probability level (P≤0.01).
Correlation of Tyrosine Hydroxylase, Orexin, and NFL Concentration with Parkinson's Disease
References:
[1]. Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., Weintraub, D., 2021, Parkinson disease-associated cognitive impairment. Nature Reviews Disease Primers, 7(1), 1-21. doi:10.1038/s41572-021-00280-3.
[2]. Bloem, B. R., Okun, M. S., Klein, C., 2021, Parkinson's disease. The Lancet, 397(10291), 2284-2303. doi:10.1016/S0140-6736(21)00218-X.
[3]. Ismael, S. S., Al-Shamaa, S. D., 2020, Mutation in microtubule-associated protein tau MAPT coding gene and its correlation with Alzheimer’s disease, International Journal of Research in Pharmaceutical Sciences, 11(4), 5150-5157, doi:10.26452/ijrps.v11i4.3119.
[4]. Calabresi, P., Mechelli, A., Natale, G., Volpicelli-Daley, L., Di Lazzaro, G., Ghiglieri, V., 2023, Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell death & disease, 14(3), 176, doi:10.1038/s41419-023-05672-9.
[5]. Hamanaka, Y., Mizunami, M., 2019, Tyrosine hydroxylase-immunoreactive neurons in the mushroom body of the field cricket, Gryllus bimaculatus. Cell and tissue research, 376, 97-111, doi:10.1007/s00441-018-2969-9.
[6]. Sofy, S., Kakey, E., Alshamaa, S., 2014, The Protective Role of Green Tae and Ginkgo biloba Extract against Aging Dysfunction Induced by D-Galactose in Rats. Glob J Biol Agric Health Sci, 3(3), 97-101.
[7]. Borkar, C. D., Bharne, A. P., Nagalakshmi, B., Sakharkar, A. J., Subhedar, N. K., Kokare, D. M., 2018, Cocaine-and amphetamine-regulated transcript peptide (CART) alleviates MK-801-induced schizophrenic dementia-like symptoms. Neuroscience, 375, 94-107, doi:10.1016/j.neuroscience.2018.01.056.
[8]. Suzuki, K., Miyamoto, M., Miyamoto, T., Iwanami, M., Hirata, K., 2011, Sleep Disturbances Associated with Parkinson′ s Disease. Parkinson’s disease, 2011(1), 219056, doi:10.4061/2011/219056.
[9]. Justinussen, J. L., Egebjerg, C., Kornum, B. R., 2023, How hypocretin agonists may improve the quality of wake in narcolepsy. Trends in Molecular Medicine, 29(1), 61-69, doi:10.1016/j.molmed.2022.10.008.
[10]. Ng, A. S. L., Tan, Y. J., Yong, A. C. W., Saffari, S. E., Lu, Z., Ng, E. Y., Tan, E. K., 2020, Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson’s disease. Molecular neurodegeneration, 15, 1-8, doi:10.1186/s13024-020-00385-5.
[11]. Halloway, S., Desai, P., Beck, T., Aggarwal, N., Agarwal, P., Evans, D., Chicago Health and Aging Project, 2022, Association of neurofilament light with the development and severity of Parkinson disease. Neurology, 98(22), e2185-e2193, doi:10.1212/WNL.0000000000200338.
[12]. Yi, L. X., Tan, E. K., & Zhou, Z. D., 2024, Tyrosine Hydroxylase Inhibitors and Dopamine Receptor Agonists Combination Therapy for Parkinson’s Disease. International Journal of Molecular Sciences, 25(9), 4643, doi:10.3390/ijms25094643.
[13]. Zhou, Z. D., Saw, W. T., Ho, P. G. H., Zhang, Z. W., Zeng, L., Chang, Y. Y., Tan, E. K., 2022, The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis. Cellular and Molecular Life Sciences, 79(12), 599, doi:10.1007/s00018-022-04574-x.
[14]. Huang, S., Zhao, Z., Ma, J., Hu, S., Li, L., Wang, Z., Zheng, J., 2021, Increased plasma orexin-A concentrations are associated with the non-motor symptoms in Parkinson’s disease patients. Neuroscience Letters, 741, 135480, doi:10.1016/j.neulet.2020.135480.
[15]. Braun, A., Manavis, J., Yamanaka, A., Ootsuka, Y., Blumbergs, P., Bobrovskaya, L., 2024, The role of orexin in Parkinson's disease. Journal of Neuroscience Research, 102(3), e25322, doi:10.1002/jnr.25322.
[16]. Oosterveld, L. P., Verberk, I. M., Majbour, N. K., El‐Agnaf, O. M., Weinstein, H. C., Berendse, H. W., van de Berg, W.D., 2020, CSF or serum neurofilament light added to α‐synuclein panel discriminates Parkinson's from controls. Movement Disorders, 35(2), 288-295, doi:10.1002/mds.27897.
[17]. Pedersen, C. C., Ushakova, A., Alves, G., Tysnes, O. B., Blennow, K., Zetterberg, H., Lange, J., 2024, Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson’s Disease. npj Parkinson's Disease, 10(1), 162, doi:10.1038/s41531-024-00768-1.
[18]. Nabizadeh, F., Mohamadzadeh, O., Hosseini, H., Rasouli, K., Afyouni, N. E., 2023, Serum neurofilament light chain in LRRK2 related Parkinson’s disease: A five years follow-up. Journal of Clinical Neuroscience, 110, 12-18, doi:10.1016/j.jocn.2023.01.015.
[19]. Teng, X., Mao, S., Wu, H., Shao, Q., Zu, J., Zhang, W., Xu, C., 2023, The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease. Journal of Neurochemistry, 165(2), 268-276, doi:10.1111/jnc.15780.
[20]. Praba, M. A., Venkataramaniah, K. G., Rashid, N. A., el Hasnaoul, R., Saadani, M. A. W., 2024, Association of Cell Viability in Huntington Chorea Rat Models and the Neuroprotective Role of Withania Somnifera in Public Health. Texila International Journal of Public Health, 12(4), 1-10, doi: 10.21522/TIJPH.2013.12.04.Art076.
Viewed PDF 30 7 -
Carbapenem Resistant Klebsiella pneumoniae Cases from India: An Overview of Current KnowledgeAuthor: Sathasivam SivamalarDOI: 10.21522/TIJPH.2013.13.01.Art084
Carbapenem Resistant Klebsiella pneumoniae Cases from India: An Overview of Current Knowledge
Abstract:
Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a significant public health concern in India. Our current review attempts a qualitative summary of observational studies published in the last ten years. The key resistance mechanisms identified include carbapenemase enzymes like New Delhi Metallo-beta-lactamase (NDM-1), Oxacillinase-48 (OXA-48), and Klebsiella pneumoniae carbapenemase (KPC), as well as non-enzymatic factors such as efflux pump overexpression and alterations in outer membrane porins (OmpK35, OmpK36). Horizontal gene transfer via plasmids and transposons was also observed to accelerate the dissemination of resistance genes. Carbapenem resistance rates in India have surged from 9% in 2008 to approximately 60% by 2024. Environmental contamination from untreated industrial and hospital waste, along with antibiotic overuse, also significantly contributed to the increased spread of CRKp strains and is associated with mortality rates of around 68%. Challenges in the diagnosis of CRKp cases arise from limitations of phenotypic methods and the non-availability of genotypic techniques such as PCR and whole-genome sequencing in resource-constrained settings. Treatment options against CRKp are limited, often relying on last-resort antibiotics like polymyxins and tigecycline, which also have significant side effects and face rising resistance. Emerging therapies, including novel β-lactam/β-lactamase inhibitor combinations and agents like cefiderocol, show a promising option but require further validation. Therefore, an urgent, integrated approach is recommended to combat rising CRKp infections in India, which involves enhancing surveillance systems, strengthening antimicrobial stewardship programs, improving infection control practices within healthcare facilities, and promoting public education on the risks of antibiotic misuse.
Carbapenem Resistant Klebsiella pneumoniae Cases from India: An Overview of Current Knowledge
References:
[1]. Ahmadi, Z., Noormohammadi, Z., Behzadi, P., & Ranjbar, R., 2022, Molecular detection of gyra mutation in clinical strains of Klebsiella pneumoniae. Iranian Journal of Public Health, 51(10), 2334–2339.
[2]. Shamanna, V., Srinivas, S., Couto, N., Nagaraj, G., Sajankila, S. P., Krishnappa, H. G., Kumar, K. A., Aanensen, D. M., & Lingegowda, R. K., 2024, Geographical distribution, disease association and diversity of klebsiella pneumoniae k/l and o antigens in india: roadmap for vaccine development. Microbial genomics, 10(7).
[3]. Indrajith, S., Mukhopadhyay, A. K., Chowdhury, G., Farraj, D. A. A., Alkufeidy, R. M., Natesan, S., Meghanathan, V., Gopal, S., &Muthupandian, S., 2020, Molecular insights of carbapenem resistance Klebsiella pneumoniae isolates with focus on multidrug resistance from clinical samples. Journal of Infection and Public Health, 14(1), 131–138.
[4]. Shankar, C., Nabarro, l. E., Anandan, S., et al., 2018, Extremely high mortality rates in patients with carbapenem-resistant, hypermucoviscous Klebsiella pneumoniae blood stream infections. The journal of the association of physicians of india, 66(12), 13–16.
[5]. Das, B. J., Banerjee, T., Wangkheimayum, J., et al., 2024, Characterization of blaoxa-232 carrying carbapenem-resistant Klebsiella pneumoniae (crkp) & their expression profiles under selective carbapenem pressure: an in-depth study from India. The Indian Journal of Medical Research, 159(6), 644–652.
[6]. Verma, G., Nayak, S. R., Jena, S., Panda, S. S., Pattnaik, D., Praharaj, A., & Singh, N., 2023, Prevalence of carbapenem-resistant enterobacterales, Acinetobacter baumannii, and pseudomonas aeruginosa in a tertiary care hospital in eastern India: a pilot study. Journal of Pure and Applied Microbiology, 17(4), 2243–2249.
[7]. Veeraraghavan, B., Shankar, C., Karunasree, S., Kumari, S., Ravi, R., & Ralph, R., 2017, Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: indian experience. Pathogens and Global Health, 111(5), 240–246.
[8]. Kunjalwar, R., &Mudey, G., 2024, A cross-sectional study on endemicity of vim, ndm, kpc, ipm& oxa-48 genes in carbapenemase producing Klebsiella pneumoniae and Escherichia coli from a tertiary hospital using mcim, ecim, and pcr in central india. F1000research, 13, 636.
[9]. Mohanty, S., Mittal, G., &Gaind, R., 2017, Identification of carbapenemase-mediated resistance among enterobacteriaceae bloodstream isolates: a molecular study from India. Indian journal of medical microbiology, 35(3), 421–425.
[10]. Firoozeh, F., Mahluji, Z., Shams, E., Khorshidi, A., &Zibaei, M., 2017, New delhimetallo-β-lactamase-1-producing klebsiella pneumoniae isolates in hospitalized patients in kashan, iran. Iranian Journal of Microbiology, 9(5), 283–287.
[11]. Mulvey, M. R., Grant, J. M., Plewes, K., Roscoe, D., &Boyd, D. A., 2011, New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerging infectious diseases, 17(1), 103–106.
[12]. Gupta, V., Garg, R., Kumaraswamy, K., et al., 2018, Phenotypic and genotypic characterization of carbapenem resistance mechanisms in Klebsiella pneumoniae from blood culture specimens: a study from north India. Journal of Laboratory Physicians, 10(02), 125-129.
[13]. Nachimuthu, R., Subramani, R., Maray, S., Gothandam, K. M., Sivamangala, K., Manohar, P., & Bozdogan, B., 2016, Characterization of carbapenem-resistant gram-negative bacteria from Tamil Nadu. Journal of chemotherapy, 28(5), 371–374.
[14]. Tsai, Y., Fung, C., Lin, J., Chen, J., Chang, F., Chen, T., & Siu, l. K., 2011, Klebsiella pneumoniae outer membrane porins ompk35 and ompk36 play roles in both antimicrobial resistance and virulence. Antimicrobial agents and chemotherapy, 55(4), 1485–1493.
[15]. Kong, H., Pan, Q., Lo, W., Liu, X., Law, C. O. K., Chan, T., Ho, P., &Lau, T. C., 2018, Fine-tuning carbapenem resistance by reducing porin permeability of bacteria activated in the selection process of conjugation. Scientific reports, 8(1).
[16]. Gupta, A. K., Chauhan, D. S., Srivastava, K., Das, R., Batra, S., & Mittal, M., 2010, Estimation of efflux-mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in mycobacteria. Journal of communicable diseases, 38(3), 246-254.
[17]. Garima, K., Pathak, R., Tandon, R., Rathor, N., Sinha, R., &Bose, M., 2015, Differential expression of efflux pump genes of Mycobacterium tuberculosis in response to varied subinhibitory concentrations of anti-tuberculosis agents. Tuberculosis (edinburgh), 95(2), 155-161.
[18]. Narang, A., Garima, K., Porwal, S., Bhandekar, A., Shrivastava, K., Giri, A., Sharma, N. K., Bose, M., & Varma-basil, M., 2019b, Potential impact of efflux pump genes in mediating rifampicin resistance in clinical isolates of Mycobacterium tuberculosis from India. Plos one, 14(9), e0223163.
[19]. Bhatia, M., Shamanna, V., Nagaraj, G., Sravani, D., Gupta, P., Omar, B. J., Chakraborty, D., &Ravikumar, K. L., 2021, Molecular characterisation of carbapenem-resistantklebsiellapneumoniaeclinical isolates: preliminary experience from a tertiary care teaching hospital in the himalayas. Transactions of the royal society of tropical medicine and hygiene, 116(7), 655–662.
[20]. Tayyaba, U., Khan, S. W., Sultan, A., Khan, F., Akhtar, A., Nagaraj, G., Ahmed, A., &Bhattacharya, B., 2024, Molecular characterization of mdr and xdr clinical strains from a tertiary care center in North India by whole genome sequence analysis. Journal of the Oman Medical Association, 1(1), 29–47.
[21]. Shukla, S., Desai, S., Bagchi, A., Singh, P., Joshi, .M, Joshi, C., Patankar, J., maheshwari, P., Rajni, E., Shah, M., &Gajjar, d., 2023, Diversity and distribution of β-lactamase genes circulating in indian isolates of multidrug-resistant Klebsiella pneumoniae. Antibiotics, 12(3), 449.
[22]. Spadar, A., Phelan, J., Elias, R., Modesto, A., Caneiras, C., Marques, C., Lito, l., Pinto, M., Cavaco-silva, P., Ferreira, H., Pomba, C., Da silva, G. J., aSavedra, M. J., Melo-cristino, J., Duarte, A., Campino, S., Perdigão, J., &Clark, T. G., 2022, Genomic epidemiological analysis of Klebsiella pneumoniae from portuguese hospitals reveals insights into circulating antimicrobial resistance. Scientific reports, 12(1).
[23]. Li, P., Luo, W., Xiang, T., Jiang, Y., Liu, P., Wei, D., Fan, l., Huang, S., Liao, W., Liu, Y., & Zhang, W., 2022, Horizontal gene transfer via omvs co-carrying virulence and antimicrobial-resistant genes is a novel way for the dissemination of carbapenem-resistant hypervirulent Klebsiella pneumoniae. Frontiers in microbiology, 13. Https://doi.org/10.3389/fmicb.2022.945972
[24]. Apisarnthanarak, A., Hsu, l. Y., Khawcharoenporn, T., & Mundy, l. M., 2013, Carbapenem-resistant gram-negative bacteria: how to prioritize infection prevention and control interventions in resource-limited settings. Expert review of anti-infective therapy, 11(2), 147-157.
[25]. Muresu, N., Deiana, G., Dettori, M., Palmieri, A., Masia, M. D., Cossu, A., . &Castiglia, p., 2023, Infection prevention control strategies of new delhimetallo-β-lactamase producing Klebsiella pneumoniae. In healthcare (vol. 11, no. 18, p. 2592). Mdpi.
[26]. Anagnostopoulos, D. A., Parlapani, F. F., Natoudi, S., Syropoulou, F., Kyritsi, M., Vergos, I., Hadjichristodoulou, C., Kagalou, I., &Boziaris, I. S., 2022, Bacterial communities and antibiotic resistance of potential pathogens involved in food safety and public health in fish and water of lake karla, thessaly, greece. Pathogens, 11(12), 1473.
[27]. Sivalingam, P. J., Poté, & Prabakar, K., 2019, Environmental prevalence of carbapenem resistance enterobacteriaceae (cre) in a tropical ecosystem in India: human health perspectives and future directives. Pathogens, 8(4), 174.
[28]. Sree, R. A., Gupta, A., Gupta, N., Veturi, S., Reddy, L. S. K., Begum, M., Shravani, E., Challa, H. R., Reddy, S. S., Singamsetty, A., Arumilli, M., Reddy, P. N., & Tirlangi, P. K., 2024, Ceftazidime-avibactam alone or in combination with Aztreonam versus Polymyxins in the management of carbapenem-Resistant Klebsiella pneumoniae nosocomial Infections (CAPRI study): a retrospective cohort study from South India. Infection, 52(2), 429–437.
[29]. Kim, H. K., Park, J. S., Sung, H., &Kim, M. N., 2015, Further modification of the modified hodge test for detecting metallo-β-lactamase-producing carbapenem-resistant enterobacteriaceae. Annals of laboratory medicine, 35(3), 298.
[30]. Hamal, D., Shrestha, R., Paudel, R., Nayak, N., Bhatta, D. R., & Gokhale, s., 2023, Combined disc test and modified hodge test for detection of carbapenemase-producing gram-negative bacilli. Nepal journal of medical sciences, 8(2), 15-21.
[31]. Wang, Y., Huang, X., Yin, D., Shen, S., Jian, C., Sun, Z., &Chen, Z, 2024, Modification of carbapenemase inhibition test and comparison of its performance with ng-test carba 5 for detection of carbapenemase-producing enterobacterales. Journal of applied microbiology, lxae197.
[32]. Kibwana, U. O., Manyahi, J., Moyo, S. J., Blomberg, B., Roberts, A. P., Langeland, N., &Mshana, S. E., 2024, Antimicrobial resistance profile of enterococcus species and molecular characterization of vancomycin resistant enterococcus faecium from the fecal samples of newly diagnosed adult hiv patients in dar es salaam, tanzania. Frontiers in tropical diseases, 5, 1307379.
[33]. Christina, S., Praveena, R., Shahul, M. R., &Saikumar, c., 2024, Carbapenemase-producing escherichia coli: comparison of a novel rapid lateral flow assay with the polymerase chain reaction (pcr) and antimicrobial resistance pattern. Cureus, 16(9), e68941.
[34]. Way, Y. A., Huang, C. W., Liao, W. C., Li, S. W., Chiang, R. L., Hsing, E. W., &Hsieh, y. C., 2024, Sequential use of capsular typing and whole-genome sequencing-based analysis for transmission of carbapenem-resistant acinetobacter baumannii in a tertiary medical center. Journal of microbiology, immunology and infection.
[35]. Naik, V. V., Kumar, S., Thrimurthy, T., Channareddy, V., &Shaw, T., 2024, Enhancing carbapenem resistance detection: lamp coupled with melting curve analysis-for rapid molecular diagnostics in clinical specimens.
[36]. Tempe, D. K., Agarwal, J., Chaudhary, K., Lalwani, P., Tudu, M. S., Hansdah, U., &Mishra, B., 2015, Carbapenem resistance patterns in general intensive care unit of a tertiary care hospital in india. Mamc journal of medical sciences, 1(2), 85-91.
[37]. Veeraraghavan, B., Shankar, C., Karunasree, S., Kumari, S., Ravi, R., & Ralph, R., 2017, Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: indian experience. Pathogens and global health, 111(5), 240-246.
[38]. Way, Y. A., Huang, C. W., Liao, W. C., Li, S. W., Chiang, R. L., Hsing, E. W., &Hsieh, y. C., 2024, Sequential use of capsular typing and whole-genome sequencing-based analysis for transmission of carbapenem-resistant acinetobacter baumannii in a tertiary medical center. Journal of microbiology, immunology and infection.
[39]. Vieceli, T., Henrique, l. R., Rech, T. H., & Zavascki, A. P., 2024, Colistin versus polymyxin b for the treatment of carbapenem-resistant klebsiella pneumoniae bloodstream infections. Journal of infection and chemotherapy, 30(7), 621-625.
[40]. Tiseo, G., Galfo, V., Riccardi, N., Suardi, l. R., Pogliaghi, M., Giordano, C., &Falcone, m., 2024, Real-world experience with meropenem/vaborbactam for the treatment of infections caused by esbl-producing enterobacterales and carbapenem-resistant Klebsiella pneumoniae. European journal of clinical microbiology & infectious diseases, 1-8.
[41]. Sophonsri, A., Kalu, M., & Wong-beringer, A., 2024, Comparative in vitro activity of ceftazidime-avibactam, imipenem-relebactam, and meropenem-vaborbactam against carbapenem-resistant clinical isolates of Klebsiella pneumoniae and Pseudomonas aeruginosa. Antibiotics, 13(5), 416.
[42]. Yang, C., Wang, l., Lv, J., Wen, Y., Gao, Q., Qian, F., & Du, H., 2024, Effects of different carbapenemase and siderophore production on cefiderocol susceptibility in Klebsiella pneumoniae. Antimicrobial agents and chemotherapy, e01019-24.
[43]. Mantzarlis, K., Manoulakas, E., Parisi, K., Sdroulia, E., Zapaniotis, N., Tsolaki, V., &Makris, D., 2024, Meropenem plus ertapenem and ceftazidime–avibactam plus aztreonam for the treatment of ventilator associated pneumonia caused by pan-drug resistant Klebsiella pneumoniae. Antibiotics, 13(2), 141.
[44]. Zhong, W., Fu, Y., Liao, X., Xu, N., Shen, l., Wu, J., & Yang, C., 2024, Enhancing safe and effective treatment of carbapenem-resistant Klebsiella pneumoniae with polymyxin b-loaded dendritic nanoparticles. Chemical Engineering Journal, 498, 155753.
[45]. Kou, X., Yang, X., & Zheng, R., 2024, Challenges and opportunities of phage therapy for klebsiella pneumoniae infections. Applied and environmental microbiology, e01353-24.
[46]. Zhou, H., Du, X., Wang, Y., Kong, J., Zhang, X., Wang, W., . & Ye, J., 2024, Antimicrobial peptide a20l: in vitro and in vivo antibacterial and antibiofilm activity against carbapenem-resistant Klebsiella pneumoniae. Microbiology spectrum, 12(8), e03979-23.
[47]. Zhu, J., Chen, T., Ju, Y., Dai, J., &Zhuge, X., 2024, Transmission dynamics and novel treatments of high risk carbapenem-resistant Klebsiella pneumoniae: the lens of one health. Pharmaceuticals, 17(9), 1206.
[48]. Fritzenwanker, M., Imirzalioglu, C., Herold, S., Wagenlehner, F. M., Zimmer, K. P., &Chakraborty, T., 2018, Treatment options for carbapenem- resistant gram-negative infections. Deutschesarzteblatt international, 115(20-21), 345–352.
[49]. Kontopidou, F., Giamarellou, H., Katerelos, P., Maragos, A., Kioumis, I., Trikka-graphakos, E., Valakis, C., &Maltezou, H., 2013, Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in greece: a multi-centre study on clinical outcome and therapeutic options. Clinical microbiology and infection, 20(2), o117–o123.
[50]. Tesfa, T., Mitiku, H., Edae, M., &Assefa, N., 2022, Prevalence and incidence of carbapenem-resistant K.pneumoniae colonization: systematic review and meta-analysis. Systematic reviews, 11(1), 240.
[51]. Ramasubramanian, V., Porwal, R., &Rajesh, N., 2014, Carbapenem resistant gram-negative bacteremia in an indian intensive care unit: a review of the clinical profile and treatment outcome of 50 patients. Indian journal of critical care medicine, 18(11), 750–753.
[52]. Suay-García, B., &Pérez-gracia, M. T., 2021, Present and future of carbapenem-resistant enterobacteriaceae infections. Advances in clinical immunology, medical microbiology, COVID-19, and big data, 435-456.
[53]. Mascellino, M. T., Oliva, A., Biswas, S., & Ceccarelli, G., 2024, Editorial: New therapeutic strategies against carbapenem-resistant Gram-negative bacteria. Frontiers in microbiology,15, 1513900. https://doi.org/10.3389/fmicb.2024.1513900
[54]. Swaminathan, S., Routray, A., & Mane, A., 2022, Early and appropriate use of ceftazidime-avibactam in the management of multidrug-resistant gram-negative bacterial infections in the indian scenario. Cureus, 14(8), e28283.
[55]. Muresu, N., Deiana, G., Dettori, M., Palmieri, A., Masia, M. D., Cossu, A., &Castiglia, P., 2023, Infection prevention control strategies of new delhimetallo-β-lactamase producing Klebsiella pneumoniae. In healthcare (vol. 11, no. 18, p. 2592). Mdpi.
[56]. Amit, S., Mishali, H., Kotlovsky, T., Schwaber, M. J., &Carmeli, Y., 2014, Bloodstream infections among carriers of carbapenem-resistant klebsiella pneumoniae: etiology, incidence and predictors. Clinical microbiology and infection, 21(1), 30–34.
[57]. Kaur, J. N., Singh, N., Smith, N. M., Klem, J. F., Cha, R., Lang, Y., . &Tsuji, B. T., 2024, Next-generation antibiotic combinations to combat pan-drug resistant Klebsiella pneumoniae. Scientific reports, 14(1), 3148.
[58]. Hu, F., Pan, Y., Li, H., Han, H., Liu, X., Ma, R., & He, P., 2024, Carbapenem-resistant klebsiella pneumoniae capsular types, antibiotic resistance and virulence factors in China: a longitudinal, multi-centre study. Nature microbiology, 9(3), 814-829.
[59]. Ph, S., Attavar, P. C., Tr, R., Kotian, M. S., & Ns, D., 2024, Emergence of high-level antibiotic resistance in Klebsiella pneumoniae: a narrative review. South asian journal of research in microbiology, 18(2), 1-8. https://doi.org/10.9734/sajrm/2024/v18i2343
Viewed PDF 36 0 -
In silico and In vitro Study Prediction of the Anti-inflammatory Activities of Identified Bioactive Compounds from Madhuca indica Flower ExtractAuthor: Mukesh Kumar Dharmalingam JothinathanDOI: 10.21522/TIJPH.2013.13.01.Art085
In silico and In vitro Study Prediction of the Anti-inflammatory Activities of Identified Bioactive Compounds from Madhuca indica Flower Extract
Abstract:
Inflammation is the body’s protective response to harmful stimuli such as pathogens, damaged cells, or toxic compounds. However, chronic inflammation can lead to various diseases, including cancer, arthritis and cardiovascular disorders. Natural products have gained attention for their anti-inflammatory properties. This study aims to predict the anti-inflammatory activities of bioactive compounds found in Madhuca indica flower using both in silico and in vitro methods to explore their therapeutic potential in managing inflammatory conditions effectively. A flower extract of M. indica was prepared and analyzed to identify its bioactive components. Phytochemical screening revealed the presence of flavonoids, tannins and saponins. Fourier Transform Infrared Spectroscopy (FTIR) confirmed the functional groups corresponding to these compounds. The extract exhibited significant antioxidant activity in the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay, supporting its free radical scavenging potential and aligning its anti-inflammatory properties. Gas Chromatography-Mass Spectrometry (GC-MS) analysis identified specific bioactive compounds, which were further assessed through molecular docking studies using AutoDock. The in silico studies demonstrated strong binding affinities of these compounds toward key inflammatory markers, suggesting their therapeutic potential. In vitro studies confirmed the extract’s anti-inflammatory effects by showing significant inhibition of inflammatory mediators. These findings indicate that M. indica flowers possess promising anti-inflammatory properties, attributable to their bioactive compounds providing scientific evidence for their potential in developing natural anti-inflammatory therapeutics. The study highlights the medical significance of M. indica, encouraging further research into its clinical applications for managing inflammatory disorders.
In silico and In vitro Study Prediction of the Anti-inflammatory Activities of Identified Bioactive Compounds from Madhuca indica Flower Extract
References:
[1]. Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X. and Zhao, L., 2018, Inflammatory responses and inflammation-associated diseases in organs. Oncotarget, 9(6),7204. https//doi.org/10.18632/oncotarget.23208
[2]. Kaur, B. and Singh, P., 2022, Inflammation: Biochemistry, cellular targets, anti-inflammatory agents and challenges with special emphasis on cyclooxygenase-2. Bioorganic Chemistry, 121,105663. https//doi.org/10.1016/j.bioorg.2022.105663
[3]. Peng, Y., Ao, M., Dong, B., Jiang, Y., Yu, L., Chen, Z., Hu, C. and Xu, R., 2021, Anti-inflammatory effects of curcumin in the inflammatory diseases: status, limitations and countermeasures. Drug design, development and therapy, 15,4503-4525. https//doi.org/10.2147/DDDT.S327378
[4]. Majeed, U., Shafi, A., Majeed, H., Akram, K., Liu, X., Ye, J. and Luo, Y., 2023, Grape (Vitis vinifera L.) phytochemicals and their biochemical protective mechanisms against leading pathologies. Food Chemistry, 405,134762. https//doi.org/10.1016/j.foodchem.2022.134762
[5]. Gomaa, A. A., Mohamed, H. S., Abd-Ellatief, R. B. and Gomaa, M. A., 2021, Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly. Inflammopharmacology, 29,1033-1048. https//doi.org/10.1007/s10787-021-00841-8
[6]. Szymczak, J., Grygiel-Górniak, B. and Cielecka-Piontek, J., 2024, Zingiber Officinale Roscoe: The Antiarthritic Potential of a Popular Spice—Preclinical and Clinical Evidence. Nutrients, 16(5),741. https//doi.org/10.3390/nu16050741
[7]. Roat, P., Hada, S., Chechani, B., Yadav, D. K., Kumar, S. and Kumari, N., 2023, Madhuca indica: a review on the phytochemical and pharmacological aspects. Pharmaceutical Chemistry Journal, 57(2),284-295. https//doi.org/10.1007/s11094-023-02878-1
[8]. Rodríguez-Yoldi, M. J., 2021, Anti-inflammatory and antioxidant properties of plant extracts. Antioxidants, 10(6),921. https//doi.org/10.3390/antiox10060921
[9]. Gonfa, Y. H., Tessema, F. B., Bachheti, A., Rai, N., Tadesse, M. G., Singab, A. N., Chaubey, K. K. and Bachheti, R. K., 2023, Anti-inflammatory activity of phytochemicals from medicinal plants and their nanoparticles: A review. Current Research in Biotechnology, 6,100152. https//doi.org/10.1016/j.crbiot.2023.100152
[10]. Ramos-González, E. J., Bitzer-Quintero, O. K., Ortiz, G., Hernández-Cruz, J. J. and Ramírez-Jirano, L. J., 2021, Relationship between inflammation and oxidative stress and its effect on multiple sclerosis. Neurología. 39, 292-301. https//doi.org/10.1016/j.nrl.2021.10.003
[11]. Chaudhary, P., Janmeda, P., Docea, A. O., Yeskaliyeva, B., Abdull Razis, A. F., Modu, B., Calina, D. and Sharifi-Rad, J., 2023, Oxidative stress, free radicals and antioxidants: Potential crosstalk in the pathophysiology of human diseases. Frontiers in chemistry, 11,1158198. https//doi.org/10.3389/fchem.2023.1158198
[12]. Singh, V., Singh, J., Kushwaha, R., Singh, M., Kumar, S. and Rai, A. K., 2021, Assessment of antioxidant activity, minerals and chemical constituents of edible mahua (Madhuca longifolia) flower and fruit of using principal component analysis. Nutrition & Food Science, 51(2),387-411. https//doi.org/10.1108/nfs-04-2020-0129
[13]. Akbari, B., Baghaei‐Yazdi, N., Bahmaie, M. and Mahdavi Abhari, F., 2022, The role of plant‐derived natural antioxidants in reduction of oxidative stress. BioFactors, 48(3),611-633. https//doi.org/10.1002/biof.1831
[14]. Sadybekov, A. V. and Katritch, V., 2023, Computational approaches streamlining drug discovery. Nature, 616(7958), pp.673-685. https//doi.org/10.1038/s41586-023-05905-z
[15]. Krishna, K. N., Krishnamoorthy, K., Veeraraghavan, V. P. and Jayaraman, S., 2024, In-vitro Biological Properties and In-Silico Studies on Tinospora cordifolia Stem Aqueous Extract. Journal of Pharmacy and Bioallied Sciences, 16(Suppl 2),S1317-S1320. https//doi.org/10.4103/jpbs.jpbs_598_23
[16]. Praveen, G., Krishnamoorthy, K., Veeraraghavan, V. P. and Jayaraman, S., 2024, Antioxidant and Anti-Inflammatory Activity of the Ethanolic Extract of Euphorbia hirta Leaf Extract: An In Vitro and In Silico Study. Journal of Pharmacy and Bioallied Sciences, 16(Suppl 2),S1304-S1307. https//doi.org/10.4103/jpbs.jpbs_591_23
[17]. Deaton, A. and Cartwright, N., 2018. Understanding and misunderstanding randomized controlled trials. Social Science & Medicine, 210,2-21. https//doi.org/10.1016/j.socscimed.2017.12.005
[18]. Salve, P., Vinchurkar, A., Raut, R., Chondekar, R., Lakkakula, J., Roy, A., Hossain, M. J., Alghamdi, S., Almehmadi, M., Abdulaziz, O. and Allahyani, M., 2022, An evaluation of antimicrobial, anticancer, anti-inflammatory and antioxidant activities of silver nanoparticles synthesized from leaf extract of Madhuca longifolia utilizing quantitative and qualitative methods. Molecules, 27(19),6404. https//doi.org/10.3390/molecules27196404
[19]. Vivek-Ananth, R. P., Mohanraj, K., Sahoo, A. K. and Samal, A., 2023, IMPPAT 2.0: An enhanced and expanded phytochemical atlas of Indian medicinal plants. ACS omega, 8(9),8827-8845. https//doi.org/10.1021/acsomega.3c00156
[21]. Rao, S.V.D.S., Ryntathiang, I., Behera, A., Saravanan, S., Prasad, M. and Jothinathan, M.K.D., 2024, Comparative In Vitro and In Silico Analyses of Phytochemicals from Butea monosperma for Wound-Healing Potential in Human Cells. Cureus, 16(6),e62078. https//doi.org/10.7759/cureus.62078
[22]. Behera, A., Jothinathan, M.K.D., Ryntathiang, I., Saravanan, S. and Murugan, R., 2024, Comparative Antioxidant Efficacy of Green-Synthesised Selenium Nanoparticles from Pongamia pinnata, Citrus sinensis, and Acacia auriculiformis: An In-vitro Analysis. Cureus, 16(4),e58439. https//doi.org/10.7759/cureus.58439
[23]. Varshan, I. and Sankar, S., 2024, Molecular Docking Analysis of Hydroxyclavicol and Eugenol from Betel Leaves Against Outer Membrane Protein (OmpH) of Dialister pneumosintes. Cureus, 16(2),e53809. https//doi.org/10.7759/cureus.53809
[24]. Sankirtha, H., Thirumani, L., Alex, A., Neha, B., Vimal, S. and Madar, I.H., 2024, Systematic Evaluation of Aegle marmelos-Derived Compounds: Potential Therapeutic Agents Against Inflammation and Oxidative Stress. Cureus, 16(4),e57499. https//doi.org/10.7759/cureus.57499
[25]. Ryntathiang, I., Behera, A., Richard, T. and Jothinathan, M.K.D., 2024, An Assessment of the In Vitro Antioxidant Activity of Cobalt Nanoparticles Synthesized from Millettia pinnata, Butea monosperma, and Madhuca indica Extracts: A Comparative Study. Cureus, 16(4),e59112. https//doi.org/10.7759/cureus.59112
[26]. Kumari, N., Prakash, S., Sharma, N., Puri, S., Thakur, M., Singh, J., and Kumar, M., 2024, Medicinal and aromatic plants as potential sources of bioactives along with health-promoting activities. Current Food Science and Technology Reports, 2(4), 359-376. https://doi.org/10.1007/s43555-024-00042-8
[27]. Thiru, S., Kola, R., Thimmaraju, M. K., Dhanalakshmi, C. S., Sharma, V., Sakthi, P., Maguluri, L. P., Ranganathan, L. and Lalvani, J. I. J., 2024, An analytical characterization study on biofuel obtained from pyrolysis of Madhuca longifolia residues. Scientific Reports, 14(1),14745. https//doi.org/10.1038/s41598-024-65393-7
[28]. Dawra, M., Bouajila, J., El Beyrouthy, M., Taillandier, P., Nehme, N. and El Rayess, Y., 2024, Phytochemical Profile, GC-MS Profiling and In Vitro Evaluation of Some Biological Applications of the Extracts of Origanum syriacum L. and Cousinia libanotica DC. Plants, 13(1),137. https://doi.org/10.3390/plants13010137
[29]. Dhayalan, M., Parveen, S., Thirumalaisamy, S., Mohammad, F., Al-Lohedan, H. A., Riyaz, S. U. M., Dinesh, R. A., Giri, J., Stalin, A., Reddy, G. R. and Anandakumar, N., 2024, Evaluating the Therapeutic Importance of Gold Nanoparticles Formed by the Biogenic Synthesis Route of Madhuca longifolia Reduction. BioResources, 19(1),823 https//doi.org/10.15376/biores.19.1.823-841
[30]. Shabbir, M. A., Naveed, M., Rehman, S. U., Ain, N. U., Aziz, T., Alharbi, M., Alsahammari, A. and Alasmari, A. F., 2023, Synthesis of iron oxide nanoparticles from Madhuca indica plant extract and assessment of their cytotoxic, antioxidant, anti-inflammatory, and anti-diabetic properties via different nano informatics approaches. ACS omega, 8(37), 33358-33366. https//doi.org/10.1021/acsomega.3c02744
[31]. Saeed, W., Ismail, T., Qamar, M. and Esatbeyoglu, T., 2024, Bioactivity profiling and phytochemical analysis of Carissa carandas extracts: Antioxidant, anti-inflammatory, and anti-urinary tract infection properties. Antioxidants, 13(9), 1037, https://doi.org/10.3390/antiox13091037
[32]. Mfotie Njoya, E., McGaw, L. J. and Makhafola, T. J., 2024, Investigating the Phytochemical Composition, Antioxidant, and Anti-Inflammatory Potentials of Cassinopsis ilicifolia (Hochst.) Kuntze Extract against Some Oxidative Stress and Inflammation Molecular Markers. Current Issues in Molecular Biology, 46(9), 9639-9658. https://doi.org/10.3390/cimb46090573
[33]. Badukale, N. A., Panchale, W. A., Manwar, J. V., Gudalwar, B. R. and Bakal, R. L., 2021, Phytochemistry, pharmacology and botanical aspects of Madhuca indica: A review. Journal of Pharmacognosy and Phytochemistry, 10(2), 1280-1286. https//doi.org/10.22271/phyto.2021.v10.i2q.13987
[34]. Peter, S. J., Kumar, K. R., Manisha, P., Sangeetha, N., Raj, N. A., Kumari, U. and Sabina, E. P., 2020, Potential activity of Madhuca longifolia leaf extract: through In vitro, Pharmacological and in silico studies. Research Journal of Pharmacy and Technology, 13(3),1083-1091. https//doi.org/10.5958/0974-360X.2020.00199.7
[35]. Das, A. P. and Agarwal, S. M., 2024, Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches. Molecular Diversity, 28(2), 901-925. https://doi.org/10.1007/s11030-022-10590-7
[36]. Sabina, E. P., 2020, Prediction of Absorption, Distribution, Metabolism, And Excretion Activity of The Components of Madhuca longifolia and Its Inhibiting Target Molecule. Asian Journal of Pharmaceutical and Clinical Research, 13(3), 148-154. https//doi.org/10.22159/ajpcr.2020.v13i3.36671
[37]. Oyanna, V. O. and Clarke, J. D., 2024, Mechanisms of intestinal pharmacokinetic natural product-drug interactions. Drug Metabolism Reviews, 56(3), 285-301. https://doi.org/10.1080/03602532.2024.2386597
Viewed PDF 32 2 -
Molecular Docking and ADME Profiling of 5-(Substituted Benzylidene)-2-(Arylamino)-1,3-Thiazol-4(5H)-ones: Insights into Pharmacokinetics and Binding InteractionsAuthor: Periasamy AnbuDOI: 10.21522/TIJPH.2013.13.01.Art086
Molecular Docking and ADME Profiling of 5-(Substituted Benzylidene)-2-(Arylamino)-1,3-Thiazol-4(5H)-ones: Insights into Pharmacokinetics and Binding Interactions
Abstract:
In the quest for effective cancer therapeutics, the optimization of pharmacokinetics, toxicity profiles, and efficacy is crucial. This study introduces a novel series of 5-(substituted benzylidene)-2-(arylamino)-1,3-thiazol-4(5H)-ones, synthesized to explore their potential as anti-cancer agents. These compounds were specifically designed based on the promising anti-tumour activity of 5-arylidene-4-thiazolidinone derivatives, known for their efficacy against MDA-MB-231 (human breast cancer cell line). To assess these new thiazol-4-ones, we used sophisticated in silico methods to perform pharmacokinetic ADME predictions and molecular docking simulations. Our molecular docking studies utilized FlexX to compare the binding affinities of these compounds with known drugs: Gestrinone (targeting EGFR alpha for breast cancer), Vandetanib (targeting VEGFR-2), and KU0058948 (targeting Poly ADP ribose polymerase for ovarian cancer). These comparative analyses revealed significant interactions with these key cancer targets. In addition, ADME predictions were performed using the iLOG predictor from Swiss ADMET software, demonstrating favourable properties for absorption, distribution, and bioavailability. Interestingly, compounds with fluorine substitutions at positions 2 or 4 of the acylamino ring showed encouraging activity and satisfied Lipinski and Veber's rules-based drug-likeness requirements, indicating that they could make good candidates for therapeutics. Furthermore, these compounds showed low toxicity levels, enhancing their suitability for further development.
Molecular Docking and ADME Profiling of 5-(Substituted Benzylidene)-2-(Arylamino)-1,3-Thiazol-4(5H)-ones: Insights into Pharmacokinetics and Binding Interactions
References:
[1]. Alam, M. K., Alqhtani, N. R., Alnufaiy, B., et al., 2024, A systematic review and meta-analysis of the impact of resveratrol on oral cancer: potential therapeutic implications. BMC Oral Health, 24, 412.
[2]. Aboul-Fadl, T., Radwan, A. A., Attia, M. I., Al-Dhfyan, A., Abdel-Aziz, H.A. 2012, Schiff bases of indoline-2,3-dione (isatin) with potential antiproliferative activity. Chem Cent J, 6, 49.
[3]. Pourbasheer, E., Amanlou, M., 2014, 3D-QSAR analysis of anti-cancer agents by CoMFA and CoMSIA. Med Chem Res, 23, 800-809.
[4]. Seboletswe, P., Cele, N., Singh, P., 2023, Thiazolidinone-heterocycle frameworks: A concise review of their pharmacological significance. ChemMedChem, 18, e202200618.
[5]. Lesyk, R., Zimenkovsky, B., Atamanyuk, D., Jensen, F., Kiec-Kononowicz, K., Gzell, A., 2006, Anticancer thiopyrano[2,3-d] [1,3] thiazol-2-ones with norbornane moiety. Synthesis, cytotoxicity, physico-chemical properties, and computational studies. Bioorg Med Chem, 14, 5230-5240.
[6]. Kaminskyy, D., Zimenkovsky, B., Lesyk, R., 2009, Synthesis and in vitro anticancer activity of 2,4-azolidinedione-acetic acids derivatives. Eur J Med Chem, 44, 3627-3636.
[7]. Vicini, P., Geronikaki, A., Anastasia, K., Incerti, M., Zani, F., 2006, Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones. Bioorg Med Chem, 14, 3859-3864.
[8]. Elbarbary, A. A., Khodair, A. L., Pedersen, E. B., Nielsen, C, 1994, Synthesis and evaluation of antiviral activity of 2′-deoxyuridines with 5-methylene-2-thiohydantoin substituents in the 5-position. Monatsh Chem, 125, 593-598.
[9]. Rydzik, E., Szadowska, A., Kaminska, A., 1984, Synthesis of benzylidene derivatives of 3-o, 3-m and 3-p-chlorophenylhydantoin and the study of their anticonvulsant action. Acta Pol Pharm, 41, 459-464.
[10]. Liu, H. L., Li, Z. C., Anthonsen, T. 2000, Synthesis and Fungicidal Activity of 2-Imino-3-(4-arylthiazol-2-yl)-thiazolidin-4-ones and Their 5-Arylidene Derivatives. Molecules, 5, 1055-1061.
[11]. Samir, B., Wesam, K., Ahmed, A. F., 2007, Synthesis and antimicrobial evaluation of some new thiazole, thiazolidinone and thiazoline derivatives starting from 1-chloro-3, 4-dihydronaphthalene-2-carboxaldehyde. Eur J Med Chem, 42, 948-954.
[12]. Zhou, H. Y., Wu, S. H., Zhai, S. M., 2008, Design, Synthesis, cytoselective toxicity, structure–activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistantlLung cancer cells. J Med Chem, 51, 1242-1251.
[13]. Muegge, I., Rarey, M., 2001, Small molecule docking and scoring. Rev Computation Chem, 17, 1.
[14]. Irie, T., Sawa, M., Ito, S., Tanaka, C., Ro, S. G., Park, C. H., 2010. PCT. Int Appl, 2010122979.
[15]. Kumar, H., Aggarwal, N., Marwaha, M. G., et al. 2022. Thiazolidin-2,4-dione scaffold: An insight into recent advances as antimicrobial, antioxidant, and hypoglycemic agents. Molecules, 27, 6763.
[16]. Chawla, P., Singh, R., Saraf, S. K., 2012, Effect of chloro and fluoro groups on the antimicrobial activity of 2,5-disubstituted 4-thiazolidinones: a comparative study. Med Chem Res, 21, 3263-3271.
[17]. Thompson, M. A., 2004, Molecular docking using arguslab, an efficient shape-based search algorithm and the scoring function. ACS meeting, Philadelphia.
[18]. Rarey, M., Kramer, B., Lengauer, T., Klebe, G. A., 1996, A fast flexible docking method using an incremental construction algorithm, J. Mol. Biol. 261 (1996) 470-489.
[19]. Cheng, T. M., Blundell, T. L., Fernandez-Recio, J., 2008, Structural assembly of two-domain proteins by rigid-body docking, BMC Bioinform. 9 (2008) 441.
[20]. Totrov, M., Abagyan, R., 2008, Flexible ligand docking to multiple receptor conformations: a practical alternative. Curr Opin Struct Biol, 18, 178-184.
[21]. Becke, A. D., 1993, Density‐functional thermochemistry. III. The role of exact exchange. J Chem Phys, 98, 5648-5652.
[22]. Daina, A., Michielin, O., Zoete, V., 2014, iLOGP: a simple, robust, and efficient description of n-octanol/water partition coefficient for drug design using the GB/SA approach. J Chem Inf Model, 54, 3284-3301.
[23]. E.M. Krovat, T. Steindl, T. Langer, Recent advances in docking and scoring. Current Computer-Aided Drug Design 10 (2005) 93-102.
[24]. J. Azizian, M.K. Mohammadi, O. Firuzi, N. Razzaghi-asl, R. Miri, Synthesis, biological activity and docking study of some new isatin Schiff base derivatives, Med. Chem. Res. 2 (2012) 3730-3740.
[25]. Potts, R.O., Guy, R. H., 1992, Predicting Skin Permeability. Pharm Res, 9, 663-669.
[26]. Thompson, P. E., Manallack, D. T., Blaney, F. E., Gallagher, T., 1992, Conformational studies on (+)-anatoxin-a and derivative. J Comput Aided Mol Des, 6, 287-298.
[27]. Madsen, U., Larsen, K., Liljefors, P., 2016, Tommy, Textbook of drug design and discovery. Washington DC: Taylor & Fracis, 8, 45.
[28]. Jones, G., Willett, P., 1995, Docking small-molecule ligands into active sites. Curr Opin Biotechnol, 6, 652-656.
[29]. Saini, R. S., Binduhayyim, R. I. H., Gurumurthy, V., et al., 2024, In silico assessment of biocompatibility and toxicity: molecular docking and dynamics simulation of PMMA-based dental materials for interim prosthetic restorations, J. Mater. Sci: Mater. Med. 35 (2024) 35, 28.
[30]. Penning, T. D., Zhu, G. D., Gong, J., et al., 2010, Optimization of phenyl-substituted benzimidazole carboxamide poly (ADP-ribose) polymerase inhibitors: identification of (S)-2-(2-fluoro-4-(pyrrolidin-2-yl)phenyl)-1H-benzimidazole-4-carboxamide (A-966492), a highly potent and efficacious inhibitor. J Med Chem, 53, 3142-3153.
Viewed PDF 18 0 -
Attenuation of Oxidative Stress and Anti-Alzheimer Effect of Ursolic AcidAuthor: Parameswari Royapuram ParthasarathyDOI: 10.21522/TIJPH.2013.13.01.Art087
Attenuation of Oxidative Stress and Anti-Alzheimer Effect of Ursolic Acid
Abstract:
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and neurodegeneration, with oxidative stress playing a pivotal role in its pathophysiology. Ursolic acid (UA), a triterpenoid found in various medicinal plants, exhibits antioxidant and neuroprotective properties that may counteract oxidative damage associated with AD. This study aimed to evaluate the antioxidant, neuroprotective, and anti-Alzheimer effects of Ursolic acid using in vitro assays. The antioxidant potential was assessed via the DPPH free radical scavenging assay. The neuroprotective effects were evaluated through acetylcholinesterase inhibition assays, while UA's anti-Alzheimer potential was examined using amyloid-beta aggregation and beta-secretase inhibition assays. Ursolic acid demonstrated significant (p<0.001) antioxidant activity, effectively scavenging DPPH radicals in a concentration-dependent manner. In the acetylcholinesterase inhibition assay, UA exhibited a notable (p<0.05) reduction in enzyme activity from 10 mM to the maximum concentration of 80mM, suggesting its potential to enhance cholinergic neurotransmission. Furthermore, UA significantly inhibited amyloid-beta aggregation and reduced beta-secretase activity between concentrations of 10 mM – 80 mM, indicating its promising role in mitigating key pathological features of Alzheimer’s disease. The findings suggest that Ursolic acid possesses potent antioxidant and neuroprotective effects, along with the ability to inhibit amyloid-beta aggregation and beta-secretase activity. These results highlight the therapeutic potential of Ursolic acid as a candidate for the prevention and treatment of Alzheimer’s disease, warranting further investigation in vivo models to validate its efficacy and mechanisms of action.
Attenuation of Oxidative Stress and Anti-Alzheimer Effect of Ursolic Acid
References:
[1]. Breijyeh, Z., & Karaman, R., 2020, Comprehensive review on Alzheimer’s disease: Causes and treatment. Molecules, 25(24), 5789. doi: 10.3390/molecules25245789.
[2]. Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T., 2011, Neuropathological alterations in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine, 1(1), a006189. doi: 10.1101/cshperspect.a006189.
[3]. Spires-Jones, T. L., & Hyman, B. T., 2014, The intersection of amyloid beta and tau at synapses in Alzheimer’s disease. Neuron, 82(4), 756-771. doi: 10.1016/j.neuron.2014.05.004.
[4]. Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y., 2020, Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease. Molecular neurodegeneration, 15, 1-37. doi: 10.1186/s13024-020-00391-7.
[5]. Parameswari, R.P., Ramesh, G., Chidambaram, S. B., & Thangavelu, L., 2022, Oxidative stress mediated neuroinflammation induced by chronic sleep restriction as triggers for Alzheimer’s disease. Alzheimer's & Dementia, 18, e059016. DOI:10.1002/alz.059016
[6]. Singh, B., Day, C. M., Abdella, S., & Garg, S., 2024, Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management. Journal of Controlled Release, 367, 402-424. doi: 10.1016/j.jconrel.2024.01.047.
[7]. Cetin, S., Knez, D., Gobec, S., Kos, J., & Pišlar, A., 2022, Cell models for Alzheimer’s and Parkinson’s disease: At the interface of biology and drug discovery. Biomedicine & Pharmacotherapy, 149, 112924. doi: 10.1016/j.biopha.2022.112924.
[8]. Jager, S., Trojan, H., Kopp, T., Laszczyk, M. N., & Scheffler, A., 2009, Pentacyclic triterpene distribution in various plants–rich sources for a new group of multi-potent plant extracts. Molecules, 14(6), 2016-2031. https://doi.org/10.3390/molecules14062016
[9]. Kadasah, S. F., & Radwan, M. O., 2023, Overview of ursolic acid potential for the treatment of metabolic disorders, autoimmune diseases, and cancers via nuclear receptor pathways. Biomedicines, 11(10), 2845. doi: 10.3390/biomedicines11102845.
[10]. Liu, J., 1995, Pharmacology of oleanolic acid and ursolic acid. Journal of Ethnopharmacology, 49(2), 57-68. doi: 10.1016/0378-8741(95)90032-2.
[11]. Seo, D. Y., Lee, S. R., Heo, J. W., No, M. H., Rhee, B. D., Ko, K. S., Kwak, H.B., Han, J., 2018, Ursolic acid in health and disease. The Korean Journal of Physiology & Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology, 22(3), 235. doi: 10.4196/kjpp.2018.22.3.235.
[12]. Liang, W., Zhao, X., Feng, J., Song, F., & Pan, Y., 2016, Ursolic acid attenuates beta-amyloid-induced memory impairment in mice. Arquivos de neuro-psiquiatria, 74(6), 482-488. doi: 10.1590/0004-282X20160065.
[13]. Koleva, I. I., Van Beek, T. A., Linssen, J. P., Groot, A. D., & Evstatieva, L. N., 2002, Screening of plant extracts for antioxidant activity: a comparative study on three testing methods. Phytochemical Analysis: An International Journal of Plant Chemical and Biochemical Techniques, 13(1), 8-17. doi: 10.1002/pca.611.
[14]. Ellman, G. L., Courtney, K. D., Andres Jr, V., & Featherstone, R. M., 1961, A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 7(2), 88-95. doi: 10.1016/0006-2952(61)90145-9.
[15]. Katayama, S., Sugiyama, H., Kushimoto, S., Uchiyama, Y., Hirano, M., & Nakamura, S., 2016, Effects of sesaminol feeding on brain Aβ accumulation in a senescence-accelerated mouse-prone 8. Journal of Agricultural and Food Chemistry, 64(24), 4908-4913. doi: 10.1021/acs.jafc.6b01237.
[16]. Miyazaki, H., Okamoto, Y., Motoi, A., Watanabe, T., Katayama, S., Kawahara, S. I., Makabe, H., Fujii, H., Yonekura, S., 2019, Adzuki bean (Vigna angularis) extract reduces amyloid-β aggregation and delays cognitive impairment in Drosophila models of Alzheimer's disease. Nutr. Res. Pract, 13, 64-69. doi: 10.4162/nrp.2019.13.1.64.
[17]. Panyatip, P., Tadtong, S., Sousa, E., & Puthongking, P., 2020, BACE1 inhibitor, neuroprotective, and neuritogenic activities of melatonin derivatives. Scientia Pharmaceutica, 88(4), 58. doi.org/10.3390/scipharm88040058
[18]. Zhao, M., Wu, F., Tang, Z., Yang, X., Liu, Y., Wang, F., & Chen, B., 2023, Anti-inflammatory and antioxidant activity of ursolic acid: A systematic review and meta-analysis. Frontiers in Pharmacology, 14, 1256946. doi.org/10.3389/fphar.2023.1256946
[19]. Pritam, P., Deka, R., Bhardwaj, A., Srivastava, R., Kumar, D., Jha, A. K., Jha, N. K., Villa, C., Jha, S. K., 2022, Antioxidants in Alzheimer’s disease: Current therapeutic significance and future prospects. Biology, 11(2), 212. doi: 10.3390/biology11020212
[20]. Mirza, F. J., & Zahid, S., 2022, Ursolic acid and rosmarinic acid ameliorate alterations in hippocampal neurogenesis and social memory induced by amyloid beta in mouse model of Alzheimer’s disease. Frontiers in Pharmacology, 13, 1058358. doi.org/10.3389/fphar.2022.1058358.
[21]. Peitzika, S. C., & Pontiki, E., 2023, A review on recent approaches on molecular docking studies of novel compounds targeting acetylcholinesterase in Alzheimer disease. Molecules, 28(3), 1084. doi: 10.3390/molecules28031084.
[22]. García-Ayllón, M. S., Small, D. H., Avila, J., & Sáez-Valero, J., 2011, Revisiting the role of acetylcholinesterase in Alzheimer’s disease: cross-talk with P-tau and β-amyloid. Frontiers in molecular neuroscience, 4, 22. doi.org/10.3389/fnmol.2011.00022.
[23]. Mlala, S., Oyedeji, A. O., Gondwe, M., & Oyedeji, O. O., 2019, Ursolic acid and its derivatives as bioactive agents. Molecules, 24(15), 2751. doi: 10.3390/molecules24152751.
[24]. Piccialli, I., Tedeschi, V., Caputo, L., D’Errico, S., Ciccone, R., De Feo, V., Secondo, A., Pannaccione, A., 2022, Exploring the therapeutic potential of phytochemicals in Alzheimer’s disease: Focus on polyphenols and monoterpenes. Frontiers in Pharmacology, 13, 876614.
[25]. Mugundhan, V., Arthanari, A., & Parthasarathy, P. R., 2024, Protective Effect of Ferulic Acid on Acetylcholinesterase and Amyloid Beta Peptide Plaque Formation in Alzheimer’s Disease: An In Vitro Study. Cureus, 16(2). doi: 10.7759/cureus.54103.
[26]. Das, B., & Yan, R., 2019, A close look at BACE1 inhibitors for Alzheimer’s disease treatment. CNS Drugs, 33(3), 251-263. doi: 10.1007/s40263-019-00613-7.
Viewed PDF 21 0 -
Extraction and Partial Characterization of Deacetylated Chitin from Cuttlefish Sepia kobiensis and their Free Radical Inhibition EfficacyAuthor: Pasiyappazham RamasamyDOI: 10.21522/TIJPH.2013.13.01.Art088
Extraction and Partial Characterization of Deacetylated Chitin from Cuttlefish Sepia kobiensis and their Free Radical Inhibition Efficacy
Abstract:
This research aimed to extract and describe a functional polymeric compound from Sepia kobiensis cuttlebone and investigate its potential to impede the oxidation process. Cuttlebone waste is readily available and regularly discarded, making it an ideal resource for extracting useful bioactive compounds. The isolation technique created a pure polymeric substance by solvent extraction, precipitation, and purification. Several analytical methods, such as Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and field emission scanning electron microscopy (FESEM), were utilized to describe the isolated polymeric material. The study found that the separated material has a specific polymeric structure with functional groups linked to antioxidant action. Furthermore, the study evaluated the bioactivity of the isolated substance by measuring its ability to suppress oxidation processes in a model system. The material demonstrated high antioxidant activity by preventing reactive oxygen species (ROS) formation and scavenging free radicals. This action was attributed to the presence of antioxidant moieties within the structure as well as its polymeric nature. Finally, a bioactive polymeric substance with significant antioxidant properties was successfully isolated and characterized from the cuttlebone of Sepia kobiensis. The findings demonstrate how cuttlebone debris may be a valuable source of bioactive compounds and aid in the development of naturally occurring antioxidants for application in the culinary, cosmetic, and pharmaceutical industries. Further research is required to properly investigate its bioactivities and understand the underlying mechanisms of action.
Extraction and Partial Characterization of Deacetylated Chitin from Cuttlefish Sepia kobiensis and their Free Radical Inhibition Efficacy
References:
[1]. Ramasamy, P., Subhapradha, N., Shanmugam, V., & Shanmugam, A., 2014, Extraction, characterization and antioxidant property of chitosan from cuttlebone Sepia kobiensis (Hoyle 1885). International Journal of Biological Macromolecules, 64, 202-212.
[2]. Seedevi, P., Moovendhan, M., Vairamani, S., & Shanmugam, A., 2017, Evaluation of antioxidant activities and chemical analysis of sulfated chitosan from Sepia prashadi. International Journal of Biological Macromolecules, 99, 519-529.
[3]. Vairamani, S., Subhapradha, N., Ramasamy, P., Raveendran, S., Srinivasan, A., & Shanmugam, A., 2013, Physicochemical characteristics and antioxidant efficacy of chitosan from the internal shell of spineless cuttlefish Sepiella inermis. Preparative Biochemistry and Biotechnology, 43(7), 696-716.
[4]. Muxika, A., Etxabide, A., Uranga, J., Guerrero, P., & De La Caba, K., 2017, Chitosan as a bioactive polymer: Processing, properties and applications. International Journal of Biological Macromolecules, 105, 1358-1368.
[5]. Sivaperumal, P., Kamala, K., Ganapathy, D. M., Dharani, G., Sundarrajan, S., Ramakrishna, S., 2023, Fabrication of AgNPs mediated fibrous membrane from Rhizophora mucronata mangrove plant extract for biological properties. Journal of Drug Delivery Science and Technology, 86, 104710.
[6]. Qin, Y., Li, P., 2020, Antimicrobial chitosan conjugates: Current synthetic strategies and potential applications. International Journal of Molecular Sciences, 21(2), 499.
[7]. Goy, R. C., Britto, D. D., & Assis, O. B., 2009, A review of the antimicrobial activity of chitosan. Polímeros, 19, 241-247.
[8]. Pauline, C. R., Akshita, Pavithra, T., Kannan, K., Sivaperumal, P., 2024, Characterization and Biological Activity of Silver Nanoparticles from (Rhizophora mucronata) Mangrove Extract. Nano LIFE, 2450018.
[9]. Karagozlu, M. Z., Kim, S. K., 2014, Anticancer effects of chitin and chitosan derivatives. Advances in Food and Nutrition Research, 72, 215-225.
[10]. Wei, L., Tan, W., Wang, G., et al., 2019, The antioxidant and antifungal activity of chitosan derivatives bearing Schiff bases and quaternary ammonium salts. Carbohydrate Polymers, 226, 115256.
[11]. Bagheri-Khoulenjani, S., Taghizadeh, S. M., Mirzadeh, H., 2009, An investigation on the short-term biodegradability of chitosan with various molecular weights and degrees of deacetylation. Carbohydrate Polymers, 78(4), 773-778.
[12]. Peers, S., Montembault, A., Ladavière, C., 2020, Chitosan hydrogels for sustained drug delivery. Journal of Controlled Release, 326, 150-163.
[13]. Das, L., Das, P., Bhowal, A., Bhattachariee, C., 2020, Synthesis of hybrid hydrogel nano-polymer composite using Graphene oxide, Chitosan and PVA and its application in waste water treatment. Environmental Technology & Innovation, 18, 100664.
[14]. Islam, M. M., Shahruzzaman, M., Biswas., et al., 2020, Chitosan based bioactive materials in tissue engineering applications-A review. Bioactive Materials, 5(1), 164-183.
[15]. Kamala, K., Sivaperumal, P., 2023, Predominance of multi-drug resistant extended spectrum β lactamase producing bacteria from marine fishes. Environmental Pollution, 323, 121314.
[16]. Younes, I., Rinaudo, M., 2015, Chitin and chitosan preparation from marine sources. Structure, properties and applications. Marine Drugs, 13(3), 1133-1174.
[17]. Varma, R., Pratihar, A., Pasumpon, N., Vasudevan, S., 2022, Extraction and Characterization of Chitosan from the Cuttlebone of Spineless Cuttlefish, Sepiella inermis.
[18]. Shimada, K., Fujikawa, K., Yahara, K., Nakamura, T., 1992, Antioxidative properties of xanthan on the autoxidation of soybean oil in cyclodextrin emulsion. Journal of Agricultural and Food Chemistry, 40(6), 945-948.
[19]. Xing, R., Yu, H., Liu, S., et al., 2005, Antioxidant activity of differently regioselective chitosan sulfates in vitro. Bioorganic & Medicinal Chemistry, 13(4), 1387-1392.
[20]. Dinis, T. C., Madeira, V. M., Almeida, L. M., 1994, Action of phenolic derivatives (acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers. Archives of Biochemistry and Biophysics, 315(1), 161-169.
[21]. Tolaimate, A., Desbrieres, J., Rhazi, M., Alagui, A., 2003, Contribution to the preparation of chitins and chitosans with controlled physico-chemical properties. Polymer, 44(26), 7939-7952.
[22]. Jothi, N., Nachiyar, R. K., 2013, Identification and isolation of chitin and chitosan from cuttle bone of Sepia prashadi Winckworth, 1936. Global Journal of Biotechnology & Biochemistry, 8(2), 33-39.
[23]. Karthik, R., Manigandan, V., Saravanan, R., et al., 2016, Structural characterization and in vitro biomedical activities of sulfated chitosan from Sepia pharaonis. International Journal of Biological Macromolecules, 84, 319-328.
[24]. Varma, R., Vasudevan, S., 2020, Extraction, characterization, and antimicrobial activity of chitosan from horse mussel modiolus modiolus. ACS Omega, 5(32), 20224-20230.
[25]. Varun, T. K., Senani, S., Jayapal, N., et al., 2017, Extraction of Chitosan and its oligomers from shrimp shell waste, their characterization and antimicrobial effect. Veterinary World, 10(2), 170.
[26]. Subhapradha, N. S., Ramasamy, P. R., Shanmugam, V. S., et al., 2013, Physicochemical characterisation of β-chitosan from Sepioteuthis lessoniana gladius. Food Chemistry, 2013, Vol. 141, No. 2, 907-913.
[27]. Jeffery, R. S., Morris, R. W., Denham, R. A., 1991, Coronal alignment after total knee replacement. The Journal of Bone & Joint Surgery Britsh Volume, 73(5), 709-714.
[28]. Rasti, H., Parivar, K., Baharara, J., et al., 2017, Chitin from the mollusc chiton: Extraction, characterization and chitosan preparation. Iranian Journal of Pharmaceutical Research: IJPR, 16(1), 366.
[29]. Sudatta, B. P., Sugumar, V., Varma, R., Nigariga, P., 2020, Extraction, characterization and antimicrobial activity of chitosan from pen shell, Pinna bicolor. International Journal of Biological Macromolecules, 163, 423-430.
[30]. Vino, A. B., Ramasamy, P., Shanmugam, V., Shanmugam, A., 2012, Extraction, characterization and in vitro antioxidative potential of chitosan and sulfated chitosan from Cuttlebone of Sepia aculeata Orbigny, 1848. Asian Pacific Journal of Tropical Biomedicine, 2(1), S334-S341.
[31]. Al Sagheer, F. A., Al-Sughayer, M. A., Muslim, S., Elsabee, M. Z., 2009, Extraction and characterization of chitin and chitosan from marine sources in Arabian Gulf. Carbohydrate Polymers, 77(2), 410-419.
[32]. Yen, M. T., Tseng, Y. H., Li, R. C., Mau, J. L., 2007, Antioxidant properties of fungal chitosan from shiitake stipes. LWT-Food Science and Technology, 40(2), 255-261.
Viewed PDF 20 1 -
Enhancing Safety Induction Programs in Malaysia’s Oil and Gas Sector: A Comprehensive Review of Best Practices and Strategic RecommendationsAuthor: Rona B. TanDOI: 10.21522/TIJPH.2013.13.01.Art089
Enhancing Safety Induction Programs in Malaysia’s Oil and Gas Sector: A Comprehensive Review of Best Practices and Strategic Recommendations
Abstract:
The study highlights the crucial role of leveraging advanced technologies, such as multimedia presentations and interactive simulations, in enhancing engagement and retention within safety training programs. This research involved a comprehensive analysis of participants from various job roles in the oil and gas sector, ensuring a diverse and representative perspective on the impact of these programs. The findings emphasize the necessity of optimizing technological integration, catering to diverse learning styles, and implementing mentorship systems to facilitate new employees' seamless integration into the safety culture. Additionally, the study underscores the effectiveness of regular safety challenges and quizzes in reinforcing critical safety concepts and promoting continuous learning. The analysis reveals significant positive correlations between several key factors: program design and employee engagement (r = 0.582, p < 0.001), organizational support and overall satisfaction (r = 0.645, p < 0.001), and participant characteristics and information retention (r = 0.489, p < 0.001). These results demonstrate the importance of well-structured, engaging, and interactive safety induction programs, supported by a strong commitment from the organization. The study provides actionable recommendations for enhancing the effectiveness of these programs, aiming to improve safety performance, increase employee satisfaction, and reduce the incidence of workplace accidents and injuries. Ultimately, this research offers valuable insights into best practices for the development and enhancement of safety induction programs, which are essential for fostering a robust safety culture within organizations. Continuous improvement of these programs is vital for protecting employees, enhancing operational efficiency, and contributing to the organization's overall success.
Enhancing Safety Induction Programs in Malaysia’s Oil and Gas Sector: A Comprehensive Review of Best Practices and Strategic Recommendations
References:
[1]. Abeni, E. A. 2020, Andragogy: A Theory in Practice in Higher Education. Journal of Research in Higher Education, 4(2), 54–69, https://doi.org/10.24193/jrhe.2020.2.4
[2]. Arbin, K., Frostenson, M., Helin, S., & Borglund, T., 2021, Explaining workers’ resistance against a health and safety programme: An understanding based on hierarchical and social accountability. Safety Science, 136, 105131, https://doi.org/10.1016/j.ssci.2020.105131
[3]. Brkić, D., & Praks, P., 2021, Offshore oil and gas safety: Protection against explosions. Journal of Marine Science and Engineering, 9(3), 331. https://doi.org/10.3390/jmse9030331
[4]. Choudhry, R. M., & Fang, D., 2008, Why operatives engage in unsafe work behavior: Investigating factors on construction sites. Safety Science, 46(4), 566-584. https://doi.org/10.1016/j.ssci.2007.06.027
[5]. Department of Statistics Malaysia, 2022, Big data analytics: National occupational accident and disease statistics 2021. Retrieved from https://www.dosm.gov.my/portal-main/release-content/big-data-analytics-national-occupational-accident-and-disease-statistics-2021-
[6]. Hutchinson, F. E., & Bhattacharya, J., 2022, Malaysia’s oil and gas sector: Challenges and opportunities. ISEAS Perspective, 2022(21). Retrieved from https://www.iseas.edu.sg/wp-content/uploads/2022/01/ISEAS_Perspective_2022_21.pdf
[7]. Mayhew, C., Quintan, M., & Ferris, R., 1997, The effects of subcontracting/outsourcing on occupational health and safety: Survey evidence from four Australian industries. Safety Science, 25(1-3), 163-178. https://doi.org/10.1016/S0925-7535(97)00014-3
[8]. McGrath, V., 2009, Reviewing the Evidence on How Adult Students Learn: An Examination of Knowles’ Model of Andragogy. Adult Learner: The Irish Journal of Adult and Community Education, 99–110. https://doi.org/10.1080/07377363.2011.614887
[9]. Mullins, F., Blair, A., & Dunlap, K., 2019, Employee engagement in safety procedures: The role of safety training. Journal of Safety Research, 70, 79-86. https://doi.org/10.1016/j.jsr.2019.04.005
[10]. Obong, M. M., Amadi, C., Ekpenyong, O. E., Harry, E. W., & Edodi, H. U., 2021, Influence of health and safety training, safety monitoring and enforcement of compliance on employee efficiency in manufacturing firms. Research in World Economy, 12(2), 86-95. https://doi.org/10.5430/rwe.v12n2p86
[11]. Pinto, L., Nunes, E., & Sousa, S., 2020, A framework to improve training and development of workers’ technical skills: Effects on operational performance during company relocation. Procedia Manufacturing, 51, 1806-1813. https://doi.org/10.1016/j.promfg.2020.10.251
[12]. Pui Teck, A. G., & Mohd Asmoni, M. N. A., 2015, A review on the effectiveness of safety training methods for Malaysia construction industry. Jurnal Teknologi, 74(2), 9-13. https://doi.org/10.11113/jt.v74.4518
[13]. Rutaihwa, A. E. B., 2013, Employee orientation programs in Tanzania public institutions and their effects on employee performance: The case of Ministry of Labour and Employment. A Dissertation for Award of MScHRM degree at Mzumbe University, Morogoro.
[14]. Snell, A., 2006, Researching onboarding best practice. Journal on Strategic HR Review, 5, 32-35. https://doi.org/10.1108/14754390680000925
[15]. Turner, S. n.d, Safety First Going Beyond Compliance. 31–33.
[16]. Tupavali, T. N., 2017, An analysis of the influence of induction programmes on beginner teachers’ professional development in the Erongo Region of Namibia. A Journal of Public Administration, 2, 120-156.
[17]. Vecchio-Sadus, A. M., & Griffiths, S., 2004, Marketing strategies for enhancing safety culture. Safety Science, 42(7), 601-619. https://doi.org/10.1016/j.ssci.2003.11.001
[18]. Wicaksono, A., Ciptomulyono, U., Artana, K. B., & Irawan, Y. S., 2022, The impact of safety management on oil and gas industry accidents. Safety Science, 135, 105145. https://doi.org/10.1016/j.ssci.2020.105145
[19]. Whitaker, S. M., Graves, R. J., James, M., & McCann, P., 2003, Safety with access scaffolds: Development of a prototype decision aid based on accident analysis. Journal of Safety Research, 34(3), 249-261. https://doi.org/10.1016/S0022-4375(03)00025-2
[20]. Zolyomi, E., & Danaj, S., 2019, Language barriers and occupational safety and health of migrant workers. International Journal of Occupational Safety and Health, 11(3), 31-39. https://doi.org/10.3126/ijosh.v11i3.25397
Viewed PDF 23 0 -
Cathepsin D as a Biomarker in Colon Cancer PatientsAuthor: Rafad R. S. MohammedDOI: 10.21522/TIJPH.2013.13.01.Art090
Cathepsin D as a Biomarker in Colon Cancer Patients
Abstract:
Colon cancer is a relatively common life-threatening malignancy for both sexes. Cancer cells are depicted by the upregulation of lysosomal proteases – cathepsin D. The study aimed to determine human cathepsin D activity in the control group as well as its role in metastasis and invasion of colon cancer. Enzymatic assay(manual) was used to measure the activity of cathepsin D and catalase, other parameters were measured using analytical kits provided by reputable companies. Carcinoembryonic antigen CEA has been determined as a biomarker for colon cancer, patients were subdivided into two classes based on carcinoembryonic antigen values: group 1, ≤5 ng/mL group 2 >5 ng/mL. The results explained that the normal value of Cathepsin D for the control group was (8.61±0.294 ngml) and the activity of the enzyme was not affected by gender, age, smoking and BMI. The results also proved a highly significant increase in cathepsin D activity in the patient's group (17.81±0. 652 ng/ml) compared to the control. A remarkable elevation in the action of cathepsin D in colon cancer patients was associated with a positive relationship with carcinoembryonic antigen levels. This supports the application of cathepsin D as a marker of tumor occurrence as well as evidence of tumor metastasis and invasion after treatment in colon cancer patients.
Cathepsin D as a Biomarker in Colon Cancer Patients
References:
[2]. Patel, S., Homaei, A., El-Seedi, H. R., Akhtar, N., 2018, Cathepsins: Proteases that are vital for survival but can also be fatal. Biomedicine & Pharmacotherapy, 105, 526-532.
[3]. Rawlings, N. D., Barrett, A. J., Finn, R., 2016, Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors. Nucleic acids research, 44(D1), D343-D350.
[4]. Metcalf, P., Fusek, M., 1993, Two crystal structures for cathepsin D: the lysosomal targeting signal and active site. The EMBO Journal, 12(4), 1293-1302.
[5]. Chen, S., Dong, H., Yang, S., Guo, H., 2017, Cathepsins in digestive cancers. Oncotarget, 8(25), 41690.
[6]. Benes, P., Vetvicka, V., Fusek, M., 2008, Cathepsin D—many functions of one aspartic protease. Critical reviews in oncology/hematology, 68(1), 12-28.
[7]. Pranjol, M. Z. I., Gutowski, N. J., Hannemann, M., Whatmore, J. L., 2018, Cathepsin D non-proteolytically induces proliferation and migration in human omental microvascular endothelial cells via activation of the ERK1/2 and PI3K/AKT pathways. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1865(1), 25-33.
[8]. Buck, M. R., Karustis, D. G., Day, N. A., Honn, K. V., Sloane, B. F., 1992, Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochemical Journal, 282(1), 273-278.
[9]. Yoshinari, M., Taurog, A., 1985, Lysosomal digestion of thyroglobulin: role of cathepsin D and thiol proteases. Endocrinology, 117(4), 1621-1631.
[10]. Seo, S. U., Woo, S. M., Im, S. S., Jang, Y., Han, E., Kim, S. H., Kwon, T. K., 2022, Cathepsin D as a potential therapeutic target to enhance anticancer drug-induced apoptosis via RNF183-mediated destabilization of Bcl-xL in cancer cells. Cell Death & Disease, 13(2), 115.
[11]. Office for National Statistics: Mortality Statistics-Deaths registered in England and Wales Published online. 2014. [Available at: http://www.ons.gov.uk/ons/publications/allreleases.html?definition=tcm%3A77-27475
[12]. WHO. Leading cause of death in Europe: fact sheet Copenhagen: WHO Regional Office for Europe; 2012 [Available at: https://data.euro.who.int/hfadb]
[13]. Mohammadpour, A. H., Salehinejad, Z., Elyasi, S., Mouhebati, M., Mirhafez, S. R., Samadi, S., Sahebkar, A., 2018, Evaluation of serum cathepsin D concentrations in coronary artery disease. Indian Heart Journal, 70(4), 471-475.
[14]. Botteri, E., Iodice, S., Bagnardi, V., Raimondi, S., Lowenfels, A. B., Maisonneuve, P., 2008, Smoking and colorectal cancer: a meta-analysis. Jama, 300(23), 2765-2778.
[15]. Liang, P. S., Chen, T. Y., Giovannucci, E., 2009, Cigarette smoking and colorectal cancer incidence and mortality: Systematic review and meta‐analysis. International Journal of cancer, 124(10), 2406-2415.
[16]. Meester, R. G., Mannalithara, A., Lansdorp-Vogelaar, I., Ladabaum, U., 2019, Trends in incidence and stage at diagnosis of colorectal cancer in adults aged 40 through 49 years, 1975-2015. Jama, 321(19), 1933-1934.
[17]. Burkitt, D. P., 1971, Epidemiology of cancer of the colon and rectum. Cancer, 28(1), 3-13.
[18]. Giovannucci, E., 2002, Modifiable risk factors for colon cancer. Gastroenterology Clinics, 31(4), 925-943.
[19]. Hastuti, S., 2024, Breast Cancer Screening Access Among Low-Income Women Under Social Health Insurance: A Scoping Review. Public Health of Indonesia, 10(1), 21-32.
[20]. Thoke, G. M., PP, A. S. U., Ganapathy, D., Sekar, D., 2024, Analysis of TGF-β Gene Expression in Carboplatin Treated Lung Cancer Cells. exila International Journal of Public Health, 12(3).
[21]. Kumar, R. S., Amudha, P., Vidya, R., Kalpana, C. S., Sudhashini, S., 2024, A Review on Anticancer Properties of Chebulagic Acid from Terminalia chebula. Texila International Journal of Public Health, 12(3).
[22]. Eshrati Yeganeh, F., Tabarzad, M., Khazraei, H., Bourbour, M., 2023, Synthesis and evaluation of Escitalopram-loaded niosomes on colon cancer cell lines. Physiology and Pharmacology, 27(3), 307-318.
[23]. Hariani, H., Wiralis, W., Faturrahman, T. F. T., Suwarni, S., 2025, Medium Time Heating of Syrop from Red Betel Leaf (Piper crocatum ruiz pav) Can Reduce Carcinoembryonic Antigen (CEA) Level Among Adult Women in Southeast Sulawesi, Indonesia. Public Health of Indonesia, 11(S1), 80-88.
[24]. Oliveira, C. S. F., Pereira, H., Alves, S., Castro, L., Baltazar, F., Chaves, S. R., Côrte-Real, M., 2015, Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria. Cell Death & Disease, 6(6), e1788-e1788.
[25]. Mijanovic, O., Petushkova, A. I., Brankovic, A., Turk, B., Solovieva, A B., Nikitkina, A. I., Zamyatnin Jr, A. A., 2021, Cathepsin D—managing the delicate balance. Pharmaceutics, 13(6), 837.
[26]. Skrzydlewska, E., Sulkowska, M., Wincewicz, A., Koda, M., Sulkowski, S., 2005, Evaluation of serum cathepsin B and D in relation to clinicopathological staging of colorectal cancer. World Journal of Gastroenterology: WJG, 11(27), 4225.
[27]. Piecuch, A., Kurek, J., Kucharzewski, M., Wyrobiec, G., Jasiński, D., Brzozowa-Zasada, M., 2020, Catalase immunoexpression in colorectal lesions. Gastroenterology Review/Przegląd Gastroenterologiczny, 15(4), 330-337.
[28]. Hong, S. W., Lee, H. J., Han, K., Moon, J. M., Park, S., Soh, H., Kim, J. S., 2021, Risk of gastrointestinal cancer in patients with an elevated level of gamma-glutamyltransferase: A nationwide population-based study, PloS One, 16(2), e0245052.
[29]. Abdul‐Wahid, A., Cydzik, M., Fischer, N. W., Prodeus, A., Shively, J. E., Martel, A., Gariépy, J., 2018, S erum‐derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re‐modeling of the extracellular matrix that favors the engraftment of CEA‐expressing tumor cells. International Journal of Cancer, 143(8), 1963-1977.
[30]. Digala1, P., Muthu, S., Subramani, N., Duraisamy, N., Sundararaj, D., 2024, Understand the Fatty Acid Metabolic Reprogramming of Immune Cells in Colorectal Cancer. Texila International Journal of Public Health, 12(3): 1-8.
Viewed PDF 32 1 -
Health Disaster Capacity and Preparedness in the Case of Tsunami and Earthquake DisasterAuthor: Setya HaksamaDOI: 10.21522/TIJPH.2013.13.01.Art091
Health Disaster Capacity and Preparedness in the Case of Tsunami and Earthquake Disaster
Abstract:
The health system has a very important role in reducing hazards, exposure and vulnerability, especially in disaster conditions. In this case, the health system can be viewed from various sides, two of which are capacity and preparedness in health disasters. Therefore, research is needed that aims to describe the capacity and preparedness based on the case of the earthquake and tsunami disaster in Palu. This descriptive study was conducted based on the case of the earthquake and tsunami disaster in Palu, Central Sulawesi, Indonesia. Disaster management capacity and preparedness in facing disasters were measured by filling out an online questionnaire. Furthermore, descriptive data analysis was carried out. For disaster management capacity, the results of the assessment of each indicator were: provision of health services = low, human resources = low, financing = low, materials and governance = high, institutional structure and health information systems = low; 6) medicines and health supplies = high and community and environmental conditions = high. For disaster preparedness, the results of the assessment of each indicator were: fulfilment of basic health needs = high and reduction in disease severity through health services = low. In general, it is concluded that based on the case of the earthquake and tsunami disaster in Palu, the capacity and preparedness of disasters in the health sector are still relatively low.
Health Disaster Capacity and Preparedness in the Case of Tsunami and Earthquake Disaster
References:
[1]. Bappeda Prov. Sulteng, 2019, Health profile of Central Sulawesi Province in 2020 (Palu, Indonesia: Bappeda Prov. Sulteng).
[2]. Wiratma, B., 2019, The recap has just been completed, this is the latest number of victims affected by the disaster in Palu City. Date of access: 26/08/2020. https://www.tribunnews.com/regional/2019/03/01/rekap-baru-dirampungkan-ini-jumlah-terbaru-korban-terdampak-bencana-di-kota-palu
[3]. Kemen. PUPR, 2018, Study of the Palu earthquake, Central Sulawesi Province (Palu, Indonesia: Balitbang Kemen. PUPR RI).
[4]. Bedi, J. S., Vijay, D., Dhaka, P., Singh Gill, J. P., Barbuddhe, S. B., 2021, Emergency preparedness for public health threats, surveillance, modelling & forecasting. Indian J Med Res., 153(3), 287-298.
[5]. Lorenzoni, N., Stühlinger, V., Stummer, H., Raich, M., 2020, Long-term impact of disasters on the public health system: a multi-case analysis. Int J Environ Res Public Health, 17(17), 6251.
[6]. Thornton, R. L., Glover, C. M., Cené, C. W., Glik, D. C., Henderson, J. A., Williams, D. R., 2016, Evaluating strategies for reducing health disparities by addressing the social determinants of health. Health Aff (Millwood), 35(8), 1416-23.
[7]. Patel, S. S., Neylan, J. H., Bavaro, K., Chai, P. R., Goralnick, E., Erickson, T. B., 2022, Chemical, biological, radiological, nuclear, and explosives (CBRNEs) preparedness for sporting event mass gatherings: A systematic review of the literature. Am J Disaster Med., 17(1), 57-74.
[8]. Watson, S. K., Rudge, J. W., Coker, R., 2013, Health systems' "surge capacity": state of the art and priorities for future research. Milbank Q., 91(1), 78-122.
[9]. Wen, J., Wan, C., Ye, Q., Yan, J., Li, W., 2023, Disaster risk reduction, climate change adaptation and their linkages with sustainable development over the past 30 years: a review. Int J Disaster Risk Sci., 14(1), 1–13.
[10]. Ayuningtyas, D., Windiarti, S., Hadi, M. S., Fasrini, U. U., Barinda, S., 2021, Disaster preparedness and mitigation in Indonesia: A narrative review. Iran J Public Health, 50(8), 1536-1546.
[11]. Gougelet, R. M., 2015, Disaster mitigation. Ciottone's Disaster Medicine, 8(2), 160–166.
[12]. Melnychuk, E., Sallade, T. D., Kraus, C. K., 2022, Hospitals as disaster victims: Lessons not learned? J Am Coll Emerg Physicians Open, 3(1), e12632.
[13]. Khirekar, J., Badge, A., Bandre, G. R., Shahu, S., 2023, Disaster preparedness in hospitals. Cureus, 15(12), e50073.
[14]. Anselmi, L., Lagarde, M., Hanson, K., 2018, The efficiency of the local health systems: investigating the roles of health administrations and health care providers. Health Econ Policy Law, 13(1), 10-32.
[15]. Ikonen, H., Jylhä, V., Kuusisto, H., 2022, Lack of human resources leads to breaches in information management processes. Stud Health Technol Inform., 294, 159-163.
[16]. Marlina, H., Ruslanjari, D., Hakim, I. B. A., 2024, Disaster risk financing and insurance for earthquake-prone state buildings in Indonesia. Jamba, 16(1), 1597.
[17]. Finucane, M. L., Acosta, J., Wicker, A., Whipkey, K., 2020, Short-term solutions to a long-term challenge: rethinking disaster recovery planning to reduce vulnerabilities and inequities. Int J Environ Res Public Health, 17(2):482.
[18]. Denis, J. L., Usher, S., 2017, Governance must dive into organizations to make a real difference comment on "governance, government, and the search for new provider models". Int J Health Policy Manag., 6(1), 49-51.
[19]. Chan, S. W., Abid, S. K., Sulaiman, N., Nazir, U., Azam, K., 2022, A systematic review of the flood vulnerability using geographic information system. Heliyon, 8(3), e09075.
[20]. Engle, R. L., Mohr, D. C., Holmes, S. K., Seibert, M. N., Afable, M., Leyson, J., Meterko, M., 2021, Evidence-based practice and patient-centered care: Doing both well. Health Care Manage Rev., 46(3), 174-184.
[21]. Adabanya, U., Awosika, A., Moon, J. H., Reddy, Y. U., Ugwuja, F., 2023, Changing a community: a holistic view of the fundamental human needs and their public health impacts. Cureus, 15(8), e44023.
[22]. Zukowski, R. S., 2014, The impact of adaptive capacity on disaster response and recovery: evidence supporting core community capabilities. Prehosp Disaster Med., 29(4), 380-387.
[23]. Haksama, S., Meilano, I., Sunarti, E., Pratama, C., Lusno, M. F. D., Sunarto, Sriram, S., Shedyta, S. Z., Prayoga, D., Zeinsar, S. R., Mamun, A. A., Aji, R. A. R. R., Nugroho, H. S. W., 2024, Availability of human resources as a determinant of health service quality in multihazard disasters in Palu City, Indonesia. Texila International Journal of Public Health, 12(4), 1-6.
[24]. Sunarto, Nugroho, H. S. W., Suparji, Rahayu, T. P., Handayani, T. H., Haksana, S., 2024, Participatory action research to realize disaster health crisis preparedness in the community. Texila International Journal of Public Health, 12(4), 1-12.
[25]. Kadoya, K., Yamato, Y., Hayashida, K., Yoshida, M., Shen, Z., 2024, Improvement awareness of disaster management using virtual reality-based tsunami disaster drills. Disaster Advances, 17(3), 1-7.
[26]. Rizal, J., Fauzi, Y., Yosmar, S., Gunawan, A. Y., Karuna, E. E., 2024, Dependence modeling for tsunami and earthquake disasters in the Indonesian megathrust zones using copula models. Disaster Advances, 17(11), 14-25.
[27]. Wibowo, A., Rohman, N., Rusdah, Achadi, A. H., Amri, I., 2024, Clustering Indonesian provinces by disaster intensity using K-means algorithm: a data mining approach. Diaster Advances, 17(12), 1-8.
Viewed PDF 29 0 -
Deciphering the Role of Kruppel-like Factor 9 in Sepsis and Immunity: Perspectives from Joint Collective Omics Data and a Literature ReviewAuthor: Basirudeen Syed Ahamed KabeerDOI: 10.21522/TIJPH.2013.13.01.Art092
Deciphering the Role of Kruppel-like Factor 9 in Sepsis and Immunity: Perspectives from Joint Collective Omics Data and a Literature Review
Abstract:
Publicly available transcriptome profiling data show that the abundance of Kruppel-like factor 9 (KLF9) transcripts is elevated in neutrophils exposed to the plasma of septic patients. KLF9 is a transcription factor involved in regulating cancer cell proliferation, neurological development and reproduction, but its possible role in sepsis has not been reported in the literature. In the context of this review, further exploration of the public literature and transcriptional profiling records revealed the following: 1) KLF9 transcript abundance is also increased in vivo in patients with sepsis across multiple datasets. 2) KLF9 is one of the few members of the KLF family that can be induced by treatment with the broad-spectrum immune activator PMA/ionomycin. 3) Among other known roles, KLF9 contributes to increased oxidative stress and tissue injury via the repression of the levels of antioxidants such as thioredoxin reductase 2. A similar role can be inferred in neutrophils in the context of sepsis. Taken together, this gene-centric review of omics and bibliographic records identified potential gaps in biomedical knowledge about the role of KLF9 in sepsis and immunity and identified potential avenues for downstream investigation.
Deciphering the Role of Kruppel-like Factor 9 in Sepsis and Immunity: Perspectives from Joint Collective Omics Data and a Literature Review
References:
[1]. Chaussabel, D., Rinchai, D., 2018. Using “collective omics data” for biomedical research training. Immunology. 155, 18-23.
[2]. Khaenam, P., Rinchai, D., Altman, M.C., Chiche, L., Buddhisa, S., Kewcharoenwong, C., et al., 2014. A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients’ plasma. J Transl Med. 12, 65.
[3]. Ley, K., Laudanna, C., Cybulsky, M.I., Nourshargh, S., 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 7, 678-89.
[4]. Phillipson, M., Kubes, P., 2011. The neutrophil in vascular inflammation. Nat Med. 17, 1381-90.
[5]. Singer, M., Deutschman, C.S., Seymour, C.W., Shankar-Hari, M., Annane, D., Bauer, M., et al., 2016. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 315, 801-10.
[6]. Almalki, W.H., Ghoneim, M.M., Alshehri, S., Imam, S.S., Kazmi, I., Gupta, G., 2022. Sepsis triggered oxidative stress-inflammatory axis: The pathobiology of reprogramming in the normal sleep-wake cycle. Mol Cell Biochem. 477, 2203–2211.
[7]. Malavika, M., Sanju, S., Poorna, M.R., Vishnu Priya, V., Sidharthan, N., Varma, P., Mony, U., 2022. Role of myeloid-derived suppressor cells in sepsis. Int Immunopharmacol. 104, 108452.
[8]. Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J., Pinsky, M.R., 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 29, 1303-10.
[9]. Seyoum, K., Sahiledengle, B., Kene, C., Geta, G., Gomora, D., Ejigu, N., Mesfin, T., Kumar Chattu, V., 2023. Determinants of neonatal sepsis among neonates admitted to neonatal intensive care units in Ethiopian hospitals: A systematic review and meta-analysis. Heliyon. 9, e20336.
[10]. Dang, D.T., Pevsner, J., Yang, V.W., 2000. The biology of the mammalian Krüppel-like family of transcription factors. Int J Biochem Cell Biol. 32, 1103-21.
[11]. McConnell, B.B., Yang, V.W., 2010. Mammalian Krüppel-like factors in health and diseases. Physiol Rev. 90, 1337-81.
[12]. Suske, G., Bruford, E., Philipsen, S., 2005. Mammalian SP/KLF transcription factors: bring in the family. Genomics. 85, 551-6.
[13]. Li, Y., Sun, Q., Jiang, M., Li, S., Zhang, J., Xu, Z., et al., 2019. KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28. FASEB J Off Publ Fed Am Soc Exp Biol. 33, 7915-28.
[14]. Bai, X.Y., Li, S., Wang, M., Li, X., Yang, Y., Xu, Z., et al., 2018. Krüppel-like factor 9 down-regulates matrix metalloproteinase 9 transcription and suppresses human breast cancer invasion. Cancer Lett. 412, 224-35.
[15]. Li, J.Z., Li, J., Wang, H.Q., Li, X., Wen, B., Wang, Y.J., 2017. MiR-141-3p promotes prostate cancer cell proliferation through inhibiting Krüppel-like factor-9 expression. Biochem Biophys Res Commun. 482, 1381-6.
[16]. Shen, P., Sun, J., Xu, G., Zhang, L., Yang, Z., Xia, S., et al., 2014. KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells. The Prostate. 74, 946-58.
[17]. Ying, M., Sang, Y., Li, Y., Guerrero-Cazares, H., Quinones-Hinojosa, A., Vescovi, A.L., et al., 2011. Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells. Stem Cells Dayt Ohio. 29, 20-31.
[18]. Sun, J., Wang, B., Liu, Y., Zhang, L., Ma, A., Yang, Z., et al., 2014. Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression. Cancer Lett. 355, 25-33.
[19]. Brown, A.R., Simmen, R.C.M., Raj, V.R., Van, T.T., MacLeod, S.L., Simmen, F.A., 2015. Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling. Carcinogenesis. 36, 946-55.
[20]. Tsukahara, T., Yamagishi, S., Matsuda, Y., Haniu, H., 2017. Lysophosphatidic acid signaling regulates the KLF9-PPARγ axis in human induced pluripotent stem cell-derived neurons. Biochem Biophys Res Commun. 491, 223-7.
[21]. Denver, R.J., Ouellet, L., Furling, D., Kobayashi, A., Fujii-Kuriyama, Y., Puymirat, J., 1999. Basic transcription element-binding protein (BTEB) is a thyroid hormone-regulated gene in the developing central nervous system. Evidence for a role in neurite outgrowth. J Biol Chem. 274, 23128-34.
[22]. Cayrou, C., Denver, R.J., Puymirat, J., 2002. Suppression of the basic transcription element-binding protein in brain neuronal cultures inhibits thyroid hormone-induced neurite branching. Endocrinology. 143, 2242-9.
[23]. Bonett, R.M., Hu, F., Bagamasbad, P., Denver, R.J., 2009. Stressor and glucocorticoid-dependent induction of the immediate early gene Krüppel-like factor 9: implications for neural development and plasticity. Endocrinology. 150, 1757-65.
[24]. Apara, A., Galvao, J., Wang, Y., Blackmore, M., Trillo, A., Iwao, K., et al., 2017. KLF9 and JNK3 interact to suppress axon regeneration in the adult CNS. J Neurosci Off J Soc Neurosci. 37, 9632-44.
[25]. Trakhtenberg, E.F., Li, Y., Feng, Q., Tso, J., Rosenberg, P.A., Goldberg, J.L., et al., 2018. Zinc chelation and KLF9 knockdown cooperatively promote axon regeneration after optic nerve injury. Exp Neurol. 300, 22-9.
[26]. Cui, A., Fan, H., Zhang, Y., Zhang, Y., Niu, D., Liu, S., et al., 2019. Dexamethasone-induced Krüppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia. J Clin Invest. 129, 2266-78.
[27]. Zhang, X.L., Zhang, D., Michel, F.J., Blum, J.L., Simmen, F.A., Simmen, R.C.M., 2003. Selective interactions of Krüppel-like factor 9/basic transcription element-binding protein with progesterone receptor isoforms A and B determine transcriptional activity of progesterone-responsive genes in endometrial epithelial cells. J Biol Chem. 278, 21474-82.
[28]. Zhang, D., Zhang, X.L., Michel, F.J., Blum, J.L., Simmen, F.A., Simmen, R.C.M., 2002. Direct interaction of the Krüppel-like family (KLF) member, BTEB1, and PR mediates progesterone-responsive gene expression in endometrial epithelial cells. Endocrinology. 143, 62-73.
[29]. Denver, R.J., Williamson, K.E., 2009. Identification of a thyroid hormone response element in the mouse Krüppel-like factor 9 gene to explain its postnatal expression in the brain. Endocrinology. 150, 3935-43.
[30]. Hu, F., Knoedler, J.R., Denver, R.J., 2016. A mechanism to enhance cellular responsivity to hormone action: Krüppel-like factor 9 promotes thyroid hormone receptor-β autoinduction during postembryonic brain development. Endocrinology. 157, 1683-93.
[31]. Avci, H.X., Lebrun, C., Wehrlé, R., Doulazmi, M., Chatonnet, F., Morel, M.P., et al., 2012. Thyroid hormone triggers the developmental loss of axonal regenerative capacity via thyroid hormone receptor α1 and Krüppel-like factor 9 in Purkinje cells. Proc Natl Acad Sci U S A. 109, 14206-11.
[32]. Zhang, Y., Xue, Y., Cao, C., Huang, J., Hong, Q., Hai, T., et al., 2017. Thyroid hormone regulates hematopoiesis via the TR-KLF9 axis. Blood. 130, 2161-70.
[33]. Velarde, M.C., Geng, Y., Eason, R.R., Simmen, F.A., Simmen, R.C.M., 2005. Null mutation of Krüppel-like factor9/basic transcription element binding protein-1 alters peri-implantation uterine development in mice. Biol Reprod. 73, 472-81.
[34]. Simmen, R.C.M., Eason, R.R., McQuown, J.R., Linz, A.L., Kang, T.J., Chatman, L., et al., 2004. Subfertility, uterine hypoplasia, and partial progesterone resistance in mice lacking the Krüppel-like factor 9/basic transcription element-binding protein-1 (BTEB1) gene. J Biol Chem. 279, 29286-94.
[35]. Pabona, J.M.P., Zhang, D., Ginsburg, D.S., Simmen, F.A., Simmen, R.C.M., 2015. Prolonged pregnancy in women is associated with attenuated myometrial expression of progesterone receptor co-regulator Krüppel-like Factor 9. J Clin Endocrinol Metab. 100, 166-74.
[36]. Zeng, Z., Velarde, M.C., Simmen, F.A., Simmen, R.C.M., 2008. Delayed parturition and altered myometrial progesterone receptor isoform A expression in mice null for Krüppel-like factor 9. Biol Reprod. 78, 1029-37.
[37]. Zhong, Z., Zhou, F., Wang, D., Wu, M., Zhou, W., Zou, Y., et al., 2018. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines. Oncol Rep. 40, 3852-60.
[38]. Zucker, S.N., Fink, E.E., Bagati, A., Mannava, S., Bianchi-Smiraglia, A., Bogner, P.N., et al., 2014. Nrf2 amplifies oxidative stress via induction of KLF9. Mol Cell. 53, 916-28.
[39]. Yang, D., Lv, Z., Zhang, H., Liu, B., Jiang, H., Tan, X., et al., 2017. Activation of the Nrf2 signaling pathway involving KLF9 plays a critical role in allicin resisting against arsenic trioxide-induced hepatotoxicity in rats. Biol Trace Elem Res. 176, 192-200.
[40]. Parga, J.A., Rodriguez-Perez, A.I., Garcia-Garrote, M., Rodriguez-Pallares, J., Labandeira-Garcia, J.L., 2018. Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells. Free Radic Biol Med. 129, 394-406.
[41]. Mannava, S., Zhuang, D., Nair, J.R., Bansal, R., Wawrzyniak, J.A., Zucker, S.N., et al., 2012. KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells. Blood. 119, 1450-8.
[42]. Pankla, R., Buddhisa, S., Berry, M., Blankenship, D.M., Bancroft, G.J., Banchereau, J., et al., 2009. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol. 10, R127.
[43]. Smith, C.L., Dickinson, P., Forster, T., Craigon, M., Ross, A., Khondoker, M.R., et al., 2014. Identification of a human neonatal immune-metabolic network associated with bacterial infection. Nat Commun. 5, 4649.
[44]. Banchereau, R., Jordan-Villegas, A., Ardura, M., Mejias, A., Baldwin, N., Xu, H., et al., 2012. Host immune transcriptional profiles reflect the variability in clinical disease manifestations in patients with Staphylococcus aureus infections. PloS One. 7, e34390.
[45]. Parnell, G.P., Tang, B.M., Nalos, M., Armstrong, N.J., Huang, S.J., Booth, D.R., et al., 2013. Identifying key regulatory genes in the whole blood of septic patients to monitor underlying immune dysfunctions. Shock Augusta Ga. 40, 166-74.
[46]. GSE29536_KLF9 [Internet]. Available from: http://cd2k.gxbsidra.org/dm3/miniURL/view/Mb
[47]. Pascual, V., Allantaz, F., Patel, P., Palucka, A.K., Chaussabel, D., Banchereau, J., 2008. How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets. Immunol Rev. 223, 39-59.
[48]. GSE71730_KLF9 [Internet]. Available from: http://sepsis.gxbsidra.org/dm3/miniURL/view/Ow
[49]. Gurram, B., Salzman, N.H., Kaldunski, M.L., Jia, S., Li, B.U.K., Stephens, M., et al., 2016. Plasma-induced signatures reveal an extracellular milieu possessing an immunoregulatory bias in treatment-naive pediatric inflammatory bowel disease. Clin Exp Immunol. 184, 36-49.
[50]. GSE35713_KLF9 [Internet]. Available from: http://sepsis.gxbsidra.org/dm3/miniURL/view/Oy
[51]. GSE35725_KLF9 [Internet]. Available from: http://sepsis.gxbsidra.org/dm3/miniURL/view/Ox
[52]. Chen, Y.G., Cabrera, S.M., Jia, S., Kaldunski, M.L., Kramer, J., Cheong, S., et al., 2014. Molecular signatures differentiate immune states in type 1 diabetic families. Diabetes. 63, 3960-73.
[53]. Chinenov, Y., Coppo, M., Gupte, R., Sacta, M.A., Rogatsky, I., 2014. Glucocorticoid receptor coordinates transcription factor-dominated regulatory network in macrophages. BMC Genomics. 15, 656.
[54]. Heard, M.E., Melnyk, S.B., Simmen, F.A., Yang, Y., Pabona, J.M.P., Simmen, R.C.M., 2016. High-fat diet promotion of endometriosis in an immunocompetent mouse model is associated with altered peripheral and ectopic lesion redox and inflammatory status. Endocrinology. 157, 2870-82.
[55]. Yu, Y., Li, C., Wang, Y., Wang, Q., Wang, S., Wei, S., et al., 2019. Molecular cloning and characterization of grouper Krüppel-like factor 9 gene: involvement in the fish immune response to viral infection. Fish Shellfish Immunol. 89, 677-86.
[56]. GSE60424_KLFs [Internet]. Available from: http://sepsis.gxbsidra.org/dm3/miniURL/view/Oz
[57]. Linsley, P.S., Speake, C., Whalen, E., Chaussabel, D., 2014. Copy number loss of the interferon gene cluster in melanomas is linked to reduced T cell infiltrate and poor patient prognosis. PloS One. 9, e109760.
[58]. Feinberg, M.W., Wara, A.K., Cao, Z., Lebedeva, M.A., Rosenbauer, F., Iwasaki, H., et al., 2007. The Krüppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J. 26, 4138-48.
[59]. Karpurapu, M., Ranjan, R., Deng, J., Chung, S., Lee, Y.G., Xiao, L., et al., 2014. Krüppel-like factor 4 promoter undergoes active demethylation during monocyte/macrophage differentiation. PloS One. 9, e93362.
[60]. Terry, R.L., Miller, S.D., 2014. Molecular control of monocyte development. Cell Immunol. 291, 16-21.
[61]. Goodman, W.A., Omenetti, S., Date, D., Di Martino, L., De Salvo, C., Kim, G.D., et al., 2016. KLF6 contributes to myeloid cell plasticity in the pathogenesis of intestinal inflammation. Mucosal Immunol. 9, 1250-62.
[62]. Kim, G.D., Das, R., Goduni, L., McClellan, S., Hazlett, L.D., Mahabeleshwar, G.H., 2016. Krüppel-like factor 6 promotes macrophage-mediated inflammation by suppressing B cell leukemia/lymphoma 6 expression. J Biol Chem. 291, 21271-82.
[63]. Kwon, S.J., Crespo-Barreto, J., Zhang, W., Wang, T., Kim, D.S., Krensky, A., et al., 2014. KLF13 cooperates with c-Maf to regulate IL-4 expression in CD4+ T cells. J Immunol Baltim Md 1950. 192, 5703-9.
[64]. Zhou, M., McPherson, L., Feng, D., Song, A., Dong, C., Lyu, S.C., et al., 2007. Krüppel-like transcription factor 13 regulates T lymphocyte survival in vivo. J Immunol Baltim Md 1950. 178, 5496-504.
[65]. Turchinovich, G., Vu, T.T., Frommer, F., Kranich, J., Schmid, S., Alles, M., et al., 2011. Programming of marginal zone B-cell fate by basic Krüppel-like factor (BKLF/KLF3). Blood. 117, 3780-92.
[66]. Vu, T.T., Gatto, D., Turner, V., Funnell, A.P.W., Mak, K.S., Norton, L.J., et al., 2011. Impaired B cell development in the absence of Krüppel-like factor 3. J Immunol Baltim Md 1950. 187, 5032-42.
[67]. GSE49755_KLFs [Internet]. Available from: http://sepsis.gxbsidra.org/dm3/miniURL/view/PV
[68]. GSE60424_KLF9 [Internet]. Available from: http://sepsis.gxbsidra.org/dm3/miniURL/view/PW
[69]. Wang, L., Brooks, A.N., Fan, J., Wan, Y., Gambe, R., Li, S., et al., 2016. Transcriptomic characterization of SF3B1 mutation reveals its pleiotropic effects in chronic lymphocytic leukemia. Cancer Cell. 30, 750-63.
[70]. Obermoser, G., Presnell, S., Domico, K., Xu, H., Wang, Y., Anguiano, E., et al., 2013. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity. 38, 831-44.
[71]. Alsina, L., Israelsson, E., Altman, M.C., Dang, K.K., Ghandil, P., Israel, L., et al., 2014. A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4. Nat Immunol. 15, 1134-42.
[72]. GSE25742_KLF9 [Internet]. Available from: http://cd2k.gxbsidra.org/dm3/miniURL/view/MX
[73]. GSE30101_KLF9 [Internet]. Available from: http://sepsis.gxbsidra.org/dm3/miniURL/view/PE
[74]. GSE25742_IL2 [Internet]. Available from: http://cd2k.gxbsidra.org/dm3/miniURL/view/MY
[75]. GSE25742_IL4 [Internet]. Available from: http://cd2k.gxbsidra.org/dm3/miniURL/view/MZ
[76]. GSE25742_IFNG [Internet]. Available from: http://cd2k.gxbsidra.org/dm3/miniURL/view/MZ
[77]. GSE25742_PRF1 [Internet]. Available from: http://cd2k.gxbsidra.org/dm3/miniURL/view/Ma
[78]. GSE44721_KLF9 [Internet]. Available from: http://monocyte.gxbsidra.org/dm3/miniURL/view/OO
[79]. Banchereau, R., Baldwin, N., Cepika, A.M., Athale, S., Xue, Y., Yu, C.I., et al., 2014. Transcriptional specialization of human dendritic cell subsets in response to microbial vaccines. Nat Commun. 5, 5283.
[80]. Godini, R., Fallahi, H., Ebrahimie, E., 2018. Network analysis of inflammatory responses to sepsis by neutrophils and peripheral blood mononuclear cells. PloS One. 13, e0201674.
[81]. McDunn, J.E., Turnbull, I.R., Polpitiya, A.D., Tong, A., MacMillan, S.K., Osborne, D.F., et al., 2006. Splenic CD4+ T cells have a distinct transcriptional response six hours after the onset of sepsis. J Am Coll Surg. 203, 365-75.
[82]. Lambeth, J.D., 2004. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol. 4, 181-9.
[83]. Dupré-Crochet, S., Erard, M., Nüsse, O., 2013. ROS production in phagocytes: why, when, and where? J Leukoc Biol. 94, 657-70.
[84]. Nathan, C., 2006. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 6, 173-82.
[85]. Gu, Y., Wu, Y.B., Wang, L.H., Yin, J.N., 2015. Involvement of Krüppel-like factor 9 in bleomycin-induced pulmonary toxicity. Mol Med Rep. 12, 5262-6.
[86]. Bagati, A., Moparthy, S., Fink, E.E., Bianchi-Smiraglia, A., Yun, D.H., Kolesnikova, M., et al., 2019. KLF9-dependent ROS regulate melanoma progression in stage-specific manner. Oncogene. 38, 3585-97.
[87]. Bagheri-Yarmand, R., Sinha, K.M., Li, L., Lu, Y., Cote, G.J., Sherman, S.I., et al., 2019. Combinations of tyrosine kinase inhibitor and ERAD inhibitor promote oxidative stress-induced apoptosis through ATF4 and KLF9 in medullary thyroid cancer. Mol Cancer Res MCR. 17, 751-60.
[88]. Yan, Q., He, B., Hao, G., Liu, Z., Tang, J., Fu, Q., et al., 2019. KLF9 aggravates ischemic injury in cardiomyocytes through augmenting oxidative stress. Life Sci. 233, 116641.
[89]. GSE49755_NRF2 [Internet]. Available from: http://sepsis.gxbsidra.org/dm3/miniURL/view/PD
[90]. Imataka, H., Nakayama, K., Yasumoto, K., Mizuno, A., Fujii-Kuriyama, Y., Hayami, M., 1994. Cell-specific translational control of transcription factor BTEB expression. The role of an upstream AUG in the 5’-untranslated region. J Biol Chem. 269, 20668-73.
[91]. Arnér, E.S.J., 2009. Focus on mammalian thioredoxin reductases--important selenoproteins with versatile functions. Biochim Biophys Acta. 1790, 495-526.
[92]. GSE49757_KLF9_By Severity.
[93]. Thimmulappa, R.K., Fuchs, R.J., Malhotra, D., Scollick, C., Traore, K., Bream, J.H., et al., 2007. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils. Antioxid Redox Signal. 9, 1963-70.
Viewed PDF 29 2 -
Comparison of the Acromio Axillosuprasternal Notch Index with Ratio of Height to Thyromental Distance and Mallampati Classification for the Anticipation of Difficult Intubation in Apparently Normal PatientsAuthor: Maghimaa MDOI: 10.21522/TIJPH.2013.13.01.Art093
Comparison of the Acromio Axillosuprasternal Notch Index with Ratio of Height to Thyromental Distance and Mallampati Classification for the Anticipation of Difficult Intubation in Apparently Normal Patients
Abstract:
Airway management is crucial in anaesthesia, with difficult intubation posing risks. The Acromio Axillo acromio-axillo-suprasternal notch Index (AASI) has shown promise in predicting difficult airways. This study compares AASI with height to thyromental distance ratio and Mallampati classification in anticipating difficult intubation. A prospective observational study at Saveetha Medical College & Hospital assessed 60 patients from September 2023 to August 2023. Inclusion criteria were ages 18-60 and consent for elective surgery under general anesthesia. Exclusions included distorted head and neck anatomy, mouth opening < 3 cm, obesity, sleep apnea, pregnancy, or refusal. Measurements utilized a Thyromental scale. Participants (n=60) had a mean age of 35.021 years, with 45% males and 55% females. The mean BMI was 31.182. Most were ASA class 2 (66.6%) and MMP grade 2 (46.6%). AASI >0.5 was seen in 76.6% of participants. CL Grade distribution showed 33.3% in Grade 1 and 73.3% in Grades 1 and 2 combined. AASI emerged as a superior predictor for Difficult Visualization of the Larynx (DVL), surpassing MMP and TMD. Its heightened sensitivity makes it an effective screening tool, complementing existing methods. Further studies are needed to validate these findings and assess AASI's applicability across diverse patient populations. Integrating AASI into routine clinical practice may enhance patient outcomes by enabling proactive airway management strategies in high-risk individuals.
Comparison of the Acromio Axillosuprasternal Notch Index with Ratio of Height to Thyromental Distance and Mallampati Classification for the Anticipation of Difficult Intubation in Apparently Normal Patients
References:
[1]. Venkatalakshmana, S. K., Kaaviya, R., 2024. Enhancing Airway Management: A Comparative Study of Macintosh and TAS Scope in Difficult Intubations. J Pharm Bioallied Sci, 16, S2205.
[2]. Avva, U., Lata, J. M., Kiel, J., 2024. Airway Management. StatPearls. Treasure Island (FL): StatPearls Publishing.
[3]. Crawley, S. M., Dalton, A. J., 2015, Predicting the difficult airway. BJA Educ, 15, 253–258.
[4]. Apfelbaum, J. L., Hagberg, C. A., Connis, R. T., Abdelmalak, B. B., Agarkar, M., Dutton, R. P., et al., 2022. American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway*. Anesthesiology, 136, 31–81.
[5]. Divatia, J., Bhowmic., 2005. Complications of endotracheal intubation and other airway management procedures. Indian J Anaesth, 49, 308–318.
[6]. Rajkhowa, T., Saikia, P., Das, D., 2018. An observational prospective study of performance of acromioaxillosuprasternal notch index in predicting difficult visualisation of the larynx. Indian J Anaesth, 62, 945–950.
[7]. Alanazi, A., 2015. Intubations and airway management: An overview of Hassles through third millennium. J Emerg Trauma Shock, 8, 99–107.
[8]. 8. Ravindran, B., 2023. Innovations in the Management of the Difficult Airway: A Narrative Review. Cureus, 15(2), e35117.
[9]. Kamranmanesh, M. R., Jafari, A. R., Gharaei, B., Aghamohammadi, H., Poor Zamany, N. K. M., Kashi, A. H., 2015. Comparison of acromioaxillosuprasternal notch index (a new test) with modified Mallampati test in predicting difficult visualization of larynx. Acta Anaesthesiol Taiwan, 51, 141–144.
[10]. Ezri, T., Gewürtz, G., Sessler, D. I., Medalion, B., Szmuk, P., Hagberg, C., 2003. Prediction of difficult laryngoscopy in obese patients by ultrasound quantification of anterior neck soft tissue. Anaesthesia, 58, 1111–1114.
[11]. Hillman, D. R., Platt, P. R., Eastwood, P. R., 2003. The upper airway during anaesthesia. Br J Anaesth, 91, 31–39.
[12]. Nasr-Esfahani, M., Honarmand, A., Safavi, S. M., Anvari Tafti, M., 2020. How to Predict Difficult Tracheal Intubation: The Application of Acromio-axillo-suprasternal Notch Index. Adv Biomed Res, 9, 19.
[13]. Stutz, E. W., Rondeau, B., 2024. Mallampati Score. StatPearls. Treasure Island (FL): StatPearls Publishing.
[14]. Mallhi, A. I., Abbas, N., Naqvi, S. M. N., Murtaza, G., Rafique, M., Alam, S. S., 2018. A comparison of Mallampati classification, thyromental distance and a combination of both to predict difficult intubation. Anaesth Pain Intensive Care, 22.
[15]. Merah, N. A., Foulkes-Crabbe, D. J. O., Kushimo, O. T., Ajayi, P. A., 2004. Prediction of difficult laryngoscopy in a population of Nigerian obstetric patients. West Afr J Med, 23, 38–41.
[16]. Merola, R., Troise, S., Palumbo, D., D’Auria, D., Dell’Aversana Orabona, G., Vargas, M., 2024. Airway management in patients undergoing maxillofacial surgery: State of art review. J Stomatol Oral Maxillofac Surg, 102044.
[17]. Shahzan, M. S., Gounder, R., Ganapathy, D., 2019. Assessment of buccal vestibular depth among completely edentulous patients. Drug Invent Today, 11, 256–258.
[18]. Antony, M., & Mohanraj, K. G., 2019. Sex determination using geometric dimensions of greater sciatic notch and subpubic angle of human pelvic bone: A morphometric study. Drug Invention Today, 12(10).
[19]. Jaganathan, R., Vishnuvanditha, V., Selvankumar, T. 2024. Control of Multidrug-Resistant Hospitalized Pathogenic Bacteria Using the Secondary Metabolites of Calotropis procera and In-silico Analysis of Bacterial Virulent Proteins. Texila International Journal of Public Health. DOI: 10.21522/TIJPH.2013.SE.24.05.Art036
[20]. Safavi, M., Honarmand, A., Hirmanpour, A., Zareian, N., 2016. Acromio-axillo-suprasternal notch index: a new screening test to predict difficult laryngoscopy in obstetric patients scheduled for caesarean delivery. Eur J Anaesthesiol, 33, 596–598.
[21]. Kamranmanesh, M. R., Jafari, A. R., Gharaei, B., 2013. Aghamohammadi, H, Poor Zamany, N K. M, Kashi, A. H. Comparison of acromioaxillosuprasternal notch index (a new test) with modified Mallampati test in predicting difficult visualization of larynx. Acta Anaesthesiol Taiwanica Off J Taiwan Soc Anesthesiol, 51, 141–144.
[22]. Honarmand, A., Kheirabadi, D., Safavi, M. R., Taghaei, M., Golshani Nasab, M., 2019. Comparison of the acromio-axillosuprasternal notch index with five anatomical indices for the prediction of difficult laryngoscopy and intubation. Eur J Anaesthesiol, 36, 542–544.
[23]. Saritha, P., Arunprakash, S., Srinivasan, P., Selvankumar, T., Aldawood, S., Kim, W., & Song, K. S., 2024, Synthesis of Luminescent Copper Nanoparticles Using Couroupita guianensis Flower Extract: Evaluation of Antibacterial and Anticancer Activities. Luminescence, 39(10), e4913.
[24]. Abareethan, M., Sathiyapriya, R., Pavithra, M. E., Parvathy, S., Thirumalaisamy, R., Selvankumar, T., & Almoallim, H. S., 2024, Biogenic silver nanoparticles from Solanum trilobatum leaf extract and assessing their antioxidant and antimicrobial potential. Chemical Physics Impact, 9, 100771.
[25]. Jaganathan, R., Kumaradhas, P. 2024. Structural insights into Furin enzyme inhibition to block SARS-CoV-2 spike protein cleavage: an in-silico approach. 3 Biotech, 14(9), 213.
[26]. Jaganathan, R., Vishnuvanditha, V., Selvankumar, T. 2024. Control of Multidrug-Resistant Hospitalized Pathogenic Bacteria Using the Secondary Metabolites of Calotropis procera and In-silico Analysis of Bacterial Virulent Proteins. Texila International Journal of Public Health. DOI: 10.21522/TIJPH.2013.SE.24.05.Art036.
Viewed PDF 25 3